PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	de Jong, R; Altare, F; Haagen, IA; Elferink, DG; de Boer, T; Vriesman, PJCV; Kabel, PJ; Draaisma, JMT; van Dissel, JT; Kroon, FP; Casanova, JL; Ottenhoff, THM				de Jong, R; Altare, F; Haagen, IA; Elferink, DG; de Boer, T; Vriesman, PJCV; Kabel, PJ; Draaisma, JMT; van Dissel, JT; Kroon, FP; Casanova, JL; Ottenhoff, THM			Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients	SCIENCE			English	Article							IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; CYTOKINE; RESISTANCE; COMPLEX; CELLS	Interleukin-12 (IL-12) is a cytokine that promotes cell-mediated immunity to intracellular pathogens by inducing type 1 helper T cell (T(H)1) responses and interferon-gamma (IFN-gamma) production. IL-12 binds to high-affinity beta 1/beta 2 heterodimeric IL-12 receptor (IL-12R) complexes on T cell and natural killer cells. Three unrelated individuals with severe, idiopathic mycobacterial and Salmonella infections were found to lack IL-12R beta 1 chain expression. Their cells were deficient in IL-12R signaling and IFN-gamma production, and their remaining T cell responses were independent of endogenous IL-12. IL-12R beta 1 sequence analysis revealed genetic mutations that resulted in premature stop codons in the extracellular domain. The lack of IL-12R beta 1 expression results in a human immunodeficiency and shows the essential role of IL-12 in resistance to infections due to intracellular bacteria.	Leiden Univ, Med Ctr, Dept Immunohematol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Blood Bank, NL-2300 RC Leiden, Netherlands; Hop Necker Enfants Malad, INSERM, U429, F-75743 Paris, France; Univ Hosp Maastricht, Dept Immunol, NL-6202 AZ Maastricht, Netherlands; St Elizabeth Hosp, Dept Med Microbiol & Immunol, NL-5000 AS Tilburg, Netherlands; St Elizabeth Hosp, Dept Pediat, NL-5000 AS Tilburg, Netherlands; Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Maastricht University Medical Centre (MUMC); Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol, POB 9600, NL-2300 RC Leiden, Netherlands.	ihbsecr@euronet.nl	Draaisma, J.M.T./L-4283-2015; altare, frederic/K-8664-2015; Casanova, Jean-Laurent/I-3418-2017	altare, frederic/0000-0002-5077-4616; Casanova, Jean-Laurent/0000-0002-7782-4169				Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Casanova JL, 1996, PEDIATRICS, V98, P774; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; deJong R, 1997, J IMMUNOL, V159, P786; DEJONG R, UNPUB; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Frucht DM, 1996, J IMMUNOL, V157, P411; Gollob JA, 1996, J IMMUNOL, V157, P1886; HENDRZAK JA, 1995, LAB INVEST, V72, P619; Hilkens CMU, 1996, J IMMUNOL, V157, P4316; HOLLAND SM, 1994, NEW ENGL J MED, V330, P1348, DOI 10.1056/NEJM199405123301904; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kohno K, 1997, J IMMUNOL, V158, P1541; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Modlin RL, 1995, RES IMMUNOL, V146, P526, DOI 10.1016/0923-2494(96)83027-6; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Presky DH, 1995, RES IMMUNOL, V146, P439, DOI 10.1016/0923-2494(96)83013-6; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; VANLIER RAW, 1988, EUR J IMMUNOL, V18, P167; Wu CY, 1997, J IMMUNOL, V159, P1658	30	668	680	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1435	1438						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603733				2022-12-28	WOS:000073883400056
J	Nagar, B; Jones, RG; Diefenbach, RJ; Isenman, DE; Rini, JM				Nagar, B; Jones, RG; Diefenbach, RJ; Isenman, DE; Rini, JM			X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2	SCIENCE			English	Article							B-CELL RESPONSE; SEQUENCE ALIGNMENTS; ACQUIRED-IMMUNITY; PROTEIN-STRUCTURE; 3RD COMPONENT; BINDING-SITE; PROGRAM; LYMPHOCYTES; THIOESTER; MODULES	Activation and covalent attachment of complement component C3 to pathogens is the key step in complement-mediated host defense. Additionally, the antigen-bound C3d fragment interacts with complement receptor 2 (CR2; also known as CD21) on B cells and thereby contributes to the initiation of an acquired humoral response. The x-ray crystal structure of human C3d solved at 2.0 angstroms resolution reveals an a-a barrel with the residues responsible for thioester formation and covalent attach ment at one end and an acidic pocket at the other. The structure supports a model whereby the transition of native C3 to its functionally active stale involves the disruption of a complementary domain interface and provides insight into the basis for the interaction between C3d and CR2.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Rini, JM (corresponding author), Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada.		Nagar, Bhushan/C-1297-2010; Jones, Russell/AAC-2861-2022; Jones, Russell Graham/ABD-5261-2021; Diefenbach, Russell J./E-9602-2015	Jones, Russell Graham/0000-0003-2250-4675; Diefenbach, Russell J./0000-0002-8433-4336				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger A. T, 1992, XPLOR 3 1 SYSTEM XRA; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DIEFENBACH RJ, 1995, J IMMUNOL, V154, P2303; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fischer MB, 1996, J IMMUNOL, V157, P549; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GADJEVA M, IN PRESS J IMMNOL; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; ISAAC L, 1992, J BIOL CHEM, V267, P10062; Isaac L, 1998, BIOCHEM J, V329, P705, DOI 10.1042/bj3290705; ISENMAN DE, 1981, BIOCHEMISTRY-US, V20, P4458, DOI 10.1021/bi00518a034; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMBRIS JD, 1985, P NATL ACAD SCI USA, V82, P4235, DOI 10.1073/pnas.82.12.4235; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LAW SKA, 1983, BIOCHEM J, V211, P381, DOI 10.1042/bj2110381; Law SKA, 1997, PROTEIN SCI, V6, P263; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; MOLINA H, 1995, J IMMUNOL, V154, P5426; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1	40	158	181	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1277	1281		10.1126/science.280.5367.1277	http://dx.doi.org/10.1126/science.280.5367.1277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596584				2022-12-28	WOS:000073852500053
J	Beecham, L				Beecham, L			Royal college proposes solutions for medical SRs	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1540	1540						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582163				2022-12-28	WOS:000073707700087
J	Lieberman, DE				Lieberman, DE			Sphenoid shortening and the evolution of modern human cranial shape	NATURE			English	Article							HOMINID FACE; MORPHOLOGY; ONTOGENY; SKULLS; HOMO	Crania of 'anatomically modern' Homo sapiens from the Holocene and Upper Pleistocene epochs differ from those of other Homo taxa, including Neanderthals, by only a few features. These include a globular braincase, a vertical forehead, a dimunitive browridge, a canine fossa and a pronounced chin(1-4). Humans are also unique among mammals in lacking facial projection: the face of the adult H. sapiens Lies almost entirely beneath the anterior cranial fossa, whereas the face in all other adult mammals, including Neanderthals, projects to some extent in front of the braincase. Here I use radiographs and computed tomography to show that many of these unique human features stem partly from a single, ontogenetically early reduction in the length of the sphenoid, the central bone of the cranial base from which the re face grows forward. Sphenoid reduction, through its effects on facial projection and cranial shape, may account for the apparently rapid evolution of modern human cranial form, and suggests that Neanderthals and other archaic Homo should be excluded from H. sapiens.	Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Lieberman, DE (corresponding author), Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA.							Aiello L, 1990, INTRO HUMAN EVOLUTIO; ARENSBURG B, 1990, AM J PHYS ANTHROPOL, V83, P137, DOI 10.1002/ajpa.1330830202; BILSBOROUGH A, 1988, AM J PHYS ANTHROPOL, V76, P61, DOI 10.1002/ajpa.1330760107; BROMAGE TG, 1992, J HUM EVOL, V23, P235, DOI 10.1016/S0047-2484(05)80002-8; BROMAGE TG, 1989, J HUM EVOL, V18, P751, DOI 10.1016/0047-2484(89)90088-2; CORRUCCINI RS, 1992, AM J PHYS ANTHROPOL, V87, P433, DOI 10.1002/ajpa.1330870405; DUTERLOO HS, 1970, AM J ANAT, V127, P357, DOI 10.1002/aja.1001270403; Enlow D. H., 1990, FACIAL GROWTH; ENLOW DH, 1975, MORPHOGENESIS MALFOR, P217; Fant G., 1960, ACOUSTIC THEORY SPEE; Howells W. W., 1989, PEABODY MUSEUM PAPER, V79; KRNGS M, 1997, CELL, V90, P19; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.3.CO;2-7; LIEBERMAN DE, 1995, CURR ANTHROPOL, V36, P159, DOI 10.1086/204348; Lieberman P., 1984, BIOL EVOLUTION LANGU; Lumley M. A, 1982, HOMO ERECTUS PLACE H, P814; MACCAMMON R, 1970, HUMAN GROWTH DEV; RAVOSA MJ, 1991, AM J PHYS ANTHROPOL, V85, P95, DOI 10.1002/ajpa.1330850111; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; SHEA BT, 1985, AM J PHYS ANTHROPOL, V68, P329, DOI 10.1002/ajpa.1330680304; Smith F. H., 1992, CONTINUITY REPLACEME, P157; SPENCER MA, 1995, AM J PHYS ANTHROPOL, V91, P1; Stevens K.N., 1972, HUMAN COMMUNICATION, P51; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; WEIDENREICH FRANZ, 1941, TRANS AMER PHIL SOC, V31, P321; White T.D., 1991, HUMAN OSTEOLOGY	29	112	115	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					158	162		10.1038/30227	http://dx.doi.org/10.1038/30227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZN200	9603517				2022-12-28	WOS:000073619900045
J	Pastan, S; Bailey, J				Pastan, S; Bailey, J			Medical progress - Dialysis therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							AMBULATORY PERITONEAL-DIALYSIS; STAGE RENAL-DISEASE; ANAPHYLACTOID REACTIONS; PATIENT MORTALITY; HEMODIALYSIS; SURVIVAL; MORBIDITY; ACCESS; MEMBRANES; DIALYZERS		Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA	Emory University	Pastan, S (corresponding author), Emory Clin, 25 Prescott St,Suite 4441, Atlanta, GA 30308 USA.		Pastan, Stephen/AAC-6622-2022					ABUELO JG, 1993, SEMIN DIALYSIS, V6, P59, DOI 10.1111/j.1525-139X.1993.tb00257.x; AHMED KR, 1997, NUTR MANAGEMENT RENA, P563; [Anonymous], 1997, AM J KIDNEY DIS S, V30, pS137; BERGSTROM J, 1993, KIDNEY INT, V44, P1048, DOI 10.1038/ki.1993.347; Besarab A, 1996, SEMIN DIALYSIS, V9, pS21; Bloembergen W E, 1996, Adv Ren Replace Ther, V3, P201; BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P177; Bregman H.D.J., 1994, HDB DIALYSIS, V2nd ed., P149; Charra B, 1996, AM J NEPHROL, V16, P35, DOI 10.1159/000168968; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; CHERTOW GM, 1997, NUTR MANAGEMENT RENA, P257; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; CHURCHILL DN, 1995, DIALYSIS MEMBRANES S, P60; CIMOCHOWSKI GE, 1990, NEPHRON, V54, P154, DOI 10.1159/000185837; CONVERSE RL, 1992, J CLIN INVEST, V90, P1657, DOI 10.1172/JCI116037; DAgati V, 1997, J AM SOC NEPHROL, V8, P138; DAUGIRDAS JT, 1985, AM J NEPHROL, V5, P163, DOI 10.1159/000166927; Depner TA., 1991, PRESCRIBING HEMODIAL, V2nd Ed.; DIAMOND SM, 1987, AM J KIDNEY DIS, V9, P3, DOI 10.1016/S0272-6386(87)80155-5; DUMLER F, 1992, AM J KIDNEY DIS, V19, P49, DOI 10.1016/S0272-6386(12)70202-0; Eknoyan G, 1996, SEMIN DIALYSIS, V9, P24, DOI 10.1111/j.1525-139X.1996.tb00897.x; FARIAS MG, 1994, KIDNEY INT, V46, P1392, DOI 10.1038/ki.1994.410; FEIG PU, 1981, NEPHRON, V27, P25, DOI 10.1159/000182015; Feldman HI, 1996, JAMA-J AM MED ASSOC, V276, P620, DOI 10.1001/jama.276.8.620; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Flanigan MJ, 1997, AM J KIDNEY DIS, V29, P383, DOI 10.1016/S0272-6386(97)90199-2; Friedman EA, 1996, JAMA-J AM MED ASSOC, V275, P1118, DOI 10.1001/jama.275.14.1118; Goldie SJ, 1996, AM J KIDNEY DIS, V28, P86, DOI 10.1016/S0272-6386(96)90135-3; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; HAKIM RM, 1984, NEW ENGL J MED, V311, P878, DOI 10.1056/NEJM198410043111403; Hakim RM, 1996, KIDNEY INT, V50, P566, DOI 10.1038/ki.1996.350; HAKIM RM, 1994, NEW ENGL J MED, V331, P1338, DOI 10.1056/NEJM199411173312003; HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272; HELD PJ, 1991, JAMA-J AM MED ASSOC, V265, P871, DOI 10.1001/jama.265.7.871; HELD PJ, 1994, KIDNEY INT, V45, P1163, DOI 10.1038/ki.1994.154; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; HELD PJ, 1987, JAMA-J AM MED ASSOC, V257, P645, DOI 10.1001/jama.257.5.645; HENRICH WL, 1982, AM J KIDNEY DIS, V2, P349, DOI 10.1016/S0272-6386(82)80093-0; HENRICH WL, 1984, NEW ENGL J MED, V310, P19, DOI 10.1056/NEJM198401053100105; Himmelfarb J, 1998, J AM SOC NEPHROL, V9, P257; *HLTH CAR FIN ADM, 1997, 1996 ANN REP ESRD CO, P35; *HLTH CAR FIN ADM, 1997, 1997 ANN REP ESRD CO, P19; Ikizler TA, 1996, KIDNEY INT, V50, P343, DOI 10.1038/ki.1996.323; Indridason O S, 1995, Curr Opin Nephrol Hypertens, V4, P307, DOI 10.1097/00041552-199507000-00004; Ing TS, 1997, AM J KIDNEY DIS, V30, P859; Ismail N, 1996, AM J NEPHROL, V16, P60, DOI 10.1159/000168972; Jacobs C, 1997, NEPHROL DIAL TRANSPL, V12, P38, DOI 10.1093/ndt/12.1.38; JOST CMT, 1993, KIDNEY INT, V44, P606, DOI 10.1038/ki.1993.287; Keane WF, 1996, PERITON DIALYSIS INT, V16, P557; LAZARUS JM, 1994, AM J KIDNEY DIS, V24, P1019, DOI 10.1016/S0272-6386(12)81077-8; Levin A, 1996, J AM SOC NEPHROL, V7, P242; LOWRIE EG, 1983, KIDNEY INT, pS1; LYSAGHT MJ, 1989, T AM SOC ART INT ORG, V35, P784; MANN JFE, 1995, NEPHROL DIAL TRANSPL, V10, P80, DOI 10.1093/ndt/10.supp2.80; MARWICK C, 1995, JAMA-J AM MED ASSOC, V273, P10; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; McLaughlin K, 1997, AM J KIDNEY DIS, V29, P553, DOI 10.1016/S0272-6386(97)90337-1; *NAT I DIAB DIG KI, 1995, REN DAT SYST USRDS 1; *NAT I DIAB DIG KI, 1997, REN DAT SYST USRDS 1; NOLPH KD, 1994, PERITON DIALYSIS INT, V14, P261; NOLPH KD, 1996, CURR NEPHRO, V19, P281; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Pascual M, 1996, KIDNEY INT, V49, P309, DOI 10.1038/ki.1996.47; PEGUES DA, 1992, KIDNEY INT, V42, P1232, DOI 10.1038/ki.1992.409; POLLAK VE, 1986, NEPHRON, V42, P217, DOI 10.1159/000183670; RADERMACHER J, 1995, CLIN NEPHROL, V44, pS56; RADOVICH JM, 1995, CONTRIB NEPHROL, V113, P11; Rocco MV, 1996, AM J KIDNEY DIS, V28, P250, DOI 10.1016/S0272-6386(96)90308-X; RODBY RA, 1994, AM J KIDNEY DIS, V23, P401, DOI 10.1016/S0272-6386(12)81003-1; ROSBOROUGH DC, 1993, SEMIN DIALYSIS, V6, P260, DOI 10.1111/j.1525-139X.1993.tb00155.x; Sang GLS, 1997, AM J KIDNEY DIS, V29, P669, DOI 10.1016/S0272-6386(97)90118-9; Scarpioni L, 1996, Perit Dial Int, V16 Suppl 1, pS275; SELGAS R, 1989, PERITON DIALYSIS INT, V9, P329; SLATOPOLSKY E, 1986, NEW ENGL J MED, V315, P157, DOI 10.1056/NEJM198607173150304; STIVELMAN JC, 1995, J AM SOC NEPHROL, V6, P1256; Sukhatme VP, 1996, KIDNEY INT, V49, P1161, DOI 10.1038/ki.1996.167; Tokars JI, 1997, ASAIO J, V43, P108, DOI 10.1097/00002480-199701000-00019; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Twardowski ZJ, 1996, PERITON DIALYSIS INT, V16, pS6; VANSTONE JC, 1980, T AM SOC ART INT ORG, V26, P383; VERRESEN L, 1994, KIDNEY INT, V45, P1497, DOI 10.1038/ki.1994.195; VIGLINO G, 1989, PERITON DIALYSIS INT, V9, P165; Wanten GJA, 1996, PERITON DIALYSIS INT, V16, P352; WING AJ, 1978, BRIT MED J, V2, P853, DOI 10.1136/bmj.2.6141.853; Winston JA, 1996, J AM SOC NEPHROL, V7, P1; 1997, AM J KIDNEY DIS S2, V2, pS1	86	197	202	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1428	1437		10.1056/NEJM199805143382006	http://dx.doi.org/10.1056/NEJM199805143382006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580651				2022-12-28	WOS:000073563700006
J	Moher, D				Moher, D			CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; EMPIRICAL-EVIDENCE; JOURNALS; STANDARDS; STATEMENT; BIAS		Childrens Hosp Eastern Ontario, Res Inst, Dept Pediat, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Dept Med, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Dept Epidemiol, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Dept Community Med, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario	Moher, D (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Dept Pediat, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	107656.3375@compuserve.com		Moher, David/0000-0003-2434-4206				Altman DG, 1997, BRIT MED J, V314, P1127; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; CLARKE M, 1997, 3 INT C BIOM PEER RE; Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007; Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011; Khan KS, 1996, FERTIL STERIL, V65, P939, DOI 10.1016/S0015-0282(16)58265-X; Kleijnen J, 1997, NONRANDOM REFLECTION, P93; LOMUS J, 1991, ANN REV PUBLIC HLTH, V12, P41; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; OToole LB, 1997, BRIT MED J, V314, P1127; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; SONIS J, 1994, J FAM PRACTICE, V39, P225; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; ZELEN M, 1983, J CLIN ONCOL, V1, P164, DOI 10.1200/JCO.1983.1.2.164; 1986, LANCET, V2, P57	24	167	170	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1489	1491		10.1001/jama.279.18.1489	http://dx.doi.org/10.1001/jama.279.18.1489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600488				2022-12-28	WOS:000073463500043
J	Walsh, BW; Kuller, LH; Wild, RA; Paul, S; Farmer, M; Lawrence, JB; Shah, AS; Anderson, PW				Walsh, BW; Kuller, LH; Wild, RA; Paul, S; Farmer, M; Lawrence, JB; Shah, AS; Anderson, PW			Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MYOCARDIAL-INFARCTION; ADJUVANT TAMOXIFEN; LY139481 HCL; PLASMA; CHOLESTEROL; TRIAL; RISK; REPLACEMENT	Context.-Raloxifene is a selective estrogen receptor modulator that has estrogen-agonistic effects on bone and estrogen-antagonistic effects on breast and uterus. Objective.-To identify the effects of raloxifene on markers of cardiovascular risk in postmenopausal women, and to compare them with those induced by hormone replacement therapy (HRT). Design.-Double-blind, randomized, parallel trial. Setting.-Eight sites in the United States. Participants.-390 healthy postmenopausal women recruited by advertisement. Intervention.-Participants were randomized to receive 1 of 4 treatments: raloxifene, 60 mg/d; raloxifene, 120 mg/d; HRT (conjugated equine estrogen, 0.625 mg/d, and medroxyprogesterone acetate, 2.5 mg/d); or placebo. Main Outcome Measures.-Change and percent change from baseline of lipid levels and coagulation parameters after 3 months and 6 months of treatment. Results.-At the last visit completed, compared with placebo, both dosages of raloxifene significantly lowered low-density lipoprotein cholesterol (LDL-C) by 12% (P < .001), similar to the 14% reduction with HRT (P < .001), Both dosages of raloxifene significantly lowered lipoprotein(a) by 7% to 8% (P < .001), less than the 19% decrease with HRT (P < .001). Raloxifene increased high-density lipoprotein-2 cholesterol (HDL2-C) by 15% to 17% (P < .05), less than the 33% increase with HRT (P <.001), Raloxifene did not significantly change high-density lipoprotein cholesterol (HDL-C), triglycerides, or plasminogen activator inhibitor-1 (PAI-1); whereas HRT increased HDL-C by 11% and triglycerides by 20%, and decreased PAI-1 by 29% (for all, P < .001). Raloxifene significantly lowered fibrinogen by 12% to 14% (P < .001), unlike HRT, which had no effect. Neither treatment changed fibrinopeptide A or prothrombin fragment 1 and 2. Conclusions.-Raloxifene favorably alters biochemical markers of cardiovascular risk by decreasing LDL-C, fibrinogen, and lipoprotein(a), and by increasing HDL2-C without raising triglycerides. In contrast to HRT, raloxifene had no effect on HDL-C and PAI-1, and a lesser effect on HDL2-C and lipoprotein(a). Further clinical trials are necessary to determine whether these favorable biochemical effects are associated with protection against cardiovascular disease.	Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Clin Studies, St Petersburg, FL USA	Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; Eli Lilly	Walsh, BW (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.	bwwalsh@bics.bwh.harvard.edu						Anzano MA, 1996, J NATL CANCER I, V88, P123, DOI 10.1093/jnci/88.2.123; Bjarnason NH, 1997, CIRCULATION, V96, P1964, DOI 10.1161/01.CIR.96.6.1964; BLACK LJ, 1994, J CLIN INVEST, V93, P63, DOI 10.1172/JCI116985; BRYANT HU, 1993, J BONE MINER RES, V8, pS123; CAINE YG, 1992, THROMB HAEMOSTASIS, V68, P392; CHMIELEWSKA J, 1986, CLIN CHEM, V32, P482; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; CONSTANTINO JP, 1997, JNCI-J NATL CANCER I, V89, P776; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Draper MW, 1996, J BONE MINER RES, V11, P835; DRAPER MW, 1993, P 4 INT S OST CONS D, P119; GILLINGS D, 1991, DRUG INF J, V25, P411, DOI DOI 10.1177/009286159102500311; Grese TA, 1997, J MED CHEM, V40, P146, DOI 10.1021/jm9606352; GREY AB, 1995, J CLIN ENDOCR METAB, V80, P3191, DOI 10.1210/jc.80.11.3191; JOHANNES CB, 1994, AM J EPIDEMIOL, V140, P439, DOI 10.1093/oxfordjournals.aje.a117266; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Kauffman RF, 1997, J PHARMACOL EXP THER, V280, P146; KAUFFMAN RF, 1995, DRUG NEWS PERSPECT, V8, P531; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Mannucci PM, 1996, ARCH INTERN MED, V156, P1806, DOI 10.1001/archinte.156.16.1806; MARCOVINA SM, 1994, LAB MEASUREMENT LIPI, P239; MCDONALD CC, 1991, BRIT MED J, V303, P435, DOI 10.1136/bmj.303.6800.435; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; PELZER H, 1991, THROMB HAEMOSTASIS, V65, P153; RUTQVIST LE, 1993, J NATL CANCER I, V85, P1398, DOI 10.1093/jnci/85.17.1398; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEWMON DA, 1994, ARTERIOSCLER THROMB, V14, P1586, DOI 10.1161/01.ATV.14.10.1586; SORIA J, 1980, THROMB RES, V20, P425, DOI 10.1016/0049-3848(80)90281-9; STEIN EA, 1994, TIETZ TXB CLIN CHEM, P1085; TRINDER P, 1981, ANN CLIN BIOCHEM, V18, P64, DOI 10.1177/000456328101800202; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; Yang NN, 1996, SCIENCE, V273, P1222, DOI 10.1126/science.273.5279.1222	35	546	564	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1445	1451		10.1001/jama.279.18.1445	http://dx.doi.org/10.1001/jama.279.18.1445			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600478	Bronze			2022-12-28	WOS:000073463500033
J	Chen, ZG; Mitchell, M; Segev, M; Coskun, TH; Christodoulides, DN				Chen, ZG; Mitchell, M; Segev, M; Coskun, TH; Christodoulides, DN			Self-trapping of dark incoherent light beams	SCIENCE			English	Article							PHOTOREFRACTIVE SCREENING SOLITONS; SPATIAL SOLITONS; VORTEX SOLITONS; MEDIA; EVOLUTION; FIELD	"Dark beams" are nonuniform optical beams that contain either a one-dimensional (1D) dark stripe or a two-dimensional (2D) dark hole resulting from a phase singularity or an amplitude depression in their optical field. Thus far, self-trapped dark beams (dark solitons) have been observed using coherent light only. Here, self-trapped dark incoherent light beams (self-trapped dark incoherent wavepackets) were observed. Both dark stripes and dark holes nested in a broad partially spatially incoherent wavefront were self-trapped to form dark solitons in a host photorefractive medium. These self-trapped 1D and 2D dark beams induced refractive-index changes akin to planar and circular dielectric waveguides. The experiments introduce the possibility of controlling high-power coherent laser beams with low-power incoherent light sources such as light emitting diodes.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Ctr Photon & Optoelect Mat, Princeton, NJ 08544 USA; Lehigh Univ, Dept Comp Sci & Elect Engn, Bethlehem, PA 18015 USA	Princeton University; Princeton University; Lehigh University	Chen, ZG (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.		Chen, Zhigang/B-2112-2010	Chen, Zhigang/0000-0001-7050-9943				ALLAN GR, 1991, OPT LETT, V16, P156, DOI 10.1364/OL.16.000156; CASTILLO MDI, 1995, OPT COMMUN, V118, P515, DOI 10.1016/0030-4018(95)00221-S; CASTILLO MDI, 1994, APPL PHYS LETT, V64, P408, DOI 10.1063/1.111163; Chen Z, 1997, PHYS REV LETT, V78, P2948; Chen ZG, 1997, OPT LETT, V22, P1751, DOI 10.1364/OL.22.001751; Chen ZG, 1997, J OPT SOC AM B, V14, P1407, DOI 10.1364/JOSAB.14.001407; Chen ZG, 1996, OPT LETT, V21, P629, DOI 10.1364/OL.21.000629; Christodoulides DN, 1997, PHYS REV LETT, V78, P646, DOI 10.1103/PhysRevLett.78.646; CHRISTODOULIDES DN, 1995, J OPT SOC AM B, V12, P1628, DOI 10.1364/JOSAB.12.001628; Christodoulides DN, 1998, PHYS REV LETT, V80, P2310, DOI 10.1103/PhysRevLett.80.2310; Coskun TH, 1998, OPT LETT, V23, P418, DOI 10.1364/OL.23.000418; DUREE G, 1995, PHYS REV LETT, V74, P1978, DOI 10.1103/PhysRevLett.74.1978; HASEGAWA A, 1977, PHYS FLUIDS, V20, P2155, DOI 10.1063/1.861822; HASEGAWA A, 1975, PHYS FLUIDS, V18, P77, DOI 10.1063/1.860997; HASEGAWA A, 1980, OPT LETT, V5, P416, DOI 10.1364/OL.5.000416; HASEGAWA A, 1997, C PRINC U DEC; Kivshar YS, 1998, PHYS REP, V298, P81, DOI 10.1016/S0370-1573(97)00073-2; KIVSHAR YS, 1993, IEEE J QUANTUM ELECT, V29, P250, DOI 10.1109/3.199266; LUTHERDAVIES B, 1994, OPT LETT, V19, P1816, DOI 10.1364/OL.19.001816; Mamaev AV, 1997, PHYS REV LETT, V78, P2108, DOI 10.1103/PhysRevLett.78.2108; Mitchell M, 1997, NATURE, V387, P880, DOI 10.1038/43079; Mitchell M, 1996, PHYS REV LETT, V77, P490, DOI 10.1103/PhysRevLett.77.490; Mitchell M, 1997, PHYS REV LETT, V79, P4990, DOI 10.1103/PhysRevLett.79.4990; SEGEV M, 1994, PHYS REV LETT, V73, P3211, DOI 10.1103/PhysRevLett.73.3211; Segev M, 1996, J OPT SOC AM B, V13, P706, DOI 10.1364/JOSAB.13.000706; SHIH MF, 1995, ELECTRON LETT, V31, P826, DOI 10.1049/el:19950570; Shih MF, 1996, OPT LETT, V21, P324, DOI 10.1364/OL.21.000324; SINGH SR, 1995, OPT COMMUN, V118, P569, DOI 10.1016/0030-4018(95)00311-U; Singh SR, 1996, OPT COMMUN, V130, P288, DOI 10.1016/0030-4018(96)00288-X; SNYDER AW, 1992, OPT LETT, V17, P789, DOI 10.1364/OL.17.000789; Snyder AW, 1998, PHYS REV LETT, V80, P1422, DOI 10.1103/PhysRevLett.80.1422; SWARTZLANDER GA, 1991, PHYS REV LETT, V66, P1583, DOI 10.1103/PhysRevLett.66.1583; SWARTZLANDER GA, 1992, PHYS REV LETT, V69, P2503, DOI 10.1103/PhysRevLett.69.2503	33	173	189	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					889	892		10.1126/science.280.5365.889	http://dx.doi.org/10.1126/science.280.5365.889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572730				2022-12-28	WOS:000073532900037
J	Aksyuk, V; Balakirev, FF; Boebinger, GS; Gammel, PL; Haddon, RC; Bishop, DJ				Aksyuk, V; Balakirev, FF; Boebinger, GS; Gammel, PL; Haddon, RC; Bishop, DJ			Micromechanical "trampoline" magnetometers for use in large pulsed magnetic fields	SCIENCE			English	Article							KAPPA-(BEDT-TTF)(2)CU(NCS)(2)	A silicon micromechanical magnetometer was constructed and successfully used in 60-tesla pulsed magnetic fields of less than 100-millisecond duration. The device is small, inexpensive to fabricate, and easy to use. It features a fast mechanical response (up to 50,000 hertz) and extremely high sensitivity yet is relatively robust against electrical and mechanical noise. Quantum oscillations in the magnetization of a 1-microgram sam pie of an organic superconductor, K-[bis(ethylenedithio)tetrathiafulvalene](2)Cu(NCS)(2), have been observed with this device.	AT&T Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Nokia Corporation; Nokia Bell Labs; United States Department of Energy (DOE); Los Alamos National Laboratory	Aksyuk, V (corresponding author), AT&T Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Balakirev, Fedor/AAS-6827-2020; Balakirev, Fedor/AAY-2860-2020; Haddon, Robert C/A-2528-2008	Balakirev, Fedor/0000-0003-4887-5140; Balakirev, Fedor/0000-0003-4887-5140; Haddon, Robert C/0000-0002-7903-5139; Aksyuk, Vladimir/0000-0002-9653-4722				BOEBINGER GS, 1994, PHYSICA B, V201, P560, DOI 10.1016/0921-4526(94)91161-4; CAULFIELD J, 1994, J PHYS-CONDENS MAT, V6, P2911, DOI 10.1088/0953-8984/6/15/013; HADDON RC, 1991, PHYS REV B, V43, P2642, DOI 10.1103/PhysRevB.43.2642; HARRISON N, 1995, PHYS REV B, V52, P5584, DOI 10.1103/PhysRevB.52.5584; Harrison N, 1996, J PHYS-CONDENS MAT, V8, P5415, DOI 10.1088/0953-8984/8/29/016; Meyer FA, 1995, EUROPHYS LETT, V32, P681, DOI 10.1209/0295-5075/32/8/011; Naughton MJ, 1997, REV SCI INSTRUM, V68, P4061, DOI 10.1063/1.1148347	7	24	24	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					720	722		10.1126/science.280.5364.720	http://dx.doi.org/10.1126/science.280.5364.720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563944				2022-12-28	WOS:000073415600042
J	Billuart, P; Bienvenu, T; Ronce, N; Des Portes, V; Vinet, MC; Zemni, R; Roest Crollius, H; Carrie, A; Fauchereau, F; Cherry, M; Briault, S; Hamel, B; Fryns, JP; Beldjord, C; Kahn, A; Moraine, C; Chelly, J				Billuart, P; Bienvenu, T; Ronce, N; Des Portes, V; Vinet, MC; Zemni, R; Roest Crollius, H; Carrie, A; Fauchereau, F; Cherry, M; Briault, S; Hamel, B; Fryns, JP; Beldjord, C; Kahn, A; Moraine, C; Chelly, J			Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation	NATURE			English	Article							GRADIENT GEL-ELECTROPHORESIS; MUTATIONS; GTPASES; GENES; RAS	Primary or nonspecific X-linked mental retardation (MRX) is a heterogeneous condition in which affected patients do not have any distinctive clinical or biochemical features in common apart from cognitive impairment(1). Although it is present in approximately 0.15-0.3% of males(2), most of the genetic defects associated with MRX, which may involve more than ten different genes, remain unknown(3). Here we report the characterization of a new gene on the long arm of the X-chromosome (position Xq12) and the identification in unrelated individuals of different mutations that are predicted to cause a loss of function. This gene is highly expressed in fetal brain and encodes a protein of relative molecular mass 91K, named oligophrenin-1, which contains a domain typical of a Rho-GTPase-activating protein (rhoGAP)(4,5). By enhancing their GTPase activity, GAP proteins inactivate small Rho and Pas proteins, so inactivation of rhoGAP proteins might cause constitutive activation of their GTPase targets. Such activation is known to affect cell migration and outgrowth of axons and dendrites in vivo(6-8). Our results demonstrate an association between cognitive impairment and a defect in a signalling pathway that depends on a Ras-like GTPase.	Fac Med Cochin, ICGM, INSERM, U129, F-75014 Paris, France; CHU Tours, Hop Bretonneau, Serv Genet, F-37044 Tours, France; Max Planck Inst Mol Genet, Berlin, Germany; CHU Nancy, Genet Lab, F-54511 Vandoeuvre Les Nancy, France; Univ Nijmegen Hosp, Dept Human Genet 417, NL-6500 HB Nijmegen, Netherlands; Univ Hosp Gasthuisberg, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU Tours; Max Planck Society; CHU de Nancy; Radboud University Nijmegen; KU Leuven; University Hospital Leuven	Chelly, J (corresponding author), Fac Med Cochin, ICGM, INSERM, U129, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	chelly@cochin.inserm.fr	Chelly, Jamel/J-7528-2015; Billuart, Pierre/K-3832-2017	Chelly, Jamel/0000-0002-0939-8719; Billuart, Pierre/0000-0003-1913-1687; ROEST CROLLIUS, Hugues/0000-0002-8209-173X				[Anonymous], 1982, MOL CLONING LAB MANU; Bienvenu T, 1997, EUR J HUM GENET, V5, P105, DOI 10.1159/000484743; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Davies HR, 1997, J MED GENET, V34, P158, DOI 10.1136/jmg.34.2.158; FERNANDEZ E, 1993, PCR METH APPL, V3, P122; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; KEL AE, 1993, COMPUT APPL BIOSCI, V9, P617; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	20	356	364	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	1998	392	6679					923	926		10.1038/31940	http://dx.doi.org/10.1038/31940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582072				2022-12-28	WOS:000073359900049
J	Lefstin, JA; Yamamoto, KR				Lefstin, JA; Yamamoto, KR			Allosteric effects of DNA on transcriptional regulators	NATURE			English	Article							SERUM-RESPONSE-FACTOR; NF-KAPPA-B; BINDING DOMAIN; GLUCOCORTICOID RECEPTOR; CONFORMATIONAL-CHANGES; THYROID-HORMONE; BASIC REGION; CRYSTAL-STRUCTURE; MURINE ETS-1; CO-REPRESSOR	Selective gene transcription is mediated in part by regulatory proteins that bind to DNA response elements. These regulatory proteins receive global information from signal-transduction events. But transcriptional regulators may also be modified in an allosteric manner by response elements themselves to generate the pattern of regulation that is appropriate to an individual gene.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lefstin, JA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	lefstin@stanford.edu						BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P13463, DOI 10.1021/bi00212a011; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cleary MA, 1997, P NATL ACAD SCI USA, V94, P8450, DOI 10.1073/pnas.94.16.8450; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; EBNETH A, 1994, BIOCHEMISTRY-US, V33, P14586, DOI 10.1021/bi00252a026; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HAY RT, 1993, NUCLEIC ACIDS RES, V21, P4592, DOI 10.1093/nar/21.19.4592; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Huang CC, 1996, MOL CELL BIOL, V16, P2967; Ikeda M, 1996, J BIOL CHEM, V271, P23096, DOI 10.1074/jbc.271.38.23096; JAMIN N, 1993, EUR J BIOCHEM, V216, P147, DOI 10.1111/j.1432-1033.1993.tb18126.x; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; KREBS D, 1995, EUR J BIOCHEM, V231, P370, DOI 10.1111/j.1432-1033.1995.tb20709.x; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LEFSTIN JA, 1994, GENE DEV, V8, P2842, DOI 10.1101/gad.8.23.2842; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Luo X, 1996, MOL CELL BIOL, V16, P1367; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; Martin ML, 1996, MOL CELL BIOL, V16, P2110; MATTHEWS JR, 1995, NUCLEIC ACIDS RES, V23, P3393, DOI 10.1093/nar/23.17.3393; MEIERHANS D, 1995, BIOCHEMISTRY-US, V34, P11026, DOI 10.1021/bi00035a008; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P426; Misra V, 1996, MOL CELL BIOL, V16, P4404; Nguyen JT, 1997, NAT STRUCT BIOL, V4, P256, DOI 10.1038/nsb0497-256; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Rahman A, 1995, J BIOL CHEM, V270, P31059, DOI 10.1074/jbc.270.52.31059; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P1310, DOI 10.1021/bi00219a022; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; SHUMAN JD, 1990, SCIENCE, V249, P771, DOI 10.1126/science.2202050; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; TAN S, 1990, CELL, V62, P367, DOI 10.1016/0092-8674(90)90373-M; TomicCanic M, 1996, J BIOL CHEM, V271, P1416, DOI 10.1074/jbc.271.3.1416; TONEY JH, 1993, BIOCHEMISTRY-US, V32, P2, DOI 10.1021/bi00052a001; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; WAGNER S, 1994, CURR OPIN CELL BIOL, V6, P410, DOI 10.1016/0955-0674(94)90034-5; WALKER S, 1994, CELL, V79, P841, DOI 10.1016/0092-8674(94)90073-6; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WERNER MH, 1995, CELL, V83, P761, DOI 10.1016/0092-8674(95)90189-2; YAMAMOTO KR, 1992, TRANSCRIPTIONAL REGU, P1169; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	66	424	432	1	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					885	888		10.1038/31860	http://dx.doi.org/10.1038/31860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582068				2022-12-28	WOS:000073359900037
J	Puri, KD; Chen, SQ; Springer, TA				Puri, KD; Chen, SQ; Springer, TA			Modifying the mechanical property and shear threshold of L-selectin adhesion independently of equilibrium properties	NATURE			English	Article							HYDRODYNAMIC SHEAR; ROLLING ADHESIONS; SIALOMUCIN CD34; P-SELECTIN; LIGAND; FLOW; BOND	Interactions between adhesion molecules on two different cells differ from interactions between receptors and soluble ligands in that the adhesion molecule interaction (bond) is often subjected to force. It is widely assumed by cell biologists that the 'strength' of a bond is a simple function of the affinity of one adhesion molecule for the other, whereas biophysicists suggest that bonds have 'mechanical properties' that affect their strength. Mechanical properties are a function of the shape of the energy landscape related to bond formation and dissociation, whereas affinity is related only to the net energy change(1-5). Mechanical properties determine the amount by which the kinetics and affinity of bonds are altered by applied force. To date there has been no experimental manipulation of an adhesion molecule that has been shown to affect mechanical properties. L-selectin is an adhesion molecule that mediates lymphocyte binding to, and rolling on, high endothelial venules; these are prerequisites for the emigration of lymphocytes from the bloodstream into lymph nodes. Here we report a selective and reversible chemical modification of a mucin-like ligand that alters the mechanical properties of its bond with L-selectin. The effect of force on the rate of bond dissociation, that is, on a mechanical property, is altered, whereas there is little or no effect of the modification on the rate of bond dissociation in the absence of force. Moreover, the puzzling requirement for hydrodynamic shear flow above a threshold level for L-selectin interactions(6-9) is dramatically altered.	Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Springer, TA (corresponding author), Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.							Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bruinsma R, 1997, P NATL ACAD SCI USA, V94, P375, DOI 10.1073/pnas.94.2.375; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DEMBO M, 1994, LECT MATH LIFE SCI, V25, P1; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kyte J., 1995, STRUCTURE PROTEIN CH; LASKY LA, 1992, INFLAMMATION BASIC P, V2, P407; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; LECKBAND D, 1995, BIOPHYS J, V69, P1162, DOI 10.1016/S0006-3495(95)79990-8; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; NORGARD KE, 1993, P NATL ACAD SCI USA, V90, P1068, DOI 10.1073/pnas.90.3.1068; Pierres A, 1996, J PHYS III, V6, P807, DOI 10.1051/jp3:1996156; Puri KD, 1996, J BIOL CHEM, V271, P5404, DOI 10.1074/jbc.271.10.5404; PURI KD, 1995, J CELL BIOL, V131, P261, DOI 10.1083/jcb.131.1.261; Puri KD, 1997, J IMMUNOL, V158, P405; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Taylor AD, 1996, BIOPHYS J, V71, P3488, DOI 10.1016/S0006-3495(96)79544-9	24	63	68	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					930	933		10.1038/31954	http://dx.doi.org/10.1038/31954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582074				2022-12-28	WOS:000073359900051
J	Pantev, C; Oostenveld, R; Engelien, A; Ross, B; Roberts, LE; Hoke, M				Pantev, C; Oostenveld, R; Engelien, A; Ross, B; Roberts, LE; Hoke, M			Increased auditory cortical representation in musicians	NATURE			English	Article							ABSOLUTE PITCH; TONOTOPIC ORGANIZATION; CORTEX; FIELDS; ADULT	Acoustic stimuli are processed throughout the auditory projection pathway including the neocortex, by neurons that are aggregated into 'tonotopic' maps according to their specific frequency tunings(1-3). Research on animals has shown that tonotopic representations are not statically fixed in the adult organism but can reorganize after damage to the cochlea(4) or after training the intact subject to discriminate between auditory stimuli(5). Here we used functional magnetic source imaging (single dipole model) to measure cortical representations int highly skilled musicians. Dipole moments for piano tones, but not for pure tones of similar fundamental frequency (matched in loudness), were found to be enlarged by about 25% in musicians compared with control subjects who had never played an instrument. Enlargement was correlated with the age at which musicians began to practise and did not differ between musicians with absolute or relative pitch. These results, when interpreted with evidence for modified somatosensory representations of the fingering digits in skilled violinists(6), suggest that use-dependent functional reorganization extends across the sensory cortices to reflect the pattern of sensory input processed by the subject during development of musical skill.	Univ Munster, Inst Expt Audiol, Biomagnetism Ctr, D-48129 Munster, Germany; Univ Munster, Dept Neurol, D-48129 Munster, Germany; McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada	University of Munster; University of Munster; McMaster University	Pantev, C (corresponding author), Univ Munster, Inst Expt Audiol, Biomagnetism Ctr, D-48129 Munster, Germany.	pantev@uni-muenster.de	Oostenveld, Robert/D-3259-2009	Oostenveld, Robert/0000-0002-1974-1293; Ross, Bernhard/0000-0001-7290-631X				BARNEA A, 1994, INT J PSYCHOPHYSIOL, V16, P29, DOI 10.1016/0167-8760(94)90039-6; BENGUEREL AP, 1991, MUSIC PERCEPT, V9, P105; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Irvine D. R. F., 1995, ADV HEARING RES, P3; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; MERZENICH MM, 1976, J COMP NEUROL, V166, P387, DOI 10.1002/cne.901660402; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; PANTEV C, 1988, ELECTROEN CLIN NEURO, V69, P160, DOI 10.1016/0013-4694(88)90211-8; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; WILLIAMSON SJ, 1990, AUDITORY EVOKED MAGN, P1; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	14	576	589	4	83	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1998	392	6678					811	814		10.1038/33918	http://dx.doi.org/10.1038/33918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZJ679	9572139				2022-12-28	WOS:000073241200052
J	Zhang, PJ; Toyoshima, C; Yonekura, K; Green, NM; Stokes, DL				Zhang, PJ; Toyoshima, C; Yonekura, K; Green, NM; Stokes, DL			Structure of the calcium pump from sarcoplasmic reticulum at 8-angstrom resolution	NATURE			English	Article							AMINO-ACIDS; NA,K PUMP; CA-2+-ATPASE; MEMBRANE; ATPASE; CA2+-ATPASE; THAPSIGARGIN; MUTAGENESIS; LOCATION; MUTATION	The calcium pump from sarcoplasmic reticulum (Ca2+-ATPase) is typical of the large family of P-type cation pumps. These couple ATP hydrolysis with cation transport, generating cation gradients across membranes. Ca2+-ATPase specifically maintains the low cytoplasmic calcium concentration of resting muscle by pumping calcium into the sarcoplasmic reticulum; subsequent release is used to initiate contraction. No high-resolution structure of a P-type pump has yet been determined, although a 14-Angstrom structure of Ca2+-ATPase, obtained by electron microscopy of frozen-hydrated, tubular crystals(1), showed a large cytoplasmic head connected to the transmembrane domain by a narrow stalk. We have now improved the resolution to 8 Angstrom and can discern ten transmembrane ol-helices, four of which continue into the stalk. On the basis of constraints from transmembrane topology, site-directed mutagenesis and disulphide crosslinking, we have made tentative assignments for these alpha-helices within the amino-acid sequence. A distinct cavity leads to the putative calcium-binding site, providing a plausible path for calcium release to the lumen of the sarcoplasmic reticulum.	NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Natl Inst Med Res, London NW7 1AA, England	New York University; University of Tokyo; MRC National Institute for Medical Research	Stokes, DL (corresponding author), NYU, Med Ctr, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.		YONEKURA, Koji/N-5060-2015; Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778; Yonekura, Koji/0000-0001-5520-4391				Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BEORUKHIM R, 1997, ULTRAMICROSCOPY, V70, P57; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; CLARKE DM, 1990, J BIOL CHEM, V265, P17405; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DUX L, 1983, J BIOL CHEM, V258, P2599; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GREEN NM, 1994, SODIUM PUMP, P110; GREEN NM, 1989, BIOCHEM SOC T, V17, P970; Guerini D, 1996, BIOCHEMISTRY-US, V35, P3290, DOI 10.1021/bi952572f; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; HUA SM, 1995, BIOCHEMISTRY-US, V34, P5137, DOI 10.1021/bi00015a026; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MATTHEWS I, 1990, J BIOL CHEM, V265, P18737; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; Rice WJ, 1997, J BIOL CHEM, V272, P31412, DOI 10.1074/jbc.272.50.31412; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; STOKES DL, 1994, J BIOL CHEM, V269, P11606; STOKES DL, 1994, FEBS LETT, V346, P32, DOI 10.1016/0014-5793(94)00297-5; TANI K, 1997, ULTRAMICROSCOPY, V65, P31; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; TOYOSHIMA C, 1993, ULTRAMICROSCOPY, V48, P165, DOI 10.1016/0304-3991(93)90179-2	26	271	275	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1998	392	6678					835	839		10.1038/33959	http://dx.doi.org/10.1038/33959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572145				2022-12-28	WOS:000073241200059
J	Duggan, AE; Tolley, K; Hawkey, CJ; Logan, RFA				Duggan, AE; Tolley, K; Hawkey, CJ; Logan, RFA			Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model	BRITISH MEDICAL JOURNAL			English	Article							DUODENAL-ULCER; THERAPY	Objective: To determine how small differences in the efficacy and cost of two antibiotic regimens to eradicate Helicobacter pylori can affect the overall cost effectiveness of H pylori eradication in duodenal ulcer disease. Design: A decision analysis to examine the cost effectiveness of eight H pylori eradication strategies for duodenal ulcer disease with and without C-13-urea breath testing to confirm eradication. Main outcome measures: Cumulative direct treatment costs per 100 patients with duodenal ulcer disease who were positive for H pylori. Results: In model 1 the strategy of omeprazole, clarithromycin, and metronidazole alone was the most cost effective of the four strategies assessed. The addition of the C-13-urea breath test and a second course of omeprazole, clarithromycin, and metronidazole achieved the highest eradication rate (97%) but was the most expensive (pound 62.63 per patient). The cost of each additional effective eradication was pound 589.00 (incremental cost per case) when compared with the cost of treating once only with omeprazole, clarithromycin, and metronidazole; equivalent to the cost of a patient receiving ranitidine for duodenal ulcer relapse for more than 15 years. Eradication strategies of omeprazole, amoxycillin, and metronidazole were less cost effective than omeprazole, clarithromycin, and metronidazole alone. in model 2 the addition of the C-13-urea breath test after treatment, and maintenance treatment, increased die cost of all the strategies and reduced the cost advantage of omeprazole, clarithromycin, and metronidazole alone. Conclusion: Small differences in efficacy can influence the comparative cost effectiveness of strategies for eradicating H pylori Of the strategies tested the most cost effective (omeprazole, clarithromycin, and metronidazole alone) was neither the least expensive (omeprazole, amoxycillin, and metronidazole alone) nor the most effective (omeprazole, clarithromycin, and metronidazole with further treatment for patients found positive for H pylori on C-13-urea breath testing). Cost effectiveness should be an important part of choosing an eradication strategy for H pylori.	Univ Nottingham, Dept Publ Hlth & Epidemiol, Nottingham NG7 2UH, England; Univ Nottingham, Div Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Duggan, AE (corresponding author), Univ Nottingham, Dept Publ Hlth & Epidemiol, Nottingham NG7 2UH, England.			hobbs, richard/0000-0001-7976-7172				BELL GD, 1993, BR J MED EC, V6, P45; Carrere MO, 1997, PHARMACOECONOMICS, V11, P216, DOI 10.2165/00019053-199711030-00003; Johnston BJ, 1997, GUT, V41, pA166; Karlsson G, 1996, PHARMACOECONOMICS, V9, P113, DOI 10.2165/00019053-199609020-00003; LAMOULIATTE H, 1996, GASTROENTEROLOGY, V110, pA170; LOGAN RPH, 1996, CLIN CHALLENGES GAST, P42; MOAYYEDI P, 1995, EUR J GASTROEN HEPAT, V7, P835; PENSTON JG, 1993, ALIMENT PHARM THERAP, V7, P259; POUNDER RE, 1981, LANCET, V1, P29; PYM B, 1990, GASTROENTEROLOGY, V99, P27, DOI 10.1016/0016-5085(90)91225-U; SONNENBERG A, 1989, GASTROENTEROLOGY, V96, P1445, DOI 10.1016/0016-5085(89)90511-8; SONNENBERG A, 1996, GUT, V39, pA37; Sugden R., 1978, PRINCIPLES PRACTICAL; van der Hulst R W, 1996, Helicobacter, V1, P6	14	25	26	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1648	1654		10.1136/bmj.316.7145.1648	http://dx.doi.org/10.1136/bmj.316.7145.1648			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603748	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000074022700025
J	Fleming, O				Fleming, O			Memorable patients - Doing as they are told	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1658	1658		10.1136/bmj.316.7145.1658	http://dx.doi.org/10.1136/bmj.316.7145.1658			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603751	Green Published			2022-12-28	WOS:000074022700028
J	Smith, GD; Hart, C; Blane, D; Hole, D				Smith, GD; Hart, C; Blane, D; Hole, D			Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; HELICOBACTER-PYLORI; CARDIOVASCULAR-DISEASE; LIVING-CONDITIONS; STOMACH-CANCER; SOCIAL-CLASS; RISK-FACTORS; EARLY-LIFE; MEN; ENGLAND	Objective: To investigate the association between social circumstances in childhood and mortality from various causes of death in adulthood. Design: Prospective observational study. Setting: 27 workplaces in the west of Scotland. Subjects: 5645 men aged 35-64 years at the time of examination. Main outcome measures: Death from various causes. Results: Men whose fathers had manual occupations when they were children were more likely as adults to have manual jobs and be living in deprived areas. Gradients in mortality fi-om coronary heart disease, stroke, lung cancer, stomach cancer, and respiratory disease were seen tall P < 0.05), generally increasing from men whose fathers had professional and managerial occupations (social class I and II) to those whose fathers had semiskilled and unskilled manual occupations (social class IV and V). Relative rates of mortality adjusted for age for men with fathers in manual versus non-manual occupations were 1.52 (95% confidence interval 1.24 to 1.87) for coronary heart disease, 1.83 (1.13 to 2.94) for stroke, 1.65 (1.12 to 2.43) for lung cancer, 2.06 (0.93 to 4.57) for stomach cancer, and 2.01 (1.17 to 3.48) for respiratory disease. Mortality from other cancers and accidental and violent death showed no association with fathers' social class. Adjustment for adult socioeconomic circumstances and risk factors did not alter results for mortality from stroke and stomach cancer, attenuated the increased risk of coronary heart disease and respiratory disease, and essentially eliminated the association with lung cancer. Conclusions: Adverse socioeconomic circumstances in childhood have a specific influence on mortality from stroke and stomach cancer in adulthood, which is not due to the continuity of social disadvantage throughout life. Deprivation in childhood influences risk of mortality from coronary heart disease and respiratory disease in adulthood, although an additive influence of adulthood circumstances is seen in these cases. Mortality from lung cancer, other cancer, and accidents and violence is predominantly influenced by risk factors that are related to social circumstances in adulthood.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ London Imperial Coll Sci Technol & Med, Div Neurosci, London W6 8RP, England; Ruchill Hosp, W Scotland Canc Surveillance Unit, Glasgow G20 9NB, Lanark, Scotland	University of Bristol; University of Glasgow; Imperial College London; University of Glasgow	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.	zetkin@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; Barker D. J. P., 1994, MOTHERS BABIES DIS L; BARKER DJP, 1990, BRIT J CANCER, V61, P575, DOI 10.1038/bjc.1990.129; BARKER DJP, 1990, ANN HUM BIOL, V17, P1, DOI 10.1080/03014469000000732; BENSHLOMO Y, 1991, LANCET, V337, P530, DOI 10.1016/0140-6736(91)91307-G; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; BURR ML, 1980, J EPIDEMIOL COMMUN H, V34, P93, DOI 10.1136/jech.34.2.93; COGGON D, 1990, BRIT J CANCER, V61, P573, DOI 10.1038/bjc.1990.128; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; FORSDAHL A, 1977, BRIT J PREV SOC MED, V31, P91; HASTE H, 1990, BRIT MED J, V300, P289; KRIEGER N, IN PRESS AM J EPIDEM; KUH D, 1993, SOC HIST MED, V6, P101; LEON DA, 1995, J EPIDEMIOL COMMUN H, V49, P5, DOI 10.1136/jech.49.1.5; MANN SL, 1992, J EPIDEMIOL COMMUNIT, V46, P256; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; MENDALL MA, 1992, LANCET, V339, P896, DOI 10.1016/0140-6736(92)90931-R; MURRAY M, 1962, ANN ASSOC AM GEOGR, V52, P130, DOI 10.1111/j.1467-8306.1962.tb00401.x; NOTKOLA V, 1985, SOC SCI MED, V21, P517, DOI 10.1016/0277-9536(85)90035-8; PAYNE G, 1987, EMPLOYMENT OPPORTUNI; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Smith GD, 1996, AM J PUBLIC HEALTH, V86, P486, DOI 10.2105/AJPH.86.4.486; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; Smith GD, 1994, EUROPEAN J PUBLIC HL, V4, P131, DOI DOI 10.1093/EURPUB/4.2.131; VAGERO D, 1994, LANCET, V343, P1224, DOI 10.1016/S0140-6736(94)92432-5; Wannamethee SG, 1996, LANCET, V348, P1259, DOI 10.1016/S0140-6736(96)02465-8; WATT GCM, 1995, SCOT MED J, V40, P108, DOI 10.1177/003693309504000403; WU JM, 1991, P 4 INT C COMB EFF E	29	433	439	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	1998	316	7145					1631	1635		10.1136/bmj.316.7145.1631	http://dx.doi.org/10.1136/bmj.316.7145.1631			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZR867	9603744	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000074022700019
J	Webb, E				Webb, E			Children and the inverse care law	BRITISH MEDICAL JOURNAL			English	Article							HEALTH		Univ Wales Coll Med, Dept Child Hlth, Cardiff CF4 4XN, S Glam, Wales	Cardiff University	Webb, E (corresponding author), Univ Wales Coll Med, Dept Child Hlth, Cardiff CF4 4XN, S Glam, Wales.							BARRIEFOY GE, 1996, HLTH VISITOR, V70, P144; Berlin A, 1997, BRIT MED J, V315, P264, DOI 10.1136/bmj.315.7103.264; BLACKMAN C, 1994, SEEN BUT NOT HEARD C; BRADSHAW J, 1990, CHILD POVERTY DEPRIV, P40; BROOKS R, 1997, P ROYAL COLL PAED CH, V1, P83; DAVIES M, 1997, TODAYS CHILDREN TOMO, P156; DEALE J, 1997, SHARE, V16, P78; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hawes D, 1997, GYPSIES TRAVELLERS H; Hiew C. C., 1994, CHILDREN WORLDWIDE, V21, P27; *HLTH VIS ASS BRIT, 1989, HOM FAM THEIR HLTH; JOBBINS D, 1997, SHARE, V16, P5; Lawrenson F, 1997, BRIT MED J, V314, P1064, DOI 10.1136/bmj.314.7087.1064; LISSAUER T, 1993, ARCH DIS CHILD, V69, P423, DOI 10.1136/adc.69.4.423; MALUS M, 1992, BRIT MED J, V305, P789, DOI 10.1136/bmj.305.6857.789; PACKMAN J, 1996, WHO NEEDS CARE; POWERS JL, 1990, CHILD ABUSE NEGLECT, V14, P87, DOI 10.1016/0145-2134(90)90084-7; *REF COUNC, 1994, HLTH REF; SMAJE C, 1994, HLTH RACE ETHNICITY; Spencer N, 1996, POVERTY CHILD HLTH; Utting W., 1991, CHILDREN PUBLIC CARE; WALKER PC, 1986, BRIT MED J, V293, P1322, DOI 10.1136/bmj.293.6558.1322; Webb E, 1996, J PUBLIC HEALTH MED, V18, P217, DOI 10.1093/oxfordjournals.pubmed.a024482; Webb E, 1996, ARCH DIS CHILD, V74, P264, DOI 10.1136/adc.74.3.264; WEST RR, 1976, BRIT MED J, V2, P843, DOI 10.1136/bmj.2.6040.843; Whitehead, 1988, HLTH DIVIDE; Whitehead M., 1995, TACKLING INEQUALITIE; WOODROFFE C, 1993, CHILDREN TEENAGERS H	28	25	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1588	1591		10.1136/bmj.316.7144.1588	http://dx.doi.org/10.1136/bmj.316.7144.1588			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596601	Green Published			2022-12-28	WOS:000073867800030
J	Delacretaz, E; Michalopoulos, PG; Ruiz, J; Saner, H; Meier, B				Delacretaz, E; Michalopoulos, PG; Ruiz, J; Saner, H; Meier, B			Management of hyperlipidaemia after coronary revascularisation: follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; CHOLESTEROL; PREVENTION		Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Lausanne Hosp, Div Endocrinol, CH-1011 Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Delacretaz, E (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	edelacreta@bics.bwh.harvard.edu						BROWN BG, 1993, CIRCULATION, V87, P1781, DOI 10.1161/01.CIR.87.6.1781; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Luepker Russell V., 1997, American Journal of Medicine, V102, P37, DOI 10.1016/S0002-9343(97)00466-X; PEDERSEN TR, 1994, LANCET, V344, P1383; PYORALA K, 1994, EUR HEART J, V15, P1300	5	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	1998	316	7143					1499	1499		10.1136/bmj.316.7143.1499	http://dx.doi.org/10.1136/bmj.316.7143.1499			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582137	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000073707700027
J	Ueda, K; Tabata, H; Kawai, T				Ueda, K; Tabata, H; Kawai, T			Ferromagnetism in LaFeO3-LaCrO3 superlattices	SCIENCE			English	Article								Ferromagnetic spin order has been realized in the LaCrO3-LaFeO3 superlattices. Ferromagnetic coupling between Fe3+ and Cr3+ through oxygen has long been expected on the basis of Anderson, Goodenough, and Kanamori rules. Despite many studies of Fe-O-Cr-based compounds, random positioning of Fe3+ and Cr3+ ions has frustrated the observation of ferromagnetic properties. By creating artificial superlattices of Fe3+ and Cr3+ layer along the [111] direction, ferromagnetic ordering has been achieved.	Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 567, Japan	Osaka University	Kawai, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 567, Japan.		Ueda, Kenji/I-6696-2014	Ueda, Kenji/0000-0001-7450-5501				ALEONARD R, 1968, J APPL PHYS, V39, P379, DOI 10.1063/1.2163451; ANDERSON PW, 1950, PHYS REV, V79, P350, DOI 10.1103/PhysRev.79.350; Belayachi A, 1996, EUR J SOL STATE INOR, V33, P1039; Belov K.P., 1972, SOV PHYS-SOLID STATE, V14, P813; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; KANAMORI J, 1959, J PHYS CHEM SOLIDS, V10, P87, DOI 10.1016/0022-3697(59)90061-7; Kawai T, 1996, MAT SCI ENG B-SOLID, V41, P123, DOI 10.1016/S0921-5107(96)01637-6; KOEHLER WC, 1960, PHYS REV, V118, P58, DOI 10.1103/PhysRev.118.58; Kramers HA, 1934, PHYSICA, V1, P182, DOI 10.1016/S0031-8914(34)90023-9; TABATA H, 1993, PHYS REV LETT, V70, P2633, DOI 10.1103/PhysRevLett.70.2633; TREVES D, 1965, J APPL PHYS, V36, P1033, DOI 10.1063/1.1714088; WOLD A, 1959, J PHYS CHEM-US, V63, P447, DOI 10.1021/j150573a030	12	335	343	6	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1064	1066		10.1126/science.280.5366.1064	http://dx.doi.org/10.1126/science.280.5366.1064			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582117				2022-12-28	WOS:000073663600043
J	Francis, ST; Duncan, KR; Moore, RJ; Baker, PN; Johnson, IR; Gowland, PA				Francis, ST; Duncan, KR; Moore, RJ; Baker, PN; Johnson, IR; Gowland, PA			Non-invasive mapping of placental perfusion	LANCET			English	Article							PLANAR MAGNETIC-RESONANCE; FETAL GROWTH-RETARDATION; PREGNANCY; WEIGHT	Background. We aim to develop a clinical technique for the non-invasive measurement of placental perfusion, to enable early detection of intrauterine growth restriction (IUGR). Pregnancies with this complication are characterised by low placental perfusion. Methods. We measured placental perfusion by means of perfusion-sensitive echoplanar imaging (EPI); a rapid method of making magnetic resonance images. Perfusion measurements were done on six healthy volunteers with normal pregnancies and nine with pregnancies complicated by IUGR. Perfusion maps were created to assess the relation between placental perfusion and fetal size at birth. Findings. Pregnancies complicated by IUGR differed significantly from normal pregnancies in patterns of perfusion within the placenta (p < 0.0001, ANOVA). Subsequent analysis showed that the proportion of placentas with low perfusion rates was higher in the IUGR group than in the normal group. A significant correlation between areas of reduced placental perfusion and fetal size was demonstrated (p = 0.041, Spearman's rank correlation). Interpretation. Non-invasive imaging of placental perfusion by means of EPI has potential as a clinical tool in assessing the dynamics of placental perfusion.	Univ Nottingham, Dept Phys, Magnet Resonance Ctr, Nottingham NG7 2RD, England; City Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham	Gowland, PA (corresponding author), Univ Nottingham, Dept Phys, Magnet Resonance Ctr, Nottingham NG7 2RD, England.		Gowland, Penny A./I-9016-2012	Gowland, Penny A./0000-0002-4900-4817; Baker, Philip/0000-0002-4592-6427				BAKER PN, 1994, LANCET, V343, P644, DOI 10.1016/S0140-6736(94)92638-7; BAKER PN, 1994, AM J OBSTET GYNECOL, V170, P32; BODIS J, 1985, EUR J NUCL MED, V10, P286, DOI 10.1007/BF00254477; DOBSON PC, 1981, AUST NZ J OBSTET GYN, V21, P69, DOI 10.1111/j.1479-828X.1981.tb00781.x; Duncan K, 1996, BRIT MED J, V312, P1421; GOWLAND PA, IN PRESS MAGN RESON; HOWSEMAN AM, 1988, BRIT J RADIOL, V61, P822, DOI 10.1259/0007-1285-61-729-822; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; MANSFIELD P, 1990, BRIT J RADIOL, V63, P833, DOI 10.1259/0007-1285-63-755-833; NICOLAIDES KH, 1988, BRIT MED J, V297, P1026, DOI 10.1136/bmj.297.6655.1026; SHEPPARD BL, 1981, BRIT J OBSTET GYNAEC, V88, P695, DOI 10.1111/j.1471-0528.1981.tb01268.x; WILCOX MA, 1993, BRIT J OBSTET GYNAEC, V100, P342, DOI 10.1111/j.1471-0528.1993.tb12977.x	12	74	78	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1397	1399		10.1016/S0140-6736(97)07089-X	http://dx.doi.org/10.1016/S0140-6736(97)07089-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593410				2022-12-28	WOS:000073563400010
J	Petukhova, G; Stratton, S; Sung, P				Petukhova, G; Stratton, S; Sung, P			Catalysis of homologous DNA pairing by yeast Rad51 and Rad54 proteins	NATURE			English	Article							STRAND EXCHANGE; RECOMBINATION; GENE	The Saccharomyces cerevisiae RAD51 and RAD54 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks(1). Previous studies have indicated that Rad51 protein, together with the single-stranded DNA-binding factor replication protein A (RPA), can promote the formation of heteroduplex DNA(2-4), which is a key intermediate in homologous recombination(1), Here we report the purification of the Rad54 protein to near homogeneity and the biochemical testing of its molecular function. We find that Rad54 protein possesses a double-stranded DNA-dependent ATPase activity, and GRAPHICS that it interacts with the Rad51 protein. Addition of Rad54 protein to reactions containing Rad51 strongly stimulates the rate of pairing between homologous single-stranded and double-stranded DNA molecules. We conclude that Rad54 acts to overcome kinetic impediments that would limit homologous DNA pairing between recombining chromosomes in vivo.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sung, P (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.	sung@uthscsa.edu						Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; EMERY HS, 1991, GENE, V104, P103, DOI 10.1016/0378-1119(91)90473-O; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; RANDERATH K, 1964, J CHROMATOGR, V16, P111, DOI 10.1016/S0021-9673(01)82445-6; SALINAS F, 1995, CELL, V82, P111, DOI 10.1016/0092-8674(95)90057-8; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4	17	343	354	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					91	94		10.1038/30037	http://dx.doi.org/10.1038/30037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590697				2022-12-28	WOS:000073497500055
J	Vu, TH; Shipley, JM; Bergers, G; Berger, JE; Helms, JA; Hanahan, D; Shapiro, SD; Senior, RM; Werb, Z				Vu, TH; Shipley, JM; Bergers, G; Berger, JE; Helms, JA; Hanahan, D; Shapiro, SD; Senior, RM; Werb, Z			MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes	CELL			English	Article							MATRIX METALLOPROTEINASES; IN-VITRO; INTERSTITIAL COLLAGENASE; MOUSE DEVELOPMENT; INDIAN HEDGEHOG; BONE-GROWTH; EXPRESSION; GENE; DEGRADATION; CARTILAGE	Homozygous mice with a null mutation in the MMP-9/gelatinase B gene exhibit an abnormal pattern of skeletal growth plate vascularization and ossification. Although hypertrophic chondrocytes develop normally, apoptosis, vascularization, and ossification are delayed, resulting in progressive lengthening of the growth plate to about eight times normal. After 3 weeks postnatal, aberrant apoptosis, vascularization, and ossification compensate to remodel the enlarged growth plate and ultimately produce an axial skeleton of normal appearance. Transplantation of wild-type bone marrow cells rescues vascularization and ossification in gelatinase B-null growth plates, indicating that these processes are mediated by gelatinase B-expressing cells of bone marrow origin, designated chondroclasts. Growth plates from gelatinase B-null mice in culture show a delayed release of an angiogenic activator, establishing a role for this proteinase in controlling angiogenesis.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Dept Orthoped Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Hormone Res Inst, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Internal Med,Div Pulm & Crit Care Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Vu, TH (corresponding author), Univ Calif San Francisco, Dept Anat, Box 0452, San Francisco, CA 94143 USA.		Bergers, Gabriele/AAJ-5535-2020	Helms, Jill/0000-0002-0463-396X; Bergers, Gabriele/0000-0003-3545-5171	NCI NIH HHS [R01 CA037395-19, R01 CA037395, R37 CA037395] Funding Source: Medline; NHLBI NIH HHS [R01 HL047328-08, T32 HL007185, T32 HL007185-26, HL47328, R01 HL047328] Funding Source: Medline; NICHD NIH HHS [P01 HD026732-070003, HD26732] Funding Source: Medline; NIDCR NIH HHS [P50 DE010306-05S10005, DE10306] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD026732] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA037395, R37CA037395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047328, T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE010306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Alexander CM, 1996, DEVELOPMENT, V122, P1723; Alini M, 1996, DEV BIOL, V176, P124, DOI 10.1006/dbio.1996.9989; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; ANDERSON CE, 1966, J BONE JOINT SURG AM, VA 48, P899, DOI 10.2106/00004623-196648050-00008; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BROWN CC, 1989, J BONE JOINT SURG AM, V71A, P580, DOI 10.2106/00004623-198971040-00014; CANCEDDA FD, 1995, EUR J CELL BIOL, V66, P60; CAPLAN AI, 1988, CIBA F SYMP, V136, P3; Carlevaro MF, 1997, J CELL BIOL, V136, P1375, DOI 10.1083/jcb.136.6.1375; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; FARNUM CE, 1989, J ORTHOPAED RES, V7, P654, DOI 10.1002/jor.1100070505; FISHER C, 1994, DEV BIOL, V162, P499, DOI 10.1006/dbio.1994.1104; Fisher S. J., 1995, EXTRACELLULAR MATRIX, P261; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Iwasaki M, 1997, MECH DEVELOP, V69, P197, DOI 10.1016/S0925-4773(97)00145-7; JINGUSHI S, 1995, J ORTHOPAED RES, V13, P761, DOI 10.1002/jor.1100130516; KARELINA TV, 1995, J INVEST DERMATOL, V105, P411, DOI 10.1111/1523-1747.ep12321097; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuettner K.E., 1983, SEFER RABIAH, V1, P281; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEWINSON D, 1992, ANAT REC, V233, P504, DOI 10.1002/ar.1092330403; MOSES MA, 1991, J CELL BIOCHEM, V47, P230, DOI 10.1002/jcb.240470308; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; OHSAWA Y, 1993, J HISTOCHEM CYTOCHEM, V41, P1075, DOI 10.1177/41.7.8515049; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; POOLE AR, 1991, CARTILAGE MOL ASPECT, P179; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; REPONEN P, 1994, J CELL BIOL, V124, P1091, DOI 10.1083/jcb.124.6.1091; SCHENK RK, 1968, ACTA ANAT, V69, P1; SCHNAPER HW, 1993, J CELL PHYSIOL, V156, P235, DOI 10.1002/jcp.1041560204; SIRES UI, 1995, J CLIN INVEST, V95, P2089, DOI 10.1172/JCI117896; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	46	1438	1490	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					411	422		10.1016/S0092-8674(00)81169-1	http://dx.doi.org/10.1016/S0092-8674(00)81169-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590175	Green Accepted, Bronze			2022-12-28	WOS:000073471500016
J	Cresswell, P				Cresswell, P			Proteases, processing, and thymic selection	SCIENCE			English	Article							MHC CLASS-II; INVARIANT-CHAIN		Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 310 Cedar St, New Haven, CT 06510 USA.	peter.cresswell@yale.edu						Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Fineschi B, 1996, J IMMUNOL, V157, P3211; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549	9	22	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	1998	280	5362					394	395		10.1126/science.280.5362.394	http://dx.doi.org/10.1126/science.280.5362.394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH907	9575085				2022-12-28	WOS:000073159600032
J	Johnston, SRD; Broadley, K; Henson, G; Fisher, C; Henk, M; Gore, ME				Johnston, SRD; Broadley, K; Henson, G; Fisher, C; Henk, M; Gore, ME			Commentary: Management of the patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							PREGNANCY; MELANOMA		Royal Marsden Hosp, Melanoma Unit, London SW3 6JJ, England; Royal Marsden Hosp, Palliat Care Unit, London SW3 6JJ, England; Royal Marsden Hosp, Dept Pathol, London SW3 6JJ, England; Whittington Hosp, Dept Obstet & Gynaecol, London N19 5NF, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; University College London	Johnston, SRD (corresponding author), Royal Marsden Hosp, Melanoma Unit, London SW3 6JJ, England.							ANDERSON J F, 1989, Pediatric Pathology, V9, P35; AVILES A, 1991, AM J HEMATOL, V36, P243, DOI 10.1002/ajh.2830360404; MACKIE RM, 1991, LANCET, V337, P653, DOI 10.1016/0140-6736(91)92462-B; Ross Merrick I., 1994, Cancer Bulletin (Houston), V46, P412; SHIU MH, 1976, CANCER, V37, P181, DOI 10.1002/1097-0142(197601)37:1<181::AID-CNCR2820370126>3.0.CO;2-F	5	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 14	1998	316	7134					851	851						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZC488	9565458				2022-12-28	WOS:000072584300043
J	Jordan, J; Dowswell, T; Harrison, S; Lilford, RJ; Mort, M				Jordan, J; Dowswell, T; Harrison, S; Lilford, RJ; Mort, M			Health needs assessment - Whose priorities? Listening to users and the public	BRITISH MEDICAL JOURNAL			English	Article							SERVICE PRIORITIES		Univ Leeds, Ctr Res Primary Care, Res Sch Med, Leeds LS2 9LN, W Yorkshire, England; Univ Leeds, Dept Psychol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9JT, W Yorkshire, England; Univ Birmingham, Birmingham, W Midlands, England; Univ Lancaster, Dept Management Studies, Lancaster LA1 4YT, England	University of Leeds; University of Leeds; University of Leeds; University of Birmingham; Lancaster University	Jordan, J (corresponding author), Univ Leeds, Ctr Res Primary Care, Res Sch Med, Leeds LS2 9LN, W Yorkshire, England.			Mort, Margaret Mary Elizabeth/0000-0003-0188-324X				BARNES M, 1996, LOCAL GOVT POLICYMAK, V22, P9; BARNES M, 1992, RES USER INVOLVEMENT, P1; BOWIE C, 1995, BMJ-BRIT MED J, V311, P1155, DOI 10.1136/bmj.311.7013.1155; BOWLING A, 1993, SOC SCI MED, V37, P851, DOI 10.1016/0277-9536(93)90138-T; Bradshaw J., 1994, RES PEOPLES HLTH, P45; Bradshaw J, 1972, PROBLEMS PROGR MED C, P71; BROWN I, 1994, COMMUNITY PARTICIPAT, P1; *DEP HLTH WELSH OF, 1989, GEN PRACT NAT HLTH S; Dockery G., 1996, PARTICIPATORY RES HL, P164; DOWSWELL T, 1995, BRIT MED J, V311, P1168, DOI 10.1136/bmj.311.7013.1168c; DOWSWELL T, 1994, COMMUNITY PARTICIPAT, P8; FINDLAY G, 1994, COMMUNITY PARTICIPAT, P29; Gillam S.J., 1996, 73 ROYAL COLL GEN PR; Harrison S, 1997, BRIT MED J, V314, P970, DOI 10.1136/bmj.314.7085.970; HEGINBOTHAM C, 1992, BRIT MED J, V304, P1168; HERITAGE Z, 1994, 64 ROYAL COLL GEN PR; HUNTER DJ, 1997, HLTH CHOICES FUTURE, P120; JORDAN J, 1995, HLTH NEEDS ASSESSMEN; LAST JM, 1963, LANCET, V2, P28; Lenaghan J, 1996, BRIT MED J, V312, P1591, DOI 10.1136/bmj.312.7046.1591; *LOND HLTH EC CONS, 1996, LOC HLTH VOC COMM RE; MORT M, 1996, CONT POLITICAL STUDI, V2, P1133; MORT M, INPRESS INNOVATIONS; NHS Executive, 1994, DEV NHS PURCH GP FUN; NHS Management Executive, 1992, LOC VOIC VIEWS LOC P; PECKHAM S, 1992, CRITICAL PUBLIC HLTH, V5, P36; Percy-Smith J, 1992, UNDERSTANDING LOCAL; PICKARD S, 1995, SOC POLICY ADMIN, V29, P135, DOI 10.1111/j.1467-9515.1995.tb00459.x; PRITCHARD P, 1994, COMMUNIKTY PARTICIPA, P26; ROBINSON J, 1996, HLTH NEEDS ASSESSMEN; Ruta DA, 1997, BRIT J GEN PRACT, V47, P353; *SECR STAT HLTH, 1997, CM 3807; Stevens A, 1991, Health Trends, V23, P20	33	52	52	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1668	1670		10.1136/bmj.316.7145.1668	http://dx.doi.org/10.1136/bmj.316.7145.1668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603758	Green Published			2022-12-28	WOS:000074022700034
J	Cartigny, P; Harris, JW; Javoy, M				Cartigny, P; Harris, JW; Javoy, M			Eclogitic diamond formation at Jwaneng: No room for a recycled component	SCIENCE			English	Article							AR-40-AR-39 LASER PROBE; ISOTOPIC COMPOSITION; INFRARED-ABSORPTION; CLINOPYROXENE INCLUSIONS; NITROGEN ISOTOPES; EARTHS MANTLE; CARBON; GROWTH; ROCKS; STATE	Eclogitic diamonds have a large range of delta(13)C values, whereas peridotitic diamonds do not. Paired delta(15)N-delta(13)C-N variations in 40 eclogitic diamonds from the Jwaneng kimberlite in Botswana show that neither the influence of recycled biogenic carbon nor the global and primordial heterogeneity of mantle carbon are likely for the origin of the large delta(13)C range; the data instead support a fractionation process. It is proposed that carbonatitic mantle melts from which diamonds crystallize undergo different evolutions before diamond precipitation, when percolating through either a peridotite or an eclogite. These different evolutions, reflecting the presence or absence of olivine, can account for their respective delta(13)C distributions.	Univ Paris 07, Inst Phys Globe Paris, Lab Geochim Isotopes Stables, F-75251 Paris, France; Univ Glasgow, Dept Geol & Appl Geol, Glasgow G12 8QQ, Lanark, Scotland	UDICE-French Research Universities; Universite Paris Cite; University of Glasgow	Cartigny, P (corresponding author), Univ Paris 07, Inst Phys Globe Paris, Lab Geochim Isotopes Stables, 4 Pl Jussieu, F-75251 Paris, France.	cartigny@ipgp.jussieu.fr	Cartigny, Pierre/A-6251-2011					APPORA I, 1996, C ABSTR, V1, P22; BALLHAUS C, 1993, CONTRIB MINERAL PETR, V114, P331, DOI 10.1007/BF01046536; BEBOUT GE, 1992, GEOCHIM COSMOCHIM AC, V56, P2839, DOI 10.1016/0016-7037(92)90363-N; BOTTINGA Y, 1969, EARTH PLANET SC LETT, V5, P301; BOYD SR, 1994, CHEM GEOL, V116, P43, DOI 10.1016/0009-2541(94)90157-0; BOYD SR, 1994, PHILOS MAG B, V69, P1149, DOI 10.1080/01418639408240185; BOYD SR, 1992, EARTH PLANET SC LETT, V109, P633, DOI 10.1016/0012-821X(92)90121-B; BOYD SR, 1995, MEAS SCI TECHNOL, V6, P297, DOI 10.1088/0957-0233/6/3/007; BOYD SR, 1994, CHEM GEOL, V116, P29, DOI 10.1016/0009-2541(94)90156-2; BOYD SR, 1987, EARTH PLANET SC LETT, V86, P341, DOI 10.1016/0012-821X(87)90231-7; BOYD SR, 1995, PHILOS MAG B, V72, P351, DOI 10.1080/13642819508239089; BURGESS R, 1992, GEOCHIM COSMOCHIM AC, V56, P389, DOI 10.1016/0016-7037(92)90140-E; BURGESS R, 1989, EARTH PLANET SC LETT, V94, P22, DOI 10.1016/0012-821X(89)90080-0; Cartigny P, 1997, TERRA NOVA, V9, P175, DOI 10.1046/j.1365-3121.1997.d01-26.x; CARTIGNY P, IN PRESS CHEM GEOL; Deines P, 1997, GEOCHIM COSMOCHIM AC, V61, P3993, DOI 10.1016/S0016-7037(97)00199-3; DEINES P, 1980, GEOCHIM COSMOCHIM AC, V44, P943, DOI 10.1016/0016-7037(80)90284-7; DEINES P, 1995, GEOCHIM COSMOCHIM AC, V59, P3173, DOI 10.1016/0016-7037(95)00205-E; DEINES P, 1993, GEOCHIM COSMOCHIM AC, V57, P2781, DOI 10.1016/0016-7037(93)90390-I; DEINES P, 1968, GEOCHIM COSMOCHIM AC, V32, P613, DOI 10.1016/0016-7037(68)90052-5; GALIMOV EM, 1991, GEOCHIM COSMOCHIM AC, V55, P1697, DOI 10.1016/0016-7037(91)90140-Z; GURNEY JJ, 1989, GEOL SOC AUSTR SPEC, V14, P935; HAENDEL D, 1986, GEOCHIM COSMOCHIM AC, V50, P749, DOI 10.1016/0016-7037(86)90351-0; HAGGERTY SE, 1986, NATURE, V320, P34, DOI 10.1038/320034a0; Haggerty SE, 1990, CONTINENTAL MANTLE, P87; Harris J.W., 1992, PROPERTIES NATURAL S, P345; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; JAVOY M, 1972, NATURE-PHYS SCI, V236, P63, DOI 10.1038/physci236063a0; JAVOY M, 1986, CHEM GEOL, V57, P41, DOI 10.1016/0009-2541(86)90093-8; Javoy M, 1997, GEOPHYS RES LETT, V24, P177, DOI 10.1029/96GL03931; JAVOY M, 1982, NATURE, V300, P171, DOI 10.1038/300171a0; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; JAVOY M, 1984, EARTH PLANET SC LETT, V68, P399, DOI 10.1016/0012-821X(84)90125-0; Kadik A, 1997, PHYS EARTH PLANET IN, V100, P157, DOI 10.1016/S0031-9201(96)03237-2; KESSON SE, 1989, CHEM GEOL, V78, P97, DOI 10.1016/0009-2541(89)90110-1; KIRKLEY MB, 1991, APPL GEOCHEM, V6, P477, DOI 10.1016/0883-2927(91)90048-T; KNOCHE R, 1997, EOS, V78, pS335; Letolle R, 1980, HDB ENV ISOTOPE GEOC, P407; LEUNG IS, 1990, AM MINERAL, V75, P1110; LUTH RW, 1993, SCIENCE, V261, P66, DOI 10.1126/science.261.5117.66; MARTY B, 1987, EARTH PLANET SC LETT, V83, P16, DOI 10.1016/0012-821X(87)90047-1; Marty B, 1997, EARTH PLANET SC LETT, V152, P101, DOI 10.1016/S0012-821X(97)00153-2; MARTY B, 1995, NATURE, V377, P326, DOI 10.1038/377326a0; Mattey D.P., 1987, TERRA COGNITA, V7, P31; MATTIOLI GS, 1989, J GEOL, V97, P521, DOI 10.1086/629332; MCDADE P, 1996, C ABSTR, V1, P391; Meyer H. O. A., 1987, MANTLE XENOLITHS, P501; NAVON O, 1991, NATURE, V353, P746, DOI 10.1038/353746a0; NAVON O, 1988, NATURE, V335, P784, DOI 10.1038/335784a0; NISBET EG, 1994, NATURE, V367, P694, DOI 10.1038/367694b0; PETERS KE, 1978, LIMNOL OCEANOGR, V23, P598, DOI 10.4319/lo.1978.23.4.0598; RAU GH, 1987, EARTH PLANET SC LETT, V82, P269, DOI 10.1016/0012-821X(87)90201-9; RICHARDSON SH, 1986, NATURE, V322, P623, DOI 10.1038/322623a0; RICHARDSON SH, 1990, NATURE, V346, P54, DOI 10.1038/346054a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHRAUDER M, 1993, NATURE, V365, P42, DOI 10.1038/365042a0; SOBOLEV NV, 1979, DOKL AKAD NAUK SSSR+, V249, P1217; VIEZER J, 1976, GEOCHIM COSMOCHIM AC, V40, P1397; WAND A, 1996, EARTH PLANET SC LETT, V141, P293; WOERMANN E, 1985, FORTSCHR MINERAL, V63, P263; WRIGHT IP, 1988, J PHYS E SCI INSTRUM, V21, P865, DOI 10.1088/0022-3735/21/9/011; WYLLIE PJ, 1983, TECTONOPHYSICS, V100, P359, DOI 10.1016/0040-1951(83)90194-4; YEFIMOVA ES, 1983, ZAP VSES MINERAL OVA, V112, P300	63	143	154	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1421	1424		10.1126/science.280.5368.1421	http://dx.doi.org/10.1126/science.280.5368.1421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603728				2022-12-28	WOS:000073883400051
J	Duthie, RA; Bruce, MF; Hutchison, JD				Duthie, RA; Bruce, MF; Hutchison, JD			Changing proximal femoral geometry in northeast Scotland: an osteometric study	BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; INCREASE; FEMUR; WOMEN; 1950S; 1990S		Univ Aberdeen, Sch Med, Dept Orthopaed, Aberdeen AB9 2ZD, Scotland; Marischal Coll, Dept Biomed Sci, Aberdeen AB10 1YS, Scotland	University of Aberdeen; University of Aberdeen	Duthie, RA (corresponding author), Univ Aberdeen, Sch Med, Dept Orthopaed, Aberdeen AB9 2ZD, Scotland.							FAULKNER KG, 1993, J BONE MINER RES, V8, P1211, DOI 10.1002/jbmr.5650081008; ONeill TW, 1996, OSTEOPOROSIS INT, V6, P136, DOI 10.1007/BF01623937; REID IR, 1994, BRIT MED J, V309, P508, DOI 10.1136/bmj.309.6953.508; Vega E, 1991, Osteoporos Int, V1, P81, DOI 10.1007/BF01880448; WALLACE WA, 1983, LANCET, V1, P1413	5	13	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1498	1498		10.1136/bmj.316.7143.1498	http://dx.doi.org/10.1136/bmj.316.7143.1498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582136	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000073707700026
J	Hendry, J				Hendry, J			A memorable patient - Piano player, pathologist, postmortem, postscript	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1510	1510		10.1136/bmj.316.7143.1510	http://dx.doi.org/10.1136/bmj.316.7143.1510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582145	Green Published			2022-12-28	WOS:000073707700035
J	Daar, ES; Bai, JX; Hausner, MA; Majchrowicz, M; Tamaddon, M; Giorgi, JV				Daar, ES; Bai, JX; Hausner, MA; Majchrowicz, M; Tamaddon, M; Giorgi, JV			Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS TYPE-1 INFECTION; T-CELL MEMORY; VIREMIA; CD38		Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; Cedars Sinai Burns & Allen Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Daar, ES (corresponding author), Cedars Sinai Med Ctr, Div Infect Dis, B217,8700 Beverly Blvd, Los Angeles, CA 90048 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032883] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-32883] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; DAAR ES, 1995, AIDS RES HUM RETROV, V11, P3, DOI 10.1089/aid.1995.11.3; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Ferbas J, 1996, J VIROL, V70, P7285, DOI 10.1128/JVI.70.10.7285-7289.1996; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; HO HN, 1993, J IMMUNOL, V150, P3070; HOEN B, 1998, 5 C RETR OPP NF, P524; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lafeuillade A, 1997, J INFECT DIS, V175, P1051, DOI 10.1086/516442; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MARKOWITZ M, 1997, P 4 C RET OPP INF WA, P207; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perrin L, 1996, AIDS, V10, P1233, DOI 10.1097/00002030-199609000-00009; PIATAK M, 1993, LANCET, V341, P1099, DOI 10.1016/0140-6736(93)92463-4; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Selin LK, 1997, J IMMUNOL, V158, P5366	20	46	50	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					827	829		10.7326/0003-4819-128-10-199805150-00005	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599194				2022-12-28	WOS:000073586500005
J	Reinertsen, JL				Reinertsen, JL			Physicians as leaders in the improvement of health care systems	ANNALS OF INTERNAL MEDICINE			English	Article								Physicians are often asked to assume leadership roles in their practices, hospitals, and academic departments. These positions can be excellent leverage points for improvement of health care quality. To make optimal use of these opportunities, physicians must learn how to lead. This paper is intended to be a primer for physicians who are asked to lead and want to learn how to lead well. A body of knowledge that physician-leaders should acquire is described, and case examples are used to address such topics as the nature of leadership, the relation between leadership and management, and ways in which physicians might approach a new leadership assignment. Guidelines for physicians who must play the role of followers are offered, and challenges that physicians who lead other physicians may face are described.	Healthsyst Minnesota, St Louis Pk, MN 55426 USA		Reinertsen, JL (corresponding author), Healthsyst Minnesota, 6500 Excelsior Blvd, St Louis Pk, MN 55426 USA.							AUTRY JA, 1992, LOVE PROFIT ART CARI, P19; Berwick DM, 1998, ANN INTERN MED, V128, P289, DOI 10.7326/0003-4819-128-4-199802150-00008; CLEMMER J, 1995, PATHWAYS PERFORMANCE, P19; CONNORS R, 1994, OZ PRINCIPLE GETTING, P25; DEBONO E, 1986, 6 THINKING HATS, P80; DEMING WE, 1982, OUT CRISIS, P54; Deming WE, 1994, NEW EC IND, P50; DEPREE M, 1987, LEADERSHIP IS ART, P9; Heifetz RA, 1997, HARVARD BUS REV, V75, P124; Kotter JP, 1996, LEADING CHANGE, P25; Nelson EC, 1998, ANN INTERN MED, V128, P460, DOI 10.7326/0003-4819-128-6-199803150-00007; REINERTSEN JL, 1995, JOINT COMM J QUAL IM, V21, P612, DOI 10.1016/S1070-3241(16)30189-4; Scholtes P. R., 1988, TEAM HDB USE TEAMS I; SENGE P, 1990, 5 DISCIPLINE ART PRA, P339; WHEELER DJ, 1993, UNDERSTANDING VARIAT, P15	15	57	58	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					833	838		10.7326/0003-4819-128-10-199805150-00007	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599196				2022-12-28	WOS:000073586500007
J	Deichmann, U; Muller-Hill, B				Deichmann, U; Muller-Hill, B			The fraud of Abderhalden's enzymes	NATURE			English	Editorial Material									Univ Cologne, Inst Genet, D-50931 Cologne, Germany	University of Cologne	Deichmann, U (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.		Deichmann, Ute/F-3946-2012; Deichmann, Ute/W-6295-2019					ABDERHALDEN E, 1912, SCHUTZFERMENTE; ABDERHALDEN R, 1954, ZELLULARTHERAPIE; GERSTENGARBE S, 1994, LEOPOLDINA, V39, P363; HARRER G, 1947, Z VITAMIN HORM FERME, V1, P484; Hillimann G, 1943, H-S Z PHYSIOL CHEM, V277, P222, DOI 10.1515/bchm2.1943.277.4-6.222; Hulton F, 1916, J BIOL CHEM, V25, P163; KANZOW U, 1957, DIE MED, V13, P447; *KRANKH BEH BED AB, 1914, MED KLIN, V11, P453; KRETSCHMER E, 1941, FERMENTCHEMISCHE STU; Latour B., 1979, LAB LIFE SOCIAL CONS; MALL G, 1948, Z VITAMIN HORM FERME, V2, P47; Muller-Hill B., 1988, MURDEROUS SCI; Schiermeier Q, 1997, NATURE, V389, P105, DOI 10.1038/38056; Van Slyke DD, 1915, J BIOL CHEM, V23, P377; von Lagermarck L., 1914, DEUT MED WOCHENSCHR, V7, P316; Wieland T., 1991, WORLD PEPTIDES BRIEF, P77, DOI [10.1007/978-3-642-75850-8, DOI 10.1007/978-3-642-75850-8]; 1951, Z VITAMIN HORM FERME, V4, P1; [No title captured]	18	27	27	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					109	111		10.1038/30090	http://dx.doi.org/10.1038/30090			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603512				2022-12-28	WOS:000073619900019
J	DiGuiseppi, C; Roberts, I; Li, L; Allen, D				DiGuiseppi, C; Roberts, I; Li, L; Allen, D			Determinants of car travel on daily journeys to school: cross sectional survey of primary school children	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Med, Inst Child Hlth,Child Hlth Monitoring Unit, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	University of London; University College London; UCL Medical School	DiGuiseppi, C (corresponding author), UCL, Sch Med, Inst Child Hlth,Child Hlth Monitoring Unit, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England.	C.DiGuiseppi@ich.ucl.ac.uk	DiGuiseppi, Carolyn/AAU-1341-2020	DiGuiseppi, Carolyn/0000-0002-6440-7817				Bly Robert., 1993, RAG BONE SHOP HEART; British Medical Association, 1997, ROAD TRANSP HLTH; *DEP TRANSP, 1995, TRANSP STAT REP NAT; Hillman M., 1990, ONE FALSE MOVE STUDY; Roberts I, 1997, Inj Prev, V3, P89	5	123	123	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	1998	316	7142					1426	1428		10.1136/bmj.316.7142.1426	http://dx.doi.org/10.1136/bmj.316.7142.1426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572753	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000073651600029
J	Pitt, B				Pitt, B			Coping with loss - Loss in late life	BRITISH MEDICAL JOURNAL			English	Article							MENTAL STATE; DEPRESSION; PREVALENCE; EUTHANASIA		Hammersmith Hosp, Imperial Coll Sch Med, Dept Psychol Med, London W2 0HA, England	Imperial College London	Pitt, B (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Dept Psychol Med, London W2 0HA, England.							ADSHEAD F, 1992, BRIT MED J, V305, P397, DOI 10.1136/bmj.305.6850.397; BARRACLOUGH BM, 1971, RECENT DEV PSYCHOGER, P87; BIRD AS, 1987, INT J GERIATR PSYCH, V2, P31, DOI 10.1002/gps.930020106; BRETSCHNEIDER JG, 1988, ARCH SEX BEHAV, V17, P109, DOI 10.1007/BF01542662; Butler R., 1982, AGING MENTAL HLTH PO; *CENTR HLTH MON UN, 1992, EP OV SER HLTH ELD P; COPELAND J, 1981, WHAT IS CASE PROBLEM; COPELAND JRM, 1987, BRIT J PSYCHIAT, V150, P815, DOI 10.1192/bjp.150.6.815; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; *DEPT HLTH SOC SEC, 1985, IN PAT STAT MENT HLT; FELDMAN E, 1987, QJ MED, V240, P301; GERMAN PS, 1987, JAMA-J AM MED ASSOC, V257, P489, DOI 10.1001/jama.257.4.489; HALL P, 1996, GUIDE CARE ELDERLY; ILIFFE S, 1991, BRIT J GEN PRACT, V41, P9; Isaacs B, 1992, CHALLENGE GERIATRIC; JEFFERYS M, 1988, MENTAL HLTH PROBLEMS; Jorm AF, 1987, UNDERSTANDING SENILE; Kelly CA, 1997, BRIT MED J, V314, P693, DOI 10.1136/bmj.314.7082.693; KRAL VA, 1962, CAN MED ASSOC J, V86, P257; LEZAK MD, 1985, NEUROPSYCHOLOGICAL A; LIVINGSTON G, 1990, PSYCHOL MED, V20, P137, DOI 10.1017/S0033291700013313; MYERS JK, 1984, ARCH GEN PSYCHIAT, V41, P959; Pritchard C, 1996, SOC PSYCH PSYCH EPID, V31, P227, DOI 10.1007/BF00785772; Roth M, 1996, BRIT MED BULL, V52, P263; TATONA C, 1995, PRIM CARE PSYCHIAT, V1, P107; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	27	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1452	1454		10.1136/bmj.316.7142.1452	http://dx.doi.org/10.1136/bmj.316.7142.1452			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZN495	9572763	Green Published			2022-12-28	WOS:000073651600038
J	Caldas, C				Caldas, C			Science, medicine, and the future - Molecular assessment of cancer	BRITISH MEDICAL JOURNAL			English	Review							COLORECTAL-CANCER; BREAST-CANCER; ALLELIC LOSS; MUTATIONS; CARCINOMA; BLADDER; IDENTIFICATION; ONCOGENE; STOOL		Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Caldas, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Box 193, Cambridge CB2 2QQ, England.		Caldas, Carlos/A-7543-2008; Caldas, Carlos/U-7250-2019	Caldas, Carlos/0000-0003-3547-1489				BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Boyle Peter, 1997, Lancet (North American Edition), V349, P23; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; CALDAS C, 1994, CANCER RES, V54, P3568; Caldas C., 1997, Lancet (North American Edition), V349, P16; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; HAYASHI N, 1995, LANCET, V345, P1255; HRUBAN RH, 1994, NEW ENGL J MED, V330, P1276, DOI 10.1056/NEJM199405053301805; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; KERN SE, 1989, JAMA-J AM MED ASSOC, V261, P3099, DOI 10.1001/jama.261.21.3099; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; MAO L, 1994, P NATL ACAD SCI USA, V91, P9871, DOI 10.1073/pnas.91.21.9871; Mao L, 1996, SCIENCE, V271, P659, DOI 10.1126/science.271.5249.659; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pack S, 1997, LANCET, V350, P264, DOI 10.1016/S0140-6736(05)62228-3; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	19	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1360	1363		10.1136/bmj.316.7141.1360	http://dx.doi.org/10.1136/bmj.316.7141.1360			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563991	Green Published			2022-12-28	WOS:000073483000022
J	Dunea, G				Dunea, G			Soundings - Death by injection	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cook Cty Hosp, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County	Dunea, G (corresponding author), Cook Cty Hosp, Chicago, IL 60612 USA.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1394	1394		10.1136/bmj.316.7141.1394	http://dx.doi.org/10.1136/bmj.316.7141.1394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9564016	Green Published			2022-12-28	WOS:000073483000071
J	Ewan, PW				Ewan, PW			ABC of allergies - Venom allergy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNOTHERAPY; INSECT; BEE		Addenbrookes Hosp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ewan, PW (corresponding author), Addenbrookes Hosp, Cambridge, England.			Ewan, Pamela/0000-0003-1298-4417				ALEXANDER A, 1993, CLIN EXP ALLERGY, V23, P65, DOI 10.1111/j.1365-2222.1993.tb02966.x; Egner W, 1998, CLIN EXP ALLERGY, V28, P26, DOI 10.1046/j.1365-2222.1998.00176.x; KAMPELMACHER MJ, 1987, CLIN ALLERGY, V17, P317, DOI 10.1111/j.1365-2222.1987.tb02021.x; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305	5	32	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1365	1368		10.1136/bmj.316.7141.1365	http://dx.doi.org/10.1136/bmj.316.7141.1365			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563993	Green Published			2022-12-28	WOS:000073483000025
J	Neubauer, H; Cumano, A; Muller, M; Wu, H; Huffstadt, U; Pfeffer, K				Neubauer, H; Cumano, A; Muller, M; Wu, H; Huffstadt, U; Pfeffer, K			Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis	CELL			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION PATHWAY; COLONY-STIMULATING FACTOR; MICE LACKING JAK3; STEM-CELL FACTOR; C-KIT; ERYTHROPOIETIN RECEPTOR; LYMPHOCYTE MATURATION; DEVELOPING MOUSE; YOLK-SAC	Janus kinases (Jaks) play an important role in signal transduction via cytokine and growth factor receptors. A targeted inactivation of Jak2 was performed. Jak2(-/-) embryos are anemic and die around day 12.5 postcoitum. Primitive erythrocytes are found, but definitive erythropoiesis is absent. Compared to erythropoietin receptor-deficient mice, the phenotype of Jak2 deficiency is more severe. Fetal liver BFU-E and CFU-E colonies are completely absent. However, multilineage hematopoietic stem cells (CD34(low), c-kit(pos)) can be found, and B lymphopoiesis appears intact. In contrast to IFN alpha stimulation, Jak2(-/-) cells do not respond to IFN gamma. Jak2(-/-) embryonic stem cells are competent for LIF signaling. The data provided demonstrate that Jak2 has pivotal functions for signal transduction of a set of cytokine receptors required in definitive erythropoiesis.	Tech Univ Munich, Inst Med Microbiol & Hyg, D-81675 Munich, Germany; GSF, Natl Res Ctr Environm & Hlth, Dept Mammalian Genet, D-85758 Neuherberg, Germany; Inst Pasteur, Unite Biol Mol Gene, F-75024 Paris, France; Univ Vet Med, Dept Vet Biotechnol & Mol Genet, Inst Genet & Anim Breeding, A-1210 Vienna, Austria; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Veterinary Medicine Vienna; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Pfeffer, K (corresponding author), Tech Univ Munich, Inst Med Microbiol & Hyg, Trogerstr 9, D-81675 Munich, Germany.		Neubauer, Hans/C-4467-2016	Neubauer, Hans/0000-0002-3467-4105; Cumano, Ana/0000-0002-4578-959X; Muller, Mathias/0000-0002-7879-3552; Pfeffer, Klaus/0000-0002-5652-6330				Aguila HL, 1997, IMMUNOL REV, V157, P13, DOI 10.1111/j.1600-065X.1997.tb00971.x; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Bach EA, 1996, MOL CELL BIOL, V16, P3214; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Chen JZ, 1996, ADV IMMUNOL, V62, P31, DOI 10.1016/S0065-2776(08)60427-7; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; CUMANO A, 1993, P NATL ACAD SCI USA, V90, P6429, DOI 10.1073/pnas.90.14.6429; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DeBerry C, 1997, BIOCHEM J, V327, P73, DOI 10.1042/bj3270073; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; EMERSON SG, 1985, J CLIN INVEST, V76, P1286, DOI 10.1172/JCI112087; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; GREGORY CJ, 1978, BLOOD, V51, P527; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Kobayashi M, 1996, BLOOD, V88, P429, DOI 10.1182/blood.V88.2.429.bloodjournal882429; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; KRAUSE DS, 1994, BLOOD, V84, P691; Ku H, 1996, BLOOD, V87, P4544, DOI 10.1182/blood.V87.11.4544.bloodjournal87114544; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PAZDRAK K, 1995, J IMMUNOL, V155, P397; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIMODA K, 1994, BIOCHEM BIOPH RES CO, V203, P922, DOI 10.1006/bbrc.1994.2270; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TANG B, 1994, MOL CELL BIOL, V14, P8432, DOI 10.1128/MCB.14.12.8432; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; Weiler SR, 1996, BLOOD, V87, P3688, DOI 10.1182/blood.V87.9.3688.bloodjournal8793688; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; WURST W, 1993, GENE TARGETING PRACT; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Yoshida M, 1997, BRIT J HAEMATOL, V98, P254, DOI 10.1046/j.1365-2141.1997.2283045.x	69	626	712	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					397	409		10.1016/S0092-8674(00)81168-X	http://dx.doi.org/10.1016/S0092-8674(00)81168-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590174	Bronze			2022-12-28	WOS:000073471500015
J	Dolmetsch, RE; Xu, KL; Lewis, RS				Dolmetsch, RE; Xu, KL; Lewis, RS			Calcium oscillations increase the efficiency and specificity of gene expression	NATURE			English	Article							INTRACELLULAR CA2+ STORES; NF-KAPPA-B; T-LYMPHOCYTES; ANTIGEN RECEPTOR; CYCLOSPORINE-A; CALCINEURIN; ACTIVATION; CHANNELS; CELLS; DEPLETION	Cytosolic calcium ([Ca2+](i)) oscillations are a nearly universal mode of signalling in excitable and non-excitable cells(1-4). Although Ca2+ is known to mediate a diverse array of cell functions, it is not known whether oscillations contribute to the efficiency or specificity of signalling or are merely an inevitable consequence of the feedback control of [Ca2+](i). We have developed a Ca2+ clamp technique to investigate the roles of oscillation amplitude and frequency in regulating gene expression driven by the proinflammatory transcription factors NF-AT, Oct/GAP and NF-kappa B. Here we report that oscillations reduce the effective Ca2+ threshold for activating transcription factors, thereby increasing signal detection at low levels of stimulation. In addition, specificity is encoded by the oscillation frequency: rapid oscillations stimulate all three transcription factors, whereas infrequent oscillations activate only NF-kappa B. The genes encoding the cytokines interleukin (IL)-2 and IL-8 are also frequency-sensitive in a way that reflects their degree of dependence on NF-AT versus NF-kappa B. Our results provide direct evidence that [Ca2+]i oscillations increase both the efficacy and the information content of Ca2+ signals that lead to gene expression and cell differentiation.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Lewis, RS (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.			Lewis, Richard/0000-0002-6010-7403	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM045374] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DOLMETSCH RE, IN PRESS IMAGING LIV; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; DURAND DB, 1987, J EXP MED, V165, P3955; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Fields RD, 1997, J NEUROSCI, V17, P7252; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WECHSLER AS, 1994, J IMMUNOL, V153, P2515; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	30	1594	1636	1	102	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					933	936		10.1038/31960	http://dx.doi.org/10.1038/31960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582075				2022-12-28	WOS:000073359900052
J	DeLong, E				DeLong, E			Microbiology - Archaeal means and extremes	SCIENCE			English	Editorial Material							RIBOSOMAL-RNA SEQUENCES; PHYLOGENETIC ANALYSIS; ARCHAEBACTERIA; EUKARYOTES; EVOLUTION; DIVERSITY		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	DeLong, E (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.							Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Bintrim SB, 1997, P NATL ACAD SCI USA, V94, P277, DOI 10.1073/pnas.94.1.277; Blochl E, 1997, EXTREMOPHILES, V1, P14; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Holden JF, 1998, FEMS MICROBIOL ECOL, V25, P33, DOI 10.1111/j.1574-6941.1998.tb00458.x; HUBER R, 1990, NATURE, V345, P179, DOI 10.1038/345179a0; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jurgens G, 1997, APPL ENVIRON MICROB, V63, P803, DOI 10.1128/AEM.63.2.803-805.1997; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kudo Y, 1997, BIOSCI BIOTECH BIOCH, V61, P917, DOI 10.1271/bbb.61.917; MASSANA R, 1997, NATURE, V63, P50; MCGREGOR BJ, 1997, APPL ENVIRON MICROB, V63, P1178; MCINERNEY JO, 1995, APPL ENVIRON MICROB, V61, P1646, DOI 10.1128/AEM.61.4.1646-1648.1995; Munson MA, 1997, APPL ENVIRON MICROB, V63, P4729, DOI 10.1128/AEM.63.12.4729-4733.1997; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Schleper C, 1997, J BACTERIOL, V179, P7803, DOI 10.1128/jb.179.24.7803-7811.1997; Schleper C, 1997, APPL ENVIRON MICROB, V63, P321, DOI 10.1128/AEM.63.1.321-323.1997; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1978, J MOL EVOL, V11, P245, DOI 10.1007/BF01734485; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	33	70	72	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	1998	280	5363					542	543		10.1126/science.280.5363.542	http://dx.doi.org/10.1126/science.280.5363.542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ684	9575100				2022-12-28	WOS:000073242100032
J	Mulle, C; Sailer, A; Perez-Otano, I; Dickinson-Anson, H; Castillo, PE; Bureau, I; Maron, C; Gage, FH; Mann, JR; Bettler, B; Heinemann, SF				Mulle, C; Sailer, A; Perez-Otano, I; Dickinson-Anson, H; Castillo, PE; Bureau, I; Maron, C; Gage, FH; Mann, JR; Bettler, B; Heinemann, SF			Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice	NATURE			English	Article							KAINIC ACID; PYRAMIDAL CELLS; RECEPTORS; EXPRESSION; DEATH; HIPPOCAMPUS; PLASTICITY; SYNAPSES; CLONING; AMPA	L-glutamate, the neurotransmitter of the majority of excitatory synapses in the brain, acts on three classes of ionotropic receptors: NMDA (N-methyl-D-aspartate), AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and kainate receptors. Little is known about the physiological role of kainate receptors because in many experimental situations it is not possible to distinguish them from AMPA receptors(1,2). Mice with disrupted kainate receptor genes enable the study of the specific role of kainate receptors in synaptic transmission as well as in the neurotoxic effects of kainate. We have now generated mutant mice lacking the kainate-receptor subunit GluR6. The hippocampal neurons in the CA3 region of these mutant mice are much less sensitive to kainate. In addition, a postsynaptic kainate current evoked in CA3 neurons by a train of stimulation of the mossy fibre system is absent in the mutant(3,4). We find that GluR6-deficient mice are less susceptible to systemic administration of kainate, as judged by onset of seizures and by the activation of immediate early genes in the hippocampus. Our results indicate that kainate receptors containing the GluR6 subunit are important in synaptic transmission as well as in the epileptogenic effects of kainate.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Fac Med, Dept Fisiol, Montevideo, Uruguay; City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; Univ Bordeaux 2, CNRS, UMR 5541, F-33076 Bordeaux, France	Salk Institute; Salk Institute; Universidad de la Republica, Uruguay; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Heinemann, SF (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.		Perez-Otano, Isabel/S-9613-2017; bettler, bernhard/AAO-8018-2020; Sailer, Andreas/M-9913-2016; Bureau, Ingrid/O-3941-2016	Perez-Otano, Isabel/0000-0002-7222-8202; Sailer, Andreas/0000-0002-9015-7946; Mulle, Christophe/0000-0003-2709-6615; Bettler, Bernhard/0000-0003-0842-8207; Castillo, Pablo/0000-0002-9834-1801; Bureau, Ingrid/0000-0001-9166-2250				BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bischoff S, 1997, J COMP NEUROL, V379, P541, DOI 10.1002/(SICI)1096-9861(19970324)379:4<541::AID-CNE6>3.0.CO;2-2; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; LASALLE GL, 1988, NEUROSCI LETT, V88, P127, DOI 10.1016/0304-3940(88)90112-7; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SMEYNE RJ, 1993, NATURE, V365, P279, DOI 10.1038/365279b0; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	26	391	402	0	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 9	1998	392	6676					601	605		10.1038/33408	http://dx.doi.org/10.1038/33408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG300	9580260				2022-12-28	WOS:000072987200059
J	deCharms, RC; Blake, DT; Merzenich, MM				deCharms, RC; Blake, DT; Merzenich, MM			Optimizing sound features for cortical neurons	SCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; CAT STRIATE CORTEX; SPECTRO-TEMPORAL CHARACTERISTICS; SPECIES-SPECIFIC VOCALIZATIONS; COMBINATION-SENSITIVE NEURONS; SIMPLE RECEPTIVE-FIELDS; SPATIOTEMPORAL ORGANIZATION; FUNCTIONAL-ORGANIZATION; MULTIFREQUENCY SOUNDS; POPULATION RESPONSES	The brain's cerebral cortex decomposes visual images into information about oriented edges, direction and velocity information, and color. How does the cortex decompose perceived sounds? A reverse correlation technique demonstrates that neurons in the primary auditory cortex of the awake primate have complex patterns of sound-feature selectivity that indicate sensitivity to stimulus edges in frequency or in time, stimulus transitions in frequency or intensity, and feature conjunctions. This allows the creation of classes of stimuli matched to the processing characteristics of auditory cortical neurons. Stimuli designed for a particular neuron's preferred feature pattern can drive that neuron with higher sustained firing rates than have typically been recorded with simple stimuli. These data suggest that the cortex decomposes an auditory scene into component parts using a feature-processing system reminiscent of that used for the cortical decomposition of visual images.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Merzenich, MM (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	merz@keck.ucsf.edu						ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BAKER CL, 1990, VISUAL NEUROSCI, V4, P101, DOI 10.1017/S0952523800002273; Bieser A, 1996, EXP BRAIN RES, V108, P273; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chew SJ, 1996, SCIENCE, V274, P1909, DOI 10.1126/science.274.5294.1909; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DEAR SP, 1993, J NEUROPHYSIOL, V70, P1988, DOI 10.1152/jn.1993.70.5.1988; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Doupe AJ, 1997, J NEUROSCI, V17, P1147; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; EGGERMONT JJ, 1983, HEARING RES, V10, P167, DOI 10.1016/0378-5955(83)90052-7; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; EGGERMONT JJ, 1994, HEARING RES, V74, P51, DOI 10.1016/0378-5955(94)90175-9; FITZPATRICK DC, 1993, J NEUROSCI, V13, P931; GLASS I, 1979, EXP BRAIN RES, V34, P489; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; Heil P, 1997, J NEUROPHYSIOL, V77, P2642, DOI 10.1152/jn.1997.77.5.2642; HERMES DJ, 1981, HEARING RES, V5, P147, DOI 10.1016/0378-5955(81)90043-5; HERMES DJ, 1982, HEARING RES, V6, P103, DOI 10.1016/0378-5955(82)90009-0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kao MC, 1997, BIOSYSTEMS, V40, P103, DOI 10.1016/0303-2647(96)01635-8; KAWASAKI M, 1988, J NEUROPHYSIOL, V59, P623, DOI 10.1152/jn.1988.59.2.623; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KONISHI M, 1994, BRAIN BEHAV EVOLUT, V44, P279, DOI 10.1159/000113582; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MENDELSON JR, 1993, EXP BRAIN RES, V94, P65; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; Merzenich MM., 1985, DYNAMIC ASPECTS NEOC, P397; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MILLER JM, 1974, BRAIN RES, V69, P101, DOI 10.1016/0006-8993(74)90374-6; Nelken I, 1997, J NEUROPHYSIOL, V78, P800, DOI 10.1152/jn.1997.78.2.800; NELKEN I, 1994, HEARING RES, V72, P237, DOI 10.1016/0378-5955(94)90222-4; NELKEN I, 1994, HEARING RES, V72, P223, DOI 10.1016/0378-5955(94)90221-6; NELKEN I, 1994, HEARING RES, V72, P206, DOI 10.1016/0378-5955(94)90220-8; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; PHILLIPS DP, 1987, EXP BRAIN RES, V67, P479; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Rieke F., 1997, SPIKES EXPLORING NEU; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; Schreiner C E, 1992, Curr Opin Neurobiol, V2, P516, DOI 10.1016/0959-4388(92)90190-V; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1988, CODING TEMPORAL PATT; SCHREINER CE, COMMUNICATION; SEMPLE MN, 1993, J NEUROPHYSIOL, V69, P462, DOI 10.1152/jn.1993.69.2.462; SEMPLE MN, 1993, J NEUROPHYSIOL, V69, P449, DOI 10.1152/jn.1993.69.2.449; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; SHAMMA SA, 1997, SOC NEUR ABSTR, V23, P805; SIMMONS JA, 1993, J COMP PHYSIOL A, V172, P533, DOI 10.1007/BF00213677; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1992, PHILOS T ROY SOC B, V336, P423, DOI 10.1098/rstb.1992.0078; SUGA N, 1989, J EXP BIOL, V146, P277; SUGA N, 1965, J PHYSIOL-LONDON, V179, P26, DOI 10.1113/jphysiol.1965.sp007648; SUTTER ML, 1995, J NEUROPHYSIOL, V73, P190, DOI 10.1152/jn.1995.73.1.190; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; WHITFIEL.IC, 1965, J NEUROPHYSIOL, V28, P655, DOI 10.1152/jn.1965.28.4.655; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212	75	335	337	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1439	1443		10.1126/science.280.5368.1439	http://dx.doi.org/10.1126/science.280.5368.1439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603734				2022-12-28	WOS:000073883400057
J	Blaser, MJ				Blaser, MJ			Science, medicine, and the future - Helicobacter pylori and gastric diseases	BRITISH MEDICAL JOURNAL			English	Review							PEPTIC-ULCERATION; DUODENAL-ULCER; INFECTION; ADENOCARCINOMA; ERADICATION; LYMPHOMA; STOMACH; RISK		Vanderbilt Univ, Sch Med, Med Ctr N A3310, Div Infect Dis, Nashville, TN 37232 USA	Vanderbilt University	Blaser, MJ (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N A3310, Div Infect Dis, 1161 21st Ave S, Nashville, TN 37232 USA.	Martin.Blaser@mcmail.vanderbilt.edu			NIDDK NIH HHS [R01 DK50837, R01 DK53707] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050837, R01DK053707] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Blaser MJ, 1997, LANCET, V349, P1020, DOI 10.1016/S0140-6736(96)09133-7; BLASER MJ, 1995, CANCER RES, V55, P562; BLASER MJ, 1995, CANCER RES, V55, P2111; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Chow WH, 1998, CANCER RES, V58, P588; Collins RD, 1997, HUM PATHOL, V28, P757, DOI 10.1016/S0046-8177(97)90145-3; CORREA P, 1992, CANCER RES, V52, P6735; Go MF, 1996, J BACTERIOL, V178, P3934, DOI 10.1128/jb.178.13.3934-3938.1996; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Labenz J, 1997, GASTROENTEROLOGY, V112, P1442, DOI 10.1016/S0016-5085(97)70024-6; MARSHALL BJ, 1984, LANCET, V1, P1311; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; VICARI JJ, IN PRESS GASTROENTER; Werdmuller BFM, 1997, DIGEST DIS SCI, V42, P103, DOI 10.1023/A:1018841222856; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	21	210	235	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1507	1510		10.1136/bmj.316.7143.1507	http://dx.doi.org/10.1136/bmj.316.7143.1507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582144	Green Published			2022-12-28	WOS:000073707700034
J	Rea, D; Poole, C; Gray, R				Rea, D; Poole, C; Gray, R			Adjuvant tamoxifen: how long before we know how long?	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; THERAPY		Univ Birmingham, Canc Res Council Inst Canc Studies, Birmingham B15 2TA, W Midlands, England	University of Birmingham	Rea, D (corresponding author), Univ Birmingham, Canc Res Council Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.			Gray, Richard/0000-0003-4440-574X				ABE O, 1992, LANCET, V339, P71; Abram P, 1996, J NATL CANCER I, V88, P1834; BERAL V, 1995, LANCET, V345, P1642, DOI 10.1016/S0140-6736(95)90151-5; DELOZIER T, 1997, P AN M AM SOC CLIN, V16, P128; *EARL BREAST CANC, IN PRESS LANCET; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; LOVE RR, 1988, BREAST CANCER RES TR, V12, P297, DOI 10.1007/BF01811242; MCDONALD CC, 1991, BRIT MED J, V303, P435, DOI 10.1136/bmj.303.6800.435; *NCI, 1995, DADJ THER BREAST CAN; Peto R, 1996, J NATL CANCER I, V88, P1791, DOI 10.1093/jnci/88.24.1791; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828	13	17	17	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1518	1519		10.1136/bmj.316.7143.1518	http://dx.doi.org/10.1136/bmj.316.7143.1518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582148	Green Published			2022-12-28	WOS:000073707700042
J	[Anonymous]				[Anonymous]			BMJ data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	1998	316	7143					1519	1520						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582149				2022-12-28	WOS:000073707700043
J	Belshe, RB; Mendelman, PM; Treanor, J; King, J; Gruber, WC; Piedra, P; Bernstein, DI; Hayden, FG; Kotloff, K; Zangwill, K; Iacuzio, D; Wolff, M				Belshe, RB; Mendelman, PM; Treanor, J; King, J; Gruber, WC; Piedra, P; Bernstein, DI; Hayden, FG; Kotloff, K; Zangwill, K; Iacuzio, D; Wolff, M			The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE OTITIS-MEDIA; SYSTEMIC ANTIBODY-RESPONSES; MIDDLE-EAR FLUIDS; A VIRUS-VACCINES; INACTIVATED VACCINE; RESPIRATORY VIRUSES; YOUNG-CHILDREN; RECOMBINANT; VIRULENCE; INFECTION	Background. Influenzavirus vaccine is used infrequently in healthy children, even though the rates of influenza in the group are high. We conducted a multicenter, double-blind, placebo-controlled trial of a live attenuated, cold-adapted, trivalent influenzavirus vaccine in children 15 to 71 months old. Methods. Two hundred eighty-eight children were assigned to receive one dose of vaccine or placebo given by intranasal spray, and 1314 were assigned to receive two doses approximately 60 days apart. The strains included in the vaccine were antigenically equivalent to those in the inactivated influenzavirus vaccine in use at the time. The subjects were monitored with viral cultures for influenza during the subsequent influenza season. A case of influenza was defined as an illness associated with the isolation of wild-type influenzavirus from respiratory secretions. Results. The intranasal vaccine was accepted and well tolerated. Among children who were initially seronegative, antibody titers increased by a factor of four in 61 and 96 percent, depending on the influenza strain. Culture-positive influenza was significantly less common in the vaccine group (14 cases among 1070 subjects) than the placebo group (95 cases among 532 subjects). The vaccine efficacy was 93 percent (95 percent confidence interval, 88 to 96 percent) against culture-confirmed influenza. Both the one-dose regimen (89 percent efficacy) and the two-dose regimen (94 percent efficacy) were efficacious, and the vaccine was efficacious against both strains of influenza circulating in 1996-1997, A(H3N2) and B. The vaccinated children had significantly fewer febrile illnesses, including 30 percent fewer episodes of febrile otitis media (95 percent confidence interval, 18 to 45 percent; P < 0.001). Conclusions. A live attenuated, cold-adapted influenzavirus vaccine was safe, immunogenic, and effective against influenza A(H3N2) and B in healthy children. (C) 1998, Massachusetts Medical Society.	St Louis Univ, Hlth Sci Ctr, Div Infect Dis, Dept Med, St Louis, MO 63110 USA; Aviron, Mountain View, CA USA; Univ Rochester, Dept Med, Rochester, NY USA; Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; Vanderbilt Univ, Dept Pediat, Nashville, TN USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Univ Virginia, Dept Internal Med, Charlottesville, VA USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; Harbor UCLA Med Ctr, Dept Pediat, Los Angeles, CA USA; Kaiser UCLA Vaccine Program, Los Angeles, CA USA; NIAID, Div Microbial & Infect Dis, NIH, Bethesda, MD 20892 USA; Emmes Corp, Potomac, MD USA	Saint Louis University; University of Rochester; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University of Virginia; University of Virginia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation	Belshe, RB (corresponding author), St Louis Univ, Hlth Sci Ctr, Div Infect Dis, Dept Med, 3635 Vista Ave,FDT-8N, St Louis, MO 63110 USA.		kotloff, karen l/E-7768-2012	kotloff, karen l/0000-0003-1808-6431	NIAID NIH HHS [N01-AI-45251, N01-AI-45250, N01-AI-45248] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045248, N01AI045251, N01AI045250] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1997, MMWR Recomm Rep, V46, P1; BELSHE RB, 1995, AM J RESP CRIT CARE, V152, pS72, DOI 10.1164/ajrccm/152.4_Pt_2.S72; *CDCP, 1995, 1995 96 WHO INFL REA; CHONMAITREE T, 1994, J INFECT DIS, V169, P1265, DOI 10.1093/infdis/169.6.1265; CHONMAITREE T, 1990, J INFECT DIS, V162, P546, DOI 10.1093/infdis/162.2.546; CHONMAITREE T, 1992, J PEDIATR-US, V120, P856, DOI 10.1016/S0022-3476(05)81950-X; CHONMAITREE T, 1986, PEDIATRICS, V77, P698; CLANCY RL, 1995, DRUGS, V50, P587, DOI 10.2165/00003495-199550040-00001; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; COX NJ, 1979, VIROLOGY, V97, P190, DOI 10.1016/0042-6822(79)90386-6; *CYT SOFTW, 1995, STATXACT 3 WIND; DONABEDIAN AM, 1987, MICROB PATHOGENESIS, V3, P97, DOI 10.1016/0882-4010(87)90068-4; *FOOD DRUG ADM, 1995, COSTART COD SYMB THE; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; GLEZEN WP, 1980, JAMA-J AM MED ASSOC, V243, P1345; GORSE GJ, 1988, J CLIN MICROBIOL, V26, P911, DOI 10.1128/JCM.26.5.911-918.1988; Gruber WC, 1996, J INFECT DIS, V173, P1313, DOI 10.1093/infdis/173.6.1313; JOHNSON PR, 1986, J INFECT DIS, V154, P121, DOI 10.1093/infdis/154.1.121; Maassab H F, 1990, Adv Biotechnol Processes, V14, P203; MAASSAB HF, 1969, J IMMUNOL, V102, P728; MAASSAB HF, 1982, J INFECT DIS, V146, P780, DOI 10.1093/infdis/146.6.780; MAASSAB HF, 1983, VIROLOGY, V130, P342, DOI 10.1016/0042-6822(83)90088-0; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; POWERS DC, 1989, J CLIN MICROBIOL, V27, P2666, DOI 10.1128/JCM.27.12.2666-2671.1989; *SAS I, 1996, SAS VERS 6 12; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; SWIERKOSZ EM, 1994, J INFECT DIS, V169, P1121, DOI 10.1093/infdis/169.5.1121; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; WRIGHT PF, 1987, PROG MED VIROL, V34, P70	31	700	758	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1405	1412		10.1056/NEJM199805143382002	http://dx.doi.org/10.1056/NEJM199805143382002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580647				2022-12-28	WOS:000073563700002
J	Kheradmand, F; Werner, E; Tremble, P; Symons, M; Werb, Z				Kheradmand, F; Werner, E; Tremble, P; Symons, M; Werb, Z			Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change	SCIENCE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; RAS TRANSFORMATION; NADPH OXIDASE; FIBROBLASTS; FIBRONECTIN; ACTIVATION; TRANSLOCATION; RECEPTOR; PROTEINS	Integrin-mediated reorganization of cell shape leads to an altered cellular phenotype. Disruption of the actin cytoskeleton, initiated by binding of soluble antibody to alpha 5 beta 1 integrin, led to increased expression of the collagenase-1 gene in rabbit synovial fibroblasts. Activation of the guanosine triphosphate-binding protein Rac1, which was downstream of the integrin, was necessary for this process, and expression of activated Rac1 was sufficient to increase expression of collagenase-1. Rac1 activation generated reactive oxygen species that were essential for nuclear factor kappa B-dependent transcriptional regulation of interleukin-1 alpha, which, in an autocrine manner, induced collagenase-1 gene expression. Remodeling of the extracellular matrix and consequent alterations of integrin-mediated adhesion and cytoarchitecture are central to development, wound healing, inflammation, and malignant disease, The resulting activation of Rac1 may lead to altered gene regulation and alterations in cellular morphogenesis, migration, and invasion.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Onyx Pharmaceut, Richmond, CA 94806 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena@itsa.ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE010306] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03732] Funding Source: Medline; NIAMS NIH HHS [AR20684] Funding Source: Medline; NIDCR NIH HHS [DE10306] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; AGGELER J, 1984, J CELL BIOL, V98, P1662, DOI 10.1083/jcb.98.5.1662; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bonizzi G, 1996, EUR J BIOCHEM, V242, P544, DOI 10.1111/j.1432-1033.1996.0544r.x; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DASH D, 1995, J BIOL CHEM, V270, P17321, DOI 10.1074/jbc.270.29.17321; FINBLOOM DS, 1994, MOL CELL BIOL, V14, P2113, DOI 10.1128/MCB.14.3.2113; FORSAYETH JR, 1994, BIOTECHNIQUES, V17, P354; HARRIS ED, 1975, NATURE, V257, P243, DOI 10.1038/257243a0; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KHERADMAND F, UNPUB; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; MICHIELS F, 1995, NATURE, V375, P388; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Roskelley CD, 1995, BIOCHEM CELL BIOL, V73, P391, DOI 10.1139/o95-046; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482; TREMBLE P, 1994, MOL BIOL CELL, V5, P439, DOI 10.1091/mbc.5.4.439; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; XU XM, 1994, J BIOL CHEM, V269, P23569; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X	43	313	319	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					898	902		10.1126/science.280.5365.898	http://dx.doi.org/10.1126/science.280.5365.898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572733				2022-12-28	WOS:000073532900040
J	Kunz, J; Staudacher, T; Allegre, CJ				Kunz, J; Staudacher, T; Allegre, CJ			Plutonium-fission xenon found in Earth's mantle	SCIENCE			English	Article							MID-ATLANTIC RIDGE; CO2 WELL GAS; NOBLE-GASES; HARDING COUNTY; BASALT GLASSES; EXCESS XE-129; EVOLUTION; CONSTRAINTS; ATMOSPHERE; ISOTOPES	Data from mid-ocean ridge basalt glasses indicate that the short-lived radionuclide plutonium-244 that was present during an early stage of the development of the solar system is responsible for roughly 30 percent of the fissiogenic xenon excesses in the interior of Earth today. The rest of the fissiogenic xenon can be ascribed to the spontaneous fission of still live uranium-238. This result, in combination with the refined determination of xenon-129 excesses from extinct iodine-129, implies that the accretion of Earth was finished roughly 50 million to 70 million years after solar system formation and that the atmosphere was formed by mantle degassing.	Inst Phys Globe, Lab Geochim & Cosmochim, CNRS, URA 1758, F-75252 Paris 05, France; Inst Phys Globe Paris, Observ Volcanol Piton Fournaise, F-97418 La Plaine Cafres, Reunion, France; Univ Paris 07, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kunz, J (corresponding author), Inst Phys Globe, Lab Geochim & Cosmochim, CNRS, URA 1758, 4 Pl Jussieu, F-75252 Paris 05, France.	kunz@ipgp.jussieu.fr						ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; BOULOS MS, 1971, SCIENCE, V174, P1334, DOI 10.1126/science.174.4016.1334; CLARKE WB, 1964, ISOTOPIC COSMIC CHEM, P471; HENNECKE EW, 1975, EARTH PLANET SC LETT, V27, P346, DOI 10.1016/0012-821X(75)90047-3; HOHENBERG CM, 1967, SCIENCE, V156, P233, DOI 10.1126/science.156.3772.233; HOHENBERG CM, 1967, J GEOPHYS RES, V72, P3139, DOI 10.1029/JZ072i012p03139; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; Hudson G.B., 1989, LUNAR PLANETARY SCI, V19, P547; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; KANEOKA I, 1980, SCIENCE, V208, P1366, DOI 10.1126/science.208.4450.1366; KANEOKA I, 1978, EARTH PLANET SC LETT, V39, P382, DOI 10.1016/0012-821X(78)90026-2; KIM JS, 1992, P LUNAR PLANET SCI, V22, P145; KUNZ J, UNPUB; KURODA PK, 1960, NATURE, V187, P36, DOI 10.1038/187036a0; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; KURZ MD, 1982, EARTH PLANET SC LETT, V58, P1, DOI 10.1016/0012-821X(82)90099-1; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; LIN WJ, 1987, GEOCHEM J, V21, P197, DOI 10.2343/geochemj.21.197; MARTY B, 1989, EARTH PLANET SC LETT, V94, P45, DOI 10.1016/0012-821X(89)90082-4; MESHIK A, 1996, J C ABSTR, V1, P400; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; OZIMA M, 1991, EARTH PLANET SC LETT, V105, P13, DOI 10.1016/0012-821X(91)90117-Z; OZIMA M, 1982, NOBLE GAS GEOCHEMIST; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; PHINNEY D, 1978, J GEOPHYS RES, V83, P2313, DOI 10.1029/JB083iB05p02313; PINEAU F, 1994, EARTH PLANET SC LETT, V123, P179, DOI 10.1016/0012-821X(94)90266-6; RAGETTLI RA, 1994, EARTH PLANET SC LETT, V128, P653, DOI 10.1016/0012-821X(94)90177-5; REYNOLDS JH, 1960, J GEOPHYS RES, V65, P3843, DOI 10.1029/JZ065i011p03843; REYNOLDS JH, 1960, PHYS REV LETT, V4, P351, DOI 10.1103/PhysRevLett.4.351; SARDA P, 1985, EARTH PLANET SC LETT, V72, P357, DOI 10.1016/0012-821X(85)90058-5; SARDA P, 1988, EARTH PLANET SC LETT, V91, P73, DOI 10.1016/0012-821X(88)90152-5; SMITH SP, 1981, EARTH PLANET SC LETT, V54, P236, DOI 10.1016/0012-821X(81)90006-6; STAUDACHER T, 1982, EARTH PLANET SC LETT, V60, P389, DOI 10.1016/0012-821X(82)90075-9; STAUDACHER T, 1989, EARTH PLANET SC LETT, V96, P119, DOI 10.1016/0012-821X(89)90127-1; STAUDACHER T, 1987, NATURE, V325, P605, DOI 10.1038/325605a0; Valbracht PJ, 1997, EARTH PLANET SC LETT, V150, P399, DOI 10.1016/S0012-821X(97)00094-0; YORK D, 1969, EARTH PLANET SC LETT, V5, P320; ZHANG YX, 1989, J GEOPHYS RES-SOLID, V94, P13719, DOI 10.1029/JB094iB10p13719	40	104	105	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					877	880		10.1126/science.280.5365.877	http://dx.doi.org/10.1126/science.280.5365.877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572726				2022-12-28	WOS:000073532900033
J	Maguire, EA; Burgess, N; Donnett, JG; Frackowiak, RSJ; Frith, CD; O'Keefe, J				Maguire, EA; Burgess, N; Donnett, JG; Frackowiak, RSJ; Frith, CD; O'Keefe, J			Knowing where and getting there: A human navigation network	SCIENCE			English	Article							CEREBRAL-CORTEX; BASAL GANGLIA; RAT; HIPPOCAMPUS; PROJECTION; LESIONS	The neural basis of navigation by humans was investigated with functional neuroimaging of brain activity during navigation ina familiar, yet complex virtual reality town. Activation of the right hippocampus was strongly associated with knowing accurately where places were located and navigating accurately between them. Getting to those places quickly was strongly associated with activation of the right caudate nucleus. These two right-side brain structures function in the context of associated activity in right inferior parietal and bilateral medial parietal regions that support egocentric movement through the virtual town, and activity in other left-side regions (hippocampus, frontal cortex) probably involved in nonspatial aspects of navigation. These findings outline a network of brain areas that support navigation in humans and link the functions of these regions to physiological observations in other mammals.	UCL, Neurol Inst, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Maguire, EA (corresponding author), UCL, Neurol Inst, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	e.maguire@fil.ion.ucl.ac.uk	Burgess, Neil/B-2420-2009; Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011; Frith, Chris D/A-2171-2009	Burgess, Neil/0000-0003-0646-6584; Frackowiak, Richard/0000-0002-3151-822X; Frith, Chris D/0000-0002-8665-0690	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; [Anonymous], 1983, CANADIAN PSYCHOL; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Buchel C, 1996, NEUROIMAGE, V4, P60, DOI 10.1006/nimg.1996.0029; Burgess N, 1997, PHILOS T ROY SOC B, V352, P1397, DOI 10.1098/rstb.1997.0125; Burgess N, 1996, HIPPOCAMPUS, V6, P749; DEJONG BM, 1994, BRAIN, V117, P1039; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Evans AC, 1993, P IEEE NUCL SCI S ME; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Karnath HO, 1997, PHILOS T ROY SOC B, V352, P1411, DOI 10.1098/rstb.1997.0127; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 1996, NEUROPSYCHOLOGIA, V34, P993, DOI 10.1016/0028-3932(96)00022-X; Maguire EA, 1997, J NEUROSCI, V17, P7103; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1991, BRAIN SPACE, P273, DOI DOI 10.1016/j.neuron.2015.06.011; OKEEFE J, IN PRESS PHILOS T B; Passingham R., 1995, FRONTAL LOBES VOLUNT; PASSINGHAM RE, 1987, NEURAL BEHAV APPROAC; POTEGAL M, 1908, SPATIAL ABILITIES DE; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SWANSON LW, 1986, J NEUROSCI, V6, P3010; Talairach I., 1988, COPLANAR STEREOTACTI; TAUBE JS, 1990, J NEUROSCI, V10, P420; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WIENER SI, 1993, J NEUROSCI, V13, P3802; Wood F., 1975, SHORT TERM MEMORY, P257	42	1024	1042	3	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					921	924		10.1126/science.280.5365.921	http://dx.doi.org/10.1126/science.280.5365.921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572740				2022-12-28	WOS:000073532900047
J	DeFries, Z				DeFries, Z			Identity matters (or does it?)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1331	1331		10.1001/jama.279.17.1331	http://dx.doi.org/10.1001/jama.279.17.1331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582026				2022-12-28	WOS:000073359800001
J	Pirrotta, V				Pirrotta, V			Polycombing the genome: PcG, trxG, and chromatin silencing	CELL			English	Review							MEDIATED REPRESSION; DROSOPHILA; ACCESSIBILITY; PROTEIN		Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland	University of Geneva	Pirrotta, V (corresponding author), Univ Geneva, Dept Zool, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.							Busturia A, 1997, DEVELOPMENT, V124, P4343; CAVALLI G, 1998, IN PRESS CELL; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marshall WF, 1997, CURR OPIN GENET DEV, V7, P259, DOI 10.1016/S0959-437X(97)80136-0; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; MULLER J, 1995, EMBO J, V14, P1209, DOI 10.1002/j.1460-2075.1995.tb07104.x; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Sigrist CJA, 1997, GENETICS, V147, P209; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Wittgenstein L. J. J., 1921, ANN NATURPHILOSOPHIE, V14; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	19	318	327	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					333	336		10.1016/S0092-8674(00)81162-9	http://dx.doi.org/10.1016/S0092-8674(00)81162-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590168	Bronze			2022-12-28	WOS:000073471500009
J	Sherratt, DJ; Wigley, DB				Sherratt, DJ; Wigley, DB			Conserved themes but novel activities in recombinases and topoisomerases	CELL			English	Review							DNA TOPOISOMERASE		Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Sherratt, DJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.							Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; JO K, 1995, SCIENCE, V267, P1817, DOI 10.1126/science.7892605; Knudsen BR, 1997, J MOL BIOL, V266, P93, DOI 10.1006/jmbi.1996.0767; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; SHUMAN S, 1998, IN PRESS MOL CELL; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wittschieben J, 1998, NUCLEIC ACIDS RES, V26, P490, DOI 10.1093/nar/26.2.490; XU CJ, 1998, IN PRESS MOL CELL; Yang W, 1997, STRUCTURE, V5, P1401, DOI 10.1016/S0969-2126(97)00290-6; Yokochi T, 1996, GENES CELLS, V1, P1069, DOI 10.1046/j.1365-2443.1996.d01-226.x	15	58	59	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					149	152		10.1016/S0092-8674(00)81566-4	http://dx.doi.org/10.1016/S0092-8674(00)81566-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568707	Bronze			2022-12-28	WOS:000073174000001
J	Walsh, BT; Devlin, MJ				Walsh, BT; Devlin, MJ			Eating disorders: Progress and problems	SCIENCE			English	Article							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; COMMUNITY SAMPLE; WOMEN; BEHAVIOR	Recent research on Anorexia Nervosa and Bulimia Nervosa has yielded an increasingly detailed understanding of the range of biological and psychological abnormalities associated with these eating disorders. Inherited vulnerabilities, cultural pressures, and adverse individual and family experiences all appear to contribute to the onset of extreme dieting, binge eating, and purging. Once initiated, these behaviors give rise to multiple physiological disturbances, some of which may serve to perpetuate the illness. Although there have been substantial advances in the management of Bulimia Nervosa, the goal of offering effective treatment to all individuals with eating disorders remains elusive. This article reviews current thinking on the etiology and treatment of the two major eating disorders and a related syndrome, Binge Eating Disorder.	New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	New York State Psychiatry Institute; Columbia University	Walsh, BT (corresponding author), New York State Psychiat Inst & Hosp, 722 W 168th St, New York, NY 10032 USA.	btw1@columbia.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053635] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53635] Funding Source: Medline; NIMH NIH HHS [MH49886, MH42206] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Attia E, 1998, AM J PSYCHIAT, V155, P548, DOI 10.1176/ajp.155.4.548; BREWERTON TD, 1995, PSYCHONEUROENDOCRINO, V20, P561, DOI 10.1016/0306-4530(95)00001-5; Carter JC, 1997, INT J EAT DISORDER, V22, P167; COHN L, 1998, EAT DISORD J TREAT P, V6; Cooper PJ, 1996, J PSYCHOSOM RES, V40, P281, DOI 10.1016/0022-3999(96)00535-1; Devlin MJ, 1997, AM J CLIN NUTR, V65, P114, DOI 10.1093/ajcn/65.1.114; Fairburn CG, 1998, ARCH GEN PSYCHIAT, V55, P425, DOI 10.1001/archpsyc.55.5.425; Fairburn CG, 1997, ARCH GEN PSYCHIAT, V54, P509; FAIRBURN CG, 1995, ARCH GEN PSYCHIAT, V52, P304; Fairburn Christopher G., 1997, P494; GARFINKEL PE, 1995, AM J PSYCHIAT, V152, P1052; GELIEBTER A, 1992, AM J CLIN NUTR, V56, P656, DOI 10.1093/ajcn/56.4.656; GOLDFEIN JA, 1993, INT J EAT DISORDER, V14, P427, DOI 10.1002/1098-108X(199312)14:4&lt;427::AID-EAT2260140405&gt;3.0.CO;2-H; GOTESTAM KG, 1995, INT J EAT DISORDER, V18, P119, DOI 10.1002/1098-108X(199509)18:2&lt;119::AID-EAT2260180203&gt;3.0.CO;2-U; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3861, DOI 10.1210/jc.81.11.3861; Hoek HW, 1998, NEW ENGL J MED, V338, P1231, DOI 10.1056/NEJM199804233381717; HOLLAND AJ, 1988, J PSYCHOSOM RES, V32, P561, DOI 10.1016/0022-3999(88)90004-9; JIMERSON DC, 1990, BIOL PSYCHIAT, V28, P443, DOI 10.1016/0006-3223(90)90412-U; Jimerson DC, 1997, ARCH GEN PSYCHIAT, V54, P529; KAYE WH, 1991, ARCH GEN PSYCHIAT, V48, P556; KAYE WH, 1997, 150 M AM PSYCH ASS S; KENDLER KS, 1991, AM J PSYCHIAT, V148, P1627; KILLEN JD, 1993, INT J EAT DISORDER, V13, P369, DOI 10.1002/1098-108X(199305)13:4&lt;369::AID-EAT2260130405&gt;3.0.CO;2-0; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; Mann T, 1997, HEALTH PSYCHOL, V16, P215, DOI 10.1037/0278-6133.16.3.215; Mantzoros CS, 1997, J CLIN ENDOCR METAB, V82, P3408, DOI 10.1210/jc.82.10.3408; NASSER M, 1993, INT J EAT DISORDER, V13, P129, DOI 10.1002/1098-108X(199301)13:1&lt;129::AID-EAT2260130116&gt;3.0.CO;2-Y; Pike KM, 1996, PSYCHOPHARMACOL BULL, V32, P265; RIGOTTI NA, 1991, JAMA-J AM MED ASSOC, V265, P1133, DOI 10.1001/jama.265.9.1133; SHARP CW, 1993, BRIT J PSYCHIAT, V162, P452, DOI 10.1192/bjp.162.4.452; SPITZER RL, 1992, INT J EAT DISORDER, V11, P191, DOI 10.1002/1098-108X(199204)11:3&lt;191::AID-EAT2260110302&gt;3.0.CO;2-S; STROBER M, 1992, AM PSYCHOP, P61; STUNKARD AJ, 1959, PSYCHIAT QUART, V33, P284, DOI 10.1007/BF01575455; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Treasure J, 1996, BRIT J PSYCHIAT, V168, P94, DOI 10.1192/bjp.168.1.94; Vandereycken Walter, 1994, FASTING SAINTS ANORE; Walsh B. Timothy, 1995, P1581; WALSH BT, 1991, AM J PSYCHIAT, V148, P1206; WALSH BT, 1997, PSYCHIATRY, P1202; WALTERS EE, 1995, AM J PSYCHIAT, V152, P64; WALTHON MA, 1991, MMWR-MORBID MORTAL W, V40, P747; Wilfley DE, 1996, INT J EAT DISORDER, V20, P377, DOI 10.1002/(SICI)1098-108X(199612)20:4<377::AID-EAT5>3.3.CO;2-E; Yanovski S Z, 1993, Obes Res, V1, P306; YANOVSKI SZ, 1992, AM J CLIN NUTR, V56, P975, DOI 10.1093/ajcn/56.6.975	44	107	113	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1387	1390		10.1126/science.280.5368.1387	http://dx.doi.org/10.1126/science.280.5368.1387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZQ591	9603723				2022-12-28	WOS:000073883400037
J	Dighiero, G; Maloum, K; Desablens, B; Cazin, B; Navarro, M; Leblay, R; Leporrier, M; Jaubert, J; Lepeu, G; Dreyfus, B; Binet, JL; Travade, P; Turpin, FL; Tertian, G; Bichoffe, A				Dighiero, G; Maloum, K; Desablens, B; Cazin, B; Navarro, M; Leblay, R; Leporrier, M; Jaubert, J; Lepeu, G; Dreyfus, B; Binet, JL; Travade, P; Turpin, FL; Tertian, G; Bichoffe, A		Fr Cooper Grp Chron Lymphoc Leukemia	Chlorambucil in indolent chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERMITTENT CHLORAMBUCIL; ARTHRITIS; THERAPY; TRIALS	Background To determine whether chlorambucil treatment benefits patients with indolent chronic lymphocytic leukemia (CLL), we conducted two randomized trials in 1535 patients with previously untreated stage A CLL. Methods In the first trial, 609 patients were randomly assigned to receive either daily chlorambucil or no treatment; in the second trial, 926 patients were randomly assigned to receive either intermittent chlorambucil plus prednisone or no treatment. Median follow-up for the first and second trials exceeded 11 and 6 years, respectively. The end points were overall survival, response to treatment, and disease progression. Results Treatment of indolent CLL did not increase survival in either trial. In the treated group, as compared with the untreated group, the relative risk of death was 1.14 (95 percent confidence interval, 0.92 to 1.41; P=0.23) in the first trial and 0.96 (95 percent confidence interval, 0.75 to 1.23; P=0.74) in the second trial, with 76 percent and 69 percent of patients, respectively, having a response to therapy. Although chlorambucil slowed disease progression, there was no effect on overall survival. In the untreated group in the first trial, 49 percent of patients did not have progression to more advanced disease and did not need therapy after follow-up of more than 11 years; however, 27 percent of patients with stage A CLL died of causes related to the disease. Conclusions Chlorambucil does not prolong survival in patients with stage A CLL. Since deferring therapy until the disease progresses to stage B or C does not compromise survival, treatment of indolent CLL is unnecessary. (C) 1998, Massachusetts Medical Society.	Inst Pasteur, Unite Immunohematol & Immunopathol, F-75724 Paris 15, France; Hop La Pitie Salpetriere, Dept Hematol, Paris, France; Ctr Hosp Reg Hop Sud, Serv Malad Sang, Amiens, France; Hop Claude Huriez, Serv Malad Sang, Lille, France; CHU Montpellier, Hop Lapeyronie, Serv Malad Sang, Montpellier, France; Ctr Hosp Reg Hop Sud, Serv Med G, Rennes, France; CHU Caen, Serv Hematol Clin, F-14000 Caen, France; CHU St Etienne, Hop Nord, St Etienne, France; Ctr Hosp Avignon, Hop Henri Duffaut, Avignon, France; CHU Poitiers, Hop Jean Bernard, Dept Hematol & Oncol Virale, Poitiers, France; Hop Hotel Dieu, Unite Immunohematol & Immunopathol, Clermont Ferrand, France; Ctr Rene Huguenin, St Cloud, France; Hop Bicetre, Lab Hematol Immunol & Cytogenet, Le Kremlin Bicetre, France; Ctr Hosp Gen Montlucon, Dept Med Interne, Montlucon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; CHU Rennes; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de St Etienne; CHU Poitiers; Universite de Poitiers; CHU Clermont Ferrand; Rene Huguenin Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Dighiero, G (corresponding author), Inst Pasteur, Unite Immunohematol & Immunopathol, 28 Rue Dr Roux, F-75724 Paris 15, France.							[Anonymous], 1990, Blood, V75, P1422; [Anonymous], 1990, Blood, V75, P1414; [Anonymous], 1989, Ann Intern Med, V110, P236; [Anonymous], 1994, Leuk Lymphoma, V13, P449; Begleiter A, 1996, LEUKEMIA LYMPHOMA, V23, P187, DOI 10.3109/10428199609054821; BERK PD, 1981, NEW ENGL J MED, V304, P441, DOI 10.1056/NEJM198102193040801; BINET JL, 1990, BRIT J HAEMATOL, V76, P45; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; CATOVSKY D, 1988, NOUV REV FR HEMATOL, V30, P423; CATOVSKY D, 1991, LEUKEMIA LYMPHOMA, V5, P105, DOI 10.3109/10428199109103389; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; COX DR, 1972, J R STAT SOC B, V34, P187; DEDRICK RL, 1992, CANCER RES, V52, P2464; Dighiero G, 1996, HEMATOL CELL THER, V38, pS41; DIGHIERO G, 1991, BLOOD, V78, P1901; JAKSIC B, 1988, NOUV REV FR HEMATOL, V30, P437; Jaksic B, 1997, CANCER-AM CANCER SOC, V79, P2107; Johnson S, 1996, Lancet, V347, P1432; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kauppi MJ, 1996, ACTA PAEDIATR, V85, P248, DOI 10.1111/j.1651-2227.1996.tb14004.x; KEATING MJ, 1989, BLOOD, V74, P19; PALMER RG, 1984, CANCER TREAT REV, V11, P121, DOI 10.1016/0305-7372(84)90004-5; PATAPANIAN H, 1988, BRIT J RHEUMATOL, V27, P44; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Rai K. R., 1996, Blood, V88, p141A; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; ROZMAN C, 1995, NEW ENGL J MED, V333, P1515; SAWITSKY A, 1977, BLOOD, V50, P1049; SHUSTIK C, 1988, HEMATOL ONCOL, V6, P7, DOI 10.1002/hon.2900060103	30	329	335	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1506	1514		10.1056/NEJM199805213382104	http://dx.doi.org/10.1056/NEJM199805213382104			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9593789	Bronze			2022-12-28	WOS:000073699100004
J	Davis, H				Davis, H			A memorable patient - Psychiatric problem dismissed	BRITISH MEDICAL JOURNAL			English	Editorial Material																		SHEEHAN DV, 1980, ARCH GEN PSYCHIAT, V37, P51	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1506	1506		10.1136/bmj.316.7143.1506	http://dx.doi.org/10.1136/bmj.316.7143.1506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582143	Green Published			2022-12-28	WOS:000073707700033
J	Shajahan, PM; Cavanagh, JTO				Shajahan, PM; Cavanagh, JTO			Admission for depression among men in Scotland, 1980-95: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Royal Edinburgh Hosp, MRC, Brain Metab Unit, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Shajahan, PM (corresponding author), Royal Edinburgh Hosp, MRC, Brain Metab Unit, Edinburgh EH10 5HF, Midlothian, Scotland.							BECK P, 1994, BRIT MED J, V308, P789, DOI 10.1136/bmj.308.6931.789; GEDDES JR, 1993, BRIT J PSYCHIAT, V163, P620, DOI 10.1192/bjp.163.5.620; POUNDER DJ, 1991, FORENSIC SCI INT, V51, P79, DOI 10.1016/0379-0738(91)90207-Y; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F	4	9	9	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1496	1497		10.1136/bmj.316.7143.1496	http://dx.doi.org/10.1136/bmj.316.7143.1496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZP020	9582135	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000073707700024
J	Strober, W; Ludviksson, BR; Fuss, IJ				Strober, W; Ludviksson, BR; Fuss, IJ			The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-BETA; CD4(+) T-CELLS; ESTABLISHED EXPERIMENTAL COLITIS; MYELIN BASIC-PROTEIN; HAPTEN-INDUCED MODEL; ULCERATIVE-COLITIS; ORAL TOLERANCE; IMMUNE-RESPONSES; MICE	In recent years, it has become apparent that overproduction of the Th1 cytokines interleukin-12 and interferon-gamma is the probable driving force behind murine models of intestinal inflammation resembling Crohn disease and intestinal inflammation in humans with Crohn disease. In addition, studies of murine models strongly suggest that this overproduction is associated with inadequate secretion of the counter-regulatory and anti-inflammatory cytokine transforming growth factor-beta. Thus, mucosal inflammation in models (and possibly in humans) may result from an imbalance between normally occurring positive (immunogenic or inflammatory) responses and negative (tolerogenic or anti-inflammatory) mucosal immune responses. These new findings and the hypotheses that arise from them are being used to construct new approaches to the treatment of Crohn disease that are based on the administration of anti-inflammatory cytokines and anticytokine antibodies.	NIAID, Mucosal Immun Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, NIH, Bldg 10,Room 11N-238, Bethesda, MD 20892 USA.		Lúðvíksson, Björn Rúnar/AFQ-7993-2022	Ludviksson, Bjorn/0000-0002-6445-148X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Boirivant M, 1996, P ASSOC AM PHYSICIAN, V108, P55; BREESE E, 1993, IMMUNOLOGY, V78, P127; BRYNSKOV J, 1994, DIGEST DIS, V12, P290, DOI 10.1159/000171464; CAVANI A, 1995, J IMMUNOL, V154, P1232; COERS W, 1994, CLIN EXP IMMUNOL, V98, P279; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; Elson CO, 1996, J IMMUNOL, V157, P2174; Firestein GS, 1997, NEW ENGL J MED, V337, P195, DOI 10.1056/NEJM199707173370310; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GELLER SA, 1994, INFLAMM BOWEL DIS, P336; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; Hornquist CE, 1997, J IMMUNOL, V158, P1068; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KUSUGAMI K, 1991, GASTROENTEROLOGY, V101, P1594, DOI 10.1016/0016-5085(91)90397-4; Ludviksson BR, 1997, J IMMUNOL, V159, P3622; Ludviksson BR, 1998, J IMMUNOL, V160, P3602; Ludviksson BR, 1997, J IMMUNOL, V158, P104; MALEFYT RD, 1991, J EXP MED, V174, P1209; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MATSUURA T, 1993, GASTROENTEROLOGY, V104, P448, DOI 10.1016/0016-5085(93)90413-7; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Moller DR, 1996, J IMMUNOL, V156, P4952; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NAGLERANDERSON C, 1986, P NATL ACAD SCI USA, V83, P7443, DOI 10.1073/pnas.83.19.7443; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; ORME IM, 1993, J IMMUNOL, V151, P518; Parronchi P, 1997, AM J PATHOL, V150, P823; Plevy SE, 1996, GASTROENTEROLOGY, V110, P1053, DOI 10.1053/gast.1996.v110.pm8612993; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; RIDDELL RH, 1988, INFLAMM BOWEL DIS, P329; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; SACHAR DB, 1990, MED CLIN N AM, V74, P183, DOI 10.1016/S0025-7125(16)30594-6; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SCHMITZMOORMANN P, 1981, RECENT ADV CROHNS DI, P76; Stack WA, 1997, LANCET, V349, P521, DOI 10.1016/S0140-6736(97)80083-9; Stokkers PCF, 1996, J INFLAMM, V47, P97; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TARGAN SR, 1995, J IMMUNOL, V154, P664; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Ueta C, 1996, EUR J IMMUNOL, V26, P3066, DOI 10.1002/eji.1830261237; vanDeventer SJH, 1997, GASTROENTEROLOGY, V113, P383, DOI 10.1053/gast.1997.v113.pm9247454; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; WEINER HL, 1994, P NATL ACAD SCI USA, V91, P10762, DOI 10.1073/pnas.91.23.10762; West GA, 1996, GASTROENTEROLOGY, V110, P1683, DOI 10.1053/gast.1996.v110.pm8964392; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003; WHELAN G, 1985, GASTROENTEROLOGY, V88, P1826, DOI 10.1016/0016-5085(85)90007-1; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	62	137	138	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					848	856		10.7326/0003-4819-128-10-199805150-00009	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599198				2022-12-28	WOS:000073586500009
J	Klein, JL; Millman, GC				Klein, JL; Millman, GC			Prospective, hospital based study of fever in children in the United Kingdom who had recently spent time in the tropics	BRITISH MEDICAL JOURNAL			English	Article									Northwick Pk & St Marks NHS Trust, Childrens Serv Directorate, Harrow HA1 3UJ, Middx, England	Imperial College London	Klein, JL (corresponding author), 177 Purves Rd,Kensal Rise, London NW10 5TH, England.							Brabin BJ, 1997, ARCH DIS CHILD, V77, P76, DOI 10.1136/adc.77.1.76; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; SHINGADIA D, 1996, CURR PAEDIAT, V6, P108	3	33	33	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1425	1426		10.1136/bmj.316.7142.1425	http://dx.doi.org/10.1136/bmj.316.7142.1425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572752	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000073651600028
J	Veeken, H				Veeken, H			Sudan: in through the back door	BRITISH MEDICAL JOURNAL			English	Article									Med Sans Frontieres, NL-1001 EA Amsterdam, Netherlands	Doctors Without Borders	Veeken, H (corresponding author), Med Sans Frontieres, POB 10014, NL-1001 EA Amsterdam, Netherlands.							NOMACHI K, 1989, NILE	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1446	1447		10.1136/bmj.316.7142.1446	http://dx.doi.org/10.1136/bmj.316.7142.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572761	Green Published			2022-12-28	WOS:000073651600036
J	Bray, D; Levin, MD; Morton-Firth, CJ				Bray, D; Levin, MD; Morton-Firth, CJ			Receptor clustering as a cellular mechanism to control sensitivity	NATURE			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; COVALENT MODIFICATION; FLAGELLAR MOTOR; PHOSPHORYLATION; CHEMORECEPTOR; COMPLEX; PROTEIN; CHEY	Chemotactic bacteria such as Escherichia coli can detect and respond to extremely low concentrations of attractants, concentrations of less than 5 nM in the case of aspartate(1), They also sense gradients of attractants extending over five orders of magnitude in concentration (up to 1 mM aspartate)(2,3). Here we consider the possibility that this combination of sensitivity and range of response depends on the clustering of chemotactic receptors on the surface of the bacterium(4). We examine what will happen if ligand binding changes the activity of a receptor, propagating this change in activity to neighbouring receptors in a cluster(5,6). Calculations based on these assumptions show that sensitivity to extracellular ligands increases with the extent of spread of activity through an array of receptors, but that the range of concentrations over which the array works is severely diminished. However, a combination of low threshold of response and wide dynamic range can be attained if the cell has both clusters and single receptors on its surface, particularly if the extent of activity spread can adapt to external conditions. A mechanism of this kind can account quantitatively for the sensitivity and response range of E. coli to aspartate.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	d.bray@zoo.cam.ac.uk						AKSAMIT RR, 1975, J BACTERIOL, V123, P1000, DOI 10.1128/JB.123.3.1000-1005.1975; BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BIEMANN HP, 1994, BIOCHEMISTRY-US, V33, P629, DOI 10.1021/bi00169a002; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; EISENBACH M, 1990, MOL MICROBIOL, V4, P161, DOI 10.1111/j.1365-2958.1990.tb00584.x; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; HAZELBAUER GL, 1981, J BACTERIOL, V145, P43, DOI 10.1128/JB.145.1.43-49.1981; KHAN S, 1993, BIOPHYS J, V65, P2368, DOI 10.1016/S0006-3495(93)81317-1; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MADDOCK JR, 1993, SCIENCE, V259, P1717; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; NINFA EG, 1991, J BIOL CHEM, V266, P9764; PARKINSON JS, 1993, SCIENCE, V259, P1701, DOI 10.1126/science.8456297; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; STEWART RC, 1993, J BIOL CHEM, V268, P1921; STOCK A, 1985, P NATL ACAD SCI USA, V82, P7989, DOI 10.1073/pnas.82.23.7989; Stock JB, 1996, ESCHERICHIA COLI SAL, P1103; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; YONEKAWA H, 1986, FEBS LETT, V198, P21, DOI 10.1016/0014-5793(86)81176-0	27	506	512	0	33	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					85	88		10.1038/30018	http://dx.doi.org/10.1038/30018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590695				2022-12-28	WOS:000073497500053
J	Croft, PR; Macfarlane, GJ; Papageorgiou, AC; Thomas, E; Silman, AJ				Croft, PR; Macfarlane, GJ; Papageorgiou, AC; Thomas, E; Silman, AJ			Outcome of low back pain in general practice: a prospective study	BRITISH MEDICAL JOURNAL			English	Article								Objectives: To investigate the claim that 90% of episodes of low back pain that present to general practice have resolved within one month. Design: Prospective study of all adults consulting in general practice because of low back pain over 12 months with follow up at 1 week, 3 months, and 12 months after consultation. Setting: Two general practices in south Manchester. Subjects: 490 subjects (203 men, 287 women) aged 18-75 years. Main outcome measures: Proportion of patients who have ceased to consult with low back pain after 3 months; proportion of patients who are free of pain and back related disability at 3 and 12 months. Results: Annual cumulative consultation late among adults in the practices was 6.4%. Of the 463 patients who consulted with a new episode of low back pain, 275 (59%) had only a single consultation, and 150 (32%) had repeat consultations confined to the 3 months after initial consultation. However, of those interviewed at 3 and 12 months follow up, only 39/188 (21%) and 42/170 (25%) respectively had completely recovered in terms of pain and disability. Conclusions: The results are consistent with the interpretation that 90% of patients with low back pain in primary care will have stopped consulting with symptoms within three months. However most will still be experiencing low back pain and related disability one year after consultation.	Univ Manchester, Sch Epidemiol & Hlth Sci, ARC Epidemiol Res Unit, Manchester M13 9PT, Lancs, England; Keele Univ, Postgrad Med Sch, Ind & Community Hlth Res Ctr, Stoke On Trent ST4 7QB, Staffs, England	University of Manchester; Keele University	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, ARC Epidemiol Res Unit, Stopford Bldg, Manchester M13 9PT, Lancs, England.		Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314				Clinical Standards Advisory Group, 1994, EP REV EP COST BACK; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; DEYO RA, 1993, SPINE, V18, P2153, DOI 10.1097/00007632-199311000-00002; DIXON ASJ, 1973, RHEUM REHABILITATION, V12, P165; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; MASON V, 1994, PREVALENCE BACK PAIN; MCCORMICK A, 1995, MORBIDITY STAT G MB5; *OFF POP CENS SURV, 1994, OPCS MON MB5 94 1 MO; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; Papageorgiou AC, 1996, PAIN, V66, P181, DOI 10.1016/0304-3959(96)03022-9; ROLAND MO, 1983, BRIT MED J, V286, P523, DOI 10.1136/bmj.286.6364.523; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227	13	459	462	3	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1356	1359		10.1136/bmj.316.7141.1356	http://dx.doi.org/10.1136/bmj.316.7141.1356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563990	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000073483000021
J	Singer, RH				Singer, RH			Triplet-repeat transcripts: A role for RNA in disease	SCIENCE			English	Article							DYSTROPHY		Albert Einstein Coll Med, Inst Mol Med, Dept Anat & Struct Biol & Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Albert Einstein Coll Med, Inst Mol Med, Dept Anat & Struct Biol & Cell Biol, Bronx, NY 10461 USA.	rhsinger@aecom.yu.edu						Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407	9	25	25	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					696	697		10.1126/science.280.5364.696	http://dx.doi.org/10.1126/science.280.5364.696			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9599147				2022-12-28	WOS:000073415600035
J	Spiegelman, BM				Spiegelman, BM			PPAR gamma in monocytes: Less pain, any gain?	CELL			English	Review							ADIPOGENESIS; LIGAND; J(2)		Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.							Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; *FDA, 1997, FDA TALK PAP WASH DC; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kawai K, 1997, ARZNEIMITTEL-FORSCH, V47, P356; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KLLEWER SA, 1997, P NATL ACAD SCI USA, V94, P4318; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1041, DOI 10.1210/jc.83.3.1041; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5	16	125	131	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					153	155		10.1016/S0092-8674(00)81567-6	http://dx.doi.org/10.1016/S0092-8674(00)81567-6			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568708	Bronze			2022-12-28	WOS:000073174000002
J	Glasziou, P				Glasziou, P			Evidence based case report: Twenty year cough in a non-smoker	BRITISH MEDICAL JOURNAL			English	Review							CHRONIC PERSISTENT COUGH		Univ Queensland, Sch Med, Queensland 4006, Australia	University of Queensland	Glasziou, P (corresponding author), Univ Queensland, Sch Med, Queensland 4006, Australia.		Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				GOROLL A, 1995, PRIMARY CARE MED OFF; HARVEY RF, 1987, LANCET, V2, P1200; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; JENKINSON LR, 1989, ANN ROY COLL SURG, V71, P117; Mello CJ, 1996, ARCH INTERN MED, V156, P997, DOI 10.1001/archinte.156.9.997; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; Sackett D. L., 1997, EVIDENCE BASED MED P	8	8	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1660	1661		10.1136/bmj.316.7145.1660	http://dx.doi.org/10.1136/bmj.316.7145.1660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603753	Green Published			2022-12-28	WOS:000074022700029
J	Campfield, LA; Smith, FJ; Burn, P				Campfield, LA; Smith, FJ; Burn, P			Strategies and potential molecular targets for obesity treatment	SCIENCE			English	Article							NEUROPEPTIDE-Y; GENE-PRODUCT; WEIGHT; PROTEIN; LEPTIN; IDENTIFICATION; RECEPTOR; TUBBY; MICE	Obesity is an increasingly prevalent and important health problem. Although treatment is available, the long-term maintenance of medically significant weight loss (5 to 10 percent of initial body weight) is rare. Since 1995 there has been an explosion of research focused on the regulation of energy balance and fat mass. Characterization of obesity-associated gene products has revealed new biochemical pathways and molecular targets for pharmacological intervention that will likely lead to new treatments. Ideally, these treatments will be viewed as adjuncts to behavioral and lifestyle changes aimed at maintenance of weight loss and improved health.	Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA	Roche Holding	Campfield, LA (corresponding author), Hoffmann La Roche Inc, Dept Metab Dis, 340 Kingsland St, Nutley, NJ 07110 USA.	l_arthur.campfield@roche.com						ALLISON DB, 1995, OBESITY TREATMENT ES; BJORNTORP P, 1992, OBESITY; Blackburn GL, 1997, NURS CLIN N AM, V32, P831; BLUNDELL J, 1991, TRENDS PHARMACOL SCI, V12, P147, DOI 10.1016/0165-6147(91)90532-W; BOGARDUS C, 1986, NEW ENGL J MED, V315, P96, DOI 10.1056/NEJM198607103150205; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BOUCHARD C, 1993, ANNU REV NUTR, V13, P337, DOI 10.1146/annurev.nu.13.070193.002005; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Campfield L. A., 1997, Overweight and weight management: the health professional's guide to understanding and practice., P466; Campfield LA, 1997, ENDOCRINOL METAB, V4, P81; CAMPFIELD LA, 1995, NATO ADV SCI INST SE, V278, P93; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867; CAMPFIELD LA, 1997, SOC NEUR ABSTR, V23, P815; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Danforth E, 1997, EUR J ENDOCRINOL, V136, P362, DOI 10.1530/eje.0.1360362; DRENT ML, 1995, INT J OBESITY, V19, P221; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; FRANKISH HM, 1995, PEPTIDES, V16, P757, DOI 10.1016/0196-9781(94)00200-P; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HILL JO, 1994, PHYSICAL ACTIVITY FI; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEMAGNEN J, 1981, BEHAV BRAIN SCI, V4, P561, DOI 10.1017/S0140525X00000236; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MORAN TH, 1993, AM J PHYSIOL, V265, pR620, DOI 10.1152/ajpregu.1993.265.3.R620; NAGGERT J, 1995, NAT GENET, V10, P134; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Rosenbaum M, 1998, PEDIATRICS, V101, P525; Ryan DH, 1995, OBES RES, V3, pS553, DOI 10.1002/j.1550-8528.1995.tb00227.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Smith FJ, 1996, NATURE, V382, P307, DOI 10.1038/382307a0; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Stock MJ, 1997, INT J OBESITY, V21, pS25; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thomas PR, 1995, WEIGHING OPTIONS CRI; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; WANG ZL, 1995, J CLIN INVEST, V95, P417, DOI 10.1172/JCI117671; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378	56	132	151	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1383	1387		10.1126/science.280.5368.1383	http://dx.doi.org/10.1126/science.280.5368.1383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603722				2022-12-28	WOS:000073883400036
J	Lucassen, PLBJ; Assendelft, WJJ; Gubbels, JW; van Eijk, JTM; van Geldrop, WJ; Neven, AK				Lucassen, PLBJ; Assendelft, WJJ; Gubbels, JW; van Eijk, JTM; van Geldrop, WJ; Neven, AK			Effectiveness of treatments for infantile colic: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED TRIAL; DOUBLE-BLIND CROSSOVER; BREAST-FED INFANTS; COWS MILK; DICYCLOMINE HYDROCHLORIDE; IRRITABLE INFANTS; FORMULA; PROTEIN; INTERVENTION; SIMETHICONE	Objective: To evaluate the effectiveness of diets, drug treatment, and behavioural interventions on infantile colic in trials with crying or the presence of colic as the primary outcome measure. Data sources: Controlled clinical trials identified by a highly sensitive search strategy in Medline (1966-96), Embase (1986-95), and the Cochrane Controlled Trials Register, in combination with reference checking for further relevant publications. Keywords were crying and colic. Study selection: Two independent assessors selected controlled trials with interventions lasting at least 3 days that included infants younger than 6 months who cried excessively. Data synthesis: Methodological quality was assessed by two assessors independently with a quality assessment scale (range 0-5). Effect sizes were calculated as percentage success. Effect sizes of trials using identical interventions were pooled using a random effects model. Results: 27 controlled trials were identified. Elimination of cows' milk protein was effective when substituted by hypoallergenic formula milks (effect size 0.22 (95% confidence interval 0.09 to 0.34)). The effectiveness of substitution by soy formula milks was unclear when only trials of good methodological quality were considered. The benefit of eliminating cows' milk protein was not restricted to highly selected populations. Dicyclomine was effective (effect size 0.46 (0.33 to 0.60)), but serious side effects have been reported. The advice to reduce stimulation was beneficial (effect size 0.48 (0.23 to 0.74)), whereas the advice to increase carrying and holding seemed not to reduce crying. No benefit was shown for simethicone. Uncertainty remained about the effectiveness of low lactose formula milks. Conclusions: Infantile colic should preferably be treated by advising carers to reduce stimulation and with a one week trial of a hypoallergenic formula milk.	Free Univ Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands; Leiden Univ, Dept Gen Practice, Leiden, Netherlands; Dutch Coll Gen Practitioners, Sci Comm, Utrecht, Netherlands; Org Res & Policy Advice, Grave, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC	Assendelft, WJJ (corresponding author), Free Univ Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands.	p.assendelft.EMGO@med.vu.nl	Lucassen, Peter L.B.J./L-4496-2015; assendelft, willem/AAW-1854-2021; Assendelft, W.J.J./H-8008-2014	assendelft, willem/0000-0002-2966-3778; Assendelft, W.J.J./0000-0002-2966-3778				ATLMAN DG, 1991, PRACTICAL STAT MED R, P404; BARR RG, 1991, PEDIATRICS, V87, P623; Barr RG, 1991, PEDIATRIC GASTROINTE, P55; Blomquist H K, 1983, Lakartidningen, V80, P116; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; BUSINCO L, 1992, J PEDIATR-US, V121, pS21, DOI 10.1016/S0022-3476(05)81402-7; CAMPBELL JPM, 1989, J ROY COLL GEN PRACT, V39, P11; CAREY WB, 1984, PEDIATR CLIN N AM, V31, P993; CAREY WB, 1994, PEDIATRICS, V94, P333; *COCHR CONTR TRIAL, 1997, COCHR LIB DAT CD ROM; DANIELSSON B, 1985, ACTA PAEDIATR SCAND, V74, P446, DOI 10.1111/j.1651-2227.1985.tb11001.x; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EVANS RW, 1981, LANCET, V1, P1340; FORSYTH BWC, 1991, PEDIATRICS, V88, P757; FORSYTH BWC, 1989, J PEDIATR-US, V115, P521, DOI 10.1016/S0022-3476(89)80274-4; GRUNSEIT F, 1977, CURR MED RES OPIN, V5, P258, DOI 10.1185/03007997709110175; Hill DJ, 1995, J ALLERGY CLIN IMMUN, V96, P886, DOI 10.1016/S0091-6749(95)70224-5; HWANG CP, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014; IACONO G, 1991, J PEDIATR GASTR NUTR, V12, P332, DOI 10.1097/00005176-199104000-00008; ILLINGWORTH R S, 1955, Acta Paediatr, V44, P203, DOI 10.1111/j.1651-2227.1955.tb04133.x; ILLINGWORTH RS, 1985, ARCH DIS CHILD, V60, P981, DOI 10.1136/adc.60.10.981; ILLINGWORTH RS, 1959, LANCET, V2, P1119; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JAIN SL, 1987, MED SURG, V27, P13; JAKOBSSON I, 1983, PEDIATRICS, V71, P268; JAMESROBERTS IS, 1991, ARCH DIS CHILD, V66, P653, DOI 10.1136/adc.66.5.653; LOTHE L, 1982, PEDIATRICS, V70, P7; LOTHE L, 1989, PEDIATRICS, V83, P262; MCKENZIE S, 1991, ARCH DIS CHILD, V66, P1416, DOI 10.1136/adc.66.12.1416; METCALF TJ, 1994, PEDIATRICS, V94, P29; MILLER AR, 1991, PEDIATR CLIN N AM, V38, P1407; MILLER JJ, 1990, J PEDIATR-US, V117, P261, DOI 10.1016/S0022-3476(05)80542-6; MOHER D, 1995, JAMA-J AM MED ASSOC, V274, P1962, DOI 10.1001/jama.274.24.1962; ODONOVAN JC, 1979, AM J DIS CHILD, V133, P999, DOI 10.1001/archpedi.1979.02130100023003; OGGERO R, 1994, ACTA PAEDIATR, V83, P222, DOI 10.1111/j.1651-2227.1994.tb13055.x; PARKIN PC, 1993, PEDIATRICS, V92, P197; POCOCK SJ, 1988, CLIN TRIALS PRACTICA, P111; RAUTAVA P, 1995, PEDIATRICS, V96, P43; SETHI KS, 1988, PRACTITIONER, V232, P508; Shadish W., 1994, HDB RES SYNTHESIS, P265; STAHLBERG MR, 1986, ARCH DIS CHILD, V61, P1232, DOI 10.1136/adc.61.12.1232; TAUBMAN B, 1988, PEDIATRICS, V81, P756; TREEM WR, 1991, J PEDIATR-US, V119, P695, DOI 10.1016/S0022-3476(05)80282-3; TREEM WR, 1994, PEDIATR CLIN N AM, V41, P1121; VANDENBOOM DC, 1994, CHILD DEV, V65, P1457, DOI 10.2307/1131511; vandenBoom DC, 1995, CHILD DEV, V66, P1798, DOI 10.2307/1131911; WEISSBLUTH M, 1984, J PEDIATR-US, V104, P951, DOI 10.1016/S0022-3476(84)80506-5; WEIZMAN Z, 1993, J PEDIATR-US, V123, P670, DOI 10.1016/S0022-3476(05)80982-5; WEIZMAN Z, 1993, J PEDIATR-US, V122, P650, DOI 10.1016/S0022-3476(05)83557-7; WESSEL MA, 1954, PEDIATRICS, V14, P421; Westphal O, 1972, LAKARTIDNINGEN, V69, P3331; WILLIAMS J, 1984, BRIT MED J, V288, P901, DOI 10.1136/bmj.288.6421.901; WOLKE D, 1994, PEDIATRICS, V94, P322; WOLKE D, 1993, INFANT CRYING FEEDIN, P47; [No title captured]	56	154	159	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1563	1569		10.1136/bmj.316.7144.1563	http://dx.doi.org/10.1136/bmj.316.7144.1563			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596593	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073867800020
J	Cibelli, JB; Stice, SL; Golueke, PJ; Kane, JJ; Jerry, J; Blackwell, C; de Leon, FAP; Robl, JM				Cibelli, JB; Stice, SL; Golueke, PJ; Kane, JJ; Jerry, J; Blackwell, C; de Leon, FAP; Robl, JM			Cloned transgenic calves produced from nonquiescent fetal fibroblasts	SCIENCE			English	Article							TRANSPLANT RABBIT EMBRYOS; CELL-CYCLE STAGE; NUCLEAR TRANSFER; LIVESTOCK	An efficient system for genetic modification and large-scale cloning of cattle is of importance for agriculture, biotechnology, and human medicine. Here, actively dividing fetal fibroblasts were genetically modified with a marker gene, a clonal line was selected, and the cells were fused to enucleated mature oocytes. Out of 28 embryos transferred to 11 recipient cows, three healthy, identical, transgenic calves were generated. Furthermore, the life-span of near senescent fibroblasts could be extended by nuclear transfer, as indicated by population doublings in fibroblast lines derived from a 40-day-old fetal clone. With the ability to extend the life-span of these primary cultured cells, this system would be useful for inducing complex genetic modifications in cattle.	Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Adv Cell Technol Inc, Worcester, MA 01605 USA; Coll Agr Food & Environm Sci, St Paul, MN 55108 USA	University of Massachusetts System; University of Massachusetts Amherst	Robl, JM (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.			Cibelli, Jose/0000-0002-2176-3854; Ponce de Leon, Federico/0000-0001-8645-553X				BONDIOLI KR, 1993, MOL REPROD DEV, V36, P274, DOI 10.1002/mrd.1080360229; CLEMENTSENGEWALD A, 1992, BERL MUNCH TIERARZTL, V105, P15; COLLAS P, 1992, BIOL REPROD, V46, P501, DOI 10.1095/biolreprod46.3.501; COLLAS P, 1992, BIOL REPROD, V46, P492, DOI 10.1095/biolreprod46.3.492; FIEDRICH G, 1991, GENE DEV, V5, P1513; GADBOIS DM, 1992, P NATL ACAD SCI USA, V89, P8626, DOI 10.1073/pnas.89.18.8626; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; PURSEL VG, 1993, J ANIM SCI, V71, P10, DOI 10.2527/1993.71suppl_310x; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SAITO S, 1992, ROUX ARCH DEV BIOL, V201, P134, DOI 10.1007/BF00188711; Stice SL, 1996, BIOL REPROD, V54, P100, DOI 10.1095/biolreprod54.1.100; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Walker SK, 1996, THERIOGENOLOGY, V45, P111, DOI 10.1016/0093-691X(95)00360-K; WALL RJ, 1992, J CELL BIOCHEM, V49, P113, DOI 10.1002/jcb.240490203; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	15	996	1261	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1256	1258		10.1126/science.280.5367.1256	http://dx.doi.org/10.1126/science.280.5367.1256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596577				2022-12-28	WOS:000073852500046
J	Scheirer, DS; Forsyth, DW; Cormier, MH; Macdonald, KC				Scheirer, DS; Forsyth, DW; Cormier, MH; Macdonald, KC			Shipboard geophysical indications of asymmetry and melt production beneath the East Pacific Rise near the MELT experiment	SCIENCE			English	Article							MIDOCEAN RIDGES; MANTLE FLOW; SEAMOUNTS; ASTHENOSPHERE; 15-DEGREES-S; 19-DEGREES-S; CRUSTAL; AXIS	Near the Mantle Electromagnetic and Tomography (MELT) Experiment, seamounts form and off-axis lava flows occur in a zone that extends farther to the west of the East Pacific Rise than to the east, indicating a broad, asymmetric region of melt production. More seamounts, slower subsidence, and less dense mantle on the western flank suggest transport of hotter mantle toward the axis from the west. Variations in axial ridge shape, axial magma chamber continuity, off-axis volcanism, and apparent mantle density indicate that upwelling is probably faster and more melt is produced beneath 17 degrees 15'S than beneath 15 degrees 55'S. Recent volcanism occurs above mantle with the lowest seismic velocities.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA	Brown University; Columbia University; University of California System; University of California Santa Barbara	Scheirer, DS (corresponding author), Brown Univ, Dept Geol Sci, Box 1846, Providence, RI 02912 USA.	scheirer@emma.geo.brown.edu	Macdonald, Ken C/G-3936-2011	Cormier, Marie-Helene/0000-0001-7094-3790				BACH W, 1994, CONTRIB MINERAL PETR, V116, P365, DOI 10.1007/BF00310905; BATIZA R, 1984, J GEOPHYS RES, V89, P11260; BAZIN S, IN PRESS GEOPHYS RES; Canales JP, 1998, SCIENCE, V280, P1218, DOI 10.1126/science.280.5367.1218; COCHRAN JR, 1986, GEOPHYS J INT, V87, P421, DOI 10.1111/j.1365-246X.1986.tb06631.x; CORMIER MH, 1995, J GEOPHYS RES-SOL EA, V100, P8063, DOI 10.1029/95JB00243; Cormier MH, 1996, MAR GEOPHYS RES, V18, P53, DOI 10.1007/BF00286203; CORMIER MH, 1994, J GEOPHYS RES-SOL EA, V99, P543, DOI 10.1029/93JB02382; CORMIER MH, 1996, EOS S, V77, P660; DAVIS EE, 1986, EARTH PLANET SC LETT, V79, P385, DOI 10.1016/0012-821X(86)90194-9; DETRICK RS, 1993, SCIENCE, V259, P499, DOI 10.1126/science.259.5094.499; EBERLE MA, IN PRESS J GEOPHYS R; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; HALL, 1996, EOS, V77, P660; HALL LS, 1996, EOS, V77, P660; Hooft EEE, 1997, J GEOPHYS RES-SOL EA, V102, P27319, DOI 10.1029/97JB02349; Hussenoeder SA, 1996, J GEOPHYS RES-SOL EA, V101, P22087, DOI 10.1029/96JB01907; LONSDALE P, 1989, J GEOPHYS RES-SOLID, V94, P12197, DOI 10.1029/JB094iB09p12197; MAGDE LS, 1995, J GEOPHYS RES-SOL EA, V100, P3747, DOI 10.1029/94JB02869; MAHONEY JJ, 1994, EARTH PLANET SC LETT, V121, P173, DOI 10.1016/0012-821X(94)90039-6; MCNUTT MK, 1990, SCIENCE, V248, P969, DOI 10.1126/science.248.4958.969; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P12753, DOI 10.1029/95JB00041; MUTTER JC, 1995, SCIENCE, V268, P391, DOI 10.1126/science.268.5209.391; NAAR DF, 1989, EVOLUTION MID OCEAN, P9; NIU YL, 1991, J GEOPHYS RES-SOL EA, V96, P21753, DOI 10.1029/91JB01933; Scheirer DS, 1996, MAR GEOPHYS RES, V18, P13, DOI 10.1007/BF00286202; Scheirer DS, 1996, MAR GEOPHYS RES, V18, P1, DOI 10.1007/BF00286201; SCHEIRER DS, 1993, J GEOPHYS RES-SOL EA, V98, P7871, DOI 10.1029/93JB00015; SCHILLING JG, 1997, MANTLE FLOW MELT GEN; SHEN Y, 1993, J GEOPHYS RES-SOL EA, V98, P17875, DOI 10.1029/93JB01721; SINTON JM, 1991, J GEOPHYS RES-SOLID, V96, P6133, DOI 10.1029/90JB02454; SU WS, 1993, J GEOPHYS RES-SOL EA, V98, P12191, DOI 10.1029/93JB00994; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; WILSON DS, 1992, EARTH PLANET SC LETT, V113, P41, DOI 10.1016/0012-821X(92)90210-M	34	65	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1221	1224		10.1126/science.280.5367.1221	http://dx.doi.org/10.1126/science.280.5367.1221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596566				2022-12-28	WOS:000073852500035
J	Cressey, DM				Cressey, DM			Ethanol, emergencies, and ethical dilemmas	BRITISH MEDICAL JOURNAL			English	Article									Royal Hallamshire Hosp, Dept Anaesthet, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Cressey, DM (corresponding author), Royal Hallamshire Hosp, Dept Anaesthet, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.								0	5	5	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1515	1516		10.1136/bmj.316.7143.1515	http://dx.doi.org/10.1136/bmj.316.7143.1515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582147	Green Submitted, Green Published			2022-12-28	WOS:000073707700038
J	Ebinu, JO; Bottorff, DA; Chan, EYW; Stang, SL; Dunn, RJ; Stone, JC				Ebinu, JO; Bottorff, DA; Chan, EYW; Stang, SL; Dunn, RJ; Stone, JC			RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs	SCIENCE			English	Article							EXCHANGE FACTOR; KINASE-C; ACTIVATION; RECEPTORS; NEURONS; CLONING; PATHWAY; GRF	RasGRP, a guanyl nucleotide-releasing protein for the small guanosine triphosphatase Ras, was characterized. Besides the catalytic domain, RasGRP has an atypical pair of "EF hands" that bind calcium and a diacylglycerol (DAG)-binding domain. RasGRP activated Ras and caused transformation in fibroblasts. A DAG analog caused sustained activation of Ras-Erk signaling and changes in cell morphology. Signaling was associated with partitioning of RasGRP protein into the membrane fraction. Sustained ligand-induced signaling and membrane partitioning were absent when the DAG-binding domain was deleted. RasGRP is expressed in the nervous system, where it may couple changes in DAG and possibly calcium concentrations to Ras activation.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	University of Alberta; McGill University	Stone, JC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.		Chan, Edmond Y.W./A-1940-2013	Chan, Edmond Y.W./0000-0001-9777-0252				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; AMBAR I, 1993, EUR J PHARM-MOLEC PH, V245, P31, DOI 10.1016/0922-4106(93)90166-7; ARIS JP, 1993, BIOCHIM BIOPHYS ACTA, V1174, P171, DOI 10.1016/0167-4781(93)90111-P; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BORASIO GD, 1989, NEURON, V2, P1087; BOTTORFF D, 1995, MOL CELL BIOL, V15, P5113; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; Chan E., UNPUB; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; EBINU JO, UNPUB; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Leonardsen L, 1996, ONCOGENE, V13, P2177; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Stang S, 1997, MOL CELL BIOL, V17, P3047, DOI 10.1128/MCB.17.6.3047; STONE JC, 1993, MOL CELL BIOL, V13, P7311, DOI 10.1128/MCB.13.12.7311; STONE JC, 1991, MOL CELL BIOL, V11, P6158, DOI 10.1128/MCB.11.12.6158; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TANAKA Y, 1986, J BIOCHEM-TOKYO, V99, P257, DOI 10.1093/oxfordjournals.jbchem.a135467; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704	31	532	547	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1082	1086		10.1126/science.280.5366.1082	http://dx.doi.org/10.1126/science.280.5366.1082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582122				2022-12-28	WOS:000073663600048
J	Howe, JR; Roth, S; Ringold, JC; Summers, RW; Jarvinen, HJ; Sistonen, P; Tomlinson, IPM; Houlston, RS; Bevan, S; Mitros, FA; Stone, EM; Aaltonen, LA				Howe, JR; Roth, S; Ringold, JC; Summers, RW; Jarvinen, HJ; Sistonen, P; Tomlinson, IPM; Houlston, RS; Bevan, S; Mitros, FA; Stone, EM; Aaltonen, LA			Mutations in the SMAD4/DPC4 gene in juvenile polyposis	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; COLORECTAL CANCERS; DPC4 GENE; CARCINOMA	Familial juvenile polyposis is an autosomal dominant disease characterized by a predisposition to hamartomatous polyps and gastrointestinal cancer. Here it is shown that a subset of juvenile polyposis families carry germ line mutations in the gene SMAD4 (also known as DPC4), located on chromosome 18q21.1, that encodes a critical cytoplasmic mediator in the transforming growth factor-beta signaling pathway. The mutant SMAD4 proteins are predicted to be truncated at the carboxyl-terminus and lack sequences required for normal function. These results confirm an important role for SMAD4 in the development of gastrointestinal tumors.	Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Iowa, Coll Med, Dept Med, Iowa City, IA 52242 USA; Univ Helsinki, Cent Hosp, Dept Surg 2, FIN-00290 Helsinki, Finland; Finnish Red Cross & Blood Transfus Serv, Helsinki 00130, Finland; Imperial Canc Res Fund, Mol Populat Genet Lab, London WC2A 3PX, England; Inst Canc Res, Sect Can Genet, Surrey SM2 5NG, England; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA	University of Iowa; University of Helsinki; University of Iowa; University of Helsinki; Helsinki University Central Hospital; Cancer Research UK; University of London; Institute of Cancer Research - UK; University of Iowa; University of Iowa	Howe, JR (corresponding author), Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA.		Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Stone, Edwin M./0000-0003-3343-4414; Howe, James/0000-0001-5312-5972; Bevan, Steve/0000-0003-0490-6830; Houlston, Richard/0000-0002-5268-0242				AALTONEN LA, UNPUB; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Grau AM, 1997, CANCER RES, V57, P3929; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; HOWE JM, UNPUB; Howe JR, 1998, AM J HUM GENET, V62, P1129, DOI 10.1086/301840; Howe JR, 1997, HISTOL HISTOPATHOL, V12, P595; JARVINEN H, 1984, GUT, V25, P792, DOI 10.1136/gut.25.7.792; Jass J.R., 1994, FAMILIAL ADENOMATOUS, P203; Kim SK, 1996, CANCER RES, V56, P2519; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Li DM, 1997, CANCER RES, V57, P2124; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Marsh DJ, 1997, CANCER RES, V57, P5017; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Moskaluk CA, 1997, DIAGN MOL PATHOL, V6, P85, DOI 10.1097/00019606-199704000-00003; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; REGGINS GJ, 1997, J NEG OBS GEN ONCOL, V1, P1; Schutte M, 1996, CANCER RES, V56, P2527; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; STEMPER TJ, 1975, ANN INTERN MED, V83, P639, DOI 10.7326/0003-4819-83-5-639; Takagi Y, 1996, GASTROENTEROLOGY, V111, P1369, DOI 10.1053/gast.1996.v111.pm8898652; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Wrana J, 1997, NATURE, V388, P28, DOI 10.1038/40290; Wrana JL, 1996, TRENDS GENET, V12, P493, DOI 10.1016/S0168-9525(96)30109-1	30	672	697	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1086	1088		10.1126/science.280.5366.1086	http://dx.doi.org/10.1126/science.280.5366.1086			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582123				2022-12-28	WOS:000073663600049
J	Vaupel, JW; Carey, JR; Christensen, K; Johnson, TE; Yashin, AI; Holm, NV; Iachine, IA; Kannisto, V; Khazaeli, AA; Liedo, P; Longo, VD; Zeng, Y; Manton, KG; Curtsinger, JW				Vaupel, JW; Carey, JR; Christensen, K; Johnson, TE; Yashin, AI; Holm, NV; Iachine, IA; Kannisto, V; Khazaeli, AA; Liedo, P; Longo, VD; Zeng, Y; Manton, KG; Curtsinger, JW			Biodemographic trajectories of longevity	SCIENCE			English	Review							AGE-SPECIFIC MORTALITY; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; UNITED-STATES; POPULATION; DYNAMICS; DENSITY; RATES; REPRODUCTION; SENESCENCE	Old-age survival has increased substantially since 1950. Death rates decelerate with age for insects, worms, and yeast, as well as humans. This evidence of extended postreproductive survival is puzzling. Three biodemographic insights-concerning the correlation of death rates across age, individual differences in survival chances, and induced alterations in age patterns of fertility and mortality-offer clues and suggest research on the failure of complicated systems, on new demographic equations for evolutionary theory, and on fertility-longevity interactions. Nongenetic changes account for increases in human life-spans to date. Explication of these causes and the genetic license for extended survival, as well as discovery of genes and other survival attributes affecting longevity, will lead to even longer lives.	Max Planck Inst Demog Res, D-18057 Rostock, Germany; Odense Univ, Sch Med, DK-5000 Odense C, Denmark; Duke Univ, Ctr Demog Studies, Durham, NC 27706 USA; Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Colegio Frontera Sur, Tapachula 30700, Mexico; Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China	Max Planck Society; University of Southern Denmark; Duke University; University of Southern California; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; El Colegio de la Frontera Sur (ECOSUR); Peking University	Vaupel, JW (corresponding author), Max Planck Inst Demog Res, Doberaner Str 114, D-18057 Rostock, Germany.	jwv@demogr.mpg.de	Zeng, Yi/B-1638-2010; Christensen, Kaare/C-2360-2009; Liedo, Pablo/E-9313-2010	Christensen, Kaare/0000-0002-5429-5292; Liedo, Pablo/0000-0002-0004-1721; Vaupel, James/0000-0003-0783-3905; /0000-0001-7147-8237	NIA NIH HHS [AG08761] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrams PA, 1995, EVOLUTION, V49, P1055, DOI 10.1111/j.1558-5646.1995.tb04433.x; [Anonymous], 1939, THEORIE ANAL ASS BIO; [Anonymous], 1983, REGIONAL MODEL LIFE; [Anonymous], 1997, ZEUS SALMON BIODEMOG; Austad SN, 1997, BETWEEN ZEUS AND THE SALMON, P161; Barker DJP, 1992, FETAL INFANT ORIGINS; BROOKS A, 1994, SCIENCE, V263, P668, DOI 10.1126/science.8303273; Carey JR, 1997, DEMOGRAPHY, V34, P17, DOI 10.2307/2061657; Carey JR, 1997, BETWEEN ZEUS AND THE SALMON, P127; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Carey JR, 1995, EXP GERONTOL, V30, P605, DOI 10.1016/0531-5565(95)00013-5; CAREY JR, UNPUB; *CENS BUR INT, 1997, CENS BUR INT DAT BAS; Charlesworth B, 1997, CURR BIOL, V7, pR440, DOI 10.1016/S0960-9822(06)00213-2; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Christensen K, 1996, J INTERN MED, V240, P333, DOI 10.1046/j.1365-2796.1996.d01-2853.x; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; CHRISTENSEN K, UNPUB; Curtsinger JW, 1995, ANNU REV GENET, V29, P553; CURTSINGER JW, 1994, AM NAT, V144, P210, DOI 10.1086/285671; CURTSINGER JW, 1995, GENETICA, V96, P187, DOI 10.1007/BF01439571; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; CURTSINGER JW, IN PRESS EXP GERONTO; DAWKINS R, 1995, SCI AM, V273, P80, DOI 10.1038/scientificamerican1195-80; DeBenedictis G, 1997, HUM GENET, V99, P312; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Finch CE, 1990, LONGEVITY SENESCENCE; Fogel RW, 1997, DEMOGRAPHY, V34, P49, DOI 10.2307/2061659; Franceschi C, 1995, Int Rev Immunol, V12, P57, DOI 10.3109/08830189509056702; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Fries JF, 1981, VITALITY AGING; Gavrilov L.A., 1991, BIOL LIFE SPAN; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hayflick L., 1994, WHY WE AGE; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; Jeune B., 1995, EXCEPTIONAL LONGEVIT; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kannisto V., 1996, ADV FRONTIER SURVIVA; KANNISTO V, 1994, POPUL DEV REV, V20, P987; Kannisto Vaino., 1994, DEV OLDEST OLD MORTA; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KELLMAN N, 1997, J OFF STAT, V13, P245; Kermack WO, 1934, LANCET, V1, P698; KESTENBAUM B, 1992, DEMOGRAPHY, V29, P565, DOI 10.2307/2061852; Khazaeli AA, 1996, GENETICA, V98, P21, DOI 10.1007/BF00120215; KHAZAELI AA, 1995, J GERONTOL, V52, P48; LAKATTA EG, 1994, AGING-CLIN EXP RES, V6, P213, DOI 10.1007/BF03324244; Lee RD, 1997, BETWEEN ZEUS AND THE SALMON, P212; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LONGO V, UNPUB; Mangel M., 1988, DYNAMIC MODELING BEH; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mueller LD, 1996, P NATL ACAD SCI USA, V93, P15249, DOI 10.1073/pnas.93.26.15249; Muller HG, 1997, P NATL ACAD SCI USA, V94, P2762, DOI 10.1073/pnas.94.6.2762; Murakami S, 1996, GENETICS, V143, P1207; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; ORZACK SH, 1989, AM NAT, V133, P901, DOI 10.1086/284959; PARTRIDGE L, 1985, NATURE, V316, P20, DOI 10.1038/316020a0; Partridge L, 1997, BETWEEN ZEUS AND THE SALMON, P78; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; Pletcher SD, 1998, GENETICS, V148, P287; PLETCHER SD, IN PRESS EVOLUTION; Promislow DEL, 1996, GENETICS, V143, P839; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SHRESTHA L, 1995, SURV METHODOL, V21, P167; SMITH JM, 1958, NATURE, V181, P496, DOI 10.1038/181496a0; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; THATCHER AR, 1998, TRAJECTORY MORTALITY; Tuljapurkar S, 1997, BETWEEN ZEUS AND THE SALMON, P65; *UN POP DIV, 1997, WORLD POP PROSP 1996; Vaupel JW, 1997, BETWEEN ZEUS AND THE SALMON, P17; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1994, SCIENCE, V266, P826, DOI 10.1126/science.7973641; VAUPEL JW, 1993, SCIENCE, V260, P1666, DOI 10.1126/science.8503016; VAUPEL JW, 1991, POLICY SCI, V24, P389, DOI 10.1007/BF00135883; VAUPEL JW, 1998, POPULATION DATA GLAN; VAUPEL JW, 1997, ZEUS SALMON BIODEMOG, P109; Vaupel JW, 1995, EXCEPTIONAL LONGEVIT, V2; VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P340; VAUPEL JW, 1997, PHILOS T R SOC LON B, V352, P1; VAUPEL JW, 1988, MATH POPUL STUD, V1, P21, DOI DOI 10.1080/08898488809525259; Wachter KW, 1997, BETWEEN ZEUS AND THE SALMON, P1; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilmoth JR, 1997, BETWEEN ZEUS AND THE SALMON, P38; WILMOTH JR, 1997, ZEUS SALMON BIODEMOG, P125; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; WISE DA, 1996, ADV EC AGING; YASHIN AI, 1994, MECH AGEING DEV, V74, P1, DOI 10.1016/0047-6374(94)90094-9; Yashin AI, 1997, DEMOGRAPHY, V34, P31, DOI 10.2307/2061658; Zeng Y, 1997, Math Popul Stud, V6, P187	98	697	710	2	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					855	860		10.1126/science.280.5365.855	http://dx.doi.org/10.1126/science.280.5365.855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZM380	9599158				2022-12-28	WOS:000073532900030
J	Lie, RT; Rasmussen, S; Brunborg, H; Gjessing, HK; Lie-Nielsen, E; Irgens, LM				Lie, RT; Rasmussen, S; Brunborg, H; Gjessing, HK; Lie-Nielsen, E; Irgens, LM			Fetal and maternal contributions to risk of pre-eclampsia: population based study	BRITISH MEDICAL JOURNAL			English	Article							PREECLAMPSIA; PREGNANCY; HYPERTENSION; GENE; ANGIOTENSINOGEN; ASSOCIATION; RECURRENCE; MOTHER; FETUS	Objective: To use familial patterns of recurrence of pre-eclampsia to investigate whether paternal genes expressed in the fetus contribute to the mother's risk of pre-eclampsia and whether mother's susceptibility to pre-eclampsia is related to maternal inheritance by mitochondrial DNA. Design: Linked data on pregnancies of different women who had children with the same father, and subsequently linked data on pregnancies of half sisters who either had same mother and different fathers or had same father and different mothers. Setting: Population based data from the Medical Birth Registry of Norway covering all births since 1967 (about 1.7 million) and the Norwegian Central Population Register. Main outcome measures: Relative risk of pre-eclampsia after a previous pre-eclamptic pregnancy in the family. Relative risks approximated by odds ratios. Results: If a woman becomes pregnant by a man who has already fathered a pre-eclamptic pregnancy in a different woman her risk of developing pre-eclampsia is 1.8 (95% confidence interval 1.2 to 2.6). If the woman has a half sister who had pre-eclampsia and with whom she shares the same mother but different fathers the risk of pre-eclampsia is 1.6 (0.9 to 2.6). If the two sisters have the same father but different mothers the risk is 1.8 (1.01 to 2.9). Conclusions: Both the mother and the fetus contribute to the risk of pre-eclampsia, the contribution of the fetus being affected by paternal genes. Mitochondrial genes, which are transmitted by mothers, do not seem to contribute to the risk.	Univ Bergen, Haukeland Hosp, Div Med Stat, N-5021 Bergen, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway; Stat Norway, N-0033 Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Statistics Norway	Lie, RT (corresponding author), Univ Bergen, Haukeland Hosp, Div Med Stat, Hansens Bldg, N-5021 Bergen, Norway.	rolv.lie@smis.uib.no	Gjessing, Hakon K/A-5871-2012					ADAMS EM, 1961, LANCET, V2, P1375; ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; ENGELMAN L, 1990, BMDP STAT SOFTWARE; Folgero T, 1996, AM J OBSTET GYNECOL, V174, P1626, DOI 10.1016/S0002-9378(96)70619-1; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; KILPATRICK DC, 1990, TISSUE ANTIGENS, V35, P178, DOI 10.1111/j.1399-0039.1990.tb01776.x; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; LISTON WA, 1991, BRIT J OBSTET GYNAEC, V98, P1079, DOI 10.1111/j.1471-0528.1991.tb15358.x; LOUDON I, 1991, BRIT J OBSTET GYNAEC, V98, P853, DOI 10.1111/j.1471-0528.1991.tb13505.x; MACGILLIVRAY I, 1958, J OBSTET GYNAECOL, V65, P536; Olsen J, 1997, EPIDEMIOLOGY, V8, P6, DOI 10.1097/00001648-199701000-00001; Olson JM, 1996, GENET EPIDEMIOL, V13, P489, DOI 10.1002/(SICI)1098-2272(1996)13:5<489::AID-GEPI5>3.0.CO;2-Y; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; SHANKLIN DR, 1990, AM J OBSTET GYNECOL, V163, P943, DOI 10.1016/0002-9378(90)91102-I; SIBAI BM, 1991, AM J OBSTET GYNECOL, V165, P1408; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; VINATIER D, 1995, EUR J OBSTET GYN R B, V61, P85, DOI 10.1016/0301-2115(95)02106-H	21	330	341	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1343	1347		10.1136/bmj.316.7141.1343	http://dx.doi.org/10.1136/bmj.316.7141.1343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563982	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073483000014
J	Breyer, S				Breyer, S			Policy: Science and society - The interdependence of science and law	SCIENCE			English	Editorial Material									Supreme Court United States, Washington, DC 20543 USA		Breyer, S (corresponding author), Supreme Court United States, Washington, DC 20543 USA.							ACKER, 1998, COMMUNICATION   0102; HUBER PW, 1991, GALILEOS REVENGE, P54; OMENN GS, 1994, ENVIRON HEALTH PERSP, V102, P674, DOI 10.2307/3432196; WEINSTEIN JACK B., 1995, INDIVIDUAL JUSTICE M, P116	4	27	27	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	1998	280	5363					537	538		10.1126/science.280.5363.537	http://dx.doi.org/10.1126/science.280.5363.537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ684	9575098				2022-12-28	WOS:000073242100028
J	Matsuoka, K; Orci, L; Amherdt, M; Bednarek, SY; Hamamoto, S; Schekman, R; Yeung, T				Matsuoka, K; Orci, L; Amherdt, M; Bednarek, SY; Hamamoto, S; Schekman, R; Yeung, T			COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes	CELL			English	Article							GTP-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; PHOSPHATIDYLINOSITOL 4-KINASE; SACCHAROMYCES-CEREVISIAE; MEMBRANE GLYCOPROTEIN; GOLGI-APPARATUS; YEAST; TRANSPORT; COMPLEX; SEC23P	COPII vesicle formation requires only three coat assembly subunits: Sar1p, Sec13/31p, and Sec23/24p. PI 4-phosphate or PI 4,5-bisphosphate is required for the binding of these proteins to liposomes. The GTP-bound form of Sar1p recruits Sec23/24p to the liposomes as well as to the ER membranes, and this Sar1p-Sec23/24p complex is required for the binding of Sec13/31p. Ultrastructural analysis shows that the binding of COPII coat proteins to liposomes results in coated patches, coated buds, and coated vesicles of 50-90 nm in diameter. Budding proceeds without rupture of the donor liposome or vesicle product. These observations suggest that the assembly of the COPII coat on the ER occurs by a sequential binding of coat proteins to specific lipids and that this assembly promotes the budding of COPII-coated vesicles.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva 4, Switzerland	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Geneva	Schekman, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.		Matsuoka, Ken/E-3215-2010; Taylor, Graham/A-4027-2012					Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bednarek SY, 1996, TRENDS CELL BIOL, V6, P468, DOI 10.1016/0962-8924(96)84943-9; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Campbell JL, 1997, P NATL ACAD SCI USA, V94, P837, DOI 10.1073/pnas.94.3.837; DENFERT C, 1991, MOL CELL BIOL, V11, P5727, DOI 10.1128/MCB.11.11.5727; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; HICKE L, 1992, MOL BIOL CELL, V3, P667, DOI 10.1091/mbc.3.6.667; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; KAIBUCHI K, 1986, P NATL ACAD SCI USA, V83, P8172, DOI 10.1073/pnas.83.21.8172; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; MATSUOKA K, 1995, J CELL BIOL, V130, P1307, DOI 10.1083/jcb.130.6.1307; Nakagawa T, 1996, BIOCHEM J, V320, P643, DOI 10.1042/bj3200643; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; WAGNER S, 1994, YEAST, V10, P1429, DOI 10.1002/yea.320101106; Waksman M, 1997, J BIOL CHEM, V272, P36; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yeung T, 1995, J BIOL CHEM, V270, P30567, DOI 10.1074/jbc.270.51.30567; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	48	498	509	0	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					263	275		10.1016/S0092-8674(00)81577-9	http://dx.doi.org/10.1016/S0092-8674(00)81577-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568718	Bronze			2022-12-28	WOS:000073174000012
J	Zhang, ZL; Huang, LS; Shulmeister, VM; Chi, YI; Kim, KK; Hung, LW; Crofts, AR; Berry, EA; Kim, SH				Zhang, ZL; Huang, LS; Shulmeister, VM; Chi, YI; Kim, KK; Hung, LW; Crofts, AR; Berry, EA; Kim, SH			Electron transfer by domain movement in cytochrome bc(1)	NATURE			English	Article							CYTOCHROME-C OXIDOREDUCTASE; IRON-SULFUR PROTEIN; HEART UBIQUINOL; COMPLEX; SITE; CRYSTALLIZATION; MITOCHONDRIA; RESOLUTION; REDUCTASE; SUBUNIT	The cytochrome bc(1) is one of the three major respiratory enzyme complexes residing in the inner mitochondrial membrane. Cytochrome bc(1) transfers electrons from ubiquinol to cytochrome c and uses the energy thus released to form an electrochemical gradient across the inner membrane. Our X-ray crystal structures of the complex from chicken, cow and rabbit In both the presence and absence of inhibitors of quinone oxidation, reveal two different locations for the extrinsic domain of one component of the enzyme, an Iron-sulphur protein. One location Is close enough to the supposed quinol oxidation site to allow reduction of the Fe-S protein by ubiquinol. The other site is close enough to cytochrome cl to allow oxidation of the Fe-S protein by the cytochrome. As neither location will allow both reactions to proceed at a suitable rate, the reaction mechanism must involve movement of the extrinsic domain of the Fe-S component In order to shuttle electrons from ubiquinol to cytochrome c(1). Such a mechanism has not previously been observed in redox protein complexes.	Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Illinois, Ctr Biophys & Comptat Biol, Urbana, IL 61801 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign	Berry, EA (corresponding author), Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.		Zhang, Zhaolei/G-2369-2017	Huang, Li-Shar/0000-0003-1427-2544				AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; [Anonymous], 1985, ENZYMES BIOL MEMBRAN, DOI DOI 10.1007/978-1-4684-4604-3_10; BEAUTEMENT K, 1991, PESTIC SCI, V31, P499, DOI 10.1002/ps.2780310406; BERRY EA, 1992, J MOL BIOL, V224, P1161, DOI 10.1016/0022-2836(92)90476-Z; BERRY EA, 1995, ACTA CRYSTALLOGR D, V51, P235, DOI 10.1107/S0907444994010486; BERRY EA, 1991, J BIOL CHEM, V266, P9064; BRANDT U, 1993, J BIOL CHEM, V268, P8387; BROGER C, 1983, EUR J BIOCHEM, V131, P349, DOI 10.1111/j.1432-1033.1983.tb07269.x; CLOUGH JM, 1995, CHEM BRIT, V31, P466; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1997, IN PRESS PHOTOTROPHI; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1992, P CCP4 STUD WEEK MOL, P91; KIM CH, 1983, J BIOL CHEM, V258, P3543; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUBOTA T, 1991, J MOL BIOL, V221, P379, DOI 10.1016/0022-2836(91)80059-4; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LINK TA, FRONTIERS CELLULAR B; LINK TA, 1987, CYTOCHROME SYSTEMS M, P289; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; RAYMENT I, 1983, ACTA CRYSTALLOGR A, V39, P102, DOI 10.1107/S0108767383000197; ROBERTSON DE, 1990, BIOCHEMISTRY-US, V29, P11249, DOI 10.1021/bi00503a014; SAUTER H, 1996, CROP PROTECTION AGEN, P50; Schagger H, 1995, METHOD ENZYMOL, V260, P82, DOI 10.1016/0076-6879(95)60132-5; SCHLAGGER H, 1986, METHOD ENZYMOL, V126, P224; *SERC UK COLL COMP, 1995, ACTA CRYSTALLOGR D, V50, P760; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; STONEHUERNER J, 1985, J BIOL CHEM, V260, P5392; VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P628, DOI 10.1021/bi00053a031; WEISS H, 1987, CHEM SCRIPTA, V27B, P73; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yu CA, 1996, BBA-BIOENERGETICS, V1275, P47, DOI 10.1016/0005-2728(96)00049-7; YUE WH, 1991, BIOCHEMISTRY-US, V30, P2303, DOI 10.1021/bi00223a002	42	924	945	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	1998	392	6677					677	684		10.1038/33612	http://dx.doi.org/10.1038/33612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565029				2022-12-28	WOS:000073129000047
J	Hughes, V				Hughes, V			Commentary: Ethical approval of study was warranted	BRITISH MEDICAL JOURNAL			English	Editorial Material									N Staffordshire Royal Infirm, Res Eth Comm, Stoke On Trent ST4 6QG, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust	Hughes, V (corresponding author), N Staffordshire Royal Infirm, Res Eth Comm, Stoke On Trent ST4 6QG, Staffs, England.								0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 21	1998	316	7135					892	893						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD691	9569394				2022-12-28	WOS:000072713300024
J	Yule, B				Yule, B			A memorable patient - Fear of tuberculosis	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1682	1682		10.1136/bmj.316.7145.1682	http://dx.doi.org/10.1136/bmj.316.7145.1682			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603772	Green Published			2022-12-28	WOS:000074022700073
J	Probst, FJ; Fridell, RA; Raphael, Y; Saunders, TL; Wang, AH; Liang, Y; Morell, RJ; Touchman, JW; Lyons, RH; Noben-Trauth, K; Friedman, TB; Camper, SA				Probst, FJ; Fridell, RA; Raphael, Y; Saunders, TL; Wang, AH; Liang, Y; Morell, RJ; Touchman, JW; Lyons, RH; Noben-Trauth, K; Friedman, TB; Camper, SA			Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene	SCIENCE			English	Article							HAIR-CELLS; MOUSE; GENE; ALIGNMENT; ACTIN	The shaker-2 mouse mutation, the homolog of human DFNB3, causes deafness and circling behavior. A bacterial artificial chromosome (BAC) transgene from the shaker-2 critical region corrected the vestibular defects, deafness, and inner ear morphology of shaker-2 mice. An unconventional myosin gene, Myo15, was discovered by DNA sequencing of this BAG. Shaker-2 mice were found to have an amino acid substitution at a highly conserved position within the motor domain of this myosin, Auditory hair cells of shaker-2 mice have very short stereocilia and a long actin-containing protrusion extending from their basal end. This histopathology suggests that Myo15 is necessary for actin organization in the hair cells of the cochlea.	NIDOCD, NIH, Rockville, MD 20850 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; Natl Human Genome Res Inst, Bethesda, MD 20892 USA; NIH, Intramural Sequencing Ctr, Rockville, MD 20850 USA; Univ Michigan, DNA Sequencing Core Facil, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Michigan State University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan	Camper, SA (corresponding author), Univ Michigan, Dept Human Genet, 4701 MSRB 111,1500 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	scamper@umich.edu	Morell, Robert James/Q-2042-2019	Camper, Sally/0000-0001-8556-3379; Saunders, Thom/0000-0003-2015-101X; Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002407] Funding Source: NIH RePORTER; NIDCD NIH HHS [Z01 DC 00035, Z01 DC 00038, Z01 DC 02407] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; DEOL MS, 1954, J GENET, V52, P562, DOI 10.1007/BF02985081; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DOBROVOLSKAIA-ZAVASDKAIA N., 1928, ARCH BIOL, V38, P457; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hogan B, 1994, MANIPULATING MOUSE E; KOHMAN D, 1998, 21 MIDW RES M ASS RE; Liang Y, 1998, AM J HUM GENET, V62, P904, DOI 10.1086/301786; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; PROBST, UNPUB; RAPHAEL Y, 1994, HEARING RES, V76, P173, DOI 10.1016/0378-5955(94)90098-1; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; Self T, 1998, DEVELOPMENT, V125, P557; Snell GD, 1939, J HERED, V30, P447, DOI 10.1093/jhered/30.10.447; SOBIN A, 1982, ARCH OTO-RHINO-LARYN, V236, P1, DOI 10.1007/BF00464051; SOBIN A, 1981, ADV OTORHINOLARYNGOL, V25, P12; STEEL K, COMMUNICATION; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wakabayashi Y, 1997, BIOCHEM BIOPH RES CO, V234, P107, DOI 10.1006/bbrc.1997.6595; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILSON REK, 1997, ANAL DNA, P398	30	323	338	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1444	1447		10.1126/science.280.5368.1444	http://dx.doi.org/10.1126/science.280.5368.1444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603735				2022-12-28	WOS:000073883400058
J	Wang, AH; Liang, Y; Fridell, RA; Probst, FJ; Wilcox, ER; Touchman, JW; Morton, CC; Morell, RJ; Noben-Trauth, K; Camper, SA; Friedman, TB				Wang, AH; Liang, Y; Fridell, RA; Probst, FJ; Wilcox, ER; Touchman, JW; Morton, CC; Morell, RJ; Noben-Trauth, K; Camper, SA; Friedman, TB			Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3	SCIENCE			English	Article							GENE; MOUSE	DFNB3, a locus for nonsyndromic sensorineural recessive deafness, maps to a 3-centimorgan interval on human chromosome 17p11.2, a region that shows conserved synteny with mouse shaker-2. A human unconventional myosin gene, MYO15, was identified by combining functional and positional cloning approaches in searching for shaker-2 and DFNB3. MYO15 has at least 50 exons spanning 36 kilobases. Sequence analyses of these exons in affected individuals from three unrelated DFNB3 families revealed two missense mutations and one nonsense mutation that cosegregated with congenital recessive deafness.	NIDOCD, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; NIH, Intramural Sequencing Ctr, Rockville, MD 20850 USA; NIH, Natl Human Genome Res Inst, Bethesda, MD 20892 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Michigan State University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Friedman, TB (corresponding author), NIDOCD, Genet Mol Lab, NIH, Rockville, MD 20850 USA.	tfriedman@pop.nidcd.nih.gov	Morell, Robert James/Q-2042-2019	Morell, Robert/0000-0003-1537-7356; Camper, Sally/0000-0001-8556-3379	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003402] Funding Source: NIH RePORTER; NIDCD NIH HHS [Z01 DC 00038-01, R01 DC 03402, Z01 DC 00035-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liang Y, 1998, AM J HUM GENET, V62, P904, DOI 10.1086/301786; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; PUSTELL J, 1984, NUCLEIC ACIDS RES, V12, P643, DOI 10.1093/nar/12.1Part2.643; Sellers JR, 1996, J MUSCLE RES CELL M, V17, P7, DOI 10.1007/BF00140320; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; VANCAMP G, 1998, HEREDITARY HEARING L; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILSON REK, 1997, ANAL DNA, P398	35	332	343	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1447	1451		10.1126/science.280.5368.1447	http://dx.doi.org/10.1126/science.280.5368.1447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603736	Green Submitted			2022-12-28	WOS:000073883400059
J	Toomey, DR; Wilcock, WSD; Solomon, SC; Hammond, WC; Orcutt, JA				Toomey, DR; Wilcock, WSD; Solomon, SC; Hammond, WC; Orcutt, JA			Mantle seismic structure beneath the MELT region of the East Pacific Rise from P and S wave tomography	SCIENCE			English	Article							MID-OCEAN RIDGES; ANELASTICITY	Relative travel time delays of teleseismic P and S waves, recorded during the Mantle Electromagnetic and Tomography (MELT) Experiment, have been inverted tomographically for upper-mantle structure beneath the southern East Pacific Rise. A broad zone of low seismic velocities extends beneath the rise to depths of about 200 kilometers and is centered to the west of the spreading center. The magnitudes of the P and S wave anomalies require the presence of retained mantle melt; the melt fraction near the rise exceeds the fraction 300 kilometers off axis by as little as 1%. Seismic anisotropy, induced by mantle flow, is evident in the P wave delays at near-vertical incidence and is consistent with a half-width of mantle upwelling of about 100 km.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	University of Oregon; University of Washington; University of Washington Seattle; Carnegie Institution for Science; University of California System; University of California San Diego; Scripps Institution of Oceanography	Toomey, DR (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	drt@newberry.uoregon.edu		Orcutt, John/0000-0001-5508-0050; Toomey, Douglas/0000-0003-2873-4084; Wilcock, William/0000-0001-7224-7246				Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; BLACKMAN DK, 1993, NATURE, V366, P675, DOI 10.1038/366675a0; BUCK WR, 1989, GEOPHYS RES LETT, V16, P641, DOI 10.1029/GL016i007p00641; COCHRAN JR, 1986, GEOPHYS J INT, V87, P421, DOI 10.1111/j.1365-246X.1986.tb06631.x; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; KENDALL JM, 1994, GEOPHYS RES LETT, V21, P301, DOI 10.1029/93GL02791; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; MCNUTT MK, 1990, SCIENCE, V248, P969, DOI 10.1126/science.248.4958.969; SCHMELING H, 1985, PHYS EARTH PLANET IN, V41, P34, DOI 10.1016/0031-9201(85)90100-1; STEIN S, 1977, EARTH PLANET SC LETT, V36, P51, DOI 10.1016/0012-821X(77)90187-X; TOOMEY DR, 1994, J GEOPHYS RES, V99, P24; VANDECAR JC, 1990, B SEISMOL SOC AM, V80, P150; Webb SC, 1998, REV GEOPHYS, V36, P105, DOI 10.1029/97RG02287; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230	16	120	123	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1224	1227		10.1126/science.280.5367.1224	http://dx.doi.org/10.1126/science.280.5367.1224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596567				2022-12-28	WOS:000073852500036
J	Goyder, EC; McNally, PG; Drucquer, M; Spiers, N; Botha, JL				Goyder, EC; McNally, PG; Drucquer, M; Spiers, N; Botha, JL			Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices	BRITISH MEDICAL JOURNAL			English	Review									Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Leicester Royal Infirm NHS Trust, Dept Endocrinol & Diabet, Leicester LE1 5WW, Leics, England; S Wigston Hlth Ctr, Leicester LE8 2SE, Leics, England	University of Leicester	Goyder, EC (corresponding author), Univ Sydney, Dept Publ Hlth & Community Med, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.		Goyder, Elizabeth E/A-2146-2010	Goyder, Elizabeth E/0000-0003-3691-1888				Alexander WD, 1997, LANCET, V349, P578, DOI 10.1016/S0140-6736(97)80134-1; Krans HMJ, 1992, DIABETES CARE RES EU; LEESE B, 1995, BRIT MED J, V311, P546, DOI 10.1136/bmj.311.7004.546; LOWY A, 1993, BRIT MED J, V307, P413, DOI 10.1136/bmj.307.6901.413; Marks L., 1996, COUNTING COST REAL I	5	50	51	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1505	1506		10.1136/bmj.316.7143.1505	http://dx.doi.org/10.1136/bmj.316.7143.1505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582142	Green Published			2022-12-28	WOS:000073707700032
J	Bergh, C; Sodersten, P				Bergh, C; Sodersten, P			Anorexia nervosa: rediscovery of a disorder	LANCET			English	Editorial Material									Karolinska Inst, Novum, Sect Appl Neuroendocrinol, S-14157 Huddinge, Sweden	Karolinska Institutet	Sodersten, P (corresponding author), Karolinska Inst, Novum, Sect Appl Neuroendocrinol, S-14157 Huddinge, Sweden.	per.sodersten@cnsf.ki.se		Sodersten, Per/0000-0002-4713-4490				Bergh C, 1996, NAT MED, V2, P21, DOI 10.1038/nm0196-21; Bergh C, 1996, LANCET, V348, P611, DOI 10.1016/S0140-6736(05)64824-6; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; CHANNON S, 1989, BEHAV RES THER, V27, P529, DOI 10.1016/0005-7967(89)90087-9; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; Crisp AH, 1995, P NUTR SOC, V54, P701, DOI 10.1079/PNS19950069; FERNANDEZ F, 1994, INT J EAT DISORDER, V16, P307, DOI 10.1002/1098-108X(199411)16:3&lt;307::AID-EAT2260160313&gt;3.0.CO;2-P; Gull W., 1874, CLIN SOC T, V7, P22; GULL WW, 1888, LANCET, V1, P516; Hankins Thomas L., 1995, INSTRUMENTS IMAGINAT; MUNTHE A, 1930, BOKEN SAN MYKELE; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; SMEETS M, 1995, THESIS U HAGUE CIPGE; STEVENSON RL, 1883, STRANGE CASE JEKYL H; Vandereycken Walter, 1994, FASTING SAINTS ANORE; WEBSTER R, 1995, FREUD WRONG; Wolf-Heidegger Gerhard, 1967, ANATOMISCHE SEKTION; 1997, LANCET, V351, P1	18	20	20	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	1998	351	9113					1427	1429		10.1016/S0140-6736(97)12033-5	http://dx.doi.org/10.1016/S0140-6736(97)12033-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZM665	9593429				2022-12-28	WOS:000073563400043
J	Tynell, E; Andersson, S; Lithander, E; Arneborn, M; Blomberg, J; Hansson, HB; Krook, A; Nomberg, M; Ramstedt, K; Shanwell, A; Bjorkman, A				Tynell, E; Andersson, S; Lithander, E; Arneborn, M; Blomberg, J; Hansson, HB; Krook, A; Nomberg, M; Ramstedt, K; Shanwell, A; Bjorkman, A			Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis	BRITISH MEDICAL JOURNAL			English	Article							LEUKEMIA-LYMPHOMA VIRUS; HTLV-I; TRANSMISSION; TRANSFUSION; ANTIBODIES; RECIPIENTS; PREVALENCE; JAPAN	Objective: To analyse the cost effectiveness of a national programme to screen blood donors for infection with the human T cell leukaemia/lymphoma virus. Design: Three models for calculating the costs and benefits of screening were developed. The first model analysed the cost of continuously testing all donations; the second analysed the cost of initially testing nerv blood dollars and then retesting them after five years; the third analysed the cost of testing donors only at the time of their first donation, Patients who had received blood components from donors confirmed to be infected with the virus were offered testing. Setting: Sweden. Main outcome measures: Prevalence of infection with the virus among blood donors, the risk of transmission of the virus, screening costs, and the outcome of infection. Results: 648 497 donations were tested for the virus; 1625 samples tested positive by enzyme linked immunosorbent assay, 6 were confirmed positive by western blotting. The prevalence of infection with the virus was 2/100 000 donors. 35 patients who had received blood infected with the virus were tested; 3 were positive. The cost of testing every donation was calculated to be $3.02m (pound 1.88m); this is 18 times higher than the cost of testing new donors only, and only 1 additional positive donor would be discovered in 7 years. Regardless of the model used, screening was estimated to prevent only 1 death every 200 years at a minimum cost of $36m (pound 22.5m). Conclusion: Based on these estimates the Swedish National Board of Health and Welfare decided that only new blood donors would be screened for infection with the virus.	Danderyd Univ Hosp, Karolinska Inst, Div Infect Dis, Danderyd, Sweden; Swedish Inst Infect Dis, Stockholm, Sweden; Karolinska Inst, Stockholm, Sweden; Natl Board Hlth & Welf, Stockholm, Sweden; Univ Lund, Dept Med Microbiol, Sect Virol, Lund, Sweden; Univ Hosp MAS, Reg Ctr Communicable Dis Control, Malmo, Sweden; Huddinge Univ Hosp, Karolinska Inst, Div Infect Dis, S-14186 Huddinge, Sweden; South Hosp, Div Transfus Med, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; National Board of Health & Welfare; Lund University; Lund University; Skane University Hospital; Karolinska Institutet	Tynell, E (corresponding author), Danderyd Univ Hosp, Karolinska Inst, Div Infect Dis, Danderyd, Sweden.	elsa.tynell@inf.ds.sll.se	Krook, Anna/K-1192-2015	Krook, Anna/0000-0002-0891-0258; Blomberg, Jonas/0000-0001-6492-2491				ANDERSSON S, 1994, 10 INT C AIDS STD YO; BOHNCHRISTANSEN C, 1995, J ACQ IMMUN DEF SYND, V10, P251; BRENNAN M, 1993, BRIT MED J, V307, P1235, DOI 10.1136/bmj.307.6914.1235; COUROUCE AM, 1993, AIDS, V7, P841, DOI 10.1097/00002030-199306000-00013; DALGLEISH AG, 1993, BRIT MED J, V307, P1224, DOI 10.1136/bmj.307.6914.1224; DEFER C, 1995, TRANSFUSION, V35, P506; DONEGAN E, 1994, TRANSFUSION, V34, P478, DOI 10.1046/j.1537-2995.1994.34694295061.x; Goubau P, 1996, J ACQ IMMUN DEF SYND, V13, P68; IWATA K, 1994, JPN J CANCER RES, V85, P231, DOI 10.1111/j.1349-7006.1994.tb02087.x; KAGESON P, 1993, GETTING PRICES RIGHT, P114; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847; KAMIHIRA S, 1987, VOX SANG, V52, P43, DOI 10.1111/j.1423-0410.1987.tb02987.x; Krook A, 1997, J ACQ IMMUN DEF SYND, V15, P381, DOI 10.1097/00042560-199708150-00009; KWOK S, 1990, TRANSFUSION, V30, P491, DOI 10.1046/j.1537-2995.1990.30690333477.x; LEE HH, 1991, LANCET, V337, P1435, DOI 10.1016/0140-6736(91)93126-T; MURPHY E, 1990, HUMAN RETROVIROLOGY, P290; Nyambi Phillipe N., 1995, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V10, P258; OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; PILLONEL J, 1995, J ACQ IMMUN DEF SYND, V10, P251; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; SULLIVAN MT, 1991, ARCH INTERN MED, V151, P2043, DOI 10.1001/archinte.151.10.2043; Tajima K., 1995, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V10, P285; YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6; ZAAIJER HL, 1994, TRANSFUSION, V34, P1; 1988, MMWR MORB MORTAL WKL, V37, P736; 1966, ECONOMIST       0316, P29; 1992, WHO WKLY EPIDEMIOLOG, V29, P213	29	31	33	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1417	1422		10.1136/bmj.316.7142.1417	http://dx.doi.org/10.1136/bmj.316.7142.1417			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572750	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000073651600025
J	Pier, GB; Grout, M; Zaidi, T; Meluleni, G; Mueschenborn, SS; Banting, G; Ratcliff, R; Evans, MJ; Colledge, WH				Pier, GB; Grout, M; Zaidi, T; Meluleni, G; Mueschenborn, SS; Banting, G; Ratcliff, R; Evans, MJ; Colledge, WH			Salmonella typhi uses CFTR to enter intestinal epithelial cells	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; FIBROSIS MOUSE MODEL; GENE; INVASION; MURINE	Homozygous mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis (CF). In the heterozygous state, increased resistance to infectious diseases may maintain mutant CFTR alleles at high levels in selected populations'. Here we investigate whether typhoid fever could be one such disease. The disease is initiated when Salmonella typhi enters gastrointestinal epithelial cells for submucosal translocation(2). We found that S, typhi but not the related murine pathogen S. typhimurium, uses CFTR for entry into epithelial cells. Cells expressing wild-type CFTR internalized more S. typhi than isogenic cells expressing the most common CFTR mutation, a phenylalanine deleted at residue 508 (Delta 508). Monoclonal antibodies and synthetic peptides containing a sequence corresponding to the first predicted extracellular domain of CFTR inhibited uptake of S. typhi. Heterozygous Delta F508 Cftr mice translocated 86% fewer S. typhi into the gastrointestinal submucosa than wild-type Cftr mice; no translocation occurred in Delta F508 Cftr homozygous mice. The Cftr genotype had no effect on the translocation of S. typhimurium. Immunoelectron microscopy revealed that more CFTR bound to S. typhi in the submucosa of Cftr wild-type mice than in Delta F508 heterozygous mice. We conclude that diminished levels of CFTR in heterozygotes may decrease susceptibility to typhoid fever.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Univ Bristol, Mol Recognit Ctr, Dept Biochem & Biotechnol & Biol Sci Res Council, Bristol BS8 1TD, Avon, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bristol; University of Cambridge; University of Cambridge; University of Cambridge	Pier, GB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	gpier@channing.harvard.edu	Colledge, William/X-4976-2019; Pier, Gerald/AAO-2692-2021	Colledge, William/0000-0002-9603-4429; Pier, Gerald/0000-0002-9112-2331; Banting, George/0000-0001-8249-1621	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALPUCHEARANDA CM, 1995, INFECT IMMUN, V63, P4456, DOI 10.1128/IAI.63.11.4456-4462.1995; Beatty WL, 1997, INFECT IMMUN, V65, P4395, DOI 10.1128/IAI.65.11.4395-4404.1997; BERTRANPETIT J, 1996, VARIATION HUMAN GENO, P97; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; COLLEDGE WH, 1995, NAT GENET, V10, P445, DOI 10.1038/ng0895-445; CUTHBERT AW, 1995, J PHYSIOL-LONDON, V482, P449, DOI 10.1113/jphysiol.1995.sp020531; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Ishibashi Y, 1996, MICROB PATHOGENESIS, V21, P435, DOI 10.1006/mpat.1996.0074; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; MILLS SD, 1994, MICROB PATHOGENESIS, V17, P409, DOI 10.1006/mpat.1994.1086; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; ORIORDAN CR, 1995, J BIOL CHEM, V270, P17033, DOI 10.1074/jbc.270.28.17033; PASCOPELLA L, 1995, INFECT IMMUN, V63, P4329, DOI 10.1128/IAI.63.11.4329-4335.1995; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; POLLITZNER R, 1959, CHOLERA; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; ROSNER B, 1990, FUNDAMENTALS BIOSTAT, P498; TSUI LC, 1995, AM J RESP CRIT CARE, V151, pS47, DOI 10.1164/ajrccm/151.3_Pt_2.S47; VANHEYNINGEN WE, 1983, CHOLERA AM SCI ENCOU, P1; WALKER J, 1995, J CELL SCI, V108, P2433	25	244	256	0	31	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					79	82		10.1038/30006	http://dx.doi.org/10.1038/30006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590693				2022-12-28	WOS:000073497500051
J	Marciniak, TA; Ellerbeck, EF; Radford, MJ; Kresowik, TF; Gold, JA; Krumholz, HM; Kiefe, CI; Allman, RM; Vogel, RA; Jencks, SF				Marciniak, TA; Ellerbeck, EF; Radford, MJ; Kresowik, TF; Gold, JA; Krumholz, HM; Kiefe, CI; Allman, RM; Vogel, RA; Jencks, SF			Improving the quality of care for Medicare patients with acute myocardial infarction - Results from the Cooperative Cardiovascular Project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES; MANAGEMENT; ASSURANCE	Context.-Medicare has a legislative mandate for quality assurance, but the effectiveness of its population-based quality improvement programs has been difficult to establish. Objective.-To improve the quality of care for Medicare patients with acute myocardial infarction. Design.-Quality improvement project with baseline measurement, feedback, remeasurement, and comparison samples. Setting.-All acute care hospitals in the United States. Patients.-Preintervention and postintervention samples included all Medicare patients in Alabama, Connecticut, Iowa, and Wisconsin discharged with principal diagnoses of acute myocardial infarctions during 2 periods, June 1992 through December 1992 and August 1995 through November 1995, Indicator comparisons were made with a random sample of Medicare patients in the rest of the nation discharged with acute myocardial infarctions from August 1995 through November 1995, Mortality comparisons involved all Medicare patients nationwide with inpatient claims for acute myocardial infarctions during 2 periods, June 1992 through May 1993 and August 1995 through July 1996. Intervention.-Data feedback by peer review organizations. Main Outcome Measures.-Quality indicators derived from clinical practice guidelines, length of stay, and mortality. Results.-Performance on all quality indicators improved significantly in the 4 pilot states. Administration of aspirin during hospitalization in patients without contraindications improved from 84% to 90% (P<.001), and prescription of beta-blockers at discharge improved from 47% to 68% (P<.001), Mortality at 30 days decreased from 18.9% to 17.1% (P=.005) and at 1 year from 32.3% to 29.6% (P<.001). These improvements in quality occurred during a period when median length of stay decreased from 8 days to 6 days. Performance on all quality indicators except reperfusion was better in the pilot states than in the rest of the nation in 1995, and the differences were statistically significant for aspirin use at discharge (P<.001), beta-blocker use (P<.001), and smoking cessation counseling (P=.02), Postinfarction mortality was not significantly different between the pilot states and the rest of the nation during the baseline period, although it was slightly but significantly better in the pilot states during the follow-up period (absolute mortality difference at 1 year, 0.9%, P=.004). Conclusions.-The quality of care for Medicare patients with acute myocardial infarction has improved in the Cooperative Cardiovascular Project pilot states. Performance on the defined quality indicators appeared to be better in the pilot states than in the rest of the nation in 1995 and was associated with reduced mortality.	US Hlth Care Financing Adm, Baltimore, MD 21244 USA; Iowa Fdn Med Care, Des Moines, IA USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; Connecticut Peer Review Org, Middletown, CT USA; Univ Connecticut, Div Cardiol, Farmington, CT USA; Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; MetaStar Inc, Madison, WI USA; Med Coll Wisconsin, Dept Prevent Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Hlth Policy Inst, Milwaukee, WI 53226 USA; Yale Univ, Sch Med, Cardiovasc Sect, New Haven, CT USA; Alabama Qual Assurance Fdn, Birmingham, AL USA; Dept Vet Affairs, Birmingham, AL USA; Univ Alabama, Div Prevent Med, Birmingham, AL USA; Univ Alabama, Ctr Aging, Birmingham, AL USA; Univ Maryland, Dept Cardiol, Baltimore, MD 21201 USA	University of Kansas; University of Kansas Medical Center; University of Connecticut; University of Iowa; Medical College of Wisconsin; Medical College of Wisconsin; Yale University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore	Marciniak, TA (corresponding author), US Hlth Care Financing Adm, 7500 Secur Blvd,Bldg S2-11-07, Baltimore, MD 21244 USA.	tmarciniak@hcfa.gov	Ellerbeck, Edward/I-8438-2014; Allman, Richard M/D-5964-2011; Allman, Richard M./O-1693-2019; , Harlan/AAI-2875-2020	Ellerbeck, Edward/0000-0002-7774-2729; Allman, Richard M./0000-0002-1850-6515; Radford, Martha/0000-0001-7503-9557; Kresowik, Timothy/0000-0003-4163-1573				Angell M, 1996, NEW ENGL J MED, V335, P883, DOI 10.1056/NEJM199609193351209; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kerr EA, 1996, JAMA-J AM MED ASSOC, V276, P1236, DOI 10.1001/jama.276.15.1236; LAMBERTHUBER DA, 1994, CLIN PERFORMANCE QUA, V2, P219; Meehan TP, 1996, JOINT COMM J QUAL IM, V22, P751, DOI 10.1016/S1070-3241(16)30280-2; National Heart Attack Alert Program Coordinating Committee, 1993, EM DEP RAP ID TREATM; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; *SAS I INC, 1996, SAS COMP SOFTW REL 6; *TEX STAT CORP, 1995, STAT STAT SOFTW REL	16	412	412	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1351	1357		10.1001/jama.279.17.1351	http://dx.doi.org/10.1001/jama.279.17.1351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582042				2022-12-28	WOS:000073359800026
J	Nightingale, SL				Nightingale, SL			Advisory on medical telemetry system interference problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Hlth Affairs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Nightingale, SL (corresponding author), US FDA, Off Hlth Affairs, Parklawn Bldg,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1339	1339		10.1001/jama.279.17.1339	http://dx.doi.org/10.1001/jama.279.17.1339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582030				2022-12-28	WOS:000073359800007
J	Prusiner, SB; Scott, MR; DeArmond, SJ; Cohen, FE				Prusiner, SB; Scott, MR; DeArmond, SJ; Cohen, FE			Prion protein biology	CELL			English	Review							CREUTZFELDT-JAKOB-DISEASE; DISRUPTED PRP GENE; TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHY; NEUROBLASTOMA-CELLS; STRAIN VARIATION; NATURAL SCRAPIE; CULTURED-CELLS; MESSENGER-RNA; CELLULAR PRP		Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.							ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Carp RI, 1997, J GEN VIROL, V78, P283, DOI 10.1099/0022-1317-78-1-283; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; CHESEBRO B, 1993, CURR BIOL, V3, P696, DOI 10.1016/0960-9822(93)90072-V; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Derkatch IL, 1996, GENETICS, V144, P1375; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; FRANKEL J, 1990, J CELL SCI, V97, P205; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; HUNTER N, 1993, J GEN VIROL, V74, P1025, DOI 10.1099/0022-1317-74-6-1025; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, J MOL BIOL, V270, P574, DOI 10.1006/jmbi.1997.1135; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KENWARD N, 1994, J NEUROCHEM, V62, P1870; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kurschner C, 1996, MOL BRAIN RES, V37, P249, DOI 10.1016/0169-328X(95)00323-K; LANDMAN OE, 1991, ANNU REV GENET, V25, P1, DOI 10.1146/annurev.ge.25.120191.000245; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Manuelidis L, 1996, VIROLOGY, V216, P46, DOI 10.1006/viro.1996.0033; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; Mastrianni James A., 1997, Neurology, V48, pA296; Meggendorfer F, 1930, Z GESAMTE NEUROL PSY, V128, P337, DOI 10.1007/BF02864269; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; OESCH B, 1990, BIOCHEMISTRY-US, V29, P5848, DOI 10.1021/bi00476a029; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PARRY HB, 1962, HEREDITY, V17, P75, DOI 10.1038/hdy.1962.4; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; PRUSINER SB, 1998, IN PRESS PRIX NOBEL; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROOS R, 1973, BRAIN, V96, P1; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1997, P NATL ACAD SCI USA, V94, P10012, DOI 10.1073/pnas.94.19.10012	94	783	843	3	77	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					337	348		10.1016/S0092-8674(00)81163-0	http://dx.doi.org/10.1016/S0092-8674(00)81163-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590169	Bronze			2022-12-28	WOS:000073471500010
J	Stams, T; Niranjanakumari, S; Fierke, CA; Christianson, DW				Stams, T; Niranjanakumari, S; Fierke, CA; Christianson, DW			Ribonuclease P protein structure: Evolutionary origins in the translational apparatus	SCIENCE			English	Article							GEL RETARDATION ANALYSIS; ELONGATION-FACTOR-G; COLI RNASE-P; 4.5 S-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; M1 RNA; MAGNESIUM-IONS; CATALYTIC RNA; NUCLEOTIDE-SEQUENCE	The crystal structure of Bacillus subtilis ribonuclease P protein is reported at 2.6 angstroms resolution. This protein binds to ribonuclease P RNA to form a ribonucleoprotein holoenzyme with optimal catalytic activity. Mutagenesis and biochemical data indicate that an unusual left-handed beta alpha beta crossover connection and a large central cleft in the protein form conserved RNA binding sites; a metal binding loop may comprise a third RNA binding site. The unusual topology is partly shared with ribosomal protein S5 and the ribosomal translocase elongation factor G, which suggests evolution from a common RNA binding ancestor in the primordial translational apparatus.	Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Pennsylvania; Duke University	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	chris@xtal.chem.upenn.edu	Stams, Travis/R-5730-2019		NIGMS NIH HHS [GM55387] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAER MF, 1989, J BACTERIOL, V171, P6862, DOI 10.1128/jb.171.12.6862-6866.1989; Beebe JA, 1996, BIOCHEMISTRY-US, V35, P10493, DOI 10.1021/bi960870m; BOTHWELL ALM, 1976, J BIOL CHEM, V251, P7709; Brown JW, 1998, NUCLEIC ACIDS RES, V26, P351, DOI 10.1093/nar/26.1.351; BROWN S, 1989, J MOL BIOL, V209, P79, DOI 10.1016/0022-2836(89)90171-X; BROWN S, 1987, CELL, V49, P825, DOI 10.1016/0092-8674(87)90620-9; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; GARDINER KJ, 1985, J BIOL CHEM, V260, P5415; Gopalan V, 1997, J MOL BIOL, V267, P818, DOI 10.1006/jmbi.1997.0906; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; GUERRIERTAKADA C, 1986, BIOCHEMISTRY-US, V25, P1509, DOI 10.1021/bi00355a006; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HANSEN FG, 1985, GENE, V38, P85, DOI 10.1016/0378-1119(85)90206-9; HARDT WD, 1993, NUCLEIC ACIDS RES, V21, P3521, DOI 10.1093/nar/21.15.3521; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIRSEBOM LA, 1995, MOL MICROBIOL, V17, P411, DOI 10.1111/j.1365-2958.1995.mmi_17030411.x; KIRSEBOM LA, 1989, J MOL BIOL, V207, P837, DOI 10.1016/0022-2836(89)90250-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MURZIN AG, 1995, NAT STRUCT BIOL, V2, P25, DOI 10.1038/nsb0195-25; NIRANJANAKUMARI S, UNPUB; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; PECKMILLER KA, 1991, J MOL BIOL, V221, P1; PERREAULT JP, 1992, J MOL BIOL, V226, P399, DOI 10.1016/0022-2836(92)90955-J; PERREAULT JP, 1993, J MOL BIOL, V230, P750, DOI 10.1006/jmbi.1993.1197; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P341; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SURRATT CK, 1990, J BIOL CHEM, V265, P22513; SVARD SG, 1993, NUCLEIC ACIDS RES, V21, P427, DOI 10.1093/nar/21.3.427; TALBOT SJ, 1994, BIOCHEMISTRY-US, V33, P1399, DOI 10.1021/bi00172a016; TALBOT SJ, 1994, BIOCHEMISTRY-US, V33, P1406, DOI 10.1021/bi00172a017; TALLSJO A, 1993, NUCLEIC ACIDS RES, V21, P51, DOI 10.1093/nar/21.1.51; Westhof E, 1996, J MOL BIOL, V258, P600, DOI 10.1006/jmbi.1996.0272; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	52	137	142	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					752	755		10.1126/science.280.5364.752	http://dx.doi.org/10.1126/science.280.5364.752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563955				2022-12-28	WOS:000073415600053
J	Garcia-Cardena, G; Fan, R; Shah, V; Sorrentino, R; Cirino, G; Papapetropoulos, A; Sessa, WC				Garcia-Cardena, G; Fan, R; Shah, V; Sorrentino, R; Cirino, G; Papapetropoulos, A; Sessa, WC			Dynamic activation of endothelial nitric oxide synthase by Hsp90	NATURE			English	Article							RECEPTOR TYROSINE KINASE; PALMITOYLATION; DROSOPHILA; SEVENLESS; PATHWAYS; CELLS	Heat-shock protein 90 (Hsp90) coordinates the trafficking and regulation of diverse signalling proteins, but its precise role in regulating specific cellular targets is not known(1,2). Here we show that Hsp90 associates with endothelial nitric oxide synthase (eNOS) and is rapidly recruited to the eNOS complex by agonists that stimulate production of nitric oxide, namely vascular endothelial growth factor, histamine and fluid shear stress. Moreover, the binding of Hsp90 to eNOS enhances the activation of eNOS. Inhibition of signalling through Hsp90 attenuates both agonist-stimulated production of nitric oxide and endothelium-dependent relaxation of isolated blood vessels. Our results indicate that Hsp90 facilitates signalling mediated by growth-factor, G-protein and mechanotransduction pathways that lead to the activation of eNOS. These observations indicate that in addition to its role as a molecular chaperone involved in protein folding and maturation, Hsp90 may also be recruited to cellular targets depending on the activation state of the cell.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Mol Cardiobiol Program, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Med, New Haven, CT 06536 USA; Univ Naples Federico II, Dipartimento Farmacol Sperimentale, I-80131 Naples, Italy	Yale University; Yale University; Yale University; University of Naples Federico II	Sessa, WC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06536 USA.	william.sessa@yale.edu	Garcia-Cardena, Guillermo/Q-6649-2019; Sessa, William C/B-6844-2011; Andreas, Papapetropoulos/AAJ-3089-2020	Sessa, William C/0000-0001-5759-1938; Papapetropoulos, Andreas/0000-0002-4253-5930; Cirino, Giuseppe/0000-0003-3954-4083; SORRENTINO, RAFFAELLA/0000-0002-0284-5424				BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; COURTNEIDGE SA, 1982, P NATL ACAD SCI-BIOL, V79, P7117, DOI 10.1073/pnas.79.23.7117; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DOYLE HJ, 1993, GENE DEV, V7, P633, DOI 10.1101/gad.7.4.633; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GIMBRONE MA, 1976, PROGR HEMOSTASIS THR, P1; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; LIU JW, 1995, BIOCHEMISTRY-US, V34, P12333, DOI 10.1021/bi00038a029; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; NAGAO T, 1992, AM J PHYSIOL, V263, pH1090, DOI 10.1152/ajpheart.1992.263.4.H1090; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; SESSA WC, 1994, J VASC RES, V31, P131, DOI 10.1159/000159039; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; TAKAHASHI K, 1990, IN VITRO CELL DEV, V25, P265; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; VENEMA VJ, 1996, BIOCHEM BIOPH RES CO, V155, P801; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074	30	834	859	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					821	824		10.1038/33934	http://dx.doi.org/10.1038/33934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9580552				2022-12-28	WOS:000073241200055
J	Stenager, EN; Madsen, C; Stenager, E; Boldsen, J				Stenager, EN; Madsen, C; Stenager, E; Boldsen, J			Suicide in patients with stroke: epidemiological study	BRITISH MEDICAL JOURNAL			English	Article									Odense Municipal Dept Social Med, DK-5000 Odense C, Denmark; Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; Esbjerg Cent Sygehus, Dept Neurol, Esbjerg, Denmark; Odense Univ, Inst Community Hlth, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Stenager, EN (corresponding author), Odense Municipal Dept Social Med, Vindegade 18, DK-5000 Odense C, Denmark.		Stenager, Egon/AAU-4463-2020; Stenager, Egon/O-2275-2017					ANDERSEN G, 1995, ACTA PSYCHIAT SCAND, V92, P193, DOI 10.1111/j.1600-0447.1995.tb09567.x; HOUSE A, 1991, BRIT J PSYCHIAT, V158, P83, DOI 10.1192/bjp.158.1.83; ROBINS M, 1981, STROKE S1, V12, P45; STENAGER EN, 1992, ARCH NEUROL-CHICAGO, V49, P1296, DOI 10.1001/archneur.1992.00530360098025; Stenager EN, 1997, DIS PAIN SUICIDAL BE	5	84	85	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 18	1998	316	7139					1206	1206		10.1136/bmj.316.7139.1206	http://dx.doi.org/10.1136/bmj.316.7139.1206			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ518	9583928	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000073224100022
J	Wu, GQ; D'Agati, V; Cai, YQ; Markowitz, G; Park, JH; Reynolds, DM; Maeda, Y; Le, TC; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S				Wu, GQ; D'Agati, V; Cai, YQ; Markowitz, G; Park, JH; Reynolds, DM; Maeda, Y; Le, TC; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S			Somatic inactivation of Pkd2 results in polycystic kidney disease	CELL			English	Article							PROTEIN; GENE; CELLS; PATTERN; ENCODES; PRODUCT; ADULT; FETAL	Germline mutations in PKD2 cause autosomal dominant polycystic kidney disease. We have introduced a mutant exon 1 in tandem with the wild-type exon 1 at the mouse Pkd2 locus. This is an unstable allele that undergoes somatic inactivation by intragenic homologous recombination to produce a true null allele. Mice heterozygous and homozygous for this mutation, as well as Pkd(+/-) mice, develop polycystic kidney and liver lesions that are indistinguishable from the human phenotype. In all cases, renal cysts arise from renal tubular cells that lose the capacity to produce Pkd2 protein. Somatic loss of Pkd2 expression is both necessary and sufficient for renal cyst formation in ADPKD, suggesting that PKD2 occurs by a cellular recessive mechanism.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University	Somlo, S (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Kucherlapati, Raju/ABC-8807-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048383] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48383] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; DAGATI V, 1992, J AM SOC NEPHROL, V3, P975; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; Ellis NA, 1996, HUM MOL GENET, V5, P1457, DOI 10.1093/hmg/5.Supplement_1.1457; EVAN AP, 1992, CYSTIC KIDNEY, P22; EVERSON GT, 1993, AM J KIDNEY DIS, V22, P520, DOI 10.1016/S0272-6386(12)80923-1; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GABOW PA, 1997, DIS KIDNEY, P521; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Griffin MD, 1996, P ASSOC AM PHYSICIAN, V108, P185; Harris PC, 1997, NEPHROL DIAL TRANSPL, V12, P1089, DOI 10.1093/ndt/12.6.1089; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; HOYER JR, 1979, KIDNEY INT, V16, P279, DOI 10.1038/ki.1979.130; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; IOFFE E, 1995, P NATL ACAD SCI USA, V92, P7357, DOI 10.1073/pnas.92.16.7357; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Ong ACM, 1997, LANCET, V349, P1039, DOI 10.1016/S0140-6736(05)62286-6; Palsson R, 1996, MOL MED, V2, P702, DOI 10.1007/BF03401654; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Peral B, 1996, AM J HUM GENET, V58, P86; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Peters DJM, 1996, LAB INVEST, V75, P221; Qian F, 1997, AM J HUM GENET, V61, P1000, DOI 10.1086/301618; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; Roelfsema JH, 1997, AM J HUM GENET, V61, P1044, DOI 10.1086/301600; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; vanAdelsberg J, 1997, AM J PHYSIOL-RENAL, V272, pF602, DOI 10.1152/ajprenal.1997.272.5.F602; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WARD CJ, 1994, CELL, V77, P881; Wu GQ, 1997, GENOMICS, V45, P220, DOI 10.1006/geno.1997.4920	44	416	424	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					177	188		10.1016/S0092-8674(00)81570-6	http://dx.doi.org/10.1016/S0092-8674(00)81570-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568711	hybrid			2022-12-28	WOS:000073174000005
J	Ahmad, M; Jarillo, JA; Smirnova, O; Cashmore, AR				Ahmad, M; Jarillo, JA; Smirnova, O; Cashmore, AR			Cryptochrome blue-light photoreceptors of Arabidopsis implicated in phototropism	NATURE			English	Article							INHIBITED HYPOCOTYL ELONGATION; THALIANA; MUTATIONS; PROTEIN; MUTANTS; GENE; DEPENDENCE; ENCODES	Phototropism-bending towards the light-is one of the best known plant tropic responses(1,2) Despite being reported by Darwin and others(3,4) over a century ago to be specifically under the control of blue light, the photoreceptors mediating phototropism have remained unknown. We have characterized a blue-light photoreceptor from Arabidopsis named CRY1 for cryptochrome 1 (ref, 5); this photoreceptor is a flavoprotein that mediates numerous blue-light-dependent responses(6). In Arabidopsis, HY4 (the gene encoding CRY1) is a member of a small gene family that also encodes a related photoreceptor, CRY2 (refs 7, 8), which shares considerable functional overlap with CRY1 (ref, 9). Here we report that mutant plants lacking both the CRY1 and the CRY2 blue-light photoreceptors are deficient in the phototropic response. Transgenic Arabidopsis plants overexpressing CRY1 or CRY2 show enhanced phototropic curvature. We conclude that cryptochrome is one of the photoreceptors mediating phototropism in plants.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Ahmad, M (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	mahmad@mail.sas.upenn.edu		Ahmad, Margaret/0000-0003-4524-5813; Jarillo, Jose Antonio/0000-0002-2963-7641				AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Ahmad M, 1996, PLANT MOL BIOL, V30, P851, DOI 10.1007/BF00020798; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; DARWIN C, 1981, POWER MOVEMENT PLANT; Hoffman PD, 1996, MOL GEN GENET, V253, P259, DOI 10.1007/s004380050321; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; IINO M, 1990, PLANT CELL ENVIRON, V13, P633, DOI 10.1111/j.1365-3040.1990.tb01080.x; Janoudi AK, 1997, PHYSIOL PLANTARUM, V101, P278, DOI 10.1034/j.1399-3054.1997.1010204.x; Janoudi AK, 1997, PLANT PHYSIOL, V113, P975, DOI 10.1104/pp.113.3.975; KHURANA J P, 1989, Planta (Heidelberg), V178, P400, DOI 10.1007/BF00391868; Koncz C., 1992, METHODS ARABIDOPSIS; KONJEVIC R, 1989, P NATL ACAD SCI USA, V86, P9876, DOI 10.1073/pnas.86.24.9876; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; Lin C., 1996, PLANT PHYSIOL, V110, P1047; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Liscum E, 1996, PLANT PHYSIOL, V112, P291, DOI 10.1104/pp.112.1.291; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; POFF LK, 1994, ARABIDOPSIS, P639; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; SACHS J, 1864, BOT Z, P353; SHROPSHIRE W, 1958, PLANT PHYSIOL, V33, P360, DOI 10.1104/pp.33.5.360; SMALL GD, 1995, PLANT MOL BIOL, V28, P443, DOI 10.1007/BF00020393; YOUNG JC, 1992, PLANTA, V188, P106, DOI 10.1007/BF00198946	28	126	141	1	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	1998	392	6677					720	723		10.1038/33701	http://dx.doi.org/10.1038/33701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565033				2022-12-28	WOS:000073129000060
J	[Anonymous]				[Anonymous]			BMA council agrees structure for devolution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1615	1615						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596617				2022-12-28	WOS:000073867800075
J	Ferzoco, LB; Raptopoulos, V; Silen, W				Ferzoco, LB; Raptopoulos, V; Silen, W			Current concepts - Acute diverticulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE COLONIC DIVERTICULITIS; PERCUTANEOUS DRAINAGE; COMPUTED-TOMOGRAPHY; HARTMANN PROCEDURE; DISEASE; CT; DIAGNOSIS; INFLAMMATION; EXPERIENCE; SONOGRAPHY		Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Silen, W (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.							AMBROSETTI P, 1994, SURGERY, V115, P546; Anderson DN, 1997, J ROY COLL SURG EDIN, V42, P102; ANSCOMBE AR, 1967, BRIT J SURG, V54, P553, DOI 10.1002/bjs.1800540613; ARFWIDSSON S, 1964, ACTA CHIR SCAND    S, V342, P1; BALTHAZAR EJ, 1990, AM J ROENTGENOL, V154, P281, DOI 10.2214/ajr.154.2.2105015; BEARD R G, 1961, Guys Hosp Rep, V110, P263; Belmonte C, 1996, ARCH SURG-CHICAGO, V131, P612; Biondo S, 1997, BRIT J SURG, V84, P222, DOI 10.1002/bjs.1800840224; BOLT DE, 1966, BRIT MED J, V5497, P1205; BRODRIBB AJM, 1976, BRIT MED J, V1, P424, DOI 10.1136/bmj.1.6007.424; Bruce CJ, 1996, DIS COLON RECTUM, V39, pS1, DOI 10.1007/BF02053798; BURKITT DP, 1974, JAMA-J AM MED ASSOC, V229, P1068, DOI 10.1001/jama.229.8.1068; CHIU TCT, 1983, DIS COLON RECTUM, V26, P59, DOI 10.1007/BF02554686; Eijsbouts QAJ, 1997, SURG ENDOSC-ULTRAS, V11, P750, DOI 10.1007/s004649900442; Elliott TB, 1997, BRIT J SURG, V84, P535; FLEISCHN.FG, 1965, RADIOLOGY, V84, P599, DOI 10.1148/84.4.599; FOXBURGH RA, 1968, BRIT MED J, V3, P465; HAFNER CD, 1962, JAMA-J AM MED ASSOC, V179, P76, DOI 10.1001/jama.1962.03050010000017b; Hinchey E J, 1978, Adv Surg, V12, P85; HULNICK DH, 1984, RADIOLOGY, V152, P491, DOI 10.1148/radiology.152.2.6739821; JOHNSON CD, 1987, AM J ROENTGENOL, V148, P541, DOI 10.2214/ajr.148.3.541; LABS JD, 1988, AM J SURG, V155, P331, DOI 10.1016/S0002-9610(88)80726-8; Lee EC, 1997, DIS COLON RECTUM, V40, P669, DOI 10.1007/BF02140895; LEVIEN DH, 1989, DIS COLON RECTUM, V32, P30, DOI 10.1007/BF02554721; LIEBERMAN JM, 1983, J COMPUT ASSIST TOMO, V7, P431, DOI 10.1097/00004728-198306000-00008; MARKHAM NI, 1992, GUT, V33, P547, DOI 10.1136/gut.33.4.547; MCKEE RF, 1993, BRIT J SURG, V80, P560, DOI 10.1002/bjs.1800800506; Munson KD, 1996, DIS COLON RECTUM, V39, P318, DOI 10.1007/BF02049475; MURRAY JJ, 1991, DIS COLON RECTUM, V34, P527; NEFF CC, 1989, RADIOL CLIN N AM, V27, P743; NEFF CC, 1987, RADIOLOGY, V163, P15, DOI 10.1148/radiology.163.1.3823429; PADIDAR AM, 1994, AM J ROENTGENOL, V163, P81, DOI 10.2214/ajr.163.1.8010253; PAINTER NS, 1968, BRIT MED J, V3, P475, DOI 10.1136/bmj.3.5616.475; PARKS TG, 1969, BRIT MED J, V4, P639, DOI 10.1136/bmj.4.5684.639; PARKS TG, 1970, BMJ-BRIT MED J, V2, P136, DOI 10.1136/bmj.2.5702.136; PERKINS JD, 1984, AM J SURG, V148, P745, DOI 10.1016/0002-9610(84)90429-X; RODKEY GV, 1965, SURG CLIN N AM, V45, P1231; SAINI S, 1986, ARCH SURG-CHICAGO, V121, P475; SCHWERK WB, 1992, DIS COLON RECTUM, V35, P1077, DOI 10.1007/BF02252999; Sher ME, 1997, SURG ENDOSC-ULTRAS, V11, P264, DOI 10.1007/s004649900340; SIEWERT B, 1994, AM J ROENTGENOL, V163, P1317, DOI 10.2214/ajr.163.6.7992721; Spivak H, 1997, DIS COLON RECTUM, V40, P570, DOI 10.1007/BF02055381; STABILE BE, 1990, AM J SURG, V159, P99, DOI 10.1016/S0002-9610(05)80613-0; TAYLOR I, 1976, BRIT MED J, V1, P988, DOI 10.1136/bmj.1.6016.988; TRUELOVE SC, 1966, PHYSIOL REV, V46, P457; TYAU ES, 1991, ARCH SURG-CHICAGO, V126, P855; VERBANCK J, 1989, J CLIN ULTRASOUND, V17, P661, DOI 10.1002/jcu.1870170909; VIGNATI PV, 1995, DIS COLON RECTUM, V38, P627, DOI 10.1007/BF02054123; Wedell J, 1997, BRIT J SURG, V84, P380, DOI 10.1046/j.1365-2168.1997.02566.x; WIGMORE SJ, 1995, BRIT J SURG, V82, P27, DOI 10.1002/bjs.1800820110; Zielke A, 1997, BRIT J SURG, V84, P385, DOI 10.1046/j.1365-2168.1997.02604.x	51	235	238	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1521	1526		10.1056/NEJM199805213382107	http://dx.doi.org/10.1056/NEJM199805213382107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9593792				2022-12-28	WOS:000073699100007
J	Schuppel, R; Buchele, G; Batz, L; Koenig, W				Schuppel, R; Buchele, G; Batz, L; Koenig, W			Sex differences in selection of pacemakers: retrospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY DISEASE; GENDER DIFFERENCES; SINGLE-CHAMBER; WOMEN; BIAS; PRESCRIPTION; MANAGEMENT; SURVIVAL; MEN; AGE	Objective: To evaluate the effect of patients' sex on selection of pacemakers. Design: Retrospective univariate and multivariate analysis of a large database. Setting: German central pacemaker register. Subjects: Records collected at the register for 1992 and 1993 (n=31 913), covering 64% of all implantations in Germany. Main outcome measure: Probability of receiving a single chamber, dual chamber, or rate responsive pacemaker in relation to sex. Results: Univariate analysis showed that women were more likely to receive single chamber pacemakers and less likely to receive dual chamber or rate responsive systems than men. After demographic and clinical variables were controlled for, women were still more likely to receive a single chamber system (atrial pacing: odds ratio 0.89, 95% confidence interval 0.74 to 1.07; ventricular pacing: 0.85, 0.80 to 0.92) and less likely to receive a dual chamber (1.20, 1.12 to 1.30) or a rate responsive system (1.26, 1.17 to 1.37) than men. Conclusions: The data suggest sex differences in the selection of a pacemaker system which cannot be explained by the underlying cardiac disorder. Further research is needed to evaluate why guidelines for implanting pacemakers are not better adhered to.	Univ Ulm, Dept Psychotherapy & Psychosomat, Med Ctr, D-89081 Ulm, Germany; Univ Ulm, Dept Biometry & Med Documentat, D-89075 Ulm, Germany; Univ Giessen, Inst Med Technol, D-36392 Giessen, Germany; Univ Ulm, Med Ctr, Dept Internal Med 2, Ulm, Germany	Ulm University; Ulm University; Justus Liebig University Giessen; Ulm University	Schuppel, R (corresponding author), Univ Ulm, Dept Psychotherapy & Psychosomat, Med Ctr, D-89081 Ulm, Germany.							Aggarwal RK, 1996, HEART, V75, P518, DOI 10.1136/hrt.75.5.518; ALPERT MA, 1987, AM HEART J, V113, P958, DOI 10.1016/0002-8703(87)90057-3; ARMITAGE KJ, 1979, JAMA-J AM MED ASSOC, V241, P2186, DOI 10.1001/jama.241.20.2186; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; CLARKE M, 1991, BRIT HEART J, V66, P185; *EUR WORK GROUP CA, 1987, EUR HEART J SUPPL, V8, P21; FORCINITO M, 1991, J AM COLL CARDIOL, V18, P1, DOI 10.1016/S0735-1097(10)80209-8; GREENSPAN AM, 1988, NEW ENGL J MED, V318, P158, DOI 10.1056/NEJM198801213180306; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; HESSELSON AB, 1992, J AM COLL CARDIOL, V19, P1542, DOI 10.1016/0735-1097(92)90616-U; HORTON HL, 1995, ARCH INTERN MED, V155, P2342, DOI 10.1001/archinte.155.21.2342; IRNICH W, 1994, HERZSCHRITTMACHER, V14, P239; KHAN SS, 1990, ANN INTERN MED, V112, P561, DOI 10.7326/0003-4819-112-8-561; KJELLSTRAND CM, 1988, ARCH INTERN MED, V148, P1305; LAMAS GA, 1995, CIRCULATION, V91, P1063, DOI 10.1161/01.CIR.91.4.1063; LAMAS GA, 1992, CIRCULATION, V86, P449; LAU CP, 1994, PACE, V17, P1838, DOI 10.1111/j.1540-8159.1994.tb03759.x; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; PROCTOR EE, 1991, AM HEART J, V122, P728, DOI 10.1016/0002-8703(91)90518-M; RAY SG, 1992, BRIT HEART J, V68, P531; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; STANGL K, 1990, HERZSCHRITIMACHER EL, V1, P42; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406	24	17	17	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	1998	316	7143					1492	1494		10.1136/bmj.316.7143.1492	http://dx.doi.org/10.1136/bmj.316.7143.1492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582133	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073707700021
J	Sampson, SD; Witmer, LM; Forster, CA; Krause, DW; O'Connor, PM; Dodson, P; Ravoavy, F				Sampson, SD; Witmer, LM; Forster, CA; Krause, DW; O'Connor, PM; Dodson, P; Ravoavy, F			Predatory dinosaur remains from Madagascar: Implications for the Cretaceous biogeography of Gondwana	SCIENCE			English	Article							PLATE TECTONIC RECONSTRUCTIONS; SYSTEMATICS; SAHARA	Recent discoveries of fossil vertebrates from the Late Cretaceous of Madagascar include several specimens of a large theropod dinosaur. One specimen includes a nearly complete and exquisitely preserved skull with thickened pneumatic nasals, a median frontal horn, and a dorsal projection on the parietals. The new materials are assigned to the enigmatic theropod group Abelisauridae on the basis of a number of unique features. Fossil remains attributable to abelisaurids are restricted to three Gondwanan landmasses: South America, Madagascar, and the Indian subcontinent. This distribution is consistent with a revised paleogeographic reconstruction that posits prolonged links between these landmasses (via Antarctica), perhaps until late in the Late Cretaceous.	New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Univ Penn, Sch Vet Med, Dept Biol Anim, Lab Anat, Philadelphia, PA 19104 USA; Univ Antananarivo, Serv Paleontol, Antananarivo 101, Madagascar	New York Institute Technology; University System of Ohio; Ohio University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; University Antananarivo	Sampson, SD (corresponding author), New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	ssampson@iris.nyit.edu	Dodson, Peter/A-9544-2009; OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806				ARDOLINO A, 1987, 10 C GEOL ARG TUC AC, V3, P193; BARRON EJ, 1987, PALAEOGEOGR PALAEOCL, V59, P207, DOI 10.1016/0031-0182(87)90080-0; Beard K. Christopher, 1998, Bulletin of Carnegie Museum of Natural History, V34, P5; Bonaparte J.F., 1991, Historical Biology, V5, P1; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; BONAPARTE JF, 1987, 4 S MES TERR EC SHOR, P24; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; BUFFETAUT E, 1988, CR ACAD SCI II, V306, P153; CURRIE PJ, COMMUNICATION; Deper ~ ~et C., 1896, B SOCIETE GEOLOGIQUE, V24, P176; Forster CA, 1996, NATURE, V382, P532, DOI 10.1038/382532a0; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GRANDE L, 1985, PALEOBIOLOGY, V11, P234, DOI 10.1017/S0094837300011544; Hallam A., 1994, OUTLINE PHANEROZOIC; HAY WW, IN PRESS EVOLUTION C; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1996, NATURAL CHANGE HUMAN, P3; Lavocat R., 1955, Bull Mus Hist nat Paris (2), V27, P256; Le Loeuff J, 1997, ENCY DINOSAURS, P51; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Novas F.E., 1997, ENCY DINOSAURS, P678; Novas FE, 1997, ENCY DINOSAURS; Pitman W. C., 1993, BIOL RELATIONSHIPS A; ROGERS RR, 1997, J VERTEBR PALEONT S3, V17, pA17; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sampson SD, 1996, J VERTEBR PALEONTOL, V16, P601, DOI 10.1080/02724634.1996.10011350; Sampson SD, 1997, NAT HIST, V106, P24; SCOTESE CR, 1991, PALAEOGEOGR PALAEOCL, V87, P493, DOI 10.1016/0031-0182(91)90145-H; SCOTESE CR, 1988, TECTONOPHYSICS, V155, P27, DOI 10.1016/0040-1951(88)90259-4; SERENO P, IN PRESS NEUES JB GE; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; SMITH AG, 1994, ATLAS MESOZOIC COAST; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; SUES HD, 1979, NATURE, V279, P633, DOI 10.1038/279633a0; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1; Ziegler A.M., 1982, TIDAL FRICTION EARTH, P240, DOI DOI 10.1007/978-3-642-68836-2_17	41	219	227	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	1998	280	5366					1048	1051		10.1126/science.280.5366.1048	http://dx.doi.org/10.1126/science.280.5366.1048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582112				2022-12-28	WOS:000073663600038
J	Irving, BA; Alt, FW; Killeen, N				Irving, BA; Alt, FW; Killeen, N			Thymocyte development in the absence of pre-T cell receptor extracellular immunoglobulin domains	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; ANTIGEN RECEPTOR; MUTANT MICE; ALPHA-BETA; DEFICIENT MICE; CHAIN; EXPRESSION; GENE; LCK; DIFFERENTIATION	Immature thymocytes express a pre-T cell receptor (pre-TCR) composed of the TCR beta chain paired with pre-T alpha. Signals from this receptor are essential for passage of thymocytes through a key developmental checkpoint in the thymus. These signals were efficiently delivered in vivo by a truncated form of the murine pre-TCR that lacked all of its extracellular immunoglobulin domains. De novo expression of the truncated pre-TCR or an intact alpha beta TCR was sufficient to activate characteristic TCR signaling pathways in a T cell line. These findings support the view that recognition of an extracellular ligand is not required for pre-TCR function.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Genet & Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Killeen, N (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.							Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hedrick Stephen M., 1993, P383; Hogan B, 1994, MANIPULATING MOUSE E; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IRVING BA, UNPUB; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KERSH GJ, 1995, J IMMUNOL, V154, P5706; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1995, P NATL ACAD SCI USA, V92, P7420, DOI 10.1073/pnas.92.16.7420; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; OShea CC, 1997, IMMUNITY, V7, P591, DOI 10.1016/S1074-7613(00)80380-5; Papavasiliou F, 1997, CURR OPIN IMMUNOL, V9, P233, DOI 10.1016/S0952-7915(97)80141-0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Shaffer AL, 1997, J IMMUNOL, V159, P1265; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	43	151	152	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					905	908		10.1126/science.280.5365.905	http://dx.doi.org/10.1126/science.280.5365.905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572735				2022-12-28	WOS:000073532900042
J	Kristensen, P; Judge, ME; Thim, L; Ribel, U; Christjansen, KN; Wulff, BS; Clausen, JT; Jensen, PB; Madsen, OD; Vrang, N; Larsen, PJ; Hastrup, S				Kristensen, P; Judge, ME; Thim, L; Ribel, U; Christjansen, KN; Wulff, BS; Clausen, JT; Jensen, PB; Madsen, OD; Vrang, N; Larsen, PJ; Hastrup, S			Hypothalamic CART is a new anorectic peptide regulated by leptin	NATURE			English	Article							MESSENGER-RIBONUCLEIC-ACID; NEUROPEPTIDE-Y; RNA; POLYPEPTIDE; AMPHETAMINE; COCAINE; MOUSE; RATS; FOOD; MICE	The mammalian hypothalamus strongly influences ingestive behaviour through several different signalling molecules and receptor systems(1-4). Here we show that CART (cocaine-and amphetamine-regulated transcript), a brain-located peptide(5-8), is a satiety factor and is closely associated with the actions of two important regulators of food intake, leptin and neuropeptide Y. Food-deprived animals show a pronounced decrease in expression of CART messenger RNA in the arcuate nucleus. In animal models of obesity with disrupted leptin signalling, CART mRNA is almost absent from the arcuate nucleus. Peripheral administration of leptin to obese mice stimulates CART mRNA expression. When injected intracerebroventricularly into rats, recombinant CART peptide inhibits both normal and starvation-induced feeding, and completely blocks the feeding response induced by neuropeptide Y. An antiserum against CART increases feeding in normal rats, indicating that CART may be an endogenous inhibitor of food intake in normal animals.	Novo Nordisk AS, Hlth Care Discovery, DK-2880 Bagsvaerd, Denmark; Hagedorn Res Inst, DK-2820 Gentofte, Denmark; Univ Copenhagen, Dept Anat, DK-2200 Copenhagen, Denmark	Novo Nordisk; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen	Kristensen, P (corresponding author), Novo Nordisk AS, Hlth Care Discovery, Novo Alle 6A1-47, DK-2880 Bagsvaerd, Denmark.	pekr@novo.dk	Madsen, Ole D./A-7415-2011	Madsen, Ole D./0000-0002-2753-5203; Jensen, Per Bo/0000-0002-2277-1135				BERGHORN KA, 1994, J HISTOCHEM CYTOCHEM, V42, P1635, DOI 10.1177/42.12.7983364; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Couceyro PR, 1997, J CHEM NEUROANAT, V12, P229, DOI 10.1016/S0891-0618(97)00212-3; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; FENGER M, 1990, SCAND J CLIN LAB INV, V50, P229; Gautvik KM, 1996, P NATL ACAD SCI USA, V93, P8733, DOI 10.1073/pnas.93.16.8733; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; KRISTENSEN P, 1991, J HISTOCHEM CYTOCHEM, V39, P341, DOI 10.1177/39.3.1899685; SANACORA G, 1990, ENDOCRINOLOGY, V127, P730, DOI 10.1210/endo-127-2-730; SPIESS J, 1981, BIOCHEMISTRY-US, V20, P1982, DOI 10.1021/bi00510a038; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Wang Q, 1997, DIABETES, V46, P335, DOI 10.2337/diabetes.46.3.335; Whitelegge T., 1890, REC AUST MUS, V1, P41, DOI DOI 10.3853/J.0067-1975.1.1890.1224; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939	20	1017	1054	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	1998	393	6680					72	76		10.1038/29993	http://dx.doi.org/10.1038/29993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590691				2022-12-28	WOS:000073497500049
J	O'Neill, RJW; O'Neill, MJ; Graves, JAM				O'Neill, RJW; O'Neill, MJ; Graves, JAM			Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid	NATURE			English	Article							TRANSPOSABLE ELEMENTS; METHYLATION; SPECIATION; DROSOPHILA; EVOLUTION; GENOMES; RNA	Genetic models(1,2) predict that genomic rearrangement in hybrids can facilitate reproductive isolation and the formation of new species by preventing gene flow between the parent species and hybrid (sunflowers are an example(3)). The mechanism underlying hybridization-induced chromosome remodelling is as yet unknown, although mobile element activity has been shown to be involved in DNA rearrangement in some dysgenic Drosophila hybrids(4,5), It has been proposed that DNA methylation evolved as a means of repressing the movement of mobile elements (the host defence model(6,7)). If such a protective mechanism were to fail, mobile elements could be activated, and could cause major and rapid genome alterations(8,9), Here we demonstrate the occurrence of genome-wide undermethylation, retroviral element amplification and chromosome remodelling in an interspecific mammalian hybrid (Macropus eugenii X Wallabia bicolor). Atypically extended centromeres of Macropus eugenii derived autosomes in the hybrid were composed primarily of an unmethylated, amplified retroviral element not detectable in either parent species. These results, taken with the observation of deficient methylation and de novo chromosome change in other mammalian hybrids, indicate that the failure of DNA methylation and subsequent mobile-element activity in hybrids could facilitate rapid karyotypic evolution.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; La Trobe Univ, Dept Genet & Human Variat, Bundoora, Vic 3083, Australia	Princeton University; La Trobe University	O'Neill, RJW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.		Graves, Jennifer A.M./A-1387-2008	Graves, Jennifer/0000-0001-6480-7856				ARNAULT C, 1994, GENETICA, V93, P149, DOI 10.1007/BF01435247; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Curcio MJ, 1996, TRENDS GENET, V12, P436; ENGELS WR, 1984, GENETICS, V107, P657; GRANT V, 1958, COLD SPRING HARB SYM, V23, P337, DOI 10.1101/SQB.1958.023.01.034; GRAUR D, 1985, J MOL EVOL, V21, P221, DOI 10.1007/BF02102356; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LOEBEL DA, 1993, CHROMOSOMA, V102, P81, DOI 10.1007/BF00356024; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; RIESEBERG LH, 1995, NATURE, V375, P313, DOI 10.1038/375313a0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SMITH MJ, 1979, AUST J ZOOL, V27, P959, DOI 10.1071/ZO9790959; SUNKEL CE, 1995, CURR OPIN GENET DEV, V5, P756, DOI 10.1016/0959-437X(95)80008-S; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; Toder R, 1996, CHROMOSOME RES, V4, P295, DOI 10.1007/BF02263680; Toder R, 1997, MAMM GENOME, V8, P418, DOI 10.1007/s003359900459; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; WICHMAN HA, 1992, GENETICA, V86, P287, DOI 10.1007/BF00133727; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	24	354	359	0	15	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					68	72		10.1038/29985	http://dx.doi.org/10.1038/29985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590690				2022-12-28	WOS:000073497500048
J	Gaist, D; Tsiropoulos, I; Sindrup, SH; Hallas, J; Ramussen, BK; Kragstrup, J; Gram, LF				Gaist, D; Tsiropoulos, I; Sindrup, SH; Hallas, J; Ramussen, BK; Kragstrup, J; Gram, LF			Inappropriate use of sumatriptan: population based register and interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Odense Univ, Inst Med Biol, Dept Clin Pharmacol, DK-5000 Odense C, Denmark; Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; Hillerod Hosp, Dept Neurol, Hillerod, Denmark; Odense Univ, Gen Practice Res Unit, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Southern Denmark	Gaist, D (corresponding author), Odense Univ, Inst Med Biol, Dept Clin Pharmacol, DK-5000 Odense C, Denmark.	d.gaist@winsloew.ou.dk	Gaist, David/I-4397-2014	Gaist, David/0000-0001-5205-7007; Sindrup, Soren/0000-0003-0357-8628				Gaist D, 1997, DAN MED BULL, V44, P445; Gaist D, 1997, BRIT J CLIN PHARMACO, V43, P429, DOI 10.1046/j.1365-2125.1997.00582.x; Gaist D, 1996, EUR J CLIN PHARMACOL, V50, P161, DOI 10.1007/s002280050086; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x	5	44	44	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1352	1353		10.1136/bmj.316.7141.1352	http://dx.doi.org/10.1136/bmj.316.7141.1352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563984	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000073483000017
J	Gsell, M; Jakob, P; Menzel, D				Gsell, M; Jakob, P; Menzel, D			Effect of substrate strain on adsorption	SCIENCE			English	Article							SURFACE STRESS; INDUCED RECONSTRUCTION; BUBBLES; OXYGEN; HELIUM; METALS; FILMS	Direct evidence for the effect of local strain at a surface on the bonding strength for adsorbates is presented. Scanning tunneling microscopy revealed that adsorbed oxygen atoms on Ru(0001) surfaces are located preferentially on top of nanometer-size protrusions above subsurface argon bubbles, where tensile strain prevails, and are depleted around their rim in regions of compression, relative to the flat surface. Such effects can be considered as the reverse of adsorbate-induced strain, and their direct local demonstration can be used to test theoretical predictions.	Tech Univ Munich, Dept Phys E 20, D-85747 Garching, Germany	Technical University of Munich	Menzel, D (corresponding author), Tech Univ Munich, Dept Phys E 20, D-85747 Garching, Germany.		Jakob, Peter/A-1829-2012	Menzel, Dietrich/0000-0002-7188-8532				BUCK V, 1979, Z PHYS B CON MAT, V33, P349, DOI 10.1007/BF01319924; KAMPSHOFF E, 1994, PHYS REV LETT, V73, P704, DOI 10.1103/PhysRevLett.73.704; KOSTOV L, 1997, SURF SCI LETT, V394, pL138; LINDROOS M, 1989, SURF SCI, V222, P451, DOI 10.1016/0039-6028(89)90371-3; MARTINEZ RE, 1990, PHYS REV LETT, V64, P1035, DOI 10.1103/PhysRevLett.64.1035; MAVRIKAKIS M, COMMUNICATION; MENZEL D, 1994, SURF SCI, V318, P437, DOI 10.1016/0039-6028(94)90118-X; Menzel D, 1997, SURF REV LETT, V4, P1283, DOI 10.1142/S0218625X97001681; MICHALK G, 1983, SURF SCI, V129, P92, DOI 10.1016/0039-6028(83)90096-1; PFNUR H, 1989, SURF SCI, V220, P43, DOI 10.1016/0039-6028(89)90462-7; Ritz G, 1996, PHYS REV B, V53, P16019, DOI 10.1103/PhysRevB.53.16019; SANDER D, 1991, PHYS REV B, V43, P4263, DOI 10.1103/PhysRevB.43.4263; SCHELLSOROKIN AJ, 1990, PHYS REV LETT, V64, P1039, DOI 10.1103/PhysRevLett.64.1039; Schmid M, 1996, PHYS REV LETT, V76, P2298, DOI 10.1103/PhysRevLett.76.2298; Schuster R, 1996, PHYS REV B, V54, P13476, DOI 10.1103/PhysRevB.54.13476; TRINKAUS H, 1983, RADIAT EFF DEFECT S, V78, P189, DOI 10.1080/00337578308207371; ULLMAIER H, 1983, RADIAT EFF DEFECT S, V78, P1, DOI 10.1080/00337578308207355; WATSON PR, 1995, MONOGR AM I PHYSICS, V5	18	298	300	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					717	720		10.1126/science.280.5364.717	http://dx.doi.org/10.1126/science.280.5364.717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563943				2022-12-28	WOS:000073415600041
J	Parganas, E; Wang, D; Stravopodis, D; Topham, DJ; Marine, JC; Teglund, S; Vanin, EF; Bodner, S; Colamonici, OR; van Deursen, JM; Grosveld, G; Ihle, JN				Parganas, E; Wang, D; Stravopodis, D; Topham, DJ; Marine, JC; Teglund, S; Vanin, EF; Bodner, S; Colamonici, OR; van Deursen, JM; Grosveld, G; Ihle, JN			Jak2 is essential for signaling through a variety of cytokine receptors	CELL			English	Article							PROTEIN-TYROSINE KINASE; STIMULATING FACTOR-RECEPTOR; TRANSCRIPTION FACTOR GATA-1; MICE LACKING JAK3; ERYTHROPOIETIN RECEPTOR; LYMPHOID DEVELOPMENT; INTERFERON-ALPHA/BETA; TRANSDUCTION PATHWAY; G-CSF; ACTIVATION	A variety of cytokines activate receptor-associated members of the Janus family of protein tyrosine kinases (Jaks). To assess the role of Jak2, we have derived Jak2-deficient mice. The mutation causes an embryonic lethality due to the absence of definitive erythropoiesis. Fetal liver myeloid progenitors, although present based on the expression of lineage specific markers, fail to respond to erythropoietin, thrombopoietin, interleukin-3 (IL-3), or granulocyte/macrophage colony-stimulating factor. In contrast, the response to granulocyte specific colony-stimulating factor is unaffected. Jak2-deficient fibroblasts failed to respond to interferon gamma (IFN gamma), although the responses to IFN alpha/beta and IL-6 were unaffected. Lastly, reconstitution experiments demonstrate that Jak2 is not required for the generation of lymphoid progenitors, their amplification, or functional differentiation. Therefore, Jak2 plays a critical, nonredundant role in the function of a specific group of cytokines receptors.	St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Expt Hematol, Memphis, TN 38105 USA; Univ Tennessee, Sch Med, Dept Biochem, Memphis, TN 38105 USA; Univ Tennessee, Sch Med, Dept Pathol, Memphis, TN 38105 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.		Marine, Jean Christophe/J-2237-2015; Wang, Demin/AAX-4449-2020; Marine, Jean-Christophe/K-3292-2016	Wang, Demin/0000-0001-5549-3795; Marine, Jean-Christophe/0000-0003-2433-9837; Stravopodis, Dimitrios/0000-0002-9535-2134	NCI NIH HHS [CA21765] Funding Source: Medline; NIDDK NIH HHS [R01 DK42932] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; ARTGETSINGER LS, 1993, CELL, V74, P237; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Barge RMY, 1996, BLOOD, V87, P2148, DOI 10.1182/blood.V87.6.2148.bloodjournal8762148; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; HANAZONO Y, 1993, BLOOD, V81, P3193; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Hogan B, 1994, MANIPULATING MOUSE E; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MACHIDE M, 1995, ONCOGENE, V11, P619; MANO H, 1995, BLOOD, V85, P343; MIYAKAWA Y, 1995, BLOOD, V86, P23, DOI 10.1182/blood.V86.1.23.bloodjournal86123; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; RAUPRICH P, 1995, BLOOD, V86, P4500, DOI 10.1182/blood.V86.12.4500.bloodjournal86124500; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; SHIMODA K, 1994, BIOCHEM BIOPH RES CO, V203, P922, DOI 10.1006/bbrc.1994.2270; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TORIGOE T, 1992, LEUKEMIA, V6, pS94; TORIGOE T, 1992, BLOOD, V80, P617; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsubokawa M, 1997, EUR J BIOCHEM, V249, P792, DOI 10.1111/j.1432-1033.1997.t01-2-00792.x; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VANDEURSEN J, 1991, NUCLEIC ACIDS RES, V19, P2637, DOI 10.1093/nar/19.10.2637; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; WILKS AF, 1991, METHOD ENZYMOL, V200, P533; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wollert KC, 1997, J MOL MED-JMM, V75, P492, DOI 10.1007/s001090050134; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	55	846	953	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					385	395		10.1016/S0092-8674(00)81167-8	http://dx.doi.org/10.1016/S0092-8674(00)81167-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590173	Bronze			2022-12-28	WOS:000073471500014
J	Pancioli, AM; Broderick, J; Kothari, R; Brott, T; Tuchfarber, A; Miller, R; Khoury, J; Jauch, E				Pancioli, AM; Broderick, J; Kothari, R; Brott, T; Tuchfarber, A; Miller, R; Khoury, J; Jauch, E			Public perception of stroke warning signs and knowledge of potential risk factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; URGENT THERAPY; PREVENTION; MINUTES; TRIAL	Context.-Decreasing the time from stroke onset to hospital arrival and improving control of stroke risk factors depend on public knowledge of stroke warning signs and risk factors. Objective.-To assess current public knowledge of stroke warning signs and risk factors. Design.-A population-based telephone interview survey using random digit dialing conducted in 1995. Setting.-The Greater Cincinnati, Ohio, metropolitan area, the population of which is similar to that of the United States overall in age, sex, percentage of blacks, and economic status. Participants.-Respondents with age, race, and sex that matched the population of patients with acute stroke. Main Outcome Measures.-Knowledge of risk factors for stroke and warning signs of stroke as defined by the National Institute of Neurological Disorders and Stroke. Results.-Telephone calls were made to 17 634 households, which yielded 2642 demographically eligible individuals. Interviews were completed by 1880 respondents (response rate, 71.2%). A total of 1066 respondents (57%) correctly listed at least 1 of the 5 established stroke warning signs, and of all respondents, 1274 (68%) correctly listed at least 1 of the established stroke risk factors. Of the respondents, 469 (57%) of 818 respondents with a history of hypertension listed hypertension, 142 (35%) of 402 respondents who were current smokers listed smoking, and 32 (13%) of 255 respondents with diabetes listed diabetes as a risk factor for stroke. Compared with those younger than 75 years, respondents 75 years or older were less likely to correctly list at least 1 stroke warning sign (60% vs 47%, respectively; P<.001) and were less likely to list at least 1 stroke risk factor (72% vs 56%, respectively; P<.001). Conclusion.-Considerable education is needed to increase the public's awareness of the warning signs and risk factors for stroke. Respondents with self-reported risk factors for stroke are largely unaware of their increased risk The population at greatest risk for stroke, the very elderly, are the least knowledgeable about stroke warning signs and risk factors.	Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Inst Policy Res, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Pancioli, AM (corresponding author), Univ Cincinnati, Coll Med, Dept Emergency Med, 231 Bethesda Ave,POB 670769, Cincinnati, OH 45267 USA.	Arthur.Pancioli@uc.edu	Khoury, Jane/O-2068-2015	Jauch, Edward/0000-0002-3533-4364	NINDS NIH HHS [R0-1 NS30678-04] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030678] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARSAN WG, 1994, STROKE, V25, P2132, DOI 10.1161/01.STR.25.11.2132; BONNER LL, 1995, NEW ENGL J MED, V333, P1392; BRODERICK J, 1993, ANN EMERG MED, V22, P1438, DOI 10.1016/S0196-0644(05)81993-6; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Brott T, 1996, ARCH NEUROL-CHICAGO, V53, P1305, DOI 10.1001/archneur.1996.00550120117025; BROTT TG, 1992, STROKE, V23, P632, DOI 10.1161/01.STR.23.5.632; Brown RD, 1996, STROKE, V27, P373; Ezzati TM, 1992, VITAL HLTH STAT 2, V2, P1; Feinberg WM, 1996, CURR OPIN NEUROL, V9, P46, DOI 10.1097/00019052-199602000-00010; FREY JH, 1989, SURVEY RES TELEPHONE, P90; GORELICK PB, 1995, ARCH NEUROL-CHICAGO, V52, P347, DOI 10.1001/archneur.1995.00540280029015; HALEY EC, 1992, STROKE, V23, P641, DOI 10.1161/01.STR.23.5.641; HALEY EC, 1993, STROKE, V24, P1000, DOI 10.1161/01.STR.24.7.1000; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MATCHAR DB, 1994, ANN INTERN MED, V121, P54; *NAT I NEUR DIS ST, 1997, BRAIN ATT STROK WARN; *NAT STROK ASS, 1994, BRAIN RISK UND PREV; National Stroke Association, 1996, AW KNOWL STROK PREV; *US BUR CENS, 1993, POP HOUS CHAR CENS T; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912	24	368	382	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1288	1292		10.1001/jama.279.16.1288	http://dx.doi.org/10.1001/jama.279.16.1288			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9565010				2022-12-28	WOS:000073090300035
J	Nagy, L; Tontonoz, P; Alvarez, JGA; Chen, HW; Evans, RM				Nagy, L; Tontonoz, P; Alvarez, JGA; Chen, HW; Evans, RM			Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; NECROSIS-FACTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; ATHEROSCLEROTIC LESIONS; CHOLESTEROL DEPOSITION; POTENTIAL ROLE; MESSENGER-RNA; RECEPTOR; INTERLEUKIN-1-BETA	Macrophage uptake of oxidized low-density lipoprotein (oxLDL) is thought to play a central role in foam cell formation and the pathogenesis of atherosclerosis. We demonstrate here that oxLDL activates PPAR gamma-dependent transcription through a novel signaling pathway involving scavenger receptor-mediated particle uptake. Moreover, we identify two of the major oxidized lipid components of oxLDL, 9-HODE and 13-HODE, as endogenous activators and ligands of PPAR gamma. Our data suggest that the biologic effects of oxLDL are coordinated by two sets of receptors, one on the cell surface, which binds and internalizes the particle, and one in the nucleus, which is transcriptionally activated by its component lipids. These results suggest that PPAR gamma may be a key regulator of foam cell gene expression.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego	Evans, RM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Nagy, Laszlo/A-3814-2008	Evans, Ronald/0000-0002-9986-5965; Nagy, Laszlo/0000-0001-6653-2155				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BUJA LM, 1983, ARTERIOSCLEROSIS, V3, P87, DOI 10.1161/01.ATV.3.1.87; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; FONG LG, 1991, J LIPID RES, V32, P1899; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GLAVIND J, 1952, ACTA PATHOL MIC SC, V30, P1; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; HARLAND WA, 1971, ATHEROSCLEROSIS, V13, P239, DOI 10.1016/0021-9150(71)90026-8; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Huh HY, 1996, BLOOD, V87, P2020; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KU G, 1992, J BIOL CHEM, V267, P14183; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEHR HA, 1993, LAB INVEST, V68, P388; LENZ ML, 1990, J LIPID RES, V31, P1043; LIPTON BA, 1995, J LIPID RES, V36, P2232; MALDEN LT, 1991, J BIOL CHEM, V266, P13901; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; THOMAS CE, 1994, J LIPID RES, V35, P417; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	48	1507	1563	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	1998	93	2					229	240		10.1016/S0092-8674(00)81574-3	http://dx.doi.org/10.1016/S0092-8674(00)81574-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568715	Bronze			2022-12-28	WOS:000073174000009
J	Savulescu, J; Marsden, R; Hope, T				Savulescu, J; Marsden, R; Hope, T			Ethical debate - Sex, drugs, and the invasion of privacy - Respect for privacy and the case of Mr K	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England; Oxford Radcliffe Hosp, Oxford OX3 9DU, England; Churchill Hosp, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Hope, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England.			Annas, George/0000-0001-5836-7831					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 21	1998	316	7135					921	922		10.1136/bmj.316.7135.921	http://dx.doi.org/10.1136/bmj.316.7135.921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD691	9569396				2022-12-28	WOS:000072713300037
J	Kengaku, M; Capdevila, J; Rodriguez-Esteban, C; De La Pena, J; Johnson, RL; Belmonte, JCI; Tabin, CJ				Kengaku, M; Capdevila, J; Rodriguez-Esteban, C; De La Pena, J; Johnson, RL; Belmonte, JCI; Tabin, CJ			Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud	SCIENCE			English	Article							TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; VERTEBRATE LIMB; XENOPUS EMBRYOS; GENE-EXPRESSION; SONIC-HEDGEHOG; CELL FATE; AXIS; INDUCTION; DOMAINS	The apical ectodermal ridge (AER) is an essential structure for vertebrate limb development. Wnt3a is expressed during the induction of the chick AER, and misexpression of Wnt3a induces ectopic expression of AER-specific genes in the limb ectoderm. The genes beta-catenin and Lef1 can mimic the effect of Wnt3a, and blocking the intrinsic Lef1 activity disrupts AER formation. Hence, Wnt3a functions in AER formation through the beta-catenin/LEF1 pathway. In contrast, neither beta-catenin nor Lef1 affects the Wnt7a-regulated dorsoventral polarity of the limb. Thus, two related Wnt genes elicit distinct responses in the same tissues by using different intracellular pathways.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Salk Institute; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; DEALY CN, 1993, MECH DEVELOP, V43, P175, DOI 10.1016/0925-4773(93)90034-U; DU SJ, 1995, MOL CELL BIOL, V15, P2625; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; GASTROP J, 1992, EUR J IMMUNOL, V22, P1327, DOI 10.1002/eji.1830220531; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; KENGAKU M, UNPUB; KENGAKU M, 1998, COLD SPRING HARBOR L, V12, P421; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Noramly S, 1996, DEV BIOL, V179, P339, DOI 10.1006/dbio.1996.0265; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; PARR BA, 1993, DEVELOPMENT, V119, P247; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; ROS MA, 1992, DEVELOPMENT, V116, P811; Ros MA, 1997, DEVELOPMENT, V124, P1821; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vogel A, 1996, DEVELOPMENT, V122, P1737; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; YOKOUCHI Y, 1991, DEVELOPMENT, V113, P431; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	46	355	363	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1274	1277		10.1126/science.280.5367.1274	http://dx.doi.org/10.1126/science.280.5367.1274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596583				2022-12-28	WOS:000073852500052
J	Bowring, SA; Erwin, DH; Jin, YG; Martin, MW; Davidek, K; Wang, W				Bowring, SA; Erwin, DH; Jin, YG; Martin, MW; Davidek, K; Wang, W			U/Pb zircon geochronology and tempo of the end-Permian mass extinction	SCIENCE			English	Article							TRIASSIC BOUNDARY; CARBON-ISOTOPE; SIBERIAN TRAPS; FLOOD BASALTS; VOLCANISM; SECTION; IRIDIUM; IMPACTS; TETHYS; EVENT	The mass extinction at the end of the Permian was the most profound in the history of life. Fundamental to understanding its cause is determining the tempo and duration of the extinction. Uranium/lead zircon data from Late Permian and Early Triassic rocks from south China place the Permian-Triassic boundary at 251.4 +/- 0.3 million years ago. Biostratigraphic controls from strata intercalated with ash beds below the boundary indicate that the Changhsingian pulse of the end-Permian extinction, corresponding to the disappearance of about 85 percent of marine species, lasted less than 1 million years. At Meishan, a negative excursion in delta(13)C at the boundary had a duration of 165,000 years or less, suggesting a catastrophic addition of light carbon.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02319 USA; Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Acad Sinica, Nanjing Inst Geol & Paleontol, Lab Paleobiol & Stratig, Nanjing 210008, Peoples R China	Massachusetts Institute of Technology (MIT); Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Bowring, SA (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02319 USA.		Wang, Wei/B-5617-2019; Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				BASU AR, 1995, SCIENCE, V269, P822, DOI 10.1126/science.269.5225.822; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; BROGLIOLORIGA C, 1992, PERMOTRIASSIC EVENTS, P78; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; CLAOUELONG JC, 1991, EARTH PLANET SC LETT, V105, P182, DOI 10.1016/0012-821X(91)90129-6; DHONDT S, 1995, GEOL SOC AM ABSTR, V27, pA164; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; ERWIN DA, UNPUB; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; ERWIN DH, 1993, GREAT PALEOZOLC CRIS; Erwin Douglas H., 1996, P398; FAURE K, 1995, GEOLOGY, V23, P507, DOI 10.1130/0091-7613(1995)023<0507:LPGCHL>2.3.CO;2; Glenister B. F., 1992, INT GEOL REV, V34, P857; Holser W. T., 1987, Modern Geology, V11, P155; Holser W. T., 1991, ABHANDLUNGEN GEOLOGI, V45, P1; HOLSER WT, 1996, 30 INT GEOL C, V2, P58; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; ISOZAKI Y, 1997, GEOL SOC AM ABSTR, V29, P339; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Jin Yugan, 1994, Canadian Society of Petroleum Geologists Memoir, V17, P813; KAJIWARA Y, 1994, PALAEOGEOGR PALAEOCL, V111, P367, DOI 10.1016/0031-0182(94)90072-8; Kamo SL, 1996, GEOCHIM COSMOCHIM AC, V60, P3505, DOI 10.1016/0016-7037(96)00173-1; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; KROGH TE, 1973, GEOCHIM COSMOCHIM AC, V37, P488; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; LANDING E, IN PRESS CAN J EARTH; LUDWIG K, 1988, 88557 US GEOL SURV; LUDWIG KR, 1980, EARTH PLANET SC LETT, V46, P212, DOI 10.1016/0012-821X(80)90007-2; MACLEOD KG, 1997, GEOL SOC AM ABSTR, V29, P462; Marshall CR, 1996, SCIENCE, V274, P1360, DOI 10.1126/science.274.5291.1360; MCLAREN DJ, 1990, ANNU REV EARTH PL SC, V18, P123; Menning M., 1995, PERMIAN NO PANGEA, V1, P77, DOI DOI 10.1007/978-3-642-78593-1_6; Mundil R, 1996, EARTH PLANET SC LETT, V141, P137, DOI 10.1016/0012-821X(96)00057-X; Palmieri V., 1994, AGSO Journal of Australian Geology and Geophysics, V15, P359; PRINN RG, 1987, EARTH PLANET SC LETT, V83, P1, DOI 10.1016/0012-821X(87)90046-X; Rampino Michael R., 1996, Geological Society of America Special Paper, V307, P11; Reinhardt J.W., 1988, Facies, V18, P231, DOI 10.1007/BF02536802; RENNE PR, 1991, SCIENCE, V253, P176, DOI 10.1126/science.253.5016.176; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Retallack GJ, 1997, AUST J EARTH SCI, V44, P185, DOI 10.1080/08120099708728303; RETALLACK GJ, 1996, GEOL SOC AM ABSTR, V28, pA368; Roberts J, 1996, AUST J EARTH SCI, V43, P401, DOI 10.1080/08120099608728264; Shen Shuzhong, 1996, Historical Biology, V12, P93; SPITZY A, 1985, MITT GEOL PALAONT I, V59, P155; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; TONG J., 1993, PERMO TRIASSIC EVENT, P90; Visscher H, 1996, P NATL ACAD SCI USA, V93, P2155, DOI 10.1073/pnas.93.5.2155; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; Wignall P. B., 1996, HIST BIOL, V12, P39, DOI DOI 10.1080/08912969609386553; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Wilde P, 1997, PALAEOGEOGR PALAEOCL, V132, P47, DOI 10.1016/S0031-0182(97)00050-3; XU DY, 1993, PALAEOGEOGR PALAEOCL, V104, P171; XU DY, 1985, NATURE, V314, P154, DOI 10.1038/314154a0; YANG ZY, 1995, EPISODES, V18, P49; ZHOU Z., 1996, PERMOPHILES, V29, P52; ZICHAO Z, 1992, B LIAIS INFORM IUG B, V10, P14	58	530	618	7	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1039	1045		10.1126/science.280.5366.1039	http://dx.doi.org/10.1126/science.280.5366.1039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582110				2022-12-28	WOS:000073663600036
J	Hahn, BH				Hahn, BH			Antibodies to DNA	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC LUPUS-ERYTHEMATOSUS; ANTI-NATIVE DNA; MURINE LUPUS; IGG; NEPHRITIS; BINDING; MICE; AUTOIMMUNITY; CELLS; AUTOANTIBODIES		Univ Calif Los Angeles, Dept Med, Rehabil Ctr 32 48, Div Rheumatol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Hahn, BH (corresponding author), Univ Calif Los Angeles, Dept Med, Rehabil Ctr 32 48, Div Rheumatol, 1000 Vet Ave, Los Angeles, CA 90024 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036834, R01AR033962] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60-AR36834, R01-AR33962] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABDOU NI, 1981, J CLIN INVEST, V67, P1297, DOI 10.1172/JCI110158; ALARCONSEGOVIA D, 1983, CLIN EXP IMMUNOL, V52, P365; BOOTSMA H, 1995, LANCET, V345, P1595, DOI 10.1016/S0140-6736(95)90114-0; BRINKMAN K, 1990, IMMUNOL TODAY, V11, P232, DOI 10.1016/0167-5699(90)90095-Q; BURLINGAME RW, 1994, J CLIN INVEST, V94, P184, DOI 10.1172/JCI117305; CasciolaRosen L, 1997, LUPUS, V6, P175, DOI 10.1177/096120339700600213; CEPPELLINI R, 1957, P SOC EXP BIOL MED, V96, P572; DESAI DD, 1993, J IMMUNOL, V151, P1614; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Early GS, 1996, J IMMUNOL, V157, P3159; EHRENSTEIN MR, 1995, KIDNEY INT, V48, P705, DOI 10.1038/ki.1995.341; EMLEN W, 1994, J IMMUNOL, V152, P3685; Esdaile JM, 1996, ARTHRITIS RHEUM, V39, P370, DOI 10.1002/art.1780390304; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; GAO CL, 1995, ARTIF ORGANS, V19, P468, DOI 10.1111/j.1525-1594.1995.tb02360.x; GAUTHIER VJ, 1997, DUBOIS LUPUS ERYTHEM, P207; GLADMAN DD, 1979, AM J MED, V66, P210, DOI 10.1016/0002-9343(79)90529-1; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hepbum Bonnie, 1996, Arthritis and Rheumatism, V39, pS307; HERRMANN M, 1995, EUR J IMMUNOL, V25, P1897, DOI 10.1002/eji.1830250716; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLBOROW EJ, 1957, BMJ-BRIT MED J, V2, P732, DOI 10.1136/bmj.2.5047.732; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; ISENBERG D, 1990, J AUTOIMMUN, V3, P393, DOI 10.1016/S0896-8411(05)80008-3; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; Kalsi JK, 1996, MOL IMMUNOL, V33, P471, DOI 10.1016/0161-5890(95)00138-7; KALUNIAN KC, 1989, ARTHRITIS RHEUM, V32, P513, DOI 10.1002/anr.1780320502; KOREN E, 1995, J IMMUNOL, V154, P4857; KRYCH M, 1992, CURR OPIN IMMUNOL, V4, P8, DOI 10.1016/0952-7915(92)90116-V; Lefkowith JB, 1996, J CLIN INVEST, V98, P1373, DOI 10.1172/JCI118924; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; MAHMOUDI M, 1995, ARTHRITIS RHEUM, V38, P389; MOHAN C, 1995, CLIN IMMUNOL IMMUNOP, V77, P209, DOI 10.1006/clin.1995.1146; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; OHNISHI K, 1994, INT IMMUNOL, V6, P817, DOI 10.1093/intimm/6.6.817; PEREZGUTTHANN S, 1991, J RHEUMATOL, V18, P1176; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; PISETSKY DS, 1990, J CLIN INVEST, V85, P899, DOI 10.1172/JCI114517; PUTTERMAN C, 1997, DUBOIS LUPUS ERYTHEM, P383; PYUN EH, 1993, J AUTOIMMUN, V6, P11, DOI 10.1006/jaut.1993.1002; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; REEVES WH, 1994, RHEUM DIS CLIN N AM, V20, P1; REKVIG OP, 1992, SCAND J IMMUNOL, V36, P487, DOI 10.1111/j.1365-3083.1992.tb02964.x; ROBBINS WC, 1957, P SOC EXP BIOL MED, V96, P575; ROTHFIELD NF, 1967, J CLIN INVEST, V46, P1785, DOI 10.1172/JCI105669; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SCHUR PH, 1968, NEW ENGL J MED, V278, P533, DOI 10.1056/NEJM196803072781004; SCHWARTZ RS, 1985, J CLIN INVEST, V75, P321, DOI 10.1172/JCI111704; SHOENFELD Y, 1994, FASEB J, V8, P1296, DOI 10.1096/fasebj.8.15.8001742; Silvestris F, 1996, CLIN EXP IMMUNOL, V104, P91, DOI 10.1111/cei.1996.104.s1.91; Singh RR, 1995, J CLIN INVEST, V96, P2990, DOI 10.1172/JCI118371; SMEENK RJT, 1991, RHEUMATOL INT, V11, P101, DOI 10.1007/BF00304496; STOLLAR BD, 1994, FASEB J, V8, P337, DOI 10.1096/fasebj.8.3.7511550; SUZUKI M, 1991, AM J KIDNEY DIS, V18, P232, DOI 10.1016/S0272-6386(12)80884-5; SUZUKI N, 1993, J IMMUNOL, V151, P1128; TAKI S, 1992, EUR J IMMUNOL, V22, P987, DOI 10.1002/eji.1830220417; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; TOJO T, 1968, SCIENCE, V161, P904, DOI 10.1126/science.161.3844.904; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; TSAO BP, 1992, IMMUNOMETHODS, V1, P185; VanBruggen MCJ, 1996, CLIN EXP IMMUNOL, V105, P132, DOI 10.1046/j.1365-2249.1996.d01-731.x; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; WEINSTEIN A, 1983, AM J MED, V74, P206, DOI 10.1016/0002-9343(83)90613-7; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Williams WM, 1995, LUPUS, V4, P464, DOI 10.1177/096120339500400608; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626; WINKLER TH, 1992, EUR J IMMUNOL, V22, P1719, DOI 10.1002/eji.1830220709; WOFSY D, 1987, J IMMUNOL, V138, P3247; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Yanase K, 1997, J CLIN INVEST, V100, P25, DOI 10.1172/JCI119517; Zouali M, 1997, METHODS, V11, P27, DOI 10.1006/meth.1996.0384; [No title captured]	77	490	510	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1359	1368		10.1056/NEJM199805073381906	http://dx.doi.org/10.1056/NEJM199805073381906			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571257				2022-12-28	WOS:000073463700006
J	Dwyer, ND; Troemel, ER; Sengupta, P; Bargmann, CI				Dwyer, ND; Troemel, ER; Sengupta, P; Bargmann, CI			Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein	CELL			English	Article							ACHIEVE BASOLATERAL LOCALIZATION; DOMINANT RETINITIS-PIGMENTOSA; CYCLOPHILIN HOMOLOG NINAA; CANINE KIDNEY-CELLS; CAENORHABDITIS-ELEGANS; C-ELEGANS; MICROSCOPY; CHAPERONE; RHODOPSIN; TRANSPORT	Seven transmembrane domain receptors can be localized to different parts of the plasma membrane or to different intracellular compartments in a receptor-specific and cell type-specific fashion. We show here that the C. elegans genes odr-4 and odr-8 are required for localization of a subset of seven transmembrane domain odorant receptors to the cilia of olfactory neurons. Other cilia-signaling proteins, including ion channels, a G alpha protein, and even other receptor types, are localized via an odr-4/odr-8-independent pathway. odr-4 encodes a novel membrane protein that is expressed exclusively on intracellular membranes of chemosensory neurons, where it acts cell-autonomously to facilitate odorant receptor folding or localization.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618; Dwyer, Noelle/0000-0002-1995-7203				AGARD DA, 1989, METHOD CELL BIOL, V30, P353; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Bohm SK, 1997, J BIOL CHEM, V272, P2363; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chou JH, 1996, COLD SPRING HARB SYM, V61, P157; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; HEIN L, 1995, NEUROPHARMACOLOGY, V34, P357, DOI 10.1016/0028-3908(95)00018-2; Hiraoka Y, 1991, Semin Cell Biol, V2, P153; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Ng GYK, 1997, ENDOCRINOLOGY, V138, P4199, DOI 10.1210/en.138.10.4199; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saunders C, 1996, J BIOL CHEM, V271, P995, DOI 10.1074/jbc.271.2.995; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1994, J NEUROSCI, V14, P5818; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Wozniak M, 1997, J RECEPT SIGNAL TR R, V17, P373, DOI 10.3109/10799899709036615; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162	46	197	211	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					455	466		10.1016/S0092-8674(00)81173-3	http://dx.doi.org/10.1016/S0092-8674(00)81173-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590179	Bronze			2022-12-28	WOS:000073471500020
J	Kunst, AE; Groenhof, F; Mackenbach, JP				Kunst, AE; Groenhof, F; Mackenbach, JP		EU Working Grp Socioeconomic Inequalities Hlth	Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS; SOCIOECONOMIC-STATUS; HEALTH; DISEASE; INEQUALITIES; FRANCE	Objectives: To compare countries in western Europe with respect to class differences in mortality from specific causes of death and to assess the contributions these causes make to class differences in total mortality. Design: Comparison of cause of death in manual and non-manual classes, using data on mortality from national studies. Setting: Eleven western European countries in the period 1980-9. Subjects: Men aged 45-59 years at death. Results: A north-south gradient was observed: mortality from ischaemic heart disease was strongly related to occupational class in England and Wales, Ireland, Finland, Sweden, Norway, and Denmark, but not in France, Switzerland, and Mediterranean countries. In the latter countries, cancers other than lung cancer and gastrointestinal diseases made a large contribution to class differences in total mortality. Inequalities in lung cancer, cerebrovascular disease, and external causes of death also varied greatly between countries. Conclusions: These variations in cause specific mortality indicate large differences between countries in the contribution that disease specific risk factors like smoking and alcohol consumption make to socioeconomic inequalities in mortality. The mortality advantage of people in higher occupational classes is independent of the precise diseases and risk factors involved.	Erasmus Univ, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Kunst, AE (corresponding author), Erasmus Univ, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	kunst@mgz.fgg.eur.nl		Kunst, Anton/0000-0002-3313-5273				ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Bartley M, 1996, SOCIOL HEALTH ILL, V18, P455, DOI 10.1111/1467-9566.ep10939068; Brunner E, 1996, HLTH SOCIAL ORG, P272; Carroll D, 1996, J Health Psychol, V1, P23, DOI 10.1177/135910539600100103; Cavelaars A E, 1997, J Health Psychol, V2, P353, DOI 10.1177/135910539700200306; CHARLTON BG, 1995, PUBLIC HEALTH, V109, P235, DOI 10.1016/S0033-3506(95)80200-2; *COM CIENT EST DES, 1996, DES SOC SAL ESP; DESPLANQUES G, 1984, MORTALITE ADULTS RES; Evans R. G., 1994, WHY ARE SOME PEOPLE, P161; ILLSLEY R, 1990, SOC SCI MED, V31, P229, DOI 10.1016/0277-9536(90)90269-X; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; KUNST A, IN PRESS SOC SCI MED; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; KUNST AE, 1997, THESIS ERASMUS U ROT; KUNST AE, 1996, SOCIOECONOMIC INEQUA; KUSHI LH, 1995, AM J CLIN NUTR, V61, p1407S, DOI 10.1093/ajcn/61.6.1407S; LAVECCHIA C, 1987, INT J EPIDEMIOL, V16, P624; LECLERC A, 1990, INT J EPIDEMIOL, V19, P1001, DOI 10.1093/ije/19.4.1001; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; MAKELA P, IN PRESS BMJ; MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109; MIELCK A, 1993, INEQUALITIES HLTH HL; POIKOLAINEN K, 1983, J STUD ALCOHOL, V44, P986, DOI 10.15288/jsa.1983.44.986; SASCO AJ, 1994, B CANCER, V81, P355; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; VAGERO D, 1989, LANCET, V2, P35, DOI 10.1016/S0140-6736(89)90266-3; VAGERO D, 1995, EUROPEAN SOCIOLOGY R, V11, P1; VAGERO D, 1995, ADULT MORTALITY DEV, P223; Valkonen T., 1989, HLTH INEQUALITIES EU, P142; Van Doorslaer E, 1992, EQUITY FINANCE DELIV; VANLOON AJM, 1995, J EPIDEMIOL COMMUN H, V49, P65, DOI 10.1136/jech.49.1.65; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	33	288	289	2	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	1998	316	7145					1636	1641		10.1136/bmj.316.7145.1636	http://dx.doi.org/10.1136/bmj.316.7145.1636			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZR867	9603745	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000074022700020
J	Beecham, L				Beecham, L			BMA calls for rethink on no fault compensation	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1540	1540						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582163				2022-12-28	WOS:000073707700089
J	Cnattingius, S; Haglund, B; Kramer, MS				Cnattingius, S; Haglund, B; Kramer, MS			Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRAUTERINE GROWTH-RETARDATION; RISK-FACTORS; MATERNAL AGE; STILLBIRTH; BIRTH; MALFORMATIONS; COMPLICATIONS; ANTEPARTUM; DURATION; SMOKING	Objective: To examine differences in late fetal death rates in association with determinants of small for gestational age fetuses. Design: Population based cohort study. Subjects: 1 026 249 pregnancies without congenital malformations. Setting: Sweden 1983-92. Main outcome measure: Late fetal death rate. Results: Depending on underlying determinants late fetal death rates were greatly increased in extremely small for gestational age fetuses (range 16 to 45 per 1000) compared with non-small for gestational age fetuses (1.4 to 4.6). In extremely small for gestational age fetuses late fetal death rates were increased from 31 per 1000 in mothers aged less than 35 years to 45 per 1000 in older mothers, and from 22 per 1000 in women < 155 cm in height to 33 per 1000 in women greater than or equal to 175 cm tall. Late fetal death rates were also higher in extremely small for gestational age fetuses in singleton compared with twin pregnancies and in non-hypertensive pregnancies compared with pregnancies complicated by severe pre-eclampsia or other hypertensive disorders. Slightly higher late fetal death rates were observed in nulliparous compared with parous women and in non-smokers compared with smokers. Conclusions: Although the risk of late fetal death is greatly increased in fetuses that are extremely small for gestational age the risk is strongly modified by underlying determinants-for example, there is a lower risk of late fetal death in a small for gestational age fetus if the mother is of short stature, has a twin pregnancy, or has hypertension.	Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada	Karolinska Institutet; National Board of Health & Welfare; McGill University	Cnattingius, S (corresponding author), Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden.							ABDELLA TN, 1984, OBSTET GYNECOL, V63, P365; Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P20; ALESSANDRI LM, 1992, BRIT J OBSTET GYNAEC, V99, P711, DOI 10.1111/j.1471-0528.1992.tb13868.x; BARROS FC, 1992, PEDIATRICS, V90, P238; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; CNATTINGIUS S, 1990, International Journal of Feto-Maternal Medicine, V3, P15; Cnattingius S, 1997, AM J EPIDEMIOL, V145, P319; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; GENEST DR, 1992, OBSTET GYNECOL, V80, P575; Haglund B, 1993, Paediatr Perinat Epidemiol, V7, P33, DOI 10.1111/j.1365-3016.1993.tb00599.x; HEINRICH UE, 1992, BAILLIERE CLIN ENDOC, V6, P589, DOI 10.1016/S0950-351X(05)80114-4; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; KHOURY MJ, 1988, PEDIATRICS, V82, P83; KRAMER MS, 1990, PEDIATRICS, V86, P18; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; LITTLE RE, 1993, AM J EPIDEMIOL, V137, P1177, DOI 10.1093/oxfordjournals.aje.a116620; NAEYE RL, 1983, OBSTET GYNECOL, V61, P210; NAEYE RL, 1979, EARLY HUM DEV, V3, P229, DOI 10.1016/0378-3782(79)90031-8; OUNSTED M, 1981, EARLY HUM DEV, V5, P367, DOI 10.1016/0378-3782(81)90017-7; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; RAYMOND EG, 1993, ACTA OBSTET GYN SCAN, V72, P633, DOI 10.3109/00016349309021156; RYDHSTROM H, 1994, ACTA OBSTET GYN SCAN, V73, P779, DOI 10.3109/00016349409072504; SANDERSON DA, 1994, BRIT J OBSTET GYNAEC, V101, P310, DOI 10.1111/j.1471-0528.1994.tb13616.x; Sciscione AC, 1996, AM J OBSTET GYNECOL, V175, P544; SNIJDERS RJM, 1993, AM J OBSTET GYNECOL, V168, P547, DOI 10.1016/0002-9378(93)90491-Z; Wennergren M, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P147; YUDKIN PL, 1987, LANCET, V1, P1192; 1990, AM J OBSTET GYNECOL, V163, P1689	31	124	125	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1483	1487		10.1136/bmj.316.7143.1483	http://dx.doi.org/10.1136/bmj.316.7143.1483			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582131	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000073707700019
J	Wilkinson, JR; Murray, SA				Wilkinson, JR; Murray, SA			Health needs assessment - Assessment in primary care: practical issues and possible approaches	BRITISH MEDICAL JOURNAL			English	Article							QUALITATIVE RESEARCH		N Yorkshire Hlth Author, York YO3 4XF, N Yorkshire, England		Wilkinson, JR (corresponding author), N Yorkshire Hlth Author, York YO3 4XF, N Yorkshire, England.	john.wilkinson@nyorks-ha.northy.nhs.uk						ACTON C, 1998, HLTH NEEDS ASSESSMEN; Annett H., 1995, GUIDELINES RAPID PAR; Gillam S.J., 1996, 73 ROYAL COLL GEN PR; Harley K, 1996, Health Bull (Edinb), V54, P410; Harris A., 1997, NEEDS KNOW GUIDE NEE; Hobbs FDR, 1997, BRIT J GEN PRACT, V47, P439; HOOPER J, 1997, HLTH NEEDS ASSESSMEN; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; LALONDE J, 1974, NEW PERSPECTIVE HLTH; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; MURRAY SA, 1994, BRIT MED J, V308, P698, DOI 10.1136/bmj.308.6930.698; MURRAY SA, 1995, BRIT MED J, V310, P1443, DOI 10.1136/bmj.310.6992.1443; PAYNE JN, 1994, J EPIDEMIOL COMMUN H, V48, P74, DOI 10.1136/jech.48.1.74; *SCOTT NEEDS ASS P, 1997, ROUGH GUID NEEDS ASS; SHANKS J, 1995, BRIT MED J, V310, P480, DOI 10.1136/bmj.310.6978.480; SMITH N, 1995, BRIT MED J, V311, P313, DOI 10.1136/bmj.311.7000.313; *STAT HLTH, 1997, CM 3807; *STAT SCOTL, 1997, DES CAR REN NHS SCOT; WILKIN D, 1992, MEASURES NEED OUTCOM; WILLIAMS R, 1994, HLTH CARE NEEDS ASSE, P31	20	17	18	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1524	1528		10.1136/bmj.316.7143.1524	http://dx.doi.org/10.1136/bmj.316.7143.1524			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582151	Green Published			2022-12-28	WOS:000073707700046
J	Coninx, R; Pfyffer, GE; Mathieu, C; Savina, D; Debacker, M; Jafarov, F; Jabrailov, I; Ismailov, A; Mirzoev, F; de Haller, R; Portaels, F				Coninx, R; Pfyffer, GE; Mathieu, C; Savina, D; Debacker, M; Jafarov, F; Jabrailov, I; Ismailov, A; Mirzoev, F; de Haller, R; Portaels, F			Drug resistant tuberculosis in prisons in Azerbaijan: case study	BRITISH MEDICAL JOURNAL			English	Article								Objectives: To document the existence of drug resistance in a tuberculosis treatment programme that adheres strictly to the DOTS principles (directly observed treatment, short course) and to determine the extent of drug resistance in a prison setting in one of the republics of the former Soviet Union. Design: Case study. Setting: Central Penitentiary Hospital in Baku, the referral centre for tuberculosis patients from all prisons in Azerbaijan. Subjects: Prisoners with tuberculosis: 28 selected patients not responding clinically or bacteriologically to the standard treatment (group 1) and 38 consecutive patients at admission to the programme (group 2). Main outcome measures: Drug resistance of Mycobacterium tuberculosis strains grown from sputum. Results: All the nan-responding patients (group 1) had strains resistant to at least one drug. 25 (89%) of the non-responding patients and nine (24%) of the consecutive patients had M tuberculosis strains resistant to both rifampicin and isoniazid. A further 17 patients in group 2 had strains resistant to one or more first line drugs. Conclusions: Drug resistant M tuberculosis strains are common in prisons in Azerbaijan. Tuberculosis problems tend to be worse in prisons, but prisoners and former prisoners may have an important role in the transmission of tuberculosis, particularly of drug resistant forms, in the community. National programmes to control tuberculosis will have to take into account and address the problems in prisons to ensure their success.	Int Comm Res Cross, CH-1202 Geneva, Switzerland; Univ Zurich, Dept Med Microbiol, Swiss Natl Ctr Mycobacteria, CH-8028 Zurich, Switzerland; Int Comm Red Cross, TB Program, Baku, Azerbaijan; Cent Penitentiary Hosp, TB Program, Baku, Azerbaijan; Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium	University of Zurich; Institute of Tropical Medicine (ITM)	Coninx, R (corresponding author), Int Comm Res Cross, CH-1202 Geneva, Switzerland.	rconinx@icrc.org						CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; Drobniewski F, 1996, TUBERCLE LUNG DIS, V77, P199, DOI 10.1016/S0962-8479(96)90001-5; *EUR CTR EP MON AI, 1996, 52 EUR CTR EP MON AI, P11; Inderlied C. B., 1996, ANTIBIOTICS LAB MED, P127; *INT UN TUB LUNG D, 1996, TUB GUID LAW INC COU; Kent PT, 1985, GUIDE LEVEL 3 LAB; KHOMENKO AG, 1996, 17 ANN M EUR SOC MYC; KLUGE H, 1997, CONTACT, V45, P24; MORGAN MA, 1983, J CLIN MICROBIOL, V18, P384, DOI 10.1128/JCM.18.2.384-388.1983; RAVIGLIONE MC, 1994, TUBERCLE LUNG DIS, V75, P400, DOI 10.1016/0962-8479(94)90113-9; *WHO, 1993, WHOTB91161; *WHO, 1995, WKLY EPIDEMIOL REC, V70, P21; World Health Organization, 1995, WHOTB95183	13	35	37	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1423	1425		10.1136/bmj.316.7142.1423	http://dx.doi.org/10.1136/bmj.316.7142.1423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572751	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000073651600027
J	Stevens, A; Gillam, S				Stevens, A; Gillam, S			Health needs assessment - Needs assessment: from theory to practice	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Primary Care Programme, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Stevens, A (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Primary Care Programme, Birmingham B15 2TT, W Midlands, England.			Stevens, Andrew/0000-0003-2079-3397				ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; BEECH R, 1994, HLTH CARE NEEDS ASSE, V1, P58; BOOTH A, 1997, 972 U SHEFF SCH HLTH; CULYER A, 1955, SOC SCI MED, V40, P727; Culyer AJ., 1976, NEED NATL HLTH SERVI; Department of Health, 1997, NEW NHS MOD DEP; Department of Health and Social Security Resource Allocation Working Party, 1976, SHAR RES HLTH ENGL; Dixon J, 1997, BRIT MED J, V314, P58, DOI 10.1136/bmj.314.7073.58; FULOP N, 1997, SURVEY NEEDS ASSESSM; Gillam S.J., 1996, 73 ROYAL COLL GEN PR; GILLAM SJ, 1992, BRIT J GEN PRACT, V42, P404; HAYNES B, 1997, EVIDENCE BASED MED, V2, P4; MAYS N, 1997, TOTAL PURCHASING PRO; National Health Service Management Executive, 1991, ASS HLTH CAR NEEDS; *NHS EX, 1997, EL9749 NHSE; *NHS MAN EX, 1991, PURC INT; PICKIN C, 1991, ASSESSMENT HLTH NEED; PRINGLE M, 1991, BRIT MED J, V302, P742; *ROYAL COLL NURS, 1993, GP PRACT POP PROF FR; SAUNDERS D, 1989, VARIETIES HOSP ADMIS; SPIEGAL N, 1992, BRIT MED J, V304, P231, DOI 10.1136/bmj.304.6821.231; Stevens A, 1991, Health Trends, V23, P20; STEVENS A, 1994, HLTH CARE NEEDS ASSE, V1, P11; STEVENS A, 1997, HLTH CARE NEEDS ASSE, pR32; STEVENS A, 1992, MEASURING MENTAL HLT, P42; WENNBERG JE, 1988, JAMA-J AM MED ASSOC, V259, P3027, DOI 10.1001/jama.259.20.3027	26	98	99	0	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1448	1452		10.1136/bmj.316.7142.1448	http://dx.doi.org/10.1136/bmj.316.7142.1448			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572762	Green Published			2022-12-28	WOS:000073651600037
J	Baigent, C; Collins, R; Appleby, P; Parish, S; Sleight, P; Peto, R				Baigent, C; Collins, R; Appleby, P; Parish, S; Sleight, P; Peto, R		ISIS-2 Collaborat Grp	ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEFT-VENTRICULAR FUNCTION; THROMBOLYTIC THERAPY; BENEFIT; TRIAL; MORTALITY; PATENCY; DETERMINANTS; DISCHARGE; ARTERY; ASSET	Objective: To assess effects of intravenous streptokinase, one month of oral aspirin, or both, on long term survival after suspected acute myocardial infarction. Design: Randomised, "2 x 2 factorial," placebo controlled trial. Setting: 417 hospitals in 16 countries. Subjects: 17 187 patients with suspected acute myocardial infarction randomised between March 1985 and December 1987. Follow up of vital status complete to at least 1 January 1990 for 95% of all patients and to mid-1997 for the 6213 patients in United Kingdom. Interventions: Intravenous streptokinase (1.5 MU in 1 hour) and oral aspirin (162 mg daily for 1 month) versus matching placebos. Main outcome measures: Mortality from all causes during up to 10 years' follow up, with subgroup analyses based on 4 year follow up. Results: After randomisation, 1841 deaths were recorded in days 0-35, 991 from day 36 to end of year 1, 1478 in years 2-4, and 1230 in Years 5-10. Allocation to streptokinase was associated with 29 (95% confidence interval 20 to 38) fewer deaths per 1000 patients during days 0-35. This early benefit persisted (death rate ratio 0.98 (0.92 to 1.04) for additional deaths between day 36 and end of year 10), so that there were 28 (14 to 42) and 23 (2 to 44) fewer deaths per 1000 patients treated with streptokinase after 4 years and 10 years respectively There was no evidence that absolute survival benefit increased with prolonged follow up among an) category of patient including those presenting early after symptoms started or with anterior ST elevation. Nor did the early benefits seem to be lost in any category (including those aged over 70). Allocation to one month of aspirin was associated with 26 (16 to 35) fewer deaths per 1000 during first 35 days, with little further benefit or loss during subsequent years (death rate ratio 0.99 (0.93 to 1.06) between day 36 and end of year 10). The early benefit obtained with combination of streptokinase and ope month of aspirin also seemed to persist long term. Conclusions: The early survival advantages produced by fibrinolytic therapy and one month of aspirin started in acute myocardial infarction seem to be maintained for at least 10 years.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Nuffield Dept Clin Med, Epidemiol Study Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	Baigent, C (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.	colin.baigent@ctsu.ox.ac.uk						ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, Lancet, V1, P545; [Anonymous], 1987, LANCET, V2, P871; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1993, Lancet, V342, P767; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; CERQUEIRA MD, 1992, J AM COLL CARDIOL, V20, P1452, DOI 10.1016/0735-1097(92)90436-Q; GRANGER CB, 1994, AM J CARDIOL, V74, P1220, DOI 10.1016/0002-9149(94)90552-5; GURWITZ JH, 1991, JAMA-J AM MED ASSOC, V265, P1720, DOI 10.1001/jama.265.13.1720; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; HAMPTON J, 1993, LANCET, V342, P759; HARRISON JK, 1993, CIRCULATION, V87, P1531, DOI 10.1161/01.CIR.87.5.1531; HILLIS W S, 1992, European Heart Journal, V13, P305; HUNT D, 1992, LANCET, V339, P753; LAMAS GA, 1995, CIRCULATION, V92, P1101, DOI 10.1161/01.CIR.92.5.1101; LENDERINK T, 1995, CIRCULATION, V92, P1110, DOI 10.1161/01.CIR.92.5.1110; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rawles J, 1996, BMJ-BRIT MED J, V312, P212; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; ROSSI P, 1991, AM J CARDIOL, V68, P585, DOI 10.1016/0002-9149(91)90348-O; SCHRODER R, 1987, J AM COLL CARDIOL, V9, P197, DOI 10.1016/S0735-1097(87)80101-8; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; SIMOONS ML, 1989, J AM COLL CARDIOL, V14, P1609, DOI 10.1016/0735-1097(89)90003-X; VANDEWERF F, 1995, CIRCULATION, V91, P2862, DOI 10.1161/01.CIR.91.12.2862; VOLPI A, 1993, CIRCULATION, V88, P416, DOI 10.1161/01.CIR.88.2.416; WHITE HD, 1994, CIRCULATION, V89, P61, DOI 10.1161/01.CIR.89.1.61; WHITE HD, 1992, LANCET, V340, P221, DOI 10.1016/0140-6736(92)90478-L; WHITE SJ, 1978, BRIT J CANCER, V37, P849, DOI 10.1038/bjc.1978.124; WILCOX RG, 1988, LANCET, V2, P525; WILCOX RG, 1990, LANCET, V335, P1175; Woods KL, 1996, LANCET, V347, P1203, DOI 10.1016/S0140-6736(96)90732-1	32	301	314	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1337	1343		10.1136/bmj.316.7141.1337	http://dx.doi.org/10.1136/bmj.316.7141.1337			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563981	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000073483000013
J	Schmidt-Rohr, K; Hu, W; Zumbulyadis, N				Schmidt-Rohr, K; Hu, W; Zumbulyadis, N			Elucidation of the chain conformation in a glassy polyester, PET, by two-dimensional NMR	SCIENCE			English	Article							DOUBLE-QUANTUM COHERENCE; AROMATIC POLYESTERS; DIPOLE-MOMENTS; POLY(ETHYLENE-TEREPHTHALATE); METHYLENE; SPECTRA; TEREPHTHALATE); ORIENTATION; CONFORMERS; DYNAMICS	The chain conformation of glassy poly(ethylene terephthalate) (PET) was characterized by two-dimensional double-quantum nuclear magnetic resonance (NMR). In amorphous carbon-13-labeled PET, the statistics of the O-(CH2)-C-13-(CH2)-C-13-O torsion angle were determined, on the basis of the distinct shapes of the two-dimensional MMR patterns of trans and gauche conformations. In crystalline PET, the trans content is 100 percent, but in the amorphous PET it is only 14 percent (+/-5 percent). An average gauche torsion angle of 70 degrees (+/-9 degrees) was obtained. Implications for materials properties of polyesters are discussed.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; Eastman Kodak Co, Imaging Res & Adv Dev, Rochester, NY 14650 USA	University of Massachusetts System; University of Massachusetts Amherst; Eastman Kodak	Schmidt-Rohr, K (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.							ABE A, 1985, POLYM J, V17, P883, DOI 10.1295/polymj.17.883; ABE A, 1976, J AM CHEM SOC, V98, P6468, DOI 10.1021/ja00437a006; ABE LA, 1976, J POLYM SCI PP, V14, P1337; Ajji A, 1996, POLYMER, V37, P3707, DOI 10.1016/0032-3861(96)00175-9; BAHAR I, 1989, J CHEM PHYS, V90, P6783, DOI 10.1063/1.456297; BAX A, 1980, J AM CHEM SOC, V102, P4849, DOI 10.1021/ja00534a056; BAX A, 1981, J MAGN RESON, V43, P478, DOI 10.1016/0022-2364(81)90060-3; CIAGETT DC, 1989, ENCY POLYM SCI ENG, V6, P114; CUNNINGHAM A, 1974, POLYMER, V15, P749, DOI 10.1016/0032-3861(74)90028-7; DABBAGH G, 1994, MACROMOLECULES, V27, P6138; DAUBENY RD, 1954, PROC R SOC LON SER-A, V226, P531; Ernst R. R., 1987, NUCL MAGNETIC RESONA; FLORY PJ, 1964, MAKROMOLEKUL CHEM, V75, P11; FLORY PJ, 1969, STAT MECH CHAIN MOL, P190; Jadhav J. Y., 1989, ENCY POLYM SCI ENG, V12, P219; LIN SB, 1982, J POLYM SCI POL PHYS, V20, P2277, DOI 10.1002/pol.1982.180201209; LIU J, 1987, ANAL CHEM, V59, P2609, DOI 10.1021/ac00148a017; MATTICE WL, 1994, CONFORMATIONAL THEOR, P234; MENDICUTI F, 1990, MACROMOLECULES, V23, P1139, DOI 10.1021/ma00206a036; NAKAI T, 1993, MOL PHYS, V79, P965, DOI 10.1080/00268979300101761; NATTA G, 1960, NUOVO CIMENTO S 10, V15, P13; RAPOLD RF, 1994, MACROMOL THEOR SIMUL, V3, P19, DOI 10.1002/mats.1994.040030103; RIANDE E, 1985, J POLYM SCI POL PHYS, V23, P1235, DOI 10.1002/pol.1985.180230614; ROBYR P, 1995, MOL PHYS, V84, P995, DOI 10.1080/00268979500100691; RODRIGUEZCABELLO JC, 1994, J RAMAN SPECTROSC, V25, P335, DOI 10.1002/jrs.1250250509; ROEBER S, 1992, POLYMER, V33, P2061; SANROMAN J, 1982, MACROMOLECULES, V15, P609; SCHMIDT-ROHR K, 1993, MAGN RESON CHEM, V31, P352, DOI 10.1002/mrc.1260310408; Schmidt-Rohr K, 1996, MACROMOLECULES, V29, P3975, DOI 10.1021/ma9517106; SCHMIDTROHR K, IN PRESS J MAGN RESO; SCHMIDTROHR K, UNPUB; STROBL G, 1996, PHYSICS POLYMERS, P169; Tomaselli M, 1996, MOL PHYS, V89, P1663, DOI 10.1080/00268979609482566; YANG XZ, 1991, POLYM COMMUN, V32, P125; YAZDANIAN M, 1985, POLYMER, V26, P1779, DOI 10.1016/0032-3861(85)90003-5; 1996, CHEM WEEK       0619, P38	37	106	106	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					714	717		10.1126/science.280.5364.714	http://dx.doi.org/10.1126/science.280.5364.714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563942				2022-12-28	WOS:000073415600040
J	Smith, SS; Gong, QH; Hsu, FC; Markowitz, RS; ffrench-Mullen, JMH; Li, HS				Smith, SS; Gong, QH; Hsu, FC; Markowitz, RS; ffrench-Mullen, JMH; Li, HS			GABA(A) receptor alpha 4 subunit suppression prevents withdrawal properties of an endogenous steroid	NATURE			English	Article							A RECEPTOR; RAT-BRAIN; PROGESTERONE; METABOLITES; DEPENDENCE; ETHANOL; WOMEN; MODEL	The hormone progesterone is readily converted to 3 alpha-OH-5 alpha-pregnan-20-one (3 alpha,5 alpha-THP) in the brains of males and females(1,2), In the brain, 3 alpha,5 alpha-THP acts like a sedative(3-5), decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid)(6-8), the brain's major inhibitory neurotransmitter, Symptoms of premenstrual syndrome (PMS), such as anxiety(9) and seizure(10,11) susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3 alpha,5 alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines(12) and ethanol(13) can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3 alpha,5 alpha-THP which enhance transcription of the gene encoding the alpha 4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesterone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha 4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expression of GABA(A) receptor subunits as a result of progesterone withdrawal.	Allegheny Univ Hlth Sci, Dept Neurobiol & Anat, EPPI, Philadelphia, PA 19129 USA; Zeneca Inc, Zeneca Pharmaceut, RIN Biosci, Wilmington, DE 19850 USA	AstraZeneca	Smith, SS (corresponding author), Allegheny Univ Hlth Sci, Dept Neurobiol & Anat, EPPI, 3200 Henry Ave, Philadelphia, PA 19129 USA.			Smith, Sheryl/0000-0003-4308-3267				ATOR NA, 1993, EUR J PHARMACOL, V241, P237, DOI 10.1016/0014-2999(93)90208-Y; BACKSTROM T, 1984, ACTA NEUROL SCAND, V69, P240; BELELLI D, 1989, EUR J PHARMACOL, V166, P325, DOI 10.1016/0014-2999(89)90077-0; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; BUCK KJ, 1990, J PHARMACOL EXP THER, V253, P713; COSTA AMN, 1995, J NEUROPHYSIOL, V74, P464, DOI 10.1152/jn.1995.74.1.464; DENNERSTEIN L, 1985, BRIT MED J, V290, P1617, DOI 10.1136/bmj.290.6482.1617; Devaud LL, 1997, J NEUROCHEM, V69, P126; FILE SE, 1990, NEUROSCI BIOBEHAV R, V14, P135, DOI 10.1016/S0149-7634(05)80214-3; FRIEDMAN L, 1993, MOL PHARMACOL, V44, P191; GALLO MA, 1993, PHARMACOL BIOCHEM BE, V46, P897, DOI 10.1016/0091-3057(93)90219-J; HERZOG AG, 1995, NEUROLOGY, V45, P1660, DOI 10.1212/WNL.45.9.1660; Holt RA, 1996, NEUROPHARMACOLOGY, V35, P1457, DOI 10.1016/S0028-3908(96)00064-0; KERN W, 1994, J NEUROCHEM, V62, P764; KOKKA N, 1993, ALCOHOL CLIN EXP RES, V17, P525, DOI 10.1111/j.1530-0277.1993.tb00793.x; LAU EC, 1993, J STEROID BIOCHEM, V46, P751, DOI 10.1016/0960-0760(93)90315-N; LAVOIE AM, 1997, BIOPHYS J, V73, P1; Mahmoudi M, 1997, J NEUROCHEM, V68, P2485; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MOSSIER B, 1994, J BIOL CHEM, V269, P25777; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; Sundstrom I, 1997, PSYCHONEUROENDOCRINO, V22, P25, DOI 10.1016/S0306-4530(96)00035-2; TWYMAN RE, 1992, J PHYSIOL-LONDON, V456, P215, DOI 10.1113/jphysiol.1992.sp019334; TYNDALE RF, 1994, J NEUROSCI, V14, P5417; Wafford KA, 1996, MOL PHARMACOL, V50, P670; WISDEN W, 1991, FEBS LETT, V289, P227, DOI 10.1016/0014-5793(91)81076-K; YU XJ, 1994, MOL PHARMACOL, V47, P603	30	462	474	1	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					926	930		10.1038/31948	http://dx.doi.org/10.1038/31948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582073				2022-12-28	WOS:000073359900050
J	Di Cunto, F; Topley, G; Calautti, E; Hsiao, J; Ong, L; Seth, PK; Dotto, GP				Di Cunto, F; Topley, G; Calautti, E; Hsiao, J; Ong, L; Seth, PK; Dotto, GP			Inhibitory function of p21(Cip1/WAF1) in differentiation of primary mouse keratinocytes independent of cell cycle control	SCIENCE			English	Article							P21(WAF1/CIP1) EXPRESSION; TERMINAL DIFFERENTIATION; GROWTH; P21; PROTEIN; PROGRESSION; WAF1/CIP1; CALCIUM; PCNA	The cyclin-dependent kinase inhibitor p21(Cip1/WAF1) has been implicated as an inducer of differentiation. However, although expression of p21 is increased in postmitotic cells immediately adjacent to the proliferative compartment, its expression is decreased in cells further along the differentiation program. Expression of the p21 protein was decreased in terminally differentiated primary keratinocytes of mice, and this occurred by a proteasome-dependent pathway. Forced expression of p21 in these cells inhibited the expression of markers of terminal differentiation at both the protein and messenger RNA levels. These inhibitory effects on differentiation were not observed with a carboxyl-terminal truncation mutant or with the unrelated cyclin-dependent kinase inhibitor p16(INK4a), although all these molecules exerted similar inhibition of cell growth. These findings reveal an inhibitory role of p21 in the late stages of differentiation that does not result from the effects of p21 on the cell cycle.	Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Turin, Dept Genet Biol & Med Chem, Torino, Italy; NCI, Med Branch, Breast Canc Sect, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Turin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 13th St, Charlestown, MA 02129 USA.	Paolo_Dotto@cbrc.mgh.harvard.edu	Calautti, Enzo/M-8283-2018; Di Cunto, Ferdinando/K-5575-2016	Calautti, Enzo/0000-0002-4439-9709; di cunto, ferdinando/0000-0001-9367-6357	NCI NIH HHS [CA16038] Funding Source: Medline; NIAMS NIH HHS [AR39190] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039190] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; DELALLE I, 1996, SOC NEUR ABSTR, V22, P254; DICUNTO F, UNPUB; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gartel AL, 1996, EXP CELL RES, V227, P171, DOI 10.1006/excr.1996.0264; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Harper JW, 1997, CANCER SURV, V29, P91; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; KATAYOSE D, 1995, CELL GROWTH DIFFER, V6, P1207; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li LW, 1996, J INVEST DERMATOL, V106, P254, DOI 10.1111/1523-1747.ep12340654; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Prabhu NS, 1996, CLIN CANCER RES, V2, P1221; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576	24	240	244	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1069	1072		10.1126/science.280.5366.1069	http://dx.doi.org/10.1126/science.280.5366.1069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582119				2022-12-28	WOS:000073663600045
J	Feray, C; Gigou, M; Samuel, D; Ducot, B; Maisonneuve, P; Reynes, M; Bismuth, A; Bismuth, H				Feray, C; Gigou, M; Samuel, D; Ducot, B; Maisonneuve, P; Reynes, M; Bismuth, A; Bismuth, H			Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation	ANNALS OF INTERNAL MEDICINE			English	Article						hepatitis C; liver transplantation; immunoglobulins; hepatitis C antibodies	VIRUS-INFECTION; IMMUNE GLOBULIN; NON-A; PREVENTION; IMMUNOPROPHYLAXIS; NEUTRALIZATION; REINFECTION; CHIMPANZEES	Background: Recurrence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection after liver transplantation is a clinical problem. Polyclonal immunoglobulins against hepatitis B surface antigen (HBIGs) prevent the recurrence of HBV infection, but no effective prophylaxis is available for HCV infection. Before screening of blood donors was introduced in France, HBIGs may have contained antibody to HCV (anti-HCV). Objective: io determine the influence of HBIG on the occurrence of hepatitis C after liver transplantation before and after 1990. Design: Retrospective cohort study. Setting: Liver transplantation unit of a university hospital. Patients: 428 consecutive patients who had liver transplantation because of cirrhosis between 1984 and 1994. Measurements: Detection of serum HCV RNA before and 1 year after transplantation and findings on liver graft biopsy. Results: Among the 218 patients who had HCV infection before transplantation, the incidence of HCV viremia after transplantation was lower in those receiving HBIG than in those not receiving HBIG (25 of 46 patients [54%] compared with 162 of 172 patients [94%]; P < 0.001). In patients receiving HBIG, the incidence of HCV viremia after transplantation was lower among those who had transplantation before March 1990 than among those who had transplantation after this date (15 of 33 patients [45%] compared with 10 of 13 patients [77%]; P = 0.05). Among the 210 patients without HCV infection before transplantation, acquired infection was significantly less frequent in those receiving HBIG than in those not receiving HBIG (18 of 68 patients [26%] compared with 40 of 86 patients [47%]; P < 0.001). Passively transmitted anti-HCV was transiently detected in patients receiving HBIG before March 1990. Multivariate analysis in patients with HCV infection before transplantation showed that the absence of HBIG and transplantation after March 1990 were independent significant risk factors for chronic hepatitis C after transplantation. Conclusions: Polyclonal immunoglobulins that are treated for viral decontamination and contain anti-HCV could prevent HCV infection.	Hop Paul Brousse, Ctr Hepatobiliare, Lab Anat Bathol & Transfus Sanguine, F-94800 Villejuif, France; Univ Paris Sud, Villejuif, France; Ctr Transfus Sanguine, Le Chesnay, France; CHU Bicetre, INSERM, U292, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Feray, C (corresponding author), Hop Paul Brousse, Ctr Hepatobiliare, Lab Anat Bathol & Transfus Sanguine, 14 Ave Paul Vaillant Couturier, F-94800 Villejuif, France.		Feray, Cyrille/S-2559-2018	cyrille, feray/0000-0002-8627-9676				ALBERTI A, 1995, J HEPATOL, V22, P38; BJORO K, 1994, NEW ENGL J MED, V331, P1607, DOI 10.1056/NEJM199412153312402; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; FARGES O, 1994, TRANSPLANTATION, V58, P891, DOI 10.1097/00007890-199410270-00006; FARGES O, 1996, HEPATOLOGY, V5, P569; FERAY C, 1992, J CLIN INVEST, V89, P1361, DOI 10.1172/JCI115723; FERAY C, 1990, TRANSPLANTATION, V49, P1155, DOI 10.1097/00007890-199006000-00025; FERAY C, 1994, HEPATOLOGY, V20, P1137, DOI 10.1016/0270-9139(94)90748-X; KNODELL RG, 1976, LANCET, V1, P557; Krawczynski K, 1996, J INFECT DIS, V173, P822, DOI 10.1093/infdis/173.4.822; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LEFRERE JJ, 1993, LANCET, V341, P834, DOI 10.1016/0140-6736(93)90615-N; NEUHAUS P, 1994, LANCET, V344, P423; NOWAK T, 1992, J MED VIROL, V36, P209, DOI 10.1002/jmv.1890360311; SAMUEL D, 1991, LANCET, V337, P813, DOI 10.1016/0140-6736(91)92515-4; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; SANCHEZQUIJANO A, 1988, LANCET, V1, P1245; SCOTTO J, 1983, HEPATOLOGY, V3, P279; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R; YAP PL, 1994, J HEPATOL, V21, P455, DOI 10.1016/S0168-8278(05)80328-9	23	106	107	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					810	+		10.7326/0003-4819-128-10-199805150-00003	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599192				2022-12-28	WOS:000073586500003
J	Wieczorek, E; Brand, M; Jacq, X; Tora, L				Wieczorek, E; Brand, M; Jacq, X; Tora, L			Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II	NATURE			English	Article							TATA-BINDING PROTEIN; ESTROGEN-RECEPTOR; TFIID COMPLEX; ACTIVATION FUNCTIONS; PROMOTER; PURIFICATION; INITIATION; EXPRESSION; DROSOPHILA; SUBUNITS	Initiation of transcription of a gene from a core promoter region by RNA polymerase II requires the assembly of several initiation factors to form a preinitiation complex. Assembly of this complex(1,2) is thought to be nucleated exclusively by the sequence-specific binding of the TFIID transcription factor complex, which is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAF(II)s) (refs 3, 4), to the different promoters. Here we isolate and characterize a new multiprotein complex that does not contain either TBP or a TBP-like factor but is composed of several TAF(II)s and other proteins. This complex can replace TFIID on both TATA-containing and TATA-lacking promoters in in vitro transcription assays. Moreover, an anti-TBP antibody that inhibits TBP- and TFIID-dependent transcription does not inhibit activity of this new complex. These results indicate that TBP-free RNA polymerase II mediated transcription may be able to occur in mammalian cells and that multiple preinitiation complexes may play an important role in regulating gene expression.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tora, L (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch, France.		Tora, Laszlo/E-9999-2018; Wieczorek, Elżbieta/GXZ-9842-2022	Tora, Laszlo/0000-0001-7398-2250; 				Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; BOAM DS, 1995, J BIOL CHEM, V270, P487; BROU C, 1993, NUCLEIC ACIDS RES, V21, P5, DOI 10.1093/nar/21.1.5; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; Chang MP, 1997, NUCLEIC ACIDS RES, V25, P4861, DOI 10.1093/nar/25.24.4861; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; DEJONG J, 1993, GENE DEV, V7, P2220, DOI 10.1101/gad.7.11.2220; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; GERARD M, 1991, J BIOL CHEM, V266, P20940; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P85; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; LAVIGNE AC, 1996, J BIOL CHEM, V271, P774; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; RUPPERT S, 1995, GENE DEV, V9, P2747, DOI 10.1101/gad.9.22.2747; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; vanderKnaap JA, 1997, P NATL ACAD SCI USA, V94, P11827, DOI 10.1073/pnas.94.22.11827; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533	29	220	228	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					187	191		10.1038/30283	http://dx.doi.org/10.1038/30283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603525				2022-12-28	WOS:000073619900054
J	Halm, EA; Fine, MJ; Marrie, TJ; Coley, CM; Kapoor, WN; Obrosky, DS; Singer, DE				Halm, EA; Fine, MJ; Marrie, TJ; Coley, CM; Kapoor, WN; Obrosky, DS; Singer, DE			Time to clinical stability in patients hospitalized with community-acquired pneumonia - Implications for practice guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	20th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 01-03, 1997	WASHINGTON, D.C.	Soc Gen Internal Med			BACTEREMIC PNEUMOCOCCAL PNEUMONIA; ANTIMICROBIAL THERAPY; LENGTH; STAY; ADULTS; MULTICENTER; MANAGEMENT; SEVERITY; DISEASE; ILLNESS	Context.-Many groups have developed guidelines to shorten hospital length of stay in pneumonia in order to decrease costs, but the length of time until a patient hospitalized with pneumonia becomes clinically stable has not been established. Objective.-To describe the time to resolution of abnormalities in vital signs, ability to eat, and mental status in patients with community-acquired pneumonia and assess clinical outcomes after achieving stability. Design.-Prospective, multicenter, observational cohort study. Setting.-Three university and 1 community teaching hospital in Boston, Mass, Pittsburgh, Pa, and Halifax, Nova Scotia. Patients.-Six hundred eighty-six adults hospitalized with community-acquired pneumonia. Main Outcome Measures-Time to resolution of vital signs, ability to eat, mental status, hospital length of stay, and admission to an intensive care, coronary care, or telemetry unit. Results.-The median time to stability was 2 days for heart rate (less than or equal to 100 beats/min) and systolic blood pressure (greater than or equal to 90 mm Hg), and 3 days for respiratory rate (less than or equal to 24 breaths/min), oxygen saturation (greater than or equal to 90%), and temperature (less than or equal to 37.2 degrees C [99 degrees F]). The median time to overall clinical stability was 3 days for the most lenient definition of stability and 7 days for the most conservative definition. Patients with more severe cases of pneumonia at presentation took longer to reach stability. Once stability was achieved, clinical deterioration requiring intensive care, coronary care, or telemetry monitoring occurred in 1% of cases or fewer. Between 65% to 86% of patients stayed in the hospital more than 1 day after reaching stability, and fewer than 29% to 46% were converted to oral antibiotics within 1 day of stability, depending on the definition of stability. Conclusions.-Our estimates of time to stability in pneumonia and explicit criteria for defining stability can provide an evidence-based estimate of optimal length of stay, and outline a clinically sensible approach to improving the efficiency of inpatient management.	Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15260 USA; Dalhousie Univ, Halifax, NS B3H 3J5, Canada; Victoria Gen Hosp, Dept Med & Microbiol, Halifax, NS B3H 2Y9, Canada; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dalhousie University; Dalhousie University; University of Victoria; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Halm, EA (corresponding author), Mt Sinai Sch Med, Dept Hlth Policy, 1 Gustave L Levy Pl,POB 1077, New York, NY 10029 USA.				AHRQ HHS [R01 HS06468] Funding Source: Medline; BHP HRSA HHS [PE11001-08] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); BHP HRSA HHS		Allison P. D., 1995, SURVIVAL ANAL USING; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; BATES JH, 1992, CHEST, V101, P1005, DOI 10.1378/chest.101.4.1005; BURNS L, 1991, MED CARE, V29, P225; CLEARY PD, 1991, JAMA-J AM MED ASSOC, V266, P73, DOI 10.1001/jama.266.1.73; Daifuku R, 1996, RESP MED, V90, P587, DOI 10.1016/S0954-6111(96)90016-5; DOUGLAS RM, 1973, MED J AUSTRALIA, V1, P42, DOI 10.5694/j.1326-5377.1973.tb119602.x; EHRENKRANZ NJ, 1992, INFECT CONT HOSP EP, V13, P21, DOI 10.2307/30146964; ESPOSITO AL, 1984, ARCH INTERN MED, V144, P945, DOI 10.1001/archinte.144.5.945; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; FEIN AM, 1995, AM J RESP CRIT CARE, V152, P1149, DOI 10.1164/ajrccm.152.4.7551362; Fine MJ, 1997, ARCH INTERN MED, V157, P36, DOI 10.1001/archinte.157.1.36; Fine MJ, 1997, ARCH INTERN MED, V157, P47, DOI 10.1001/archinte.157.1.47; FINE MJ, 1993, MED CARE, V31, P371, DOI 10.1097/00005650-199304000-00008; FINE MJ, 1995, J GEN INTERN MED, V10, P359, DOI 10.1007/BF02599830; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FINKELSTEIN MS, 1983, J AM GERIATR SOC, V31, P19, DOI 10.1111/j.1532-5415.1983.tb06283.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KELLEHER C, 1993, HEALTH SERV RES, V27, P841; KHAN FA, 1989, CHEST, V96, P453; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lieberman D, 1996, CHEST, V109, P1243, DOI 10.1378/chest.109.5.1243; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; MCCORMICK D, 1996, J GEN INTERN MED S, V11, P72; MCMAHON LF, 1989, MED CARE, V27, P623, DOI 10.1097/00005650-198906000-00005; NORDSTROM K, 1983, SCAND J INFECT DIS, V15, P43, DOI 10.3109/inf.1983.15.issue-1.08; ORTQVIST A, 1988, SCAND J INFECT DIS, V20, P163, DOI 10.3109/00365548809032433; PEARSON SD, 1995, ANN INTERN MED, V123, P941, DOI 10.7326/0003-4819-123-12-199512150-00008; QUINTILIANI R, 1987, AM J MED, V82, P269; RAMIREZ JA, 1995, ARCH INTERN MED, V155, P1273, DOI 10.1001/archinte.155.12.1273; SANDERS WE, 1991, AM J MED, V91, P261, DOI 10.1016/0002-9343(91)90125-H; SELKER HP, 1989, MED CARE, V27, P112, DOI 10.1097/00005650-198902000-00003; SELKER HP, 1993, AM J CARDIOL, V71, P339, DOI 10.1016/0002-9149(93)90802-J; Siegel RE, 1996, CHEST, V110, P965, DOI 10.1378/chest.110.4.965; TUNIS SR, 1994, ANN INTERN MED, V120, P956, DOI 10.7326/0003-4819-120-11-199406010-00008; *VOL HOSP AM, 1993, EX PNEUM AN COST QUA; WEINGARTEN SR, 1994, CHEST, V105, P1109, DOI 10.1378/chest.105.4.1109; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553; WEITZMAN S, 1983, ISRAEL J MED SCI, V19, P591; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; 1995, HLT CARE FINANCE SEP, P16	41	366	377	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1452	1457		10.1001/jama.279.18.1452	http://dx.doi.org/10.1001/jama.279.18.1452			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600479	Bronze			2022-12-28	WOS:000073463500034
J	Becker, DS				Becker, DS			Toxic epidermal necrolysis	LANCET			English	Review							STEVENS-JOHNSON SYNDROME; SCALDED SKIN SYNDROME; ERYTHEMA MULTIFORME; LYMPHOCYTE SUBSETS; LANGERHANS CELLS; BURN CENTER; CORTICOSTEROIDS; INVOLVEMENT; MECHANISM; SINGAPORE		Cornell Univ, Med Ctr, New York Hosp, Dept Dermatol, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital	Becker, DS (corresponding author), Cornell Univ, Med Ctr, New York Hosp, Dept Dermatol, 520 E 70th St,Starr 326, New York, NY 10021 USA.	dsbecker@mail.med.cornell.edu						ACKERMAN A, 1982, DIFFERENTIAL DIAGNOS, P26; ACKERMAN AB, 1985, AM J DERMATOPATH, V7, P132; AKOSA AB, 1995, J CUTAN PATHOL, V22, P359, DOI 10.1111/j.1600-0560.1995.tb01420.x; AVAKIAN R, 1991, J AM ACAD DERMATOL, V25, P69, DOI 10.1016/0190-9622(91)70176-3; BAGOT M, 1993, ARCH DERMATOL, V129, P721, DOI 10.1001/archderm.129.6.721; BAIRD BJ, 1988, INT J DERMATOL, V27, P170, DOI 10.1111/j.1365-4362.1988.tb04923.x; BARNES RL, 1973, BMJ-BRIT MED J, V4, P466, DOI 10.1136/bmj.4.5890.466; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; BILLINGHAM RE, 1968, ARCH DERMATOL, V98, P528, DOI 10.1001/archderm.98.5.528; Blum L, 1996, J AM ACAD DERMATOL, V34, P1088, DOI 10.1016/S0190-9622(96)90297-2; CHAN HL, 1984, J AM ACAD DERMATOL, V10, P973, DOI 10.1016/S0190-9622(84)80317-5; CHAN HL, 1995, ARCH DERMATOL, V131, P1212, DOI 10.1001/archderm.131.10.1212; CORREIA O, 1993, ARCH DERMATOL, V129, P466, DOI 10.1001/archderm.129.4.466; ELDER D, 1997, LEVERS HISTOPATHOLOG, P209; ELIAS PM, 1977, ARCH DERMATOL, V113, P207, DOI 10.1001/archderm.113.2.207; FINE JD, 1995, NEW ENGL J MED, V333, P1475, DOI 10.1056/NEJM199511303332207; FRIEDMANN PS, 1994, ARCH DERMATOL, V130, P598, DOI 10.1001/archderm.130.5.598; GOENS J, 1986, BRIT J DERMATOL, V114, P255, DOI 10.1111/j.1365-2133.1986.tb02806.x; GOLDSTEIN SM, 1987, ARCH DERMATOL, V123, P1153, DOI 10.1001/archderm.123.9.1153; GOODMAN H, 1953, AMA ARCH DERM SYPH, V68, P334, DOI 10.1001/archderm.1953.01540090096013; GREEN D, 1993, BURNS, V19, P411, DOI 10.1016/0305-4179(93)90063-E; GUILLAUME JC, 1987, ARCH DERMATOL, V123, P1166, DOI 10.1001/archderm.123.9.1166; HALEBIAN PH, 1986, ANN SURG, V204, P503, DOI 10.1097/00000658-198611000-00001; HEIMBACH DM, 1987, JAMA-J AM MED ASSOC, V257, P2171; HOWLAND WW, 1984, J AM ACAD DERMATOL, V10, P438, DOI 10.1016/S0190-9622(84)80090-0; KAUFMAN DW, 1994, J INVEST DERMATOL, V102, pS31, DOI 10.1111/1523-1747.ep12388468; KELLY JP, 1995, J CLIN EPIDEMIOL, V48, P1099, DOI 10.1016/0895-4356(95)00004-N; Khoo AKM, 1996, BURNS, V22, P275, DOI 10.1016/0305-4179(95)00140-9; KRUMLOVSKY F, 1975, LYELL DIS, V57, P817; LYELL A, 1956, BRIT J DERMATOL, V68, P355, DOI 10.1111/j.1365-2133.1956.tb12766.x; LYELL A, 1979, BRIT J DERMATOL, V100, P69, DOI 10.1111/j.1365-2133.1979.tb03571.x; LYELL A, 1967, BRIT J DERMATOL, V79, P662, DOI 10.1111/j.1365-2133.1967.tb11434.x; LYESS A, 1990, BRIT J DERMATOL, V122, P837; MARGOLIS RJ, 1983, J INVEST DERMATOL, V81, P403, DOI 10.1111/1523-1747.ep12522001; McIvor R. A., 1996, Journal of Burn Care and Rehabilitation, V17, P237, DOI 10.1097/00004630-199605000-00009; MEROT Y, 1986, ARCH DERMATOL, V122, P455, DOI 10.1001/archderm.122.4.455; MIYAUCHI H, 1991, ARCH DERMATOL, V127, P851, DOI 10.1001/archderm.127.6.851; MONCADA B, 1994, ARCH DERMATOL, V130, P116; NALDI L, 1990, ARCH DERMATOL, V126, P1103, DOI 10.1001/archderm.1990.01670320127028; Paquet P, 1997, AM J DERMATOPATH, V19, P127, DOI 10.1097/00000372-199704000-00005; Pasricha JS, 1996, INT J DERMATOL, V35, P523, DOI 10.1111/j.1365-4362.1996.tb01674.x; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; PION IA, 1993, ARCH DERMATOL, V129, P1057, DOI 10.1001/archderm.129.8.1057; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; RASMUSSEN J, 1980, MED CLIN N AM, V64, P901, DOI 10.1016/S0025-7125(16)31573-5; RECONDO P, 1996, BRIT J DERMATOL, V135, P999; RENFRO L, 1989, INT J DERMATOL, V28, P441, DOI 10.1111/j.1365-4362.1989.tb02502.x; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; ROUJEAU J, 1995, NEW ENGL J MED, V24, P1600; ROUJEAU JC, 1994, J AM ACAD DERMATOL, V31, P301, DOI 10.1016/S0190-9622(08)81995-0; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1987, ARCH DERMATOL, V123, P1171, DOI 10.1001/archderm.123.9.1171; ROUJEAU JC, 1990, J AM ACAD DERMATOL, V23, P1039, DOI 10.1016/0190-9622(90)70333-D; ROUJEAU JC, 1994, J INVEST DERMATOL, V102, pS28, DOI 10.1111/1523-1747.ep12388434; RUIZMALDONADO R, 1985, J AM ACAD DERMATOL, V13, P623, DOI 10.1016/S0190-9622(85)70207-1; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; Rzany B, 1996, BRIT J DERMATOL, V135, P6; RZANY B, 1991, ACTA DERM-VENEREOL, V71, P171; SAIAG P, 1992, J AM ACAD DERMATOL, V26, P567, DOI 10.1016/0190-9622(92)70082-Q; SCHOPF E, 1991, ARCH DERMATOL, V127, P839, DOI 10.1001/archderm.127.6.839; SCULLY R, 1996, NEW ENGL J MED, V19, P1254; SHEAR NH, 1986, ANN INTERN MED, V105, P179, DOI 10.7326/0003-4819-105-2-179; STABLES GI, 1993, BRIT J DERMATOL, V128, P357, DOI 10.1111/j.1365-2133.1993.tb00185.x; STERN RS, 1989, J AM ACAD DERMATOL, V21, P317, DOI 10.1016/S0190-9622(89)70176-6; Stevens AM, 1922, AM J DIS CHILD, V24, P526, DOI 10.1001/archpedi.1922.04120120077005; VILLADA G, 1990, J AM ACAD DERMATOL, V23, P870, DOI 10.1016/0190-9622(90)70307-4; VILLADA G, 1992, ARCH DERMATOL, V128, P50, DOI 10.1001/archderm.128.1.50; WOLKESTEIN P, 1955, ARCH DERMATOL, V131, P544	68	110	113	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	1998	351	9113					1417	1420		10.1016/S0140-6736(97)11369-1	http://dx.doi.org/10.1016/S0140-6736(97)11369-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593426				2022-12-28	WOS:000073563400040
J	Donnan, GA; Davis, SM; Chambers, BR; Gates, PC				Donnan, GA; Davis, SM; Chambers, BR; Gates, PC			Surgery for prevention of stroke	LANCET			English	Editorial Material							STENOSIS; DISEASE		Univ Melbourne, Austin & Repatriat Med Ctr, Dept Neurol, Heidelberg, Vic 3084, Australia; Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3052, Australia; Geelong Hosp, Dept Neurol, Geelong, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Geelong Hospital	Donnan, GA (corresponding author), Univ Melbourne, Austin & Repatriat Med Ctr, Dept Neurol, Heidelberg, Vic 3084, Australia.		Davis, Stephen M/L-5260-2013; DONNAN, GEOFFREY A/A-9947-2008	Davis, Stephen M/0000-0003-0962-2300; Donnan, Geoffrey/0000-0001-6324-3403				BANRETT HJM, 1998, 23 JOINT C STROK CER; BROWN MM, 1992, NEUROL RES, V14, P159, DOI 10.1080/01616412.1992.11740040; EASTCOTT HHG, 1954, LANCET, V2, P994; ELIZASZIW M, 1994, STROKE, V25, P304; Levi CR, 1996, CEREBROVASC DIS, V6, P231, DOI 10.1159/000108026; Levi CR, 1997, BRAIN, V120, P621, DOI 10.1093/brain/120.4.621; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Slattery J, 1996, LANCET, V347, P1591; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WHISNANT JP, 1973, MAYO CLIN PROC, V48, P194	11	54	54	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1372	1373		10.1016/S0140-6736(98)22019-8	http://dx.doi.org/10.1016/S0140-6736(98)22019-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593402				2022-12-28	WOS:000073563400002
J	Kerry, SM; Bland, JM				Kerry, SM; Bland, JM			Statistics notes - The intracluster correlation coefficient in cluster randomisation	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Div Gen Practice & Primary Care, London SW17 0RE, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	St Georges University London; St Georges University London	Kerry, SM (corresponding author), St George Hosp, Sch Med, Div Gen Practice & Primary Care, Cranmer Terrace, London SW17 0RE, England.							Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; DONNER A, 1990, INT J EPIDEMIOL, V19, P795, DOI 10.1093/ije/19.4.795; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; MEADE TW, 1992, THROMB HAEMOSTASIS, V68, P1; OAKESHOTT P, 1994, BRIT J GEN PRACT, V44, P197	6	187	187	0	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1455	1455		10.1136/bmj.316.7142.1455	http://dx.doi.org/10.1136/bmj.316.7142.1455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572764	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000073651600039
J	Soldan, K; Barbara, JAJ; Heptonstall, J				Soldan, K; Barbara, JAJ; Heptonstall, J			Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5	BRITISH MEDICAL JOURNAL			English	Article							VIRUS; TRANSMISSION; INFECTION	Objective: To estimate the rate of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England and to describe the probable routes of infection in these donors. Design: Retrospective survey of blood donors becoming positive for hepatitis C antibody and of the results of donation testing. Setting: The 14 blood centres in England. Subjects: All repeat donors giving blood between January 1993 and December 1995. Main outcome measures: Number of donors developing hepatitis C between donations during the three years of testing for hepatitis C antibody at English blood centres and the rate of seroconversion among repeat blood donors. Probable routes of infection. Results: 14 donors during 1993-5 fulfilled the case definition for seroconversion to positivity for hepatitis C antibody. The estimated seroconversion rate for infection with hepatitis C in repeat donors was 0.26 per 100 000 person years (95% confidence interval 0.15 to 0.43). Counselling after diagnosis found that four of these donors had risk factors specified in the criteria excluding people from giving blood but these factors had not come to light before donation. Another of the donors who seroconverted had a risk factor that has since been included in the exclusion criteria. Heterosexual intercourse was considered to be the most likely route of infection for five of the 14 donors. Conclusions: The rate of seroconversion for positivity to hepatitis C antibody in repeat blood donors in England was extremely low. During 1993-5 fewer than 1 in 450 000 donations were estimated to have come from repeat donors who had become positive for hepatitis C antibody since the previous donation.	Natl Blood Serv, London NW9 5BG, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Natl Blood Author, London NW9 5EQ, England	Public Health England	Barbara, JAJ (corresponding author), Natl Blood Serv, London & SE Zone, London NW9 5BG, England.			Soldan, Kate/0000-0002-0361-3174				Allain JP, 1997, TRANSFUSION, V37, P989, DOI 10.1046/j.1537-2995.1997.37997454034.x; Atrah HI, 1996, TRANSFUSION, V36, P339, DOI 10.1046/j.1537-2995.1996.36496226149.x; ATRAH HI, 1994, J CLIN PATHOL, V47, P87, DOI 10.1136/jcp.47.1.87; ATRAH HI, 1995, J MED VIROL, V46, P329, DOI 10.1002/jmv.1890460407; CRAWFORD RJ, 1994, TRANSFUSION MED, V4, P121, DOI 10.1111/j.1365-3148.1994.tb00252.x; GESINDE MO, 1992, LANCET, V339, P928; GOODRICK MJ, 1994, TRANSFUSION MED, V4, P113, DOI 10.1111/j.1365-3148.1994.tb00251.x; Hewitt PE, 1997, TRANSFUSION, V37, P987, DOI 10.1046/j.1537-2995.1997.37997454033.x; KESSLER C, 1995, LANCET, V356, P1297; Kitchen AD, 1996, VOX SANG, V70, P112, DOI 10.1111/j.1423-0410.1996.tb01302.x; MACLENNAN S, 1994, TRANSFUSION MED, V4, P125, DOI 10.1111/j.1365-3148.1994.tb00253.x; NEAL KR, 1994, EPIDEMIOL INFECT, V112, P595, DOI 10.1017/S0950268800051293; RYAN KE, 1994, BRIT MED J, V308, P696, DOI 10.1136/bmj.308.6930.696; SHOPNICK RI, 1995, LANCET, V346, P645, DOI 10.1016/S0140-6736(95)91483-8; *UK BLOOD TRANSF S, 1993, GUID BLOOD TRANSF SE	15	21	21	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1413	1417		10.1136/bmj.316.7142.1413	http://dx.doi.org/10.1136/bmj.316.7142.1413			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572749	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073651600024
J	Hirsch, RE; Lewis, BD; Spalding, EP; Sussman, MR				Hirsch, RE; Lewis, BD; Spalding, EP; Sussman, MR			A role for the AKT1 potassium channel in plant nutrition	SCIENCE			English	Article							RECTIFYING K+ CHANNELS; ARABIDOPSIS-THALIANA; ION-TRANSPORT; LINEAR COMPONENT; CORN ROOTS; INWARD; MECHANISM; EXPRESSION; AMMONIUM; CELLS	In plants, potassium serves an essential role as an osmoticum and charge carrier. Its uptake by roots occurs by poorly defined mechanisms. To determine the role of potassium channels in planta, we performed a reverse genetic screen and identified an Arabidopsis thaliana mutant in which the AKT1 channel gene was disrupted. Roots of this mutant lacked inward-rectifying potassium channels and displayed reduced potassium (rubidium-86) uptake. Compared with wild type, mutant plants grew poorly on media with a potassium concentration of 100 micromolar or less. These results and membrane potential measurements suggest that the AKT1 channel mediates potassium uptake from solutions that contain as little as 10 micromolar potassium.	Univ Wisconsin, Dept Hort, Ctr Biotechnol, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sussman, MR (corresponding author), Univ Wisconsin, Dept Hort, Ctr Biotechnol, 1575 Linden Dr, Madison, WI 53706 USA.		Spalding, Edgar P/GWC-1811-2022; Spalding, Edgar P/A-9034-2008; Spalding, Edgar P/ABF-3253-2021	Spalding, Edgar P/0000-0002-6890-4765; Spalding, Edgar P/0000-0002-6890-4765; 	NIGMS NIH HHS [GM07215] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Cho MH, 1996, P NATL ACAD SCI USA, V93, P8134, DOI 10.1073/pnas.93.15.8134; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; GASSMANN W, 1994, PLANT PHYSIOL, V105, P1399, DOI 10.1104/pp.105.4.1399; GASSMANN W, 1993, PLANT CELL, V5, P1491, DOI 10.2307/3869732; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; KOCHIAN LV, 1982, PLANT PHYSIOL, V70, P1723, DOI 10.1104/pp.70.6.1723; KOCHIAN LV, 1985, PLANT PHYSIOL, V79, P771, DOI 10.1104/pp.79.3.771; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lewis BD, 1997, PLANT PHYSIOL, V114, P1327, DOI 10.1104/pp.114.4.1327; MAATHUIS FJM, 1993, PLANTA, V191, P302, DOI 10.1007/BF00195686; MAATHUIS FJM, 1994, P NATL ACAD SCI USA, V91, P9272, DOI 10.1073/pnas.91.20.9272; MAATHUIS FJM, 1995, PLANTA, V197, P456, DOI 10.1007/BF00196667; Roberts SK, 1995, PLANT J, V8, P811, DOI 10.1046/j.1365-313X.1995.8060811.x; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; SCHROEDER JI, 1991, P NATL ACAD SCI USA, V88, P11583, DOI 10.1073/pnas.88.24.11583; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; VALE FR, 1987, PLANT PHYSIOL, V84, P1416, DOI 10.1104/pp.84.4.1416; VALE FR, 1988, PLANTA, V173, P424, DOI 10.1007/BF00401031; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510	23	504	565	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					918	921		10.1126/science.280.5365.918	http://dx.doi.org/10.1126/science.280.5365.918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572739				2022-12-28	WOS:000073532900046
J	Brockington, IF				Brockington, IF			John Beasley - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1392	1392		10.1136/bmj.316.7141.1392	http://dx.doi.org/10.1136/bmj.316.7141.1392			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9564015	Green Published			2022-12-28	WOS:000073483000059
J	Lewin, B				Lewin, B			The mystique of epigenetics	CELL			English	Review																		CAVALLI G, 1998, IN PRESS CELL; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7	4	53	65	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					301	303		10.1016/S0092-8674(00)81154-X	http://dx.doi.org/10.1016/S0092-8674(00)81154-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590160	Bronze			2022-12-28	WOS:000073471500001
J	Packer, C; Tatar, M; Collins, A				Packer, C; Tatar, M; Collins, A			Reproductive cessation in female mammals	NATURE			English	Article							MENOPAUSE; LIONS; COSTS	In female mammals, fertility declines abruptly at an advanced age. The human menopause is one example, but reproductive cessation has also been documented in non-human primates, rodents, whales, dogs, rabbits, elephants and domestic livestock(1-3). The human menopause has been considered an evolutionary adaptation(4-7), assuming that elderly women avoid the increasing complications of continued childbirth to better nurture their current children and grandchildren. But an abrupt reproductive decline might be only a non-adaptive by-product of life-history patterns. Because so many individuals die from starvation, disease and predation, detrimental genetic traits can persist (or even be favoured) as long as their deleterious effects are delayed until an advanced age is reached, and, for a given pattern of mortality, there should be an age by which selection would be too weak to prevent the onset of reproductive senescence(4,5,8). We provide a systematic test of these alternatives using field data from two species in which grandmothers frequently engage in kin-directed behaviour. Both species show abrupt age-specific changes in reproductive performance that are characteristic of menopause. But elderly females do not suffer increased mortality costs of reproduction, nor do post-reproductive females enhance the fitness of grandchildren or older children. Instead, reproductive cessation appears to result from senescence.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA; Gombe Stream Res Ctr, Kigoma, Tanzania	University of Minnesota System; University of Minnesota Twin Cities; Brown University	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	packer@biosci.umn.edu		Tatar, Marc/0000-0003-3232-6884				Altmann J., 1970, LAB ANIM DIG, V6, P7; Caswell H, 1989, MATRIX POPULATION MO; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Finch CE, 1990, LONGEVITY SENESCENCE; Gouzoules S., 1987, P299; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Hill K, 1991, Hum Nat, V2, P313, DOI 10.1007/BF02692196; Laws R.M., 1975, ELEPHANTS THEIR HABI; Lee E, 2013, STAT METHODS SURVIVA; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Medawar P.B, 1952, UNIQUENESS INDIVIDUA; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1995, AM NAT, V145, P833, DOI 10.1086/285771; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; ROGERS AR, 1993, EVOL ECOL, V7, P406, DOI 10.1007/BF01237872; Stolwijk AM, 1997, FERTIL STERIL, V67, P702, DOI 10.1016/S0015-0282(97)81370-2; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vom Saal Frederick S., 1994, P1213; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wise PM, 1996, SCIENCE, V273, P67, DOI 10.1126/science.273.5271.67	25	229	234	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					807	811		10.1038/33910	http://dx.doi.org/10.1038/33910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572138				2022-12-28	WOS:000073241200051
J	Brattstrom, L; Landgren, F; Israelsson, B; Lindgren, A; Hultberg, B; Andersson, A; Cuskelly, G; McNulty, H; Strain, SS; McPartlin, J; Weir, DG; Scott, JM; den Heijer, M; Brouwer, IA; Blom, HJ; Bos, GMJ; Spaans, A; Rosendaal, FR; Thomas, CMG; Haak, HL; Wijermans, PW; Gerrits, WBJ; Naurath, HJ; Joosten, E; Riezler, R; Stabler, SP; Allen, RH; Lindenbaum, J; Pietrzik, K; Prinz-Langenohl, R; Dierkes, J; Saltzman, E; Mason, JB; Jacques, P; Selhub, J; Salem, D; Schaefer, E; Rosenberg, IH; Ubbink, J; van der Mere, A; Vermack, WJH; Delport, R; Becker, PJ; Potgieter, HC; Woodside, JV; Yarnell, JWG; McMaster, D; Young, IS; McCrum, EE; Patterson, SS; Gey, KF; Evans, AE; Clarke, R; Appleby, P; Harding, P; Sherliker, P; Collins, R; Frost, C; Leroy, V				Brattstrom, L; Landgren, F; Israelsson, B; Lindgren, A; Hultberg, B; Andersson, A; Cuskelly, G; McNulty, H; Strain, SS; McPartlin, J; Weir, DG; Scott, JM; den Heijer, M; Brouwer, IA; Blom, HJ; Bos, GMJ; Spaans, A; Rosendaal, FR; Thomas, CMG; Haak, HL; Wijermans, PW; Gerrits, WBJ; Naurath, HJ; Joosten, E; Riezler, R; Stabler, SP; Allen, RH; Lindenbaum, J; Pietrzik, K; Prinz-Langenohl, R; Dierkes, J; Saltzman, E; Mason, JB; Jacques, P; Selhub, J; Salem, D; Schaefer, E; Rosenberg, IH; Ubbink, J; van der Mere, A; Vermack, WJH; Delport, R; Becker, PJ; Potgieter, HC; Woodside, JV; Yarnell, JWG; McMaster, D; Young, IS; McCrum, EE; Patterson, SS; Gey, KF; Evans, AE; Clarke, R; Appleby, P; Harding, P; Sherliker, P; Collins, R; Frost, C; Leroy, V		Homocysteine Lower Trial Collaborat	Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERUM TOTAL HOMOCYSTEINE; CORONARY HEART-DISEASE; PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY POPULATION; DIALYSIS PATIENTS; RISK FACTOR; HYPERHOMOCYSTEINEMIA; PRAVASTATIN	Objective: To determine the size of reduction in homocysteine concentrations produced by dietary supplementation with folic acid and with vitamins B-12 or B-6. Design: Meta-analysis of randomised controlled trials that assessed the effects of folic acid based supplements on blood homocysteine concentrations. Multivariate regression analysis was used to determine the effects on homocysteine concentrations of different doses of folic acid and of the addition of vitamin B-12 or B-6. Subjects: Individual data on 1114 people included in 12 trials. Findings: The proportional and absolute reductions in blood homocysteine produced by folic acid supplements were greater at higher pretreatment blood homocysteine concentrations (P < 0.001) and at lower pretreament blood folate concentrations (P < 0.001). After standardisation to pretreatment blood concentrations of homocysteine of 12 mu mol/l and of folate of 12 nmol/l (approximate average concentrations for Western populations), dietary folic acid reduced blood homocysteine concentrations by 25% (95% confidence interval 23% to 28%; P < 0.001), with similar effects in the range of 0.5-5 mg folic acid daily, Vitamin B-12 (mean 0.5 mg daily) produced an additional 7% (3% to 10%) reduction in blood homocysteine, Vitamin B-6 (mean 16.5 mg daily) did not have a significant additional effect. Conclusions: Typically in Western populations, daily supplementation with both 0.5-5 mg folic acid and about 0.5 mg vitamin B-12 would be expected to reduce blood homocysteine concentrations by about a quarter to a third (for example, from about 12 mu mol/l to 8-9 mu mol/l). Large scale randomised trials of such regimens in high risk populations are now needed to determine whether lowering blood homocysteine concentrations reduces the risk of vascular disease.	Radcliffe Infirm, Clin Trial Serv Unit, Homocysteine Lowering Trialists Collaborat, Oxford OX2 6HE, England; Lund Univ, S-22100 Lund, Sweden; Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland; Trinity Coll Dublin, Dublin, Ireland; Leyenburg Hosp, The Hague, Netherlands; Univ Nijmegen, Nijmegen, Netherlands; Univ Leuven, Louvain, Belgium; Univ Witten Herdecke, Witten, Germany; Univ Bonn, Bonn, Germany; Tufts Univ, USDA, HNRC, Medford, MA 02155 USA; Univ Pretoria, ZA-0002 Pretoria, South Africa; Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; Univ Oxford, Clin Trial Serv Unit, Oxford OX1 2JD, England; Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England	Radcliffe Infirmary; University of Oxford; Lund University; Ulster University; Trinity College Dublin; Radboud University Nijmegen; KU Leuven; Witten Herdecke University; University of Bonn; Tufts University; United States Department of Agriculture (USDA); University of Pretoria; Queens University Belfast; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Clarke, R (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Homocysteine Lowering Trialists Collaborat, Oxford OX2 6HE, England.	robert.clarke@ctsu.ox.ac.uk	Delport, Rhena/I-4614-2014; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/AAO-5175-2020; Leroy, Valeriane/GQB-1102-2022; Thomas, C.M.G./L-4687-2015	Delport, Rhena/0000-0002-6274-0923; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Young, Ian/0000-0003-3890-3152; Ward, Mary/0000-0001-6470-1728; Cuskelly, Geraldine/0000-0003-1645-7243; Woodside, Jayne/0000-0002-5691-4659; McNulty, Helene/0000-0002-4366-6457				ARNADOTTIR M, 1993, CLIN NEPHROL, V40, P236; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; Bostom AG, 1996, KIDNEY INT, V49, P147, DOI 10.1038/ki.1996.19; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Campbell NRC, 1996, ARCH INTERN MED, V156, P1638, DOI 10.1001/archinte.156.15.1638; CHAVEAU P, 1995, IRISH J MED SCI, V164, P25; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cuskelly G. J., 1995, IRISH J MED SCI, V164; DENHEIJER M, IN PRESS ARTERIOSCLE; DIERKES J, 1995, THESIS U BONN BONN; FRANKEN DG, 1994, ARTERIOSCLER THROMB, V14, P465, DOI 10.1161/01.ATV.14.3.465; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; LANDGREN F, 1995, J INTERN MED, V237, P381, DOI 10.1111/j.1365-2796.1995.tb01190.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; MUDD SH, 1985, AM J HUM GENET, V37, P1; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; PEDERSEN TR, 1994, LANCET, V344, P1383; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; RYAN M, 1993, IRISH J MED SCI, V162, P197; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALTZMAN E, 1994, CLIN RES, V42, pA172; Savage D.G., 1995, FOLATE HLTH DIS, V1st, P237; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tucker KL, 1996, JAMA-J AM MED ASSOC, V276, P1879, DOI 10.1001/jama.276.23.1879; UBBINK JB, 1994, J NUTR, V124, P1927, DOI 10.1093/jn/124.10.1927; UBBINK JB, 1993, CLIN INVESTIGATOR, V71, P993, DOI 10.1007/BF00180030; VANDENBERG M, 1994, J VASC SURG, V20, P933, DOI 10.1016/0741-5214(94)90230-5; WILCKEN DEL, 1988, METABOLISM, V37, P697, DOI 10.1016/0026-0495(88)90093-5; Woodside JV, 1997, P NUTR SOC, V56, P479, DOI 10.1079/PNS19970048	32	875	905	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	1998	316	7135					894	898						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD691	9569395	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000072713300026
J	Kernick, DP				Kernick, DP			Economic evaluation in health: a thumb nail sketch	BRITISH MEDICAL JOURNAL			English	Article							CARE		St Thomas Med Grp, Exeter EX4 1HJ, Devon, England		Kernick, DP (corresponding author), St Thomas Med Grp, Exeter EX4 1HJ, Devon, England.							BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Drummond M., 1994, EC ANAL ALONGSIDE CO; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; NEUBERGER H, 1992, HEALTH ECON, V1, P71; RITTENHOUSE B, 1996, USE MODELS EC EVALUA; ROBINSON R, 1993, BRIT MED J, V307, P859, DOI 10.1136/bmj.307.6908.859; ROBINSON R, 1993, BRIT MED J, V307, P924, DOI 10.1136/bmj.307.6909.924; ROBINSON R, 1993, BRIT MED J, V307, P793, DOI 10.1136/bmj.307.6907.793; Ryan M, 1995, Qual Health Care, V4, P207, DOI 10.1136/qshc.4.3.207; Sacristan JA, 1997, PHARMACOECONOMICS, V11, P289; Torgerson DJ, 1996, BRIT MED J, V312, P35, DOI 10.1136/bmj.312.7022.35	11	15	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1663	1665		10.1136/bmj.316.7145.1663	http://dx.doi.org/10.1136/bmj.316.7145.1663			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZR867	9603756	Green Published			2022-12-28	WOS:000074022700032
J	Brunet, LJ; McMahon, JA; McMahon, AP; Harland, RM				Brunet, LJ; McMahon, JA; McMahon, AP; Harland, RM			Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton	SCIENCE			English	Article							CHICK LIMB; BONE; EXPRESSION; MOUSE; GENES; REGULATORS; BMP-4; MICE	Noggin is a bone morphogenetic protein (BMP) antagonist expressed in Spemann's organizer. Murine Noggin is expressed in condensing cartilage and immature chondrocytes, as are many BMPs. In mice lacking Noggin, cartilage condensations initiated normally but developed hyperplasia, and initiation of joint development failed as measured by the expression of growth and differentiation factor-5. The maturation of cartilage and Herd expression were unaffected. Excess BMP activity in the absence of Noggin antagonism may enhance the recruitment of cells into cartilage, resulting in oversized growth plates; chondrocytes are also refractory to joint-inducing positional cues.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; Harvard Univ, Biolabs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Harvard University	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	harland@socrates.berkeley.edu	McMahon, Andrew P/ABE-7520-2020		NIGMS NIH HHS [GM49346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049346] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Davis AP, 1996, DEVELOPMENT, V122, P1175; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; GROFF DJ, 1997, DEVELOPMENT, V124, P627; Hofmann C, 1996, DEV GENET, V19, P43, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;43::AID-DVG5&gt;3.0.CO;2-0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; Macias D, 1997, DEVELOPMENT, V124, P1109; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Thorogood P.V., 1983, CARTILAGE DEV DIFFER, VVol. 2, P223; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	24	647	676	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1455	1457		10.1126/science.280.5368.1455	http://dx.doi.org/10.1126/science.280.5368.1455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603738				2022-12-28	WOS:000073883400061
J	Cochrane, J				Cochrane, J			William Lees Price - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1613	1613		10.1136/bmj.316.7144.1613	http://dx.doi.org/10.1136/bmj.316.7144.1613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596616	Green Published			2022-12-28	WOS:000073867800061
J	Forsyth, DW; Scheirer, DS; Webb, SC; Dorman, LM; Orcutt, JA; Harding, AJ; Blackman, DK; Morgan, JP; Detrick, RS; Shen, Y; Wolfe, CJ; Canales, JP; Toomey, DR; Sheehan, AF; Solomon, SC; Wilcock, WSD				Forsyth, DW; Scheirer, DS; Webb, SC; Dorman, LM; Orcutt, JA; Harding, AJ; Blackman, DK; Morgan, JP; Detrick, RS; Shen, Y; Wolfe, CJ; Canales, JP; Toomey, DR; Sheehan, AF; Solomon, SC; Wilcock, WSD		MELT Seismic Team	Imaging the deep seismic structure beneath a mid-ocean ridge: The MELT experiment	SCIENCE			English	Article							EAST PACIFIC RISE; SPREADING CENTERS; MANTLE FLOW; EXTRACTION; GENERATION; ANOMALIES	The Mantle Electromagnetic and Tomography (MELT) Experiment was designed to distinguish between competing models of magma generation beneath mid-ocean ridges. Seismological observations demonstrate that basaltic melt is present beneath the East Pacific Rise spreading center in a broad region several hundred kilometers across and extending to depths greater than 100 kilometers, not just in a narrow region of high melt concentration beneath the spreading center, as predicted by some models. The structure of the ridge system is strongly asymmetric: mantle densities and seismic velocities are lower and seismic anisotropy is stronger to the west of the rise axis.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Brown University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; University of Oregon; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Carnegie Institution for Science; University of Washington; University of Washington Seattle	Forsyth, DW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	donald_forsyth@brown.edu	Sheehan, Anne F/B-3954-2014; Wolfe, Cecily/E-7874-2011	Sheehan, Anne F/0000-0002-9629-1687; Canales, Juan Pablo/0000-0003-3066-7888; Shen, Yang/0000-0002-4185-6089; Webb, Spahr/0000-0002-7277-174X; Morgan, Jason/0000-0002-3100-0877; Wolfe, Cecily/0000-0003-3144-5697; Orcutt, John/0000-0001-5508-0050; Toomey, Douglas/0000-0003-2873-4084; Wilcock, William/0000-0001-7224-7246				BAZIN S, IN PRESS GEOPHYS RES; Canales JP, 1998, SCIENCE, V280, P1218, DOI 10.1126/science.280.5367.1218; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; HESS PC, 1992, GEOPH MONOG SERIES, V71, P67; HUNG SH, 1997, EOS, V78, pF688; Jull M, 1996, J GEOPHYS RES-SOL EA, V101, P21815, DOI 10.1029/96JB01308; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; MAHONEY JJ, 1994, EARTH PLANET SC LETT, V121, P173, DOI 10.1016/0012-821X(94)90039-6; MCKENZIE D, 1984, J PETROL, V25, P713, DOI 10.1093/petrology/25.3.713; MCNUTT MK, 1990, SCIENCE, V248, P969, DOI 10.1126/science.248.4958.969; MORGAN JP, 1987, GEOPHYS RES LETT, V14, P1238, DOI 10.1029/GL014i012p01238; PARMENTIER EM, 1990, NATURE, V348, P325, DOI 10.1038/348325a0; SALTERS VJM, 1989, NATURE, V342, P420, DOI 10.1038/342420a0; Scheirer DS, 1998, SCIENCE, V280, P1221, DOI 10.1126/science.280.5367.1221; Shen Y, 1998, SCIENCE, V280, P1232, DOI 10.1126/science.280.5367.1232; SMITH WHF, 1994, J GEOPHYS RES-SOL EA, V99, P21803, DOI 10.1029/94JB00988; SPARKS DW, 1991, EARTH PLANET SC LETT, V105, P368, DOI 10.1016/0012-821X(91)90178-K; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; SU WJ, 1992, NATURE, V360, P149, DOI 10.1038/360149a0; SU WS, 1993, J GEOPHYS RES-SOL EA, V98, P12191, DOI 10.1029/93JB00994; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; VERA EE, 1990, J GEOPHYS RES-SOLID, V95, P15529, DOI 10.1029/JB095iB10p15529; Wang XJ, 1996, J GEOPHYS RES-SOL EA, V101, P17927, DOI 10.1029/96JB00194; Webb SC, 1998, SCIENCE, V280, P1227, DOI 10.1126/science.280.5367.1227; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230; WYLLIE PJ, 1971, J GEOPHYS RES, V76, P1328, DOI 10.1029/JB076i005p01328	28	259	265	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1215	1218						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596564				2022-12-28	WOS:000073852500033
J	Kalgutkar, AS; Crews, BC; Rowlinson, SW; Garner, C; Seibert, K; Marnett, LJ				Kalgutkar, AS; Crews, BC; Rowlinson, SW; Garner, C; Seibert, K; Marnett, LJ			Aspirin-like molecules that covalently inactivate cyclooxygenase-2	SCIENCE			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; SELECTIVE-INHIBITION; EPITHELIAL-CELLS; ACID; ACETYLATION; BINDING; MECHANISM; AGENTS; DRUGS; OVINE	Many of aspirin's therapeutic effects arise from its acetylation of cyclooxygenase-2 (COX-2), whereas its antithrombotic and ulcerogenic effects result from its acetylation of COX-1. Here, aspirin-like molecules were designed that preferentially acetylate and irreversibly inactivate COX-2. The most potent of these compounds was o-(acetoxyphenyl)hept-2-ynyl sulfide (APHS). Relative to aspirin, APHS was 60 times as reactive against COX-2 and 100 times as selective for its inhibition; it also inhibited COX-2 in cultured macrophages and colon cancer cells and in the rat air pouch in vivo. Such compounds may lead to the development of aspirin-like drugs for the treatment or prevention of immunological and proliferative diseases without gastrointestinal or hematologic side effects.	Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Canc Ctr, Ctr Mol Toxicol,Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Canc Ctr, Ctr Mol Toxicol,Dept Chem, Nashville, TN 37232 USA; Searle Monsanto, St Louis, MO 63167 USA	Vanderbilt University; Vanderbilt University; Monsanto	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Canc Ctr, Ctr Mol Toxicol,Dept Biochem, Nashville, TN 37232 USA.				NCI NIH HHS [CA47479, CA68485] Funding Source: Medline; NIEHS NIH HHS [ES00267] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047479, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; Dreser M. H., 1970, PFLUGERS ARCH, V76, P306, DOI [10.1007/bf01662127, DOI 10.1007/BF01662127]; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; Guo QP, 1996, J BIOL CHEM, V271, P19134, DOI 10.1074/jbc.271.32.19134; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; Kawamori T, 1998, CANCER RES, V58, P409; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; MEADE EA, 1993, J BIOL CHEM, V268, P6610; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; VANDEROUDERAA FJ, 1980, EUR J BIOCHEM, V109, P1; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANE JR, 1990, STROKE, V21, P12; VANE JR, 1996, SCAND J RHEUMAT S102, V25, P9, DOI DOI 10.3109/03009749609097226; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u	24	239	256	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1268	1270		10.1126/science.280.5367.1268	http://dx.doi.org/10.1126/science.280.5367.1268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596581				2022-12-28	WOS:000073852500050
J	Nevitt, MC; Ettinger, B; Black, DM; Stone, K; Jamal, SA; Ensrud, K; Segal, M; Genant, HK; Cummings, SR				Nevitt, MC; Ettinger, B; Black, DM; Stone, K; Jamal, SA; Ensrud, K; Segal, M; Genant, HK; Cummings, SR			The association of radiographically detected vertebral fractures with back pain and function: A prospective study	ANNALS OF INTERNAL MEDICINE			English	Article						spinal fractures; back pain; osteoporosis, postmenopausal; activities of daily living	RESTRICTED ACTIVITY DAYS; BONE-MINERAL DENSITY; POSTMENOPAUSAL OSTEOPOROSIS; OLDER ADULTS; WOMEN; DISABILITY; DEFORMITIES; ALENDRONATE; PREDICTORS; MANAGEMENT	Background: Vertebral fractures are a hallmark of postmenopausal osteoporosis and an important end point in trials of osteoporosis treatment, but the clinical significance of these fractures remains uncertain. Objective: To determine the association of new vertebral fractures with back pain and back-related functional limitation in older women. Design: Prospective observational study. Setting: Multicenter Study of Osteoporotic Fractures. Participants: 7223 white women aged 65 years and older. Measurements: Lateral spine radiographs were obtained at baseline and at a follow-up examination an average of 3.7 years later. Prevalent and incident radiographic vertebral fractures were assessed by quantitative morphometry. Frequency and severity of back pain, disability in doing six activities involving the back, and days of bed rest and days of limited activity due to back pain were assessed annually by questionnaire during follow-up. Results: Among women without a vertebral fracture at baseline, those with at least one incident vertebral fracture were more likely to have increased back pain (odds ratio [OR], 2.4 [95% CI, 1.7 to 3.3]) and back disability (OR, 2.6 [CI, 1.9 to 3.7]) and at least 1 day of bed rest due to back pain (OR, 6.7 [CI, 4.4 to 10.2]) and 7 days of limited activity due to back pain per year (OR, 3.8 [CI, 2.7 to 5.0]). Among women with a fracture at baseline, those with an incident vertebral fracture also had a greater risk for increased back pain (OR, 2.0 [CI, 1.4 to 2.8]) and back disability (OR, 2.2 [CI, 1.5 to 3.1]) and at least 1 day of bed rest (OR, 7.9 [CI, 4.9 to 12.9]) and 7 days of limited activity per year (OR, 3.5 [CI, 2.4 to 5.0]). Women with incident fracture had about 10 additional limited-activity days and 1 to 2 days of bed rest per year. New vertebral fractures that did not come to medical attention were associated with increased back pain and functional limitation. Conclusion: New vertebral fractures, even those not recognized clinically, are associated with substantial increases in back pain and functional limitation due to back pain in older white women. Prevention of new vertebral fractures should reduce the burden of back pain and functional limitation in women with vertebral osteoporosis.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Kaiser Permanente Med Care Program, Oakland, CA USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; Vet Affairs Med Ctr, Minneapolis, MN USA	University of California System; University of California San Francisco; Kaiser Permanente; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Nevitt, MC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 74 New Montgomery St,Suite 600, San Francisco, CA 94105 USA.			Ensrud, Kristine/0000-0002-9069-3036	NIAMS NIH HHS [1-RO1-AR35582] Funding Source: Medline; NIA NIH HHS [5-RO1-AG05394, 1-RO1-AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005407, R01AG005394] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLACK DM, 1995, J BONE MINER RES, V10, P890; BLACK DM, 1991, J BONE MINER RES, V6, P883; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BURGER H, 1994, BRIT MED J, V309, P991, DOI 10.1136/bmj.309.6960.991; COOK DJ, 1993, ARTHRITIS RHEUM, V36, P750, DOI 10.1002/art.1780360603; COOPER C, 1991, OSTEOPOROSIS INT, V2, P48, DOI 10.1007/BF01627079; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; ETTINGER B, 1992, J BONE MINER RES, V7, P449; ETTINGER B, 1988, MATURITAS, V10, P283, DOI 10.1016/0378-5122(88)90064-3; ETTINGER B, 1994, OSTEOPOROSIS INT, V4, P55, DOI 10.1007/BF02352262; FROST HM, 1981, ORTHOP CLIN N AM, V12, P671; Genant HK, 1996, J BONE MINER RES, V11, P984; GENANT HK, 1995, VERTEBRAL FRACTURE O; Gold DT, 1996, BONE, V18, pS185, DOI 10.1016/8756-3282(95)00500-5; Hallal J C, 1991, Geriatr Nurs, V12, P285, DOI 10.1016/S0197-4572(05)80266-6; Huang C, 1996, J BONE MINER RES, V11, P1026; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; LANE NE, 1993, J RHEUMATOL, V20, P1911; LEIDIG G, 1990, BONE MINER, V8, P217, DOI 10.1016/0169-6009(90)90107-Q; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NICHOLSON PHF, 1993, OSTEOPOROSIS INT, V3, P300, DOI 10.1007/BF01637315; PAK CYC, 1994, ANN INTERN MED, V120, P625, DOI 10.7326/0003-4819-120-8-199404150-00001; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Ross P D, 1991, Osteoporos Int, V1, P134, DOI 10.1007/BF01625442; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; RYAN PJ, 1994, BONE, V15, P27, DOI 10.1016/8756-3282(94)90887-7; SCHOLES D, 1991, AM J PUBLIC HEALTH, V81, P485, DOI 10.2105/AJPH.81.4.485; SPECTOR TD, 1993, J BONE MINER RES, V8, P817; WAGNER EH, 1993, J AM GERIATR SOC, V41, P241, DOI 10.1111/j.1532-5415.1993.tb06700.x; WIPF JE, 1995, MED CLIN N AM, V79, P231, DOI 10.1016/S0025-7125(16)30065-7; ZETTERBERG C, 1990, SPINE, V15, P783, DOI 10.1097/00007632-199008010-00009	38	603	614	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					793	+		10.7326/0003-4819-128-10-199805150-00001	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00001			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599190				2022-12-28	WOS:000073586500001
J	Glynn, MK; Bopp, C; Dewitt, W; Dabney, P; Mokhtar, M; Angulo, FJ				Glynn, MK; Bopp, C; Dewitt, W; Dabney, P; Mokhtar, M; Angulo, FJ			Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTERITIDIS; ANIMALS; HUMANS	Background Strains of salmonella that are resistant to antimicrobial agents have become a worldwide health problem. A distinct strain of Salmonella enterica serotype typhimurium, known as definitive type 104 (DT104), is resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline and has become a major cause of illness in humans and animals in Europe, especially the United Kingdom. Methods To characterize typhimurium DT104 infections in the United States, we analyzed data collected by local and state health departments and public health laboratories between 1979 and 1996 in national surveys of the antimicrobial-drug resistance of salmonella. Selected typhimurium isolates with the five-drug pattern of resistance were phage typed. Results The prevalence of typhimurium isolates with the five-drug pattern of resistance increased from 0.6 percent in 1979-1980 to 34 percent in 1996. In 1994-1995, such isolates were identified in samples from 36 of the 46 surveillance sites (78 percent). Thirty-nine of 43 typhimurium isolates with the five-drug pattern of resistance identified in 1994-1995 and 1996 were phage type DT104 or a closely related phage type. Conclusions Multidrug-resistant typhimurium DT104 has become a widespread pathogen in the United States. More prudent use of antimicrobial agents in farm animals and more effective disease prevention on farms are necessary to reduce the dissemination of multidrug-resistant typhimurium DT104 and to slow the emergence of resistance to additional agents in this and other strains of salmonella. (C)1998, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; US FDA, Rockville, MD 20857 USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Glynn, MK (corresponding author), Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A-38, Atlanta, GA 30333 USA.							ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; ANGULO FJ, 1995, CLIN INFECT DIS, V21, pS84, DOI 10.1093/clinids/21.Supplement_1.S84; Barry AL., 1991, MANUAL CLIN MICROBIO, P117; BEAN NH, 1992, AM J PUBLIC HEALTH, V82, P1273, DOI 10.2105/AJPH.82.9.1273; Besser TE, 1997, VET REC, V140, P75; BLACK PH, 1960, NEW ENGL J MED, V262, P921, DOI 10.1056/NEJM196005052621806; BLACK PH, 1960, NEW ENGL J MED, V262, P864, DOI 10.1056/NEJM196004282621706; BLASER MJ, 1981, J INFECT DIS, V143, P743, DOI 10.1093/infdis/143.5.743; *CDCP, 1996, SALMONELLA SURVILLAN; CELUM CL, 1987, J INFECT DIS, V156, P998, DOI 10.1093/infdis/156.6.998; CHALKER RB, 1988, REV INFECT DIS, V10, P111; CODY S, 1997, 35 ANN M INF DIS SOC, P77; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; *DIV EM OTH COMM D, 1997, WHO M BERL GERM 13 1; Fone D L, 1994, Commun Dis Rep CDR Rev, V4, pR136; FRIEDMAN CR, 1998, KINT C EM INF DIS AT, P68; Hargrett-Bean N T, 1988, MMWR CDC Surveill Summ, V37, P25; HELMICK CG, 1994, NIH PUBLICATION, P85; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103; MACDONALD KL, 1987, JAMA-J AM MED ASSOC, V258, P1496, DOI 10.1001/jama.258.11.1496; MISHU B, 1994, J INFECT DIS, V169, P547, DOI 10.1093/infdis/169.3.547; OBRIEN TF, 1982, NEW ENGL J MED, V307, P1, DOI 10.1056/NEJM198207013070101; Ramos JM, 1996, EUR J CLIN MICROBIOL, V15, P85, DOI 10.1007/BF01586193; RILEY LW, 1984, J INFECT DIS, V149, P878, DOI 10.1093/infdis/149.6.878; TAUXE RV, 1991, J FOOD PROTECT, V54, P563, DOI 10.4315/0362-028X-54.7.563; TAUXE RV, 1997, TXB INTERNAL MED, P1639; Threlfall E.J., 1997, Euro Surveill, V2, P81; THRELFALL EJ, 1993, EPIDEMIOL INFECT, V111, P189, DOI 10.1017/S0950268800056892; Wall P G, 1994, Commun Dis Rep CDR Rev, V4, pR130; 1997, MMWR MORB MORTAL WKL, V46, P308; 1996, MMWR MORB MORTAL WKL, V45, P110	32	460	473	0	24	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1333	1338		10.1056/NEJM199805073381901	http://dx.doi.org/10.1056/NEJM199805073381901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571252				2022-12-28	WOS:000073463700001
J	Graudal, NA; Galloe, AM; Garred, P				Graudal, NA; Galloe, AM; Garred, P			Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DIETARY SALT RESTRICTION; ESSENTIAL HYPERTENSIVE PATIENTS; CONVERTING-ENZYME-INHIBITOR; MILD ESSENTIAL-HYPERTENSION; LOW URINARY SODIUM; DOUBLE-BLIND; MYOCARDIAL-INFARCTION; POTASSIUM SUPPLEMENTATION; MODERATE HYPERTENSION; NORMOTENSIVE SUBJECTS	Context.-One of the controversies in preventive medicine is whether a general reduction in sodium intake can decrease the blood pressure of a population and thereby reduce the number of strokes and myocardial infarctions. In recent years the debate has been extended by studies indicating that reduced sodium intake has adverse effects. Objective.-To estimate the effects of reduced sodium intake on systolic and diastolic blood pressure (SBP and DBP), body weight, and plasma or serum levels of renin, aldosterone, catecholamines, cholesterols, and triglyceride, and to evaluate the stability of the blood pressure effect in relation to additional trials. Data Sources.-MEDLINE search from 1966 through December 1997 and reference lists of relevant articles. Study Selection.-Studies randomizing persons to high-sodium and low-sodium diets were included if they evaluated at least one of the effect parameters. Data Extraction.-Two authors independently recorded data. Data Synthesis.-In 58 trials of hypertensive persons, the effect of reduced sodium intake as measured by urinary sodium excretion (mean, 118 mmol/24 h) on SEP was 3.9 mm Hg (95% confidence interval [CI], 3.0-4.8 mm Hg) (P<.001) and on DBP was 1.9 mm Hg (95% CI, 1.3-2.5 mm Hg) (P<.001). In 56 trials of normotensive persons, the effect of reduced sodium intake (mean, 160 mmol/24 h) on SEP was 1.2 mm Hg (95% CI, 0.6-1.8 mm Hg) (P<.001) and on DBP was 0.26 mm Hg (95% CI, -0.3-0.9 mm Hg) (P=.12). The cumulative analysis showed that this effect size has been stable since 1985. In plasma, the renin level increased 3.6-fold (P<.001), and the aldosterone level increased 3.2-fold (P<.001); the increases were proportional to the degree of sodium reduction for both renin (r=0.66; P<.001) and aldosterone (r=0.64; P<.001). Body weight decreased significantly, and noradrenaline, cholesterol, and low-density lipoprotein cholesterol levels increased. There was no effect on adrenaline, triglyceride, and high-density lipoprotein cholesterol. Conclusion.-These results do not support a general recommendation to reduce sodium intake. Reduced sodium intake may be used as a supplementary treatment in hypertension. Further long-term studies of the effects of high reduction of sodium intake on blood pressure and metabolic variables may clarify the disagreements as to the role of reduced sodium intake, but ideally trials with hard end points such as morbidity and survival should end the controversy.	Univ Copenhagen, Rigshosp, Dept Clin Immunol, Tissue Typing Lab,Sect 7631, DK-2200 Copenhagen, Denmark; Gentofte Univ Hosp, Dept Med, DK-2900 Copenhagen, Denmark; Gentofte Univ Hosp, Dept Cardiol, DK-2900 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Graudal, NA (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Immunol, Tissue Typing Lab,Sect 7631, 20 Tagensvej, DK-2200 Copenhagen, Denmark.			Garred, Peter/0000-0002-2876-8586				ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; AMBROSIONI E, 1982, HYPERTENSION, V4, P789, DOI 10.1161/01.HYP.4.6.789; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; BEARD TC, 1982, LANCET, V2, P455; BENETOS A, 1992, J HYPERTENS, V10, P355, DOI 10.1097/00004872-199204000-00006; BRUUN NE, 1990, J HYPERTENS, V8, P219; BUCKLEY MG, 1994, J HYPERTENS, V12, P809; BURNIER M, 1993, HYPERTENSION, V22, P339, DOI 10.1161/01.HYP.22.3.339; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; CARNEY SL, 1991, CLIN EXP HYPERTENS A, V13, P401, DOI 10.3109/10641969109045059; CHALMERS J, 1986, J HYPERTENS, V4, pS629; CHALMERS JP, 1989, LANCET, V1, P399; COBIAC L, 1992, J HYPERTENS, V10, P87, DOI 10.1097/00004872-199201000-00014; Cooper R, 1984, J Hypertens, V2, P361; COUNSELL CE, 1994, BMJ-BRIT MED J, V309, P1677, DOI 10.1136/bmj.309.6970.1677; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; CUTLER JA, 1991, HYPERTENSION, V17, pI27, DOI 10.1161/01.HYP.17.1_Suppl.I27; DELRIO A, 1993, J INTERN MED, V233, P409; DIMSDALE JE, 1990, AM J HYPERTENS, V3, P429, DOI 10.1093/ajh/3.6.429; DODSON PM, 1989, BMJ-BRIT MED J, V298, P227, DOI 10.1136/bmj.298.6668.227; DONOVAN DS, 1993, AM J PHYSIOL, V264, pE730, DOI 10.1152/ajpendo.1993.264.5.E730; EGAN BM, 1991, AM J HYPERTENS, V4, P416, DOI 10.1093/ajh/4.5.416; ELASHRY A, 1987, J HUM HYPERTENS, V1, P105; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; ERWTEMAN TM, 1984, BMJ-BRIT MED J, V289, P406, DOI 10.1136/bmj.289.6442.406; FAGERBERG B, 1984, BRIT MED J, V288, P11, DOI 10.1136/bmj.288.6410.11; Feldman RD, 1996, CLIN PHARMACOL THER, V60, P444, DOI 10.1016/S0009-9236(96)90201-5; Ferri C, 1996, J AM SOC NEPHROL, V7, P443; FLISER D, 1993, AM J HYPERTENS, V6, P320; FOTHERBY MD, 1993, J HYPERTENS, V11, P657, DOI 10.1097/00004872-199306000-00010; FRIBERG P, 1990, HYPERTENSION, V16, P121, DOI 10.1161/01.HYP.16.2.121; FUCHS FD, 1987, BRAZ J MED BIOL RES, V20, P25; Grey A, 1996, AM J HYPERTENS, V9, P317, DOI 10.1016/0895-7061(95)00390-8; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; GROBBEE DE, 1986, BRIT MED J, V293, P27, DOI 10.1136/bmj.293.6538.27; HARGREAVES M, 1989, CLIN SCI, V76, P553, DOI 10.1042/cs0760553; JULA A, 1992, J INTERN MED, V231, P521, DOI 10.1111/j.1365-2796.1992.tb00968.x; JULA AM, 1992, SCAND J CLIN LAB INV, V52, P159, DOI 10.3109/00365519209088780; JULA AM, 1994, CIRCULATION, V89, P1023, DOI 10.1161/01.CIR.89.3.1023; Koolen M I, 1984, J Hypertens, V2, P55, DOI 10.1097/00004872-198402000-00010; KOOLEN MI, 1984, HYPERTENSION, V6, P820, DOI 10.1161/01.HYP.6.6.820; KURTZ TW, 1987, NEW ENGL J MED, V317, P1043, DOI 10.1056/NEJM198710223171702; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; LAWTON WJ, 1988, HYPERTENSION, V11, P529, DOI 10.1161/01.HYP.11.6.529; LOGAN AG, 1986, CAN J PHYSIOL PHARM, V64, P793, DOI 10.1139/y86-136; MacGregor G, 1996, HYPERTENSION, V27, P156; MACGREGOR GA, 1987, BMJ-BRIT MED J, V294, P531, DOI 10.1136/bmj.294.6571.531; MACGREGOR GA, 1982, LANCET, V1, P351, DOI 10.1016/S0140-6736(82)91389-7; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; MARK AL, 1975, CIRC RES, V36, P194, DOI 10.1161/01.RES.36.6.194; MASCIOLI S, 1991, HYPERTENSION, V17, pI21, DOI 10.1161/01.HYP.17.1_Suppl.I21; MAXWELL MH, 1984, ARCH INTERN MED, V144, P1581, DOI 10.1001/archinte.144.8.1581; McCarron DA, 1997, AM J HYPERTENS, V10, P68, DOI 10.1016/S0895-7061(96)00295-6; MEADE TW, 1993, NEW ENGL J MED, V329, P616, DOI 10.1056/NEJM199308263290905; Meltzer JI, 1996, HYPERTENSION, V27, P155; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Miller JA, 1997, J AM SOC NEPHROL, V8, P749; MORGAN T, 1988, J HUM HYPERTENS, V1, P311; MORGAN T, 1987, CAN J PHYSIOL PHARM, V65, P1752, DOI 10.1139/y87-274; MORGAN T, 1978, LANCET, V1, P227; MORGAN TO, 1981, MED J AUSTRALIA, V2, P396, DOI 10.5694/j.1326-5377.1981.tb101026.x; MTABAJI JP, 1990, J HUM HYPERTENS, V4, P80; Muhlhauser I, 1996, DIABETOLOGIA, V39, P212, DOI 10.1007/BF00403965; MYERS J, 1982, CLIN EXP PHARMACOL P, V9, P287, DOI 10.1111/j.1440-1681.1982.tb00808.x; NBS, 1953, APPL MATH SER, V23; NESTEL PJ, 1993, J HYPERTENS, V11, P1387, DOI 10.1097/00004872-199312000-00011; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; OVERLACK A, 1993, HYPERTENSION, V22, P331, DOI 10.1161/01.HYP.22.3.331; OVERLACK A, 1995, AM J HYPERTENS, V8, P829, DOI 10.1016/0895-7061(95)00213-9; PARIJS J, 1973, AM HEART J, V85, P22, DOI 10.1016/0002-8703(73)90522-X; PARKER M, 1990, HYPERTENSION, V16, P398, DOI 10.1161/01.HYP.16.4.398; PUSKA P, 1983, LANCET, V1, P1; REDONMAS J, 1993, J HYPERTENS, V11, P665, DOI 10.1097/00004872-199306000-00011; Resnick L M, 1985, Trans Assoc Am Physicians, V98, P313; RICHARDS AM, 1986, J HYPERTENS, V4, pS559; RICHARDS AM, 1984, LANCET, V1, P757, DOI 10.1016/S0140-6736(84)91276-5; Rosenthal R., 1984, EDUC RESEARCHER; RUILOPE LM, 1993, J HYPERTENS, V11, pS17; RUPPERT M, 1993, J HYPERTENS, V11, P743, DOI 10.1097/00004872-199307000-00010; RUPPERT M, 1991, KLIN WOCHENSCHR, V69, P51; RUPPERT M, 1994, AM J MED SCI, V307, pS87; SCHMID M, 1990, J HYPERTENS, V8, P277; Schorr U, 1996, J HYPERTENS, V14, P131; Schorr U, 1997, J HYPERTENS, V15, P715, DOI 10.1097/00004872-199715070-00002; SCIARRONE SEG, 1992, J HYPERTENS, V10, P287, DOI 10.1097/00004872-199203000-00013; SHARMA AM, 1991, J HYPERTENS, V9, P329, DOI 10.1097/00004872-199104000-00004; SHARMA AM, 1990, KLIN WOCHENSCHR, V68, P664, DOI 10.1007/BF01667013; SHARMA AM, 1993, J HYPERTENS, V11, P1381, DOI 10.1097/00004872-199312000-00010; SHORE AC, 1988, J HYPERTENS, V6, P613, DOI 10.1097/00004872-198808000-00003; SILMAN AJ, 1983, LANCET, V1, P1179; SINGER DRJ, 1991, HYPERTENSION, V17, P798, DOI 10.1161/01.HYP.17.6.798; SKRABAL F, 1981, LANCET, V2, P895; SKRABAL F, 1984, HYPERTENSION, V6, P152, DOI 10.1161/01.HYP.6.2_Pt_1.152; SKRABAL F, 1985, SCAND J CLIN LAB INV, V45, P47; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; STAMLER R, 1991, HYPERTENSION, V17, pI16, DOI 10.1161/01.HYP.17.1_Suppl.I16; STEEGERS EAP, 1991, BRIT J OBSTET GYNAEC, V98, P980, DOI 10.1111/j.1471-0528.1991.tb15335.x; SULLIVAN JM, 1980, HYPERTENSION, V2, P506, DOI 10.1161/01.HYP.2.4.506; TEOW BH, 1985, CLIN EXP HYPERTENS A, V7, P1681, DOI 10.3109/10641968509073618; WARREN S E, 1980, Clinical Cardiology, V3, P348; WATT GCM, 1983, BMJ-BRIT MED J, V286, P432, DOI 10.1136/bmj.286.6363.432; WATT GCM, 1985, BMJ-BRIT MED J, V291, P1525, DOI 10.1136/bmj.291.6508.1525; WEIR MR, 1995, HYPERTENSION, V25, P1339, DOI 10.1161/01.HYP.25.6.1339; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; ZOCCALI C, 1994, J HYPERTENS, V12, P1249	107	360	365	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1383	1391		10.1001/jama.279.17.1383	http://dx.doi.org/10.1001/jama.279.17.1383			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582047				2022-12-28	WOS:000073359800031
J	Barclay, G				Barclay, G			A memorable patient - Do I say anything?	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1368	1368		10.1136/bmj.316.7141.1368	http://dx.doi.org/10.1136/bmj.316.7141.1368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563994	Green Published			2022-12-28	WOS:000073483000026
J	Carter, CS; Braver, TS; Barch, DM; Botvinick, MM; Noll, D; Cohen, JD				Carter, CS; Braver, TS; Barch, DM; Botvinick, MM; Noll, D; Cohen, JD			Anterior cingulate cortex, error detection, and the online monitoring of performance	SCIENCE			English	Article							PET; ACTIVATION; ATTENTION; SYSTEM	An unresolved question in neuroscience and psychology is how the brain monitors performance to regulate behavior. It has been proposed that the anterior cingulate cortex (ACC), on the medial surface of the frontal lobe, contributes to performance monitoring by detecting errors. In this study, event-related functional magnetic resonance imaging was used to examine ACC function. Results confirm that this region shows activity during erroneous responses. However, activity was also observed in the same region during correct responses under conditions of increased response competition. This suggests that the ACC detects conditions under which errors are likely to occur rather than errors themselves.	Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Presbyterian Univ Hosp, Univ Pittsburgh Hlth Syst, Magnet Resonance Res Ctr, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Carnegie Mellon University	Carter, CS (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.	cscarter+@pitt.edu	Barch, Deanna M/G-8638-2013; Noll, Douglas C/D-8124-2014; Kennedy, Kristen M/B-4699-2008	Noll, Douglas C/0000-0002-0983-3805; Kennedy, Kristen M/0000-0001-5373-9026; Braver, Todd/0000-0002-2631-3393	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052864, K08MH001306] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH52864, K08MH01306] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; COLES MGH, 1995, ACTA PSYCHOL, V90, P129, DOI 10.1016/0001-6918(95)00020-U; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GHERING WJ, 1990, PSYCHOPHYSIOLOGY S, V27, pS34; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	23	2468	2522	2	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					747	749		10.1126/science.280.5364.747	http://dx.doi.org/10.1126/science.280.5364.747			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZL268	9563953				2022-12-28	WOS:000073415600051
J	Langer, R				Langer, R			Drug delivery and targeting	NATURE			English	Review							CONTROLLED-RELEASE; BIOERODIBLE POLYANHYDRIDES; POLYMER; PROTEINS; MATRICES; INVIVO; ELECTROPORATION; CHEMOTHERAPY; MICROSPHERES; PERMEABILITY	When a pharmaceutical agent is encapsulated within, or attached to, a polymer or lipid, drug safety and efficacy can be greatly improved and new therapies are possible. This has provided the impetus for active study of the design of degradable materials, intelligent delivery systems and approaches for delivery through different portals in the body.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, Dept Chem Engn, 45 Carlton St,Bldg E25, Cambridge, MA 02139 USA.			Zheng, Qiangqiang/0000-0001-5842-9318; Iliescu, Florina Silvia/0000-0001-8808-8876				Allcock HR, 1997, ANN NY ACAD SCI, V831, P13; ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988; Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o; Bartus RT, 1996, EXP NEUROL, V142, P14, DOI 10.1006/exnr.1996.0175; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6; Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z; BURNHAM NL, 1994, AM J HOSP PHARM, V51, P210, DOI 10.1093/ajhp/51.2.210; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Chen HM, 1996, PHARMACEUT RES, V13, P1378, DOI 10.1023/A:1016030202104; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COSTANTINO HR, 1994, J PHARM SCI-US, V83, P1662, DOI 10.1002/jps.2600831205; CRAMER MP, 1994, PHARMACOECONOMICS, V5, P482, DOI 10.2165/00019053-199405060-00005; CREMERS HFM, 1995, INT J PHARM, V120, P51, DOI 10.1016/0378-5173(94)00408-W; DANG WB, 1994, CANCER RES, V54, P1729; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Duncan R, 1996, STP PHARMA SCI, V6, P237; DUNN R, 1996, J BIOACT COMPAT POLY, V11, P287; EDELMAN ER, 1987, J BIOMED MATER RES, V21, P339, DOI 10.1002/jbm.820210307; Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868; ELDRIDGE JH, 1990, J CONTROL RELEASE, V11, P205, DOI 10.1016/0168-3659(90)90133-E; FLORENCE AT, 1994, DRUG SAFETY, V10, P233, DOI 10.2165/00002018-199410030-00005; Florence AT, 1997, PHARM RES-DORDR, V14, P259, DOI 10.1023/A:1012029517394; FOLKMAN J, 1964, J Surg Res, V4, P139, DOI 10.1016/S0022-4804(64)80040-8; GOLDRAICH M, 1993, CLIN MATER, V13, P135, DOI 10.1016/0267-6605(93)90100-L; Goodson J M, 1996, Technol Health Care, V4, P269; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Gregoriadis G, 1997, FEBS LETT, V402, P107, DOI 10.1016/S0014-5793(96)01507-4; Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4; Heller J., 1997, CONTROLLED DRUG DELI, P127; HENNINGFIELD JE, 1995, NEW ENGL J MED, V333, P1196, DOI 10.1056/NEJM199511023331807; HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236; Hoes CJT, 1996, J CONTROL RELEASE, V38, P245, DOI 10.1016/0168-3659(95)00126-3; James K, 1997, CONTROLLED DRUG DELI, P389; Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218; Johnson OL, 1996, NAT MED, V2, P795, DOI 10.1038/nm0796-795; Kadiyala Sudha, 1995, P33; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; KOHN J, 1986, J IMMUNOL METHODS, V95, P31, DOI 10.1016/0022-1759(86)90314-5; Krewson CE, 1996, BRAIN RES, V727, P169; KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; LANGER R, 1980, CHEM ENG COMMUN, V6, P15; LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002/jor.1100110213; LAVON I, IN PRESS J CONTR REL; Lenaerts VM, 1990, BIOADHESIVE DRUG DEL; LeoneBay A, 1996, J MED CHEM, V39, P2571, DOI 10.1021/jm960038f; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806; LEVY RJ, 1985, SCIENCE, V228, P1900; Li S, 1996, J CONTROL RELEASE, V39, P373, DOI 10.1016/0168-3659(95)00167-0; Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k; MAEDA H, 1991, ADV DRUG DELIVER REV, V6, P181, DOI 10.1016/0169-409X(91)90040-J; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; MCKENNEY JM, 1976, AM J HOSP PHARM, V33, P792, DOI 10.1093/ajhp/33.8.792; McLean JW, 1997, AM J PHYSIOL-HEART C, V273, pH387, DOI 10.1152/ajpheart.1997.273.1.H387; Merino V, 1997, TRENDS BIOTECHNOL, V15, P288, DOI 10.1016/S0167-7799(97)01069-X; Milstein SJ, 1998, J CONTROL RELEASE, V53, P259, DOI 10.1016/S0168-3659(97)00259-9; MITRA A, 1993, OPHTHALMIC DRUG DELI, P223; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Murakami Y, 1997, DRUG DELIV, V4, P23, DOI 10.3109/10717549709033184; Musch DC, 1997, NEW ENGL J MED, V337, P83, DOI 10.1056/NEJM199707103370203; Narasimhan B, 1997, CONTROLLED DRUG DELI, P529; Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626; NIVEN RW, 1995, CRIT REV THER DRUG, V12, P151, DOI 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.20; OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095; Pardridge WM, 1997, J CEREBR BLOOD F MET, V17, P713, DOI 10.1097/00004647-199707000-00001; Park J W, 1997, Adv Pharmacol, V40, P399, DOI 10.1016/S1054-3589(08)60146-5; Patton JS, 1996, ADV DRUG DELIVER REV, V19, P3, DOI 10.1016/0169-409X(95)00113-L; Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3; Poiani GJ, 1997, AM J RESP CRIT CARE, V155, P1384, DOI 10.1164/ajrccm.155.4.9105083; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; PRAUSNITZ MR, 1995, BIO-TECHNOL, V13, P1205, DOI 10.1038/nbt1195-1205; PUTNAM D, 1995, ADV POLYM SCI, V122, P59; RODGERS C, 1992, J INTERV CARDIOL, V5, P195; Schuster J, 1997, PHARM RES-DORDR, V14, P354, DOI 10.1023/A:1012058323754; Service RF, 1997, SCIENCE, V277, P1199, DOI 10.1126/science.277.5330.1199; Sherwood JK, 1996, NAT BIOTECHNOL, V14, P468, DOI 10.1038/nbt0496-468; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; Spragg DD, 1997, P NATL ACAD SCI USA, V94, P8795, DOI 10.1073/pnas.94.16.8795; Tabata Y, 1996, VACCINE, V14, P1677, DOI 10.1016/S0264-410X(96)00149-1; TAMADA JA, 1993, P NATL ACAD SCI USA, V90, P552, DOI 10.1073/pnas.90.2.552; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Torchilin V P, 1994, Immunomethods, V4, P244, DOI 10.1006/immu.1994.1027; Valtonen S, 1997, NEUROSURGERY, V41, P44, DOI 10.1097/00006123-199707000-00011; Vandorpe J, 1997, BIOMATERIALS, V18, P1147, DOI 10.1016/S0142-9612(97)00052-5; YEH PY, 1995, J CONTROL RELEASE, V36, P109, DOI 10.1016/0168-3659(95)00057-F; YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0	91	1904	2046	11	862	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679		S			5	10						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK760	9579855				2022-12-28	WOS:000073360100003
J	Nabel, GJ				Nabel, GJ			From rhyme to reason	NATURE			English	Editorial Material							GENE-EXPRESSION INVIVO; ARTERIAL-WALL; DELIVERY; THERAPY		Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Nabel, GJ (corresponding author), Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, 1150 W Med Ctr Dr,4520 MSRBI, Ann Arbor, MI 48109 USA.							ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; Bach FH, 1996, IMMUNOL TODAY, V17, P379, DOI 10.1016/0167-5699(96)10024-4; Bach FH, 1997, NAT MED, V3, P944, DOI 10.1038/nm0997-944; BLAU HM, 1995, NEW ENGL J MED, V333, P1554, DOI 10.1056/NEJM199512073332308; BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6; CHANG PL, 1995, SOMAT GENET HER; CHEN KS, 1995, J NEUROSCI, V15, P2819; Ellem KAO, 1997, CANCER IMMUNOL IMMUN, V44, P10, DOI 10.1007/s002620050349; EMERICH DP, 1997, NATURE, V27, P395; Grill R, 1997, J NEUROSCI, V17, P5560; Kim S, 1997, J CLIN INVEST, V100, P1006, DOI 10.1172/JCI119611; KREMERS E, 1940, HIST PHARM, V3, P286; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; Magovern CJ, 1997, HUM GENE THER, V8, P215, DOI 10.1089/hum.1997.8.2-215; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; NABEL EG, 1989, SCIENCE, V244, P1342, DOI 10.1126/science.2499928; Nabel GJ, 1996, P NATL ACAD SCI USA, V93, P15388, DOI 10.1073/pnas.93.26.15388; NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307; Parker W, 1996, IMMUNOL TODAY, V17, P373, DOI 10.1016/0167-5699(96)10028-1; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Petsko GA, 1996, NATURE, V384, P7; Simons JW, 1997, CANCER RES, V57, P1537; Stopeck AT, 1997, J CLIN ONCOL, V15, P341, DOI 10.1200/JCO.1997.15.1.341; Tsurumi Y, 1997, CIRCULATION, V96, P382; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0	26	8	9	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679		S			3	4						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK760	9579854				2022-12-28	WOS:000073360100002
J	Fisher, M; Bogousslavsky, J				Fisher, M; Bogousslavsky, J			Further evolution toward effective therapy for acute ischemic stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; MIDDLE CEREBRAL-ARTERY; THROMBOLYTIC THERAPY; RECANALIZATION; OCCLUSION; TIME; ANTAGONIST; CONSENSUS; RATS	The effective treatment of acute ischemic stroke remains an important goal of modern medicine and substantive advances are occurring. Recently, thrombolytic therapy with tissue-type plasminogen activator was approved for selected patients with acute ischemic stroke when therapy is started within 3 hours of onset. Streptokinase therapy for acute ischemic stroke has not been shown to be effective and is associated with an increased risk of hemorrhage, although it was not evaluated as early after stroke onset as tissue-type plasminogen activator. Various types of neuroprotective interventions are effective in animal models, but none has yet been proven effective in patients. In the future, combinations of thrombolytic and neuroprotective drugs may be used to attempt maximum rates of recovery after acute ischemic stroke. For combination therapy to achieve its maximum potential, patients with acute ischemic stroke will have to be carefully selected and treated.	Univ Massachusetts, Sch Med, Mem Hlth Care, Dept Neurol, Worcester, MA 01605 USA; Univ Lausanne, Dept Neurol, Lausanne, Switzerland	University of Massachusetts System; University of Massachusetts Worcester; University of Lausanne	Fisher, M (corresponding author), Univ Massachusetts, Sch Med, Mem Hlth Care, Dept Neurol, 119 Belmont St, Worcester, MA 01605 USA.	fisherm@memorialhc.org						*AC STROK TREATM I, 1998, STROKE, V29, P286; Adams HP, 1996, CIRCULATION, V94, P1167, DOI 10.1161/01.CIR.94.5.1167; Adams HP, 1996, NEUROLOGY, V47, P835; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Barnard E A, 1988, Adv Exp Med Biol, V236, P31; BARON JC, 1995, STROKE, V26, P2219, DOI 10.1161/01.STR.26.12.2219; BergDammer E, 1996, CEREBROVASC DIS, V6, P222, DOI 10.1159/000108100; Bogousslavsky J, 1996, CEREBROVASC DIS, V6, P315; Bogousslavsky J, 1996, BRIT MED J, V313, P640; Boysen G, 1996, CEREBROVASC DIS, V6, P376, DOI 10.1159/000108060; Brandt T, 1996, STROKE, V27, P875, DOI 10.1161/01.STR.27.5.875; BROTT T, 1997, ACUTE STROKE TREATME, P109; CANDELISE L, 1995, LANCET, V346, P1509; Chopp M, 1996, STROKE, V27, P363, DOI 10.1161/01.STR.27.3.363; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Clark WM, 1998, STROKE, V29, P287; Del Zoppo Gregory J., 1996, Stroke, V27, P164; Diener H. C., 1997, Stroke, V28, P271; Donnan GA, 1996, JAMA-J AM MED ASSOC, V276, P961, DOI 10.1001/jama.276.12.961; DONNAN GA, 1995, LACUNAR OTHER SUBCOR; Edwards Keith, 1996, Neurology, V46, pA424; *ENL AC STROK TRIA, 1997, NEUROLOGY, V48, pA270; FAYAD PB, 1996, CURRENT REV CEREBROV, P81; FIESCHI C, 1989, J NEUROL SCI, V91, P311, DOI 10.1016/0022-510X(89)90060-9; FISHER CM, 1979, ARCH NEUROL-CHICAGO, V36, P65, DOI 10.1001/archneur.1979.00500380035003; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; FISHER M, 1995, JAMA-J AM MED ASSOC, V274, P908; FISHER M, 1993, JAMA-J AM MED ASSOC, V270, P360, DOI 10.1001/jama.270.3.360; Gillum RF, 1997, STROKE, V28, P1527, DOI 10.1161/01.STR.28.8.1527; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hommel M, 1996, NEW ENGL J MED, V335, P145; HOMMEL M, 1994, EXPERT OPIN INV DRUG, V3, P1011; HOROWITZ M, 1995, ANN NEUROL, V38, P56; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Jorgensen HS, 1997, NEUROLOGY, V49, P1335, DOI 10.1212/WNL.49.5.1335; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; KEYT BA, 1994, P NATL ACAD SCI USA, V91, P3670, DOI 10.1073/pnas.91.9.3670; KOH JY, 1990, J NEUROSCI, V10, P693; Lyden PD, 1997, NEUROLOGY, V49, P14, DOI 10.1212/WNL.49.1.14; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MINEMATSU K, 1993, STROKE, V24, P2074, DOI 10.1161/01.STR.24.12.2074; Mitchell PJ, 1997, CEREBROVASC DIS, V7, P94, DOI 10.1159/000108174; MOHR JP, 1994, CEREBROVASC DIS, V4, P197, DOI 10.1159/000108482; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; PULSINELLI W, 1992, LANCET, V339, P533, DOI 10.1016/0140-6736(92)90347-6; RINGELSTEIN EB, 1992, NEUROLOGY, V42, P289, DOI 10.1212/WNL.42.2.289; Samuelsson M, 1996, STROKE, V27, P842, DOI 10.1161/01.STR.27.5.842; SANDERCOCK P, 1995, LANCET, V346, P1504, DOI 10.1016/S0140-6736(95)92044-7; Scheller D., 1995, J CEREBR BLOOD F MET, V15, pS379; Scott P, 1996, STROKE, V27, P1453; Silver B, 1996, CLIN NEUROPHARMACOL, V19, P101, DOI 10.1097/00002826-199619020-00001; SILVER B, 1997, ACUTE STROKE TREATME, P150; Smith AG, 1997, NEUROLOGY, V48, P1613, DOI 10.1212/WNL.48.6.1613; Tietjen G. E., 1996, Neurology, V46, pA424; TOUZANI O, 1995, STROKE, V26, P2112, DOI 10.1161/01.STR.26.11.2112; VONKUMMER R, 1995, STROKE, V26, P581, DOI 10.1161/01.STR.26.4.581; WAHLGREN NG, 1997, CEREBROVASC DIS, V7, P19; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; WOLPERT SM, 1993, AM J NEURORADIOL, V14, P3; ZHANG AG, 1997, J CEREB BLOOD FLOW M, V16, P599	62	61	64	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1298	1303		10.1001/jama.279.16.1298	http://dx.doi.org/10.1001/jama.279.16.1298			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9565012				2022-12-28	WOS:000073090300037
J	Bradley, DC; Chang, GC; Andersen, RA				Bradley, DC; Chang, GC; Andersen, RA			Encoding of three-dimensional structure-from-motion by primate area MT neurons	NATURE			English	Article							3-DIMENSIONAL STRUCTURE; PERCEPTION; INTEGRATION; STEREOPSIS; MONKEY; DEPTH	We see the world as three-dimensional, but because the retinal image is flat, we must derive the third dimension, depth, from two-dimensional cues. Image movement provides one of the most potent cues for depth(1-6). For example, the shadow of a contorted wire appears flat when the wire is stationary, but rotating the wire causes motion in the shadow, which suddenly appears three-dimensional. The neural mechanism of this effect, known as 'structure-from-motion', has not been discovered. Here we study cortical area MT, a primate region that is involved in visual motion perception. Two rhesus monkeys were trained to fixate their gaze while viewing two-dimensional projections of transparent, revolving cylinders. These stimuli appear to be three-dimensional, but the surface order perceived (front as opposed to back) tends to reverse spontaneously. These reversals occur because the stimulus does not specify which surface is in front or at the back, Monkeys reported which surface order they perceived after viewing the stimulus. In many of the neurons tested, there was a reproducible change in activity that coincided with reversals of the perceived surface order, even though the stimulus remained identical. This suggests that area MT has a basic role in structure-from-motion perception.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Div Biol, 391 S Holliston Ave, Pasadena, CA 91125 USA.	andersen@vis.caltech.edu						ANDERSEN RA, 1990, NEUROSCI IN, P163; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; HILDRETH EC, 1995, VISION RES, V35, P117, DOI 10.1016/0042-6989(94)E0068-V; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Miles WR, 1931, AM J PSYCHOL, V43, P392, DOI 10.2307/1414610; NAWROT M, 1991, VISUAL NEUROSCI, V6, P219, DOI 10.1017/S0952523800006234; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Ringach DL, 1996, VISION RES, V36, P1479, DOI 10.1016/0042-6989(95)00285-5; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; SIEGEL RM, 1988, NATURE, V331, P259, DOI 10.1038/331259a0; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880	15	235	237	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	1998	392	6677					714	717		10.1038/33688	http://dx.doi.org/10.1038/33688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565031				2022-12-28	WOS:000073129000058
J	Kolter, R; Losick, R				Kolter, R; Losick, R			Microbiology - One for all and all for one	SCIENCE			English	Article									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kolter, R (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.							COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DWORKIN M, 1997, BACTERIA MULTICELLUL; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Losick R, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0297-68; OTOOLE GA, IN PRESS MOL MICROBI, V28	6	94	98	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	1998	280	5361					226	227		10.1126/science.280.5361.226	http://dx.doi.org/10.1126/science.280.5361.226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH195	9565532				2022-12-28	WOS:000073082400035
J	Bland, JM				Bland, JM			Medical students may not like statistics, but as doctors they will	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	St Georges University London	Bland, JM (corresponding author), St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.							Sharpe M, 1998, BRIT MED J, V316, P796, DOI 10.1136/bmj.316.7134.796	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	1998	316	7145					1674	1675		10.1136/bmj.316.7145.1674	http://dx.doi.org/10.1136/bmj.316.7145.1674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603763				2022-12-28	WOS:000074022700046
J	Cornelissen, JJLM; Fischer, M; Sommerdijk, NAJM; Nolte, RJM				Cornelissen, JJLM; Fischer, M; Sommerdijk, NAJM; Nolte, RJM			Helical superstructures from charged poly(styrene)-poly(isocyanodipeptide) block copolymers	SCIENCE			English	Article							SENSE SELECTIVE POLYMERIZATION; BILAYER-MEMBRANES; SINGLE-CHAIN; ISOCYANIDES; AMPHIPHILE; NICKEL(II); COMPLEXES; POLYMERS; COIL	Amphiphilic block copolymers containing a poly(styrene) tail and a charged helical poly(isocyanide) headgroup derived from isocyano-L-alanine-L-alanine and isocyano-L-alanine-L-histidine were prepared. Analogous to low-molecular mass surfactants, these block copolymers self-assembled in aqueous systems to form micelles, vesicles, and bilayer aggregates. The morphology of these aggregates can be controlled by variation of the length of the poly(isocyanide) block, the pH, and the anion-headgroup interactions. The chirality of the macromolecules results in the formation of helical superstructures that have a helical sense opposite to that of the constituent block copolymers. The great variety of morphologies displayed by these block copolymers and the fact that they are easily accessible from poly(styrene) and different types of peptides open new opportunities for applications in the fields of life and materials sciences.	Univ Nijmegen, Nijmegen SON Res Ctr, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Nolte, RJM (corresponding author), Univ Nijmegen, Nijmegen SON Res Ctr, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	tijdink@sci.kun.nl	Sommerdijk, Nico A.J.M./B-7239-2013; Nolte, Roeland/C-9930-2013	Sommerdijk, Nico A.J.M./0000-0002-8956-195X; Nolte, Roeland/0000-0002-5612-7815				Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343; Clericuzio M, 1997, J AM CHEM SOC, V119, P1059, DOI 10.1021/ja961692n; FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008; GREEN MM, 1995, SCIENCE, V268, P1860, DOI 10.1126/science.268.5219.1860; GREEN MM, 1988, MACROMOLECULES, V21, P1839, DOI 10.1021/ma00184a051; HAFKAMP RJH, 1994, ANGEW CHEM, V106, P1054; KAMER PCJ, 1988, J AM CHEM SOC, V110, P6818, DOI 10.1021/ja00228a035; KAMER PCJ, 1986, J CHEM SOC CHEM COMM, P1789, DOI 10.1039/c39860001789; KAURANEN M, 1995, SCIENCE, V270, P966, DOI 10.1126/science.270.5238.966; KOLMARR C, 1990, J AM CHEM SOC, V112, P8230; KUNITAKE T, 1986, J CHEM SOC CHEM COMM, P655, DOI 10.1039/c39860000655; KUNITAKE T, 1991, J CHEM SOC PERK T 2, P885, DOI 10.1039/p29910000885; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043; NOLTE RJM, 1994, CHEM SOC REV, V23, P11, DOI 10.1039/cs9942300011; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; SOMMERDIJK NAJM, 1994, J CHEM SOC CHEM COMM, P1941, DOI 10.1039/c39940001941; Sommerdijk NAJM, 1997, CHEM COMMUN, P1423, DOI 10.1039/a703161k; Sommerdijk NAJM, 1997, CHEM COMMUN, P455, DOI 10.1039/a608500h; STEPHANY RW, 1972, RECL TRAV CHIM PAY B, V91, P1453; STRALEY JP, 1976, PHYS REV A, V14, P1835, DOI 10.1103/PhysRevA.14.1835; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; STUPP SI, 1997, SCIENCE, V277, P1213; VANBEIJNEN AJM, 1983, MACROMOLECULES, V16, P1679, DOI 10.1021/ma00245a001; VANDEREIJK JM, 1980, MACROMOLECULES, V13, P1391, DOI 10.1021/ma60078a012; vanHest JCM, 1996, CHEM-EUR J, V2, P1616, DOI 10.1002/chem.19960021221; VANHEST JCM, 1995, SCIENCE, V268, P1592, DOI 10.1126/science.268.5217.1592; VISSER HGJ, 1985, J ORG CHEM, V17, P3139; YANAGAWA H, 1988, CHEM LETT, P269, DOI 10.1246/cl.1988.269; YANAGAWA H, 1989, J AM CHEM SOC, V114, P3414; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang LF, 1996, SCIENCE, V272, P1777, DOI 10.1126/science.272.5269.1777	32	563	573	5	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1427	1430		10.1126/science.280.5368.1427	http://dx.doi.org/10.1126/science.280.5368.1427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603730				2022-12-28	WOS:000073883400053
J	Rundquist, A; Durfee, CG; Chang, ZH; Herne, C; Backus, S; Murnane, MM; Kapteyn, HC				Rundquist, A; Durfee, CG; Chang, ZH; Herne, C; Backus, S; Murnane, MM; Kapteyn, HC			Phase-matched generation of coherent soft X-rays	SCIENCE			English	Article							ORDER HARMONIC-GENERATION; OPTICAL PARAMETRIC OSCILLATORS; FREQUENCY-CONVERSION; RARE-GASES; LASER; PULSES; PROPAGATION; RADIATION; XENON	Phase-matched harmonic conversion of visible laser light into soft x-rays was demonstrated, The recently developed technique of guided-wave frequency conversion was used to upshift light from 800 nanometers to the range from 17 to 32 nanometers. This process increased the coherent x-ray output by factors of 10(2) to 10(3) compared to the non-phase-matched case. This source uses a small-scale (sub-millijoule) high repetition-rate laser and will enable a wide variety of new experimental investigations in linear and nonlinear x-ray science.	Univ Michigan, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Murnane, MM (corresponding author), Univ Michigan, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA.		Kapteyn, Henry C/H-6559-2011; Chang, Zenghu/K-8143-2012; Hädrich, Steffen/B-4331-2008; Backus, Sterling/C-2506-2008	Kapteyn, Henry C/0000-0001-8386-6317; Chang, Zenghu/0000-0001-9015-0747; 				Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; ASAKI MT, 1993, OPT LETT, V18, P977, DOI 10.1364/OL.18.000977; Backus S, 1997, OPT LETT, V22, P1256, DOI 10.1364/OL.22.001256; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; DiTrapani P, 1997, J OPT SOC AM B, V14, P1245, DOI 10.1364/JOSAB.14.001245; Durfee CG, 1997, OPT LETT, V22, P1565, DOI 10.1364/OL.22.001565; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; HEITMANN U, 1992, APPL PHYS B-PHOTO, V55, P419, DOI 10.1007/BF00325180; Kan C, 1996, PHYS REV A, V54, pR1026, DOI 10.1103/PhysRevA.54.R1026; KUNG AH, 1973, APPL PHYS LETT, V22, P301, DOI 10.1063/1.1654647; LHUILLIER A, 1991, PHYS REV LETT, V66, P2200, DOI 10.1103/PhysRevLett.66.2200; LHUILLIER A, 1990, J OPT SOC AM B, V7, P527, DOI 10.1364/JOSAB.7.000527; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; MAHON R, 1979, IEEE J QUANTUM ELECT, V15, P444, DOI 10.1109/JQE.1979.1070036; MARCATILI EAJ, 1964, AT&T TECH J, V43, P1783, DOI 10.1002/j.1538-7305.1964.tb04108.x; MILCHBERG HM, 1995, PHYS REV LETT, V75, P2494, DOI 10.1103/PhysRevLett.75.2494; MYERS LE, 1995, J OPT SOC AM B, V12, P2102, DOI 10.1364/JOSAB.12.002102; RAE SC, 1994, PHYS REV A, V50, P3438, DOI 10.1103/PhysRevA.50.3438; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; TANG CL, 1992, P IEEE, V80, P365, DOI 10.1109/5.135353; Zhou J, 1996, PHYS REV LETT, V76, P752, DOI 10.1103/PhysRevLett.76.752	23	790	811	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1412	1415		10.1126/science.280.5368.1412	http://dx.doi.org/10.1126/science.280.5368.1412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603725				2022-12-28	WOS:000073883400048
J	Xu, YS; Poe, BT; Shankland, TJ; Rubie, DC				Xu, YS; Poe, BT; Shankland, TJ; Rubie, DC			Electrical conductivity of olivine, wadsleyite, and ringwoodite under upper-mantle conditions	SCIENCE			English	Article							ORDER HARMONIC-GENERATION; OPTICAL PARAMETRIC OSCILLATORS; FREQUENCY-CONVERSION; RARE-GASES; LASER; PULSES; PROPAGATION; RADIATION; XENON	Geophysical models show that electrical conductivity in Earth's mantle rises about two orders of magnitude through the transition zone in the depth range 410 to 660 kilometers. Impedance measurements obtained on Mg1.8Fe0.2SiO4 olivine, wadsleyite, and ringwoodite at up to 20 gigapascals and 1400 degrees C show that the electrical conductivities of wadsleyite and ringwoodite are similar and are almost two orders of magnitude higher than that of olivine. A conductivity-depth profile to 660 kilometers, based on these laboratory data, shows a conductivity increase of almost two orders of magnitude across the 410-kilometer discontinuity; such a profile favors a two-layer model for the upper mantle. Activation enthalpies of 1.2 to 1.7 electron volts permit appreciable lateral variations of conductivity with lateral temperature variations.	Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	Xu, YS (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.			Poe, Brent/0000-0002-0816-0258				Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; ASAKI MT, 1993, OPT LETT, V18, P977, DOI 10.1364/OL.18.000977; Backus S, 1997, OPT LETT, V22, P1256, DOI 10.1364/OL.22.001256; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; DiTrapani P, 1997, J OPT SOC AM B, V14, P1245, DOI 10.1364/JOSAB.14.001245; Durfee CG, 1997, OPT LETT, V22, P1565, DOI 10.1364/OL.22.001565; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; HEITMANN U, 1992, APPL PHYS B-PHOTO, V55, P419, DOI 10.1007/BF00325180; Kan C, 1996, PHYS REV A, V54, pR1026, DOI 10.1103/PhysRevA.54.R1026; KUNG AH, 1973, APPL PHYS LETT, V22, P301, DOI 10.1063/1.1654647; LHUILLIER A, 1991, PHYS REV LETT, V66, P2200, DOI 10.1103/PhysRevLett.66.2200; LHUILLIER A, 1990, J OPT SOC AM B, V7, P527, DOI 10.1364/JOSAB.7.000527; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; MAHON R, 1979, IEEE J QUANTUM ELECT, V15, P444, DOI 10.1109/JQE.1979.1070036; MARCATILI EAJ, 1964, AT&T TECH J, V43, P1783, DOI 10.1002/j.1538-7305.1964.tb04108.x; MILCHBERG HM, 1995, PHYS REV LETT, V75, P2494, DOI 10.1103/PhysRevLett.75.2494; MYERS LE, 1995, J OPT SOC AM B, V12, P2102, DOI 10.1364/JOSAB.12.002102; RAE SC, 1994, PHYS REV A, V50, P3438, DOI 10.1103/PhysRevA.50.3438; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; TANG CL, 1992, P IEEE, V80, P365, DOI 10.1109/5.135353; Zhou J, 1996, PHYS REV LETT, V76, P752, DOI 10.1103/PhysRevLett.76.752	23	173	203	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1415	1418		10.1126/science.280.5368.1415	http://dx.doi.org/10.1126/science.280.5368.1415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603726				2022-12-28	WOS:000073883400049
J	Bazzino, O; Barrero, C; Garre, L; Sosa, A; Aylward, P; Slany, J; Beaudry, P; Bedard, J; DeLarochelliere, R; Nguyen, M; Bogaty, P; Boudreault Jr; Diodati, JG; Dupuis, J; Fitchett, D; Fung, A; Gervais, P; Gossard, D; Grandmont, D; Huynh, T; Kouz, S; Langer, A; Laramee, P; Lemay, M; Maillette, S; Maranda, C; Nasmith, J; Pesant, Y; Phanuef, D; Proulx, G; Ruel, M; Thompson, C; Corbalan, R; Botero, R; Husted, S; Heikkila, J; Charbonnier, B; Moguel, R; Commerford, P; Landless, P; Weich, D; Maritz, F; Marx, J; Fernandes, F; Lidon, R; Sanz, G; Bosch X; Moccetti, T; Ali, N; Anderson, HV; Bajwa, T; Borzak, S; Boyek, T; Brewer, D; Cambier, P; Chivukula, S; Corder, C; Ezekowitz, M; Feldman, R; Glickman, L; Jang, IK; Klein, M; Korn, D; Kraus, S; Kwan, T; Mann, JT; Marshall, J; Martin, J; Monrad, ES; Mueller, H; Penny, W; Schmedtje, J; Strony, J; Armstrong, P; DeCani, J; Hirsh, J; Pepine, C; Ryan, TJ; Theroux, P; Catella-Lawson, F; Diodati, J; Roy, L; Willerson, JT; Yusuf, S; Zhao X; Sax, FL; Harris, KH; Pelletier, G; Davies, R; Flather, M; Gosselin, G; Herrmann, H; Kells, C; Knudtson, M; Thadani, U; Snapinn, SM; Ghannam, A; Haggert, B; Watson, A; Lis, J; Brancato, C; Fong, D				Bazzino, O; Barrero, C; Garre, L; Sosa, A; Aylward, P; Slany, J; Beaudry, P; Bedard, J; DeLarochelliere, R; Nguyen, M; Bogaty, P; Boudreault, JR; Diodati, JG; Dupuis, J; Fitchett, D; Fung, A; Gervais, P; Gossard, D; Grandmont, D; Huynh, T; Kouz, S; Langer, A; Laramee, P; Lemay, M; Maillette, S; Maranda, C; Nasmith, J; Pesant, Y; Phanuef, D; Proulx, G; Ruel, M; Thompson, C; Corbalan, R; Botero, R; Husted, S; Heikkila, J; Charbonnier, B; Moguel, R; Commerford, P; Landless, P; Weich, D; Maritz, F; Marx, J; Fernandes, F; Lidon, R; Sanz, G; Bosch, X; Moccetti, T; Ali, N; Anderson, HV; Bajwa, T; Borzak, S; Boyek, T; Brewer, D; Cambier, P; Chivukula, S; Corder, C; Ezekowitz, M; Feldman, R; Glickman, L; Jang, IK; Klein, M; Korn, D; Kraus, S; Kwan, T; Mann, JT; Marshall, J; Martin, J; Monrad, ES; Mueller, H; Penny, W; Schmedtje, J; Strony, J; Armstrong, P; DeCani, J; Hirsh, J; Pepine, C; Ryan, TJ; Theroux, P; Catella-Lawson, F; Diodati, J; Roy, L; Willerson, JT; Yusuf, S; Zhao, X; Sax, FL; Harris, KH; Pelletier, G; Davies, R; Flather, M; Gosselin, G; Herrmann, H; Kells, C; Knudtson, M; Thadani, U; Snapinn, SM; Ghannam, A; Haggert, B; Watson, A; Lis, J; Brancato, C; Fong, D		PRISM PLUS Investigators	Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED TRIAL; HEPARIN; CLASSIFICATION; MECHANISMS; ANTAGONIST; DISEASE; ASPIRIN; MK-383	Background Antithrombotic therapy improves the prognosis of patients with acute coronary syndromes, yet the syndromes remain a therapeutic challenge. We evaluated tirofiban, a specific inhibitor of the platelet glycoprotein IIb/IIIa receptor, in the treatment of unstable angina and non-Q-wave myocardial infarction. Methods A total of 1915 patients were randomly assigned in a double-blind manner to receive tirofiban, heparin, or tirofiban plus heparin. Patients received aspirin if its use was not contraindicated. The study drugs were infused for a mean (+/-SD) of 71.3+/-20 hours, during which time coronary angiography and angioplasty were performed when indicated after 48 hours. The composite primary end point consisted of death, myocardial infarction, or refractory ischemia within seven days after randomization. Results The study was stopped prematurely for the group receiving tirofiban alone because of excess mortality at seven days (4.6 percent, as compared with 1.1 percent for the patients treated with heparin alone). The frequency of the composite primary end point at seven days was lower among the patients who received tirofiban plus heparin than among those who received heparin alone (12.9 percent vs, 17.9 percent; risk ratio, 0.68; 95 percent confidence interval, 0.53 to 0.88; P=0.004). The rates of the composite end point in the tirofiban-plus-heparin group were also lower than those in the heparin-only group at 30 days (18.5 percent vs. 22.3 percent, P=0.03) and at 6 months (27.7 percent vs, 32.1 percent, P=0.02). At seven days, the frequency of death or myocardial infarction was 4.9 percent in the tirofiban-plus-heparin group, as compared with 8.3 percent in the heparin-only group (P=0.006). The comparable figures at 30 days were 8.7 percent and 11.9 percent (P=0.03), respectively, and those at 6 months were 12.3 percent and 15.3 percent (P=0.06). The benefit was consistent in the various subgroups of patients and in those treated medically as well as those treated with angioplasty. Major bleeding occurred in 3.0 percent of the patients receiving heparin alone and 4.0 percent of the patients receiving combination therapy (P=0.34). Conclusions When administered with heparin and aspirin, the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was associated with a lower incidence of ischemic events in patients with acute coronary syndromes than in patients who received only heparin and aspirin. (C) 1998, Massachusetts Medical Society.	Italian Hosp, Buenos Aires, DF, Argentina; Clin Bazterrica, Buenos Aires, DF, Argentina; Hosp Naval, Buenos Aires, DF, Argentina; Sanatorio Bartoleme, Buenos Aires, DF, Argentina; Flinders Med Ctr, Flinders, SA, Australia; Krankenanstalt Rudolfstiftung Wien, Vienna, Austria; Cent Hosp Ste Marie, Trois Rivieres, PQ, Canada; Ctr Hosp Sherbrooke, Sherbrooke, PQ, Canada; Laval Hosp, Quebec City, PQ, Canada; Hop Enfants Jesus, Quebec City, PQ, Canada; McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; Vancouver Gen Hosp, Vancouver, BC, Canada; Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; Ctr Hosp Honore Mercier, St Hyacinthe, PQ, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Ctr Hosp Reg Lanaudiere, Joliette, PQ, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Univ Montreal, Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Ctr Hosp Pierre Boucher, Longueuil, PQ, Canada; Queen Elizabeth Hosp, Montreal, PQ, Canada; Sacre Coeur Hosp, Montreal, PQ, Canada; Hotel Dieu St Jerome, St Jerome, PQ, Canada; Hotel Dieu Montreal, Montreal, PQ, Canada; Hotel Dieu Quebec, Quebec City, PQ, Canada; Hop St Luc, Montreal, PQ H2X 1P1, Canada; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Hosp Clin Univ Catolica, Santiago, Chile; Cardiovasc Clin, Medellin, Colombia; Ctr Med Fdn Valle Lili, Cali, Colombia; Skejby Hosp, Aarhus, Denmark; Helsinki Univ Hosp, Helsinki, Finland; Ctr Hosp Univ Trousseau, Tours, France; Hosp Reg Octubre, Mexico City, DF, Mexico; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Johannesburg Hosp, Parktown, South Africa; Tygerberg Hosp, Cape Town, South Africa; Univ Hosp, Bloemfontein, South Africa; Serv Cardiol, Valladolid, Spain; Hosp Gen Valle Hebron, Barcelona, Spain; Hosp Clin Barcelona, Barcelona, Spain; Osped Civico, Lugano, Switzerland; Baylor Coll Med, Houston, TX 77030 USA; Univ Texas, Sch Med, Houston, TX USA; Sinai Samaritan Med Ctr, Milwaukee, WI USA; Henry Ford Hosp, Detroit, MI 48202 USA; Chester Cty Hosp, W Chester, PA USA; St Francis Hosp, Tulsa, OK USA; Madigan Army Med Ctr, Tacoma, WA 98431 USA; Lower Bucks Hosp, Bristol, PA USA; Oklahoma Fdn Cardiovasc Res, Oklahoma City, OK USA; W Haven Vet Affairs Med Ctr, New Haven, CT USA; Monroe Med Ctr, Ocala, FL USA; Mercer Med Ctr, Trenton, NJ USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Boston Univ, Med Ctr, Boston, MA USA; Mt Sinai Med Ctr, Miami Beach, FL 33140 USA; Albuquerque Med Ctr, Albuquerque, NM USA; SUNY Brooklyn, Brooklyn, NY USA; Wake Heart Associates, Raleigh, NC USA; Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; Bryn Mawr Hosp, Bryn Mawr, PA USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Montefiore Hosp, Bronx, NY USA; Univ Calif San Diego, Vet Affairs Med Ctr, San Diego, CA 92161 USA; Univ Texas, Med Branch, Galveston, TX 77550 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Hospital Italiano de Buenos Aires; Flinders Medical Centre; Rudolfstiftung Hospital; Laval University; McGill University; McGill University; Royal Victoria Hospital; University of British Columbia; Universite de Montreal; McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; University of Ottawa; University of Ottawa Heart Institute; McGill University; Universite de Montreal; Universite de Montreal; Laval University; Universite de Montreal; St. Paul's Hospital; University of Saskatchewan; Pontificia Universidad Catolica de Chile; Fundacion Valle del Lili; Aarhus University; University of Helsinki; Helsinki University Central Hospital; CHU Tours; University of Cape Town; Tygerberg Hospital; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; Baylor College of Medicine; University of Texas System; Henry Ford Health System; Henry Ford Hospital; St. Francis Hospital - Oklahoma; Madigan Army Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Massachusetts General Hospital; Boston University; Mount Sinai Medical Center; State University of New York (SUNY) System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Medical Branch Galveston; University Hospitals of Cleveland	Theroux, P (corresponding author), Montreal Heart Inst, 5000 Belanger St E, Montreal, PQ H1T 1C8, Canada.		Dupuis, Jocelyn/C-6613-2013; Bosch, Xavier/E-7890-2014; Ezekowitz, Michael/AAJ-2543-2021; Lima, Thaísa/AAG-6483-2021; Dupuis, Jocelyn/B-3898-2009	Dupuis, Jocelyn/0000-0002-3193-1014; Bosch, Xavier/0000-0002-0133-1587; 				Bazzino O, 1998, NEW ENGL J MED, V338, P1498; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Braunwald E, 1994, AHCPR PUBLICATION, V94-0602, P1; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; EGBERTSON MS, 1994, J MED CHEM, V37, P2537, DOI 10.1021/jm00042a007; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GOULD RJ, 1993, THROMB HAEMOSTASIS, V69, P976; Hanrath P, 1997, CIRCULATION, V96, P1445; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; PEERLINCK K, 1993, CIRCULATION, V88, P1512, DOI 10.1161/01.CIR.88.4.1512; RIZIK DG, 1995, AM J CARDIOL, V75, P993, DOI 10.1016/S0002-9149(99)80710-3; Schulman SP, 1996, CIRCULATION, V94, P2083, DOI 10.1161/01.CIR.94.9.2083; Simoons ML, 1997, LANCET, V349, P1429; SIMOONS ML, 1994, CIRCULATION, V89, P596, DOI 10.1161/01.CIR.89.2.596; Tcheng JE, 1997, LANCET, V349, P1422; Theroux P, 1996, CIRCULATION, V94, P899, DOI 10.1161/01.CIR.94.5.899; Theroux P, 1998, CIRCULATION, V97, P1195, DOI 10.1161/01.CIR.97.12.1195; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; THEROUX P, 1994, CIRCULATION, V90, P231; TOPOL EJ, 1994, LANCET, V343, P881, DOI 10.1016/S0140-6736(94)90007-8; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Wallentin L, 1996, LANCET, V347, P561; WALLENTIN L, 1990, LANCET, V336, P827; WILLERSON JT, 1989, CIRCULATION, V80, P198, DOI 10.1161/01.CIR.80.1.198	28	1266	1294	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1488	1497						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9599103				2022-12-28	WOS:000073699100002
J	Redelmeier, DA; Tan, SH; Booth, GL				Redelmeier, DA; Tan, SH; Booth, GL			The treatment of unrelated disorders in patients with chronic medical diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ONTARIO; HEALTH; RISK; CARE; BENEFIT; FRAUD	Background Patients can have several illnesses concurrently, yet some of these diseases may be neglected if one problem consumes attention. We conducted a population-based analysis in Ontario, Canada - where universal health insurance is provided - to determine whether unrelated disorders are less likely to be treated in patients with chronic diseases, Methods We studied the 1,344,145 residents of Ontario in 1995 who were 65 or older and eligible to receive prescription medications free of charge as part of the Ontario Drug Benefit program. Patients with diabetes mellitus were identified by prescriptions for insulin, pulmonary emphysema by prescriptions for ipratropium bromide, and psychotic syndromes by prescriptions for haloperidol. For each chronic disease, we selected an unrelated treatment: estrogen-replacement therapy for patients with diabetes mellitus, lipid-lowering medications for those with pulmonary emphysema, and medical treatment of arthritis for those with psychotic syndromes. Results The 30,669 patients with diabetes mellitus were less likely to receive estrogen-replacement therapy than the other subjects in the study (2.4 percent vs. 5.9 percent, P<0.001). The disease was associated with a 60 percent reduction in the odds of estrogen treatment (odds ratio, 0.40; 95 percent confidence interval, 0.37 to 0.43). Findings were similar for the 56,779 patients with pulmonary emphysema, who were less likely to receive lipid-lowering medications (odds ratio, 0.69; 95 percent confidence interval, 0.67 to 0.72; P<0.001), and the 17,336 patients with psychotic syndromes, who were less likely to receive medical treatments for arthritis (odds ratio, 0.59; 95 percent confidence interval, 0.57 to 0.62; P<0.001). Conclusions In patients 65 or older who have chronic medical diseases and who receive prescription medications free of charge, unrelated disorders are undertreated. Clinicians caring for patients with chronic diseases should remain alert to other disorders and minimize the number of missed opportunities for treating them. (C) 1998, Massachusetts Medical Society.	Sunnybrook Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.							ABRAMSON JH, 1982, J CHRON DIS, V35, P221, DOI 10.1016/0021-9681(82)90143-6; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; BARHILLEL M, 1973, ORGAN BEHAV HUM PERF, V9, P396, DOI 10.1016/0030-5073(73)90061-5; BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; BEERS M, 1988, JAMA-J AM MED ASSOC, V260, P3016, DOI 10.1001/jama.260.20.3016; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; ENRIGHT PL, 1995, CHEST, V107, P28, DOI 10.1378/chest.107.1.28; Estes W. K, 1964, CATEGORIES HUMAN LEA, P89; Fischhoff Baruch, 1982, JUDGMENT UNCERTAINTY, p[335, 341], DOI [10.1017/CBO9780511809477.024, DOI 10.1017/CB09780511809477.024]; FONG GT, 1986, COGNITIVE PSYCHOL, V18, P253, DOI 10.1016/0010-0285(86)90001-0; Fontana SA, 1997, AM J PUBLIC HEALTH, V87, P1190, DOI 10.2105/AJPH.87.7.1190; FRENCH O, 1995, CAN MED ASSOC J, V152, P569; GOEL V, 1996, PATTERNS HLTH CARE O, P27; Haffner SM, 1998, DIABETES CARE, V21, P160, DOI 10.2337/diacare.21.1.160; HARRIS MI, 1995, NIH PUBLICATION, P127; Hibbard JH, 1997, MILBANK Q, V75, P395, DOI 10.1111/1468-0009.00061; HOSMER DW, 1989, APPL LOGISTIC REGRES; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KARASU TB, 1980, HOSP COMMUNITY PSYCH, V31, P463; LINDMAN H, 1961, J EXP PSYCHOL, V62, P630, DOI 10.1037/h0046635; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; MANSON JE, 1992, NEW ENGL J MED, V326, P1406, DOI 10.1056/NEJM199205213262107; MCISAAC W, 1994, CAN MED ASSOC J, V150, P473; McLaughlin TJ, 1997, J GEN INTERN MED, V12, P1, DOI 10.1046/j.1525-1497.1997.12105.x; MENDELSSOHN DC, 1995, ARCH INTERN MED, V155, P2473, DOI 10.1001/archinte.155.22.2473; Millman M, 1993, ACCESS HLTH CARE AM, P31; MYKKANEN L, 1993, DIABETOLOGIA, V36, P553, DOI 10.1007/BF02743273; QUINN K, 1992, CAN MED ASSOC J, V146, P2177; Shu A, 1996, CAN MED ASSOC J, V154, P1412; SOUMERAI SB, 1995, NEW ENGL J MED, V332, P1641, DOI 10.1056/NEJM199506153322411; SYME SL, 1976, AM J EPIDEMIOL, V104, P1; THALER RH, 1991, QUASIRATIONAL EC, P25; Thorburn WM., 1918, MIND 26, VI, P345, DOI DOI 10.1093/MIND/XXVII.3.345; Thurnheer R, 1997, CHEST, V112, P122, DOI 10.1378/chest.112.1.122; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223	37	509	514	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1516	1520		10.1056/NEJM199805213382106	http://dx.doi.org/10.1056/NEJM199805213382106			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZN943	9593791				2022-12-28	WOS:000073699100006
J	Frenkel, LM; Mullins, JI; Learn, GH; Manns-Arcuino, L; Herring, BL; Kalish, ML; Steketee, RW; Thea, DM; Nichols, JE; Liu, SL; Harmache, A; He, X; Muthui, D; Madan, A; Hood, L; Haase, AT; Zupancic, M; Staskus, K; Wolinsky, S; Krogstad, P; Zhao, JQ; Chen, I; Koup, R; Ho, D; Korber, B; Apple, RJ; Coombs, RW; Pahwa, S; Roberts, NJ				Frenkel, LM; Mullins, JI; Learn, GH; Manns-Arcuino, L; Herring, BL; Kalish, ML; Steketee, RW; Thea, DM; Nichols, JE; Liu, SL; Harmache, A; He, X; Muthui, D; Madan, A; Hood, L; Haase, AT; Zupancic, M; Staskus, K; Wolinsky, S; Krogstad, P; Zhao, JQ; Chen, I; Koup, R; Ho, D; Korber, B; Apple, RJ; Coombs, RW; Pahwa, S; Roberts, NJ			Genetic evaluation of suspected cases of transient HIV-1 infection of infants	SCIENCE			English	Article							VIRUS; TRANSMISSION; INDIVIDUALS; ZIDOVUDINE; RESISTANCE; CLEARANCE; CHILDREN; AIDS	Detection of human immunodeficiency virus-type 1 (HIV-1) on only one or a few occasions in infants born to infected mothers has been interpreted to indicate that infection may be transient rather than persistent. Forty-two cases of suspected transient HIV-1 viremia among 1562 perinatally exposed seroreverting infants and one mother were reanalyzed. HIV-1 env sequences were not found in specimens from 20; in specimens from 6, somatic genetic analysis revealed that specimens were mistakenly attributed to an infant; and in specimens from 17, phylogenetic analysis failed to demonstrate the expected linkage between the infant's and the mother's virus. These findings argue that transient HIV-1 infection, if it exists, will only rarely be satisfactorily documented.	Univ Washington, Dept Pediat, Div Infect Dis, Seattle, WA 98105 USA; Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Med & Hlth Res Assoc New York City, New York, NY 10013 USA; Univ Rochester, Dept Med, Rochester, NY 14642 USA; Univ Texas, Med Branch, Dept Med & Microbiol & Immunol, Galveston, TX 77555 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Northwestern Univ, Dept Med, Chicago, IL 60611 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Med & Microbiol & Immunol, Los Angeles, CA 90024 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Santa Fe Inst, Los Alamos, NM 87545 USA; Roche Mol Diagnost, Alameda, CA 94501 USA; NYU, N Shore Hosp, Dept Pediat, Manhasset, NY 11030 USA	University of Washington; University of Washington Seattle; University of Rochester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; University of Rochester; University of Texas System; University of Texas Medical Branch Galveston; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; The Santa Fe Institute; Roche Holding; New York University	Frenkel, LM (corresponding author), Univ Washington, Dept Pediat, Div Infect Dis, 4800 Sand Point Way NE,Box 329500, Seattle, WA 98105 USA.		Krogstad, Paul/AAQ-8495-2020; Pahwa, Savita/AAA-4900-2019; HARMACHE, ABDALLAH/E-7274-2011; HARMACHE, Abdallah/AAS-2586-2021; apple, raymond J/I-4506-2012; Learn, Jerry/E-3356-2012; Herring, Belinda/M-7252-2015; Wolinsky, Steven/B-2893-2012; Liu, Shan-Lu/L-5923-2016; Learn, Gerald H/B-6934-2011	Pahwa, Savita/0000-0002-4470-4216; apple, raymond J/0000-0002-8007-0345; Liu, Shan-Lu/0000-0003-1620-3817; Learn, Gerald H/0000-0003-0434-7733; Korber, Bette/0000-0002-2026-5757; /0000-0001-8284-1505; Wolinsky, Steven/0000-0002-9625-6697; Harmache, Abdallah/0000-0002-7377-7641; Thea, Donald/0000-0002-6933-1030; Roberts Jr, Norbert J/0000-0002-4427-2986	NIAID NIH HHS [AI32910, AI27757] Funding Source: Medline; PHS HHS [UO1-27658] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI032910] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BORKOWSKY W, 1990, AIDS RES HUM RETROV, V6, P673, DOI 10.1089/aid.1990.6.673; BRYSON YJ, 1995, NEW ENGL J MED, V332, P833, DOI 10.1056/NEJM199503303321301; Cao YZ, 1997, NAT MED, V3, P549, DOI 10.1038/nm0597-549; CONNOR EM, 1995, PEDIATR INFECT DIS J, V14, P536, DOI 10.1097/00006454-199506000-00012; Contag CH, 1997, J VIROL, V71, P1292, DOI 10.1128/JVI.71.2.1292-1300.1997; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; DELWART EL, 1995, AIDS RES HUM RETROV, V11, P1181; FRENKEL LM, 1995, CLIN INFECT DIS, V20, P1321, DOI 10.1093/clinids/20.5.1321; FRENKEL LM, UNPUB; HOFFENBACH A, 1989, J IMMUNOL, V142, P452; HOLMES EC, 1993, J INFECT DIS, V167, P1411, DOI 10.1093/infdis/167.6.1411; JAFFE HW, 1994, ANN INTERN MED, V121, P855, DOI 10.7326/0003-4819-121-11-199412010-00005; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; LIU TM, 1995, J IMMUNOL, V154, P3147; MCCLURE MO, 1995, NATURE, V375, P637, DOI 10.1038/375637a0; McMichael A, 1996, NEW ENGL J MED, V334, P801, DOI 10.1056/NEJM199603213341215; Newell ML, 1996, LANCET, V347, P213, DOI 10.1016/S0140-6736(96)90401-8; PALUMBO P, 1995, J ACQ IMMUN DEF SYND, V10, P436, DOI 10.1097/00042560-199512000-00006; ROQUES PA, 1995, AIDS, V9, pF19; Schochetman Gerald, 1996, P25; Steketee RW, 1997, J INFECT DIS, V175, P707, DOI 10.1093/infdis/175.3.707	22	54	54	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1073	1077		10.1126/science.280.5366.1073	http://dx.doi.org/10.1126/science.280.5366.1073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582120				2022-12-28	WOS:000073663600046
J	Hargreave, TB; Mills, JA				Hargreave, TB; Mills, JA			Fortnightly review - Investigating and managing infertility in general practice	BRITISH MEDICAL JOURNAL			English	Review							DIAGNOSIS; FERTILITY; RATES		Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Edinburgh; University of Dundee	Hargreave, TB (corresponding author), Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland.							[Anonymous], 1996, Hum Reprod, V11, P1779; BRINDLEY GS, 1982, BRIT J UROL, V54, P49, DOI 10.1111/j.1464-410X.1982.tb13510.x; COLLINS JA, 1992, INT J GYNECOL OBSTET, V39, P267, DOI 10.1016/0020-7292(92)90257-J; COOKE H, IN PRESS FERTIL STER; *DEP HLTH, 1996, IMM INF DIS, P193; HARGREAVE TB, 1983, BRIT J UROL, V55, P774, DOI 10.1111/j.1464-410X.1983.tb03424.x; HARGREAVE TB, 1986, BRIT J UROL, V58, P194, DOI 10.1111/j.1464-410X.1986.tb09025.x; HARGREAVE TB, 1997, CURRENT ADV ANDROLOG; HOWE G, 1985, BRIT MED J, V290, P1697, DOI 10.1136/bmj.290.6483.1697; KOPITZKE EJ, 1991, FERTIL STERIL, V55, P1137; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; MARMOR D, 1995, REPROD TOXICOL, V9, P219, DOI 10.1016/0890-6238(95)00002-R; Ostergaard L, 1996, BRIT MED J, V313, P1186, DOI 10.1136/bmj.313.7066.1186; REID RL, 1987, FERTIL STERIL, V48, P905; Swerdlow AJ, 1997, BRIT MED J, V314, P1507, DOI 10.1136/bmj.314.7093.1507; TAN SL, 1992, LANCET, V339, P1390, DOI 10.1016/0140-6736(92)91205-M; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9	17	9	9	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1438	1441		10.1136/bmj.316.7142.1438	http://dx.doi.org/10.1136/bmj.316.7142.1438			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572759	Green Published			2022-12-28	WOS:000073651600034
J	Tunstall-Pedoe, H				Tunstall-Pedoe, H			Myth and paradox of coronary risk and the menopause	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; HEART-DISEASE; CASE-FATALITY; WOMEN; POPULATION; DEATHS; HEALTH; SEX		Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, Dundee DD1 9SY, Scotland	University of Dundee	Tunstall-Pedoe, H (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, Dundee DD1 9SY, Scotland.							[Anonymous], 1977, MANUAL INT STAT CLAS; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; FURMAN RH, 1968, ANN NY ACAD SCI, V149, P822, DOI 10.1111/j.1749-6632.1968.tb53838.x; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; HELLER RF, 1978, BRIT MED J, V1, P472, DOI 10.1136/bmj.1.6111.472; KHAW KT, 1992, BRIT MED BULL, V48, P249, DOI 10.1093/oxfordjournals.bmb.a072546; LINDQUIST O, 1982, PREV MED, V11, P162, DOI 10.1016/0091-7435(82)90015-9; MEADE TW, 1992, BRIT MED BULL, V48, P276, DOI 10.1093/oxfordjournals.bmb.a072548; ROSENBERG L, 1981, AM J OBSTET GYNECOL, V139, P47, DOI 10.1016/0002-9378(81)90410-5; Stevenson JC, 1996, EUR J OBSTET GYN R B, V65, P39, DOI 10.1016/0028-2243(95)02301-8; TRACY RE, 1966, J CHRON DIS, V19, P1245, DOI 10.1016/0021-9681(66)90022-1; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; TUNSTALLPEDOE H, 1992, BRIT MED J, V305, P1096, DOI 10.1136/bmj.305.6861.1096-b; 1996, WRLD HLTH STAT ANN 1	17	135	136	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1425	1427		10.1016/S0140-6736(97)11321-6	http://dx.doi.org/10.1016/S0140-6736(97)11321-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593428				2022-12-28	WOS:000073563400042
J	Lee, M; Lenman, M; Banas, A; Bafor, M; Singh, S; Schweizer, M; Nilsson, R; Liljenberg, C; Dahlqvist, A; Gummeson, PO; Sjodahl, S; Green, A; Stymne, S				Lee, M; Lenman, M; Banas, A; Bafor, M; Singh, S; Schweizer, M; Nilsson, R; Liljenberg, C; Dahlqvist, A; Gummeson, PO; Sjodahl, S; Green, A; Stymne, S			Identification of non-heme diiron proteins that catalyze triple bond and epoxy group formation	SCIENCE			English	Article							FATTY-ACIDS; TRANSFORMATION; MONOOXYGENASE; BIOSYNTHESIS; DESATURASE; VECTORS; ENZYME	Acetylenic bonds are present in more than 600 naturally occurring compounds. Plant enzymes that catalyze the formation of the Delta 12 acetylenic bond in 9-octadecen-12-ynoic acid and the Delta 12 epoxy group in 12,13-epoxy-9-octadecenoic acid were characterized, and two genes, similar in sequence, were cloned. When these complementary DNAs were expressed in Arabidopsis thaliana, the content of acetylenic or epoxidated fatty acids in the seeds increased from 0 to 25 or 15 percent, respectively. Both enzymes have characteristics similar to the membrane proteins containing non-heme iron that have histidine-rich motifs.	Swedish Univ Agr Sci, Dept Plant Breeding Res, S-26831 Svalov, Sweden; Svalov Welbull AB, S-26881 Svalov, Sweden; CSIRO, Canberra, ACT 2601, Australia; Inst Food Res, Norwich NR4 7UA, Norfolk, England; Univ Gothenburg, Dept Plant Physiol, S-41319 Gothenburg, Sweden	Swedish University of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Gothenburg	Stymne, S (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding Res, S-26831 Svalov, Sweden.	sten.stymne@vf.slu.se	Green, Allan G/C-6572-2008; singh, surinder/C-9528-2009; Green, Allan/AAM-6856-2021	singh, surinder/0000-0003-4488-8147; Green, Allan/0000-0002-3248-2089; Lee, Michael/0000-0002-6643-1984; Banas, Antoni/0000-0001-9397-7627				Badami R. C., 1981, Progress in Lipid Research, V19, P119, DOI 10.1016/0163-7827(80)90002-8; BAFOR M, 1993, ARCH BIOCHEM BIOPHYS, V303, P145, DOI 10.1006/abbi.1993.1265; BAGBY MO, 1967, Patent No. 3356699; Banas A, 1996, PHYSL BIOCH MOL BIOL, P57; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; BOHLMAN F, 1973, NATURALLY OCCURRING; BROUN P, 1996, PHYSL BIOCH MOL BIOL, P342; COLBERT JE, 1990, J AM CHEM SOC, V112, P3993, DOI 10.1021/ja00166a041; EARLE FR, 1966, LIPIDS, V1, P325, DOI 10.1007/BF02532675; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Engeseth N, 1996, PLANTA, V198, P238, DOI 10.1007/BF00206249; HAIGH WG, 1968, LIPIDS, V3, P307, DOI 10.1007/BF02530929; KOHN G, 1994, J PLANT PHYSIOL, V144, P265, DOI 10.1016/S0176-1617(11)81185-5; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; SHANKLIN J, 1996, PHYSL BIOCH MOL BIOL, P6; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Van De Loo Frank J., 1993, P91; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7	23	198	251	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					915	918		10.1126/science.280.5365.915	http://dx.doi.org/10.1126/science.280.5365.915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572738				2022-12-28	WOS:000073532900045
J	Li, WH; Llopis, J; Whitney, M; Zlokarnik, G; Tsien, RY				Li, WH; Llopis, J; Whitney, M; Zlokarnik, G; Tsien, RY			Cell-permeant caged InsP(3) ester shows that Ca2+ spike frequency can optimize gene expression	NATURE			English	Article							INOSITOL TRISPHOSPHATE; 1,4,5-TRISPHOSPHATE; RECOGNITION; RECEPTOR; SIGNALS	Inositol 1,4,5-trisphosphate (InsP(3)) releases calcium from intracellular stores and triggers complex waves and oscillations in levels of cytosolic free calcium(1-5). To determine which longer-term responses are controlled by oscillations in InsP(3) and cytosolic free calcium, it would be useful to deliver exogenous InsP(3), under spatial and temporal control, into populations of unpermeabilized cells. Here we report the 15-step synthesis of a membrane-permeant, caged InsP(3) derivative from myo-inositol. This derivative diffused into intact cells and was hydrolysed to produce a caged, metabolically stable InsP(3) derivative. This latter derivative accumulated in the cytosol at concentrations of hundreds of micromolar, without activating the InsP(3) receptor. Ultraviolet illumination uncaged an InsP(3) analogue nearly as potent as real InsP(3), and generated spikes of cytosolic free calcium, and stimulated gene expression via the nuclear factor of activated T cells(6,7). The same total amount of InsP(3) analogue elicited much more gene expression when released by repetitive flashes at 1-minute intervals than when released at 0.5- or greater than or equal to 2-minute intervals, as a single pulse, or as a slow sustained plateau, Thus, oscillations in cytosolic free calcium levels at roughly physiological rates maximize gene expression for a given amount of InsP(3).	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Aurora Biosci Corp, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Llopis, Juan/I-2622-2012	Llopis, Juan/0000-0002-9460-0642				ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102; HIRATA M, 1993, J BIOL CHEM, V268, P19260; HIRATA M, 1990, J BIOL CHEM, V265, P8404; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KOZIKOWSKI AP, 1993, J AM CHEM SOC, V115, P4429, DOI 10.1021/ja00064a002; Kuchtey J, 1996, J CELL PHYSIOL, V166, P643, DOI 10.1002/(SICI)1097-4652(199603)166:3<643::AID-JCP20>3.0.CO;2-6; Li WH, 1997, TETRAHEDRON, V53, P12017, DOI 10.1016/S0040-4020(97)00714-X; Oancea E, 1996, J BIOL CHEM, V271, P17253, DOI 10.1074/jbc.271.29.17253; POTTER BVL, 1995, ANGEW CHEM INT EDIT, V34, P1933, DOI 10.1002/anie.199519331; Smith GD, 1996, AM J PHYSIOL-CELL PH, V270, pC939, DOI 10.1152/ajpcell.1996.270.3.C939; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VACCA JP, 1989, TETRAHEDRON, V45, P5679, DOI 10.1016/S0040-4020(01)89510-7; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	26	741	751	0	29	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					936	941		10.1038/31965	http://dx.doi.org/10.1038/31965			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582076				2022-12-28	WOS:000073359900053
J	Rundlett, SE; Carmen, AA; Suka, N; Turner, BM; Grunstein, M				Rundlett, SE; Carmen, AA; Suka, N; Turner, BM; Grunstein, M			Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST	The histone deacetylase RPD3 can be targeted to certain genes through its interaction with DNA-binding regulatory proteins. RPD3 can then repress gene transcription(1-6). In the yeast Saccharomyces cerevisiae, association of RPD3 with the transcriptional repressors SIN3 and UME6 results in repression of reporter genes containing the UME6-binding site(3). RPD3 can deacetylate all histone HS acetylation sites in cell extracts(7). However, it is unknown how H4 proteins located at genes near UME6-binding sites are affected, nor whether the effect of RPD3 is localized to the promoter regions. Here we study the mechanism by which RPD3 represses gene activity by examining the acetylation state of histone proteins at UME6-regulated genes. We used antibodies specific for individual acetylation sites in H4 to immunoprecipitate chromatin fragments. A deletion of RPD3 or SIN3, but not of the related histone-deacetylase gene HDA1, results in increased acetylation of the lysine 5 residue of H4 in the promoters of the UME6-regulated INO1 (ref. 8), IME2! (ref. 3) and SPO13 (ref. 9) genes. As increased acetylation of this residue is not merely a consequence of gene transcription, acetylation of this site may be essential for regulating gene activity.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Birmingham, Sch Med, Dept Anat, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Birmingham	Grunstein, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mg@mbi.ucla.edu						Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; CLARKE DJ, 1993, BIOCHEM J, V294, P557, DOI 10.1042/bj2940557; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; FLOMERFELT FA, 1993, J CELL PHYSIOL, V154, P573, DOI 10.1002/jcp.1041540316; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Guthrie C, 1991, GUIDE YEAST GENETICS; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SLEKAR KH, 1995, NUCLEIC ACIDS RES, V23, P1964, DOI 10.1093/nar/23.11.1964; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; VIDAL M, 1991, MOL CELL BIOL, V11, P6306, DOI 10.1128/MCB.11.12.6306; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	24	359	366	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					831	835		10.1038/33952	http://dx.doi.org/10.1038/33952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572144				2022-12-28	WOS:000073241200058
J	Nilson, LA; Schupbach, T				Nilson, LA; Schupbach, T			Localized requirements for windbeutel and pipe reveal a dorsoventral prepattern within the follicular epithelium of the Drosophila ovary	CELL			English	Article							DORSAL-VENTRAL POLARITY; EGF RECEPTOR HOMOLOG; FAINT-LITTLE-BALL; NUCLEAR-LOCALIZATION; EMBRYONIC POLARITY; TOLL GENE; GERM LINE; PROTEIN; PATTERN; CELLS	Establishment of dorsoventral polarity within the Drosophila embryo requires extraembryonic positional information generated during oogenesis. The genes windbeutel, pipe, and nudel are required within the somatic follicle cells of the ovary for production of this spatial cue. Using a novel follicle cell marker system, we have directly evaluated the effect of mutant follicle cell clones on the embryonic dorsoventral pattern. We find no spatially localized requirement for nudel activity. In contrast, windbeutel and pipe are required only within a restricted ventral region of the follicular epithelium. This ventral region can determine lateral embryonic cell fates nonautonomously, indicating that spatial information originating ventrally is subsequently refined, perhaps via diffusion, to yield the gradient of positional information that determines the embryonic dorsoventral pattern.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Schupbach, T (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.				NCI NIH HHS [P01 CA41086] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA041086] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; CHASAN R, 1992, DEVELOPMENT, V115, P607; Chasan Rebecca, 1993, P387; Chou TB, 1996, GENETICS, V144, P1673; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HAWLEY RJ, 1988, GENE DEV, V2, P341, DOI 10.1101/gad.2.3.341; HONG CC, 1995, CELL, V82, P785, DOI 10.1016/0092-8674(95)90475-1; Hong CC, 1996, GENETICS, V143, P1653; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; King R. C., 1970, OVARIAN DEV DROSOPHI; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; ROTH S, 1994, DEVELOPMENT, V120, P2245; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROTH S, 1993, DEVELOPMENT, V117, P1385; RUSHLOW CA, 1989, CELL, V59, P779; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; SCHUPACH T, 1991, CELL-CELL INTERACTIONS IN EARLY DEVELOPMENT, P163; SCHUPBACH T, 1989, GENETICS, V121, P101; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; Spradling Allan C., 1993, P1; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STEIN D, 1992, CELL, V68, P429, DOI 10.1016/0092-8674(92)90181-B; STEVENS LM, 1990, NATURE, V346, P660, DOI 10.1038/346660a0; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; WIESCHAUS E, 1981, DEV BIOL, V88, P92, DOI 10.1016/0012-1606(81)90221-9; Wieschaus E., 1986, P199; XU T, 1993, DEVELOPMENT, V117, P1223	42	59	61	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					253	262		10.1016/S0092-8674(00)81576-7	http://dx.doi.org/10.1016/S0092-8674(00)81576-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568717	Bronze			2022-12-28	WOS:000073174000011
J	Sikorski, R; Peters, R				Sikorski, R; Peters, R			Synthetic protease switch	SCIENCE			English	Article																		SICES H, 1996, P NATL ACAD SCI USA, V95, P2828	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	1998	280	5362					456	456						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH907	9575087				2022-12-28	WOS:000073159600054
J	Kirsch, J; Betz, H				Kirsch, J; Betz, H			Glycine-receptor activation is required for receptor clustering in spinal neurons	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; DORSAL HORN NEURONS; GEPHYRIN; SYNAPSES; LOCALIZATION; SUBUNITS; PROTEIN; IDENTIFICATION; DEPOLARIZATION; EXPRESSION	The ability of nerve cells to receive up to several thousands of synaptic inputs from other neurons provides the anatomical basis for information processing in the vertebrate brain. The formation of functional synapses involves selective clustering of neurotransmitter receptors at presumptive postsynaptic regions of the neuronal plasma membrane(1-4). Receptor-associated proteins are believed to be crucial for this process. In spinal neurons, synaptic targeting of the inhibitory glycine receptor (GlyR)(5,6) depends on the expression of the anchoring protein gephyrin(7-9), Here we show that the competitive GlyR antagonist strychnine and L-type Ca2+ channel blockers inhibit the accumulation of GlyR and gephyrin at postsynaptic membrane areas in cultured rat spinal neurons. Our data are consistent with a model in which GlyR activation that results in Ca2+ influx is required for the clustering of gephyrin and GlyR at developing postsynaptic sites. Similar activity-driven mechanisms may be of general importance in synaptogenesis.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany	Max Planck Society	Kirsch, J (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Duetschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de						ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; BECKER CM, 1992, HDB EXPT PHARM, V102, P540; BETZ H, 1985, ANGEW CHEM INT EDIT, V24, P365, DOI 10.1002/anie.198503651; Boehm S, 1997, J PHYSIOL-LONDON, V504, P683, DOI 10.1111/j.1469-7793.1997.683bd.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Craig AM, 1996, J NEUROSCI, V16, P3166; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Goslin K., 1991, CULTURING NERVE CELL, P251; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; KNAUS P, 1986, J NEUROCHEM, V47, P1302; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Virginio C, 1997, DEV BRAIN RES, V98, P30, DOI 10.1016/S0165-3806(96)00164-2; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x	29	223	227	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	1998	392	6677					717	720		10.1038/33694	http://dx.doi.org/10.1038/33694			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565032				2022-12-28	WOS:000073129000059
J	Doherty, PC				Doherty, PC			Update: Immunology - The numbers game for virus-specific CD8(+) T cells	SCIENCE			English	Editorial Material							MEMORY		St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Doherty, PC (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Doherty, Peter Charles/C-4185-2013	Doherty, Peter Charles/0000-0002-5028-3489				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; KURODA MJ, IN PRESS J EXP MED; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	10	72	80	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	1998	280	5361					227	227		10.1126/science.280.5361.227	http://dx.doi.org/10.1126/science.280.5361.227			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH195	9565533				2022-12-28	WOS:000073082400036
J	Pal, B				Pal, B			Following up outpatients by telephone: pilot study	BRITISH MEDICAL JOURNAL			English	Article									S Manchester Univ Hosp NHS Trust, Withington Hosp, Manchester M20 2LR, Lancs, England	Wythenshawe Hospital NHS Foundation Trust	Pal, B (corresponding author), S Manchester Univ Hosp NHS Trust, Withington Hosp, Manchester M20 2LR, Lancs, England.	bpal@fs1.with.man.ac.uk						HALLAM L, 1991, BRIT MED J, V302, P629, DOI 10.1136/bmj.302.6777.629; Lattimer V, 1997, BRIT MED J, V314, P198; PAL B, 1996, BR J RHEUMATOL S1, V35, pA250; RAO JN, 1994, BRIT MED J, V309, P1527, DOI 10.1136/bmj.309.6968.1527; Wootton R, 1996, BRIT MED J, V313, P1375, DOI 10.1136/bmj.313.7069.1375	5	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1647	1647		10.1136/bmj.316.7145.1647	http://dx.doi.org/10.1136/bmj.316.7145.1647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603747	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000074022700024
J	Chou, CF; Jin, AJ; Hui, SW; Huang, CC; Ho, JT				Chou, CF; Jin, AJ; Hui, SW; Huang, CC; Ho, JT			Multiple-step melting in two-dimensional hexatic liquid-crystal films	SCIENCE			English	Article							BOND-ORIENTATIONAL ORDER; X-RAY-OBSERVATION; HEAT-CAPACITY; 2 DIMENSIONS; THIN-FILMS; PHASE; TRANSITION; DENSITY; FLUCTUATIONS	An unexpected three-stage melting transition has been observed in two-dimensional (2D) free-standing liquid-crystal films by in situ electron-diffraction and optical-reflectivity measurements. These data suggest the existence of two phases between the 2D solid and liquid: a hexatic phase and, at a higher temperature, an intermediate liquid phase with hexatic-like positional correlations (similar to 40 angstroms) but no long-range orientational order. Previous high-resolution heat-capacity measurements have revealed a divergent-like anomaly at the hexatic-liquid transition that sharply contradicts the predictions of 2D melting theories. The observation of an intermediate isotropic phase may alter our understanding of 2D melting and lead to reconciliation between current experiments and theories.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Appl Mat Inc, Santa Clara, CA 95054 USA; Roswell Pk Canc Inst, Dept Biophys, Buffalo, NY 14263 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA	Princeton University; Applied Materials Inc; Roswell Park Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chou, CF (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	cchou@princeton.edu	Chou, Chia-Fu/H-4084-2013	Chou, Chia-Fu/0000-0003-0070-5556				AEPPLI G, 1984, PHYS REV LETT, V53, P2133, DOI 10.1103/PhysRevLett.53.2133; [Anonymous], 2007, PRINCIPLES CONDENSED; [Anonymous], 1988, STRUCTURE LIQUID CRY; BERKER AN, 1979, PHYS REV B, V19, P2488, DOI 10.1103/PhysRevB.19.2488; BRINKMAN WF, 1982, SCIENCE, V217, P693, DOI 10.1126/science.217.4561.693; BROCK JD, 1986, PHYS REV LETT, V57, P98, DOI 10.1103/PhysRevLett.57.98; CHENG M, 1987, PHYS REV LETT, V59, P1112, DOI 10.1103/PhysRevLett.59.1112; CHENG M, 1988, PHYS REV LETT, V61, P550, DOI 10.1103/PhysRevLett.61.550; Chou CF, 1996, PHYS REV LETT, V76, P4556, DOI 10.1103/PhysRevLett.76.4556; CHOU JT, 1997, PHYS REV E, V56, P592; DAI HJ, 1992, PHYS REV LETT, V69, P1576, DOI 10.1103/PhysRevLett.69.1576; DAVEY SC, 1984, PHYS REV LETT, V53, P2129, DOI 10.1103/PhysRevLett.53.2129; GEER R, 1991, REV SCI INSTRUM, V62, P415, DOI 10.1063/1.1142136; GRIER DG, 1991, PHYS REV LETT, V66, P2270, DOI 10.1103/PhysRevLett.66.2270; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; HUANG CC, 1993, ADV PHYS, V42, P343, DOI 10.1080/00018739300101504; JIN AJ, 1994, PHYS REV E, V49, pR4791, DOI 10.1103/PhysRevE.49.R4791; JIN AJ, 1995, PHYS REV LETT, V74, P4863, DOI 10.1103/PhysRevLett.74.4863; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; MURRAY CA, 1987, PHYS REV LETT, V58, P1200, DOI 10.1103/PhysRevLett.58.1200; NELSON DR, 1979, PHYS REV B, V19, P2457, DOI 10.1103/PhysRevB.19.2457; PINDAK R, 1981, PHYS REV LETT, V46, P1135, DOI 10.1103/PhysRevLett.46.1135; SESHADRI R, 1991, PHYS REV LETT, V66, P2774, DOI 10.1103/PhysRevLett.66.2774; Sikes HD, 1997, SCIENCE, V278, P1604, DOI 10.1126/science.278.5343.1604; SIROTA EB, 1987, PHYS REV A, V35, P2283, DOI 10.1103/PhysRevA.35.2283; SOLLA SA, 1981, PHYS REV B, V23, P6008, DOI 10.1103/PhysRevB.23.6008; STOEBE T, 1992, PHYS REV LETT, V68, P2944, DOI 10.1103/PhysRevLett.68.2944; STOEBE T, 1994, PHYS REV E, V49, P5238, DOI 10.1103/PhysRevE.49.5238; STRANDBURG KJ, 1988, REV MOD PHYS, V60, P161, DOI 10.1103/RevModPhys.60.161; Strandburg KJ., 1992, BOND ORIENTATIONAL O, DOI 10.1007/978-1-4612-2812-7; YOUNG AP, 1979, PHYS REV B, V19, P1855, DOI 10.1103/PhysRevB.19.1855; YOUNG CY, 1978, PHYS REV LETT, V40, P773, DOI 10.1103/PhysRevLett.40.773	32	59	60	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1424	1426		10.1126/science.280.5368.1424	http://dx.doi.org/10.1126/science.280.5368.1424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603729				2022-12-28	WOS:000073883400052
J	Woods, SC; Seeley, RJ; Porte, D; Schwartz, MW				Woods, SC; Seeley, RJ; Porte, D; Schwartz, MW			Signals that regulate food intake and energy homeostasis	SCIENCE			English	Review							NEUROPEPTIDE GENE-EXPRESSION; BODY-WEIGHT; OBESE GENE; LEPTIN ACTION; OB/OB MICE; MEAL SIZE; INTRAVENTRICULAR INSULIN; PARAVENTRICULAR NUCLEUS; PLASMA LEPTIN; OB PROTEIN	Feeding behavior is critical for survival. In addition to providing all of the body's macronutrients (carbohydrates, lipids, and proteins) and most micronutrients (minerals and vitamins), feeding behavior is a fundamental aspect of energy homeostasis, the process by which body fuel stored in the form of adipose tissue is held constant over long intervals. For this process to occur, the amount of energy consumed must match precisely the amount of energy expended. This review focuses on the molecular signals that modulate food intake while integrating the body's immediate and long-term energy needs.	Univ Cincinnati, Med Ctr, Dept Psychiat, Cincinnati, OH 45267 USA; Univ Washington, Dept Med, Seattle, WA 98108 USA; Vet Adm Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University System of Ohio; University of Cincinnati; University of Washington; University of Washington Seattle	Woods, SC (corresponding author), Univ Cincinnati, Med Ctr, Dept Psychiat, POB 670559, Cincinnati, OH 45267 USA.	swoods@uc.campus.mci.net	Schwartz, Michael W/H-9950-2012; Wise, Roy A/A-6465-2012	Seeley, Randy/0000-0002-3721-5625	NIDDK NIH HHS [DK 17844, DK 54890, DK 54080] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017844, R01DK054080, R01DK017844, R01DK054890] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTIN J, 1975, J COMP PHYSIOL PSYCH, V89, P784, DOI 10.1037/h0077040; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; BASKIN DG, 1988, TRENDS NEUROSCI, V11, P107, DOI 10.1016/0166-2236(88)90155-5; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; BILLINGTON CJ, 1991, AM J PHYSIOL, V260, pR321, DOI 10.1152/ajpregu.1991.260.2.R321; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; BRAY GA, 1990, FRONT NEUROENDOCRIN, V11, P128; BRAY GA, 1992, AM J CLIN NUTR, V55, P265; CAMPFIELD LA, 1990, INT J OBESITY, V14, P15; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; CHAVEZ M, 1995, BEHAV NEUROSCI, V109, P547, DOI 10.1037/0735-7044.109.3.547; Chavez M, 1996, AM J PHYSIOL-REG I, V271, pR727, DOI 10.1152/ajpregu.1996.271.3.R727; Chavez M, 1997, PHYSIOL BEHAV, V62, P631, DOI 10.1016/S0031-9384(97)00188-1; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; CHUA SC, 1991, MOL BRAIN RES, V11, P291, DOI 10.1016/0169-328X(91)90038-Y; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DagogoJack S, 1996, DIABETES, V45, P695, DOI 10.2337/diabetes.45.5.695; DALLMAN MF, 1993, TRENDS ENDOCRIN MET, V4, P62, DOI 10.1016/S1043-2760(05)80017-7; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DeCastro JM, 1996, NEUROSCI BIOBEHAV R, V20, P119, DOI 10.1016/0149-7634(95)00047-I; DRENICK EJ, 1978, INT J OBESITY, V2, P123; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; EVEN P, 1985, BRAIN RES BULL, V15, P429, DOI 10.1016/0361-9230(85)90012-7; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; FIGIEWICZ DP, 1986, AM J PHYSIOL, V250, pR856; FIGLEWICZ DP, 1989, AM J PHYSIOL, V256, pR1313, DOI 10.1152/ajpregu.1989.256.6.R1313; FIGLEWICZ DP, 1986, BRAIN RES BULL, V17, P535, DOI 10.1016/0361-9230(86)90222-4; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman MI, 1997, P NUTR SOC, V56, P41, DOI 10.1079/PNS19970008; GEARY N, 1990, NEUROSCI BIOBEHAV R, V14, P323, DOI 10.1016/S0149-7634(05)80042-9; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIBBS J, 1979, NATURE, V282, P208, DOI 10.1038/282208a0; Golden PL, 1997, J CLIN INVEST, V99, P14, DOI 10.1172/JCI119125; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; GREEN PK, 1992, ENDOCRINOLOGY, V130, P269, DOI 10.1210/en.130.1.269; GRILL HJ, 1988, AM J PHYSIOL, V254, pR853, DOI 10.1152/ajpregu.1988.254.6.R853; GWOHWA L, 1996, NATURE, V379, P632; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; HOLT J, 1974, PHYSIOL BEHAV, V12, P497, DOI 10.1016/0031-9384(74)90127-9; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; IKEDA H, 1986, APPETITE, V7, P381, DOI 10.1016/S0195-6663(86)80006-X; KENNEDY GC, 1953, P ROY SOC LOND B BIO, V140, P579; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; KISSILEFF HR, 1970, PHYSIOL BEHAV, V5, P163, DOI 10.1016/0031-9384(70)90060-0; Kolaczynski JW, 1996, DIABETES, V45, P699, DOI 10.2337/diabetes.45.5.699; KULKOSKY PJ, 1981, PEPTIDES, V2, P61, DOI 10.1016/S0196-9781(81)80012-5; Ladenheim EE, 1996, PHARMACOL BIOCHEM BE, V54, P705, DOI 10.1016/0091-3057(96)00023-8; Langhans W, 1996, P NUTR SOC, V55, P497, DOI 10.1079/PNS19960044; LEMAGNEN J, 1966, J PHYSIOL-PARIS, V58, P323; LEMAGNEN J, 1985, HUNGER; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; LEWIS DE, 1993, AM J PHYSIOL, V264, pE279, DOI 10.1152/ajpendo.1993.264.2.E279; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Matson CA, 1997, PEPTIDES, V18, P1275, DOI 10.1016/S0196-9781(97)00138-1; MAYER J, 1967, SCIENCE, V156, P328, DOI 10.1126/science.156.3773.328; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; MORAN TH, 1988, AM J PHYSIOL, V255, pR1059, DOI 10.1152/ajpregu.1988.255.6.R1059; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; MUURAHAINEN N, 1988, PHYSIOL BEHAV, V44, P645, DOI 10.1016/0031-9384(88)90330-7; MUURAHAINEN NE, 1993, AM J PHYSIOL, V264, pR350, DOI 10.1152/ajpregu.1993.264.2.R350; ODONOHUE TL, 1985, PEPTIDES, V6, P755, DOI 10.1016/0196-9781(85)90180-9; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PISUNYER X, 1982, PHYSIOL BEHAV, V29, P627, DOI 10.1016/0031-9384(82)90230-X; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; PONSALLE P, 1992, J NEUROENDOCRINOL, V4, P585, DOI 10.1111/j.1365-2826.1992.tb00207.x; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; REIDELBERGER RD, 1989, AM J PHYSIOL, V257, pR1512, DOI 10.1152/ajpregu.1989.257.6.R1512; RITTER S, 1994, BRAIN RES, V646, P53, DOI 10.1016/0006-8993(94)90057-4; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; ROTHWELL NJ, 1990, NEUROSCI BIOBEHAV R, V14, P263, DOI 10.1016/S0149-7634(05)80037-5; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; SAKAGUCHI T, 1988, AM J PHYSIOL, V255, pR284, DOI 10.1152/ajpregu.1988.255.2.R284; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SCHLOTH HB, 1997, J ENDOCRINOL, V155, P73; SCHWARTZ GJ, 1993, AM J PHYSIOL, V265, pR872, DOI 10.1152/ajpregu.1993.265.4.R872; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802, DOI 10.1056/NEJM199706193362507; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; SEELEY RJ, 1994, BEHAV NEUROSCI, V108, P347, DOI 10.1037/0735-7044.108.2.347; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; Smith G. P., 1992, MULTIPLE CHOLECYSTOK, P166; SMITH GP, 1985, AM J PHYSIOL, V249, pR638, DOI 10.1152/ajpregu.1985.249.5.R638; SMITH MS, 1993, ENDOCRINOLOGY, V133, P1258, DOI 10.1210/en.133.3.1258; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; STALLONE D D, 1991, Annals of Behavioral Medicine, V13, P220; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEIN LJ, 1982, PEPTIDES, V3, P833, DOI 10.1016/0196-9781(82)90023-7; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; STRUBBE JH, 1980, PHYSIOL BEHAV, V25, P775, DOI 10.1016/0031-9384(80)90383-2; Thiele TE, 1997, AM J PHYSIOL-REG I, V272, pR726, DOI 10.1152/ajpregu.1997.272.2.R726; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; TRAVERS JB, 1987, ANNU REV NEUROSCI, V10, P595, DOI 10.1146/annurev.ne.10.030187.003115; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; WOODS SC, 1994, PSYCHON B REV, V1, P141, DOI 10.3758/BF03200770; WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488; Woods SC, 1996, NEUROSCI BIOBEHAV R, V20, P139, DOI 10.1016/0149-7634(95)00044-F; Wu DF, 1997, J CLIN INVEST, V100, P1804, DOI 10.1172/JCI119708; Zakrzewska KE, 1997, DIABETES, V46, P717, DOI 10.2337/diabetes.46.4.717; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	121	886	936	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1378	1383		10.1126/science.280.5368.1378	http://dx.doi.org/10.1126/science.280.5368.1378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603721				2022-12-28	WOS:000073883400035
J	Greenhalgh, T				Greenhalgh, T			The other side	BRITISH MEDICAL JOURNAL			English	Editorial Material													Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1616	1616		10.1136/bmj.316.7144.1616	http://dx.doi.org/10.1136/bmj.316.7144.1616			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596618	Green Published			2022-12-28	WOS:000073867800079
J	Canales, JP; Detrick, RS; Bazin, S; Harding, AJ; Orcutt, JA				Canales, JP; Detrick, RS; Bazin, S; Harding, AJ; Orcutt, JA			Off-axis crustal thickness across and along the East Pacific Rise within the MELT area	SCIENCE			English	Article							OVERLAPPING SPREADING CENTERS; MAGMA CHAMBER BENEATH; SEISMIC IMAGES; LAU BASIN; EVOLUTION; RIDGE	Wide-angle seismic data along the Mantle Electromagnetic and Tomography (MELT) arrays show that the thickness of 0.5- to 1.5-million-year-old crust of the Nazca Plate is not resolvably different from that of the Pacific Plate, despite an asymmetry in depth and gravity across this portion of the East Pacific Rise. Crustal thickness on similarly aged crust on the Nazca plate near a magmatically robust part of the East Pacific Rise at 17 degrees 15'S is slightly thinner (5.1 to 5.7 kilometers) than at the 15 degrees 55'S overlapping spreading center (5.8 to 6.3 kilometers). This small north-south off-axis crustal thickness difference may reflect along-axis temporal variations in magma supply, whereas the across-axis asymmetry in depth and gravity must be caused by density variations in the underlying mantle.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	Woods Hole Oceanographic Institution; University of California System; University of California San Diego; Scripps Institution of Oceanography	Canales, JP (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	juan@sienna.whoi.edu	Bazin, Sara/AAL-3694-2020; Bazin, Sara/A-5654-2011	Bazin, Sara/0000-0001-6478-7760; Canales, Juan Pablo/0000-0003-3066-7888				Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; BAZIN S, IN PRESS GEOPHYS RES; COLLIER J, 1990, NATURE, V346, P646, DOI 10.1038/346646a0; COLLIER JS, 1992, J GEOPHYS RES-SOL EA, V97, P14031, DOI 10.1029/91JB02751; Cormier MH, 1996, MAR GEOPHYS RES, V18, P53, DOI 10.1007/BF00286203; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DETRICK RS, 1993, SCIENCE, V259, P499, DOI 10.1126/science.259.5094.499; EBERLE MA, IN PRESS J GEOPHYS R; Hooft EEE, 1997, J GEOPHYS RES-SOL EA, V102, P27319, DOI 10.1029/97JB02349; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13971, DOI 10.1029/93JB00706; LONSDALE P, 1989, J GEOPHYS RES-SOLID, V94, P12197, DOI 10.1029/JB094iB09p12197; MACDONALD K, 1984, J GEOPHYS RES, V89, P6049, DOI 10.1029/JB089iB07p06049; MACDONALD KC, 1988, EARTH PLANET SC LETT, V88, P119, DOI 10.1016/0012-821X(88)90051-9; MAGDE LS, 1995, J GEOPHYS RES-SOL EA, V100, P3747, DOI 10.1029/94JB02869; MUTTER JC, 1995, SCIENCE, V268, P391, DOI 10.1126/science.268.5209.391; Scheirer DS, 1998, SCIENCE, V280, P1221, DOI 10.1126/science.280.5367.1221; SCHEIRER DS, 1993, J GEOPHYS RES-SOL EA, V98, P7871, DOI 10.1029/93JB00015; SINTON JM, 1991, J GEOPHYS RES-SOLID, V96, P6133, DOI 10.1029/90JB02454; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; WILLOUGHBY DF, 1993, B SEISMOL SOC AM, V83, P190; ZELT CA, 1992, GEOPHYS J INT, V108, P16, DOI 10.1111/j.1365-246X.1992.tb00836.x	21	56	56	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1218	1221		10.1126/science.280.5367.1218	http://dx.doi.org/10.1126/science.280.5367.1218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596565				2022-12-28	WOS:000073852500034
J	Treleaven, J				Treleaven, J			Patrick ("Paddy") Francis Ahern - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1537	1537		10.1136/bmj.316.7143.1537	http://dx.doi.org/10.1136/bmj.316.7143.1537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582162	Green Published			2022-12-28	WOS:000073707700066
J	Lupton, JE; Baker, ET; Garfield, N; Massoth, GJ; Feely, RA; Cowen, JP; Greene, RR; Rago, TA				Lupton, JE; Baker, ET; Garfield, N; Massoth, GJ; Feely, RA; Cowen, JP; Greene, RR; Rago, TA			Tracking the evolution of a hydrothermal event plume with a RAFOS neutrally buoyant drifter	SCIENCE			English	Article							DE-FUCA RIDGE; 1993 COAXIAL EVENT; BAROCLINIC VORTEX; CLEFT SEGMENT; VENT PLUMES; JUAN; MANGANESE; SEA; MEGAPLUMES; MODEL	The migration and evolution of a deep ocean hydrothermal event plume were tracked with a neutrally buoyant RAFOS float. The float remained entrained in the plume for 60 days, and the plume vorticity was calculated directly from the anticyclonic motion of the float. Concentrations of suspended particles, particulate iron, and dissolved manganese in the plume did not decay significantly during the 60 days, which indicates that event plumes would be easily detectable a year after formation.	NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; USN, Postgrad Sch, Monterey, CA 93943 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of Defense; United States Navy; Naval Postgraduate School; University of Hawaii System	Lupton, JE (corresponding author), NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA.		Baker, Edward/C-7688-2015; Feely, Richard A./ABI-5740-2020	Baker, Edward/0000-0002-8794-4180; 				ARMI L, 1989, J PHYS OCEANOGR, V19, P354, DOI 10.1175/1520-0485(1989)019<0354:TYITLO>2.0.CO;2; BAKER ES, UNPUB; BAKER ET, 1987, NATURE, V329, P149, DOI 10.1038/329149a0; BAKER ET, 1995, GEOPHYS RES LETT, V22, P147, DOI 10.1029/94GL02403; BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; CHADWICK WW, UNPUB; CHIN CS, 1994, J GEOPHYS RES-SOL EA, V99, P4969, DOI 10.1029/93JB02036; COWEN JP, 1991, J MAR RES, V49, P517, DOI 10.1357/002224091784995800; COWEN JP, IN PRESS DEEP SEA RE; DASARO E, 1994, J GEOPHYS RES-OCEANS, V99, P20361, DOI 10.1029/94JC01846; EMBLEY RW, 1991, GEOLOGY, V19, P771, DOI 10.1130/0091-7613(1991)019<0771:GOTNCS>2.3.CO;2; EMBLEY RW, 1994, J GEOPHYS RES-SOL EA, V99, P4741, DOI 10.1029/93JB02038; EMBLEY RW, 1995, GEOPHYS RES LETT, V22, P143, DOI 10.1029/94GL02281; FEELY R, IN PRESS DEEP SEA RE; Feely RA, 1996, GEOCHIM COSMOCHIM AC, V60, P2297, DOI 10.1016/0016-7037(96)00099-3; FOX C, UNPUB; GENDRON JF, 1993, DEEP-SEA RES PT I, V40, P1559, DOI 10.1016/0967-0637(93)90016-V; HELFRICH KR, 1991, J GEOPHYS RES-OCEANS, V96, P12511, DOI 10.1029/90JC02643; HELFRICH KR, 1995, SEAFLOOR HYDROTHERMA, P347; KADKO DC, 1990, EARTH PLANET SC LETT, V99, P315, DOI 10.1016/0012-821X(90)90137-M; KELLEY DS, IN PRESS DEEP SEA RE; LAVELLE JW, 1995, GEOPHYS RES LETT, V22, P159, DOI 10.1029/94GL01463; LAVELLE JW, 1992, J GEOPHYS RES-OCEANS, V97, P7413, DOI 10.1029/92JC00406; LUPTON JE, 1989, NATURE, V337, P161, DOI 10.1038/337161a0; LUPTON JE, 1995, GEOPHYS RES LETT, V22, P155, DOI 10.1029/94GL02797; LUPTON JM, UNPUB; MASSOTH GJ, 1994, J GEOPHYS RES-SOL EA, V99, P4905, DOI 10.1029/93JB02799; MASSOTH GJ, IN PRESS DEEP SEA RE; MCWILLIAMS JC, 1985, REV GEOPHYS, V23, P165, DOI 10.1029/RG023i002p00165; MULLINEAUX LS, 1991, OCEANUS, V34, P64; MULLINEAUX LS, 1995, SEAFLOOR HYDROTHERMA, P408; POND S, 1978, INTRO DYNAMIC OCEANO, P120; ROSSBY HT, 1986, J ATMOS OCEAN TECH, V3, P672; SPEER KG, 1989, GEOPHYS RES LETT, V16, P461, DOI 10.1029/GL016i005p00461	34	33	33	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1052	1055		10.1126/science.280.5366.1052	http://dx.doi.org/10.1126/science.280.5366.1052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582113				2022-12-28	WOS:000073663600039
J	Shannon, MC; Agee, CB				Shannon, MC; Agee, CB			Percolation of core melts at lower mantle conditions	SCIENCE			English	Article							HIGH-PRESSURE; DIHEDRAL ANGLE; CONSTRAINTS; PHASE	Experiments at high pressure and temperature to determine the dihedral angle of core melts in lower mantle phases yielded a value of similar to 71 degrees for perovskite-dominated matrices. This angle, although greater than the 60 degrees required for completely efficient percolation, is considerably less than the angles observed in mineral matrices at upper mantle pressure-temperature conditions in experiments. In other words, molten iron alloy can flow much more easily in lower mantle mineralogies than in upper mantle mineralogies. Accordingly, although segregation of core material by melt percolation is probably not feasible in the upper mantle, core formation by percolation may be possible in the lower mantle.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Shannon, MC (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.							AGEE CB, 1995, J GEOPHYS RES-SOL EA, V100, P17725, DOI 10.1029/95JB00049; Ballhaus C, 1996, EARTH PLANET SC LETT, V143, P137, DOI 10.1016/0012-821X(96)00135-5; BULAU JR, 1979, J GEOPHYS RES, V84, P6102, DOI 10.1029/JB084iB11p06102; Elliott MT, 1997, GEOLOGY, V25, P355, DOI 10.1130/0091-7613(1997)025<0355:OTIOTE>2.3.CO;2; Faul UH, 1997, J GEOPHYS RES-SOL EA, V102, P10299, DOI 10.1029/96JB03460; GOARANT F, 1992, J GEOPHYS RES-SOL EA, V97, P4477, DOI 10.1029/92JB00018; HERPFER MA, 1992, THESIS ARIZONA STATE; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Jurewicz S, 1995, P LUNAR PLANET SCI C, V26, P709; JUREWICZ SR, 1986, J GEOPHYS RES-SOLID, V91, P9277, DOI 10.1029/JB091iB09p09277; LAPORTE D, 1995, CHEM GEOL, V124, P161, DOI 10.1016/0009-2541(95)00052-N; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Manga M, 1996, GEOPHYS RES LETT, V23, P3091, DOI 10.1029/96GL03021; Minarik WG, 1996, SCIENCE, V272, P530, DOI 10.1126/science.272.5261.530; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; Shannon MC, 1996, GEOPHYS RES LETT, V23, P2717, DOI 10.1029/96GL02817; Smith C. E., 1964, MET REV, V9, P1, DOI DOI 10.1179/MTLR.1964.9.1.1; Stevenson DJ., 1990, ORIGIN EARTH, P231; STICKELS CA, 1964, T METALL SOC AIME, V230, P795; Urakawa S., 1987, HIGH PRESS RES MINER, V39, P95, DOI DOI 10.1029/GM039P0095; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; WRAY PJ, 1976, ACTA METALL MATER, V24, P125, DOI 10.1016/0001-6160(76)90015-8	22	57	58	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1059	1061		10.1126/science.280.5366.1059	http://dx.doi.org/10.1126/science.280.5366.1059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582115				2022-12-28	WOS:000073663600041
J	Beecham, L				Beecham, L			BMA calls for risk management approach to stress	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1465	1465						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572776				2022-12-28	WOS:000073651600072
J	Crossan, L; Delamothe, T				Crossan, L; Delamothe, T			Letters to the editor: the new order - Please respond to articles using website, email, or disk - but not paper	BRITISH MEDICAL JOURNAL			English	Editorial Material																		BHOPAL RS, 1994, BRIT MED J, V308, P1582, DOI 10.1136/bmj.308.6944.1582; Bonnema J, 1998, BRIT MED J, V316, P1267, DOI 10.1136/bmj.316.7140.1267; WHITLOCK S, MY OWN EXPERIENCES E	3	11	11	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1406	1406		10.1136/bmj.316.7142.1406	http://dx.doi.org/10.1136/bmj.316.7142.1406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572748	Green Published			2022-12-28	WOS:000073651600008
J	Farrell, B; Fraser, A; Sandercock, P; Slattery, J; Warlow, CP				Farrell, B; Fraser, A; Sandercock, P; Slattery, J; Warlow, CP		Europ Carotid Surg Trial Collaborat Grp	Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST)	LANCET			English	Article							STROKE	Background. Our objective was to assess the risks and benefits of carotid endarterectomy, primarily in terms of stroke prevention, in patients with recently symptomatic carotid stenosis. Methods. This multicentre, randomised controlled trial enrolled 3024 patients. We enrolled men and women of any age, with some degree of carotid stenosis, who within the previous 6 months had had at least one transient or mild symptomatic ischaemic vascular event in the distribution of one or both carotid arteries. Between 1981 and 1994, we allocated 1811 (60%) patients to surgery and 1213 (40%) to control (surgery to be avoided for as long as possible). Follow-up was until the end of 1995 (mean 6.1 years), and the main analyses were by intention to treat. Findings The overall outcome (major stroke or death) occurred in 669 (37.0%) surgery-group patients and 442 (36.5%) control-group patients. The risk of major stroke or death complicating surgery (7.0%) did not vary substantially with severity of stenosis. On the other hand, the risk of major ischaemic stroke ipsilateral to the unoperated symptomatic carotid artery increased with severity of stenosis, particularly above about 70-80% of the original luminal diameter, but only for 2-3 years after randomisation. On average, the immediate risk of surgery was worth trading off against the long-term risk of stroke without surgery when the stenosis was greater than about 80% diameter; the Kaplan-Meier estimate of the frequency of a major stroke or death at 3 years was 26.5% for the control group and 14.9% for the surgery group, an absolute benefit from surgery of 11.6%. However, consideration of variations in risk with age and sex modified this simple rule based on stenosis severity. We present a graphical procedure that should improve the selection of patients for surgery. Interpretation Carotid endarterectomy is indicated for most patients with a recent non-disabling carotid-territory ischaemic event when the symptomatic stenosis is greater than about 80%. Age and sex should also be taken into account in decisions on whether to operate.	Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Warlow, CP (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	cpw@skull.dcn.ed.ac.uk	sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135				BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Hankey GJ, 1994, TRANSIENT ISCHAEMIC; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Slattery J, 1996, LANCET, V347, P1591; STREIFLER JY, 1995, ARCH NEUROL-CHICAGO, V52, P246, DOI 10.1001/archneur.1995.00540270034016; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P	8	2316	2434	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	1998	351	9113					1379	1387		10.1016/s0140-6736(97)09292-1	http://dx.doi.org/10.1016/s0140-6736(97)09292-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593407				2022-12-28	WOS:000073563400007
J	Lyne, P				Lyne, P			Maurice Anthony Barker - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1464	1464		10.1136/bmj.316.7142.1464	http://dx.doi.org/10.1136/bmj.316.7142.1464			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572775	Green Published			2022-12-28	WOS:000073651600067
J	Kortenkamp, SJ; Dermott, SF				Kortenkamp, SJ; Dermott, SF			A 100,000-year periodicity in the accretion rate of interplanetary dust	SCIENCE			English	Article							EXTRATERRESTRIAL HE-3; EARTH; METEORITES; SEDIMENT; OBJECTS; FLUX; RING	Numerical modeling of the orbital evolution of interplanetary dust particles revealed that, over the past 1.2 million years, the rate of accretion of dust by Earth has varied by a factor of 2 to 3. These variations display a 100,000-year periodicity and are anticorrelated with Earth's changing orbital eccentricity. Extraterrestrial helium-3 concentrations in a deepsea sediment core display a similar periodicity but are 50,000 years out of phase with the predicted variations. Also, because collisions between large bodies in the asteroid belt are inevitable, it is expected that large-amplitude stochastic variations on 10(7)- to 10(8)-year time scales would be superimposed on the 10(5)-year periodic variations.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Florida, Dept Astron, Gainesville, FL 32611 USA	Carnegie Institution for Science; State University System of Florida; University of Florida	Kortenkamp, SJ (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	kortenka@dtm.ciw.edu; dermott@astro.ufl.edu						Bottke WF, 1997, ICARUS, V126, P470, DOI 10.1006/icar.1997.5685; BOTTKE WF, 1997, NATURE, V386, P154; Bradley J. P., 1988, METEORITES EARLY SOL, P861; DERMOTT SF, 1992, IAU SYMP, V152, P333; DERMOTT SF, 1994, NATURE, V369, P719, DOI 10.1038/369719a0; Dermott SF, 1996, AIP CONF PROC, P25, DOI 10.1063/1.49229; DERMOTT SF, 1984, NATURE, V312, P505, DOI 10.1038/312505a0; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Everhart E., 1985, DYNAMICS COMETS THEI, P185; FARLEY KA, 1995, NATURE, V376, P153, DOI 10.1038/376153a0; FARLEY KA, 1995, NATURE, V378, P600, DOI 10.1038/378600a0; Farley KA, 1997, GEOCHIM COSMOCHIM AC, V61, P2309, DOI 10.1016/S0016-7037(97)00068-9; FLYNN GJ, 1990, P LUNAR PLANET SCI C, V20, P363; Grogan K, 1997, PLANET SPACE SCI, V45, P1657, DOI 10.1016/S0032-0633(97)00100-1; GRUN E, 1994, ASTRON ASTROPHYS, V286, P915; GUSTAFSON BAS, 1994, ANNU REV EARTH PL SC, V22, P553, DOI 10.1146/annurev.ea.22.050194.003005; Harris A.W., 1996, LUNAR PLANET SCI, V27, P493; Jayaraman S, 1996, ASTR SOC P, V104, P155; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; KESSLER DJ, 1981, ICARUS, V48, P39, DOI 10.1016/0019-1035(81)90151-2; KORTENKAMP SJ, 1996, THESIS U FLORIDA GAI; Love SG, 1996, ICARUS, V124, P141, DOI 10.1006/icar.1996.0195; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; LOW FJ, 1984, ASTROPHYS J, V278, pL19, DOI 10.1086/184213; Marcantonio F, 1996, NATURE, V383, P705, DOI 10.1038/383705a0; Muller RA, 1997, SCIENCE, V277, P215, DOI 10.1126/science.277.5323.215; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; PROTHERO DR, 1994, ANNU REV EARTH PL SC, V22, P145, DOI 10.1146/annurev.ea.22.050194.001045; RAMPINO MR, 1988, ANNU REV EARTH PL SC, V16, P73, DOI 10.1146/annurev.ea.16.050188.000445; Reach WT, 1997, ICARUS, V127, P461, DOI 10.1006/icar.1997.5704; REACH WT, 1995, NATURE, V374, P521, DOI 10.1038/374521a0; Schmitz B, 1997, SCIENCE, V278, P88, DOI 10.1126/science.278.5335.88; Veverka J, 1997, SCIENCE, V278, P2109, DOI 10.1126/science.278.5346.2109; WETHERILL GW, 1976, GEOCHIM COSMOCHIM AC, V40, P1297, DOI 10.1016/0016-7037(76)90120-4; Whipple F.L., 1967, SAO SPECIAL REP, V239, P1; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0; Yeomans DK, 1997, SCIENCE, V278, P2106, DOI 10.1126/science.278.5346.2106	39	32	36	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					874	876		10.1126/science.280.5365.874	http://dx.doi.org/10.1126/science.280.5365.874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572725				2022-12-28	WOS:000073532900032
J	Volberding, PA; Deeks, SG				Volberding, PA; Deeks, SG			Antiretroviral therapy for HIV infection - Promises and problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, San Francisco Gen Hosp, AIDS Program, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Deeks, SG (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, AIDS Program, 995 Potrero Ave,Bldg 80,Ward 84, San Francisco, CA 94110 USA.							Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; CONNICK E, 1998, 5 C RETR OPP INF FEB; Deeks S., 1997, 37 INT C ANT AG CHEM; DEMETER L, 1998, 5 C RETR OPP INF FEB; DENNING P, 1998, 5 C RETR OPP INF FEB; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GULICK R, 1997, 87 INT C ANT AG CHEM; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HECHT FM, 1998, 5 C RETR OPP INF FEB; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; *US DEP HHS, 1998, PAN CLIN PRACT TREAT; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	15	48	51	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1343	1344		10.1001/jama.279.17.1343	http://dx.doi.org/10.1001/jama.279.17.1343			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582033				2022-12-28	WOS:000073359800010
J	Kumar, S; Hedges, SB				Kumar, S; Hedges, SB			A molecular timescale for vertebrate evolution	NATURE			English	Article							CLOCK; DIVERGENCE; PHYLOGENY; ORIGINS; MAMMALS	A timescale is necessary for estimating rates of molecular and morphological change in organisms and for interpreting patterns of macroevolution and biogeography(1-9). Traditionally, these times have been obtained from the fossil record, where the earliest representatives of two lineages establish a minimum time of divergence of these lineages(10). The clock-like accumulation of sequence differences in some genes provides an alternative method(11) by which the mean divergence time can be estimated. Estimates from single genes may have large statistical errors, but multiple genes can be studied to obtain a more reliable estimate of divergence time(1,12-13). However, until recently, the number of genes available for estimation of divergence time has been limited. Here we present divergence-time estimates for mammalian orders and major lineages of vertebrates, from an analysis of 658 nuclear genes. The molecular times agree with most early (Palaeozoic) and late (Cenozoic) fossil-based times, but indicate major gaps in the Mesozoic fossil record. At least five lineages of placental mammals arose more than 100 million years ago, and most of the modern orders seem to have diversified before the Cretaceous/Tertiary extinction of the dinosaurs.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Inst Mol Evolutionary Genet, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedges, SB (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212				Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; Avise John C., 1994, pi; Benefit BR, 1997, NATURE, V388, P368, DOI 10.1038/41078; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; Benton MJ, 1997, VERTEBRATE PALEONTOL; BENTON MJ, 1993, FOSSIL RECORD, V2; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; Easteal S., 1995, MAMMALIAN MOL CLOCK; Gee C. H. R., COMMUNICATION; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Hallam A, 1995, OUTLINE PHANEROZOIC; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; JAEGER JJ, 1986, CR ACAD SCI II, V302, P917; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Kielan-Jaworowska Z., 1992, Historical Biology, V6, P185; Kumar S., 1993, MEGA MOL EVOLUTIONAR; MARTIN RD, 1993, NATURE, V363, P223, DOI 10.1038/363223a0; Nei M., 1987, MOL EVOLUTIONARY GEN; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; PARKER PH, 1996, THESIS PENNSYLVANIA; Pilbeam D, 1996, MOL PHYLOGENET EVOL, V5, P155, DOI 10.1006/mpev.1996.0010; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Ward Steve, 1997, P269; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; ZUCKERKANDL E, 1987, J MOL EVOL, V26, P34, DOI 10.1007/BF02111280	30	1552	1595	2	375	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					917	920		10.1038/31927	http://dx.doi.org/10.1038/31927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582070				2022-12-28	WOS:000073359900047
J	Shaller, DV; Sharpe, RS; Rubin, RD				Shaller, DV; Sharpe, RS; Rubin, RD			A national action plan to meet health care quality information needs in the age of managed care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Concerted national action is needed to meet the growing demand for health care quality information among all health care stakeholders. We propose a coordinated national network of independent, public-private quality measurement alliances established through strong purchaser and consumer leadership at the state, regional, or local levels. These independent alliances could assume a variety of organizational forms, but all would undertake specific quality measurement and consumer information projects to meet local health care market needs by drawing on various combinations of the emerging national standardized quality measures. Local implementation of quality measures based on national standards will facilitate cross-market benchmarking and multistate comparisons useful not only to state and local market constituencies, but to national employers, health plans, provider organizations, and the federal government as well. Successful models of such alliances already exist that demonstrate the feasibility of this national strategy, but concerted national leadership and federal matching funding will be needed to meet the scope of implementation required in markets across the country.	Fdn Hlth Care Qual, Seattle, WA 98104 USA; Qual Measurement Advisory Serv, Seattle, WA USA		Shaller, DV (corresponding author), Fdn Hlth Care Qual, 83 S King St,Suite 215, Seattle, WA 98104 USA.							Advisory Commission on Consumer Protection and Quality in the Health Care Industry, 1998, QUAL 1 BETT HLTH CAR; *HJ KAIS FAM FDN A, 1996, AM HLTH CAR CONS ROL; *NAT COMM QUAL ASS, 1997, ROAD MAP INF SYST EV, V4	3	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1254	1258		10.1001/jama.279.16.1254	http://dx.doi.org/10.1001/jama.279.16.1254			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9564995				2022-12-28	WOS:000073090300013
J	Lacey, DL; Timms, E; Tan, HL; Kelley, MJ; Dunstan, CR; Burgess, T; Elliott, R; Colombero, A; Elliott, G; Scully, S; Hsu, H; Sullivan, J; Hawkins, N; Davy, E; Capparelli, C; Eli, A; Qian, YX; Kaufman, S; Sarosi, I; Shalhoub, V; Senaldi, G; Guo, J; Delaney, J; Boyle, WJ				Lacey, DL; Timms, E; Tan, HL; Kelley, MJ; Dunstan, CR; Burgess, T; Elliott, R; Colombero, A; Elliott, G; Scully, S; Hsu, H; Sullivan, J; Hawkins, N; Davy, E; Capparelli, C; Eli, A; Qian, YX; Kaufman, S; Sarosi, I; Shalhoub, V; Senaldi, G; Guo, J; Delaney, J; Boyle, WJ			Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation	CELL			English	Article							BONE-RESORPTION; IDENTIFICATION; CULTURES; MATRIX	The ligand for osteoprotegerin has been identified, and it is a TNF-related cytokine that replaces the requirement for stromal cells, vitamin D3, and glucocorticoids in the coculture model of in vitro osteoclastogenesis. OPG ligand (OPGL) binds to a unique hematopoeitic progenitor cell that is committed to the osteoclast lineage and stimulates the rapid induction of genes that typify osteoclast development. OPGL directly activates isolated mature osteoclasts in vitro, and shortterm administration into normal adult mice results in osteoclast activation associated with systemic hypercalcemia. These data suggest that OPGL is an osteoclast differentiation and activation factor. The effects of OPGL are blocked in vitro and in vivo by OPG, suggesting that OPGL and OPG are key extracellular regulators of osteoclast development.	Amgen Inc, Dept Cell Biol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Prot Chem, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Mammalian Cell Mol Biol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Bacterial Express, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Proc Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Boyle, WJ (corresponding author), Amgen Inc, Dept Cell Biol, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.		Dunstan, Colin/G-6214-2013	Dunstan, Colin/0000-0001-7586-4071; Sullivan, John/0000-0001-9840-852X				ABE E, 1986, P NATL ACAD SCI USA, V83, P5958, DOI 10.1073/pnas.83.16.5958; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ARNETT TR, 1986, ENDOCRINOLOGY, V119, P119, DOI 10.1210/endo-119-1-119; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; CHEN PCH, 1995, J BIOL CHEM, V270, P2874, DOI 10.1074/jbc.270.6.2874; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; EVANS RA, 1979, MINER ELECTROL METAB, V2, P179; FULLER K, 1991, BIOCHEM BIOPH RES CO, V181, P67, DOI 10.1016/S0006-291X(05)81382-8; HENTUNEN TA, 1994, BONE MINER, V25, P183, DOI 10.1016/S0169-6009(08)80238-3; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; LACEY DL, 1995, ENDOCRINOLOGY, V136, P2367, DOI 10.1210/en.136.6.2367; LEE MY, 1991, P NATL ACAD SCI USA, V88, P8500, DOI 10.1073/pnas.88.19.8500; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Udagawa N, 1996, BONE, V18, P511, DOI 10.1016/8756-3282(96)00076-2; WILCOX JN, 1993, J HISTOCHEM CYTOCHEM, V41, P1725, DOI 10.1177/41.12.8245419; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; YONEDA T, 1993, J PERIODONTAL RES, V28, P521, DOI 10.1111/j.1600-0765.1993.tb02117.x	24	4258	4560	13	207	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					165	176		10.1016/S0092-8674(00)81569-X	http://dx.doi.org/10.1016/S0092-8674(00)81569-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568710	Bronze			2022-12-28	WOS:000073174000004
J	Sharpe, PC; Young, IS; Evans, AE				Sharpe, PC; Young, IS; Evans, AE			Effect of moderate alcohol consumption on Lp(a) lipoprotein concentrations - Reduction is supported by other studies	BRITISH MEDICAL JOURNAL			English	Letter							CORONARY HEART-DISEASE; WINE		Queens Univ Belfast, Dept Clin Biochem, Belfast BT12 6BA, Antrim, North Ireland; Royal Hosp Trust, Belfast BT12 6BA, Antrim, North Ireland; Queens Univ Belfast, Div Epidemiol, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Sharpe, PC (corresponding author), Queens Univ Belfast, Dept Clin Biochem, Belfast BT12 6BA, Antrim, North Ireland.			Young, Ian/0000-0003-3890-3152				Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; Paassilta M, 1998, BRIT MED J, V316, P594, DOI 10.1136/bmj.316.7131.594; PAUNIO M, 1994, CIRCULATION, V90, P2909, DOI 10.1161/01.CIR.90.6.2909; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; SHARPE PC, 1995, QJM-INT J MED, V88, P101	5	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1675	1675		10.1136/bmj.316.7145.1675	http://dx.doi.org/10.1136/bmj.316.7145.1675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603764	Green Published			2022-12-28	WOS:000074022700047
J	Mostefaoui, S; Hoppe, P; El Goresy, A				Mostefaoui, S; Hoppe, P; El Goresy, A			In situ discovery of graphite with interstellar isotopic signatures in a chondrule-free clast in an L3 chondrite	SCIENCE			English	Article							INTER-STELLAR CLOUDS; GAS-PHASE CHEMISTRY; METEORITES; METAMORPHISM; ABUNDANCES; MURCHISON; GRAINS; MODEL	Optical and scanning electron microscopy of a chondrule-free clast in the unequilibrated L3 chondrite Khohar revealed a spherical object consisting of an aggregate of small (similar to 2-micrometer diameter), Ni-poor (0.5 to 2.89 weight percent) metal particles and fine-grained graphite (< 1-micrometer diameter). The graphite has large D and N-15 excesses (delta D similar to 1500 per mil and delta(15)N similar to 1300 per mil) with two isotopically distinct signatures: N rich with a high D/H ratio and N poor with a high N-15/N-14 ratio. These excesses are the largest D and N-15 excesses observed in situ in a well-characterized phase in a meteorite. The isotopic characteristics are suggestive of an interstellar origin, probably by ion-molecule reactions at low temperature in the interstellar molecular cloud from which the solar system formed. The structure and nonchondritic composition of the metal particles suggest they did not form under equilibrium conditions in the solar nebula.	Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Max Planck Inst Chem, D-55020 Mainz, Germany	Max Planck Society; University of Bern; Max Planck Society	El Goresy, A (corresponding author), Max Planck Inst Kernphys, Postfach 103980, D-69029 Heidelberg, Germany.	goresy@pluto.mpi-hd.mpg.de	Hoppe, Peter/B-3032-2015	Hoppe, Peter/0000-0003-3681-050X				ADAMS NG, 1981, ASTROPHYS J, V247, pL123, DOI 10.1086/183604; AFIATTALAB F, 1980, GEOCHIM COSMOCHIM AC, V44, P431, DOI 10.1016/0016-7037(80)90042-3; BISCHOFF A, 1992, EUR J MINERAL, V4, P707; GEISS J, 1982, GEOCHIM COSMOCHIM AC, V46, P529, DOI 10.1016/0016-7037(82)90156-9; HERMSEN W, 1985, ASTRON ASTROPHYS, V146, P13; HOPPE P, 1995, GEOCHIM COSMOCHIM AC, V59, P4029, DOI 10.1016/0016-7037(95)00280-D; JAROSEWICH E, 1990, METEORITICS, V25, P323, DOI 10.1111/j.1945-5100.1990.tb00717.x; LANGER WD, 1989, ASTROPHYS J SUPPL S, V69, P241, DOI 10.1086/191313; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; MOSTEFAOUI S, 1997, LUNAR PLANET SCI, V28, P989; MOSTEFAOUI S, 1996, THESIS MUSEUM NATL H; PRASAD SS, 1980, ASTROPHYS J SUPPL S, V43, P1, DOI 10.1086/190665; PRASAD SS, 1980, ASTROPHYS J, V239, P151, DOI 10.1086/158097; TIELENS AGGM, 1990, NASA CONF P, V3061, P59; WIDGE S, 1977, T MET A, V8, P309; WOOLUM DS, 1981, GEOCHIM COSMOCHIM AC, V45, P1619, DOI 10.1016/0016-7037(81)90290-8; ZINNER E, 1995, METEORITICS, V30, P209, DOI 10.1111/j.1945-5100.1995.tb01115.x	18	19	19	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1418	1420		10.1126/science.280.5368.1418	http://dx.doi.org/10.1126/science.280.5368.1418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603727				2022-12-28	WOS:000073883400050
J	Hart, C; Chesson, R				Hart, C; Chesson, R			Children as consumers	BRITISH MEDICAL JOURNAL			English	Article							ILLNESS		Robert Gordon Univ, Fac Hlth & Food, Aberdeen AB251 LD, Scotland; Royal Aberdeen Childrens Hosp, Dept Child & Family Psychiat, Aberdeen AB9 2ZG, Scotland	Robert Gordon University; University of Aberdeen	Chesson, R (corresponding author), Robert Gordon Univ, Fac Hlth & Food, Aberdeen AB251 LD, Scotland.							Alderson P., 1993, CHILDRENS CONSENT SU; BACH S, 1991, LIFE PAINTS ITS OWN; BIBACE R, 1981, CHILDRENS CONCEPTION; BREWSTER AB, 1982, PEDIATRICS, V69, P355; Chesson R., 1997, CLIN CHILD PSYCHOL P, V2, P251; DENTREAD CH, 1991, COMMUNICATING HOSP C; *DEP HLTH, 1996, PAT CHART SERV CHILD; *DEP HLTH, 1991, WELFARE CHILDREN YOU; Department of Health, 1993, HLTH PERS SOC SERV S; Donabedian A, 1992, Qual Health Care, V1, P247, DOI 10.1136/qshc.1.4.247; Geldard D., 1997, COUNSELLING CHILDREN; *GEN MED COUNC, 1993, TOM DOCT REC UND MED; GILLIES ML, 1994, HLTH B, V52, P193; Hobbs CJ, 1997, BRIT MED J, V314, P622, DOI 10.1136/bmj.314.7081.622; *HOUS COMM HLTH CO, 1997, SPEC HLTH NEEDS CHIL, V1; JESSOP DJ, 1988, J DEV BEHAV PEDIATR, V9, P147; Joy D, 1998, BR J OCCUP THERAPY, V61, P116; KING P, 1992, TALKING PICTURES TRI; LANSDOWN R, 1996, CHILDREN HOSP; Liberati A, 1997, BRIT MED J, V315, P499, DOI 10.1136/bmj.315.7107.499; Martin J, 1994, Prof Nurse, V10, P14; MELVER S, 1991, OBTAINING VIEWS USER; OSMAN L, 1996, EUR RESP J S21, V9, P35; PALMER KT, 1988, NOTES MRCGP; Parish L, 1986, Can Nurse, V82, P21; PERRIN EC, 1981, PEDIATRICS, V67, P841; Pittman K P, 1992, Pediatr Nurs, V18, P132; SCHOFFSTALL MC, 1988, NURS TIMES, V84, P60; SIMONIAN SJ, 1993, J DEV BEHAV PEDIATR, V14, P8; 1996, CHILDHOOD MATTERS RE, V2; 1996, CHILDHOOD MATTERS RE, V1	31	62	64	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1600	1603		10.1136/bmj.316.7144.1600	http://dx.doi.org/10.1136/bmj.316.7144.1600			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596605	Green Published			2022-12-28	WOS:000073867800035
J	Beecham, L				Beecham, L			Funds allocated to reduce waiting lists	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1465	1465						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572776				2022-12-28	WOS:000073651600076
J	Hankinson, SE; Willett, WC; Colditz, GA; Hunter, DJ; Michaud, DS; Deroo, B; Rosner, B; Speizer, FE; Pollak, M				Hankinson, SE; Willett, WC; Colditz, GA; Hunter, DJ; Michaud, DS; Deroo, B; Rosner, B; Speizer, FE; Pollak, M			Circulating concentrations of insulin-like growth factor-I and risk of breast cancer	LANCET			English	Article							FACTOR-BINDING PROTEIN-3; BODY-MASS INDEX; CELL-PROLIFERATION; SERUM LEVELS; IGF-II; MICE; HORMONE; STAGE; SEX; ADOLESCENTS	Background. Insulin-like growth factor (IGF)-I, a mitogenic and antiapoptotic peptide, can affect the proliferation of breast epithelial cells, and is thought to have a role in breast cancer. We hypothesised that high circulating IGF-I concentrations would be associated with an increased risk of breast cancer. Methods. We carried out a nested case-control study within the prospective Nurses' Health Study cohort. Plasma concentrations of IGF-I and IGF binding protein 3 (IGFBP-3) were measured in blood samples collected in 1989-90. We identified 397 women who had a diagnosis of breast cancer after this date and 620 age-matched controls, IGF-I concentrations were compared by logistic regression with adjustment for other breast-cancer risk factors. Findings. There was no association between IGF-I concentrations and breast-cancer risk among the whole study group. In postmenopausal women there was no association between IGF-I concentrations and breast-cancer risk (top vs bottom quintile of IGF-I, relative risk 0.85 [95% CI 0.53-1.39]). The relative risk of breast cancer among premenopausal women by IGF-I concentration (top vs bottom tertile) was 2.33 (1.06-5.16; p for trend 0.08). Among premenopausal women less than 50 years old at the time of blood collection, the relative risk was 4.58 (1.75-12.0; p for trend 0.02). After further adjustment for plasma IGFBP-3 concentrations these relative risks were 2.88 and 7.28, respectively. Interpretation. A positive relation between circulating IGF-I concentration and risk of breast cancer was found among premenopausal but not postmenopausal women. Plasma IGF-I concentrations may be useful in the identification of women at high risk of breast cancer and in the development of risk reduction strategies. Additional larger studies of this association among premenopausal women are needed to provide more precise estimates of effect.	Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Oncol,Canc Prevent Res Unit, Montreal, PQ H3T 1E2, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Hankinson, SE (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Michaud, Dominique S/I-5231-2014; Pollak, Michael/G-9094-2011	Colditz, Graham/0000-0002-7307-0291; Pollak, Michael/0000-0003-3047-0604	NATIONAL CANCER INSTITUTE [R01CA049449, R01CA040356, R37CA040356, U01CA049449] Funding Source: NIH RePORTER; NCI NIH HHS [CA-49449, CA-40356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; BRUNING PF, 1995, INT J CANCER, V62, P266, DOI 10.1002/ijc.2910620306; CAMPAGNOLI C, 1993, GYNECOL ENDOCRINOL, V7, P251, DOI 10.3109/09513599309152509; Cats A, 1996, CANCER RES, V56, P523; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chen NY, 1997, ENDOCRINOLOGY, V138, P851, DOI 10.1210/en.138.2.851; COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Gucev ZS, 1996, CANCER RES, V56, P1545; Hadsell DL, 1996, ENDOCRINOLOGY, V137, P321, DOI 10.1210/en.137.1.321; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUNTER DJ, 1993, EPIDEMIOL REV, V15, P110, DOI 10.1093/oxfordjournals.epirev.a036096; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Ng ST, 1997, NAT MED, V3, P1141, DOI 10.1038/nm1097-1141; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; Osorio M, 1996, EARLY HUM DEV, V46, P15, DOI 10.1016/0378-3782(96)01737-9; PEYRAT JP, 1993, EUR J CANCER, V29A, P492, DOI 10.1016/S0959-8049(05)80137-6; Pollak M, 1997, ADJ THER CANC, V8, P145; POLLAK M, 1990, J NATL CANCER I, V82, P1693, DOI 10.1093/jnci/82.21.1693; Pollak MN, 1998, P SOC EXP BIOL MED, V217, P143; Pollak MN, 1998, BREAST CANCER RES TR, V47, P209, DOI 10.1023/A:1005950916707; ROSNER B, 1984, BIOMETRICS, V40, P1025, DOI 10.2307/2531153; Rozen F, 1997, J NATL CANCER I, V89, P652, DOI 10.1093/jnci/89.9.652; RUAN W, 1997, P END SOC 79 ANN M, V79, P165; RUAN W, 1995, ENDOCRINOLOGY, V36, P1296; RUGGERI B, 1998, CANCER RES, V49, P4135; SINHA YN, 1979, INT J CANCER, V24, P40; TORNELL J, 1992, J STEROID BIOCHEM, V43, P237, DOI 10.1016/0960-0760(92)90213-3; Yang XF, 1996, CANCER RES, V56, P1509; ZARANDI M, 1994, P NATL ACAD SCI USA, V91, P12298, DOI 10.1073/pnas.91.25.12298	36	1456	1504	3	50	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1393	1396		10.1016/S0140-6736(97)10384-1	http://dx.doi.org/10.1016/S0140-6736(97)10384-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593409				2022-12-28	WOS:000073563400009
J	Boddy, MN; Furnari, B; Mondesert, O; Russell, P				Boddy, MN; Furnari, B; Mondesert, O; Russell, P			Replication checkpoint enforced by kinases Cds1 and Chk1	SCIENCE			English	Article							FISSION YEAST; CDC2; PHOSPHORYLATION; MITOSIS; PATHWAY; CELLS	Cdc2, the kinase that induces mitosis, is regulated by checkpoints that couple mitosis to the completion of DNA replication and repair. The repair checkpoint kinase Chk1 regulates Cdc25, a phosphatase that activates Cdc2, Effecters of the replication checkpoint evoked by hydroxyurea (HU) are unknown. Treatment of fission yeast with HU stimulated the kinase Cds1, which appears to phosphorylate the kinase Wee1, an inhibitor of Cdc2, The protein kinase Cds1 was also required for a large HU-induced increase in the amount of Mik1, a second inhibitor of Cdc2. HU-induced arrest of cell division was abolished in cds? chk1 cells. Thus, Cds1 and Chk1 appear to jointly enforce the replication checkpoint.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	prussell@scripps.edu	Boddy, Michael/A-7214-2009					Aligue R, 1997, J BIOL CHEM, V272, P13320, DOI 10.1074/jbc.272.20.13320; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Blasina A, 1997, MOL BIOL CELL, V8, P1013, DOI 10.1091/mbc.8.6.1013; BODDY MN, UNPUB; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; RHIND N, UNPUB; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0	23	287	296	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					909	912		10.1126/science.280.5365.909	http://dx.doi.org/10.1126/science.280.5365.909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572736				2022-12-28	WOS:000073532900043
J	Nachtigal, MW; Hirokawa, Y; Enyeart-VanHouten, DL; Flanagan, JN; Hammer, GD; Ingraham, HA				Nachtigal, MW; Hirokawa, Y; Enyeart-VanHouten, DL; Flanagan, JN; Hammer, GD; Ingraham, HA			Wilms' tumor 1 and DAX-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression	CELL			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; ADRENAL HYPOPLASIA CONGENITA; AFFINITY DNA-BINDING; TRANSCRIPTION FACTOR; SUBNUCLEAR LOCALIZATION; STEROIDOGENIC FACTOR-1; WT1; MUTATIONS; PROTEIN; MICE	Products of steroidogenic factor 1 (SF-1) and Wilms' tumor 1 (WT1) genes are essential for mammalian gonadogenesis prior to sexual differentiation. In males, SF-1 participates in sexual development by regulating expression of the polypeptide hormone Mullerian inhibiting substance (MIS). Here, we show that WT1 -KTS isoforms associate and synergize with SF-1 to promote MIS expression. In contrast, WT1 missense mutations, associated with male pseudohermaphroditism in Denys-Drash syndrome, fail to synergize with SF-1. Additionally, the X-linked, candidate dosage-sensitive sex-reversal gene, Dax-1, antagonizes synergy between SF-1 and WT1, most likely through a direct interaction with SF-1. We propose that WT1 and Dax-1 functionally oppose each other in testis development by modulating SF-1-mediated transactivation.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ingraham, HA (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.		Flanagan, John/AAG-4857-2019	Flanagan, John/0000-0001-6957-756X; Nachtigal, Mark/0000-0003-3291-8628				Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Giuili G, 1997, DEVELOPMENT, V124, P1799; Guo WW, 1996, GENE, V178, P31, DOI 10.1016/0378-1119(96)00320-4; HATANO O, 1994, DEVELOPMENT, V120, P2787; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Kent J, 1996, DEVELOPMENT, V122, P2813; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lalli E, 1997, MOL ENDOCRINOL, V11, P1950, DOI 10.1210/me.11.13.1950; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MOFFETT P, 1995, P NATL ACAD SCI USA, V92, P11105, DOI 10.1073/pnas.92.24.11105; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899; ZHANG P, 1996, MOL ENDOCRINOL, V6, P1249	43	460	475	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					445	454		10.1016/S0092-8674(00)81172-1	http://dx.doi.org/10.1016/S0092-8674(00)81172-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590178	Bronze			2022-12-28	WOS:000073471500019
J	Philips, AV; Timchenko, LT; Cooper, TA				Philips, AV; Timchenko, LT; Cooper, TA			Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy	SCIENCE			English	Article							CARDIAC TROPONIN-T; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; REPEAT EXPANSION; EXPRESSION; MUTATIONS; ISOFORMS; LENGTH; CELLS	Myotonic dystrophy (DM) is caused by a CTG expansion in the 3' untranslated region of the DM gene. One model of DM pathogenesis suggests that RNAs from the expanded allele create a gain-of-function mutation by the inappropriate binding of proteins to the CUG repeats. Data presented here indicate that the conserved heterogeneous nuclear ribonucleoprotein, CUG-binding protein (CUG-BP), may mediate the trans-dominant effect of the RNA. CUG-BP was found to bind to the human cardiac troponin T (cTNT) pre-messenger RNA and regulate its alternative splicing. Splicing of cTNT was disrupted in DM striated muscle and in normal cells expressing transcripts that contain CUG repeats. Altered expression of genes regulated posttranscriptionally by CUG-BP therefore may contribute to DM pathogenesis.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	tcooper@bcm.tmc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL045565, R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45565] Funding Source: Medline; NIAMS NIH HHS [AR 44387] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; Bertrand E, 1997, RNA, V3, P75; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Caskey CT, 1996, COLD SPRING HARB SYM, V61, P607; COOPER TA, 1992, J BIOL CHEM, V267, P5330; COOPER TA, 1985, J BIOL CHEM, V260, P1140; COOPER TA, 1984, SCIENCE, V226, P979, DOI 10.1126/science.6095446; COOPER TM, UNPUB; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; Harper P.S., 1989, MYOTONIC DYSTROPHY; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; Korade-Mirnics Z, 1998, NUCLEIC ACIDS RES, V26, P1363, DOI 10.1093/nar/26.6.1363; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Phillips MF, 1997, CARDIOVASC RES, V33, P13, DOI 10.1016/S0008-6363(96)00163-0; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Roeder E., 1994, American Journal of Human Genetics, V55, pA7; Ryan KJ, 1996, MOL CELL BIOL, V16, P4014; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; TOKGOZOGLU LS, 1995, JAMA-J AM MED ASSOC, V274, P813, DOI 10.1001/jama.274.10.813; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; TOYOTA N, 1983, MUSCULAR DYSTROPHY B, P89; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334	33	639	657	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					737	741		10.1126/science.280.5364.737	http://dx.doi.org/10.1126/science.280.5364.737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563950				2022-12-28	WOS:000073415600048
J	Yao, TP; Oh, SP; Fuchs, M; Zhou, ND; Ch'ng, LE; Newsome, D; Bronson, RT; Li, E; Livingston, DM; Eckner, R				Yao, TP; Oh, SP; Fuchs, M; Zhou, ND; Ch'ng, LE; Newsome, D; Bronson, RT; Li, E; Livingston, DM; Eckner, R			Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300	CELL			English	Article							CREB-BINDING-PROTEIN; COACTIVATOR CBP; BHLH PROTEINS; NEURAL-TUBE; COMPLEX; ACETYLTRANSFERASE; SUPPRESSOR; ACTIVATION; EXPRESSION; LETHALITY	The transcriptional coactivator and integrator p300 and its closely related family member CBP mediate multiple, signal-dependent transcriptional events. We have generated mice lacking a functional p300 gene. Animals nullizygous for p300 died between days 9 and 11.5 of gestation, exhibiting defects in neurulation, cell proliferation, and heart development. Cells derived from p300-deficient embryos displayed specific transcriptional defects and proliferated poorly. Surprisingly, p300 heterozygotes also manifested considerable embryonic lethality. Moreover, double heterozygosity for p300 and cbp was invariably associated with embryonic death. Thus, mouse development is exquisitely sensitive to the overall gene dosage of p300 and cbp. Our results provide genetic evidence that a coactivator endowed with histone acetyltransferase activity is essential for mammalian cell proliferation and development.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Boston, MA 02111 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tufts University; Tufts University; University of Zurich	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; HOWE JA, 1990, P NATL ACAD SCI USA, V87, P5883, DOI 10.1073/pnas.87.15.5883; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MORAN E, 1993, CURR OPIN GENET DEV, V3, P63, DOI 10.1016/S0959-437X(05)80342-9; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NEVINS JR, 1992, SCIENCE, V258, P424; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parker D, 1996, MOL CELL BIOL, V16, P694; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SCHULE R, 1991, TRENDS GENET, V7, P377, DOI 10.1016/0168-9525(91)90259-S; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Smith CL, 1996, P NATL ACAD SCI USA, V93, P8884, DOI 10.1073/pnas.93.17.8884; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; VANTAGGIATI ML, 1997, CELL, V89, P1175; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; WHITE P, 1989, CELL, V56, P67; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626	55	788	815	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					361	372		10.1016/S0092-8674(00)81165-4	http://dx.doi.org/10.1016/S0092-8674(00)81165-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590171	Bronze			2022-12-28	WOS:000073471500012
J	Nimmo, ER; Pidoux, AL; Perry, PE; Allshire, RC				Nimmo, ER; Pidoux, AL; Perry, PE; Allshire, RC			Defective meiosis in telomere-silencing mutants of Schizosaccharomyces pombe	NATURE			English	Article							POSITION-EFFECT VARIEGATION; FISSION YEAST CENTROMERES; CHROMOSOME MOVEMENT; MEIOTIC PROPHASE; EXPRESSION; MUTATIONS; DISRUPT; GENOME; GENE	During meiotic prophase, chromosomes frequently adopt a bouquet-like arrangement, with their telomeres clustered close to the nuclear periphery(1-3). A dramatic example of this occurs in the fission yeast, Schizosaccharomyces pombe, where all telomeres aggregate adjacent to the spindle pole body (SPB)(4-7). Nuclei then undergo rapid traverses of the cell, known as 'horsetail' movement, which is led by the SPB dragging telomeres and chromosomes behind(4,6,7). This process may initiate or facilitate chromosome pairing before recombination and meiosis. With the aim of identifying components involved in telomere structure and function, we report here the isolation of S. pombe mutants defective in the ability to impose transcriptional silencing on genes placed near telomeres(8). Two of these mutants, lot2-s17 and lot3-uv3, also display a dramatic lengthening of telomeric repeats. lot3-uv3 carries a mutation in Tazl (ref. 9), a telomere-binding protein containing a Myb-like moth similar to two human telomere-binding proteins(10,11). Meiosis is aberrant in these mutant yeast strains, and our analysis demonstrates a decreased association of telomeres with the SPB in meiotic prophase, This results in defective 'horsetail' movement, a significant reduction in recombination, low spore viability and chromosome missegregation through meiosis.	Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Canc Res Campaign Project, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Allshire, RC (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	robin.allshire@hgu.mrc.ac.uk		Allshire, Robin/0000-0002-8005-3625				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DERNBURG AF, 1995, TELOMERES, P295; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HELM R, 1995, NATURE, V373, P663; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; KOHLI J, 1994, CURR BIOL, V4, P724, DOI 10.1016/S0960-9822(00)00160-3; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; MIZUKAMI T, 1993, CELL, V73, P121, DOI 10.1016/0092-8674(93)90165-M; MOLNAR M, 1995, GENETICS, V141, P61; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MUNZ P, 1994, GENETICS, V137, P701; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; NIWA O, 1985, CURR GENET, V9, P463, DOI 10.1007/BF00434051; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; SCHERTHAN H, 1994, J CELL BIOL, V127, P273, DOI 10.1083/jcb.127.2.273; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; SVOBODA A, 1995, CHROMOSOMA, V104, P203, DOI 10.1007/s004120050109; THON G, 1992, GENETICS, V131, P287	30	218	221	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					825	828		10.1038/33941	http://dx.doi.org/10.1038/33941			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572142				2022-12-28	WOS:000073241200056
J	Wolters-Arts, M; Lush, WM; Mariani, C				Wolters-Arts, M; Lush, WM; Mariani, C			Lipids are required for directional pollen-tube growth	NATURE			English	Article							DRY STIGMAS; ARABIDOPSIS; POLLINATION; PLANTS; COMPONENTS; NICOTIANA; RESPONSES; GRADIENTS; BRASSICA; FIELDS	Successful pollination and fertilization are absolute requirements for sexual reproduction in higher plants. Pollen hydration, germination and penetration of the stigma by pollen tubes are influenced by the exudate on wet stigmas(1) and by the pollen coat in species with dry stigmas(2-5). The exudate allows pollen tubes to grow directly into the stigma, whereas the pollen coat establishes the contact with the stigma. Pollen tubes then grow into the papillae, which are covered by a cuticle. The components of the exudate or pollen coat that are responsible for pollen tube penetration are not known. To discover the role of the exudate, we tested selected compounds for their ability to act as functional substitutes for exudate in the initial stages of pollen-tube growth on transgenic stigmaless tobacco plants' that did not produce exudate. Here we show that lipids are the essential factor needed for pollen tubes to penetrate the stigma, and that, in the presence of these lipids, pollen tubes will also penetrate leaves. We propose that lipids direct pollen-tube growth by controlling the flow of water to pollen in species with dry and wet stigmas.	Catholic Univ Nijmegen, Dept Expt Bot, Grad Sch Expt Plant Sci, NL-6525 ED Nijmegen, Netherlands; Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3052, Australia	Radboud University Nijmegen; University of Melbourne	Wolters-Arts, M (corresponding author), Catholic Univ Nijmegen, Dept Expt Bot, Grad Sch Expt Plant Sci, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	mwolters@sci.kun.nl	Mariani, Celestina/C-6920-2013					BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Boden N., 1994, MICELLES MEMBRANES M, P153; Cheung AY, 1996, P NATL ACAD SCI USA, V93, P3853, DOI 10.1073/pnas.93.9.3853; CRESTI M, 1986, AM J BOT, V73, P1713, DOI 10.2307/2444237; DICKINSON H, 1995, SEX PLANT REPROD, V8, P1, DOI 10.1007/BF00228756; DICKINSON H, 1993, NATURE, V364, P573, DOI 10.1038/364573a0; DICKINSON H, 1994, NATURE, V367, P517, DOI 10.1038/367517a0; DUMAS C, 1977, PLANTA, V137, P177, DOI 10.1007/BF00387556; Elleman CJ, 1996, NEW PHYTOL, V133, P197, DOI 10.1111/j.1469-8137.1996.tb01886.x; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; EVANS DE, 1990, PLANT PHYSIOL, V92, P418; GOLDMAN MHS, 1994, EMBO J, V13, P2976, DOI 10.1002/j.1460-2075.1994.tb06596.x; HULSKAMP M, 1995, PLANT J, V8, P703, DOI 10.1046/j.1365-313X.1995.08050703.x; HYDE GJ, 1995, EUR J CELL BIOL, V67, P356; Ikeda S, 1997, SCIENCE, V276, P1564, DOI 10.1126/science.276.5318.1564; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; KONAR RN, 1966, PLANTA, V71, P378; LABARCA C, 1970, PLANT PHYSIOL, V46, P150, DOI 10.1104/pp.46.1.150; LOLLE SJ, 1993, DEV BIOL, V155, P250, DOI 10.1006/dbio.1993.1022; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; MALHO R, 1992, SEX PLANT REPROD, V5, P57, DOI 10.1007/BF00714558; MARET G, 1985, TOP APPL PHYS, V57, P143; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; Piffanelli P, 1997, PLANT J, V11, P549, DOI 10.1046/j.1365-313X.1997.11030549.x; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; Pruitt RE, 1997, TRENDS PLANT SCI, V2, P328, DOI 10.1016/S1360-1385(97)84615-8; REGER BJ, 1992, SEX PLANT REPROD, V5, P47, DOI 10.1007/BF00714557; ROBBERTSE PJ, 1990, S AFR J BOT, V56, P487, DOI 10.1016/S0254-6299(16)31046-8; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; WoltersArts M, 1996, SEX PLANT REPROD, V9, P243, DOI 10.1007/BF02152698	30	278	289	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					818	821		10.1038/33929	http://dx.doi.org/10.1038/33929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572141				2022-12-28	WOS:000073241200054
J	Beecham, L				Beecham, L			Changes in NHS will be "historic"	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1540	1540						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582163				2022-12-28	WOS:000073707700088
J	Le, XC; Xing, JZ; Lee, J; Leadon, SA; Weinfeld, M				Le, XC; Xing, JZ; Lee, J; Leadon, SA; Weinfeld, M			Inducible repair of thymine glycol detected by an ultrasensitive assay for DNA damage	SCIENCE			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; LASER-INDUCED FLUORESCENCE; ADAPTIVE RESPONSE; IONIZING-RADIATION; CAPILLARY ELECTROPHORESIS; HUMAN-LYMPHOCYTES; STRAND BREAKS; CELLS; HYPERSENSITIVITY; BASE	An ultrasensitive assay for measuring DNA base damage is described that couples immunochemical recognition with capillary electrophoresis and laser-induced fluorescence detection. The method provides a detection limit of 3 x 10(-21) moles, an improvement of four to five orders of magnitude over current methods. Induction and repair of thymine glycols were studied in irradiated A549 cells (a human lung carcinoma cell line). Exposure of these cells to a low dose of radiation (0.25 Gray) 4 hours before a clinically relevant dose (2 Gray) enhanced removal of thymine glycols after the higher dose. These data provide evidence for an inducible repair response for radiation-induced damage to DNA bases.	Univ Alberta, Fac Med & Oral Hlth Sci, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alberta	Le, XC (corresponding author), Univ Alberta, Fac Med & Oral Hlth Sci, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada.	xc.le@ualberta.ca,; mweinfel@gpu.srv.ualberta.ca	Supreme, Jez WR/A-9015-2011; Le, X. Chris/O-4947-2015	Le, X. Chris/0000-0002-7690-6701	NATIONAL CANCER INSTITUTE [R01CA062059, R01CA040453] Funding Source: NIH RePORTER; NCI NIH HHS [CA40453, CA62059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABELSON PH, 1994, SCIENCE, V265, P1507, DOI 10.1126/science.7832844; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Boothman DA, 1996, MUTAT RES-FUND MOL M, V358, P143, DOI 10.1016/S0027-5107(96)00115-7; CHAUDHRY MA, 1995, J MOL BIOL, V249, P614; CHENG YF, 1988, SCIENCE, V242, P562, DOI 10.1126/science.3140381; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; DIZDAROGLU M, 1994, METHOD ENZYMOL, V234, P3; Douki T, 1996, CARCINOGENESIS, V17, P347, DOI 10.1093/carcin/17.2.347; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; FRIEDBERG EC, 1988, DNA REPAIR LAB MANUA; HAAB BB, 1995, ANAL CHEM, V67, P3253, DOI 10.1021/ac00114a023; Hemminki K, 1993, IARC Sci Publ, P51; Hilbert TP, 1997, J BIOL CHEM, V272, P6733, DOI 10.1074/jbc.272.10.6733; Ikushima T, 1996, MUTAT RES-FUND MOL M, V358, P193, DOI 10.1016/S0027-5107(96)00120-0; Joiner MC, 1996, MUTAT RES-FUND MOL M, V358, P171, DOI 10.1016/S0027-5107(96)00118-2; KOW YW, 1990, MUTAT RES, V235, P147, DOI 10.1016/0921-8777(90)90068-G; LE XC, 1995, J CHROMATOGR A, V716, P215, DOI 10.1016/0021-9673(95)00645-4; LEADON SA, 1983, MUTAT RES, V112, P191, DOI 10.1016/0167-8817(83)90006-8; LEADON SA, 1986, NUCLEIC ACIDS RES, V14, P8979, DOI 10.1093/nar/14.22.8979; Lehnert S, 1997, RADIAT ENVIRON BIOPH, V36, P67, DOI 10.1007/s004110050056; LJUNGMAN M, 1991, RADIAT RES, V126, P58, DOI 10.2307/3578171; LJUNGMAN M, 1991, RADIAT RES, V127, P171, DOI 10.2307/3577962; Longo JA, 1997, RADIAT RES, V147, P35, DOI 10.2307/3579440; MARPLES B, 1995, RADIAT RES, V141, P160, DOI 10.2307/3579043; Marples B, 1997, INT J RADIAT BIOL, V71, P721, DOI 10.1080/095530097143725; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Pfeifer GP, 1996, TECHNOLOGIES DETECTI; RAVANAT JL, 1995, CHEM RES TOXICOL, V8, P1039, DOI 10.1021/tx00050a007; SEONG J, 1995, INT J RADIAT ONCOL, V33, P869, DOI 10.1016/0360-3016(95)00085-X; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Weinfeld Michael, 1996, P63; YOUNGBLOM JH, 1989, MUTAT RES, V227, P257, DOI 10.1016/0165-7992(89)90107-3	34	176	186	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	1998	280	5366					1066	1069		10.1126/science.280.5366.1066	http://dx.doi.org/10.1126/science.280.5366.1066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582118				2022-12-28	WOS:000073663600044
J	Holly, J				Holly, J			Insulin-like growth factor-I and new opportunities for cancer prevention	LANCET			English	Editorial Material							BREAST-CANCER		Univ Bristol, Bristol Royal Infirm, Div Surg, Bristol BS2 8HW, Avon, England	Bristol Royal Infirmary; University of Bristol	Holly, J (corresponding author), Univ Bristol, Bristol Royal Infirm, Div Surg, Bristol BS2 8HW, Avon, England.							BASERGA R, 1995, CANCER RES, V55, P249; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Colao A, 1998, J CLIN ENDOCR METAB, V83, P775, DOI 10.1210/jc.83.3.775; Cuneo RC, 1998, J CLIN ENDOCR METAB, V83, P107, DOI 10.1210/jc.83.1.107; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; Gill ZP, 1997, J BIOL CHEM, V272, P25602, DOI 10.1074/jbc.272.41.25602; Helle SI, 1996, INT J CANCER, V69, P335; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Ng ST, 1997, NAT MED, V3, P1141, DOI 10.1038/nm1097-1141; ORME SM, 1996, J ENDOCRINOL S, V148, p3C22; Osterziel KJ, 1998, LANCET, V351, P1233, DOI 10.1016/S0140-6736(97)11329-0; RAJAH R, 1997, J BIOL CHEM, V272, P11281; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005	13	57	59	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1373	1375		10.1016/S0140-6736(05)79438-1	http://dx.doi.org/10.1016/S0140-6736(05)79438-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593403				2022-12-28	WOS:000073563400003
J	Wise, R				Wise, R			Bioterrorism: Thinking the unthinkable	LANCET			English	Editorial Material									City Hosp, Dept Clin Microbiol, Birmingham B8 7QH, W Midlands, England	University of Birmingham	Wise, R (corresponding author), City Hosp, Dept Clin Microbiol, Birmingham B8 7QH, W Midlands, England.							BOYCE N, NEW SCI, V158, P4; CHEVRIER MI, 1997, WASHINGTON POST 1221, pC1; EITZEN E, 1998, INT C EM INF DIS MA; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; STEFFEN R, 1997, J INFECTION, V34, P27; WOODALL JP, 1998, INT C EM INF DIS MAR; 1998, IMPROVING CIVILIAN M	7	11	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1378	1378		10.1016/S0140-6736(05)79441-1	http://dx.doi.org/10.1016/S0140-6736(05)79441-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593406				2022-12-28	WOS:000073563400006
J	Black, D				Black, D			Coping with loss - The dying child	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-STUDENTS; DEATH; ILLNESS; CANCER; ADJUSTMENT; CARE; DIAGNOSIS; GRIEF; HOME		Traumat Stress Clin, London W1P 1LB, England	University of London; University College London	Black, D (corresponding author), Traumat Stress Clin, London W1P 1LB, England.							BARBARIN OA, 1986, AM J COMMUN PSYCHOL, V14, P221, DOI 10.1007/BF00911822; BLACK D, 1989, ARCH DIS CHILD, V64, P750, DOI 10.1136/adc.64.5.750; BLEEKER JAC, 1979, MED EDUC, V13, P117, DOI 10.1111/j.1365-2923.1979.tb00933.x; Bloch S, 1976, Med Educ, V10, P269; Bluebond-Langner M., 1978, PRIVATE WORLDS DYING, P210; CARANDANG MLA, 1979, AM J ORTHOPSYCHIAT, V49, P474, DOI 10.1111/j.1939-0025.1979.tb02630.x; CHAMBERS EJ, 1989, BRIT MED J, V298, P937, DOI 10.1136/bmj.298.6678.937; COOK JA, 1984, J PSYCHOSOC ONCOL, V2, P71; DANIELS D, 1987, J ABNORM CHILD PSYCH, V15, P295, DOI 10.1007/BF00916356; DAVIDSON GW, 1995, CHILDHOOD DEATH, P243; FIELD D, 1984, MED EDUC, V18, P429, DOI 10.1111/j.1365-2923.1984.tb01298.x; FORREST CG, 1982, BRIT MED J, V285, P1475; HOWELLS K, 1986, MED EDUC, V20, P502, DOI 10.1111/j.1365-2923.1986.tb01390.x; JESSOP DJ, 1988, J DEV BEHAV PEDIATR, V9, P147; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; LAUER ME, 1989, CANCER, V63, P988, DOI 10.1002/1097-0142(19890301)63:5<988::AID-CNCR2820630534>3.0.CO;2-Y; LUNDIN T, 1984, BRIT J PSYCHIAT, V145, P424, DOI 10.1192/bjp.145.4.424; MARTINSON IM, 1986, LOSS GRIEF CARE, V1, P97; OSTFELD BM, 1993, J DEV BEHAV PEDIATR, V14, P156; ROSSER JE, 1982, SOC SCI MED, V16, P315, DOI 10.1016/0277-9536(82)90341-0; SABBETH BF, 1984, PEDIATRICS, V73, P762; SLAVIN LA, 1982, AM J PSYCHIAT, V139, P179; SPINETTA JJ, 1988, J PSYCHOSOC ONCOL, V6, P179; Stein A, 1990, LISTEN MY CHILD HAS, P66; Stewart M, 1987, Birth Defects Orig Artic Ser, V23, P52; THEUT SK, 1990, J AM ACAD CHILD PSY, V29, P521, DOI 10.1097/00004583-199007000-00003; WAECHTER EH, 1971, AM J NURS, V7, P1168; WHITE MP, 1984, BRIT MED J, V289, P167, DOI 10.1136/bmj.289.6438.167; WOOLLEY H, 1989, BRIT MED J, V298, P1623, DOI 10.1136/bmj.298.6688.1623	29	16	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1376	1378		10.1136/bmj.316.7141.1376	http://dx.doi.org/10.1136/bmj.316.7141.1376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZL882	9563996	Green Published			2022-12-28	WOS:000073483000029
J	Diaz, E; Pfeffer, SR				Diaz, E; Pfeffer, SR			TIP47: A cargo selection device for mannose 6-phosphate receptor trafficking	CELL			English	Article							TRANS-GOLGI NETWORK; FACTOR-II RECEPTOR; HIGH-AFFINITY INTERACTION; CYTOPLASMIC DOMAIN; RAPID INTERNALIZATION; ASSEMBLY PROTEINS; CYTOSOLIC PROTEIN; PLASMA-MEMBRANE; SIGNALS; TAIL	Mannose B-phosphate receptors (MPRs) transport newly synthesized lysosomal hydrolases from the Golgi to prelysosomes and then return to the Golgi for another round of transport. We have identified a 47 kDa protein (TIP47) that binds selectively to the cytoplasmic domains of cation-independent and cation-dependent MPRs. TIP47 is present in cytosol and on endosomes and is required for MPR transport from endosomes to the trans-Golgi network in vitro and in vivo. TIP47 recognizes a phenylalanine/tryptophan signal in the tail of the cation-dependent MPR that is essential for its proper sorting within the endosomal pathway. These data suggest that TIP47 binds MPR cytoplasmic domains and facilitates their collection into transport vesicles destined for the Golgi.	Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R01DK037332, R56DK037332] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37332] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brodsky FM, 1997, TRENDS CELL BIOL, V7, P175, DOI 10.1016/S0962-8924(97)01038-6; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; DINTZIS SM, 1994, J BIOL CHEM, V269, P12159; DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; Itin C, 1997, J BIOL CHEM, V272, P27737, DOI 10.1074/jbc.272.44.27737; JADOT M, 1992, J BIOL CHEM, V267, P11069; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; ROHRER J, 1995, J CELL BIOL, V130, P1297, DOI 10.1083/jcb.130.6.1297; ROSORIUS O, 1993, J BIOL CHEM, V268, P21470; Schimmoller F, 1997, CURR BIOL, V7, pR235, DOI 10.1016/S0960-9822(06)00109-6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Schweizer A, 1997, P NATL ACAD SCI USA, V94, P14471, DOI 10.1073/pnas.94.26.14471; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOSA MA, 1993, J BIOL CHEM, V268, P12537; Wang XL, 1997, FEBS LETT, V402, P57, DOI 10.1016/S0014-5793(96)01500-1; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0	42	320	330	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					433	443		10.1016/S0092-8674(00)81171-X	http://dx.doi.org/10.1016/S0092-8674(00)81171-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590177	Bronze			2022-12-28	WOS:000073471500018
J	Henikoff, S; Comai, L				Henikoff, S; Comai, L			Trans-sensing effects: The ups and downs of being together	CELL			English	Review							HOMOLOG		Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619; Henikoff, Steven/0000-0002-7621-8685				AragonAlcaide L, 1997, CURR BIOL, V7, P905, DOI 10.1016/S0960-9822(06)00383-6; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Donaldson KM, 1997, GENETICS, V145, P325; Dorer DR, 1997, GENETICS, V147, P1181; GEORGIEV PG, 1995, P NATL ACAD SCI USA, V92, P5184, DOI 10.1073/pnas.92.11.5184; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; Golic MM, 1996, GENETICS, V143, P385; Gubb D, 1997, GENETICS, V146, P919; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; Hollick JB, 1997, TRENDS GENET, V13, P302, DOI 10.1016/S0168-9525(97)01184-0; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; MartinMorris LE, 1997, GENETICS, V147, P671; MIKULA BC, 1995, GENETICS, V140, P1379; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Sigrist CJA, 1997, GENETICS, V147, P209	17	73	75	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					329	332		10.1016/S0092-8674(00)81161-7	http://dx.doi.org/10.1016/S0092-8674(00)81161-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590167	Bronze			2022-12-28	WOS:000073471500008
J	Panning, B; Jaenisch, R				Panning, B; Jaenisch, R			RNA and the epigenetic regulation of X chromosome inactivation	CELL			English	Review							LINKED GENES		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Panning, B (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.							BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; CLEMSON CM, 1996, J CELL BIOL, V132, P1; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MIGEON BR, 1994, TRENDS GENET, V10, P230, DOI 10.1016/0168-9525(94)90169-4; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Willard H, 1997, NATURE, V386, P228, DOI 10.1038/386228a0	19	172	179	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					305	308		10.1016/S0092-8674(00)81155-1	http://dx.doi.org/10.1016/S0092-8674(00)81155-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590161	Bronze			2022-12-28	WOS:000073471500002
J	Kreusch, A; Pfaffinger, PJ; Stevens, CF; Choe, S				Kreusch, A; Pfaffinger, PJ; Stevens, CF; Choe, S			Crystal structure of the tetramerization domain of the Shaker potassium channel	NATURE			English	Article							K+ CHANNEL; INACTIVATION; DROSOPHILA; STOICHIOMETRY; DIVERSITY; RECEPTOR; PEPTIDE; GENE	Voltage-dependent, ion-selective channels such as Na+, Ca2+ and K+ channel proteins function as tetrameric assemblies of identical or similar subunits(1-4). The clustering of four subunits is thought to create an aqueous pore(5,6) centred at the four-fold symmetry axis. The highly conserved, amino-terminal cytoplasmic domain (similar to 130 amino acids) immediately preceding the first putative transmembrane helix S1 is designated T1 It is known to confer specificity for tetramer formation(7,8), so the heteromeric assembly of K+-channel subunits is an important mechanism for the observed channel diversity(9-11). We have determined the crystal structure of the T1 domain of a Shaker potassium channel at 1.55 Angstrom resolution. The structure reveals that four identical subunits are arranged in a four-fold symmetry surrounding a centrally located pore about 20 Angstrom in length. Subfamily-specific assembly is provided primarily by polar interactions encoded in a conserved set of amino acids at its tetramerization interface. Most highly conserved amino acids in the T1 domain of all known potassium channels are found in the core of the protein, indicating a common structural framework for the tetramer assembly.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Baylor Coll Med, Houston, TX 77030 USA	Salk Institute; Salk Institute; Baylor College of Medicine	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; BRUNGER AT, 1996, XPLOR VERSION 3 8; *COLL COMP PROJ, 1994, ACTA CRYSTALLOGR D, V50, P670; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FOSTER CD, 1992, NEURON, V9, P229, DOI 10.1016/0896-6273(92)90162-7; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOL WG, 1978, NATURE, V2734, P43; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIU T, 1997, NEURON, V19, P175; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHEN NV, 1993, NEURON, V11, P67; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TORO L, 1992, NEURON, V9, P237, DOI 10.1016/0896-6273(92)90163-8; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511	30	263	266	1	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					945	948		10.1038/31978	http://dx.doi.org/10.1038/31978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582078				2022-12-28	WOS:000073359900055
J	Auer, M; Scarborough, GA; Kuhlbrandt, W				Auer, M; Scarborough, GA; Kuhlbrandt, W			Three-dimensional map of the plasma membrane H+-ATPase in the open conformation	NATURE			English	Article							ELECTRON-MICROSCOPY; CYTOPLASMIC LOCATION; PROTEIN; MODEL; IDENTIFICATION; CRYOMICROSCOPY; VISUALIZATION; REGIONS; AMINO	The H+-ATPase from the plasma membrane of Neurospora crassa is an integral membrane protein of relative molecular mass 100K, which belongs to the P-type ATPase family that includes the plasma membrane Na+/K+-ATPase and the sarcoplasmic reticulum Ca2+-ATPase. The H+-ATPase pumps protons across the cell's plasma membrane using ATP as an energy source, generating a membrane potential in excess of 200 mV (refs 1-3). Despite the importance of P-type ATPases in controlling membrane potential and intracellular ion concentrations, little is known about the molecular mechanism they use for ion transport. This is largely due to the difficulty in growing well ordered crystals and the resulting lack of detail in the three-dimensional structure of these large membrane proteins. We have now obtained a three-dimensional map of the H+-ATPase by electron crystallography of two-dimensional crystals grown directly on electron microscope grids. At an in-plane resolution of 8 Angstrom, this map reveals ten membrane-spanning alpha-helices in the membrane domain, and four major cytoplasmic domains in the open conformation of the enzyme without bound ligands.	Max Planck Inst Biophys, Abt Strukturbiol, D-60528 Frankfurt, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Max Planck Society; European Molecular Biology Laboratory (EMBL); University of North Carolina; University of North Carolina Chapel Hill	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Abt Strukturbiol, Heinrich Hoffman Str 7, D-60528 Frankfurt, Germany.	kuehlbrandt@biophys.mpg.de		Kuhlbrandt, Werner/0000-0002-2013-4810; Auer, Manfred/0000-0001-8920-3522				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENNESSEY JP, 1990, J BIOL CHEM, V265, P532; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; KUHLBRANDT W, 1982, ULTRAMICROSCOPY, V7, P221, DOI 10.1016/0304-3991(82)90169-3; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; NAKAMOTO RK, 1989, ANN NY ACAD SCI, V574, P165; NAKAMOTO RK, 1989, J BIOENERG BIOMEMBR, V21, P621, DOI 10.1007/BF00808117; RAO US, 1991, J BIOL CHEM, V266, P14740; RAO US, 1992, BIOCHIM BIOPHYS ACTA, V1108, P153, DOI 10.1016/0005-2736(92)90020-M; SCARBOROUGH GA, 1994, ACTA CRYSTALLOGR D, V50, P643, DOI 10.1107/S0907444993014283; SCARBOROUGH GA, 1990, J BIOL CHEM, V265, P16145; SCARBOROUGH GA, 1996, HDB BIOL PHYS, V2, P75; SCARBOROUGH GA, 1992, MOL ASPECTS MEMBRANE, P117; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; Sheehan B, 1996, J STRUCT BIOL, V116, P99, DOI 10.1006/jsbi.1996.0017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512	30	184	191	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					840	843		10.1038/33967	http://dx.doi.org/10.1038/33967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572146				2022-12-28	WOS:000073241200060
J	Cooper, JP; Watanabe, Y; Nurse, P				Cooper, JP; Watanabe, Y; Nurse, P			Fission yeast Taz1 protein is required for meiotic telomere clustering and recombination	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; MEIOSIS; CENTROMERES; INTEGRATION; GENES; DNA	The alignment of homologous chromosomes during meiosis is essential for their recombination and segregation. Telomeres form and protect the ends of eukaryotic linear chromosomes, and are composed of tandem repeats of a simple DNA sequence and the proteins that bind to these repeats(1-3). A role for telomeres in meiosis was suspected from observations of telomere clustering in meiotic cells(4-7), and has now been supported experimentally by the dramatic rearrangement of telomere locations during premeiotic stages in fission yeast(8,9). Here we show that the fission yeast telomere protein, Tazl (ref. 10), is required for stable association between telomeres and spindle pole bodies during meiotic prophase. In the absence of Tazl, telomere clustering at the spindle pole bodies is disrupted, meiotic recombination is reduced, and both spore viability and the ability of zygotes to re-enter mitosis are impaired to a level that would be expected if chromosome segregation were occurring randomly. Such telomeric association mediated by telomere-specific proteins may also be important for proper chromosome alignment and recombination during meiosis in humans.	Imperial Canc Res Fund, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Imperial Canc Res Fund, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	cooperj@essex.uchsc.edu		Watanabe, Yoshinori/0000-0002-5488-4812; cooper, julia promisel/0000-0003-2171-2587				BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Blackburn EH, 1995, TELOMERES; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DERNBURG AF, 1995, TELOMERES, P295; EGEL R, 1973, MOL GEN GENET, V121, P277, DOI 10.1007/BF00267055; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUTZ H, 1971, GENETICS, V69, P331; GUTZ H, 1974, HDB GENETICS, P211; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; LOIDL J, 1990, GENOME, V33, P759, DOI 10.1139/g90-115; MELOSIS JB, 1990, DEV CELL BIOL SER, V22; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; SCHERTHAN H, 1994, J CELL BIOL, V127, P273, DOI 10.1083/jcb.127.2.273; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; UZAWA S, 1992, J CELL SCI, V101, P267; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	26	238	242	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					828	831		10.1038/33947	http://dx.doi.org/10.1038/33947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572143				2022-12-28	WOS:000073241200057
J	Tollefson, AE; Hermiston, TW; Lichtenstein, DL; Colle, CF; Tripp, RA; Dimitrov, T; Toth, K; Wells, CE; Doherty, PC; Wold, WSM				Tollefson, AE; Hermiston, TW; Lichtenstein, DL; Colle, CF; Tripp, RA; Dimitrov, T; Toth, K; Wells, CE; Doherty, PC; Wold, WSM			Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR RECEPTOR; REGION E3; MEDIATED CYTOTOXICITY; PLASMA-MEMBRANE; MW PROTEIN; CYTOLYSIS; ACTIVATION; TRANSFORMATION; 10,400-DALTON	DNA viruses have evolved elaborate mechanisms To overcome host antiviral defences. In adenovirus-infected cells, programmed cell death (apoptosis) induced by the cytokine tumour necrosis factor (TNF) is inhibited by several adenovirus-encoded proteins(1-3). Occupation of the cell-surface receptor Fas, a member of the TNF-receptor superfamily that is expressed on most cell types, triggers apoptosis of that cell(4-6). Here we show that the adenovirus RID (for receptor internalization and degradation) protein complex, which is an inhibitor of TNF-induced apoptosis(2), mediates internalization of cell-surface Fas and its destruction inside lysosomes within the cell. Fas has not previously been shown to be internalized and then degraded. RID also mediates internalization of the receptor for epidermal growth factor(7,8), but it does not affect the transferrin receptor or class I antigens of the major histocompatibility complex. Removal of Fas from the surface of adenovirus-infected cells expressing RID may allow infected cells to resist Fas-mediated cell death and thus promote their survival.	St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Saint Louis University; St Jude Children's Research Hospital	Wold, WSM (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	woldws@slu.edu	Tripp, Ralph/F-5218-2011; Doherty, Peter Charles/C-4185-2013	Tripp, Ralph/0000-0002-2924-9956; Doherty, Peter Charles/0000-0002-5028-3489; Toth, Karoly/0000-0001-6624-9683				AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; BABISS LE, 1984, J VIROL, V52, P389, DOI 10.1128/JVI.52.2.389-395.1984; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CARLIN CR, 1989, CELL, V57, P135, DOI 10.1016/0092-8674(89)90179-7; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CLARK WR, 1995, IMMUNOL REV, V146, P33, DOI 10.1111/j.1600-065X.1995.tb00682.x; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; GOODING LR, 1991, J VIROL, V65, P4114, DOI 10.1128/JVI.65.8.4114-4123.1991; GOODING LR, 1991, J VIROL, V65, P3083, DOI 10.1128/JVI.65.6.3083-3094.1991; GOODING LR, 1988, CELL, V53, P341, DOI 10.1016/0092-8674(88)90154-7; HASHIMOTO S, 1991, INT IMMUNOL, V3, P343, DOI 10.1093/intimm/3.4.343; HOFFMAN P, 1992, J BIOL CHEM, V267, P13480; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAATTELA M, 1995, ONCOGENE, V10, P2297; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; OHEM A, 1992, J BIOL CHEM, V267, P10709; RANHEIM TS, 1993, J VIROL, V67, P2159, DOI 10.1128/JVI.67.4.2159-2167.1993; STEWART AR, 1995, J VIROL, V69, P172, DOI 10.1128/JVI.69.1.172-181.1995; SUBRAMANIAN T, 1984, J VIROL, V52, P336, DOI 10.1128/JVI.52.2.336-343.1984; TOLLEFSON AE, 1991, J VIROL, V65, P3095, DOI 10.1128/JVI.65.6.3095-3105.1991; TOLLEFSON AE, 1990, VIROLOGY, V175, P19, DOI 10.1016/0042-6822(90)90182-Q; TOLLEFSON AE, 1990, J VIROL, V64, P794, DOI 10.1128/JVI.64.2.794-801.1990; TRIPP RA, 1995, J IMMUNOL, V154, P6013; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	30	172	176	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 16	1998	392	6677					726	730		10.1038/33712	http://dx.doi.org/10.1038/33712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565035				2022-12-28	WOS:000073129000062
J	James, D				James, D			Recent advances - Fetal medicine	BRITISH MEDICAL JOURNAL			English	Review							TWIN-TWIN TRANSFUSION; THERAPEUTIC AMNIOCENTESIS; DEATH; SURGERY; AMNIOINFUSION; PREGNANCY; FETUSES		Queens Med Ctr, Nottingham NG7 2UH, England	University of Nottingham	James, D (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.							ADZICK NS, 1994, LANCET, V343, P897, DOI 10.1016/S0140-6736(94)90012-4; ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; BEALER JF, 1995, J PEDIATR SURG, V30, P1150, DOI 10.1016/0022-3468(95)90009-8; BEJOR R, 1990, AM J OBSTET GYNECOL, V162, P1230; BERNASCHEK G, 1994, PRENATAL DIAG, V14, P821, DOI 10.1002/pd.1970140910; Danielian P, 1996, EUR J OBSTET GYN R B, V67, P121; DELIA JE, 1995, AM J OBSTET GYNECOL, V172, P1202, DOI 10.1016/0002-9378(95)91480-3; ELLIOTT JP, 1991, OBSTET GYNECOL, V77, P537; EVANS MI, 1991, OBSTET GYNECOL, V77, P545; FISK NM, 1991, OBSTET GYNECOL, V78, P270; Fitzgerald M., 1995, FOETAL PAIN UPDATE C; FLAKE AW, 1995, ANNU REV MED, V46, P67; FUSI L, 1991, OBSTET GYNECOL, V78, P517; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; Glover V, 1996, BRIT MED J, V313, P796; Harrison MR, 1996, AM J OBSTET GYNECOL, V174, P1255, DOI 10.1016/S0002-9378(96)70668-3; HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; HOFMEYER GJ, 1996, PREGNANCY CHILDBIRTH; HOFMEYER GJ, 1992, BRIT J OBSTET GYNAEC, V92, P449; HYETT J, 1996, FETAL MATERNAL MED R, V8, P67; JAMES DK, 1992, AM J OBSTET GYNECOL, V166, P1486, DOI 10.1016/0002-9378(92)91624-J; KUMBER C, 1997, ARCH DIS CHILD, V76, pF134; *MAT CHILD HLTH RE, 1997, 4 MAT CHILD HLTH RES; MCCARTHY A, 1995, ROYAL COLL OBSTET GY, P271; MOLINDE P, 1989, EFFECTIVE CARE PREGN, P477; OKAMURA K, 1994, OBSTET GYNECOL, V83, P975, DOI 10.1097/00006250-199406000-00016; PINETTE MG, 1993, OBSTET GYNECOL, V82, P841; POSNER MD, 1990, AM J OBSTET GYNECOL, V163, P813, DOI 10.1016/0002-9378(90)91074-M; REISNER DP, 1993, AM J OBSTET GYNECOL, V169, P991, DOI 10.1016/0002-9378(93)90041-G; RIZZO G, 1994, EARLY HUM DEV, V39, P15, DOI 10.1016/0378-3782(94)90066-3; Roberts L. J., 1995, P203; *ROYAL COLL OBST G, 1997, FET AW WORK PART REP; Royal College of Obstetricians and Gynaecologists and the Royal College of Paediatrics and Child Health Working Party, 1997, FET ABN GUID SCREEN; SANTEMA JG, 1995, BRIT J OBSTET GYNAEC, V102, P26, DOI 10.1111/j.1471-0528.1995.tb09021.x; SAUNDERS NJ, 1992, AM J OBSTET GYNECOL, V166, P820, DOI 10.1016/0002-9378(92)91340-G; SHERER DM, 1993, AM J OBSTET GYNECOL, V169, P85, DOI 10.1016/0002-9378(93)90136-7; SIRIS D, 1993, ULTRASOUND OBST GYN, V3, P11; Stringer M, 1990, J Perinatol, V10, P143; Ville Y, 1997, ULTRASOUND OBST GYN, V10, P82, DOI 10.1046/j.1469-0705.1997.10020082.x	39	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1580	1583		10.1136/bmj.316.7144.1580	http://dx.doi.org/10.1136/bmj.316.7144.1580			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596599	Green Published			2022-12-28	WOS:000073867800027
J	Bazzino, O; Aylward, P; Hains, A; Slany, J; Steinbach, K; Van de Werf, F; Vrints, C; Coelho, O; Ramires, J; Bogaty, P; Boudreault, J; Diodati, J; Gossard, D; Kouz, S; Laramee, P; Lemay, M; Maillette, S; Theroux, P; Botero, R; Arce, M; Heikkila, J; Danchin, D; Weber, S; Kromer, EP; Neumann, FJ; Nienaber, C; Katritsis, D; Papazaglou, N; Benhorin, J; David, D; Tzivoni, D; Guazzi, M; Moguel, R; Verdejo, J; Bonnier, J; DeZwaan, C; Hamer, AW; White, HD; Aarones, M; Arvesen, K; Fossum, E; Henestam, B; Rollag, A; Ribeiro, V; Commerford, P; Landless, P; Marx, J; Weich, H; Ancillo, P; Caturla, J; Civeira, E; Ferrero, J; Figueras, J; Ginestal, R; Ruano, M; Erhardt, L; Sylven, C; Luscher, T; Moccetti, T; Adams, P; Adgey, AAJ; Buller, N; Canepa, R; Furniss, S; Greenbaum, R; Hall, J; Jennings, K; Kooner, J; Levy, R; Lipkin, D; Noble, M; Rothman, M; Abrahamson, D; Aguirre, F; Ambrose, J; Anderson, HV; Anderson, J; Arora, R; Babb, J; Bhasin, S; Bittar, N; Botti, R; Bowles, M; Brown, A; Cohen, M; Colfer, H; Daley, W; Dawley, D; Detrano, R; Eisenberg, P; Farhat, N; Faxon, D; Frey, M; Friedman, S; Goldschlager, N; Gradman, A; Gutierrez, F; Hattemer, C; Herrmann, H; Hochman, J; Israel, N; Kiernan, J; Koren, M; Kramer, J; Ling, F; Mehta, J; Mody, F; Mohiuddin, S; Nafziger, A; Nair, R; Niederman, A; Palabrica, T; Rodriguez, S; Rosenson, R; Rutherford, J; Schmedtje, J; Shah, PK; Sharma, S; Smith, S; Smitherman, T; Stillabower, M; Tierstein, P; Vaughan, D; Waters, D; Weinstock, P; Williams, M; Yakubov, S; Zoble, R; Kleiman, NS; Lipschutz, KH; Sax, FL; Cairns, J; Espeland, M; FitzGerald, G; Verstraete, M; Weaver, WD; Williams, DO; Dreifus, LS; Nasmith, J; Runge, M; Grossman, W; Snapinn, SM; Bremer, M; Frame, V; Hutnyan, J; Lappe, JT; Sergio, M; Thornton, A				Bazzino, O; Aylward, P; Hains, A; Slany, J; Steinbach, K; Van de Werf, F; Vrints, C; Coelho, O; Ramires, J; Bogaty, P; Boudreault, J; Diodati, J; Gossard, D; Kouz, S; Laramee, P; Lemay, M; Maillette, S; Theroux, P; Botero, R; Arce, M; Heikkila, J; Danchin, D; Weber, S; Kromer, EP; Neumann, FJ; Nienaber, C; Katritsis, D; Papazaglou, N; Benhorin, J; David, D; Tzivoni, D; Guazzi, M; Moguel, R; Verdejo, J; Bonnier, J; DeZwaan, C; Hamer, AW; White, HD; Aarones, M; Arvesen, K; Fossum, E; Henestam, B; Rollag, A; Ribeiro, V; Commerford, P; Landless, P; Marx, J; Weich, H; Ancillo, P; Caturla, J; Civeira, E; Ferrero, J; Figueras, J; Ginestal, R; Ruano, M; Erhardt, L; Sylven, C; Luscher, T; Moccetti, T; Adams, P; Adgey, AAJ; Buller, N; Canepa, R; Furniss, S; Greenbaum, R; Hall, J; Jennings, K; Kooner, J; Levy, R; Lipkin, D; Noble, M; Rothman, M; Abrahamson, D; Aguirre, F; Ambrose, J; Anderson, HV; Anderson, J; Arora, R; Babb, J; Bhasin, S; Bittar, N; Botti, R; Bowles, M; Brown, A; Cohen, M; Colfer, H; Daley, W; Dawley, D; Detrano, R; Eisenberg, P; Farhat, N; Faxon, D; Frey, M; Friedman, S; Goldschlager, N; Gradman, A; Gutierrez, F; Hattemer, C; Herrmann, H; Hochman, J; Israel, N; Kiernan, J; Koren, M; Kramer, J; Ling, F; Mehta, J; Mody, F; Mohiuddin, S; Nafziger, A; Nair, R; Niederman, A; Palabrica, T; Rodriguez, S; Rosenson, R; Rutherford, J; Schmedtje, J; Shah, PK; Sharma, S; Smith, S; Smitherman, T; Stillabower, M; Tierstein, P; Vaughan, D; Waters, D; Weinstock, P; Williams, M; Yakubov, S; Zoble, R; Kleiman, NS; Lipschutz, KH; Sax, FL; Cairns, J; Espeland, M; FitzGerald, G; Verstraete, M; Weaver, WD; Williams, DO; Dreifus, LS; Nasmith, J; Runge, M; Grossman, W; Snapinn, SM; Bremer, M; Frame, V; Hutnyan, J; Lappe, JT; Sergio, M; Thornton, A		PRISM Study Investigators	A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; IN-HOSPITAL PROGNOSIS; CLINICAL-TRIAL; MULTICENTER; THERAPY; THROMBOLYSIS; ISCHEMIA; DEATH	Background Activation of platelets is central to the pathophysiology of unstable angina. We studied whether inhibition of the final common pathway for platelet aggregation with tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist, would improve clinical outcome in this condition. Methods In a double-blind study, we randomly assigned 3232 patients who were already receiving aspirin to additional treatment with intravenous tirofiban or heparin for 48 hours. The primary end point was a composite of death, myocardial infarction, or refractory ischemia at 48 hours. Results The incidence of the composite end point was 32 percent lower at 48 hours in the group that received tirofiban (3.8 percent, vs. 5.6 percent with heparin; risk ratio, 0.67; 95 percent confidence interval, 0.48 to 0.92; P=0.01), Percutaneous revascularization was performed in 1.9 percent of the patients during the first 48 hours. At 30 days, the frequency of the composite end point (with the addition of readmission for unstable angina) was similar in the two groups (15.9 percent in the tirofiban group vs. 17.1 percent in the heparin group, P=0.34). There was a trend toward a reduction in the rate of death or myocardial infarction with tirofiban (a rate of 5.8 percent, as compared with 7.1 percent in the heparin group; risk ratio, 0.80; 95 percent confidence interval, 0.61 to 1.05; P=0.11), and mortality was 2.3 percent, as compared with 3.6 percent in the heparin group (P=0.02). Major bleeding occurred in 0.4 percent of the patients in both groups. Reversible thrombocytopenia occurred more frequently with tirofiban than with heparin (1.1 percent vs. 0.4 percent, P=0.04). Conclusions Tirofiban was generally well tolerated and, as compared with heparin, reduced ischemic events during the 48-hour infusion period, during which revascularization procedures were not performed. The incidence of refractory ischemia and myocardial infarction was not reduced at 30 days, but mortality was lower among the patients given tirofiban. Platelet inhibition with aspirin plus tirofiban may have a role in the management of unstable angina. (C) 1998, Massachusetts Medical Society.	Green Lane Hosp, Dept Cardiol, Auckland 1030, New Zealand		White, HD (corresponding author), Green Lane Hosp, Dept Cardiol, Private Bag 92189, Auckland 1030, New Zealand.		Cairns, John/AAI-8744-2021; Lima, Thaísa/AAG-6483-2021; FitzGerald, Garret A/A-4222-2010	Aristizabal, Fabio/0000-0002-6405-7079				ARMSTRONG PW, 1996, CIRCULATION S1, V94, P381; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; BAR FW, 1992, CIRCULATION, V86, P131, DOI 10.1161/01.CIR.86.1.131; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; BAZZINO O, 1993, CIRCULATION, V88, P608; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; COHEN M, 1994, CIRCULATION, V89, P81, DOI 10.1161/01.CIR.89.1.81; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Granger CB, 1996, CIRCULATION, V93, P870, DOI 10.1161/01.CIR.93.5.870; GRANGER CB, 1995, CIRCULATION, V91, P1929, DOI 10.1161/01.CIR.91.7.1929; GURFINKEL EP, 1995, J AM COLL CARDIOL, V26, P313, DOI 10.1016/0735-1097(95)80001-W; Hanrath P, 1997, CIRCULATION, V96, P1445; HOLDRIGHT D, 1994, J AM COLL CARDIOL, V24, P39, DOI 10.1016/0735-1097(94)90539-8; LEE HS, 1993, LANCET, V342, P1204, DOI 10.1016/0140-6736(93)92186-W; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; LYNCH JJ, 1995, J PHARMACOL EXP THER, V272, P20; RIZIK D, 1991, CIRCULATION S2, V84, P347; Simoons ML, 1997, LANCET, V349, P1429; TCHENG JE, 1995, CIRCULATION, V91, P2151, DOI 10.1161/01.CIR.91.8.2151; THEROUX P, 1992, NEW ENGL J MED, V327, P141, DOI 10.1056/NEJM199207163270301; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; THEROUX P, 1994, CIRCULATION, V90, P231; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; VERMEER F, 1991, CIRCULATION S2, V84, P252; WALLENTIN L, 1990, LANCET, V336, P827	28	753	771	0	20	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1498	1505						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9599104				2022-12-28	WOS:000073699100003
J	Jamal, SA; Browner, WS; Bauer, DC; Cummings, SR				Jamal, SA; Browner, WS; Bauer, DC; Cummings, SR		Study Osteoporotic Fractures Res Grp	Warfarin use and risk for osteoporosis in elderly women	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM UNDERCARBOXYLATED OSTEOCALCIN; BONE-MINERAL DENSITY; HIP FRACTURE; VITAMIN-K; CIRCULATING LEVELS; ANTICOAGULANT; THERAPY; NECK; MASS	Background: Vitamin K deficiency may be associated with osteoporosis. Objective: To assess the effects of warfarin on bone. Design: Prospective observational study. Setting: Four centers in the United States. Participants: 6201 elderly, postmenopausal women. Measurements: Self-reported warfarin use, bone mineral density at the hip and the heel, hip bone loss over 2 years, and fractures during 3.5 years of follow-up. Analyses were adjusted for baseline differences, age, weight, and estrogen use. Results: Compared with warfarin nonusers (n = 6052), warfarin users (n = 149) more frequently had poor health, involuntary weight loss, nonthiazide diuretic use, and frailty but had similar bone mineral density at the hip (difference, 1.6% [95% CI, -0.7% to 4.1%]) and heel (difference, 2.1% [CI, -1.6% to 5.6%]). Users and nonusers had similar rates of bone loss (1.1% and 0.8%; P = 0.18) and fractures (relative hazard, 1.0 [CI, 0.60 to 1.7]). Conclusion: In this population, warfarin use did not decrease bone mineral density or increase fracture rates.	Prevent Sci Grp, Suite 512,74 New Montgomery St, San Francisco, CA 94105 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)		sophie_jamal@quickmail.ucsf.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35582] Funding Source: Medline; NIA NIH HHS [AG05407, AG05394] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BINKLEY NC, 1995, J NUTR, V125, P1812, DOI 10.1093/jn/125.7.1812; BITENSKY L, 1988, J BONE JOINT SURG BR, V70, P663, DOI 10.1302/0301-620X.70B4.3403621; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; FIORE CE, 1990, SOUTH MED J, V83, P538, DOI 10.1097/00007611-199005000-00013; HART JP, 1984, LANCET, V2, P283, DOI 10.1016/S0140-6736(84)90321-0; HART JP, 1985, J CLIN ENDOCR METAB, V60, P1268, DOI 10.1210/jcem-60-6-1268; HODGES SJ, 1993, J BONE MINER RES, V8, P1241; HODGES SJ, 1991, BONE, V12, P387, DOI 10.1016/8756-3282(91)90027-G; HOUVENAGEL E, 1989, REV RHUM, V56, P677; MENON RK, 1987, J CLIN ENDOCR METAB, V64, P59, DOI 10.1210/jcem-64-1-59; MONREAL M, 1991, LANCET, V338, P706, DOI 10.1016/0140-6736(91)91292-3; PHILIP WJU, 1995, QJM-INT J MED, V88, P635; PIRO LD, 1982, J CLIN ENDOCR METAB, V54, P470, DOI 10.1210/jcem-54-2-470; PRICE PA, 1985, VITAM HORM, V42, P65; RESCH H, 1991, EUR HEART J, V12, P439, DOI 10.1093/oxfordjournals.eurheartj.a059914; ROSEN HN, 1993, AM J MED, V94, P62, DOI 10.1016/0002-9343(93)90121-5; Sato Y, 1997, STROKE, V28, P2390, DOI 10.1161/01.STR.28.12.2390; STEIGER P, 1992, J BONE MINER RES, V7, P625; SZULC P, 1994, J BONE MINER RES, V9, P1591; SZULC P, 1993, J CLIN INVEST, V91, P1769, DOI 10.1172/JCI116387	20	109	115	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					829	832		10.7326/0003-4819-128-10-199805150-00006	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599195				2022-12-28	WOS:000073586500006
J	Kopp, MU; de Mello, AJ; Manz, A				Kopp, MU; de Mello, AJ; Manz, A			Chemical amplification: Continuous-flow PCR on a chip	SCIENCE			English	Article							CAPILLARY ELECTROPHORESIS; DEVICE	A micromachined chemical amplifier was successfully used to perform the polymerase chain reaction (PCR) in continuous flow at high speed. The device is analogous to an electronic amplifier and relies on the movement of sample through thermostated temperature zones on a glass microchip. Input and output of material (DNA) is continuous, and amplification is independent of input concentration. A 20-cycle PCR amplification of a 176-base pair fragment from the DNA gyrase gene of Neisseria gonorrhoeae was performed at various flow rates, resulting in total reaction times of 90 seconds to 18.7 minutes.	Univ London Imperial Coll Sci Technol & Med, Zeneca SmithKline Beecham Ctr Analyt Sci, Dept Chem, London SW7 2AY, England	GlaxoSmithKline; Imperial College London	Manz, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Zeneca SmithKline Beecham Ctr Analyt Sci, Dept Chem, London SW7 2AY, England.		Manz, Andreas/C-4483-2008	Manz, Andreas/0000-0001-9712-711X				Cheng J, 1996, J CHROMATOGR A, V732, P151, DOI 10.1016/0021-9673(95)01257-5; Chiem N, 1997, ANAL CHEM, V69, P373, DOI 10.1021/ac9606620; Cussler E.L., 2009, DIFFUSION MASS TRANS; EFFENHAUSER CS, 1994, ANAL CHEM, V66, P2949, DOI 10.1021/ac00090a024; LARSEN UD, 1996, P 2 INT S MIN TOT AN, P228; LAURELL T, 1995, BIOSENS BIOELECTRON, V10, P289, DOI 10.1016/0956-5663(95)96848-S; MANZ A, 1998, TOPICS CURRENT CHEM, V194; Mullis K.B, 1994, POLYM CHAIN REACTION; RAYMOND DE, 1994, ANAL CHEM, V66, P2858, DOI 10.1021/ac00090a011; SWERDLOW H, 1993, BIOTECHNIQUES, V15, P512; Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q	11	1060	1414	12	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1046	1048		10.1126/science.280.5366.1046	http://dx.doi.org/10.1126/science.280.5366.1046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582111				2022-12-28	WOS:000073663600037
J	Rocha, BA; Scearce-Levie, K; Lucas, JJ; Hiroi, N; Castanon, N; Crabbe, JC; Nestler, EJ; Hen, R				Rocha, BA; Scearce-Levie, K; Lucas, JJ; Hiroi, N; Castanon, N; Crabbe, JC; Nestler, EJ; Hen, R			Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor	NATURE			English	Article							PROGRESSIVE-RATIO SCHEDULE; 5-HT1B; ADDICTION; DOPAMINE; PROTEINS; ALCOHOL; ABUSE; BRAIN	There is increasing evidence that genetic factors can influence individual differences in vulnerability to drugs of abuse(1,2). Serotonin (5-hydroxytryptamine, 5-HT), acting through many receptors can modulate the activity of neural reward pathways and thus the effects of various drugs of abuse(3-8). Here we examine the effects of cocaine in mice lacking one of the serotonin-receptor subtypes, the 5-HT1B receptor(9). We show that mice lacking 5-HT1B display increased locomotor responses to cocaine and that they are more motivated to self-administer cocaine. We propose that even drug-naive 5-HT1B-knockout mice are in a behavioural and biochemical state that resembles that of wild-type mice sensitized to cocaine by repeated exposure to the drug. This altered state might be responsible for their increased vulnerability to cocaine.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ N Texas, Hlth Sci Ctr, Dept Pharmacol, Ft Worth, TX 76107 USA; Yale Univ, Sch Med, Mol Psychiat Lab, New Haven, CT 06508 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Dept Vet Affairs Med Ctr, Portland, OR 97201 USA	Columbia University; University of North Texas System; University of North Texas Health Science Center; Yale University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 722 W 168th St,PI Annes 731, New York, NY 10032 USA.	rh95@columbia.edu	Hiroi, Noboru/E-2215-2013; Lucas, Jose J./U-6543-2019	Hiroi, Noboru/0000-0002-6846-5969; Castanon, Nathalie/0000-0002-0079-0562; Lucas, Jose J./0000-0003-1597-3916	NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BOSCHERT U, 1994, NEUROSCIENCE, V58, P167, DOI 10.1016/0306-4522(94)90164-3; BROWNE SP, 1991, J FORENSIC SCI, V36, P1662; Brunner D, 1997, ANN NY ACAD SCI, V836, P81, DOI 10.1111/j.1749-6632.1997.tb52356.x; CALLAHAN PM, 1995, J PHARMACOL EXP THER, V274, P1414; CAMERON DL, 1994, J NEUROSCI, V14, P6763; CARROLL ME, 1990, PHARMACOL BIOCHEM BE, V35, P237, DOI 10.1016/0091-3057(90)90232-7; CASTANON N, 1996, SOC NEUR 26 ANN M WA; Chen JS, 1997, J NEUROSCI, V17, P4933; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; DEPOORTERE RY, 1993, PHARMACOL BIOCHEM BE, V45, P539, DOI 10.1016/0091-3057(93)90503-L; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; HORGER BA, 1990, PHARMACOL BIOCHEM BE, V37, P707, DOI 10.1016/0091-3057(90)90552-S; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LOH EA, 1990, PSYCHOPHARMACOLOGY, V101, P262, DOI 10.1007/BF02244137; Lucas JJ, 1997, MOL PHARMACOL, V51, P755, DOI 10.1124/mol.51.5.755; Mandelzys A, 1997, J NEUROSCI, V17, P5407; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; Parsons LH, 1996, PSYCHOPHARMACOLOGY, V128, P150, DOI 10.1007/s002130050120; PARSONS LH, 1993, BRAIN RES, V606, P195, DOI 10.1016/0006-8993(93)90984-U; PARSONS LH, 1996, SOC NEUR 26 ANN M WA; PELTIER R, 1993, PSYCHOPHARMACOLOGY, V110, P390, DOI 10.1007/BF02244643; Rocha BA, 1997, PHARMACOL BIOCHEM BE, V57, P407, DOI 10.1016/S0091-3057(96)00444-3; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	29	266	270	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	1998	393	6681					175	178		10.1038/30259	http://dx.doi.org/10.1038/30259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603521				2022-12-28	WOS:000073619900050
J	Meinert, CL				Meinert, CL			Beyond CONSORT: Need for improved reporting standards for clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED TRIALS; STATEMENT		Johns Hopkins Univ, Ctr Clin Trials, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University	Meinert, CL (corresponding author), Johns Hopkins Univ, Ctr Clin Trials, Sch Hyg & Publ Hlth, Dept Epidemiol, 615 N Wolfe St,Room 5010, Baltimore, MD 21205 USA.	cmeinert@jhsph.edu						ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; [Anonymous], 1977, Journal of Chronic Diseases, V30, P261; [Anonymous], 1984, J AM COLL CARDIOL, V3, P114; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; FACKLER ML, 1994, ANN INTERN MED, V121, P894, DOI 10.7326/0003-4819-121-11-199412010-00015; *HYP PREV TRIAL RE, 1989, CONTROL CLIN TRIAL S, V10, pS1; *INT C HARM STEER, 1995, DRAFT CONS GUID STRU; KILLIP T, 1981, CIRCULATION, V63, P1; MEINERT CL, 1980, CONTROL CLIN TRIALS, V1, P97, DOI 10.1016/0197-2456(80)90012-4; Meinert CL, 1996, CLIN TRIALS DICT TER; Meinert CL., 1986, CLIN TRIALS DESIGN C; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649; Schulz KF, 1996, LANCET, V348, P596, DOI 10.1016/S0140-6736(96)01201-9; WERKO L, 1995, J INTERN MED, V237, P507, DOI 10.1111/j.1365-2796.1995.tb00877.x	15	52	55	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1487	1489		10.1001/jama.279.18.1487	http://dx.doi.org/10.1001/jama.279.18.1487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600487				2022-12-28	WOS:000073463500042
J	Tucker, AW; Haddix, AC; Bresee, JS; Holman, RC; Parashar, UD; Glass, RI				Tucker, AW; Haddix, AC; Bresee, JS; Holman, RC; Parashar, UD; Glass, RI			Cost-effectiveness analysis of a rotavirus immunization program for the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ECONOMIC-ANALYSIS; YOUNG-CHILDREN; US CHILDREN; DIARRHEA; GASTROENTERITIS; INFECTION; VACCINES; INFANTS; TRIAL; MORTALITY	Context.-Rotavirus is the most common cause of severe diarrhea in children, and a live, oral vaccine may soon be licensed for prevention. Objective.-To estimate the economic impact of a national rotavirus immunization program in the United States. Design.-Cost-effectiveness was analyzed from the perspectives of the health care system and society. A decision tree used estimates of disease burden, costs, vaccine coverage, efficacy, and price obtained from published and unpublished sources. Intervention.-The proposed vaccine would be administered to infants at ages 2, 4, and 6 months as part of the routine schedule of childhood immunizations. Main Outcome Measures.-Total costs, outcomes prevented, and incremental cost-effectiveness. Results.-A routine, universal rotavirus immunization program would prevent 1.08 million cases of diarrhea, avoiding 34 000 hospitalizations, 95 000 emergency department visits, and 227 000 physician visits in the first 5 years of life. At $20 per dose, the program would cost $289 million and realize a net loss of $107 million to the health care system-$103 per case prevented. The program would provide a net savings of $296 million to society. Threshold analysis identified a break-even price per dose of $9 for the health care system and $51 for the societal perspective. Greater disease burden and greater vaccine efficacy and lower vaccine price increased cost-effectiveness. Conclusions.-A US rotavirus immunization program would be cost-effective from the perspectives of society and the health care system, although the cost of the immunization program would not be fully offset by the reduction in health care cost of rotavirus diarrhea unless the price fell to $9 per dose.	Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Resp & Enter Viruses Branch, US DHHS, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Prevent Effectiveness Branch, Div Prevent Res & Analyt Methods, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control, Natl Ctr Infect Dis, Off Director, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Glass, RI (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Resp & Enter Viruses Branch, US DHHS, 1600 Clifton Rd NE,Mailstom G04, Atlanta, GA 30333 USA.							*ADV COMM IMM PRAC, 1997, ROT VACC PREV ROT DI, P1; AVENDANO P, 1993, PEDIATR INFECT DIS J, V12, P897, DOI 10.1097/00006454-199311000-00001; BERNSTEIN DI, 1995, JAMA-J AM MED ASSOC, V273, P1191, DOI 10.1001/jama.273.15.1191; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P57; CHALMERS TC, 1982, CONTROL CLIN TRIALS, P285; CHUNG MA, 1997, THESIS YALE U NEW HA; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; CLEMENS JD, 1992, AM J EPIDEMIOL, V135, P865, DOI 10.1093/oxfordjournals.aje.a116382; DRUMMOND MF, 1984, CONTROL CLIN TRIALS, V5, P115, DOI 10.1016/0197-2456(84)90118-1; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; GLASS RI, 1990, PROSPECTS PUBLIC HLT, V2, P102; GONZALEZ ML, 1996, SOCIOECONOMIC CHARAC, P77; GRIFFITHS RI, 1995, ARCH PEDIAT ADOL MED, V149, P407, DOI 10.1001/archpedi.1995.02170160061009; GURWITH M, 1981, J INFECT DIS, V144, P218, DOI 10.1093/infdis/144.3.218; GURWITH M, 1983, J INFECT DIS, V147, P685, DOI 10.1093/infdis/147.4.685; HADDIX A, 1994, PRACTICAL GUIDE PREV; *HEALTHC CONS AM, 1996, 1996 PHYS FEE COD GU, P42; HO MS, 1988, J INFECT DIS, V158, P1112, DOI 10.1093/infdis/158.5.1112; Jin SX, 1996, PEDIATR INFECT DIS J, V15, P397, DOI 10.1097/00006454-199605000-00004; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; KAPIKIAN AZ, 1993, JAMA-J AM MED ASSOC, V269, P627, DOI 10.1001/jama.269.5.627; KILGORE PE, 1995, JAMA-J AM MED ASSOC, V274, P1143, DOI 10.1001/jama.274.14.1143; KOOPMAN JS, 1984, AM J EPIDEMIOL, V119, P114, DOI 10.1093/oxfordjournals.aje.a113712; KOTLOFF KL, 1988, PEDIATR INFECT DIS J, V7, P753, DOI 10.1097/00006454-198811000-00002; LIEU TA, 1994, JAMA-J AM MED ASSOC, V271, P375, DOI 10.1001/jama.271.5.375; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; MATSON DO, 1990, J INFECT DIS, V162, P598, DOI 10.1093/infdis/162.3.598; *NAT CTR HLTH STAT, 1996, US DEP HLTH HUM SERV; Parashar UD, 1998, J INFECT DIS, V177, P13, DOI 10.1086/513808; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Rennels MB, 1996, PEDIATRICS, V97, P7; RODRIGUEZ WJ, 1980, AM J DIS CHILD, V134, P777, DOI 10.1001/archpedi.1980.02130200047015; RODRIGUEZ WJ, 1987, PEDIATR INFECT DIS J, V6, P170, DOI 10.1097/00006454-198702000-00006; Santosham M, 1997, J PEDIATR-US, V131, P632, DOI 10.1016/S0022-3476(97)70076-3; SMITH JC, 1995, PEDIATRICS, V96, P609; United States Census Bureau, 1996, CURR POP REP POP PRO	36	252	263	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1371	1376		10.1001/jama.279.17.1371	http://dx.doi.org/10.1001/jama.279.17.1371			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582045	Bronze			2022-12-28	WOS:000073359800029
J	Williams, R; Wright, J				Williams, R; Wright, J			Health needs assessment - Epidemiological issues in health needs assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England; Bradford Royal Infirm, Bradfors Hosp NHS Trust, Bradford BD9 6RJ, W Yorkshire, England	University of Leeds; Bradford Royal Infirmary	Williams, R (corresponding author), Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England.	hssdrrw@leeds.ac.uk	Wright, John/H-1624-2012	Wright, John/0000-0001-9572-7293				Doyal L, 1995, Qual Health Care, V4, P273, DOI 10.1136/qshc.4.4.273; Last JM, 1995, DICT EPIDEMIOLOGY, P55; *NAT ASTHM ED PROG, 1991, GUID DIAGN MAN ASTHM; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; STEVENS A, 1994, HLTH CARE NEEDS ASSE, V1, P1; WILLIAMS R, 1994, HLTH CARE NEEDS ASSE, V1, P31; World Health Organization, 1985, WHO TECHN REP SER, P727; Wright J, 1998, BRIT MED J, V316, P1310, DOI 10.1136/bmj.316.7140.1310; ZANCHETTI A, 1993, BMJ-BRIT MED J, V307, P1541, DOI 10.1136/bmj.307.6918.1541	9	32	33	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1379	1382		10.1136/bmj.316.7141.1379	http://dx.doi.org/10.1136/bmj.316.7141.1379			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563997	Green Published			2022-12-28	WOS:000073483000030
J	Chua, PR; Roeder, GS				Chua, PR; Roeder, GS			Zip2, a meiosis-specific protein required for the initiation of chromosome synapsis	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; ESCHERICHIA-COLI; GENE-EXPRESSION; SHUTTLE VECTORS; RECA HOMOLOGS; DNA-REPAIR; YEAST	We describe the identification and characterization of the Saccharomyces cerevisiae ZIP2 gene, which encodes a novel meiosis-specific protein essential for synaptonemal complex formation. In the zip2 mutant, chromosomes are homologously paired but not synapsed. The Zip2 protein localizes to discrete foci on meiotic chromosomes; these foci correspond to sites of convergence between paired homologs that are believed to be sites of synapsis initiation. Localization of Zip2p requires the initiation of meiotic recombination. In a mutant defective in double-strand break repair, Zip2p colocalizes with proteins involved in double-strand break formation and processing. We propose that Zip2p promotes the initiation of chromosome synapsis and that localization of Zip2p to sites of interhomolog recombination ensures synapsis between homologous chromosomes.	Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Chua, PR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; ANDERSON LK, 1988, CHROMOSOMA, V97, P96, DOI 10.1007/BF00331799; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; BUCKINGHAM LE, 1990, P NATL ACAD SCI USA, V87, P9406, DOI 10.1073/pnas.87.23.9406; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; DEMASSY B, 1994, P NATL ACAD SCI USA, V91, P11929, DOI 10.1073/pnas.91.25.11929; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; ENGEBRECHT J, 1990, CELL, V62, P927, DOI 10.1016/0092-8674(90)90267-I; ENGEBRECHT J, 1990, MOL CELL BIOL, V10, P2379, DOI 10.1128/MCB.10.5.2379; GILBERTSON LA, 1994, P NATL ACAD SCI USA, V91, P11934, DOI 10.1073/pnas.91.25.11934; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; IVANOV EL, 1992, GENETICS, V132, P651; JOHZUKA K, 1995, GENETICS, V139, P1521; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KLECKNER N, 1991, COLD SH Q B, V56, P729; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; LOIDL J, 1986, CHROMOSOMA, V93, P420, DOI 10.1007/BF00285824; McKee AHZ, 1997, GENETICS, V146, P797; MCKNIGHT GL, 1981, CELL, V25, P409, DOI 10.1016/0092-8674(81)90059-3; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; MOENS PB, 1969, CHROMOSOMA, V28, P1, DOI 10.1007/BF00325986; NAG DK, 1995, GENETICS, V141, P75; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; NEWLON CS, 1991, GENETICS, V129, P343; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Prinz S, 1997, GENETICS, V146, P781; RASMUSSEN SW, 1978, CARLSBERG RES COMMUN, V43, P275, DOI 10.1007/BF02906106; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROCKMILL B, 1990, GENETICS, V126, P563; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; ROEDER GS, 1995, P NATL ACAD SCI USA, V92, P10450, DOI 10.1073/pnas.92.23.10450; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHERTHAN H, 1992, CHROMOSOMA, V101, P590, DOI 10.1007/BF00360535; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SEIFERT HS, 1986, GENETIC ENG PRINCIPL, P123; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; Sherman F., 1986, METHODS YEAST GENETI; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; STACK S, 1986, CHROMOSOMA, V94, P253, DOI 10.1007/BF00290853; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tettelin H, 1997, NATURE, V387, P81, DOI 10.1038/387s081; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; TUNG KS, 1998, IN PRESS GENETICS; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; ZICKLER D, 1992, GENETICS, V132, P135	66	189	191	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					349	359		10.1016/S0092-8674(00)81164-2	http://dx.doi.org/10.1016/S0092-8674(00)81164-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590170	hybrid			2022-12-28	WOS:000073471500011
J	Kim, SJ; Crowley, TJ; Stossel, A				Kim, SJ; Crowley, TJ; Stossel, A			Local orbital forcing of Antarctic climate change during the last interglacial	SCIENCE			English	Article							VOSTOK ICE-CORE; OCEAN; MODEL; RECORD; CYCLE; SENSITIVITY; CIRCULATION; AGES; KYR; SEA	During the last interglacial, Antarctic climate changed before that of the Northern Hemisphere. Large local changes in precession forcing could have produced this pattern if there were a rectified response in sea ice cover. Results from a coupled sea ice-ocean general circulation model supported this hypothesis when it was tested for three intervals around the last interglacial. Such a mechanism may play an important role in contributing to phase offsets between Northern and Southern Hemisphere climate change for other time intervals.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Kim, SJ (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	ksj@ocean.tamu.edu						Arakawa A., 1977, METHODS COMPUTATIONA, V17, P173, DOI DOI 10.1016/B978-0-12-460817-7.50009-4; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; CAL W, 1996, J GEOPHYS RES, V101, P14073; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; CROWLEY TJ, 1986, SCIENCE, V231, P579, DOI 10.1126/science.231.4738.579; CROWLEY TJ, 1991, J GEOPHYS RES-ATMOS, V96, P9217, DOI 10.1029/91JD00530; CROWLEY TJ, 1988, CLIM DYNAM, V3, P93; DEANGELIS M, 1987, NATURE, V325, P318, DOI 10.1038/325318a0; Drijfhout S, 1996, J PHYS OCEANOGR, V26, P559, DOI 10.1175/1520-0485(1996)026<0559:MCAIVI>2.0.CO;2; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; GLOERSEN P, 1992, ARCTIC ANTARCTIC SEA, P290; Hall MM, 1997, J PHYS OCEANOGR, V27, P1903, DOI 10.1175/1520-0485(1997)027<1903:ABWFIT>2.0.CO;2; HAYS JD, 1976, SCIENCE, V194, P121; HELLERMAN S, 1983, J PHYS OCEANOGR, V13, P1093, DOI 10.1175/1520-0485(1983)013<1093:NMWSOT>2.0.CO;2; HIBLER WD, 1979, J PHYS OCEANOGR, V9, P815, DOI 10.1175/1520-0485(1979)009<0815:ADTSIM>2.0.CO;2; Hyde WT, 1989, J CLIMATE, V2, P864, DOI 10.1175/1520-0442(1989)002<0864:COGAEB>2.0.CO;2; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Imbrie J., 1989, CLIMATE GEO SCI, P121, DOI DOI 10.1007/978-94-009-2446-8_7; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; JOUZEL J, 1993, NATURE, V364, P407, DOI 10.1038/364407a0; JOUZEL J, 1987, NATURE, V329, P403, DOI 10.1038/329403a0; Labeyrie L, 1996, PALEOCEANOGRAPHY, V11, P57, DOI 10.1029/95PA02255; Levitus S., 1982, 13 NOAA; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; MANABE S, 1985, J ATMOS SCI, V42, P2643, DOI 10.1175/1520-0469(1985)042<2643:ACOCMS>2.0.CO;2; Manabe S, 1996, J CLIMATE, V9, P376, DOI 10.1175/1520-0442(1996)009<0376:LFVOSA>2.0.CO;2; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Montoya M, 1998, PALEOCEANOGRAPHY, V13, P170, DOI 10.1029/97PA02550; NORTH GR, 1983, J GEOPHYS RES-OCEANS, V88, P6576, DOI 10.1029/JC088iC11p06576; OWENS WB, 1990, J GEOPHYS RES-OCEANS, V95, P9527, DOI 10.1029/JC095iC06p09527; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; SOWERS T, 1993, PALEOCEANOGRAPHY, V8, P737, DOI 10.1029/93PA02328; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; STOSSEL A, IN PRESS J PHYS OCEA; TOGGWEILER JR, 1985, CARBON CYCLE ATMOSPH, P163; vonStorch JS, 1997, J CLIMATE, V10, P1525, DOI 10.1175/1520-0442(1997)010<1525:ADOAYC>2.0.CO;2; Weyl P. K., 1968, METEOROL MONOGR, V8, P37; WOLFF J, 1997, 13 DTSCH KLIM, P81; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2	41	34	37	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					728	730		10.1126/science.280.5364.728	http://dx.doi.org/10.1126/science.280.5364.728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563947				2022-12-28	WOS:000073415600045
J	Jan, YN; Jan, LY				Jan, YN; Jan, LY			Asymmetric cell division	NATURE			English	Article							MESSENGER-RNA LOCALIZATION; CAENORHABDITIS-ELEGANS; NUMB PROTEIN; DROSOPHILA; GENE; PROSPERO; ENCODES; FATES; NOTCH; POLARITY	With the recent identification of intrinsic cell-fate determinants for asymmetric cell division in several systems, biologists have begun to gain insight into the cellular mechanisms by which these determinants are preferentially segregated into one of the two daughter cells during mitosis so that the daughter cells acquire different fates.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Parnassus & 3rd Ave, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				Adam G., 1968, STRUCTURAL CHEM MOL, P198; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chang F, 1996, CURR BIOL, V6, P651, DOI 10.1016/S0960-9822(09)00440-0; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; EVANS TC, 1994, CELL, V77, P183, DOI 10.1016/0092-8674(94)90311-5; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GOMEZ R, 1997, DEVELOPMENT, V124, P4857; Grunert S, 1996, CURR OPIN GENET DEV, V6, P395, DOI 10.1016/S0959-437X(96)80059-1; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Knoblich JA, 1997, COLD SPRING HARB SYM, V62, P71; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schnabel R., 1997, C ELEGANS, P361; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SHEN CP, IN PRESS GENE DEV; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tetzlaff MT, 1996, EMBO J, V15, P1247, DOI 10.1002/j.1460-2075.1996.tb00466.x; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wang SW, 1997, DEVELOPMENT, V124, P4435; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	51	218	230	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1998	392	6678					775	778		10.1038/33854	http://dx.doi.org/10.1038/33854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572136				2022-12-28	WOS:000073241200042
J	Gawiser, E; Silk, J				Gawiser, E; Silk, J			Extracting primordial density fluctuations	SCIENCE			English	Review							COLD DARK-MATTER; LARGE-SCALE STRUCTURE; MICROWAVE BACKGROUND-RADIATION; CAMPANAS REDSHIFT SURVEY; POWER SPECTRUM; COSMOLOGICAL CONSTANT; MODELS; UNIVERSE; ANISOTROPIES; HOT	The combination of detections of anisotropy in cosmic microwave background radiation and observations of the large-scale distribution of galaxies probes the primordial density fluctuations of the universe on spatial scales varying by three orders of magnitude. These data are found to be inconsistent with the predictions of several popular cosmological models. Agreement between the data and the cold + hot dark matter model, however, suggests that a significant fraction of the matter in the universe may consist of massive neutrinos.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Ctr Particle Astrophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys & Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gawiser, E (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	gawiser@astron.berkeley.edu		silk, joe/0000-0002-1566-8148; Gawiser, Eric/0000-0003-1530-8713				Albrecht A, 1997, PHYS REV LETT, V79, P4736, DOI 10.1103/PhysRevLett.79.4736; Alcock C, 1997, ASTROPHYS J, V486, P697, DOI 10.1086/304535; Avelino PP, 1997, PHYS REV D, V56, P4568, DOI 10.1103/PhysRevD.56.4568; Bahcall NA, 1997, ASTROPHYS J, V485, pL53, DOI 10.1086/310814; BAKER JC, 1997, P PART PHYS EARL UNI; BALLINGER WE, 1997, THESIS U EDINBURGH; Bartelmann M, 1998, ASTRON ASTROPHYS, V330, P1; BATTYE RA, UNPUB PHYS REV LETT; BAUGH CM, 1993, MON NOT R ASTRON SOC, V265, P145, DOI 10.1093/mnras/265.1.145; Bennett CL, 1996, ASTROPHYS J, V464, pL1, DOI 10.1086/310075; Bond JR, 1997, MON NOT R ASTRON SOC, V291, pL33; BOND JR, 1997, P 16 MOR ASTR M, P197; BRANCH D, UNPUB ANN REV ASTRON; Bunn EF, 1997, ASTROPHYS J, V480, P6, DOI 10.1086/303955; Caldwell RR, 1998, PHYS REV LETT, V80, P1582, DOI 10.1103/PhysRevLett.80.1582; CARROLL SM, 1992, ANNU REV ASTRON ASTR, V30, P499, DOI 10.1146/annurev.aa.30.090192.002435; Chaboyer B, 1998, ASTROPHYS J, V494, P96, DOI 10.1086/305201; Cheng ES, 1997, ASTROPHYS J, V488, pL59, DOI 10.1086/310923; CHOI E, IN PRESS MON NOT R A; Coble K, 1997, PHYS REV D, V55, P1851, DOI 10.1103/PhysRevD.55.1851; DAVIS M, 1992, NATURE, V359, P393, DOI 10.1038/359393a0; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; Dodelson S, 1996, SCIENCE, V274, P69, DOI 10.1126/science.274.5284.69; EFSTATHIOU G, 1992, MON NOT R ASTRON SOC, V258, pP1, DOI 10.1093/mnras/258.1.1P; Einasto J, 1997, NATURE, V385, P139, DOI 10.1038/385139a0; Eisenstein DJ, 1998, ASTROPHYS J, V494, pL1, DOI 10.1086/311171; Evrard AE, 1997, MON NOT R ASTRON SOC, V292, P289, DOI 10.1093/mnras/292.2.289; Fan XH, 1997, ASTROPHYS J, V490, pL123, DOI 10.1086/311031; Ferreira PG, 1997, PHYS REV LETT, V79, P4740, DOI 10.1103/PhysRevLett.79.4740; FREEDMAN WL, 1997, CRITICAL DIALOGUES C, P92; GANGA K, 1994, ASTROPHYS J, V432, pL15, DOI 10.1086/187500; Gardner JP, 1997, ASTROPHYS J, V486, P42, DOI 10.1086/304526; Garnavich PM, 1998, ASTROPHYS J, V493, pL53, DOI 10.1086/311140; GAWISER E, 1997, P PART PHYS EARL UNI; GAWISER E, 1996, P 18 TEX S REL ASTR; Gaztanaga E, 1998, MON NOT R ASTRON SOC, V294, P229, DOI 10.1046/j.1365-8711.1998.01166.x; Goldberg DM, 1998, ASTROPHYS J, V495, P29, DOI 10.1086/305284; Gramann M, 1998, ASTROPHYS J, V493, P28, DOI 10.1086/305105; GUNDERSEN JO, 1995, ASTROPHYS J, V443, pL57, DOI 10.1086/187835; Gutierrez CM, 1997, ASTROPHYS J, V480, pL83, DOI 10.1086/310634; Hancock S, 1997, MON NOT R ASTRON SOC, V289, P505, DOI 10.1093/mnras/289.3.505; HARRISON ER, 1970, PHYS REV D, V1, P2726, DOI 10.1103/PhysRevD.1.2726; HU WZ, UNPUB; Jing YP, 1998, ASTROPHYS J, V494, P1, DOI 10.1086/305209; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; KAISER N, 1984, ASTROPHYS J, V284, pL9, DOI 10.1086/184341; Kauffmann G, 1997, MON NOT R ASTRON SOC, V286, P795, DOI 10.1093/mnras/286.4.795; Klypin A, 1996, ASTROPHYS J, V466, P13, DOI 10.1086/177489; KLYPIN A, 1993, ASTROPHYS J, V416, P1, DOI 10.1086/173210; Kochanek CS, 1996, ASTROPHYS J, V466, P638, DOI 10.1086/177538; Kolatt T, 1997, ASTROPHYS J, V479, P592, DOI 10.1086/303894; Landy SD, 1998, ASTROPHYS J, V494, pL133, DOI 10.1086/311197; Landy SD, 1996, ASTROPHYS J, V456, pL1, DOI 10.1086/309863; LEITCH E, 1997, THESIS CALTECH; Liddle AR, 1996, MON NOT R ASTRON SOC, V282, P281, DOI 10.1093/mnras/282.1.281; Liddle AR, 1996, MON NOT R ASTRON SOC, V281, P531, DOI 10.1093/mnras/281.2.531; Liddle AR, 1996, MON NOT R ASTRON SOC, V278, P644; Lim MA, 1996, ASTROPHYS J, V469, pL69, DOI 10.1086/310276; Lin H, 1996, ASTROPHYS J, V471, P617, DOI 10.1086/177993; Lineweaver CH, 1998, ASTROPHYS J, V496, P624, DOI 10.1086/305408; Ma CP, 1997, ASTROPHYS J, V484, pL1, DOI 10.1086/310778; Mann RG, 1998, MON NOT R ASTRON SOC, V293, P209, DOI 10.1046/j.1365-8711.1998.01053.x; Masi S, 1996, ASTROPHYS J, V463, pL47, DOI 10.1086/310069; MATHER JC, 1994, ASTROPHYS J, V420, P439, DOI 10.1086/173574; Netterfield CB, 1997, ASTROPHYS J, V474, P47, DOI 10.1086/303438; OLINTO A, IN PRESS; PARK CB, 1994, ASTROPHYS J, V431, P569, DOI 10.1086/174508; Peacock JA, 1997, MON NOT R ASTRON SOC, V284, P885, DOI 10.1093/mnras/284.4.885; PEACOCK JA, 1994, MON NOT R ASTRON SOC, V267, P1020, DOI 10.1093/mnras/267.4.1020; Peacock JA, 1996, MON NOT R ASTRON SOC, V280, pL19, DOI 10.1093/mnras/280.3.L19; Peebles PJE, 1997, ASTROPHYS J, V483, pL1, DOI 10.1086/310738; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; Perlmutter S., 1997, B AM ASTRON SOC, V29, P1351; Platt SR, 1997, ASTROPHYS J, V475, pL1, DOI 10.1086/310453; POGOSYAN DY, 1993, MON NOT R ASTRON SOC, V265, P507, DOI 10.1093/mnras/265.2.507; PRIMACK JR, 1995, PHYS REV LETT, V74, P2160, DOI 10.1103/PhysRevLett.74.2160; SANDAGE A, 1997, CRITICAL DIALOGUES C, P130; SCOTT D, 1995, SCIENCE, V268, P829, DOI 10.1126/science.268.5212.829; Scott PF, 1996, ASTROPHYS J, V461, pL1, DOI 10.1086/310000; Seljak U, 1996, ASTROPHYS J, V469, P437, DOI 10.1086/177793; Shepherd CW, 1997, ASTROPHYS J, V479, P82, DOI 10.1086/303846; Smith Coby, UNPUB; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; SMOOT GF, REV PART PROP; STIRLING A, 1998, THESIS U EDINBURGH; SUGIYAMA N, UNPUB; TADROS H, 1995, MON NOT R ASTRON SOC, V276, pL45; TADROS H, UNPUB; Tanaka ST, 1996, ASTROPHYS J, V468, pL81, DOI 10.1086/310248; TAYLOR AN, 1992, NATURE, V359, P396, DOI 10.1038/359396a0; Tucker GS, 1997, ASTROPHYS J, V475, pL73, DOI 10.1086/310468; Turner MS, 1997, PHYS REV D, V56, pR4439, DOI 10.1103/PhysRevD.56.R4439; Tytler D, 1996, NATURE, V381, P207, DOI 10.1038/381207a0; Viana PTP, 1996, MON NOT R ASTRON SOC, V281, P323; VITTORIO N, 1992, ASTROPHYS J, V385, pL9, DOI 10.1086/186265; VLANA PTP, 1998, PHYS REV D, V57, P674; VOGELEY M, COMMUNICATION; WANG Y, UNPUB; Weinberg S., 1972, GRAVITATION COSMOLOG; WHITE M, 1995, MON NOT R ASTRON SOC, V276, pL69; White M, 1996, MON NOT R ASTRON SOC, V283, P107, DOI 10.1093/mnras/283.1.107; WHITE M, 1996, COMMENTS ASTROPHYS, V8, P289; Zaldarriaga M, 1998, ASTROPHYS J, V494, P491, DOI 10.1086/305223; Zaroubi S, 1997, ASTROPHYS J, V486, P21, DOI 10.1086/304481; ZELDOVICH YB, 1972, MON NOT R ASTRON SOC, V160, pP1, DOI 10.1093/mnras/160.1.1P	106	149	148	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1405	1411		10.1126/science.280.5368.1405	http://dx.doi.org/10.1126/science.280.5368.1405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603724	Green Submitted			2022-12-28	WOS:000073883400047
J	Bannon, MJ; Ross, EM				Bannon, MJ; Ross, EM			Administration of medicines in school: who is responsible?	BRITISH MEDICAL JOURNAL			English	Article							TEACHERS; ASTHMA; CHILDREN; EPILEPSY; ILLNESS; SERVICE; AGE		Northwick Pk Hosp, Northwick Pk & St Marks NHS Trust, Harrow HA1 3UJ, Middx, England; Univ London Kings Coll, Mary Sheridan Ctr, London SE11 4QW, England	Imperial College London; University of London; King's College London	Bannon, MJ (corresponding author), Northwick Pk Hosp, Northwick Pk & St Marks NHS Trust, Harrow HA1 3UJ, Middx, England.							ANDERSON HR, 1994, BRIT MED J, V308, P1600, DOI 10.1136/bmj.308.6944.1600; BAGNALL P, 1996, DIFFERENT LIGHT SCH; BANNON M. J., 1995, PROG COM CH HLTH, V1, P125; BANNON MJ, 1992, ARCH DIS CHILD, V67, P1467, DOI 10.1136/adc.67.12.1467; BEVIS M, 1990, ARCH DIS CHILD, V65, P622, DOI 10.1136/adc.65.6.622; Billingham K, 1998, BRIT MED J, V316, P406, DOI 10.1136/bmj.316.7129.406; *BMA COMM HLTH DOC, 1994, MED SCH; BRADBURY AJ, 1983, ARCH DIS CHILD, V58, P692, DOI 10.1136/adc.58.9.692; CASEY FA, 1994, ARCH DIS CHILD, V70, P382, DOI 10.1136/adc.70.5.382; CELANO MP, 1993, J LEARN DISABIL-US, V26, P23, DOI 10.1177/002221949302600103; CHETCUTI P, 1993, ARCH DIS CHILD, V68, P167, DOI 10.1136/adc.68.2.167; *DEP ED EMPL DEP H, 1996, SUPP PUP MED NEEDS S; Dyer J, 1996, Prof Nurse, V11, P518; Eboh W O, 1996, Br J Nurs, V5, P30; EISER C, 1995, ARCH DIS CHILD, V72, P302, DOI 10.1136/adc.72.4.302; FILIMORE EJ, 1997, ARCH DIS CHILD, V77, P420; FOX TK, 1991, PUBLIC HEALTH, V105, P399, DOI 10.1016/S0033-3506(05)80600-6; Leffert Nancy, 1993, Current Opinion in Pediatrics, V5, P429; METCALFE MA, 1991, BRIT MED J, V302, P443, DOI 10.1136/bmj.302.6774.443; *NHS MAN EX, 1992, PAT CHART PRIM HLTH; *NHS MAN EX, 1995, CHILDR CHART; PAPOLA P, 1994, PEDIATRICS, V94, P914; Polnay L, 1995, HLTH NEEDS SCH AGE C; STURNIOLO MG, 1994, ARCH DIS CHILD, V70, P424, DOI 10.1136/adc.70.5.424; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; VERITY CM, 1985, PAEDIAT PERSPECTIVES; WHITMORE K, 1984, PROGR CHILD HLTH, V1; 1991, CONTACT FAMILY DIREC	28	11	13	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1591	1593		10.1136/bmj.316.7144.1591	http://dx.doi.org/10.1136/bmj.316.7144.1591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596602	Green Published			2022-12-28	WOS:000073867800031
J	Farley, KA; Montanari, A; Shoemaker, EM; Shoemaker, CS				Farley, KA; Montanari, A; Shoemaker, EM; Shoemaker, CS			Geochemical evidence for a comet shower in the Late Eocene	SCIENCE			English	Article							INTERPLANETARY DUST; OORT CLOUD; MASS EXTINCTIONS; ORIGIN; MASSIGNANO; SEDIMENTS; IMPACTS; FLUX	Analyses of pelagic limestones indicate that the flux of extraterrestrial helium-3 to Earth was increased for a 2.5-million year (My) period in the late Eocene. The enhancement began similar to 1 My before and ended similar to 1.5 My after the major impact events that produced the large Popigai and Chesapeake Bay craters similar to 36 million years ago. The correlation between increased concentrations of helium-3, a tracer of fine-grained interplanetary dust, and large impacts indicates that the abundance of Earth-crossing objects and dustiness in the inner solar system were simultaneously but only briefly enhanced. These observations provide evidence for a comet shower triggered by an impulsive perturbation of the Oort cloud.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Ecole Mines, Paris, France; Osservatorio Geol Coldigioco, I-62020 Frontale Apiro, Apiro, Italy; US Geol Survey, Flagstaff, AZ 86001 USA	California Institute of Technology; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; United States Department of the Interior; United States Geological Survey	Farley, KA (corresponding author), CALTECH, Div Geol & Planetary Sci, MS 170-25, Pasadena, CA 91125 USA.	farley@gps.caltech.edu	Farley, Kenneth/AAE-7735-2020	Farley, Kenneth/0000-0002-7846-7546				AMARI S, 1985, NATURE, V317, P520, DOI 10.1038/317520a0; Bottomley R, 1997, NATURE, V388, P365, DOI 10.1038/41073; Clymer AK, 1996, GEOLOGY, V24, P483, DOI 10.1130/0091-7613(1996)024<0483:SQFTLE>2.3.CO;2; DERMOTT SF, 1984, NATURE, V312, P505, DOI 10.1038/312505a0; Dermott SF, 1996, ASTR SOC P, V104, P143; FARLEY KA, 1995, NATURE, V376, P153, DOI 10.1038/376153a0; Farley KA, 1997, GEOCHIM COSMOCHIM AC, V61, P2309, DOI 10.1016/S0016-7037(97)00068-9; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; Grieve RAF, 1996, EARTH MOON PLANETS, V72, P357, DOI 10.1007/BF00117541; HAZEL J, 1988, PALAIOS, V4, P318; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; KELLER G, 1983, SCIENCE, V221, P150, DOI 10.1126/science.221.4606.150; Koeberl C, 1996, SCIENCE, V271, P1263, DOI 10.1126/science.271.5253.1263; Lanci L, 1996, EARTH PLANET SC LETT, V143, P37, DOI 10.1016/0012-821X(96)00136-7; LIOU JC, 1995, PLANET SPACE SCI, V43, P717, DOI 10.1016/0032-0633(95)00065-D; Liou JC, 1996, ICARUS, V123, P491, DOI 10.1006/icar.1996.0174; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; MARZARI F, 1995, ICARUS, V113, P168, DOI 10.1006/icar.1995.1014; MATESE JJ, 1995, ICARUS, V116, P255, DOI 10.1006/icar.1995.1124; MERRIHUE C, 1964, ANN NY ACAD SCI, V119, P351; MOLINA E, 1993, GEOL MAG, V130, P483, DOI 10.1017/S0016756800020550; MONTANARI A, 1993, PALAIOS, V8, P420, DOI 10.2307/3515017; OZIMA M, 1984, NATURE, V311, P448, DOI 10.1038/311448a0; PATTERSON DB, UNPUB; Pierrard O, 1998, GEOLOGY, V26, P307, DOI 10.1130/0091-7613(1998)026<0307:ENRSIU>2.3.CO;2; PREMOLISILVA I, 1988, EOCENE OLIGOCENE BOU; RAMPINO MR, 1984, NATURE, V308, P709, DOI 10.1038/308709a0; SHOEMAKER EM, 1990, GEOL S AM S, V247, P155; VISHNEVSKY SA, UNPUB; WEISSMAN P, COMMUNICATION; WEISSMAN PR, 1990, NATURE, V344, P825, DOI 10.1038/344825a0	32	135	141	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1250	1253		10.1126/science.280.5367.1250	http://dx.doi.org/10.1126/science.280.5367.1250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596575				2022-12-28	WOS:000073852500044
J	Ford, CE; Skiba, NP; Bae, HS; Daaka, YH; Reuveny, E; Shekter, LR; Rosal, R; Weng, GZ; Yang, CS; Iyengar, R; Miller, RJ; Jan, LY; Lefkowitz, RJ; Hamm, HE				Ford, CE; Skiba, NP; Bae, HS; Daaka, YH; Reuveny, E; Shekter, LR; Rosal, R; Weng, GZ; Yang, CS; Iyengar, R; Miller, RJ; Jan, LY; Lefkowitz, RJ; Hamm, HE			Molecular basis for interactions of G protein beta gamma subunits with effectors	SCIENCE			English	Article							HETEROTRIMERIC G-PROTEIN; PHOSPHOLIPASE-C; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; ACTIVATION; ADENYLYL-CYCLASE-2; MODULATION; BINDING	Both the alpha and beta gamma subunits of heterotrimeric guanine nucleotide-binding proteins (G proteins) communicate signals from receptors to effecters. G beta gamma subunits, can regulate a diverse array of effecters, including ion channels and enzymes. G alpha subunits bound to guanine diphosphate (G alpha-GDP) inhibit signal transduction through G beta gamma subunits, suggesting a common interface on G beta gamma subunits for G alpha binding and effector interaction. The molecular basis for interaction of G beta gamma with effecters was characterized by mutational analysis of G beta residues that make contact with G alpha-GDP. Analysis of the ability of these mutants to regulate the activity of calcium and potassium channels, adenylyl cyclase 2, phospholipase C-beta 2, and beta-adrenergic receptor kinase revealed the G beta residues required for activation of each effector and provides evidence for partially overlapping domains on G beta for regulation of these effecters. This organization of interaction regions on G beta for different effecters and G alpha explains why subunit dissociation is crucial for signal transmission through G beta gamma subunits.	Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Weizmann Inst Sci, Dept Membrane Res & Biophys, IL-76100 Rehovot, Israel; Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol & Biochem, San Francisco, CA 94143 USA	Northwestern University; Northwestern University; Duke University; Duke University; Howard Hughes Medical Institute; Weizmann Institute of Science; University of Chicago; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hamm, HE (corresponding author), Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA.		Lefkowitz, Robert/AAW-2649-2021; Hamm, Heidi E/G-2374-2014; Bae, Hyunsu/ABH-6248-2020	YANG, CHII-SHEN/0000-0002-2792-6247; Jan, Lily/0000-0003-3938-8498; Bae, Hyunsu/0000-0002-0299-3582	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040165, R37MH040165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002575, R01DA002121] Funding Source: NIH RePORTER; NIDA NIH HHS [DA02121, DA02575] Funding Source: Medline; NIMH NIH HHS [MH40165] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CHEN J, 1995, SCIENCE, V268, P1168; Chen YB, 1997, P NATL ACAD SCI USA, V94, P2711, DOI 10.1073/pnas.94.6.2711; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DEVIVO M, 1994, METHOD ENZYMOL, V238, P131; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; GRISHIN AV, 1994, MOL CELL BIOL, V14, P4571, DOI 10.1128/MCB.14.7.4571; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; KATADA T, 1994, METHOD ENZYMOL, V237, P131; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Pellegrino S, 1997, J BIOL CHEM, V272, P25360, DOI 10.1074/jbc.272.40.25360; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Schneider T, 1997, TRENDS PHARMACOL SCI, V18, P8, DOI 10.1016/S0165-6147(96)01001-2; Shekter LR, 1997, MOL PHARMACOL, V52, P282, DOI 10.1124/mol.52.2.282; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Stoffel RH, 1997, J MEMBRANE BIOL, V157, P1, DOI 10.1007/s002329900210; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Weng GZ, 1996, J BIOL CHEM, V271, P26445, DOI 10.1074/jbc.271.43.26445; Yamauchi J, 1997, J BIOL CHEM, V272, P7602, DOI 10.1074/jbc.272.12.7602; Yan K, 1997, J BIOL CHEM, V272, P2056; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597; Zhang SY, 1996, J BIOL CHEM, V271, P20208, DOI 10.1074/jbc.271.33.20208	40	354	364	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1271	1274		10.1126/science.280.5367.1271	http://dx.doi.org/10.1126/science.280.5367.1271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596582				2022-12-28	WOS:000073852500051
J	Fiorino, AS				Fiorino, AS			Electron-beam computed tomography, coronary artery calcium, and evaluation of patients with coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Review							AMERICAN-HEART-ASSOCIATION; DIGITAL SUBTRACTION FLUOROSCOPY; RISK-FACTORS; ATHEROSCLEROTIC LESIONS; ASYMPTOMATIC MEN; PROGNOSTIC-SIGNIFICANCE; VASCULAR-LESIONS; YOUNG-ADULTS; CALCIFICATION; CT	Purpose: To briefly review the role of calcium in the pathophysiology of atherosclerosis and to comprehensively review and analyze studies of coronary artery calcium detected by electron-beam computed tomography (CT). Data Sources: The English-language literature located through MEDLINE and Current Contents. Study Selection: All studies of electron-beam CT in symptomatic and asymptomatic patients with and without known coronary artery disease were selected. Data Extraction: Significant findings on the association of cardiac risk factors and angiographically evident coronary artery disease with coronary artery calcium detected on electron-beam CT were compared. Prospective data on clinical outcomes in patients with coronary artery calcium were assessed. Data Synthesis: Coronary artery calcium is common in patients with known coronary artery disease or risk factors for coronary artery disease, and it becomes more common with increasing age. Coronary artery calcium detected by electron-beam CT is a sensitive but nota specific indicator of angiographically evident atherosclerosis; sensitivity is increased and specificity is decreased for angiographically significant disease. Test characteristics can be adjusted to improve specificity at the cost of sensitivity. Very limited data suggest that patients with coronary artery calcium are more likely to have cardiac events. Conclusions: Electron-beam CT is a promising new tool for the evaluation of coronary artery disease because patients who have coronary artery calcium are likely to have angiographically evident atherosclerosis. However, too few data currently exist to support the broad use of this tool in clinical decision making during the evaluation of patients with known or suspected coronary artery disease.	Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Fiorino, AS (corresponding author), Hosp Univ Penn, Dept Dermatol, 2 Rhoads Pavil, Philadelphia, PA 19104 USA.	fiorino@alum.mit.edu						AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; AGATSTON AS, 1994, AM J CARDIOL, V74, P1272, DOI 10.1016/0002-9149(94)90563-0; Alexopoulos D, 1996, AM J CARDIOL, V78, P474, DOI 10.1016/S0002-9149(96)00340-2; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Baumgart D, 1997, J AM COLL CARDIOL, V30, P57, DOI 10.1016/S0735-1097(97)00147-2; BEADENKOPF WG, 1964, AMER J ROENTGENOL RA, V92, P865; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; BOSTROM K, 1995, AM J CARDIOL, V75, pB88, DOI 10.1016/0002-9149(95)80020-S; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; BREEN JF, 1992, RADIOLOGY, V185, P435, DOI 10.1148/radiology.185.2.1410350; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; Buja LM, 1996, CIRCULATION, V94, P872, DOI 10.1161/01.CIR.94.5.872; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; DAVIES MJ, 1990, CIRCULATION, V82, P38; DEMER LL, 1994, TRENDS CARDIOVAS MED, V4, P45, DOI 10.1016/1050-1738(94)90025-6; DETRANO R, 1987, ANN INTERN MED, V106, P846, DOI 10.7326/0003-4819-106-6-846; DETRANO R, 1985, CIRCULATION, V71, P725, DOI 10.1161/01.CIR.71.4.725; DETRANO R, 1994, INVEST RADIOL, V29, P733, DOI 10.1097/00004424-199408000-00001; Detrano R, 1996, J AM COLL CARDIOL, V27, P285, DOI 10.1016/0735-1097(95)00460-2; Detrano R, 1992, Int J Card Imaging, V8, P209, DOI 10.1007/BF01146839; DETRANO RC, 1994, AM HEART J, V127, P1526, DOI 10.1016/0002-8703(94)90381-6; Detrano RC, 1997, AM J MED, V102, P344, DOI 10.1016/S0002-9343(97)00085-5; DETRANO RC, 1994, J AM COLL CARDIOL, V24, P354, DOI 10.1016/0735-1097(94)90287-9; DEVRIES S, 1995, J AM COLL CARDIOL, V25, P76, DOI 10.1016/0735-1097(94)00342-N; FALLAVOLLITA JA, 1994, CIRCULATION, V89, P285, DOI 10.1161/01.CIR.89.1.285; Fallavollita JA, 1996, AM J CARDIOL, V78, P1281, DOI 10.1016/S0002-9149(96)00612-1; FernandezOrtiz A, 1996, CLIN GERIATR MED, V12, P1; FITZPATRICK LA, 1993, J CLIN INVEST, V92, P2814; FRINK R, 1974, AM J CADIOL, V26, P241; GOEL M, 1992, AM J CARDIOL, V70, P977, DOI 10.1016/0002-9149(92)90346-Z; Guerci AD, 1997, AM J CARDIOL, V79, P128, DOI 10.1016/S0002-9149(96)00698-4; HAUST MD, 1970, AM J PATHOL, V60, P329; Hernigou A, 1996, EUR RADIOL, V6, P210; HOEG JM, 1994, ARTERIOSCLER THROMB, V14, P1066, DOI 10.1161/01.ATV.14.7.1066; Hundley WG, 1996, AM J CARDIOL, V78, P1265, DOI 10.1016/S0002-9149(96)00626-1; JANOWITZ WR, 1993, AM J CARDIOL, V72, P247, DOI 10.1016/0002-9149(93)90668-3; JANOWITZ WR, 1991, AM J CARDIOL, V68, P1, DOI 10.1016/0002-9149(91)90700-U; KAJINAMI K, 1995, J AM COLL CARDIOL, V26, P1209, DOI 10.1016/0735-1097(95)00314-2; Kajinami K, 1997, J AM COLL CARDIOL, V29, P1549, DOI 10.1016/S0735-1097(97)00090-9; KAUFMANN RB, 1995, J AM COLL CARDIOL, V25, P626, DOI 10.1016/0735-1097(94)00435-S; KAUFMANN RB, 1995, MAYO CLIN PROC, V70, P223, DOI 10.4065/70.3.223; KRAGEL AH, 1989, CIRCULATION, V80, P1747, DOI 10.1161/01.CIR.80.6.1747; Lazem F, 1997, TRANSPL P, V29, P572, DOI 10.1016/S0041-1345(96)00308-9; Levenson J, 1997, ARTERIOSCL THROM VAS, V17, P45, DOI 10.1161/01.ATV.17.1.45; Little William C., 1996, Cardiology Clinics, V14, P221; Maher JE, 1996, AM J EPIDEMIOL, V144, P943, DOI 10.1093/oxfordjournals.aje.a008864; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; MARGOLIS JR, 1980, RADIOLOGY, V137, P609, DOI 10.1148/radiology.137.3.7444045; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; MAUTNER SL, 1994, RADIOLOGY, V192, P625, DOI 10.1148/radiology.192.3.8058925; MCCARTHY JH, 1979, BRIT HEART J, V36, P499; MEGNIEN JL, 1992, CIRCULATION, V85, P1799, DOI 10.1161/01.CIR.85.5.1799; MOLLOI S, 1991, MED PHYS, V18, P295, DOI 10.1118/1.596674; MOSHAGE WEL, 1995, RADIOLOGY, V196, P707, DOI 10.1148/radiology.196.3.7644633; Nakanishi T, 1997, J COMPUT ASSIST TOMO, V21, P121, DOI 10.1097/00004728-199701000-00024; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7; Rumberger JA, 1997, J AM COLL CARDIOL, V29, P1542, DOI 10.1016/S0735-1097(97)00093-4; Rumberger JA, 1996, MAYO CLIN PROC, V71, P369, DOI 10.4065/71.4.369; SCHMID K, 1980, ATHEROSCLEROSIS, V37, P199, DOI 10.1016/0021-9150(80)90005-2; Schroeder Anne Pauline, 1996, Cardiology Clinics, V14, P211; Secci A, 1997, CIRCULATION, V96, P1122, DOI 10.1161/01.CIR.96.4.1122; Shah Prediman K., 1996, Cardiology Clinics, V14, P17; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; SIMON A, 1995, CIRCULATION, V92, P1414, DOI 10.1161/01.CIR.92.6.1414; SIMONS DB, 1992, J AM COLL CARDIOL, V20, P1118, DOI 10.1016/0735-1097(92)90367-V; Stanford W, 1995, Am J Card Imaging, V9, P257; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; TANENBAUM SR, 1989, AM J CARDIOL, V63, P870, DOI 10.1016/0002-9149(89)90060-X; TANG W, 1994, INVEST RADIOL, V29, P147, DOI 10.1097/00004424-199402000-00004; TANG WY, 1995, AM J CARDIOL, V75, P1088, DOI 10.1016/S0002-9149(99)80735-8; Teng W, 1996, CORONARY ARTERY DIS, V7, P383, DOI 10.1097/00019501-199605000-00009; Wang SJ, 1996, AM HEART J, V132, P550, DOI 10.1016/S0002-8703(96)90237-9; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; WONG ND, 1994, AM J CARDIOL, V73, P223, DOI 10.1016/0002-9149(94)90223-2; WONG ND, 1994, AM HEART J, V127, P422, DOI 10.1016/0002-8703(94)90133-3; Zhou YF, 1996, NEW ENGL J MED, V335, P624, DOI 10.1056/NEJM199608293350903	82	57	59	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					839	847		10.7326/0003-4819-128-10-199805150-00008	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599197				2022-12-28	WOS:000073586500008
J	Campbell, NC; Thain, J; Deans, HG; Ritchie, LD; Rawles, JM				Campbell, NC; Thain, J; Deans, HG; Ritchie, LD; Rawles, JM			Secondary prevention in coronary heart disease: baseline survey of provision in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; MYOCARDIAL-INFARCTION; HYPERTENSION; EXERCISE; SOCIETY; ANGINA; RISK	Objective: To determine secondary preventive treatment and habits among patients with coronary heart disease in general practice. Design: Process of care data on a random sample of patients were collected from medical records. Health and lifestyle data were collected by postal questionnaire (response rate 71%). Setting: Stratified, random sample of general practices in Grampian. Subjects: 1921 patients aged under 80 years with coronary heart disease identified from pre-existing registers of coronary heart disease and nitrate prescriptions. Main outcome measures: Treatment with aspirin, beta blockers, and angiotensin converting enzyme inhibitors. Management of lipid concentrations and hypertension according to local guidelines. Dietary habits (dietary instrument for nutritional evaluation score), physical activity (health practice indices), smoking, and body mass index. Results: 825/1319 (63%) patients took aspirin. Of 414 patients with recent myocardial infarction, 131 (32%) took beta blockers, and of 257 with heart failure, 102 (40%) took angiotensin converting enzyme inhibitors. Blood pressure was managed according to current guidelines for 1566 (82%) patients but lipid concentrations for only 133 (17%). 673 of 1327 patients (51%) took little or no exercise, 245 of 1333 (18%) were current smokers, 808 of 1264 (64%) were overweight and 627 of 1213 (52%) ate more fat than recommended. Conclusion: In terms of secondary prevention, half of patients had at least two aspects of their medical management that were suboptimal and nearly two thirds had at least two aspects of their health behaviour that would benefit from change. There seems to be considerable potential to increase secondary prevention of coronary heart disease in general practice.	Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; Grampian Healthcare, Denburn Hlth Ctr, Aberdeen AB25 1QB, Scotland; Univ Aberdeen, Med Assessment Res Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Campbell, NC (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.	ncampbell@abdn.ac.uk						ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ, V308, P313; Berkman LF, 1983, HLTH WAYS LIVING ALA; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; BROWN MA, 1989, ENERG BUILDINGS, V13, P1, DOI 10.1016/0378-7788(89)90010-8; CANNON PJ, 1988, LANCET, V1, P979; COULTER A, 1994, BRIT MED J, V308, P308; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; DALY LE, 1983, BMJ-BRIT MED J, V287, P324, DOI 10.1136/bmj.287.6388.324; GANDHI MM, 1995, BRIT J GEN PRACT, V45, P11; *GRAMP LIP MAN GUI, 1993, GRAMP GEN PRACT LIP; KATZEL LI, 1995, JAMA-J AM MED ASSOC, V274, P1915, DOI 10.1001/jama.274.24.1915; KONSTAM M, 1994, HEART FAILURE EVALUA; Moher M, 1997, BMJ-BRIT MED J, V315, P69, DOI 10.1136/bmj.315.7100.69; Moher M., 1995, EVIDENCE EFFECTIVENE; *NHS SCOTL MAN EX, 1996, HLTH PROM PRIM CAR R; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; PEDERSEN TR, 1994, LANCET, V344, P1383; PYORALA K, 1994, EUR HEART J, V15, P1300; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SEVER P, 1993, BMJ-BRIT MED J, V306, P983, DOI 10.1136/bmj.306.6883.983; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	25	154	155	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	1998	316	7142					1430	1434		10.1136/bmj.316.7142.1430	http://dx.doi.org/10.1136/bmj.316.7142.1430			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572757	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073651600032
J	Drife, JO				Drife, JO			Soundings - Valedictory lecture	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1466	1466		10.1136/bmj.316.7142.1466	http://dx.doi.org/10.1136/bmj.316.7142.1466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572777	Green Published			2022-12-28	WOS:000073651600077
J	Posfai, M; Buseck, PR; Bazylinski, DA; Frankel, RB				Posfai, M; Buseck, PR; Bazylinski, DA; Frankel, RB			Reaction sequence of iron sulfide minerals in bacteria and their use as biomarkers	SCIENCE			English	Article							MAGNETOTACTIC MICROORGANISM; GREIGITE FE3S4; BIOMINERALIZATION; PYRITE; LIFE; FES	Some bacteria form intracellular nanometer-scale crystals of greigite (Fe3S4) that cause the bacteria to be oriented in magnetic fields. Transmission electron microscope observations showed that ferrimagnetic greigite in these bacteria forms from nonmagnetic mackinawite (tetragonal FeS) and possibly from cubic FeS. These precursors apparently transform into greigite by rearrangement of iron atoms over a period of days to weeks. Neither pyrrhotite nor pyrite was found. These results have implications for the interpretation of the presence of pyrrhotite and greigite in the martian meteorite ALH84001.	Arizona State Univ, Dept Geol, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem Biochem, Tempe, AZ 85287 USA; Iowa State Univ, Dept Microbiol Immunol & Prevent Med, Ames, IA 50011 USA; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA; Univ Veszprem, Dept Earth & Environm Sci, H-8200 Veszprem, Hungary	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Iowa State University; California State University System; California Polytechnic State University San Luis Obispo; University of Pannonia	Posfai, M (corresponding author), Arizona State Univ, Dept Geol, Tempe, AZ 85287 USA.		Pósfai, Mihály/C-1792-2012	Pósfai, Mihály/0000-0001-9355-3533				Bazylinski D. A., 1990, IRON BIOMINERALS, P239; Bazylinski DA, 1997, REV MINERAL, V35, P181; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BERNER RA, 1967, AM J SCI, V265, P773, DOI 10.2475/ajs.265.9.773; Bertaut EF, 1965, SOLID STATE COMMUN, V3, P335, DOI 10.1016/0038-1098(65)90090-6; DELONG EF, 1993, SCIENCE, V259, P803, DOI 10.1126/science.259.5096.803; FARINA M, 1983, BIOL CELL, V48, P85; FARINA M, 1990, NATURE, V343, P256, DOI 10.1038/343256a0; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; HEYWOOD BR, 1991, MATER RES SOC SYMP P, V218, P93; KRUPP RE, 1994, EUR J MINERAL, V6, P265; Lennie AR, 1997, AM MINERAL, V82, P302; MANN S, 1990, NATURE, V343, P258, DOI 10.1038/343258a0; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MEDICIS RD, 1970, SCIENCE, V170, P1191, DOI 10.1126/science.170.3963.1191; MORSE JW, 1987, EARTH-SCI REV, V24, P1, DOI 10.1016/0012-8252(87)90046-8; MUROWCHICK JB, 1986, AM MINERAL, V71, P1243; MUROWOHICK JB, 1989, GEOL SOC AM PROGR AB, V21, pA120; Rickard D., 1969, STOCK CONTRIB GEOL, V20, P67; RICKARD DT, 1969, STOCKHOLM CONTRIB GE, V20, P55; SCHOONEN MAA, 1991, GEOCHIM COSMOCHIM AC, V55, P1505, DOI 10.1016/0016-7037(91)90123-M; SKINNER BJ, 1964, AM MINERAL, V49, P543; WACHTERSHAUSER G, 1988, SYST APPL MICROBIOL, V10, P207; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; WILLIAMS RJP, 1990, NATURE, V343, P213, DOI 10.1038/343213a0; WINTENBERGER M, 1978, J PHYS-PARIS, V39, P965, DOI 10.1051/jphys:01978003909096500	26	160	164	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					880	883		10.1126/science.280.5365.880	http://dx.doi.org/10.1126/science.280.5365.880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572727	Green Submitted			2022-12-28	WOS:000073532900034
J	Kemp, M				Kemp, M			Noticing Nature	NATURE			English	Article									Univ Oxford, Dept Hist Art, Oxford OX1 2PG, England	University of Oxford	Kemp, M (corresponding author), Univ Oxford, Dept Hist Art, 35 Beaumont St, Oxford OX1 2PG, England.								0	1	1	1	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					25	26		10.1038/29897	http://dx.doi.org/10.1038/29897			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590686				2022-12-28	WOS:000073497500028
J	Nightingale, SL				Nightingale, SL			Ultrasound device for evaluating bone strength approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Hlth Affairs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Nightingale, SL (corresponding author), US FDA, Off Hlth Affairs, Parklawn Bldg,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1339	1339		10.1001/jama.279.17.1339	http://dx.doi.org/10.1001/jama.279.17.1339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582030				2022-12-28	WOS:000073359800006
J	Cheng, YK; Rossky, PJ				Cheng, YK; Rossky, PJ			Surface topography dependence of biomolecular hydrophobic hydration	NATURE			English	Article							MOLECULAR-DYNAMICS; PROTEIN; WATER; MELITTIN; SOLVENT; SOLVATION	Many biomolecules are characterized by surfaces containing extended nonpolar regions(1), and the aggregation and subsequent removal of such surfaces from water is believed to play a critical role in the biomolecular assembly in cells(2). A better understanding of the hydrophobic hydration of biomolecules may therefore yield new insights into intracellular assembly, Conventional views hold that the hydration shell of small hydrophobic solutes is clathrate-like, characterized by local cage-like hydrogen-bonding structures and a distinct loss in entropy(2). The hydration of extended nonpolar planar surfaces, however, appears to involve structures that are orientationally inverted relative to clathrate-like hydration shells(3,4), with unsatisfied hydrogen bonds that are directed towards the hydrophobic surface. Here we present computer simulations of the interaction between the polypeptide melittin and water that demonstrate that the two different hydration structures also exist near a biomolecular surface. We find that the two structures are distinguished by a substantial difference in the water-water interaction enthalpy, and that their relative contributions depend strongly on the surface topography of the melittin molecule: clathrate-like structures dominate near con-vex surface patches, whereas the hydration shell near flat surfaces fluctuates between clathrate-like and less-ordered or inverted structures. The strong influence of surface topography on the structure and free energy of hydrophobic hydration is likely to hold in general, and will be particularly important for the many biomolecules whose surfaces contain convex patches, deep or shallow concave grooves and roughly planar areas(5).	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Rossky, PJ (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.			Cheng, Yuen-Kit/0000-0002-5643-5949				Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Clarke Anthony R., 1996, P167, DOI 10.1016/B978-012237455-5/50008-7; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; FREIRE E, 1992, BIOCHEMISTRY-US, V31, P250, DOI 10.1021/bi00116a034; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; KUHN LA, 1992, J MOL BIOL, V228, P13, DOI 10.1016/0022-2836(92)90487-5; LEE CY, 1984, J CHEM PHYS, V80, P4448, DOI 10.1063/1.447226; MEHROTRA PK, 1980, J AM CHEM SOC, V102, P4287, DOI 10.1021/ja00533a001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PASCUALAHUIR JL, 1994, J COMPUT CHEM, V15, P1127, DOI 10.1002/jcc.540151009; ROSSKY PJ, 1979, J AM CHEM SOC, V101, P1913, DOI 10.1021/ja00502a001; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SanchezRuiz JM, 1996, EUR BIOPHYS J BIOPHY, V24, P261; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; TEETER MM, 1991, ANNU REV BIOPHYS BIO, V20, P577, DOI 10.1146/annurev.bb.20.060191.003045; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; ZICHI DA, 1985, J CHEM PHYS, V83, P797, DOI 10.1063/1.449495	22	360	360	0	105	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 16	1998	392	6677					696	699		10.1038/33653	http://dx.doi.org/10.1038/33653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565030				2022-12-28	WOS:000073129000052
J	Prentice, A				Prentice, A			Promising results but wider recruitment needed	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England	University of Cambridge	Prentice, A (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.							Barrington JW, 1997, BRIT J OBSTET GYNAEC, V104, P614, DOI 10.1111/j.1471-0528.1997.tb11542.x; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1360, DOI 10.1111/j.1471-0528.1997.tb11004.x; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1367, DOI 10.1111/j.1471-0528.1997.tb11005.x; Garry R, 1997, BRIT J OBSTET GYNAEC, V104, P1329, DOI 10.1111/j.1471-0528.1997.tb10998.x; Lilford RJ, 1997, BRIT MED J, V314, P160, DOI 10.1136/bmj.314.7075.160; Overton C, 1997, BRIT J OBSTET GYNAEC, V104, P1351, DOI 10.1111/j.1471-0528.1997.tb11003.x	6	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 11	1998	316	7138					1126	1126						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH054	9569415				2022-12-28	WOS:000073067500021
J	Brown, RH; Cruikshank, DP; Pendleton, Y; Veeder, GJ				Brown, RH; Cruikshank, DP; Pendleton, Y; Veeder, GJ			Identification of water ice on the Centaur 1997 CU26	SCIENCE			English	Article							SHORT-PERIOD COMETS; OUTER SOLAR-SYSTEM; OPTICAL-CONSTANTS; KUIPER BELT; OBJECTS	Spectra of the Centaur 1997 CU26 were obtained at the Keck Observatory on 27 October 1997 (universal time). The data show strong absorptions at 1.52 and 2.03 micrometers attributable to water ice on the surface of 1997 CU26. The reflectance spectrum of 1997 CU26 is matched by the spectrum of a mixture of low-temperature particulate water ice and spectrally featureless but otherwise red-colored material. Water ice dominates the Spectrum of 1997 CU26, whereas methane or methane-like hydrocarbons apparently dominate the spectrum of the Kuiper belt object 1993 SC, perhaps indicating different origins, thermal histories, or both for these two objects.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Brown, RH (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.							BELL JF, 1988, LUNAR PLANET SCI, V19, P57; Brown RH, 1997, SCIENCE, V276, P937, DOI 10.1126/science.276.5314.937; CRUIKSHANK DP, 1997, STARDUST PLANETESIMA; CRUIKSHANK DP, UNPUB; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; EDGEWORTH KE, 1949, MON NOT R ASTRON SOC, V109, P600, DOI 10.1093/mnras/109.5.600; GLADMAN B, 1990, ASTRON J, V100, P1680, DOI 10.1086/115628; Hapke B, 1993, REMOTE GEOCHEMICAL A, P31; HOLMAN MJ, 1993, ASTRON J, V105, P1987, DOI 10.1086/116574; Irwin M, 1995, ASTRON J, V110, P3082, DOI 10.1086/117749; Jewitt D, 1996, ASTRON J, V112, P1225, DOI 10.1086/118093; JEWITT DC, UNPUB; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; LUU J, 1994, ICARUS, V109, P133, DOI 10.1006/icar.1994.1081; Luu JX, 1998, ASTROPHYS J, V494, pL117, DOI 10.1086/311172; Matthews M. S., 1989, ASTEROIDS, VII; SAGAN C, 1984, SATURN, P788; TOON OB, 1994, J GEOPHYS RES-ATMOS, V99, P25631, DOI 10.1029/94JD02388; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; [No title captured]; 1997, 31010 MIN PLAN	21	44	44	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1430	1432		10.1126/science.280.5368.1430	http://dx.doi.org/10.1126/science.280.5368.1430			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603731				2022-12-28	WOS:000073883400054
J	Christensen, MB; Olesen, F				Christensen, MB; Olesen, F			Out of hours service in Denmark: evaluation five years after reform	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective: Five years after its introduction, to evaluate the 1992 reform in the out of hours service in Denmark. Design: Comparison of data before and after reform. Data were collected from published reports, Danish national health statistics, and the Danish trade union for general practitioners. Setting: Denmark. Main outcome measures: Number of out of hours services; workload of general practitioners; cost of the service; patient satisfaction. Results: Five years after the reform, the percentage of telephone consultations had almost doubled, to 48%. Consultations in doctors' surgeries were relatively unchanged, but home visits were much reduced, to 18%. The percentage of doctors who worked 5 hours or more out of hours per week dropped from about 70% to about 50%. Overall patient satisfaction in 1995 was high (72%). Conclusion: The organisation of the out of hours service, with a fully trained general practitioner in a telephone triage function, is working satisfactorily. Many calls that previously would have required home visits are now dealt with by telephone or through consultations. The out of hours workload for general practitioners has decreased considerably.	Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark	Aarhus University	Christensen, MB (corresponding author), Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark.	Christensen.MBC@alm.aau.dk		Christensen, Morten Bondo/0000-0002-8342-7418				ANDERSEN F, 1996, UGESKRIFT LAEGER, V158, P6328; ANDERSEN F, 1994, UGESKRIFT LAEGER, V156, P6910; Christensen M B, 1997, Ugeskr Laeger, V159, P2375; Christensen M B, 1997, Ugeskr Laeger, V159, P2381; CHRISTENSEN MB, 1994, SMERTEPATIENTERS BRU; CHRISTENSEN MB, 1994, MAANEDSSKR PRAKT LAE, P1071; Cragg DK, 1997, BMJ-BRIT MED J, V314, P187, DOI 10.1136/bmj.314.7075.187; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; HANSEN BL, 1995, BRUGERVURDERING LAEG; *HLTH INS COUNT VE, 1995, RAPP PAT LAEG VEJL A; KJELDSEN HC, 1995, SUBSTITUTIONSMULIGHE; McKinley RK, 1997, BMJ-BRIT MED J, V314, P193, DOI 10.1136/bmj.314.7075.193; McKinley RK, 1997, BMJ-BRIT MED J, V314, P190, DOI 10.1136/bmj.314.7075.190; *NAT HLTH INS, 1997, RAPP TILR AK; *NAT HLTH INS, 1996, SYG STAT 1993 94; *NAT HLTH INS, 1996, SUG STAT 1991 92; OLESEN F, 1994, BRIT MED J, V309, P1624, DOI 10.1136/bmj.309.6969.1624; Olesen F, 1996, SCAND J PRIM HEALTH, V14, P62, DOI 10.3109/02813439608997070; WHITBY M, 1989, PRACTITIONER, V233, P493	19	96	97	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	1998	316	7143					1502	1505		10.1136/bmj.316.7143.1502	http://dx.doi.org/10.1136/bmj.316.7143.1502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582141	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000073707700031
J	Gho, M; Schweisguth, F				Gho, M; Schweisguth, F			Frizzled signalling controls orientation of asymmetric sense organ precursor cell divisions in Drosophila	NATURE			English	Article							NUMB PROTEIN; NOTCH; MECHANISMS; ENCODES; DOMAINS; FATES; GENE	During metazoan development, cell-fate diversity is brought about, in part, by asymmetric cell divisions(1). In Drosophila, bristle mechanosensory organs are composed of four different cells that originate from a single precursor cell, pI, after two rounds of asymmetric division(2). At each division, distinct fates are conferred on sister cells by the asymmetric segregation ofNumb, a negative regulator of Notch signalling(3-6). Here we show that the orientation of the mitotic spindles and the localization of the Numb crescent follow a stereotyped pattern. Mitosis of pI is orientated parallel eo the anteroposterior axis of the fly. We show that signalling mediated by the Frizzled receptor polarizes pi along this axis, thereby specifying the orientation of the mitotic spindle and positioning the Numb crescent. The mitoses of the two cells produced by mitosis of pI are orientated parallel and orthogonal, respectively, to the division axis of pI. This difference in cell-division orientation is largely independent of the identity of the secondary precursor cells, and is regulated by Frizzled-independent mechanisms.	Ecole Normale Super, Lab Genet Dev Drosophile, URA 1857,46 Rue Ulm, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Gho, M (corresponding author), Ecole Normale Super, Lab Genet Dev Drosophile, URA 1857,46 Rue Ulm, F-75005 Paris, France.	mgho@wotan.ens.fr						ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; BATE CM, 1978, HDB SENSORY PHYSL, P1; EMERY JF, 1995, DEVELOPMENT, V121, P3549; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Gho M, 1996, DEVELOPMENT, V122, P1673; Gonczy P, 1996, TRENDS CELL BIOL, V6, P382, DOI 10.1016/0962-8924(96)10035-0; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P398; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jones KH, 1996, GENETICS, V142, P205; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; PARK WJ, 1994, MECH DEVELOP, V45, P127, DOI 10.1016/0925-4773(94)90026-4; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Wang SW, 1997, DEVELOPMENT, V124, P4435	22	188	190	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					178	181		10.1038/30265	http://dx.doi.org/10.1038/30265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603522				2022-12-28	WOS:000073619900051
J	Beecham, L				Beecham, L			Juniors set catering standards charter	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1465	1465						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572776				2022-12-28	WOS:000073651600073
J	Hart, SR; Blusztajn, J				Hart, SR; Blusztajn, J			Clams as recorders of ocean ridge volcanism and hydrothermal vent field activity	SCIENCE			English	Article							EAST PACIFIC RISE; GALAPAGOS SPREADING CENTER; GIANT WHITE CLAM; CALYPTOGENA-MAGNIFICA; MIDOCEAN RIDGE; SEA-FLOOR; GROWTH; RECONSTRUCTION; ECOLOGY	The clam Calyptogena magnifica lives at abyssal depths in association with hydrothermal venting on midocean ridges. Analysis of strontium/calcium ratios in C. magnifica shells provides a temperature proxy with submonthly time resolution. A 21-year strontium/calcium record of two clams from 9 degrees 50'N on the East Pacific Rise captures the known 1991 and 1992 eruptive events, documents several additional events between 1992 and 1996, and demonstrates the absence of major hydrothermal episodes during the period 1974 to 1991. These clam archives can increase our understanding of the thermal and chemical history of midocean ridge hydrothermal and volcanic activity on decadal time scales.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hart, SR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.		Facility, NENIMF/B-8811-2015					BENNETT JT, 1993, NATURE, V303, P55; BOSS KJ, 1980, MALACOLOGIA, V20, P161; CHASSARDBOUCHAUD C, 1986, CR ACAD SCI III-VIE, V302, P117; CHILDRESS JJ, 1991, PHYSIOL ZOOL, V64, P1444, DOI 10.1086/physzool.64.6.30158224; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FISHER CR, 1988, DEEP-SEA RES, V35, P1811, DOI 10.1016/0198-0149(88)90051-9; FOMANI D, 1996, RIDGE EVENTS, V7, P13; FOMARI D, UNPUB; FORNARI DJ, IN PRESS J GEOPHYS R; Hart SR, 1996, GEOCHIM COSMOCHIM AC, V60, P3075, DOI 10.1016/0016-7037(96)00154-8; HART SR, 1997, LPI CONTRIBUTION, V921, P89; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; Hessler R., 1985, B BIOL SOC WASH, V6, P411; James RH, 1996, GEOLOGY, V24, P1147, DOI 10.1130/0091-7613(1996)024<1147:COOFFA>2.3.CO;2; Kadko D, 1996, REV GEOPHYS, V34, P349, DOI 10.1029/96RG01762; KENNISH MJ, 1992, REV AQUAT SCI, V6, P29; KENNISH MJ, 1997, RIDGE EVENTS, V8, P6; KILLINGLEY JS, 1980, NATURE, V287, P218, DOI 10.1038/287218a0; LALOU C, 1993, J GEOPHYS RES-SOL EA, V98, P9705, DOI 10.1029/92JB01898; Liu ZH, 1997, GEOCHIM COSMOCHIM AC, V61, P2879, DOI 10.1016/S0016-7037(97)00143-9; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; LUTZ RA, 1988, DEEP-SEA RES, V35, P1793, DOI 10.1016/0198-0149(88)90050-7; LUTZ RA, 1985, B BIOL SOC WASH, V6, P199; OBERLING JJ, 1979, REV SUISSE ZOOL, V77, P81; RIO M, 1984, CR ACAD SCI II, V299, P167; ROESIJADI G, 1984, MAR BIOL, V83, P155, DOI 10.1007/BF00394723; Roux M., 1985, B BIOL SOC WASH, P211; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; SHANK TM, 1995, EOS, V76, pF701; SHANK TM, IN PRESS DEEP SEA RE; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; TUREKIAN KK, 1981, SCIENCE, V214, P909, DOI 10.1126/science.214.4523.909; Von Damm KL, 1995, GEOPHYS MONOGR SER, V91, P222, DOI DOI 10.1029/GM091P0222; WEIDMAN CR, 1994, J GEOPHYS RES-OCEANS, V99, P18305, DOI 10.1029/94JC01882	34	40	43	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					883	886		10.1126/science.280.5365.883	http://dx.doi.org/10.1126/science.280.5365.883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572728				2022-12-28	WOS:000073532900035
J	Grunstein, M				Grunstein, M			Yeast heterochromatin: Regulation of its assembly and inheritance by histones	CELL			English	Review							PROTEINS; SIR3		Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.							Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Fox CA, 1996, CURR OPIN CELL BIOL, V8, P354, DOI 10.1016/S0955-0674(96)80009-3; Gotta M, 1996, EXPERIENTIA, V52, P1136, DOI 10.1007/BF01952113; Guarente L, 1997, GENE DEV, V11, P2449, DOI 10.1101/gad.11.19.2449; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; LOWELL JE, 1998, IN PRESS CELL MOL LI; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; VERRAULT A, 1997, CURR BIOL, V8, P96; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9	17	242	248	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					325	328		10.1016/S0092-8674(00)81160-5	http://dx.doi.org/10.1016/S0092-8674(00)81160-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590166	Bronze			2022-12-28	WOS:000073471500007
J	Scanlon, TJ; Tomkins, A; Lynch, MA; Scanlon, F				Scanlon, TJ; Tomkins, A; Lynch, MA; Scanlon, F			Street children in Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BELO-HORIZONTE; BRAZIL; YOUTH		Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; UCL, Sch Med, Great Ormond St Hosp Children NHS Trust, London WC1N 1EH, England; Guys Hosp, UMDS, Newcomen Ctr, London SE1 9RT, England; Horsham & Crawley Healthcare Trust, Dept Child & Family Psychiat, Horsham, W Sussex, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Scanlon, TJ (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.	cich@ich.ucl.ac.uk						Aptekar L., 1988, STREET CHILDREN CALI; BARKER G, 1 CHILDH US; BRANDAO C, 1995, KILLINGS ESCALATE BR; CAMPOS R, 1994, CHILD DEV, V65, P319; COTRIM B, 1987, REV ABP ABAL, V9, P69; DEOLIVEIRA W, 1992, INT SOCIAL WORK, V35, P163; DEREXEL J, 1994, CHILD PSYCHOL, V7, P31; DEWEES A, 1995, COMP EDUC REV, V39, P76, DOI 10.1086/447290; ENNEW J, 1994, HLTH SCH AGE CHILDRE; GIGENGACK R, 1994, COMMUNITY DEV J, V29, P380, DOI 10.1093/cdj/29.4.380; *HUM RIGHTS WATCH, 1994, FIN JUST POL DEATH S; *IBASE MOV NAC MEN, 1990, VID EM RISC ASS CRIA; *INT CATH CHILD BU, 1989, PROJ PROF SER INT CA, V1; Jones G A, 1997, Dev Pract, V7, P39, DOI 10.1080/09614529754747; *JUCONI FDN, 1997, PROJ MET 2000 MOD AT; LUCCHINI R, 1994, 237 U FRIB I EC SOC; Lusk M., 1989, J SOCIOL SOC WELFARE, V16, P55; MARTINS SB, 1995, J TROP PEDIATRICS, V41, P43, DOI 10.1093/tropej/41.1.43; PINTO JA, 1994, J ADOLESCENT HEALTH, V15, P179, DOI 10.1016/1054-139X(94)90547-9; PORTO SOB, 1994, J ADOLESCENT HEALTH, V15, P577, DOI 10.1016/1054-139X(94)90142-P; RAFFAELLI M, 1993, SOC SCI MED, V37, P661, DOI 10.1016/0277-9536(93)90105-D; RIZZINI I, 1992, INNOCENTI OCCASIONAL, V3; ROSA CSA, 1992, J TROP PAED, V387, P349; SCANLON T, 1993, DEV PRACTICE, V3, P16; SWIFT A, 1989, NEW INT, V194, P13; WILLIAMS C, 1993, CHILD ABUSE NEGLECT, V17, P831, DOI 10.1016/S0145-2134(08)80013-0; WRIGHT JD, 1993, STUD COMP INT DEV, V28, P81, DOI 10.1007/BF02687117; 1997, BRAZIL NETWORK NEWSL	28	53	54	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1596	1600		10.1136/bmj.316.7144.1596	http://dx.doi.org/10.1136/bmj.316.7144.1596			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZQ495	9596604	Green Published			2022-12-28	WOS:000073867800034
J	Aaltonen, LA; Salovaara, R; Kristo, P; Canzian, F; Hemminki, A; Peltomaki, P; Chadwick, RB; Kaariainen, H; Eskelinen, M; Jarvinen, H; Mecklin, JP; de la Chapelle, A; Percesepe, A; Ahtola, H; Harkonen, N; Julkunen, R; Kangas, E; Ojala, S; Tulikoura, J; ValKamo, E				Aaltonen, LA; Salovaara, R; Kristo, P; Canzian, F; Hemminki, A; Peltomaki, P; Chadwick, RB; Kaariainen, H; Eskelinen, M; Jarvinen, H; Mecklin, JP; de la Chapelle, A; Percesepe, A; Ahtola, H; Harkonen, N; Julkunen, R; Kangas, E; Ojala, S; Tulikoura, J; ValKamo, E			Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRADIENT GEL-ELECTROPHORESIS; COLON-CANCER; MUTATION DETECTION; FAMILIES; HNPCC; INSTABILITY; GENETICS; HISTORY; TUMORS; GENES	Background Genetic disorders that predispose people to colorectal cancer include the polyposis syndromes and hereditary nonpolyposis colorectal cancer. In contrast to the polyposis syndromes, hereditary nonpolyposis colorectal cancer lacks distinctive clinical features. However, a germ-line mutation of DNA mismatch-repair genes is a characteristic molecular feature of the disease. Since clinical screening of carriers of such mutations can help prevent cancer, it is important to devise strategies applicable to molecular screening for this disease. Methods We prospectively screened tumor specimens obtained from 509 consecutive patients with colorectal adenocarcinomas for DNA replication errors, which are characteristic of hereditary colorectal cancers. These replication errors were detected through microsatellite-marker analyses of tumor DNA. DNA from normal tissue from the patients with replication errors was screened for germ-line mutations of the mismatch-repair genes MLH1 and MSH2. Results Among the 509 patients, 63 (12 percent) had replication errors. Specimens of normal tissue from 10 of these 63 patients had a germ-line mutation of MLH1 or MSH2. Of these 10 patients (2 per cent of the 509 patients), 9 had a first-degree relative with endometrial or colorectal cancer, 7 were under 50 years of age, and 4 had had colorectal or endometrial cancer previously. Conclusions In this series of patients with colorectal-cancer in Finland, at least 2 percent had hereditary nonpolyposis colorectal cancer. We recommend testing for replication errors in all patients with colorectal cancer who meet one or more of the following criteria: a family history of colorectal or endometrial cancer, an age of less than 50 years, and a history of multiple colorectal or endometrial cancers. Patients found to have replication errors should undergo further analysis for germ-line mutations in DNA mismatch-repair genes. (C) 1998, Massachusetts Medical Society.	Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; Perkin Elmer Corp, Appl Biosyst Div, Foster City, CA USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Family Federat Finland, Helsinki, Finland; Cent Hosp Jyvaskyla, Dept Surg, Jyvaskyla, Finland; Kuopio Univ Hosp, Dept Surg, SF-70210 Kuopio, Finland; Univ Helsinki, Cent Hosp, Dept Surg 2, Helsinki, Finland; Cent Hosp Joensuu, Dept Surg, Joensuu, Finland; Cent Hosp Mikkeli, Dept Surg, Mikkeli, Finland; Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland; Cent Hosp Lappenranta, Dept Surg, Lappeenranta, Finland; Cent Hosp Kajaani, Dept Surg, Kajaani, Finland; Cent Hosp Kotka, Dept Surg, Kotka, Finland; Cent Hosp Savonlinna, Dept Surg, Savonlinna, Finland	University of Helsinki; University of Helsinki; Thermo Fisher Scientific; Applied Biosystems; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Family Federation of Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Aaltonen, LA (corresponding author), Univ Helsinki, Haartman Inst, Dept Med Genet, POB 21, FIN-00014 Helsinki, Finland.		Canzian, Federico/I-2804-2014; Mecklin, Jukka-Pekka/AAC-9650-2019; Percesepe, Antonio/A-6076-2012; Aaltonen, Lauri/A-5375-2010; Mecklin, Jukka-Pekka/AAB-5378-2020	Percesepe, Antonio/0000-0002-3268-6786; Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Peltomaki, Paivi/0000-0001-8819-2980; Canzian, Federico/0000-0002-4261-4583	NATIONAL CANCER INSTITUTE [P30CA016058, U01CA067941, R01CA067941] Funding Source: NIH RePORTER; NCI NIH HHS [CA16058, CA67941] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; AKIYAMA Y, 1957, CANCER RES, V57, P3920; Brassett C, 1996, J MED GENET, V33, P981, DOI 10.1136/jmg.33.12.981; *CANC SOC FINL, 1996, CANC SOC FINL PUBL, V57; Canzian F, 1996, CANCER RES, V56, P3331; Chadwick RB, 1996, BIOTECHNIQUES, V20, P676; delaChapelle A, 1995, ANNU REV GENET, V29, P329, DOI 10.1146/annurev.ge.29.120195.001553; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; Hoang JM, 1997, CANCER RES, V57, P300; HOULSTON RS, 1992, ANN HUM GENET, V56, P99, DOI 10.1111/j.1469-1809.1992.tb01136.x; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KYLLONEN LEJ, 1987, ANN CHIR GYNAECOL FE, V76, P185; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Macek M, 1997, HUM MUTAT, V9, P136, DOI 10.1002/(SICI)1098-1004(1997)9:2<136::AID-HUMU6>3.3.CO;2-M; MECKLIN JP, 1994, SCAND J GASTROENTERO, V29, P673, DOI 10.3109/00365529409092492; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Moisio AL, 1996, AM J HUM GENET, V59, P1243; MOYRET C, 1994, ONCOGENE, V9, P1739; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; PHILLIPS RK, 1994, FAMILIAL ADENOMATOUS; TANNERGARD P, 1995, NAT MED, V1, P1104, DOI 10.1038/nm1195-1104b; TANNERGARD P, 1995, NAT MED, V1, P1319; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VANDEWATER NS, 1994, AUST NZ J MED, V24, P682; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z; YUASA Y, 1997, UICC S FAM CANC PREV, P64; Zhou XP, 1997, ONCOGENE, V15, P1713, DOI 10.1038/sj.onc.1201337	41	880	910	1	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1481	1487		10.1056/NEJM199805213382101	http://dx.doi.org/10.1056/NEJM199805213382101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9593786				2022-12-28	WOS:000073699100001
J	Parkes, CM				Parkes, CM			Coping with loss - Facing loss	BRITISH MEDICAL JOURNAL			English	Article									St Christophers Hospice, London SE26 6DZ, England		Parkes, CM (corresponding author), St Christophers Hospice, London SE26 6DZ, England.							Bennet G, 1998, BRIT MED J, V316, P1238, DOI 10.1136/bmj.316.7139.1238; Bowlby J, 1988, SECURE BASE CLIN APP; BROCKINGTON I, 1986, PRACTICAL REV PSYCHI, V8, P1; Bryan Elizabeth, 1995, INFERTILITY NEW CHOI; Doka K.J., 1989, DISENFRANCHISED GRIE; Hollins S, 1997, BRIT J PSYCHIAT, V170, P497, DOI 10.1192/bjp.170.6.497; Jacobs SC, 1993, PATHOLOGIC GRIEF MAL; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Parkes CM, 1983, RECOVERY BEREAVEMENT; Rosenblatt P. C., 1976, GRIEF MOURNING CROSS; Schut HAW, 1997, BRIT J CLIN PSYCHOL, V36, P63, DOI 10.1111/j.2044-8260.1997.tb01231.x	11	18	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1521	1524		10.1136/bmj.316.7143.1521	http://dx.doi.org/10.1136/bmj.316.7143.1521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582150	Green Published			2022-12-28	WOS:000073707700045
J	Duesbery, NS; Webb, CP; Leppla, SH; Gordon, VM; Klimpel, KR; Copeland, TD; Ahn, NG; Oskarsson, MK; Fukasawa, K; Paull, KD; Vande Woude, GF				Duesbery, NS; Webb, CP; Leppla, SH; Gordon, VM; Klimpel, KR; Copeland, TD; Ahn, NG; Oskarsson, MK; Fukasawa, K; Paull, KD; Vande Woude, GF			Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor	SCIENCE			English	Article							BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; ADENYLATE-CYCLASE; MAMMALIAN-CELLS; TOXIN; PROTEIN; INHIBITORS; TRANSFORMATION; COMPONENTS; INVITRO	Anthrax lethal toxin, produced by the bacterium Bacillus anthracis, is the major cause of death in animals infected with anthrax. One component of this toxin, lethal factor (LF), is suspected to be a metalloprotease, but no physiological substrates have been identified. Here it is shown that LF is a protease that cleaves the amino terminus of mitogen-activated protein kinase kinases 1 and 2 (MAPKK1 and MAPKK2) and that this cleavage inactivates MAPKK1 and inhibits the MAPK signal transduction pathway. The identification of a cleavage site for LF may facilitate the development of LF inhibitors.	NCI, Adv Biosci Lab, Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NIDR, NIH, Bethesda, MD 20892 USA; Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA; NCI, Div Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vande Woude, GF (corresponding author), NCI, Adv Biosci Lab, Basic Res Program, Frederick Canc Res & Dev Ctr, POB B, Frederick, MD 21702 USA.		Webb, Craig/I-8123-2012	Duesbery, Nicholas/0000-0002-5708-4984; DUESBERY, NICK/0000-0002-4258-5655				DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duesbery NS, 1997, P NATL ACAD SCI USA, V94, P9165, DOI 10.1073/pnas.94.17.9165; DUESBERY NS, UNPUB; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; HAMMOND SE, 1997, 97 GEN M AM SOC MICR; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; KOCHI SK, 1994, FEMS MICROBIOL LETT, V124, P343, DOI 10.1111/j.1574-6968.1994.tb07306.x; Koo HM, 1996, CANCER RES, V56, P5211; Leppla S. H., 1995, Bacterial toxins and virulence factors in disease., P543; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Mansour SJ, 1996, CELL GROWTH DIFFER, V7, P243; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matten Wayne T., 1994, Seminars in Developmental Biology, V5, P173, DOI 10.1006/sedb.1994.1023; Menard A, 1996, BIOCHEM J, V320, P687, DOI 10.1042/bj3200687; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moriguchi T, 1996, Adv Pharmacol, V36, P121, DOI 10.1016/S1054-3589(08)60579-7; Murakami MS, 1997, METHOD ENZYMOL, V283, P584; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; SINGH Y, 1994, J BIOL CHEM, V269, P29039; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	31	853	909	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					734	737		10.1126/science.280.5364.734	http://dx.doi.org/10.1126/science.280.5364.734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563949				2022-12-28	WOS:000073415600047
J	Murphy, TD; Karpen, GH				Murphy, TD; Karpen, GH			Centromeres take flight: Alpha satellite and the quest for the human centromere	CELL			English	Review									Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA	Salk Institute	Murphy, TD (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA.							duSart D, 1997, NAT GENET, V16, P144; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; IKENO M, 1998, IN PRESS NAT BIOTECH; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Warburton PE, 1997, CHROMOSOMA, V106, P149, DOI 10.1007/s004120050234; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4	12	106	107	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					317	320		10.1016/S0092-8674(00)81158-7	http://dx.doi.org/10.1016/S0092-8674(00)81158-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590164	Bronze			2022-12-28	WOS:000073471500005
J	Holland, NB; Qiu, YX; Ruegsegger, M; Marchant, RE				Holland, NB; Qiu, YX; Ruegsegger, M; Marchant, RE			Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers	NATURE			English	Article							FORCE MICROSCOPY; LIQUID; ADSORPTION; INTERFACES; GRAPHITE	The external region of a cell membrane, known as the glycocalyx, is dominated by glycosylated molecules(1-3), which direct specific interactions such as cell-cell recognition and contribute to the steric repulsion that prevents undesirable non-specific adhesion of other molecules and cells. Mimicking the non-adhesive properties of a glycocalyx provides a potential solution to the clinical problems, such as thrombosis(4), that are associated with implantable devices owing to non-specific adsorption of plasma proteins. Here we describe a biomimetic surface modification of graphite using oligosaccharide surfactant polymers, which, like a glycocalyx, provides a dense and confluent layer of oligosaccharides. The surfactant polymers consist of a flexible poly(vinyl amine) with dextran and alkanoyl side chains. We show that alkanoyl side chains assemble on graphite through hydrophobic interaction and epitaxial adsorption. This constrains the polymer backbone to lie parallel to the substrate, with solvated dextran side chains protruding into the aqueous phase, creating a glycocalyx-like coating. The resulting biomimetic surface is effective in suppressing protein adsorption from human plasma protein solution.	Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Marchant, RE (corresponding author), Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.	rxm4@po.cwru.edu	Holland, Nolan B./F-6933-2011	Holland, Nolan B./0000-0002-0752-6887				Badesso R. J., 1993, P AM CHEM SOC DIV PO, V69, P251; BONGRAND P, 1987, PHYSICAL BASIS CELL, P1; EVANS WH, 1991, MEMBRANE STRUCTURE F, P1; Fukuda M., 1994, MOL GLYCOBIOLOGY, P1; Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.; GROSZEK AJ, 1970, PROC R SOC LON SER-A, V314, P473, DOI 10.1098/rspa.1970.0019; HELMUS MN, 1993, CARDIOVASC PATHOL, V2, pS53; MANNE S, 1994, LANGMUIR, V10, P4409, DOI 10.1021/la00024a003; MANNE S, 1995, SCIENCE, V270, P1480, DOI 10.1126/science.270.5241.1480; MCGONIGAL GC, 1990, APPL PHYS LETT, V57, P28, DOI 10.1063/1.104234; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; NEMANICH RJ, 1977, SOLID STATE COMMUN, V23, P117, DOI 10.1016/0038-1098(77)90663-9; OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610; PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597; Qiu Y., 1997, T SOC BIOMATER, V20, P224; Qiu YX, 1998, MACROMOLECULES, V31, P165, DOI 10.1021/ma9707401; RABE JP, 1991, SCIENCE, V253, P424, DOI 10.1126/science.253.5018.424; Salzman E. W., 1994, HEMOSTASIS THROMBOSI, P1469; Sharma R, 1995, ACS SYM SER, V615, P1; WELLINGHOFF S, 1974, J MACROMOL SCI PHYS, VB 10, P1, DOI 10.1080/00222347408219394; WHITTMANN JC, 1990, PROG POLYM SCI, V15, P909; Zhang TH, 1996, J COLLOID INTERF SCI, V177, P419, DOI 10.1006/jcis.1996.0054	22	271	297	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	1998	392	6678					799	801		10.1038/33894	http://dx.doi.org/10.1038/33894			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572137				2022-12-28	WOS:000073241200048
J	Legault, P; Li, J; Mogridge, J; Kay, LE; Greenblatt, J				Legault, P; Li, J; Mogridge, J; Kay, LE; Greenblatt, J			NMR structure of the bacteriophage lambda N peptide/boxB RNA complex: Recognition of a GNRA fold by an arginine-rich motif	CELL			English	Article							NUSA GENE PROTEIN; ESCHERICHIA-COLI; RIBOSOMAL-RNA; TRANSCRIPTION ANTITERMINATION; HAMMERHEAD RIBOZYME; CRYSTAL-STRUCTURE; ANTI-TERMINATION; GAAA TETRALOOP; PHAGE-LAMBDA; LOOP	The structure of the complex formed by the arginine-rich motif of the transcriptional antitermination protein N of phage lambda and boxB RNA was determined by heteronuclear magnetic resonance spectroscopy. A bent alpha helix in N recognizes primarily the shape and negatively charged surface of the boxB hairpin through multiple hydrophobic and ionic interactions. The GAAGA boxB loop forms a GNRA fold, previously described for tetraloops, which is essential for N binding. The fourth nucleotide of the loop extrudes from the GNRA fold to enable the E. coli elongation factor NusA to recognize the N protein/RNA complex. This structure reveals a new mode of RNA-protein recognition and shows how a small RNA element can facilitate a protein-protein interaction and thereby nucleate formation of a large ribonucleoprotein complex.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Prot Engn Network Ctr Excellence, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Legault, P (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 100 Coll St, Toronto, ON M5S 1A8, Canada.			Legault, Pascale/0000-0003-1782-5204				Abramovitz DL, 1997, J MOL BIOL, V266, P493, DOI 10.1006/jmbi.1996.0810; Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; Chattopadhyay S, 1995, P NATL ACAD SCI USA, V92, P12131, DOI 10.1073/pnas.92.26.12131; Cilley CD, 1997, RNA, V3, P57; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; deQuinto SL, 1997, J VIROL, V71, P4171; DOELLING JH, 1989, NUCLEIC ACIDS RES, V17, P5565, DOI 10.1093/nar/17.14.5565; FRANKLIN NC, 1993, J MOL BIOL, V231, P343, DOI 10.1006/jmbi.1993.1287; FRANKLIN NC, 1985, J MOL BIOL, V181, P75, DOI 10.1016/0022-2836(85)90325-0; FRIEDMAN DI, 1995, MOL MICROBIOL, V18, P191, DOI 10.1111/j.1365-2958.1995.mmi_18020191.x; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; GREENBLATT J, 1981, J MOL BIOL, V147, P11, DOI 10.1016/0022-2836(81)90076-0; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; JUCKER FM, 1995, RNA, V1, P219; Konrat R, 1997, J BIOMOL NMR, V9, P409, DOI 10.1023/A:1018354712430; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; LeCuyer KA, 1996, EMBO J, V15, P6847, DOI 10.1002/j.1460-2075.1996.tb01076.x; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOGRIDGE J, 1995, GENE DEV, V9, P2831, DOI 10.1101/gad.9.22.2831; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MUNOZ V, 1995, NAT STRUCT BIOL, V2, P380, DOI 10.1038/nsb0595-380; MURPHY FL, 1994, J MOL BIOL, V236, P49, DOI 10.1006/jmbi.1994.1117; OLSON ER, 1984, J MOL BIOL, V180, P1053, DOI 10.1016/0022-2836(84)90270-5; ORITA M, 1993, NUCLEIC ACIDS RES, V21, P5670, DOI 10.1093/nar/21.24.5670; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; Saenger W., 1984, PRINCIPLES NUCL ACID; SALSTROM JS, 1978, J MOL BIOL, V124, P195, DOI 10.1016/0022-2836(78)90156-0; Schultze P, 1997, NATURE, V387, P668, DOI 10.1038/42632; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; Su LL, 1997, GENE DEV, V11, P2214, DOI 10.1101/gad.11.17.2214; Su LL, 1997, BIOCHEMISTRY-US, V36, P12722, DOI 10.1021/bi971408k; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; VanGilst MR, 1997, BIOCHEMISTRY-US, V36, P1514, DOI 10.1021/bi961920q; Varani G, 1997, ACCOUNTS CHEM RES, V30, P189, DOI 10.1021/ar960035x; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wijmenga S. S., 1993, NMR MACROMOLECULES P, P217; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6; Ye XM, 1996, NAT STRUCT BIOL, V3, P1026, DOI 10.1038/nsb1296-1026; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	58	223	226	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					289	299		10.1016/S0092-8674(00)81579-2	http://dx.doi.org/10.1016/S0092-8674(00)81579-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568720	Bronze			2022-12-28	WOS:000073174000014
J	Fain, O; Mathieu, E; Thomas, M				Fain, O; Mathieu, E; Thomas, M			Scurvy in patients with cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Jean Verdier Hosp, Dept Internal Med, F-93140 Bondy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Fain, O (corresponding author), Jean Verdier Hosp, Dept Internal Med, F-93140 Bondy, France.	olivier.fain@jvr.ap-hop-paris.fr						CUNNINGHAM JJ, 1991, METABOLISM, V40, P146, DOI 10.1016/0026-0495(91)90165-S; DALY JM, 1990, JPEN-PARENTER ENTER, V14, pS244, DOI 10.1177/014860719001400517; GHORBANI AJ, 1994, J AM ACAD DERMATOL, V30, P881, DOI 10.1016/S0190-9622(94)70105-9; REULER JB, 1985, JAMA-J AM MED ASSOC, V253, P805, DOI 10.1001/jama.253.6.805; SCHECTMAN G, 1993, ANN NY ACAD SCI, V686, P335, DOI 10.1111/j.1749-6632.1993.tb39197.x	5	43	43	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	1998	316	7145					1661	1662		10.1136/bmj.316.7145.1661	http://dx.doi.org/10.1136/bmj.316.7145.1661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603754	Green Published			2022-12-28	WOS:000074022700030
J	Fontana, W; Schuster, P				Fontana, W; Schuster, P			Continuity in evolution: On the nature of transitions	SCIENCE			English	Article							RNA SECONDARY STRUCTURES; SEQUENCES; SELECTION	To distinguish continuous from discontinuous evolutionary change, a relation of nearness between phenotypes is needed. Such a relation is based on the probability of one phenotype being accessible from another through changes in the genotype. This nearness relation is exemplified by calculating the shape neighborhood of a transfer RNA secondary structure and provides a characterization of discontinuous shape transformations in RNA. The simulation of replicating and mutating RNA populations under selection shows that sudden adaptive progress coincides mostly, but not always, with discontinuous shape transformations. The nature of these transformations illuminates the key role of neutral genetic drift in their realization.	Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Santa Fe Inst, Santa Fe, NM 87501 USA	University of Vienna; The Santa Fe Institute	Fontana, W (corresponding author), Univ Vienna, Inst Theoret Chem, Wahringerstr 17, A-1090 Vienna, Austria.							BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; Eldredge N., 1972, P82; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; ELINGTON AD, 1990, NATURE, V346, P818; FONTANA W, 1987, BIOPHYS CHEM, V26, P123, DOI 10.1016/0301-4622(87)80017-0; FONTANA W, 1997, 9711081 SANT FE I; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gruner W, 1996, MONATSH CHEM, V127, P355, DOI 10.1007/BF00810881; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006; PUTZ J, 1991, SCIENCE, V252, P1696, DOI 10.1126/science.2047878; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 1997, BIOPHYS CHEM, V66, P75, DOI 10.1016/S0301-4622(97)00058-6; SPIEGELMAN S, 1971, Quarterly Reviews of Biophysics, V4, P213; TUREK C, 1990, SCIENCE, V249, P505; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Waterman M.S., 1978, ADV MATH SUPPLEMENTA, V1, P167; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	26	322	334	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1451	1455		10.1126/science.280.5368.1451	http://dx.doi.org/10.1126/science.280.5368.1451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603737	Green Submitted			2022-12-28	WOS:000073883400060
J	Hill, JO; Peters, JC				Hill, JO; Peters, JC			Environmental contributions to the obesity epidemic	SCIENCE			English	Article							EATING AD-LIBITUM; DIETARY-FAT; ENERGY-INTAKE; FOOD-INTAKE; COVERT MANIPULATION; CARBOHYDRATE; DENSITY	The current epidemic of obesity is caused largely by an environment that promotes excessive food intake and discourages physical activity. Although humans have evolved excellent physiological mechanisms to defend against body weight loss, they have only weak physiological mechanisms to defend against body weight gain when food is abundant. Control of portion size, consumption of a diet low in fat and energy density, and regular physical activity are behaviors that protect against obesity, but it is becoming difficult to adopt and maintain these behaviors in the current environment. Because obesity is difficult to treat, public health efforts need to be directed toward prevention.	Univ Colorado, Hlth Sci Ctr, Clin Nutr Res Unit, Denver, CO 80262 USA; Procter & Gamble Co, Cincinnati, OH 45224 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Procter & Gamble	Hill, JO (corresponding author), Univ Colorado, Hlth Sci Ctr, Clin Nutr Res Unit, 4200 E 9th Ave, Denver, CO 80262 USA.	james.hill@uchsc.edu			NIDDK NIH HHS [DK38088, DK42549, DK48520] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042549, R01DK038088, P30DK048520, R37DK042549] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Astrup A, 1997, J AM DIET ASSOC, V97, pS82, DOI 10.1016/S0002-8223(97)00737-2; Bell EA, 1998, AM J CLIN NUTR, V67, P412; BIRCH LL, 1991, NEW ENGL J MED, V324, P232, DOI 10.1056/NEJM199101243240405; Ernst ND, 1997, J AM DIET ASSOC, V97, pS47, DOI 10.1016/S0002-8223(97)00729-3; FLATT JP, 1996, DIABETES REV, V4, P433; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FOREYT J, 1995, LANCET, V346, P134, DOI 10.1016/S0140-6736(95)91205-3; GRAHAM B, 1990, AM J PHYSIOL, V259, pR1096, DOI 10.1152/ajpregu.1990.259.6.R1096; Hill JO, 1994, GENETICS OBESITY, P35; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; LEAN MEJ, 1988, INT J OBESITY, V12, P15; LISSNER L, 1987, AM J CLIN NUTR, V46, P886, DOI 10.1093/ajcn/46.6.886; Organization WH, 1998, WELLB MEAS PRIM HLTH; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; ROLLS BJ, 1992, NUTR REV, V50, P283, DOI 10.1111/j.1753-4887.1992.tb02466.x; ROLLS BJ, 1995, AM J CLIN NUTR, V62, P1086; SALMON DMW, 1985, INT J OBESITY, V9, P443; SCLAFANI A, 1989, ANN NY ACAD SCI, V575, P281; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P330, DOI 10.1093/ajcn/62.2.330; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P316; STUBBS RJ, 1994, NUTR B, V19, P53; Troiano RP, 1998, PEDIATRICS, V101, P497; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P14, DOI 10.1038/sj.ijo.0800538; Willett WC, 1998, AM J CLIN NUTR, V67, p556S, DOI 10.1093/ajcn/67.3.556S	26	1500	1580	4	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1371	1374		10.1126/science.280.5368.1371	http://dx.doi.org/10.1126/science.280.5368.1371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603719				2022-12-28	WOS:000073883400033
J	Abbasi, K				Abbasi, K			Di Bella's miracle method	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	7	7	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1617	1617		10.1136/bmj.316.7144.1617	http://dx.doi.org/10.1136/bmj.316.7144.1617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596620	Green Published			2022-12-28	WOS:000073867800081
J	Clamp, M; Kendrick, D				Clamp, M; Kendrick, D			A randomised controlled trial of general practitioner safety advice for families with children under 5 years	BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT PREVENTION; BURN PREVENTION; HEALTH; CARE; PARENTS; HOME	Objective: To assess effectiveness of general practitioner advice about child safety, and provision of low cost safety equipment to low income families, on use of safety equipment and safe practices at home. Design: Randomised, unblinded, controlled trial with initial assessment and six week follow up by telephone survey. Twenty families from intervention and control groups were randomly selected for a home visit to assess validity of responses to second survey. Setting: A general practice in Nottingham. Subjects: 98% (165/169) of families with children aged under 5 years registered with the practice. Interventions: General practitioner safety advice plus, for families receiving means tested state benefits, access to safety equipment at low cost. Control families received usual care. Main outcome measures: Possession and use of safety equipment and safe practices at home. Results: Before intervention, the two groups differed only in possession of fireguards. After intervention, significantly more families in intervention group used fireguards (relative risk 1.89, 95% confidence interval 1.18 to 2.94), smoke alarms (1.14, 1.04 to 1.25), socket covers (1.27, 1.10 to 1.48), locks on cupboards for storing cleaning materials (1.38, 1.02 to 1.88), and door slam devices (3.60, 2.17 to 5.97). Also, significantly more families in intervention group showed very safe practice in storage of sharp objects (1.98, 1.38 to 2.83), storage of medicines (1.15, 1.03 to 1.28), window safety (1.30, 1.06 to 1.58), fireplace safety (1.84, 1.34 to 2.54), socket safety (1.77, 1.37 to 2.28), smoke alarm safety (1.11, 1.01 to 1.22), and door slam safety (7.00, 3.15 to 15.6). Stratifying results by receipt of state benefits showed that intervention was at least as effective in families receiving benefits as others. Conclusions: General practitioner advice, coupled with access to low cost equipment for low income families, increased use of safety equipment and other safe practices. These findings are encouraging for provision of injury prevention in primary care.	Univ Nottingham, Sch Med, Div Gen Practice, Queens Med Ctr, Nottingham NG7 2UH, England; Colwick Vale Surg, Nottingham NG4 2DU, England	University of Nottingham	Kendrick, D (corresponding author), Univ Nottingham, Sch Med, Div Gen Practice, Queens Med Ctr, Nottingham NG7 2UH, England.			Kendrick, Denise/0000-0003-3603-6542				BASS JL, 1985, PEDIATR CLIN N AM, V32, P233; Carter Y H, 1992, Health Visit, V65, P115; CARTER YH, 1993, BRIT J GEN PRACT, V43, P463; *DEP HLTH, 1993, HLTH NAT KEY AR HDB; DERSHEWITZ RA, 1977, AM J PUBLIC HEALTH, V67, P1148, DOI 10.2105/AJPH.67.12.1148; DERSHEWITZ RA, 1979, AM J DIS CHILD, V133, P61, DOI 10.1001/archpedi.1979.02130010067011; GREIG T, 1987, PRACTITIONER, V231, P1612; KATCHER ML, 1989, PEDIATRICS, V83, P766; KELLY B, 1987, PEDIATRICS, V79, P818; Kendrick D, 1997, Inj Prev, V3, P170, DOI 10.1136/ip.3.3.170; KENDRICK D, 1994, PUBLIC HEALTH, V108, P21, DOI 10.1016/S0033-3506(05)80031-9; KENDRICK D, 1994, BRIT J GEN PRACT, V44, P372; Kendrick D, 1995, Inj Prev, V1, P159, DOI 10.1136/ip.1.3.159; KENDRICK D, 1995, HEALTH EDUC RES, V10, P345, DOI 10.1093/her/10.3.345; Kravitz H, 1973, IMJ Ill Med J, V144, P570; LAIDMAN P, 1987, 12 HLTH ED AUTH; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEVENE S, 1992, HLTH VISITOR, V62, P340; MARSH P, 1995, J PUBLIC HEALTH MED, V17, P193, DOI 10.1093/oxfordjournals.pubmed.a043092; MILLER RE, 1982, AM J PUBLIC HEALTH, V72, P392, DOI 10.2105/AJPH.72.4.392; Moller J, 1997, Inj Prev, V3, P162, DOI 10.1136/ip.3.3.162; *OFF POP CENS SURV, 1993, 1991 CENS REP ENGL 2; *OFF POP CENS SURV, 1993, 1991 CENS REP ENGL 1; PHALP A, 1994, PRACTITIONER, V238, P766; Scott I, 1997, Inj Prev, V3, P5, DOI 10.1136/ip.3.1.5; *SPSS, 1995, STAT PACK SOC SCI WI; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; THOMAS KA, 1984, PEDIATRICS, V74, P879; Ward H, 1997, Inj Prev, V3, P160, DOI 10.1136/ip.3.3.160	29	77	79	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1576	1579		10.1136/bmj.316.7144.1576	http://dx.doi.org/10.1136/bmj.316.7144.1576			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZQ495	9596598	Green Published			2022-12-28	WOS:000073867800025
J	Morgan, MZ; Evans, MR				Morgan, MZ; Evans, MR			Initiatives to improve childhood immunisation uptake: a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION; EXPERIENCE		Temple Peace & Hlth, Publ Hlth Directorate, Bro Taf Hlth Author, Cardiff CF1 3NW, S Glam, Wales		Evans, MR (corresponding author), Temple Peace & Hlth, Publ Hlth Directorate, Bro Taf Hlth Author, Cardiff CF1 3NW, S Glam, Wales.		Morgan, Maria/D-3379-2009; Evans, Meirion/C-2990-2008	Evans, Meirion/0000-0003-3578-1866; Morgan, Maria/0000-0002-5182-7222	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRAMBLEBY P, 1989, PUBLIC HEALTH, V103, P289, DOI 10.1016/S0033-3506(89)80042-3; Crittenden P, 1994, Commun Dis Rep CDR Rev, V4, pR79; NEWPORT MJ, 1993, J INFECTION, V26, P295, DOI 10.1016/0163-4453(93)95481-W; Peckham C, 1989, PECKHAM REPORT NATL; STEHRGREEN PA, 1993, PUBLIC HEALTH REP, V108, P426	5	3	3	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1569	1570						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZQ495	9596594	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000073867800021
J	Ando, Y; Anan, I; Suhr, O; Holmgren, G; Costa, PMP				Ando, Y; Anan, I; Suhr, O; Holmgren, G; Costa, PMP			Detection of a variant protein in hair: new diagnostic method in Portuguese type familial amyloid polyneuropathy	BRITISH MEDICAL JOURNAL			English	Article							TRANSTHYRETIN		Umea Univ Hosp, Dept Med, S-90185 Umea, Sweden; Umea Univ Hosp, Dept Clin Genet, S-90185 Umea, Sweden; Hosp St Antonio, Ctr Estudos Paramiloidose, P-4000 Porto, Portugal	Umea University; Umea University	Ando, Y (corresponding author), Umea Univ Hosp, Dept Med, S-90185 Umea, Sweden.		Costa, Paulo Pinho/B-4392-2008	Costa, Paulo Pinho/0000-0001-6125-7000; Ando, Yukio/0000-0001-7115-9105; Suhr, Ole/0000-0002-1175-2369				ANDO Y, 1993, INTERNAL MED, V32, P920, DOI 10.2169/internalmedicine.32.920; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; COSTA PMP, 1993, SCAND J IMMUNOL, V38, P177, DOI 10.1111/j.1365-3083.1993.tb01710.x; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; Petersen RB, 1997, ANN NEUROL, V41, P307, DOI 10.1002/ana.410410305	5	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1500	1501		10.1136/bmj.316.7143.1500	http://dx.doi.org/10.1136/bmj.316.7143.1500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582138	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000073707700028
J	Byford, S; Raftery, J				Byford, S; Raftery, J			Economics notes - Perspectives in economic evaluation	BRITISH MEDICAL JOURNAL			English	Article									Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Univ Birmingham, Hlth Serv Management Ctr, Hlth Econ Facil, Birmingham B15 2RT, W Midlands, England	University of York - UK; University of Birmingham	Byford, S (corresponding author), Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England.		Byford, Sarah/D-1699-2010	Byford, Sarah/0000-0001-7084-1495				GOLD M. R., 1996, COSTEFFECTIVENESS HL; Goodin Robert, 1995, UTILITARIANISM PUBLI; JOHANNESSON M, 1995, HEALTH POLICY, V33, P59, DOI 10.1016/0168-8510(94)00677-7; Knapp M, 1993, Health Econ, V2, P313, DOI 10.1002/hec.4730020404; Sackett DL, 1996, DOCTORS ETHICAL EC D; WHYNES DK, 1995, HEALTH ECON, V4, P31, DOI 10.1002/hec.4730040104	6	108	109	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1529	1529		10.1136/bmj.316.7143.1529	http://dx.doi.org/10.1136/bmj.316.7143.1529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZP020	9582152	Green Published			2022-12-28	WOS:000073707700047
J	Pisetsky, DS				Pisetsky, DS			Doing everything	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vet Adm Med Ctr, Durham, NC 27705 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pisetsky, DS (corresponding author), Vet Adm Med Ctr, Box 151G,Room E-1008,508 Fulton St, Durham, NC 27705 USA.								0	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					869	870		10.7326/0003-4819-128-10-199805150-00013	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599202				2022-12-28	WOS:000073586500013
J	Liebowitz, D				Liebowitz, D			Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAPPA-B ACTIVATION; LATENT MEMBRANE PROTEIN-1; TRANSFORMING PROTEIN; CELLS; EXPRESSION; LMP1; INDUCTION; DELETION; BCL-2; GENE	Background. Epstein-Barr virus (EBV) is associated with various malignant and benign lymphoproliferative disorders. It also efficiently transforms human B lymphocytes in vitro. The latent membrane protein 1 (LMP1) of EBV-infected cells plays a central part in this process by mimicking members of the family of tumor necrosis factor (TNF) receptors, thereby transmitting growth signals from the cell membrane to the nucleus through cytoplasmic TNF-receptor-associated factors (TRAFs). I sought evidence of LMP1-mediated signal transduction through TRAFs in tumor tissue from patients with post-transplantation lymphoproliferative disease and non-Hodgkin's lymphomas related to the acquired immunodeficiency syndrome (AIDS). Methods. The association of LMP1 with TRAF-1 or TRAF-3 in tumor tissue was studied with double-immunofluorescence microscopy and immunoprecipitation assays. Evidence of LMP1-TRAF signaling was sought with an electrophoretic mobility shift assay for the nuclear factor-kappa B (NF-kappa B) transcription factor. Results. Tumors from eight patients with post-transplantation lymphoproliferative disease, two patients with AIDS-associated non-Hodgkin's lymphoma, and three patients with endemic Burkitt's lymphoma were analyzed. Tumors from six of the patients with post-transplantation lymphoproliferative disease were positive for EBV and expressed LMP1; two samples were EBV-negative. Tumors from both patients with AIDS-associated non-Hodgkin's lymphoma were EBV-positive and expressed LMP1, whereas tumors from all three patients with Burkitt's tumors were positive for EBV but negative for LMP1. Double-immunofluorescence microscopy showed that LMP1 localized with and immunoprecipitated with TRAF-1 and TRAF-3 in all eight of the EBV-positive, LMP1-positive samples. An electrophoretic mobility shift assay revealed activated NF-kappa B in all eight EBV-positive, LMP1-positive samples as well, but not in either of the EBV-negative, LMP1-negative samples or in the three EBV-positive, LMP1-negative samples. Conclusions. LMP1-mediated signaling through the TRAF system has a role in the pathogenesis of the EBV-positive lymphomas that arise in immunosuppressed patients. (C) 1998, Massachusetts Medical Society.	Univ Chicago, Dept Med, Viral Oncol Labs, Sect Hematol Oncol & Virol, Chicago, IL 60637 USA	University of Chicago	Liebowitz, D (corresponding author), Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.				NCI NIH HHS [CA 73545] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA073545] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAICHWAL VR, 1988, ONCOGENE, V2, P461; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Devergne O, 1996, MOL CELL BIOL, V16, P7098; FAHRAEUS R, 1990, NATURE, V345, P447, DOI 10.1038/345447a0; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; HATZUBAI A, 1987, INT J CANCER, V40, P358, DOI 10.1002/ijc.2910400313; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KIEFF E, 1996, FIELDS VIROLOGY, V2, P2343; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; LIEBOWITZ D, 1992, J VIROL, V66, P4612, DOI 10.1128/JVI.66.7.4612-4616.1992; Liebowitz D., 1997, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V14, pA51; Liebowitz David, 1993, P107; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; ROWE DT, 1986, EMBO J, V5, P2599, DOI 10.1002/j.1460-2075.1986.tb04540.x; ROWE M, 1994, J VIROL, V68, P5602, DOI 10.1128/JVI.68.9.5602-5612.1994; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; WANG D, 1988, J VIROL, V62, P2337, DOI 10.1128/JVI.62.7.2337-2346.1988; WILSON JB, 1990, CELL, V61, P1315, DOI 10.1016/0092-8674(90)90695-B	22	165	171	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1413	1421		10.1056/NEJM199805143382003	http://dx.doi.org/10.1056/NEJM199805143382003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580648				2022-12-28	WOS:000073563700003
J	Oberhauser, AF; Marszalek, PE; Erickson, HP; Fernandez, JM				Oberhauser, AF; Marszalek, PE; Erickson, HP; Fernandez, JM			The molecular elasticity of the extracellular matrix protein tenascin	NATURE			English	Article							ATOMIC-FORCE MICROSCOPE; ADHESION; MODULES; DOMAIN; FLOW	Extracellular matrix proteins are thought to provide a rigid mechanical anchor that supports and guides migrating and rolling cells(1-4). Here we examine the mechanical properties of the extracellular matrix protein tenascin by using atomic-force-microscopy techniques. Our results indicate that tenascin is an elastic protein. Single molecules of tenascin could be stretched to several times their resting length. Force-extension curves showed a saw-tooth pattern, with peaks of force at 137 pN. These peaks were similar to 25 nm apart. Similar results have been obtained by study of titin(5). We also found similar results by studying recombinant tenascin fragments encompassing the 15 fibronectin type III domains of tenascin. This indicates that the extensibility of tenascin map be due to the stretch-induced unfolding of its fibronectin type III domains. Refolding of tenascin after stretching, observed when the force was reduced to near zero, showed a double-exponential recovery with time constants of 42 domains refolded per second and 0.5 domains per second. The former speed of refolding is more than twice as fast as any previously reported speed of refolding of a fibronectin type III domain(6,7). We suggest that the extensibility of the modular fibronectin type III region may be important in allowing tenascin-ligand bonds to persist over long extensions. These properties of fibronectin type III modules may be of widespread use in extracellular proteins containing such domain(8,9).	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Mayo Clinic; Duke University	Fernandez, JM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA.							Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; AUKHIL I, 1993, J BIOL CHEM, V268, P2542; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4; CHIQUETEHRISMANN R, 1995, EXPERIENTIA, V51, P853, DOI 10.1007/BF01921736; Clark RA, 1997, J CELL BIOL, V137, P755, DOI 10.1083/jcb.137.3.755; Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Keller TCS, 1997, NATURE, V387, P233, DOI 10.1038/387233a0; KELLERMAYER SB, 1997, SCIENCE, V276, P1112; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1996, P NATL ACAD SCI USA, V93, P10703, DOI 10.1073/pnas.93.20.10703; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; REIF M, 1997, SCIENCE, V276, P1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0	27	707	721	1	85	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					181	185		10.1038/30270	http://dx.doi.org/10.1038/30270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603523				2022-12-28	WOS:000073619900052
J	Harrison, B; Moody, AM; Harper, PL				Harrison, B; Moody, AM; Harper, PL			Were there metastases?	LANCET			English	Article							GAUCHERS-DISEASE		W Suffolk Hosp, Dept Haematol & Oncol, Bury St Edmunds IP33 2QZ, Suffolk, England		Harper, PL (corresponding author), W Suffolk Hosp, Dept Haematol & Oncol, Bury St Edmunds IP33 2QZ, Suffolk, England.							BALICKI D, 1995, MEDICINE, V74, P305, DOI 10.1097/00005792-199511000-00002; BARTON NW, 1993, NEW ENGL J MED, V328, P1564; BERREBI A, 1984, NOUV REV FR HEMATOL, V26, P201; WHITTINGTON R, 1992, DRUGS, V44, P72, DOI 10.2165/00003495-199244010-00007	4	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1402	1402		10.1016/S0140-6736(98)01437-8	http://dx.doi.org/10.1016/S0140-6736(98)01437-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593412				2022-12-28	WOS:000073563400012
J	Levine, MM; Dougan, G				Levine, MM; Dougan, G			Optimism over vaccines administered via mucosal surfaces	LANCET			English	Editorial Material							ADP-RIBOSYLTRANSFERASE ACTIVITY		Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; WHO, Global Programme Vaccines & Immunizat, Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London, England	University System of Maryland; University of Maryland Baltimore; World Health Organization; Imperial College London	Levine, MM (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.							Aggerbeck H, 1997, VACCINE, V15, P307, DOI 10.1016/S0264-410X(96)00175-2; Agren LC, 1997, J IMMUNOL, V158, P3936; BELSHE RB, IN PRESS N ENGL J ME; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; DOUCE G, 1995, P NATL ACAD SCI USA, V92, P1644, DOI 10.1073/pnas.92.5.1644; Galen JE, 1997, VACCINE, V15, P700, DOI 10.1016/S0264-410X(96)00227-7; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Glenn GM, 1998, NATURE, V391, P851, DOI 10.1038/36014; GONZALEZ C, 1994, J INFECT DIS, V169, P927, DOI 10.1093/infdis/169.4.927; Hohmann EL, 1996, J INFECT DIS, V173, P1408, DOI 10.1093/infdis/173.6.1408; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Levine MM, 1995, B I PASTEUR, V93, P243, DOI 10.1016/0020-2452(96)85758-7; LOWELL GH, 1997, NEW GENERATION VACCI, P193; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Snapper CM, 1996, J IMMUNOL, V157, P2229; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997	18	78	80	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1375	1376		10.1016/S0140-6736(05)79439-3	http://dx.doi.org/10.1016/S0140-6736(05)79439-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593404				2022-12-28	WOS:000073563400004
J	Ferrell, JE; Machleder, EM				Ferrell, JE; Machleder, EM			The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; MOS; MATURATION; CASCADE; SYSTEMS; AMPLIFICATION; SENSITIVITY; INITIATION; EXTRACTS	Xenopus oocytes convert a continuously variable stimulus, the concentration of the maturation-inducing hormone progesterone, into an all-or-none biological response-oocyte maturation, Here evidence is presented that the all-or-none character of the response is generated by the mitogen-activated protein kinase (MAPK) cascade. Analysis of individual oocytes showed that the response of MAPK to progesterone or Mos was equivalent to that of a cooperative enzyme with a Hill coefficient of at least 35, more than 10 times the Hill coefficient for the binding of oxygen to hemoglobin. The response can be accounted for by the intrinsic ultrasensitivity of the oocyte's MAPK cascade and a positive feedback loop in which the cascade is embedded. These findings provide a biochemical rationale for the all-or-none character of this cell fate switch.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.	ferrell@cmgm.stanford.edu			NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [GM56383] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Gerhart J.C., 1980, Biological Regulation and Development, V2, P133; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; MASUI Y, 1967, J EXP ZOOL, V166, P365, DOI 10.1002/jez.1401660309; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; NISHIZAWA M, 1993, EMBO J, V12, P4021, DOI 10.1002/j.1460-2075.1993.tb06080.x; NOVAK B, 1993, J CELL SCI, V106, P1153; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; Roy LM, 1996, ONCOGENE, V12, P2203; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; SMITH LD, 1991, METHOD CELL BIOL, V36, P45; STRYER L, 1995, BIOCHEMISTRY-US, P168; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 1996, TRENDS BIOCHEM SCI, V21, P89; WALLACE RA, 1973, J EXP ZOOL, V184, P321, DOI 10.1002/jez.1401840305; WASSERMAN WJ, 1974, BIOL REPROD, V11, P133, DOI 10.1095/biolreprod11.2.133; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	35	815	828	7	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					895	898		10.1126/science.280.5365.895	http://dx.doi.org/10.1126/science.280.5365.895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572732				2022-12-28	WOS:000073532900039
J	Gupta, S; Ferguson, N; Anderson, R				Gupta, S; Ferguson, N; Anderson, R			Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents	SCIENCE			English	Article							OUTER-MEMBRANE PROTEIN; PLASMODIUM-FALCIPARUM; ERYTHROCYTES; DYNAMICS; CHILDREN	The effects of selection by host immune responses on transmission dynamics was analyzed in a broad class of antigenically diverse pathogens. Strong selection can cause pathogen populations to stably segregate into discrete strains with nonoverlapping antigenic repertoires. However, over a wide range of intermediate levels of selection, strain structure is unstable, varying in a manner that is either cyclical or chaotic. These results have implications for the interpretation of longitudinal epidemiological data on strain or serotype abundance, design of surveillance strategies, and the assessment of multivalent vaccine trials.	Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3PS, England	University of Oxford	Gupta, S (corresponding author), Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, S Parks Rd, Oxford OX1 3PS, England.	sunetra.gupta@zoology.ox.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; ANTHONY BF, 1976, AM J EPIDEMIOL, V104, P652, DOI 10.1093/oxfordjournals.aje.a112344; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; CAUGANT DA, 1990, J INFECT DIS, V162, P867, DOI 10.1093/infdis/162.4.867; *CDC, 1997, MMWR-MORBID MORTAL W, P1; CLIFF A, 1986, SPATIAL ASPECTS INFL; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Feavers IM, 1996, CLIN DIAGN LAB IMMUN, V3, P444, DOI 10.1128/CDLI.3.4.444-450.1996; FERGUSON NM, 1997, SPATIAL ECOLOGY ROLE; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; GUPTA S, IN PRESSS P R SOC B; MAIDEN MCJ, 1995, SYMP SOC GEN MICROBI, V52, P269; RAKONJAC JV, 1995, INFECT IMMUN, V63, P622, DOI 10.1128/IAI.63.2.622-631.1995; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; WATSON DA, 1995, EUR J CLIN MICROBIOL, V14, P479, DOI 10.1007/BF02113425; 1993, MORB MORTAL WKLY REP, V42, P1; 1992, MORB MORTAL WKLY REP, V41, P3; 1992, MORB MORTAL WKLY REP, V41, P5	23	213	216	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					912	915		10.1126/science.280.5365.912	http://dx.doi.org/10.1126/science.280.5365.912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572737				2022-12-28	WOS:000073532900044
J	Qiu, Y; Ravi, L; Kung, HJ				Qiu, Y; Ravi, L; Kung, HJ			Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells	NATURE			English	Article							GROWTH-FACTOR; RECEPTOR; EXPRESSION; TRANSFORMATION; TRANSDUCTION; ACTIVATION	Interleukin-6 (IL-6) is a cytokine that was initially recognized as a regulator of immune and inflammatory responses(1), but it also regulates the growth of many tumour cells, including prostrate carcinoma(2-4). Overexpression of the growth-factor receptors ErbB2/neu and ErbB3 has been implicated in the neoplastic transformation of prostate carcinoma(5-7). Here we show that treatment of the prostate cancer cell line LNCaP with IL-6 induces tyrosine phosphorylation of ErbB2 and ErbB3, but not ErbB1/ EGFR. We also show that ErbB2 forms a complex with the gp130 subunit of the IL-6 receptor in an IL-6-dependent manner. This association is important because the inhibition of ErbB2 activity results in abrogation of IL-6-induced MAPK activation. Thus ErbB2 is a critical component of IL-6 signalling through the MAP kinase pathway. These data show how a cytokine receptor can diversify its signalling pathways by engaging with a growth-factor receptor kinase.	Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; Natl Hlth Res Inst, Mol & Genom Med Div, Taipei, Taiwan	Case Western Reserve University; National Health Research Institutes - Taiwan	Kung, HJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk5@po.cwru.edu	Kung, Hsing-Jien/C-7651-2013					BEERLI RR, 1994, J BIOL CHEM, V269, P23931; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chen-Kiang S, 1995, Curr Top Microbiol Immunol, V194, P189; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DOUGALL WC, 1994, ONCOGENE, V9, P2109; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HIRANO T, 1992, CHEM IMMUNOL, V51, P153; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MYERS RB, 1994, J NATL CANCER I, V86, P1140, DOI 10.1093/jnci/86.15.1140; Okamoto M, 1997, CANCER RES, V57, P141; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; RUI H, 1994, J BIOL CHEM, V269, P5364; SIEGALL CB, 1990, CANCER RES, V50, P7786; SIEGSMUND MJ, 1994, J UROLOGY, V151, P1396, DOI 10.1016/S0022-5347(17)35267-9; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; ZHAU HE, 1994, J CELL BIOCHEM, P208	24	242	251	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	1998	393	6680					83	85		10.1038/30012	http://dx.doi.org/10.1038/30012			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590694				2022-12-28	WOS:000073497500052
J	Zimetbaum, P; Josephson, ME				Zimetbaum, P; Josephson, ME			Evaluation of patients with palpitations	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INAPPROPRIATE SINUS TACHYCARDIA; TERM FOLLOW-UP; SUPRAVENTRICULAR TACHYCARDIA; MEDICAL OUTPATIENTS		Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div GZ 435, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zimetbaum, P (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div GZ 435, 330 Brookline Ave, Boston, MA 02215 USA.							BARSKY AJ, 1994, J NERV MENT DIS, V182, P63, DOI 10.1097/00005053-199402000-00001; BARSKY AJ, 1995, ARCH INTERN MED, V155, P1782, DOI 10.1001/archinte.155.16.1782; BARSKY AJ, 1994, J GEN INTERN MED, V9, P306, DOI 10.1007/BF02599176; BRUGADA P, 1993, LANCET, V341, P1254, DOI 10.1016/0140-6736(93)91155-F; COUMEL P, 1990, CLIN CARDIOL, V13, P209, DOI 10.1002/clc.4960130311; DUREN DR, 1988, J AM COLL CARDIOL, V11, P42; Fogel RI, 1997, AM J CARDIOL, V79, P207, DOI 10.1016/S0002-9149(96)00717-5; GOLDREYER BN, 1976, CIRCULATION, V54, P783, DOI 10.1161/01.CIR.54.5.783; JOSEPHSON M E, 1990, Cardiology Clinics, V8, P411; KENNEDY HL, 1985, NEW ENGL J MED, V312, P193, DOI 10.1056/NEJM198501243120401; Kinlay S, 1996, ANN INTERN MED, V124, P16, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00003; Krahn AD, 1995, J CARDIOVASC ELECTR, V6, P1124, DOI 10.1111/j.1540-8167.1995.tb00391.x; LEITCH JW, 1992, CIRCULATION, V85, P1064, DOI 10.1161/01.CIR.85.3.1064; Lessmeier TJ, 1997, ARCH INTERN MED, V157, P537, DOI 10.1001/archinte.157.5.537; MORILLO CA, 1994, CIRCULATION, V90, P873, DOI 10.1161/01.CIR.90.2.873; Schwartz PJ, 1995, CARDIAC ELECTROPHYSI, P788; Varma N, 1997, J CARDIOVASC ELECTR, V8, P104; Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X; WOLFE RR, 1993, CIRCULATION, V87, P89; Zimetbaum P, 1997, AM J CARDIOL, V79, P371, DOI 10.1016/S0002-9149(96)00766-7; ZIMETBAUM PJ, IN PRESS ANN INTERN; ZIPES DP, 1995, CIRCULATION, V92, P673	22	110	112	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1369	1373		10.1056/NEJM199805073381907	http://dx.doi.org/10.1056/NEJM199805073381907			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571258				2022-12-28	WOS:000073463700007
J	Rosenblatt, RA; Hart, LG; Baldwin, LM; Chan, L; Schneeweiss, R				Rosenblatt, RA; Hart, LG; Baldwin, LM; Chan, L; Schneeweiss, R			The generalist role of specialty physicians - Is there a hidden system of primary care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMBULATORY MEDICAL-CARE; UNITED-STATES; SUBSPECIALISTS; PERFORMANCE; QUALITY; COSTS; REIMBURSEMENT; PERSPECTIVE; CONTINUITY; OUTCOMES	Context.-Despite increased emphasis on primary care in the United States, most care continues to be provided by specialists. The extent to which specialists incorporate elements of primary care in their approach to ambulatory patients is unknown. Objectives.-To examine the extent to which selected medical and surgical subspecialties provide generalist care to Medicare patients, and to compare patterns of care between specialists and generalists. Design.-A cross-sectional study of all ambulatory care recorded in Part B of the Washington State Medicare Claims Database in 1994 and 1995. Setting.-Ambulatory practices in Washington State. Patients.-Medicare beneficiaries 65 years or older who made office visits to the study physicians. Main Outcome Measures.-The extent to which individual specialties accounted for the majority of visits made by patients to physicians (a measure of continuity), provided care outside the traditional domain of their specialty (a measure of comprehensiveness), and provided influenza immunization. Results.-A total of 373 505 patients constituted the sample. Patients had an average of 7.48 outpatient visits per year; 9.6% saw only generalists, while 14.7% saw only specialists. The practices of general internists and family physicians differ systematically from the practices of most specialists. Approximately half (49.8%) of all ambulatory visits to general internists and family physicians are made by patients for whom they provide the majority of outpatient care, compared with 21.0% of medical specialist and 11.7% of surgical specialist visits. The rate of influenza immunization was 55.4% for patients who received the majority of their care from generalists, 47.7% from medical specialists, and 39.6% from surgical specialists. Pulmonologists, general surgeons, and gynecologists were more likely than other specialists to provide services outside their specialty. Conclusions.-Most specialists do not assume the principal care responsibility for elderly patients, although a substantial proportion of patients see only specialists for their care. Selected specialties assume the generalist role more often, particularly when they provide the majority of outpatient care for an individual patient.	Univ Washington, Sch Med, Dept Family Med, Seattle, WA 98195 USA; Hlth Care Financing Adm, Div Clin Stand & Qual, Seattle, WA USA	University of Washington; University of Washington Seattle	Rosenblatt, RA (corresponding author), Univ Washington, Sch Med, Dept Family Med, Box 354696, Seattle, WA 98195 USA.							*ACCR COUNC GRAD M, 1993, ESS INF IT 1993 1994; AIKEN LH, 1979, NEW ENGL J MED, V300, P1363, DOI 10.1056/NEJM197906143002404; BARR DM, 1980, JAMA-J AM MED ASSOC, V243, P2510; BRAUNWALD E, 1991, ANN INTERN MED, V114, P76, DOI 10.7326/0003-4819-114-1-76; DIETRICH AJ, 1982, J FAM PRACTICE, V15, P929; DIETRICH AJ, 1984, AM J PUBLIC HEALTH, V74, P223, DOI 10.2105/AJPH.74.3.223; Donaldson MS, 1996, J FAM PRACTICE, V42, P113; EISENBERG JM, 1985, ANN INTERN MED, V102, P537, DOI 10.7326/0003-4819-102-4-537; Forrest CB, 1996, J FAM PRACTICE, V43, P40; FRANKS P, 1992, NEW ENGL J MED, V327, P424, DOI 10.1056/NEJM199208063270613; GOLDBERG HI, 1985, MED CARE, V23, P63, DOI 10.1097/00005650-198501000-00007; GRUMBACH K, IN PRESS N ENGL J ME; Institute of Medicine, 1978, MANP POL PRIM HLTH C; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; IVES DG, 1994, PREV MED, V23, P134, DOI 10.1006/pmed.1994.1019; KINDIG DA, 1993, JAMA-J AM MED ASSOC, V270, P1069; KRAVITZ RL, 1992, JAMA-J AM MED ASSOC, V267, P1617, DOI 10.1001/jama.267.12.1617; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; LAVE JR, 1994, MED CARE, V32, pJS77; LUNDERG GD, 1993, JAMA-J AM MED ASSOC, V270, P380, DOI 10.1001/jama.270.3.380; Mark DH, 1996, J FAM PRACTICE, V43, P33; Meltzer D, 1993, JAMA, V269, P1714, DOI 10.1001/jama.269.13.1711; MENDENHALL RC, 1979, ANN INTERN MED, V91, P275, DOI 10.7326/0003-4819-91-2-275; MILLIS JS, 1966, GRADUATE ED PHYSICIA; MOORE GT, 1992, MILBANK Q, V70, P361, DOI 10.2307/3350064; MORRISSEY JP, 1995, MED CARE, V33, P315, DOI 10.1097/00005650-199504000-00001; Parente S T, 1995, Am J Med Qual, V10, P162, DOI 10.1177/0885713X9501000402; PAYNE BC, 1984, HEALTH SERV RES, V19, P307; PETERSON ML, 1980, ANN INTERN MED, V92, P843, DOI 10.7326/0003-4819-92-6-843; RHEE S, 1981, MED CARE, V19, P14, DOI 10.1097/00005650-198101000-00003; ROGERS DE, 1981, NEW ENGL J MED, V305, P577, DOI 10.1056/NEJM198109033051010; ROSENBLATT RA, 1983, NEW ENGL J MED, V309, P892, DOI 10.1056/NEJM198310133091505; SAFRAN DG, 1994, JAMA-J AM MED ASSOC, V271, P1579, DOI 10.1001/jama.271.20.1579; SCHNEEWEISS R, 1983, MED CARE, V21, P105, DOI 10.1097/00005650-198301000-00008; SCHROEDER SA, 1993, ACAD MED, V68, P118, DOI 10.1097/00001888-199302000-00002; SCHROEDER SA, 1993, NEW ENGL J MED, V328, P961, DOI 10.1056/NEJM199304013281312; SCHWARTZ WB, 1988, JAMA-J AM MED ASSOC, V259, P233, DOI 10.1001/jama.259.2.233; SPIEGEL JS, 1983, NEW ENGL J MED, V308, P1208, DOI 10.1056/NEJM198305193082007; VLADECK BC, 1995, JAMA-J AM MED ASSOC, V274, P259, DOI 10.1001/jama.274.3.259; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	41	156	157	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1364	1370		10.1001/jama.279.17.1364	http://dx.doi.org/10.1001/jama.279.17.1364			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZK758	9582044	Bronze			2022-12-28	WOS:000073359800028
J	Chicurel, ME; Singer, RH; Meyer, CJ; Ingber, DE				Chicurel, ME; Singer, RH; Meyer, CJ; Ingber, DE			Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions	NATURE			English	Article							ANCHORAGE-DEPENDENT FIBROBLASTS; SIGNAL-TRANSDUCTION MECHANISMS; PROTEIN-KINASE-C; MESSENGER-RNA; ENDOTHELIAL-CELLS; GROWTH; FIBRONECTIN; EIF-4E; HYBRIDIZATION; CYTOSKELETON	The extracellular matrix (ECM) activates signalling pathways that control cell behaviour by binding to cell-surface integrin receptors and inducing the formation of focal adhesion complexes (FACs)(1,2). In addition to clustered integrins, FACs contain proteins that mechanically couple the integrins to the cytoskeleton(3) and to immobilized signal-transducing molecules(1,2). Cell adhesion to the ECM also induces a rapid increase in the translation of preexisting messenger RNAs4,5. Gene expression can be controlled locally by targeting mRNAs to specialized cytoskeletal domains(6). Here we investigate whether cell binding to the ECM promotes formation of a cytoskeletal microcompartment specialized for translational control at the site of integrin binding. High-resolution in situ hybridization revealed that mRNA and ribosomes rapidly and specifically localized to FACs that form when cells bind to ECM-coated microbeads, Relocation of these protein synthesis components to the FAC depended on the ability of integrins to mechanically couple the ECM to the contractile cytoskeleton and on associated tension-moulding of the actin lattice. Our results suggest a new type of gene regulation by integrins and by mechanical stress which may involve translation of mRNAs into proteins near the sites of signal reception.	Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Ingber, DE (corresponding author), Childrens Hosp, Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA.		Ingber, Donald E/AAC-5894-2019					Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; EDMONDS BT, 1995, J BIOL CHEM, V270, P15222, DOI 10.1074/jbc.270.25.15222; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803; INGBER DE, 1993, J CELL SCI, V104, P613; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; LUCAS JJ, 1976, CELL, V7, P115, DOI 10.1016/0092-8674(76)90261-0; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MORLEY SJ, 1994, MOL BIOL REP, V19, P221, DOI 10.1007/BF00986964; NAKANISHI S, 1990, MOL PHARMACOL, V37, P482; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; SONENBERG N, 1994, BIOCHIMIE, V76, P839, DOI 10.1016/0300-9084(94)90185-6; TANEJA KL, 1992, J CELL BIOL, V119, P1245, DOI 10.1083/jcb.119.5.1245; VANMANTEUFFEL S, 1996, P NATL ACAD SCI USA, V93, P4076; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 1995, BIOCHEM CELL BIOL, V73, P327, DOI 10.1139/o95-041; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831; ZHANG GH, 1994, NATURE, V372, P809	30	305	313	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 16	1998	392	6677					730	733		10.1038/33719	http://dx.doi.org/10.1038/33719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565036				2022-12-28	WOS:000073129000063
J	Oglesby, DD; Archuleta, RJ; Nielsen, SB				Oglesby, DD; Archuleta, RJ; Nielsen, SB			Earthquakes on dipping faults: The effects of broken symmetry	SCIENCE			English	Article							NORTHRIDGE EARTHQUAKE; RUPTURE VELOCITY; HALF-SPACE; FRICTION; STRESS; PARAMETERS; SIMULATION; COMPLEXITY; MOTIONS; STRAIN	Dynamic simulations of earthquakes on dipping faults show asymmetric near-source ground motion caused by the asymmetric geometry of such faults. The ground motion from a thrust or reverse fault is larger than that of a normal fault by a factor of 2 or more, given identical initial stress magnitudes. The motion of the hanging wall is larger than that of the footwall in both thrust (reverse) and normal earthquakes. The asymmetry between normal and thrust (reverse) faults results from time-dependent normal stress caused by the interaction of the earthquake-generated stress field with Earth's free surface. The asymmetry between hanging wall and footwall results from the asymmetric mass and geometry on the two sides of the fault.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Archuleta, RJ (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.		Nielsen, Stefan B/F-6210-2011	Nielsen, Stefan B/0000-0002-9214-2932; Oglesby, David/0000-0001-7779-8741				Abrahamson NA, 1996, B SEISMOL SOC AM, V86, pS93; Aki K., 1966, B EARTHQ RES I TOKYO, V44, P73; ANDREWS DJ, 1976, J GEOPHYS RES, V81, P3575, DOI 10.1029/JB081i020p03575; ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA R, THESIS U CALIFORNIA; ARCHULETA RJ, 1978, B SEISMOL SOC AM, V68, P541; Brune JN, 1996, P INDIAN AS-EARTH, V105, pL197; BURRIDGE R, 1971, GEOPHYS J ROY ASTR S, V25, P261, DOI 10.1111/j.1365-246X.1971.tb02339.x; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; DAVIS PM, 1991, GEOPHYS J INT, V106, P581, DOI 10.1111/j.1365-246X.1991.tb06331.x; DAY SM, 1982, B SEISMOL SOC AM, V72, P1881; DAY SM, 1982, B SEISMOL SOC AM, V72, P705; EBERHARTPHILLIP.D, 1990, US GEOL SURV PROF PA, V1487, P171; IDA Y, 1972, J GEOPHYS RES, V77, P3796, DOI 10.1029/JB077i020p03796; JUNGELS PH, 1973, J GEOPHYS RES, V78, P5062, DOI 10.1029/JB078i023p05062; Madariaga R, 1996, P NATL ACAD SCI USA, V93, P3819, DOI 10.1073/pnas.93.9.3819; MCGARR A, 1984, J GEOPHYS RES, V89, P6969, DOI 10.1029/JB089iB08p06969; MIKUMO T, 1993, GEOPHYS J INT, V112, P481, DOI 10.1111/j.1365-246X.1993.tb01182.x; Nason R., 1973, SAN FERNANDO CALIFOR, V3, P123; Nielsen SB, 1998, GEOPHYS RES LETT, V25, P125, DOI 10.1029/97GL03445; RICHINS WD, 1987, B SEISMOL SOC AM, V77, P694; RUDNICKI JW, 1995, J GEOPHYS RES-SOL EA, V100, P22173, DOI 10.1029/95JB02246; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; SCHOLZ C, 1989, MECH EARTHQUAKES FAU, P44; SHI B, UNPUB; SIBSON R, COMMUNICATION; STEINBRUGGE K, 1975, CALIF DIV MINES GEOL, V196, P323; Thio HK, 1996, B SEISMOL SOC AM, V86, pS84; Wald DJ, 1996, B SEISMOL SOC AM, V86, pS49; Whirley R. G., 1992, UCRLMA110630; ZENG Y, COMMUNICATION	31	179	191	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1055	1059		10.1126/science.280.5366.1055	http://dx.doi.org/10.1126/science.280.5366.1055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582114				2022-12-28	WOS:000073663600040
J	Schurch, MA; Rizzoli, R; Slosman, D; Vadas, L; Vergnaud, P; Bonjour, JP				Schurch, MA; Rizzoli, R; Slosman, D; Vadas, L; Vergnaud, P; Bonjour, JP			Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article						osteoporosis; hip fracture; protein; nutritional disorders; insulin-like growth factor-I	IGF-BINDING PROTEINS; BODY-COMPOSITION; ELDERLY PATIENTS; MINERAL DENSITY; NUTRITIONAL REGULATION; VERTEBRAL FRACTURE; HORMONE; WOMEN; RISK; OSTEOPOROSIS	Background: Elderly persons who have osteoporotic hip fracture are often undernourished, particularly with respect to protein. Protein malnutrition may contribute to the occurrence and outcome of hip fracture. Objective: To investigate whether oral protein supplements benefit bone metabolism in patients with recent hip fracture. Design: 6-month, randomized, double-blind, placebo-controlled trial with a 6-month post-treatment follow-up. Setting: University orthopedic ward. Patients: 82 patients (mean age, 80.7 +/- 7.4 years) with recent osteoporotic hip fracture. Patients received calcium supplementation, 550 mg/d, and one dose of vitamin D, 200 000 IU (at baseline). Intervention: Protein supplementation, 20 g/d, or isocaloric placebo (among controls). Measurements: Bone mineral density, biochemical markers of bone remodeling, calciotropic hormone levels, biochemically evaluated nutritional and immunologic status, and muscle strength were measured every 6 months. Results: Compared with controls, patients who received protein supplements had significantly greater increases in serum levels of insulin-like growth factor-1 (85.6% +/- 14.8% and 34.1% +/- 7.2% at 6 months; difference, 51.5 percentage points [95% CI, 18.6 to 84.4 percentage points]; P = 0.003) and an attenuation of the decrease in proximal femur bone mineral density (-2.29% +/- 0.75% and -4.71% +/- 0.77% at 12 months; difference, 2.42 percentage points [CI, 0.26 to 4.59 percentage points]; P = 0.029). Seven and 13 new vertebral deformities were found among patients who received protein supplements and controls, respectively (P > 0.2). Median stay in rehabilitation wards was shorter for patients who received protein supplements than for controls (33 days [CI, 29 to 56 days] and 54 days [CI, 44 to 62 days]; difference, 21 days [CI, 4 to 25 days]; P = 0.018). Conclusion: Protein repletion after hip fracture was associated with increased serum levels of insulin-like growth factor-1, attenuation of proximal femur bone loss, and shorter stay in rehabilitation hospitals.	WHO, Ctr Osteoporosis & Bone Dis, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, CH-1211 Geneva 14, Switzerland; Hop Edouard Herriot, INSERM, U403, Lyon, France	World Health Organization; University of Geneva; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rizzoli, R (corresponding author), Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, CH-1211 Geneva 14, Switzerland.	rizzoli@cmu.unige.ch						Ammann P, 1996, OSTEOPOROSIS INT, V6, P219, DOI 10.1007/BF01622738; AMMANN P, 1993, AM J PHYSIOL, V265, pE770, DOI 10.1152/ajpendo.1993.265.5.E770; Auernhammer CJ, 1995, EUR J ENDOCRINOL, V133, P635, DOI 10.1530/eje.0.1330635; BARRETTCONNOR E, 1995, AM J MED, V98, pS3, DOI 10.1016/S0002-9343(05)80037-3; BASTOW MD, 1983, BRIT MED J, V287, P1589, DOI 10.1136/bmj.287.6405.1589; BASTOW MD, 1983, LANCET, V1, P143; Bonjour JP, 1996, BONE, V18, pS139, DOI 10.1016/8756-3282(95)00494-7; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; CHANDRA RK, 1989, IMMUNOLOGY, V67, P141; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chevalley T, 1991, Osteoporos Int, V1, P147, DOI 10.1007/BF01625444; CHEVALLEY T, 1994, OSTEOPOROSIS INT, V4, P245, DOI 10.1007/BF01623348; CLEMMONS DR, 1985, AM J CLIN NUTR, V41, P191, DOI 10.1093/ajcn/41.2.191; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1987, AM J EPIDEMIOL, V126, P796, DOI 10.1093/oxfordjournals.aje.a114716; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DAWSONHUGHES B, 1995, CHALL MOD MED, V7, P317; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; Duboeuf F, 1991, Osteoporos Int, V1, P242; EBELING PR, 1993, J CLIN ENDOCR METAB, V77, P1384, DOI 10.1210/jc.77.5.1384; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; GEINOZ G, 1993, OSTEOPOROSIS INT, V3, P242, DOI 10.1007/BF01623827; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; HEANEY RP, 1993, ANNU REV NUTR, V13, P287, DOI 10.1146/annurev.nu.13.070193.001443; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; ISLEY WL, 1983, J CLIN INVEST, V71, P175, DOI 10.1172/JCI110757; JENSEN JE, 1982, J BONE JOINT SURG AM, V64, P1263, DOI 10.2106/00004623-198264090-00001; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KLIDJIAN AM, 1980, BRIT MED J, V281, P899, DOI 10.1136/bmj.281.6245.899; LESOURD B, 1982, CLIN EXP IMMUNOL, V50, P635; Mauras N, 1996, J CLIN ENDOCR METAB, V81, P2222, DOI 10.1210/jc.81.6.2222; MINUTO F, 1989, JPEN-PARENTER ENTER, V13, P392, DOI 10.1177/0148607189013004392; OLDER MWJ, 1980, BRIT J SURG, V67, P884, DOI 10.1002/bjs.1800671215; ORWOLL ES, 1992, BONE, V13, P343, DOI 10.1016/8756-3282(92)90081-7; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; PATTERSON BM, 1992, J BONE JOINT SURG AM, V74A, P251, DOI 10.2106/00004623-199274020-00011; PUCILOWSKA JB, 1993, J CLIN ENDOCR METAB, V77, P1516, DOI 10.1210/jc.77.6.1516; Rosen CJ, 1995, TRENDS ENDOCRIN MET, V6, P235, DOI 10.1016/1043-2760(95)00124-Z; ROSEN CJ, 1994, J CELL BIOCHEM, V56, P348, DOI 10.1002/jcb.240560311; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Schurch MA, 1996, J BONE MINER RES, V11, P1935; SERNBO I, 1993, OSTEOPOROSIS INT, V3, P148, DOI 10.1007/BF01623276; Slosman D O, 1990, Osteoporos Int, V1, P23, DOI 10.1007/BF01880412; SLOSMAN DO, 1992, RADIOLOGY, V185, P593, DOI 10.1148/radiology.185.2.1410379; SMITH WJ, 1995, J CLIN ENDOCR METAB, V80, P443, DOI 10.1210/jc.80.2.443; SMITHBINDMAN R, 1991, J BONE MINER RES, V6, P25; STRAUS DS, 1990, ENDOCRINOLOGY, V127, P1849, DOI 10.1210/endo-127-4-1849; SULLIVAN DH, 1994, J AM COLL NUTR, V13, P184; SULLIVAN DH, 1990, AM J CLIN NUTR, V51, P749, DOI 10.1093/ajcn/51.5.749; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; THISSEN JP, 1991, ENDOCRINOLOGY, V129, P429, DOI 10.1210/endo-129-1-429; THISSEN JP, 1991, ENDOCRINOLOGY, V128, P885, DOI 10.1210/endo-128-2-885; TKATCH L, 1992, J AM COLL NUTR, V11, P519; VELLAS BJ, 1992, AM J CLIN NUTR, V55, P1225; WOOTTON R, 1979, CLIN SCI, V57, P93, DOI 10.1042/cs0570093; World Health Organization, 1994, WHO TECHN REP SER, V843	58	425	432	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					801	+		10.7326/0003-4819-128-10-199805150-00002	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599191				2022-12-28	WOS:000073586500002
J	Deliagina, TG; Arshavsky, YI; Orlovsky, GN				Deliagina, TG; Arshavsky, YI; Orlovsky, GN			Control of spatial orientation in a mollusc	NATURE			English	Article							CLIONE-LIMACINA; NEURONAL MECHANISMS; RHYTHMIC BEHAVIORS; PTEROPOD MOLLUSK; LOCOMOTION; MODULATION	The main function of postural nervous mechanisms in different species, from mollusc to man, is to counteract the force of gravity and stabilize body orientation in space(1-3). Here we investigate the basic principles of postural control in a simple animal model, the marine mollusc Clione limacina. When swimming, C. limacina maintains its vertical orientation because of the activity of the postural neuronal network. Driven by gravity-sensing organs (statocysts), the network causes postural corrections by producing tail flexions. To understand how this function occurs, we studied network activity by using a new method, We used an in vitro preparation that consisted of the central nervous system isolated with the statocysts, Output signals from the network (electrical activity of tail motor neurons) controlled an electrical motor which rotated the preparation in space. We analysed the activity of individual neurons involved in postural stabilization under opened or closed feedback loop. When we closed this artificial feedback leap, the network stabilized the vertical orientation of the preparation, This stabilization is based on the tendency of the network to minimize the difference between the activities of the two antagonistic groups of neurons, which are driven by orientation-dependent sensory inputs.	Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-17177 Stockholm, Sweden; Moscow State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia; Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 101447, Russia	Karolinska Institutet; Lomonosov Moscow State University; University of Puerto Rico; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Deliagina, TG (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-17177 Stockholm, Sweden.	Tatiana.Deliagina@neuro.ki.se						ALKON DL, 1975, J GEN PHYSIOL, V66, P507, DOI 10.1085/jgp.66.4.507; ARSHAVSKY YI, 1993, J NEUROPHYSIOL, V69, P522, DOI 10.1152/jn.1993.69.2.522; ARSHAVSKY YI, 1985, EXP BRAIN RES, V58, P255; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; ARSHAVSKY YI, 1991, SIMPLER NERVOUS SYST, P290; Deliagina TG, 1997, ARCH ITAL BIOL, V135, P239; Deliagina TG, 1997, J EXP BIOL, V200, P1459; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HENSLER K, 1989, J EXP BIOL, P531; HORAK FB, 1995, HDB PHYSL 12, P1; JANSE C, 1982, J COMP PHYSIOL, V145, P311, DOI 10.1007/BF00619335; MACPHERSON JM, 1997, NEURONS NETWORKS MOT, P257; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Orlovsky G. N, 1991, CURR BIOL, V1, P612; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1912, DOI 10.1152/jn.1995.73.5.1912; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1924, DOI 10.1152/jn.1995.73.5.1924; Panchin YV, 1997, NEUROREPORT, V8, P3345, DOI 10.1097/00001756-199710200-00030; SATTERLIE RA, 1985, J EXP BIOL, V116, P189; SELVERSTON A, 1995, J COMP PHYSIOL A, V176, P139; Selverston A., 1997, NEURONS NETWORKS MOT, P105; SELVERSTON AI, 1993, INT REV CYTOL, V147, P1, DOI 10.1016/S0074-7696(08)60765-2; TAKAHATA M, 1985, J EXP BIOL, V114, P599; TSIRULIS TP, 1974, J EVOL BIOCHEM PHYS, V10, P181	23	36	36	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					172	175		10.1038/30251	http://dx.doi.org/10.1038/30251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603520				2022-12-28	WOS:000073619900049
J	Goldstein, I; Lue, TF; Padma-Nathan, H; Rosen, RC; Steers, WD; Wicker, PA				Goldstein, I; Lue, TF; Padma-Nathan, H; Rosen, RC; Steers, WD; Wicker, PA		Sildenafil Study Grp	Oral sildenafil in the treatment of erectile dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSIOLOGY	Background. Sildenafil is a potent inhibitor of cyclic guanosine monophosphate in the corpus cavernosum and therefore increases the penile response to sexual stimulation. We evaluated the efficacy and safety of sildenafil, administered as needed in two sequential double-blind studies of men with erectile dysfunction of organic, psychogenic, or mixed causes. Methods. In a 24-week dose-response study, 532 men were treated with oral sildenafil (25, 50, or 100 mg) or placebo. In a 12-week, flexible dose-escalation study, 329 different men were treated with sildenafil or placebo, with dose escalation to 100 mg based on efficacy and tolerance. After this dose-escalation study, 225 of the 329 men entered a 32-week, open-label extension study. We assessed efficacy according to the International Index of Erectile Function, a patient log, and a global-efficacy question. Results. In the dose-response study, increasing doses of sildenafil were associated with improved erectile function (P values for increases in scores for questions about achieving and maintaining erections were < 0.001). For the men receiving 100 mg of sildenafil, the mean score for the question about achieving erections was 100 percent higher after treatment than at base line (4.0 vs. 2.0 of a possible score of 5.) In the last four weeks of treatment in the dose-escalation study, 69 percent of all attempts at sexual intercourse were successful for the mean receiving sildenafil, as compared with 22 percent for those receiving placebo (P < 0.001). The mean numbers of successful attempts per month were 5.9 for the men receiving sildenafil and 1.5 for those receiving placebo (P < 0.001). Headache, flushing, and dyspepsia were the most common adverse effects in the dose-escalation study, occurring in 6 percent to 18 percent of the men. Ninety-two percent of the men completed the 32-week extension study. Conclusions. Oral sildenafil is an effective, well-tolerated treatment for men with erectile dysfunction. (C) 1998, Massachusetts Medical Society.	Boston Univ, Med Ctr, Dept Urol, Boston, MA 02118 USA; Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; Univ So Calif, Dept Urol, Los Angeles, CA 90033 USA; Male Clin, Santa Monica, CA USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA; Univ Virginia, Dept Urol, Charlottesville, VA USA; Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA	Boston University; University of California System; University of California San Francisco; University of Southern California; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Virginia; Pfizer	Goldstein, I (corresponding author), Boston Univ, Med Ctr, Dept Urol, 720 Harrison Ave,P 606, Boston, MA 02118 USA.			Rosen, Richard/0000-0001-8492-3475				ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Boolell M, 1996, BRIT J UROL, V78, P257, DOI 10.1046/j.1464-410X.1996.10220.x; Boolell M, 1996, Int J Impot Res, V8, P47; BURNETT AL, 1995, BIOL REPROD, V52, P485, DOI 10.1095/biolreprod52.3.485; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; KINSEY AC, 1948, SEXUAL BEHAV HUMAN M, P218; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; Montague DK, 1996, J UROLOGY, V156, P2007, DOI 10.1016/S0022-5347(01)65419-3; Moreland RB, 1998, LIFE SCI, V62, pPL309, DOI 10.1016/S0024-3205(98)00158-1; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; RAJFER J, 1992, NEW ENGL J MED, V326, P90, DOI 10.1056/NEJM199201093260203; Riley AJ, 1997, BRIT J CLIN PRACT, V51, P99; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0	14	1720	1803	1	90	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1397	1404		10.1056/NEJM199805143382001	http://dx.doi.org/10.1056/NEJM199805143382001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580646				2022-12-28	WOS:000073563700001
J	Hermus, AR; Huysmans, DA				Hermus, AR; Huysmans, DA			Drug therapy - Treatment of benign nodular thyroid disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SPORADIC NONTOXIC GOITER; PERCUTANEOUS ETHANOL INJECTION; NEEDLE ASPIRATION CYTOLOGY; TOXIC MULTINODULAR GOITER; TERM FOLLOW-UP; SUPPRESSIVE THERAPY; I-131 THERAPY; L-THYROXINE; RADIOIODINE TREATMENT; TREATMENT GUIDELINES		Univ Nijmegen Hosp, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; Catharina Hosp, Dept Nucl Med, Eindhoven, Netherlands	Radboud University Nijmegen; Catharina Hospital	Hermus, AR (corresponding author), Univ Nijmegen Hosp, Dept Endocrinol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Hermus, A.R.M.M./H-8043-2014	Hermus, A.R.M.M./0000-0003-1075-2655				AIN KB, 1995, ENDOCRIN METAB CLIN, V24, P711, DOI 10.1016/S0889-8529(18)30020-3; BEAHRS OH, 1963, SURG GYNECOL OBSTET, V117, P535; BELFIORE A, 1992, AM J MED, V93, P363, DOI 10.1016/0002-9343(92)90164-7; BERGHOUT A, 1990, LANCET, V336, P193, DOI 10.1016/0140-6736(90)91730-X; BERGHOUT A, 1990, AM J MED, V89, P602, DOI 10.1016/0002-9343(90)90178-G; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; Burch H B, 1994, Curr Ther Endocrinol Metab, V5, P64; CHEUNG PSY, 1989, WORLD J SURG, V13, P818, DOI 10.1007/BF01658447; Ching GW, 1996, HEART, V75, P363, DOI 10.1136/hrt.75.4.363; COOPER DS, 1995, J CLIN ENDOCR METAB, V80, P331, DOI 10.1210/jc.80.2.331; deKlerk JMH, 1997, J NUCL MED, V38, P372; DELOSSANTOS ET, 1990, ARCH INTERN MED, V150, P1422, DOI 10.1001/archinte.150.7.1422; EDMONDS CJ, 1987, BMJ-BRIT MED J, V295, P529, DOI 10.1136/bmj.295.6597.529; Ferrari C, 1996, EUR J ENDOCRINOL, V135, P383, DOI 10.1530/eje.0.1350383; FRANKLYN JA, 1994, NEW ENGL J MED, V331, P559; FRANKLYN JA, 1993, BRIT MED J, V307, P240, DOI 10.1136/bmj.307.6898.240; FRANKLYN JA, 1995, QJM-MON J ASSOC PHYS, V88, P175; FRANKLYN JA, 1994, NEW ENGL J MED, V330, P1731; GHARIB H, 1987, NEW ENGL J MED, V317, P70, DOI 10.1056/NEJM198707093170202; GHARIB H, 1993, CLIN LAB MED, V13, P699, DOI 10.1016/S0272-2712(18)30434-7; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; GIUFFRIDA D, 1995, AM J MED, V99, P642, DOI 10.1016/S0002-9343(99)80252-6; GORMAN CA, 1978, ANN INTERN MED, V89, P85, DOI 10.7326/0003-4819-89-1-85; GREBE SKG, 1995, ENDOCRIN METAB CLIN, V24, P761, DOI 10.1016/S0889-8529(18)30021-5; HAMBURGER JI, 1980, J CLIN ENDOCR METAB, V50, P1089, DOI 10.1210/jcem-50-6-1089; HANSEN JM, 1979, CLIN ENDOCRINOL, V10, P1, DOI 10.1111/j.1365-2265.1979.tb03027.x; Hay Ian D., 1996, P566; HEGEDUS L, 1988, BRIT MED J, V297, P661, DOI 10.1136/bmj.297.6649.661; HEGEDUS L, 1986, ACTA ENDOCRINOL-COP, V113, P226, DOI 10.1530/acta.0.1130226; HOLM LE, 1991, JNCI-J NATL CANCER I, V83, P1072, DOI 10.1093/jnci/83.15.1072; Huysmans D, 1997, THYROID, V7, P235, DOI 10.1089/thy.1997.7.235; HUYSMANS DAKC, 1993, EUR J NUCL MED, V20, P1056; Huysmans DAKC, 1996, J NUCL MED, V37, P2072; Huysmans DAKC, 1997, THYROID, V7, P535, DOI 10.1089/thy.1997.7.535; HUYSMANS DAKC, 1994, ANN INTERN MED, V121, P757, DOI 10.7326/0003-4819-121-10-199411150-00005; JENSEN MD, 1986, WORLD J SURG, V10, P673, DOI 10.1007/BF01655554; KAPLAN EL, 1995, ENDOCRINOLOGY, V1, P900; KINSER JA, 1989, J NUCL MED, V30, P1960; KUMA K, 1992, WORLD J SURG, V16, P583, DOI 10.1007/BF02067327; LaRosa GL, 1996, J CLIN ENDOCR METAB, V81, P4385, DOI 10.1210/jc.81.12.4385; LAROSA GL, 1995, ANN INTERN MED, V122, P1, DOI 10.7326/0003-4819-122-1-199501010-00001; Lippi F, 1996, J CLIN ENDOCR METAB, V81, P3261, DOI 10.1210/jc.81.9.3261; MARIOTTI S, 1986, ACTA ENDOCRINOL-COP, V113, P500, DOI 10.1530/acta.0.1130500; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; MOLITCH ME, 1984, ENDOCR REV, V5, P185, DOI 10.1210/edrv-5-2-185; MONZANI F, 1994, J CLIN ENDOCR METAB, V78, P800, DOI 10.1210/jc.78.3.800; Monzani F, 1997, CLIN ENDOCRINOL, V46, P9, DOI 10.1046/j.1365-2265.1997.d01-1752.x; NYGAARD B, 1993, BRIT MED J, V307, P828, DOI 10.1136/bmj.307.6908.828; Nygaard B, 1997, J CLIN ENDOCR METAB, V82, P2926, DOI 10.1210/jc.82.9.2926; Nygaard B, 1996, J ENDOCRINOL INVEST, V19, P71, DOI 10.1007/BF03349839; NYGAARD B, 1994, CLIN ENDOCRINOL, V41, P715, DOI 10.1111/j.1365-2265.1994.tb02784.x; PAPINI E, 1993, CLIN ENDOCRINOL, V38, P507, DOI 10.1111/j.1365-2265.1993.tb00347.x; PERRILD H, 1982, ACTA ENDOCRINOL-COP, V100, P382, DOI 10.1530/acta.0.1000382; REVERTER JL, 1992, CLIN ENDOCRINOL, V36, P25, DOI 10.1111/j.1365-2265.1992.tb02898.x; RIDGWAY EC, 1992, J CLIN ENDOCR METAB, V74, P231, DOI 10.1210/jc.74.2.231; ROJDMARK J, 1995, EUR J SURG, V161, P725; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; ROSS DS, 1992, THYROID, V2, P263, DOI 10.1089/thy.1992.2.263; SANDROCK D, 1993, ACTA ENDOCRINOL-COP, V128, P51, DOI 10.1530/acta.0.1280051; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; SCHNEIDER DL, 1994, JAMA-J AM MED ASSOC, V271, P1245, DOI 10.1001/jama.271.16.1245; Shapiro LE, 1997, J CLIN ENDOCR METAB, V82, P2592, DOI 10.1210/jc.82.8.2592; SHEPPARD MC, 1992, CLIN ENDOCRINOL, V37, P398, DOI 10.1111/j.1365-2265.1992.tb02348.x; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; Singer PA, 1996, OTOLARYNG CLIN N AM, V29, P577; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; STUDLEY J, 1993, SURG ENDOCRINOLOGY, P231; TAN GH, 1995, ARCH INTERN MED, V155, P2418, DOI 10.1001/archinte.155.22.2418; TOFT AD, 1994, NEW ENGL J MED, V331, P174; TOFT AD, 1994, NEW ENGL J MED, V331, P1035; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; VANDER JB, 1954, NEW ENGL J MED, V251, P970, DOI 10.1056/NEJM195412092512403; VANDER JB, 1968, ANN INTERN MED, V69, P537, DOI 10.7326/0003-4819-69-3-537; WESCHE MF, 1995, EUR J ENDOCRINOL, V132, P86, DOI 10.1530/eje.0.1320086; WIENER JD, 1987, CLIN NUCL MED, V12, P198, DOI 10.1097/00003072-198703000-00008; Zingrillo M, 1996, THYROID, V6, P403, DOI 10.1089/thy.1996.6.403	79	91	108	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1438	1447		10.1056/NEJM199805143382007	http://dx.doi.org/10.1056/NEJM199805143382007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580652				2022-12-28	WOS:000073563700007
J	Lazowski, P; Goldfarb, DS				Lazowski, P; Goldfarb, DS			Calcified mass in a patient on long-term hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Vet Adm Med Ctr, New York, NY 10010 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lazowski, P (corresponding author), Vet Adm Med Ctr, New York, NY 10010 USA.			Goldfarb, David/0000-0002-9215-1273					0	1	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1427	1427		10.1056/NEJM199805143382005	http://dx.doi.org/10.1056/NEJM199805143382005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM667	9580650				2022-12-28	WOS:000073563700005
J	Veit, B; Briggs, SP; Schmidt, RJ; Yanofsky, MF; Hake, S				Veit, B; Briggs, SP; Schmidt, RJ; Yanofsky, MF; Hake, S			Regulation of leaf initiation by the terminal ear 1 gene of maize	NATURE			English	Article							CELL-LINEAGE PATTERNS; SHOOT APICAL MERISTEM; EXPRESSION; PROTEINS; MEIOSIS	Higher plants elaborate much of their architecture post-embryonically through development initiated at the tips of shoots(1,2) During vegetative growth, leaf primordia arise at predictable sires to give characteristic leaf arrangements, or phyllotaxies(3,4). How these sites are determined is a long-standing question(5,6) that bears on the nature of pattern-formation mechanisms in plants, Fate-mapping studies in several species indicate that each leaf primordium becomes organized from a group of 100-200 cells on the flank of the shoot apes'. Although molecular studies indicate that the regulated expression of specific homeobox genes plays some part in this determination process(8-11), mechanisms that regulate the timing and position of leaf initiation are less well understood. Here we describe a gene from maize, terminal ear 1. Patterns of expression of this gene in the shoot and phenotypes of mutants indicate a role for terminal ear 1 in regulating leaf initiation. The te1 gene product contains conserved RNA-binding motifs, indicating that it may function through an RNA-binding activity.	Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; Univ Calif Berkeley, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Pioneer Hi Bred Int Inc, Johnston, IA 50131 USA	Massey University; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California San Diego; DuPont; Pioneer Hi-Bred International, Inc.	Veit, B (corresponding author), Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand.							BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CHURCH AH, 1904, RELATION PHYLLOTAXY; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; ITIS H, 1983, SCIENCE, V222, P886; JACKSON D, 1994, DEVELOPMENT, V120, P405; KIESSELBACH TA, 1949, STRUCTURE REPRODUCTI; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; MATTHEWS DL, 1974, J AGR SCI-CAMBRIDGE, V82, P433, DOI 10.1017/S0021859600051327; MCDANIEL CN, 1988, PLANTA, V175, P13, DOI 10.1007/BF00402877; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; RICHARDS FJ, 1951, PHILOS T ROY SOC B, V235, P509, DOI 10.1098/rstb.1951.0007; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; SMITH LG, 1992, PLANT CELL, V4, P1017, DOI 10.1105/tpc.4.9.1017; SMITH LG, 1992, DEVELOPMENT, V116, P21; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; SUSSEX IM, 1989, CELL, V56, P225, DOI 10.1016/0092-8674(89)90895-7; WALBOT V, 1985, TRENDS GENET, V1, P165, DOI 10.1016/0168-9525(85)90071-X; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; WATANABE Y, 1988, EMBO J, V7, P761, DOI 10.1002/j.1460-2075.1988.tb02873.x; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0	23	105	118	2	24	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					166	168		10.1038/30239	http://dx.doi.org/10.1038/30239			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603518				2022-12-28	WOS:000073619900047
J	de Bruijn, SFTM; Stam, J; Vandenbroucke, JP				de Bruijn, SFTM; Stam, J; Vandenbroucke, JP		Cereb Ven Sinus Thromb Study Grp	Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives	LANCET			English	Article									Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DE Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Stam, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, H2-219,PO Box 22700, NL-1100 DE Amsterdam, Netherlands.		Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716				de Bruijn SFTM, 1998, BRIT MED J, V316, P589, DOI 10.1136/bmj.316.7131.589; *GEN INF GIP ZIEK, 1996, UNPUB GEBR OR ANT 19; *WHO, 1997, WEEKLY EPIDEMIOLOGIC, V48, P361	3	57	58	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1404	1404		10.1016/S0140-6736(05)79442-3	http://dx.doi.org/10.1016/S0140-6736(05)79442-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593414				2022-12-28	WOS:000073563400014
J	Baynes, K; Eliassen, JC; Lutsep, HL; Gazzaniga, MS				Baynes, K; Eliassen, JC; Lutsep, HL; Gazzaniga, MS			Modular organization of cognitive systems masked by interhemispheric integration	SCIENCE			English	Article							CALLOSOTOMY PATIENT; CALLOSAL SECTION; RIGHT-HEMISPHERE; SPEECH; CONSEQUENCE; PLASTICITY	After resection of the corpus callosum, V.J., a left-handed woman with left-hemisphere dominance for spoken language, demonstrated a dissociation between spoken and written language. In the key experiment, words flashed to V.J.'s dominant left hemisphere were easily spoken out loud, but could not be written. However, when the words were flashed to her right hemisphere, she could not speak them out loud, but could write them with her left hand. This marked dissociation supports the view that spoken and written language output can be controlled by independent hemispheres, even though before her hemispheric disconnection, they appeared as inseparable cognitive entities.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; VA No Calif Hlth Care Syst, Martinez, CA 94553 USA; Oregon Hlth Sci Univ, Oregon Stroke Ctr, Portland, OR 97201 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03654 USA	University of California System; University of California Davis; Oregon Health & Science University; Dartmouth College	Baynes, K (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.				NINDS NIH HHS [P01 NS 17778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams, 1990, BEGINNING READ THINK; Baynes K, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P79; BAYNES K, 1995, NEUROPSYCHOLOGIA, V33, P1225, DOI 10.1016/0028-3932(95)00039-6; BAYNES K, 1992, NEUROPSYCHOLOGIA, V30, P187, DOI 10.1016/0028-3932(92)90027-J; CARTER RL, 1980, NEUROPSYCHOLOGIA, V18, P569, DOI 10.1016/0028-3932(80)90158-X; ELIASSEN JC, 1997, THESIS U CALIFORNIA; FRANCIS WN, 1982, FREQUENCY ANAL ENGLI; Gazzaniga M., 1970, THE BISECTED BRAIN; Gazzaniga MS, 1996, BRAIN, V119, P1255, DOI 10.1093/brain/119.4.1255; GAZZANIGA MS, 1979, BRAIN, V102, P805, DOI 10.1093/brain/102.4.805; GAZZANIGA MS, 1982, BRAIN, V105, P53, DOI 10.1093/brain/105.1.53; GAZZANIGA MS, 1967, BRAIN, V90, P206; Gleitman L., 1982, LANG ACQUIS, P3; HERRON J, 1979, SCIENCE, V205, P1285, DOI 10.1126/science.472745; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; LEVY J, 1976, SCIENCE, V194, P337, DOI 10.1126/science.968487; LOCKE JL, 1909, CHILDS PATH SPOKEN L, P93; Loring DW., 1992, AMOBARBITAL EFFECTS; Milner B, 1975, Adv Neurol, V8, P299; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; SASS KJ, 1990, J NEUROSURG, V72, P85, DOI 10.3171/jns.1990.72.1.0085; SIDTIS JJ, 1981, SCIENCE, V212, P344, DOI 10.1126/science.6782673; SNODGRASS JG, 1980, J EXP PSYCHOL HUM PE, V6; Sperry RW., 1969, DISORDERS SPEECH, P273, DOI DOI 10.1023/B:HUMP.0000036333.34541.54; SUSSMAN NM, 1983, J NEUROSURG, V59, P514, DOI 10.3171/jns.1983.59.3.0514	25	46	46	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					902	905		10.1126/science.280.5365.902	http://dx.doi.org/10.1126/science.280.5365.902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572734				2022-12-28	WOS:000073532900041
J	Turner, CF; Ku, L; Rogers, SM; Lindberg, LD; Pleck, JH; Sonenstein, FL				Turner, CF; Ku, L; Rogers, SM; Lindberg, LD; Pleck, JH; Sonenstein, FL			Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology	SCIENCE			English	Article							UNITED-STATES; CONDOM USE; PREVALENCE; ATTITUDES; CONTACT; MEN	Surveys of risk behaviors have been hobbled by their reliance on respondents to report accurately about engaging in behaviors that are highly sensitive and may be illegal. An audio computer-assisted self-interviewing (audio-CASI) technology for measuring those behaviors was tested with 1690 respondents in the 1995 National Survey of Adolescent Males. The respondents were randomly assigned to answer questions using either audio-CASI or a more traditional self-administered questionnaire. Estimates of the prevalence of male-male sex, injection drug use, and sexual contact with intravenous drug users were higher by factors of 3 or more when audio-CASI was used. Increased reporting was also found for several other risk behaviors.	Res Triangle Inst, Program Hlth & Behav Measurement, Washington, DC 20036 USA; Urban Inst, Washington, DC 20037 USA; Univ Illinois, Dept Human Dev & Community Studies, Urbana, IL 61801 USA	Research Triangle Institute; Urban Institute; University of Illinois System; University of Illinois Urbana-Champaign	Turner, CF (corresponding author), Res Triangle Inst, Program Hlth & Behav Measurement, 1635 M St NW, Washington, DC 20036 USA.			Ku, Leighton/0000-0002-6154-9289; Lindberg, Laura/0000-0003-2660-9407	NICHD NIH HHS [R01-HD30861] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030861] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS WH, 1992, J MATH CHEM, V10, P1, DOI 10.1007/BF01169168; Bergstein JM, 1996, J TRAUMA, V41, P794, DOI 10.1097/00005373-199611000-00005; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bradburn NM, 1979, IMPROVING INTERVIEW; CATANIA JA, 1992, SCIENCE, V258, P1101, DOI 10.1126/science.1439818; DAVIS JA, 1972, GEN SOCIAL SURVEYS 1; DAVIS PB, 1993, AIDS, V7, P1509, DOI 10.1097/00002030-199311000-00016; FAY RE, 1989, SCIENCE, V243, P338, DOI 10.1126/science.2911744; Goodman L.A., 1978, ANAL QUALITATIVE CAT; GOODMAN LA, 1968, J AM STAT ASSOC, V63, P1091, DOI 10.2307/2285873; GOODMAN LA, 1978, ANAL CATEGORICAL DAT; HENDERSHOT TP, 1996, HLTH SURVEY RES METH, P165; JENKINS C, 1997, M AM ASS PUBL OP RES; Johnson AM, 1994, SEXUAL ATTITUDES LIF; JOHNSTON G, 1992, SEM NAT CTR HLTH STA; KU L, 1993, AM J PUBLIC HEALTH, V83, P1609, DOI 10.2105/AJPH.83.11.1609; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; KU LC, 1992, FAM PLANN PERSPECT, V24, P100, DOI 10.2307/2135538; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; LEWONTIN EF, 1995, DEMOGRAPHY, P24; MILLER HG, IN PRESS SCI SELF RE; MILLER HG, 1992, AIDS 2ND DECADE, P147; NEWCOMER S, 1988, J ADOLESCENT RES, V2, P419; O'Reilly James M, 1994, J Off Stat, V10, P197; OREILLY JM, 1992, WASH STAT SOC 18 MAR; PLECK JH, 1993, FAM PLANN PERSPECT, V25, P106, DOI 10.2307/2136157; *RES TRIANGL I, 1995, NAT SURV AD MAL FIEL; ROGERS SM, 1991, J SEX RES, V28, P491, DOI 10.1080/00224499109551621; ROSENBERG ML, 1995, J HEALTH CARE POOR U, V6, P102; SANER H, 1994, J ADOLESCENT HEALTH, V19, P94; SHAH BV, 1996, SOFTWARE SURVEY DATA; SONENSTEIN FL, 1989, FAM PLANN PERSPECT, V21, P152, DOI 10.2307/2135805; TANFER K, 1993, FAM PLANN PERSPECT, V25, P83, DOI 10.2307/2136210; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Turner C. F., 1992, SURVEY MEASUREMENT D, P177; Turner CF, 1996, PUBLIC HEALTH REP, V111, P276; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; TURNER CF, 1996, SURVEY STAT COMPUTIN; TURNER CF, IN PRESS SURVEY RES; TURNER CF, IN PRESS RES SEXUAL; *US BUR CENS, 1995, PREL PROJ NON POP AG; WATERTON JJ, 1984, INT STAT REV, V52, P173, DOI 10.2307/1403100; WITT M, 1992, SURVEY MEASUREMENT D, P85	43	1606	1617	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					867	873		10.1126/science.280.5365.867	http://dx.doi.org/10.1126/science.280.5365.867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZM380	9572724				2022-12-28	WOS:000073532900031
J	Meinert, CL				Meinert, CL			Masked monitoring in clinical trials - Blind stupidity?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Baltimore, MD 21205 USA	Johns Hopkins University	Meinert, CL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.							ELLENBERG SS, 1993, STAT MED, V12, P415, DOI 10.1002/sim.4780120502; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; LEVINE RJ, 1988, ETHICS REGULATION CL; Meinert CL, 1996, CLIN TRIALS DICT TER; MEINERT CL, 1986, MONOGRAPHS EPIDEMIOL, V8; PIANTADOSI S, 1997, CLIN TRIALS METHODOL	6	37	37	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1381	1382		10.1056/NEJM199805073381911	http://dx.doi.org/10.1056/NEJM199805073381911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571262				2022-12-28	WOS:000073463700011
J	Stanley, CA; Lieu, YK; Hsu, BYL; Burlina, AB; Greenberg, CR; Hopwood, NJ; Perlman, K; Rich, BH; Zammarchi, E; Poncz, M				Stanley, CA; Lieu, YK; Hsu, BYL; Burlina, AB; Greenberg, CR; Hopwood, NJ; Perlman, K; Rich, BH; Zammarchi, E; Poncz, M			Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SULFONYLUREA RECEPTOR GENE; INSULIN RELEASE; AMINO-ACID; HYPOGLYCEMIA; LEUCINE; ORGANIZATION; SITE	Background A new form of congenital hyperinsulinism characterized by hypoglycemia and hyperammonemia was described recently. We hypothesized that this syndrome of hyperinsulinism and hyperammonemia was caused by excessive activity of glutamate dehydrogenase, which oxidizes glutamate to alpha-ketoglutarate and which is a potential regulator of insulin secretion in pancreatic beta cells and of ureagenesis in the liver. Methods We measured glutamate dehydrogenase activity in lymphoblasts from eight unrelated children with the hyperinsulinism-hyperammonemia syndrome: six with sporadic cases and two with familial cases. We identified mutations in the glutamate dehydrogenase gene by sequencing glutamate dehydrogenase complementary DNA prepared from lymphoblast messenger RNA. Site-directed mutagenesis was used to express the mutations in COS-7 cells. Results The sensitivity of glutamate dehydrogenase to inhibition by guanosine 5'-triphosphate was a quarter of the normal level in the patients with sporadic hyperinsulinism-hyperammonemia syndrome and half the normal level in patients with familiar cases and their affected relatives, findings consistent with overactivity of the enzyme. These differences in enzyme insensitivity correlated with differences in the severity of hypoglycemia in the two groups. All eight children were heterozygous for the wild-type allele and had a mutation in the proposed allosteric domain of the enzyme. Four different mutations were identified in the six patients with sporadic cases; the two patients with familiar cases shared a fifth mutation. In two clones of COS-7 cells transfected with the mutant sequence from one patient, the sensitivity of the enzyme to guanosine 5'-triphosphate was reduced, findings similar to those in the child's lymphoblasts. Conclusions The hyperinsulinism-hyperammonemia syndrome is caused by mutations in the glutamate dehydrogenase gene that impair the control of enzyme activity. (C)1998, Massachusetts Medical Society.	Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Hematol, Philadelphia, PA 19104 USA; Univ Padua, Dept Pediat, Padua, Italy; Univ Manitoba, Dept Pediat & Child Hlth, Sect Genet & Metab, Winnipeg, MB R3T 2N2, Canada; Univ Michigan, CS Mott Childrens Hosp, Sch Med, Div Endocrinol, Ann Arbor, MI USA; Univ Toronto, Hosp Sick Children, Sch Med, Div Endocrinol, Toronto, ON M5G 1X8, Canada; Univ Chicago, Chicago Childrens Hosp, Pritzker Sch Med, Endocrinol Sect, Chicago, IL 60637 USA; Univ Florence, Dept Pediat, Florence, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Padua; University of Manitoba; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Chicago; University of Florence	Stanley, CA (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.		burlina, alberto/AHE-6095-2022	STANLEY, CHARLES/0000-0003-4881-9392	NCRR NIH HHS [RR-00240] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BRUNHUBER NMW, 1994, CRIT REV BIOCHEM MOL, V29, P415, DOI 10.3109/10409239409083486; BRUSILOW SW, 1995, METABOLIC BASIS INHE, V1, P1187; BRYLA J, 1994, METABOLISM, V43, P1187, DOI 10.1016/0026-0495(94)90064-7; Cho SW, 1996, BIOCHEMISTRY-US, V35, P13907, DOI 10.1021/bi9618575; COLMAN RF, 1991, STUDY ENZYMES, V2, P173; Dunne MJ, 1997, NEW ENGL J MED, V336, P703, DOI 10.1056/NEJM199703063361005; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; FAHIEN LA, 1981, ARCH BIOCHEM BIOPHYS, V212, P247, DOI 10.1016/0003-9861(81)90364-7; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; Kukuvitis A, 1997, J CLIN ENDOCR METAB, V82, P1192, DOI 10.1210/jc.82.4.1192; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSCHINSKY FM, 1996, DIABETES REV, V4, P130; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; NAKATANI Y, 1988, NUCLEIC ACIDS RES, V16, P6237, DOI 10.1093/nar/16.13.6237; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; PERMUTT MA, 1996, DIABETES REV, V4, P347; Plaitakis A, 1993, Can J Neurol Sci, V20 Suppl 3, pS109; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Stanley CA, 1997, PEDIATR CLIN N AM, V44, P363, DOI 10.1016/S0031-3955(05)70481-8; STEWART PM, 1980, J BIOL CHEM, V255, P5270; TELLER JK, 1995, BBA-PROTEIN STRUCT M, V1247, P231, DOI 10.1016/0167-4838(94)00240-H; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; THORNTON PS, 1991, J PEDIATR-US, V119, P721, DOI 10.1016/S0022-3476(05)80286-0; Thornton PS, 1998, J PEDIATR-US, V132, P9, DOI 10.1016/S0022-3476(98)70477-9; Weinzimer SA, 1997, J PEDIATR-US, V130, P661, DOI 10.1016/S0022-3476(97)70256-7; WRZESZCZYNSKI KO, 1994, BIOCHEMISTRY-US, V33, P11544, DOI 10.1021/bi00204a017; Zammarchi E, 1996, METABOLISM, V45, P957, DOI 10.1016/S0026-0495(96)90262-0	30	517	543	1	12	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1352	1357		10.1056/NEJM199805073381904	http://dx.doi.org/10.1056/NEJM199805073381904			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571255				2022-12-28	WOS:000073463700004
J	Adkins, JF; Cheng, H; Boyle, EA; Druffel, ERM; Edwards, RL				Adkins, JF; Cheng, H; Boyle, EA; Druffel, ERM; Edwards, RL			Deep-sea coral evidence for rapid change in ventilation of the deep North Atlantic 15,400 years ago	SCIENCE			English	Article							YOUNGER-DRYAS; LAST DEGLACIATION; WATER CIRCULATION; GREENLAND ICE; VEDDE ASH; CLIMATE; OCEAN; RADIOCARBON; ATMOSPHERE; SEDIMENTS	Coupled radiocarbon and thorium-230 dates from benthic coral species reveal that the ventilation rate of the North Atlantic upper deep water varied greatly during the last deglaciation. Radiocarbon ages in several corals of the same age, 15.41 +/- 0.17 thousand years, and nearly the same depth, 1800 meters, in the western North Atlantic Ocean increased by as much as 670 years during the 30- to 160-year life spans of the samples. Cadmium/calcium ratios in one coral imply that the nutrient content of these deep waters also increased. Our data show that the deep ocean changed on decadal-centennial time scales during rapid changes in the surface ocean and the atmosphere.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	Adkins, JF (corresponding author), Lamont Doherty Earth Observ, Route 9W, Palisades, NY 10964 USA.		CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014; Adkins, Jess/GYI-8778-2022	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; 				Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; ANKLIN M, 1993, NATURE, V364, P203, DOI 10.1038/364203a0; AUSTIN WEN, 1995, RADIOCARBON, V37, P53, DOI 10.1017/S0033822200014788; Bainbridge A. E., 1980, GEOSECS ATLANTIC OCE, V2; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; BARD E, 1993, RADIOCARBON, V35, P191, DOI 10.1017/S0033822200013886; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Birchfield GE, 1990, PALEOCEANOGRAPHY, V5, P835, DOI 10.1029/PA005i006p00835; Birks HH, 1996, QUATERNARY RES, V45, P119, DOI 10.1006/qres.1996.0014; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; BROECKER W, 1960, J GEOPHYS RES, V65, P2903, DOI 10.1029/JZ065i009p02903; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1991, CYCLES, V5, P87; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; CAIRNS SD, 1981, 4TH P INT COR REEF S, V1, P611; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; CHENG HY, UNPUB, P5019; CRAIG H, 1953, GEOCHIM COSMOCHIM AC, V3, P53, DOI 10.1016/0016-7037(53)90001-5; Curry WB, 1997, PALEOCEANOGRAPHY, V12, P1, DOI 10.1029/96PA02413; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; GRONVOLD K, 1995, EARTH PLANET SC LETT, V135, P149, DOI 10.1016/0012-821X(95)00145-3; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; KEIGWIN LD, 1994, J GEOPHYS RES-OCEANS, V99, P12397, DOI 10.1029/94JC00525; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; LEHMAN S, COMMUNICATION; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; MAYEWSKI PA, 1993, SCIENCE, V261, P195, DOI 10.1126/science.261.5118.195; Oppo DW, 1990, PALEOCEANOGRAPHY, V5, P277, DOI 10.1029/PA005i003p00277; OPPO DW, 1987, EARTH PLANET SC LETT, V86, P1, DOI 10.1016/0012-821X(87)90183-X; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Smith JE, 1997, NATURE, V386, P818, DOI 10.1038/386818a0; STUIVER M, 1980, RADIOCARBON, V22, P1, DOI 10.1017/S0033822200004690; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079	42	178	181	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					725	728		10.1126/science.280.5364.725	http://dx.doi.org/10.1126/science.280.5364.725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563946	Green Submitted			2022-12-28	WOS:000073415600044
J	Alroy, J				Alroy, J			Cope's rule and the dynamics of body mass evolution in North American fossil mammals	SCIENCE			English	Article							ISLAND RULE; SIZE; PHYLOGENY; TRENDS; RECORD	Body mass estimates for 1534 North American fossil mammal species show that new species are on average 9.1% larger than older species in the same genera. This within-lineage effect is not a sampling bias. It persists throughout the Cenozoic; accounting for the gradual overall increase in average mass (Cope's rule). The effect is stronger for larger mammals, being near zero for small mammals. This variation partially explains the unwavering lower size limit and the gradually expanding mid-sized gap, but not the sudden large increase in the upper size limit, at the Cretaceous-Tertiary boundary.	Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Alroy, J (corresponding author), Smithsonian Inst, Dept Paleobiol, MRC 121, Washington, DC 20560 USA.		Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				ALROY J, 1994, PALEOBIOLOGY, V20, P191, DOI 10.1017/S0094837300012677; Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; ALROY J, 1992, PALEOBIOLOGY, V18, P326, DOI 10.1017/S0094837300010873; ARNOLD AJ, 1995, J PALEONTOL, V69, P203, DOI 10.1017/S0022336000034557; Brown J.H., 1995, MACROECOLOGY; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BROWN JH, 1993, AM NAT, V142, P574; Cope ED., 1887, ORIGIN FITTEST; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; Damuth J., 1990, P229; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FISHER DC, 1994, INTERPRETING HIERARC, P133; Foote M, 1996, PALEOBIOLOGY, V22, P121, DOI 10.1017/S0094837300016134; Foote M, 1996, PALEOBIOLOGY, V22, P141, DOI 10.1017/S0094837300016146; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gingerich P.D., 1979, P41; GINGERICH PD, 1980, ANNU REV EARTH PL SC, V8, P407, DOI 10.1146/annurev.ea.08.050180.002203; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; Gunnell GF., 1989, U MICH PAP PALEONT, V27, P1; Gunnell Gregg F., 1996, Contributions from the Museum of Paleontology University of Michigan, V29, P413; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hitchin R, 1997, PALEOBIOLOGY, V23, P20, DOI 10.1017/S0094837300016626; Huelsenbeck JP, 1997, PALEOBIOLOGY, V23, P174, DOI 10.1017/S0094837300016778; HUELSENBECK JP, 1994, PALEOBIOLOGY, V20, P470, DOI 10.1017/S009483730001294X; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jablonski David, 1996, P256; KURTEN BJORN, 1953, ACTA ZOOL FENNICA, V76, P1; Legendre S., 1986, Palaeovertebrata (Montpellier), V16, P191; Legendre S., 1988, Historical Biology, V1, P85; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MacFadden B.J., 1990, P337; MACFADDEN BJ, 1986, PALEOBIOLOGY, V12, P355, DOI 10.1017/S0094837300003109; Martins E. P., 1996, PHYLOGENIES COMP MET; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; McKinney M.L., 1990, P75; MCKINNEY ML, 1986, PALEOBIOLOGY, V12, P282, DOI 10.1017/S0094837300013786; McNamara K.J., 1990, P205; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Miles DB, 1996, EVOLUTION, V50, P594, DOI 10.1111/j.1558-5646.1996.tb03871.x; NEWELL ND, 1949, EVOLUTION, V3, P103, DOI 10.2307/2405545; NORRIS RD, 1991, PALEOBIOLOGY, V17, P388, DOI 10.1017/S0094837300010721; RUMMEL JD, 1985, EVOLUTION, V39, P1009, DOI 10.1111/j.1558-5646.1985.tb00444.x; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Trammer J, 1997, ACTA PALAEONTOL POL, V42, P1; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P153, DOI 10.1017/S009483730001318X; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.1111/j.1558-5646.1959.tb02996.x; WING SL, 1995, PALAEOGEOGR PALAEOCL, V115, P117, DOI 10.1016/0031-0182(94)00109-L	48	339	346	0	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					731	734		10.1126/science.280.5364.731	http://dx.doi.org/10.1126/science.280.5364.731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563948	Green Submitted			2022-12-28	WOS:000073415600046
J	Doll, JJ				Doll, JJ			The patenting of DNA	SCIENCE			English	Editorial Material									US Patent & Trademark Off, Technol Ctr 1600, Washington, DC 20231 USA		Doll, JJ (corresponding author), US Patent & Trademark Off, Technol Ctr 1600, Washington, DC 20231 USA.							COLLINS FS, 1997, SCIENCE, V278, P180	1	61	65	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					689	690		10.1126/science.280.5364.689	http://dx.doi.org/10.1126/science.280.5364.689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9599146				2022-12-28	WOS:000073415600030
J	Faundez, V; Horng, JT; Kelly, RB				Faundez, V; Horng, JT; Kelly, RB			A function for the AP3 coat complex in synaptic vesicle formation from endosomes	CELL			English	Article							GUINEA-PIG MEGAKARYOCYTE; ADP-RIBOSYLATION FACTOR; TRANSPORT VESICLES; GOLGI MEMBRANES; ENDOPLASMIC-RETICULUM; BREFELDIN-A; DEPENDENT FORMATION; GUANINE-NUCLEOTIDE; ARF PROTEIN; CLATHRIN	Synaptic vesicles can be coated in vitro in a reaction that is ARF-, ATP-, and temperature-dependent and requires synaptic vesicle membrane proteins. The coat is largely made up of the heterotetrameric complex, adaptor protein 3, recently implicated in Golgi-to-vacuole traffic in yeast. Depletion of AP3 from brain cytosol inhibits small vesicle formation from PC12 endosomes in vitro. Budding from washed membranes can be reconstituted with purified AP3 and recombinant ARF1. We conclude that AP3 coating is involved in at least one pathway of small vesicle formation from endosomes.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kelly, RB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		Faundez, Victor/H-5539-2012	Faundez, Victor/0000-0002-2114-5271	NIDA NIH HHS [DA10154] Funding Source: Medline; NINDS NIH HHS [NS09878, NS15927] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927, R01NS009878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DELLANGELICA EC, 1998, IN PRESS SCIENCE; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Erickson RP, 1997, P NATL ACAD SCI USA, V94, P8924, DOI 10.1073/pnas.94.17.8924; Estes PS, 1996, J NEUROSCI, V16, P5443; FAUNDEZ V, 1992, J BIOL CHEM, V267, P20363; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; FRANCO M, 1993, J BIOL CHEM, V268, P24531; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; HANDAGAMA P, 1993, J CLIN INVEST, V91, P193, DOI 10.1172/JCI116170; HANDAGAMA PJ, 1989, J CLIN INVEST, V84, P73, DOI 10.1172/JCI114173; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LEPOOLE IC, 1993, EXP CELL RES, V205, P388, DOI 10.1006/excr.1993.1102; LERNER AB, 1979, COLD SPRING HARBOR C, V6, P187; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; NEWMAN LS, 1995, CELL, V82, P773, DOI 10.1016/0092-8674(95)90474-3; NOEBELS JL, 1989, J NEUROGENET, V6, P53, DOI 10.3109/01677068909107100; OKA T, 1994, J CELL BIOL, V124, P25; Ooi CE, 1997, EMBO J, V16, P4508; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PEVSNER J, 1994, GENE, V146, P279, DOI 10.1016/0378-1119(94)90306-9; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SCHRAERMEYER U, 1994, CELL TISSUE RES, V276, P273, DOI 10.1007/BF00306113; Seymour A. B., 1997, Molecular Biology of the Cell, V8, p227A; SHAYWITZ DA, 1995, J CELL BIOL, V128, P769, DOI 10.1083/jcb.128.5.769; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; WAGNER JA, 1978, BIOCHEMISTRY-US, V17, P1199, DOI 10.1021/bi00600a010; WHITNEY JA, 1995, CELL, V83, P703; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	60	239	244	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					423	432		10.1016/S0092-8674(00)81170-8	http://dx.doi.org/10.1016/S0092-8674(00)81170-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590176	Bronze			2022-12-28	WOS:000073471500017
J	Rodig, SJ; Meraz, MA; White, JM; Lampe, PA; Riley, JK; Arthur, CD; King, KL; Sheehan, KCF; Yin, L; Pennica, D; Johnson, EM; Schreiber, RD				Rodig, SJ; Meraz, MA; White, JM; Lampe, PA; Riley, JK; Arthur, CD; King, KL; Sheehan, KCF; Yin, L; Pennica, D; Johnson, EM; Schreiber, RD			Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the jaks in cytokine-lnduced biologic responses	CELL			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION PATHWAY; LEUKEMIA INHIBITORY FACTOR; MICE LACKING JAK3; TARGETED DISRUPTION; INTERFERON-GAMMA; LYMPHOID DEVELOPMENT; INTERLEUKIN-6 FAMILY; CYTOPLASMIC DOMAIN; FACTOR-RECEPTOR	Herein we report the generation of mice lacking the ubiquitously expressed Janus kinase, Jak1. Jak1(-/-) mice are runted at birth, fail to nurse, and die perinatally. Although Jak1(-/-) cells are responsive to many cytokines, they fail to manifest biologic responses to cytokines that bind to three distinct families of cytokine receptors. These include all class II cytokine receptors, cytokine receptors that utilize the gamma(c) subunit for signaling, and the family of cytokine receptors that depend on the gp130 subunit for signaling. Our results thus demonstrate that Jak1 plays an essential and nonredundant role in promoting biologic responses induced by a select subset of cytokine receptors, including those in which Jak utilization was thought to be nonspecific.	Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, S San Francisco, CA 94080 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Genentech; Roche Holding; Genentech	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA.		Schreiber, Robert D/A-1276-2013; MERAZ RIOS, MARCO ANTONIO/F-4194-2016; Lampe, Patricia/AAH-9545-2020; Rodig, Scott/Y-3889-2019; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; MERAZ RIOS, MARCO ANTONIO/0000-0001-6748-8117; White, James Michael/0000-0001-5110-6567; Schreiber, Robert/0000-0003-1590-2341	NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER; NCI NIH HHS [CA43059] Funding Source: Medline; NIA NIH HHS [AG12947] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GRIBAUDO G, 1985, J BIOL CHEM, V260, P9936; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HO ASY, 1995, MOL CELL BIOL, V15, P5043; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; King KL, 1996, ENDOCRINE, V5, P85, DOI 10.1007/BF02738660; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kouro T, 1996, INT IMMUNOL, V8, P237, DOI 10.1093/intimm/8.2.237; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; SUDA T, 1989, BLOOD, V74, P1936; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WARE CB, 1995, DEVELOPMENT, V121, P1283; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	37	630	737	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					373	383		10.1016/S0092-8674(00)81166-6	http://dx.doi.org/10.1016/S0092-8674(00)81166-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590172	Bronze			2022-12-28	WOS:000073471500013
J	Wakimoto, BT				Wakimoto, BT			Beyond the nucleosome: Epigenetic aspects of position-effect variegation in Drosophila	CELL			English	Review							CELL-CYCLE; HETEROCHROMATIN; EXPRESSION; GENE		Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wakimoto, BT (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.							Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; DEMBURG AF, 1996, CELL, V85, P745; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; HENIKOFF S, 1989, P NATL ACAD SCI USA, V86, P6704, DOI 10.1073/pnas.86.17.6704; KELLUM R, 1995, J CELL SCI, V108, P1407; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; PLATERO JS, 1998, IN PRESS J CELL BIOL; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; WAKIMOTO BT, 1990, GENETICS, V125, P141; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045	13	178	183	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					321	324		10.1016/S0092-8674(00)81159-9	http://dx.doi.org/10.1016/S0092-8674(00)81159-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590165	Bronze			2022-12-28	WOS:000073471500006
J	Eberstadt, M; Huang, BH; Chen, ZH; Meadows, RP; Ng, SC; Zheng, LX; Lenardo, MJ; Fesik, SW				Eberstadt, M; Huang, BH; Chen, ZH; Meadows, RP; Ng, SC; Zheng, LX; Lenardo, MJ; Fesik, SW			NMR structure and mutagenesis of the FADD (Mort1) death-effector domain	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CELL-DEATH; PROTEINS; PROTEASE; FAS; INTERACTS; C-13	When activated, membrane-bound receptors for Fas and tumour-necrosis factor initiate programmed cell death by recruiting the death domain of the adaptor protein FADD(1) (Mort1; ref, 2) to the membrane. FADD then activates caspase 8 (ref. 3) (also known as FLICE4 or MACH(5)) through an interaction between the death-effector domains of FADD and caspase 8. This ultimately leads to the apoptotic response. Death-effector domains and homologous protein modules known as caspase-recruitment domains(6) have been found in several proteins(1-14) and are important regulators of caspase (FLICE) activity and of apoptosis. Here we describe the solution structure of a soluble, biologically active mutant of the FADD death-effector domain. The structure consists of six antiparallel, amphipathic alpha-helices and resembles the overall fold of the death domains of Fas(15) and p75 (ref. 16). Despite this structural similarity, mutations that inhibit protein-protein interactions involving the Fas death domain have no effect when introduced into the FADD death-effector domain. Instead, a hydrophobic region of the FADD death-effector domain that is not present in the death domains is vital for binding to FLICE and for apoptotic activity.	Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA; NIH, Immunol Lab, Bethesda, MD 20892 USA	Abbott Laboratories; National Institutes of Health (NIH) - USA	Fesik, SW (corresponding author), Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA.							Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNGER AT, 1992, XPLOR 3 2 MANUAL; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eberstadt M, 1997, NAT STRUCT BIOL, V4, P983, DOI 10.1038/nsb1297-983; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Keane MM, 1996, CANCER RES, V56, P4791; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	28	195	203	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					941	945		10.1038/31972	http://dx.doi.org/10.1038/31972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582077				2022-12-28	WOS:000073359900054
J	Cebul, RD; Snow, RJ; Pine, R; Hertzer, NR; Norris, DG				Cebul, RD; Snow, RJ; Pine, R; Hertzer, NR; Norris, DG			Indications, outcomes, and provider volumes for carotid endarterectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AD-HOC-COMMITTEE; VASCULAR-SURGERY; OPERATIONS; EXPERIENCE; GUIDELINES; MORTALITY; SPECIALTY; STENOSIS; PERFECT; STROKE	Context.-While trials have demonstrated that carotid endarterectomy is superior to best medical therapy, most recently among asymptomatic patients, uses and outcomes of the procedure in more representative settings have not been established. Objectives.-To profile the use and outcomes of carotid endarterectomy in a representative sample of Ohio's Medicare beneficiaries and to examine the relationships between provider-specific procedural volumes and patient outcomes. Design.-Retrospective cohort using Medicare Provider Analysis and Review files supplemented by detailed reviews of medical records on a random sample of patients. Setting.-Ohio hospitals performing carotid endarterectomy. Patients.-A random sample of 678 charts of the 4120 non-health maintenance organization Medicare beneficiaries who underwent carotid endarterectomy between July 1, 1993, and June 30, 1994. Main Outcome Measures.-Nonfatal stroke or death within 30 days of surgery. Results.-The reviewed patients were similar to all eligible patients in sociodemographic characteristics and 30-day mortality rates. Among the 678 patients, indications for surgery were asymptomatic carotid stenosis in 167 (24.6%), transient ischemic attack in 294 (43.4%), completed stroke in 62 (9.1%), and nonspecific symptoms in 155 (22.9%), Thirty-two patients (4.7%) died or suffered nonfatal strokes by 30 days postoperatively. In univariate analyses, rates varied by hospital volume (P=.004) but not surgeons' volume (P=.47), although power to detect this difference was limited. Patients at higher- and lower-volume hospitals had similar indications and distributions of comorbidities. In analyses controlling for indications, comorbid conditions, and surgeon's volume, being operated on in a higher-volume hospital conferred a 71% reduction in risk for 30-day stroke or death (odds ratio, 0.29; 95% confidence interval, 0.12-0.69; P=.006). Conclusions.-Almost half (47.5%) of the carotid endarterectomies among Ohio's Medicare population are performed on persons who are asymptomatic or who have nonspecific symptoms. These results highlight the importance of identifying patients and providers having the most favorable outcome profiles. The higher rate of adverse outcomes observed in lower-volume hospitals deserves further investigation, as it does not appear to be due to differences in patient selection.	Case Western Reserve Univ, Metrohlth Med Ctr, Inst Publ Hlth Sci, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Case Western Reserve Univ, Metrohlth Med Ctr, Inst Publ Hlth Sci, Dept Med, Cleveland, OH 44109 USA; Cleveland Clin Fdn, Dept Vasc Surg, Cleveland, OH 44106 USA; Peer Review Syst Inc, Westerville, OH USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Cleveland Clinic Foundation	Cebul, RD (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Inst Publ Hlth Sci, Dept Epidemiol & Biostat, 2500 MetroHlth Dr,Room 220A, Cleveland, OH 44109 USA.	rdc@po.cwru.edu		Hertzer, Norman/0000-0002-9698-1776	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG010418] Funding Source: NIH RePORTER; AHRQ HHS [HS-00059-03] Funding Source: Medline; NIA NIH HHS [AG-10418-03] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; BARNETT HJM, 1995, NEW ENGL J MED, V332, P238, DOI 10.1056/NEJM199501263320408; Barnett HJM, 1996, NEUROLOGY, V46, P603, DOI 10.1212/WNL.46.3.603; BROTT T, 1984, STROKE, V15, P950, DOI 10.1161/01.STR.15.6.950; CEBUL RD, 1989, ANN INTERN MED, V111, P660, DOI 10.7326/0003-4819-111-8-660; CEBUL RD, 1993, QUAL REV B, P150; EASTON JD, 1977, STROKE, V8, P565, DOI 10.1161/01.STR.8.5.565; FISHER ES, 1989, AM J PUBLIC HEALTH, V79, P1617, DOI 10.2105/AJPH.79.12.1617; FLOOD AB, 1984, MED CARE, V22, P115, DOI 10.1097/00005650-198402000-00003; FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002; FRIEDMANN P, 1988, STROKE, V19, P1323, DOI 10.1161/01.STR.19.11.1323; HERTZER NR, 1995, J VASC SURG, V21, P6, DOI 10.1016/S0741-5214(95)70239-3; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; KEMPCZINSKI RF, 1986, J VASC SURG, V3, P911, DOI 10.1067/mva.1986.avs0030911; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; MATTOS MA, 1995, J VASC SURG, V21, P719, DOI 10.1016/S0741-5214(05)80003-5; MOORE WS, 1995, CIRCULATION, V91, P566, DOI 10.1161/01.CIR.91.2.566; MOORE WS, 1992, J VASC SURG, V15, P469, DOI 10.1016/0741-5214(92)90185-B; Moore WS, 1996, J VASC SURG, V23, P323, DOI 10.1016/S0741-5214(96)70277-X; RICHARDSON JD, 1989, J VASC SURG, V9, P65, DOI 10.1067/mva.1989.vs0090065; Ruby ST, 1996, ANN VASC SURG, V10, P22, DOI 10.1007/BF02002337; Sarasin FP, 1995, NEUROLOGY, V45, P2147, DOI 10.1212/WNL.45.12.2147; *SAS I INC, 1996, SAS COMP PROGR VERS; Segal H E, 1993, QRB Qual Rev Bull, V19, P152; SLAKENBORG GJ, 1997, ARCH NEUROL-CHICAGO, V54, P826; SLAVISH LG, 1984, STROKE, V15, P956, DOI 10.1161/01.STR.15.6.956; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TOOLE JF, 1989, STROKE, V20, P844; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WHITE LJ, 1989, ANN INTERN MED, V111, P675, DOI 10.7326/0003-4819-111-8-675	32	168	169	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1282	1287		10.1001/jama.279.16.1282	http://dx.doi.org/10.1001/jama.279.16.1282			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9565009	Bronze			2022-12-28	WOS:000073090300034
J	Shmerling, D; Hegyi, I; Fischer, M; Blattler, T; Brandner, S; Gotz, J; Rulicke, T; Flechsig, E; Cozzio, A; von Mering, C; Hangartner, C; Aguzzi, A; Weissmann, C				Shmerling, D; Hegyi, I; Fischer, M; Blattler, T; Brandner, S; Gotz, J; Rulicke, T; Flechsig, E; Cozzio, A; von Mering, C; Hangartner, C; Aguzzi, A; Weissmann, C			Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions	CELL			English	Article							HUMAN PRION PROTEIN; TRANSGENIC MICE; SYNAPTIC TRANSMISSION; PURKINJE-CELLS; KNOCKOUT MICE; NULL MICE; WILD-TYPE; SCRAPIE; GENE; NEURODEGENERATION	The physiological role of prion protein (PrP) remains unknown. Mice devoid of PrP develop normally but are resistant to scrapie; introduction of a PrP transgene restores susceptibility to the disease. To identify the regions of PrP necessary for this activity, we prepared PrP knockout mice expressing PrPs with amino-proximal deletions. Surprisingly, PrP lacking residues 32-121 or 32-134, but not with shorter deletions, caused severe ataxia and neuronal death limited to the granular layer of the cerebellum as early as 1-3 months after birth. The defect was completely abolished by introducing one copy of a wild-type PrP gene. We speculate that these truncated PrPs may be nonfunctional and compete with some other molecule with a PrP-like function for a common ligand.	Univ Zurich, Inst Mol Biol, Abt 1, CH-8093 Zurich, Switzerland; Universitatsspital Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; Universitatsspital Zurich, Biol Zent Lab, CH-8091 Zurich, Switzerland	University of Zurich	Weissmann, C (corresponding author), Univ Zurich, Inst Mol Biol, Abt 1, CH-8093 Zurich, Switzerland.		von Mering, Christian/B-3300-2008; Brandner, Sebastian/J-4562-2014; Aguzzi, Adriano/A-3351-2008; Götz, Jürgen/C-2448-2014	von Mering, Christian/0000-0001-7734-9102; Brandner, Sebastian/0000-0002-9821-0342; Götz, Jürgen/0000-0001-8501-7896; Aguzzi, Adriano/0000-0002-0344-6708				BARRY RA, 1988, J IMMUNOL, V140, P1188; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FISCHER M, 1995, RESTORATION SUSCEPTI; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; HALTIA M, 1993, ACTA NEUROPATHOL, V85, P241; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Herms JW, 1995, EUR J NEUROSCI, V7, P2508, DOI 10.1111/j.1460-9568.1995.tb01049.x; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 1997, NAT MED, V3, P1376, DOI 10.1038/nm1297-1376; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MCKUSICK VA, 1988, MENDELIAN INHERITANC; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Norman RM, 1940, BRAIN, V63, P365, DOI 10.1093/brain/63.4.365; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PASCUALCASTROVIEJO I, 1994, NEUROPEDIATRICS, V25, P183, DOI 10.1055/s-2008-1073020; PETTY KJ, 1996, CURRENT PROTOCOLS PR; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sakata H, 1996, CELL GROWTH DIFFER, V7, P1513; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMSON JAV, 1994, LAB INVEST, V71, P680; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Weissmann C, 1996, CURR BIOL, V6, P1359, DOI 10.1016/S0960-9822(96)00729-4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; WHITTINGTON MA, 1995, NAT GENET, V9, P197, DOI 10.1038/ng0295-197; WILMUT I, 1991, J REPROD FERTIL, V92, P245, DOI 10.1530/jrf.0.0920245; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130	45	424	430	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					203	214		10.1016/S0092-8674(00)81572-X	http://dx.doi.org/10.1016/S0092-8674(00)81572-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568713	Bronze, Green Accepted			2022-12-28	WOS:000073174000007
J	Camps, M; Nichols, A; Gillieron, C; Antonsson, B; Muda, M; Chabert, C; Boschert, U; Arkinstall, S				Camps, M; Nichols, A; Gillieron, C; Antonsson, B; Muda, M; Chabert, C; Boschert, U; Arkinstall, S			Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase	SCIENCE			English	Article							DUAL-SPECIFICITY PHOSPHATASE; SIGNAL-REGULATED KINASE; OF-FUNCTION MUTATION; MAP KINASE; TYROSINE-PHOSPHATASE; GENE-PRODUCT; TRANSFORMATION; EXPRESSION; CELLS	MAP kinase phosphatase-3 (MKP-3) dephosphorylates phosphotyrosine and phosphothreonine and inactivates selectively ERK family mitogen-activated protein (MAP) kinases. MKP-3 was activated by direct binding to purified ERK2. Activation was independent of protein kinase activity and required binding of ERK2 to the noncatalytic amino-terminus of MKP-3. Neither the gain-of-function Sevenmaker ERK2 mutant D319N nor c-Jun amino-terminal kinase-stress-activated protein kinase (JNK/SAPK) or p38 MAP kinases bound MKP-3 or caused its catalytic activation. These kinases were also resistant to enzymatic inactivation by MKP-3. Another homologous but nonselective phosphatase, MKP-4, bound and was activated by ERK2, JNK/SAPK, and p38 MAP kinases. Catalytic activation of MAP kinase phosphatases through substrate binding may regulate MAP kinase activation by a large number of receptor systems.	Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland	GlaxoSmithKline	Arkinstall, S (corresponding author), Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland.			Camps, Montserrat/0000-0002-9849-8657				BIGGS WH, 1992, P NATL ACAD SCI USA, V89, P6295, DOI 10.1073/pnas.89.14.6295; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CAMPS M, UNPUB; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ferrell JE, 1996, CURR TOP DEV BIOL, V33, P1, DOI 10.1016/S0070-2153(08)60336-1; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTELL KJ, 1995, J NEUROCHEM, V65, P1823; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; MUDA M, 1998, EMBO J, V273, P9323; Reszka AA, 1997, MOL BIOL CELL, V8, P1219, DOI 10.1091/mbc.8.7.1219; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WU J, 1993, P NATL ACAD SCI USA, V90, P173, DOI 10.1073/pnas.90.1.173; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	28	421	430	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1262	1265		10.1126/science.280.5367.1262	http://dx.doi.org/10.1126/science.280.5367.1262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596579				2022-12-28	WOS:000073852500048
J	Carnall, D				Carnall, D			Medicine and the media - What makes a healthy website?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1542	1542		10.1136/bmj.316.7143.1542	http://dx.doi.org/10.1136/bmj.316.7143.1542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582166	Green Published			2022-12-28	WOS:000073707700093
J	Meehan, P; Toomey, KE; Drinnon, J; Cunningham, S; Anderson, N; Baker, E				Meehan, P; Toomey, KE; Drinnon, J; Cunningham, S; Anderson, N; Baker, E			Public health response for the 1996 Olympic Games	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Extensive planning and preparation by public health agencies were required for the provision of public health services during the 1996 Centennial Olympic Games, which brought together more than 10 000 athletes from 197 countries and more than 2 million visitors. Public health activities included the develop ment and use of an augmented surveillance system to monitor health conditions and detect disease outbreaks; creation and implementation of 6 environmental health regulations; establishment of a central Public Health Command Center and response teams to coordinate response to public health emergencies; planning for potential mass casualties and the provision of emergency medical services; implementation of strategies for the prevention of heat-related illness; and distribution of health promotion and disease prevention information. Public health agencies should take the lead in organizing and implementing a system for preventing and managing public health issues at future large-scale public events such as the Olympics.	Ctr Dis Control & Prevent, Publ Hlth Practice Program Off, Atlanta, GA USA; Georgia Dept Human Resources, Div Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Meehan, P (corresponding author), POB 897, Lawrenceville, GA 30246 USA.	pmj@ph.dhr.state.ga.us						[Anonymous], 1988, FUT PUBL HLTH; *ATL COMM OL GAM, 1996, 1996 OL GAM PRESS GU; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P453; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P577; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P631; Centers for Disease Control and Prevention. Heat-related deaths-United States, 1993, MMWR-MORBID MORTAL W, V42, P558; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; Layton MC, 1997, INFECT CONT HOSP EP, V18, P115; MEEHAN PJ, 1992, AM J EPIDEMIOL, V136, P611, DOI 10.1093/oxfordjournals.aje.a116539; Noji EK, 1997, PUBLIC HLTH CONSEQUE, P3; Roth Paul B., 1996, Emergency Medicine Clinics of North America, V14, P371, DOI 10.1016/S0733-8627(05)70256-X; Ryan M J, 1996, Commun Dis Rep CDR Rev, V6, pR179; WEISS BP, 1988, AM J PUBLIC HEALTH, V78, P686, DOI 10.2105/AJPH.78.6.686; Wetterhall SF, 1998, JAMA-J AM MED ASSOC, V279, P1463, DOI 10.1001/jama.279.18.1463	14	49	51	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1469	1473		10.1001/jama.279.18.1469	http://dx.doi.org/10.1001/jama.279.18.1469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600482				2022-12-28	WOS:000073463500037
J	Baker, EH; Dong, YB; Sagnella, GA; Rothwell, M; Onipinla, AK; Markandu, ND; Cappuccio, FP; Cook, DG; Persu, A; Corvol, P; Jeunemaitre, X; Carter, ND; MacGregor, GA				Baker, EH; Dong, YB; Sagnella, GA; Rothwell, M; Onipinla, AK; Markandu, ND; Cappuccio, FP; Cook, DG; Persu, A; Corvol, P; Jeunemaitre, X; Carter, ND; MacGregor, GA			Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London	LANCET			English	Article							LIDDLES SYNDROME; GAMMA-SUBUNIT	Background. Liddle's syndrome is a rare inherited form of hypertension in which mutations of the epithelial sodium channel result in increased renal sodium reabsorption. Essential hypertension in black patients also shows clinical features of sodium retention so we screened black people for the T594M mutation, the most commonly identified sodium-channel mutation. Methods. In a case-control study, 206 hypertensive (mean age 48.0 [SD 11.8] years, men:women 80:126) and 142 normotensive (48.7 [7.4] years; 61:81) black people who lived in London, UK, were screened for T594M. Part of the last exon of the epithelial sodium-channel beta subunit from genomic DNA was amplified by PCR. The T594M variant was detected by single-strand conformational polymorphism analysis of PCR products and confirmed by DNA sequencing. Findings. 17 (8.3%) of 206 hypertensive participants compared with three (2.1%) of 142 normotensive partcipants possessed the T594M variant (odds ratio [OR]=4.17 [95% CI 1.12-18.25], p = 0.029). A high proportion of participants with the T594M variant were women (15 of 17 hypertensive participants and all three normotensive participants), whereas women comprised a lower proportion of the individuals screened (61.2% hypertensive, 57.7% normotensive). However, the association between the T594M variant and hypertension persisted after adjustment for sex and body-mass index (Mantel-Haenszel OR=5.52 [1.40-30.61], p = 0.012). Plasma renin activity was significantly lower in 13 hypertensive participants with the T594M variant (median=0.19 ng mL(-1) h(-1)) than in 39 untreated hypertensive individuals without the variant (median=0.45 ng mL(-1) h(-1), p=0.009). Interpretation. Among black London people the T594M sodium-channel beta subunit mutation occurs more frequently in people with hypertension than those without. The T594M variant may increase sodium-channel activity and could raise blood pressure in affected people by increasing renal tubular sodium reabsorption. These findings suggest that the T594M mutation could be the most common secondary cause of essential hypertension in black people identified to date.	St George Hosp, Sch Med, Dept Pharmacol, London SW17 0RE, England; St George Hosp, Sch Med, Blood Pressure Unit, London SW17 0RE, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; St George Hosp, Sch Med, Med Genet Unit, London SW17 0RE, England; Coll France, INSERM, U36, F-75231 Paris, France	St Georges University London; St Georges University London; St Georges University London; St Georges University London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Baker, EH (corresponding author), St George Hosp, Sch Med, Dept Pharmacol, London SW17 0RE, England.	ebaker@sghms.ac.uk	Cappuccio, Francesco/D-3028-2009; Cappuccio, Francesco Paolo/ABF-1094-2020; JEUNEMAITRE, Xavier/AAQ-4853-2021	Cappuccio, Francesco Paolo/0000-0002-7842-5493; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Persu, Alexandre/0000-0002-4007-9695; Baker, Emma/0000-0002-0871-3721; Cook, Derek/0000-0002-9723-5759				[Anonymous], 1985, J HYPERTENS, V3, P293; BOTEROVELEZ M, 1994, NEW ENGL J MED, V330, P178, DOI 10.1056/NEJM199401203300305; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chang HG, 1996, J HYPERTENS, V14, P1417, DOI 10.1097/00004872-199612000-00005; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; DEWARDENER HE, 1982, LANCET, V1, P1450; GEORGE CF, 1975, BRIT HEART J, V37, P804; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; JAMES VHT, 1976, METHODOLOGICAL DEV B, V5, P149; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MUNROE PB, 1997, AM J HYPERTENS, V10, pA5; PERSU A, 1998, IN PRESS HYPERTENSIO; ROULSTON JE, 1978, CLIN CHIM ACTA, V88, P45, DOI 10.1016/0009-8981(78)90147-X; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Su YR, 1996, J AM SOC NEPHROL, V7, P2543; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188	19	198	204	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1388	1392		10.1016/S0140-6736(97)07306-6	http://dx.doi.org/10.1016/S0140-6736(97)07306-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593408				2022-12-28	WOS:000073563400008
J	Campbell, NC; Thain, J; Deans, HG; Ritchie, LD; Rawles, JM; Squair, JL				Campbell, NC; Thain, J; Deans, HG; Ritchie, LD; Rawles, JM; Squair, JL			Secondary prevention clinics for coronary heart disease: randomised trial of effect on health	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; REHABILITATION; RISK	Objective: To evaluate the effects of secondary prevention clinics run by nurses in general practice on the health of patients with coronary heart disease. Design: Randomised controlled trial of clinics over one year with assessment by self completed postal questionnaires and audit of medical records at the start and end of the trial. Setting: Random sample of 19 general practices in northeast Scotland. Subjects: 1173 patients (685 men and 488 women) under 80 years with corking diagnoses of coronary heart disease who did not have terminal illness or dementia and were not housebound. Intervention: Clinic staff promoted medical and lifestyle aspects of secondary prevention and offered regular follow up. Main outcome measures: Health status measured by the SF-36 questionnaire, chest pain by the angina type specification, and anxiety and depression by the hospital anxiety and depression scale. Use of health services before and during the study. Results: There were significant improvements in six of eight health status domains (all functioning scales, pain, and general health) among patients attending the clinic. Role limitations attributed to physical problems improved most (adjusted difference 8.52, 95% confidence interval 4.16 to 12.9). Fewer patients reported worsening chest pain (odds ratio 0.59, 95% confidence interval 0.37 to 0.94), There were no significant effects on anxiety or depression. Fewer intervention group patients required hospital admissions (0.64, 0.48 to 0.86), but general practitioner consultation rates did not alter. Conclusions: Within their first year secondary prevention clinics improved patients' health and reduced hospital admissions.	Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland; Denburn Hlth Ctr, Aberdeen AB25 1QB, Scotland; Sch Med, Med Assessment Res Unit, Aberdeen AB25 2ZD, Scotland; Sch Med, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Campbell, NC (corresponding author), Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland.	n.campbell@abdn.ac.uk						ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BROWN RL, 1989, APPL PSYCH MEAS, V13, P151, DOI 10.1177/014662168901300205; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; Cupples ME, 1996, HLTH ED J, V55, P75; DALY LE, 1983, BMJ-BRIT MED J, V287, P324, DOI 10.1136/bmj.287.6388.324; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Hale AS, 1997, BRIT MED J, V315, P43, DOI 10.1136/bmj.315.7099.43; Hale AS, 1997, BRIT MED J, V314, P1886, DOI 10.1136/bmj.314.7098.1886; Mayou R, 1996, BRIT MED J, V313, P1498, DOI 10.1136/bmj.313.7071.1498; Moher M, 1997, BMJ-BRIT MED J, V315, P69, DOI 10.1136/bmj.315.7100.69; Moher M., 1995, EVIDENCE EFFECTIVENE; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; PEDERSEN TR, 1994, LANCET, V344, P1383; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; PRYOR DB, 1993, USERS MANUAL ANGINA; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Ware J. E., 1993, SF36 HLTH SURVEY MAN; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	19	115	115	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	1998	316	7142					1434	1437		10.1136/bmj.316.7142.1434	http://dx.doi.org/10.1136/bmj.316.7142.1434			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572758	Green Published			2022-12-28	WOS:000073651600033
J	Cullen, MR				Cullen, MR			Chrysotile asbestos: enough is enough	LANCET			English	Editorial Material							MORTALITY; MESOTHELIOMA; TREMOLITE; EXPOSURE; CANCER		Yale Univ, Sch Med, Yale Occupat & Environm Med Program, New Haven, CT 06510 USA	Yale University	Cullen, MR (corresponding author), Yale Univ, Sch Med, Yale Occupat & Environm Med Program, 333 Cedar St, New Haven, CT 06510 USA.							AMANDUS HE, 1987, AM J IND MED, V11, P15, DOI 10.1002/ajim.4700110103; CULLEN MR, 1987, OCCUP MED, V2, P259; DEMENT JM, 1983, AM J IND MED, V4, P421, DOI 10.1002/ajim.4700040304; Liddell FDK, 1997, ANN OCCUP HYG, V41, P13, DOI 10.1016/S0003-4878(96)00044-0; Liddell FDK, 1998, ANN OCCUP HYG, V42, P7, DOI 10.1016/S0003-4878(97)00053-7; MCDONALD AD, 1983, BRIT J IND MED, V40, P361; McDonald AD, 1997, ANN OCCUP HYG, V41, P707, DOI 10.1016/S0003-4878(97)00020-3; MCDONALD JC, 1989, CANCER, V63, P1544, DOI 10.1002/1097-0142(19890415)63:8<1544::AID-CNCR2820630815>3.0.CO;2-G; McDonald JC, 1997, ANN OCCUP HYG, V41, P699, DOI 10.1093/annhyg/41.6.699; MCDONALD JC, 1998, ANN OCCUP HYG, V42, P1; Smith AH, 1996, AM J IND MED, V30, P252, DOI 10.1002/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0; Stayner LT, 1996, AM J PUBLIC HEALTH, V86, P179, DOI 10.2105/AJPH.86.2.179; WAGNER JC, 1982, BRIT J CANCER, V45, P352, DOI 10.1038/bjc.1982.61	13	27	27	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	1998	351	9113					1377	1378		10.1016/S0140-6736(05)79440-X	http://dx.doi.org/10.1016/S0140-6736(05)79440-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593405				2022-12-28	WOS:000073563400005
J	Fryer, CJ; Archer, TK				Fryer, CJ; Archer, TK			Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex	NATURE			English	Article							MMTV PROMOTER; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; STEROID-RECEPTORS; NUCLEAR RECEPTORS; BINDING; COACTIVATOR; NUCLEOSOME; PROTEIN; CBP	The assembly of transcriptional regulatory DNA sequences into chromatin plays a fundamental role in modulating gene expression(1,2). The promoter of the mouse mammary-tumour virus (MMTV) is packaged into a regular array of nucleosomes when it becomes stably integrated into mammalian chromosomes, and has been used to investigate the relationship between chromatin architecture and transcriptional activation by the hormone-bound glucocorticoid and progesterone receptors(3,4). In mammalian cells that express both of these receptors, the progesterone receptor activates transcription from transiently transfected MMTV DNA(5,6) but not from organized chromatin templates(7). Moreover, the activated progesterone receptor inhibits the chromatin remodelling and consequent transcriptional stimulation that is mediated by the glucocorticoid receptor. Here we investigate the mechanism of this inhibition by characterizing the interaction of the glucocorticoid receptor with transcriptional co-activator and chromatin remodelling protein complexes(2,8). We show that when this receptor is prevented from interacting with the hBRG1/BAF chromatin remodelling complex, it can activate transcription from transiently transfected DNA but not from organized chromatin templates. Our results indicate that it may be possible to separate the transcriptional activation and chromatin remodelling activities of proteins that interact with hormone receptors.	Univ Western Ontario, London Reg Canc Ctr, Dept Obstet & Gynaecol, London, ON N6A 4L6, Canada; Univ Western Ontario, London Reg Canc Ctr, Dept Biochem, London, ON N6A 4L6, Canada; Univ Western Ontario, London Reg Canc Ctr, Dept Oncol, London, ON N6A 4L6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Archer, TK (corresponding author), Univ Western Ontario, London Reg Canc Ctr, Dept Obstet & Gynaecol, 790 Commissioners Rd E, London, ON N6A 4L6, Canada.		Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644				ARCHER TK, 1995, J STEROID BIOCHEM, V53, P421, DOI 10.1016/0960-0760(95)00088-H; ARCHER TK, 1994, MOL ENDOCRINOL, V8, P1154, DOI 10.1210/me.8.9.1154; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; ESTES PA, 1987, BIOCHEMISTRY-US, V26, P6250, DOI 10.1021/bi00393a045; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; MCKNIGHT GS, 1980, CELL, V22, P469; MCKNIGHT GS, 1997, NATURE, V387, P677; MIZUTANI T, 1992, J STEROID BIOCHEM, V42, P695, DOI 10.1016/0960-0760(92)90110-5; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Smith CL, 1996, P NATL ACAD SCI USA, V93, P8884, DOI 10.1073/pnas.93.17.8884; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wu C, 1997, J BIOL CHEM, V272, P28171, DOI 10.1074/jbc.272.45.28171; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	30	404	413	1	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					88	91		10.1038/30032	http://dx.doi.org/10.1038/30032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590696				2022-12-28	WOS:000073497500054
J	Vadodaria, B				Vadodaria, B			Innovations - An unusual use of a stethoscope	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1382	1382		10.1136/bmj.316.7141.1382	http://dx.doi.org/10.1136/bmj.316.7141.1382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563999	Green Published			2022-12-28	WOS:000073483000031
J	Walters, K				Walters, K			A lesson learnt - A view from the other side	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1395	1395		10.1136/bmj.316.7141.1395	http://dx.doi.org/10.1136/bmj.316.7141.1395			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9564018	Green Published			2022-12-28	WOS:000073483000073
J	Varon, R; Vissinga, C; Platzer, M; Cerosaletti, KM; Chrzanowska, KH; Saar, K; Beckmann, G; Seemanova, E; Cooper, PR; Nowak, NJ; Stumm, M; Weemaes, CMR; Gatti, RA; Wilson, RK; Digweed, M; Rosenthal, A; Sperling, K; Concannon, P; Reis, A				Varon, R; Vissinga, C; Platzer, M; Cerosaletti, KM; Chrzanowska, KH; Saar, K; Beckmann, G; Seemanova, E; Cooper, PR; Nowak, NJ; Stumm, M; Weemaes, CMR; Gatti, RA; Wilson, RK; Digweed, M; Rosenthal, A; Sperling, K; Concannon, P; Reis, A			Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome	CELL			English	Article							CHROMOSOMAL INSTABILITY DISORDER; ATAXIA-TELANGIECTASIA; HUMAN GENOME; HUMAN MRE11; GENE; IMMUNODEFICIENCY; COMPLEMENTATION; MAP	Nijmegen breakage syndrome (NBS) Is an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. Cells from NBS patients are hypersensitive to ionizing radiation with cytogenetic features indistinguishable from ataxia telangiectasia. We describe the positional cloning of a gene encoding a novel protein, nibrin. It contains two modules found in cell cycle checkpoint proteins, a forkhead-associated domain adjacent to a breast cancer carboxy-terminal domain. A truncating 5 bp deletion was identified in the majority of NBS patients, carrying a conserved marker haplotype. Five further truncating mutations were identified in patients with other distinct haplotypes. The domains found in nibrin and the NBS phenotype suggest that this disorder is caused by defective responses to DNA double-strand breaks.	Humboldt Univ, Charite, Inst Human Genet, D-13353 Berlin, Germany; Univ Washington, Sch Med, Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98101 USA; Inst Mol Biol, Dept Genome Anal, D-07745 Jena, Germany; Childrens Mem Hlth Inst, Dept Med Genet, PL-04736 Warsaw, Poland; Max Delbruck Ctr Mol Med, Mikrosatellitenzentrum, D-14059 Berlin, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, D-13125 Berlin, Germany; Charles Univ Prague, Dept Med Genet, CR-15018 Prague, Czech Republic; Roswell Pk Canc Inst, Dept Human Genet, Buffalo, NY 14263 USA; Univ Magdeburg, Inst Human Genet, D-39112 Magdeburg, Germany; Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Children's Memorial Health Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Charles University Prague; Roswell Park Cancer Institute; Otto von Guericke University; Radboud University Nijmegen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL)	Reis, A (corresponding author), Humboldt Univ, Charite, Inst Human Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.		Weemaes, C.M.R./L-4747-2015; Reis, André/D-2309-2009; Wilson, Richard K./AAF-4139-2019	Reis, André/0000-0002-6301-6363; Wilson, Richard K./0000-0002-1992-1358; Cooper, Paul/0000-0003-1305-7287; Chrzanowska, Krystyna/0000-0003-3888-0624; Saar, Kathrin/0000-0002-4483-1557; Concannon, Patrick/0000-0002-5801-1859	NATIONAL CANCER INSTITUTE [R01CA057569, R01CA063333] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000333] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057569, CA63333, CA57569] Funding Source: Medline; NHGRI NIH HHS [HG00333] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; DIGWEED M, 1993, TOXICOL LETT, V67, P259, DOI 10.1016/0378-4274(93)90061-2; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; HANAWALT P, 1985, ATAXIA TELANGIECTASI, P67; Hendrickson EA, 1997, AM J HUM GENET, V61, P795, DOI 10.1086/514895; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; Komatsu K, 1996, AM J HUM GENET, V58, P885; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V242, P602, DOI 10.1006/bbrc.1997.7924; MEYN MS, 1995, CANCER RES, V55, P5991; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Saar K, 1997, AM J HUM GENET, V60, P605; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVOV A, 1992, NUCLEIC ACIDS RES, V20, P6741, DOI 10.1093/nar/20.24.6741; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SEYSCHAB H, 1992, EUR J PEDIATR, V151, P756, DOI 10.1007/BF01959085; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stumm M, 1997, AM J HUM GENET, V60, P1246; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TROELSTRA C, 1994, CURR BIOL, V4, P1149, DOI 10.1016/S0960-9822(00)00260-8; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WEGNER RD, 1988, CLIN GENET, V33, P20; WEGNER RD, 1998, IN PRESS PRIMARY IMM; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016	40	799	823	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					467	476		10.1016/S0092-8674(00)81174-5	http://dx.doi.org/10.1016/S0092-8674(00)81174-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590180	Green Submitted, Bronze			2022-12-28	WOS:000073471500021
J	Wiens, GR; Sorger, PK				Wiens, GR; Sorger, PK			Centromeric chromatin and epigenetic effects in kinetochore assembly	CELL			English	Review							FISSION YEAST; PROTEIN		MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wiens, GR (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sorger, Peter/0000-0002-3364-1838				BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; BLOOM KS, 1984, J CELL BIOL, V99, P1559, DOI 10.1083/jcb.99.5.1559; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; duSart D, 1997, NAT GENET, V16, P144; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Grewal SIS, 1997, GENETICS, V146, P1221; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; Searle JB, 1998, GENOME RES, V8, P1; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Szeto L, 1997, GENE DEV, V11, P1899, DOI 10.1101/gad.11.15.1899; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30	20	73	73	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					313	316		10.1016/S0092-8674(00)81157-5	http://dx.doi.org/10.1016/S0092-8674(00)81157-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590163	Bronze			2022-12-28	WOS:000073471500004
J	Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Overstall, P; Ockelford, J; Lees, AJ				Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Overstall, P; Ockelford, J; Lees, AJ			Investigation by Parkinson's disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early mild Parkinson's disease: further results of randomised trial and confidential inquiry	BRITISH MEDICAL JOURNAL			English	Article							DEPRENYL	Objective: To determine whether the excess mortality observed in patients who received both levodopa and selegiline in a randomised trial could be explained by revised diagnosis of Parkinson's disease, autonomic or cardiovascular effects, more rapid disease progression, or drug interactions. Design: Open randomised trial and blind comparison and reclassification of the cause of death of patients who were recruited from 93 hospitals between 1985 and 1990 and who had died before December 1993 in arms 1 and 2. Setting: United Kingdom. Subjects: 624 patients with early Parkinson's disease who were not receiving dopaminergic treatment and a subgroup of 120 patients who died during the trial. Interventions: Levodopa and a dopa decarboxylase inhibitor (arm 1), levodopa and a dopa decarboxylase inhibitor in combination with selegiline (arm 2), or bromocriptine alone (arm 3). Main outcome measures: All cause mortality for 520 subjects in arms 1 and 2 and for 104 subjects who were randomised into these arms from arm 3. Cause specific mortality for people who died in the original arms 1 and 2 on the basis of the opinion of a panel, revised diagnosis and disability ratings, evidence from clinical records of either autonomic or cardiovascular episodes, other clinical features before death, and drug interactions. Results: After extended follow up (mean 6.8 years) until the end of September 1995, when arm 2 was terminated, the hazard ratio for arm 2 compared with arm 1 was 1.32 (95% confidence interval 0.98 to 1.79). For subjects who were randomised from arm 3 the hazard ratio for arm 2 was 1.54 (0.83 to 2.87). When all subjects were included the hazard ratio was 1.33 (1.02 to 1.74) and after adjustment for other baseline factors it was 1.30 (0.99 to 1.72). The excess mortality seemed to be greatest in the third and fourth year of follow up. Cause specific death rates showed an excess of deaths from Parkinson's disease only (hazard ratio 2.5 (1.3 to 4.7)). No significant differences were found for revised diagnosis, disability rating scores, autonomic or cardiovascular events, other clinical features, or drug interactions. Patients who died in arm 2 were more likely to have had possible dementia and a history of falls before death compared with those who died in arm 1. Conclusion: The results consistently show excess mortality in patients treated with combined levodopa and selegiline. Revised diagnosis, autonomic or cardiovascular events, or drug interactions could not explain this finding, but falls and possible dementia were more common in arm 2. The results do not support combined treatment in patients with newly diagnosed Parkinson's disease. Ln more advanced disease, combined treatment should perhaps be avoided in patients with postural hypotension, frequent falls, confusion, or dementia.	Natl Hosp Neurol & Neurosurg, Parkinsons Dis Res Grp United Kingdom, London WC1N 3BG, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; UCL Hosp, London WC1, England; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England; Hereford Gen Hosp, Hereford HR1 2PA, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Bristol; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; Imperial College London	Lees, AJ (corresponding author), Natl Hosp Neurol & Neurosurg, Parkinsons Dis Res Grp United Kingdom, Queen Sq, London WC1N 3BG, England.		Lees, Andrew J/A-6605-2009; Head, Jenny/GYA-2625-2022; Ben-Shlomo, Yoav/ABD-2004-2021	Lees, Andrew J/0000-0002-2476-4385; Ben-Shlomo, Yoav/0000-0001-6648-3007; Head, Jennifer/0000-0002-6054-0872				ALDERSON MR, 1967, BRIT J PREV SOC MED, V21, P22; BenShlomo Y, 1996, BMJ-BRIT MED J, V312, P724; BIRKMAYER W, 1985, J NEURAL TRANSM, V64, P113, DOI 10.1007/BF01245973; BROWN RG, 1984, LANCET, V2, P1262, DOI 10.1016/S0140-6736(84)92807-1; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Churchyard A, 1997, J NEUROL NEUROSUR PS, V63, P228, DOI 10.1136/jnnp.63.2.228; COLLETT D, 1994, MODELLING SURVIVAL; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Gerlach M, 1996, BRIT MED J, V312, P704; Jellinger KA, 1996, BMJ-BRIT MED J, V312, P704; Lees AJ, 1995, BRIT MED J, V311, P1602, DOI 10.1136/bmj.311.7020.1602; Lees AJ, 1996, BRIT MED J, V312, P704; Lees AJ, 1997, ANN NEUROL, V41, P282, DOI 10.1002/ana.410410223; LEES AJ, 1993, BRIT MED J, V307, P469; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Olanow CW, 1996, ANN NEUROL, V40, P841, DOI 10.1002/ana.410400605; RAJPUT AH, 1991, CAN J NEUROL SCI, V18, P275, DOI 10.1017/S0317167100031814; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Silva M, 1996, BRIT MED J, V312, P703; TATTON WG, 1991, J NEUROSCI RES, V30, P666, DOI 10.1002/jnr.490300410; Turkka J, 1997, NEUROLOGY, V48, P662, DOI 10.1212/WNL.48.3.662; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; *WHO, 1978, MAN INT CLASS DIS IN	24	75	76	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 18	1998	316	7139					1191	1196		10.1136/bmj.316.7139.1191	http://dx.doi.org/10.1136/bmj.316.7139.1191			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ518	9583926	Green Published			2022-12-28	WOS:000073224100018
J	Tontonoz, P; Nagy, L; Alvarez, JGA; Thomazy, VA; Evans, RM				Tontonoz, P; Nagy, L; Alvarez, JGA; Thomazy, VA; Evans, RM			PPAR gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; ACTIVATED RECEPTOR-GAMMA; RETINOIC ACID; ADIPOCYTE DIFFERENTIATION; CHOLESTEROL DEPOSITION; GENE-EXPRESSION; THYROID-HORMONE; HUMAN CD36; MACROPHAGE; BINDING	The formation of foam cells from macrophages in the arterial wall is characterized by dramatic changes in lipid metabolism, including increased expression of scavenger receptors and the uptake of oxidized low-density lipoprotein (oxLDL). We demonstrate here that the nuclear receptor PPAR gamma is induced in human monocytes following exposure to oxLDL and is expressed at high levels in the foam cells of atherosclerotic lesions. Ligand activation of the PPBR gamma:RXR alpha heterodimer in myelomonocytic cell lines induces changes characteristic of monocytic differentiation and promotes uptake of oxLDL through transcriptional induction of the scavenger receptor CD36. These results reveal a novel signaling pathway controlling differentiation and lipid metabolism in monocytic cells, and suggest that endogenous PPAR gamma ligands may be important regulators of gene expression during atherogenesis.	Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Texas, Sch Med, Dept Pathol, Houston, TX 77225 USA; Univ Texas, Sch Med, Dept Integrat Biol, Houston, TX 77225 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of Texas System; University of Texas System	Evans, RM (corresponding author), Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Nagy, Laszlo/A-3814-2008; Evans, Ronald/AAF-4001-2019	Nagy, Laszlo/0000-0001-6653-2155; Evans, Ronald/0000-0002-9986-5965				ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ACTON SL, 1994, J BIOL CHEM, V269, P21003; ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BUJA LM, 1983, ARTERIOSCLEROSIS, V3, P87, DOI 10.1161/01.ATV.3.1.87; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; Greene M. E., 1995, Gene Expression, V4, P281; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LUBBERT M, 1991, BLOOD, V77, P909; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; MOULTON KS, 1992, P NATL ACAD SCI USA, V89, P8102, DOI 10.1073/pnas.89.17.8102; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; NAGELKERKE JF, 1984, ARTERIOSCLEROSIS, V4, P256, DOI 10.1161/01.ATV.4.3.256; NAGY L, 1995, MOL CELL BIOL, V15, P3540; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSS TK, 1994, VITAM HORM, V49, P281; SANAN DA, 1998, IN PRESS P ACAD NATL; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Sears IB, 1996, MOL CELL BIOL, V16, P3410; SFEIR Z, 1997, ESSENT FATTY ACIDS, V57, P17; STANTON LW, 1992, J BIOL CHEM, V267, P22446; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Yesner LM, 1996, ARTERIOSCL THROM VAS, V16, P1019, DOI 10.1161/01.ATV.16.8.1019; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	55	1517	1573	1	93	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					241	252		10.1016/S0092-8674(00)81575-5	http://dx.doi.org/10.1016/S0092-8674(00)81575-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568716	Bronze			2022-12-28	WOS:000073174000010
J	Simpson, K; Gordon, M				Simpson, K; Gordon, M			The anatomy of a clinical information system	BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE; MANAGEMENT; PROVIDE		Glasgow Royal Infirm, Renal Unit, Glasgow G4 0SF, Lanark, Scotland; Clin Comp, Brentford TW8 0HF, Middx, England	University of Glasgow	Simpson, K (corresponding author), Glasgow Royal Infirm, Renal Unit, Glasgow G4 0SF, Lanark, Scotland.							*AUD COMM, 1995, INF STUD INF MAN SYS; BLACK N, 1989, BRIT MED J, V298, P586, DOI 10.1136/bmj.298.6673.586; BLEICH HL, 1985, NEW ENGL J MED, V312, P756, DOI 10.1056/NEJM198503213121205; BUCKLEY FJ, 1984, IEEE T SOFTWARE ENG, V10, P36, DOI 10.1109/TSE.1984.5010196; Campbell J R, 1994, Proc Annu Symp Comput Appl Med Care, P201; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dick R.S., 1991, COMPUTER BASED PATIE; DONELSON WC, 1978, P SIGGRAPH ATL GA; Geddes CC, 1998, NEPHROL DIAL TRANSPL, V13, P67, DOI 10.1093/ndt/13.1.67; GORDON M, 1983, KIDNEY INT, V24, P455, DOI 10.1038/ki.1983.182; Gordon M, 1970, Biomed Eng, V5, P539; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; HALPERN NA, 1995, CRIT CARE MED, V23, P2054, DOI 10.1097/00003246-199512000-00014; INCE D, 1995, GUARDIAN ON LIN 1012, P5; Information Management Group, 1992, GETT BETT INF IM T S; JOHNSON DW, 1992, CLIN PHARMACOKINET, V22, P434, DOI 10.2165/00003088-199222060-00003; Junor BJR, 1997, NEPHROL DIAL TRANSPL, V12, P29, DOI 10.1093/ndt/12.1.29; Lock C, 1996, BRIT MED J, V312, P1407; ROBERTS DE, 1993, CRIT CARE MED, V21, P1452, DOI 10.1097/00003246-199310000-00011; SIMPSON K, 1993, SCOT MED J, V38, P107, DOI 10.1177/003693309303800403; SMITH M, 1993, BR J HLTH CARE COMP, V10, P25; Tonks A, 1996, BRIT MED J, V313, P438; WHITINGOKEEFE QE, 1985, JAMA-J AM MED ASSOC, V254, P1185, DOI 10.1001/jama.254.9.1185; WYATT JC, 1995, BRIT MED J, V311, P175, DOI 10.1136/bmj.311.6998.175; [No title captured]	25	17	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1655	1658		10.1136/bmj.316.7145.1655	http://dx.doi.org/10.1136/bmj.316.7145.1655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603750	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000074022700027
J	Cross, S; Buck, S; Hubbard, J				Cross, S; Buck, S; Hubbard, J			ABC of allergies - Allergy in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Natl Asthma & Resp Training Ctr, Warwick, England		Cross, S (corresponding author), Natl Asthma & Resp Training Ctr, Warwick, England.							Sibbald B, 1997, J ADV NURS, V26, P537, DOI 10.1046/j.1365-2648.1997.t01-14-00999.x; VENGE P, 1994, ALLERGY, V49, P1, DOI 10.1111/j.1398-9995.1994.tb00765.x; 1997, THORAX S1, V52	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1584	1587		10.1136/bmj.316.7144.1584	http://dx.doi.org/10.1136/bmj.316.7144.1584			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZQ495	9596600	Green Published			2022-12-28	WOS:000073867800028
J	Morley, C				Morley, C			Concerns about using and interpreting covert video surveillance	BRITISH MEDICAL JOURNAL			English	Article									Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England	Addenbrooke's Hospital; University of Cambridge	Morley, C (corresponding author), Royal Womens Hosp, Neonatal Intens Care Unit, 132 Grattan St, Carlton, Vic 3053, Australia.			Morley, Colin/0000-0001-5388-0214				SAMUELS MP, 1994, BRIT MED J, V308, P1101; SAMUELS MP, 1992, ARCH DIS CHILD, V67, P162, DOI 10.1136/adc.67.2.162; SAMUELS MP, 1904, LANCET, V344, P414; *WORK PART BRIT PA, 1994, EV SUSP IMP UPP AIRW, P24	4	10	10	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1603	1604		10.1136/bmj.316.7144.1603	http://dx.doi.org/10.1136/bmj.316.7144.1603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596606	Green Published			2022-12-28	WOS:000073867800036
J	Liu, J; Rinzler, AG; Dai, HJ; Hafner, JH; Bradley, RK; Boul, PJ; Lu, A; Iverson, T; Shelimov, K; Huffman, CB; Rodriguez-Macias, F; Shon, YS; Lee, TR; Colbert, DT; Smalley, RE				Liu, J; Rinzler, AG; Dai, HJ; Hafner, JH; Bradley, RK; Boul, PJ; Lu, A; Iverson, T; Shelimov, K; Huffman, CB; Rodriguez-Macias, F; Shon, YS; Lee, TR; Colbert, DT; Smalley, RE			Fullerene pipes	SCIENCE			English	Article							SINGLE-WALLED NANOTUBES; CARBON NANOTUBES	Single-wall fullerene nanotubes were converted from nearly endless, highly tangled ropes into short, open-ended pipes that behave as individual macromolecules. Raw nanotube material was purified in large batches, and the ropes were cut into 100- to 300-nanometer lengths. The resulting pieces formed a stable colloidal suspension in water with the help of surfactants. These suspensions permit a variety of manipulations, such as sorting by length, derivatization, and tethering to gold surfaces.	Rice Univ, Ctr Nanoscale Sci & Technol, Rice Quantum Inst, Dept Chem, Houston, TX 77005 USA; Rice Univ, Ctr Nanoscale Sci & Technol, Rice Quantum Inst, Dept Phys, Houston, TX 77005 USA; Univ Houston, Dept Chem, Houston, TX 77204 USA	Rice University; Rice University; University of Houston System; University of Houston	Smalley, RE (corresponding author), Rice Univ, Ctr Nanoscale Sci & Technol, Rice Quantum Inst, Dept Chem, Houston, TX 77005 USA.		Han, Jinhua/F-9464-2010; Milton, Ross D/J-7164-2012; Rodriguez-Macias, Fernando J/A-9841-2013; Liu, Jie/B-4440-2010; Lee, T. Randall/G-6666-2019; Dai, Hongjie/ABC-4574-2021; Hafner, Jason H/A-7959-2008	Rodriguez-Macias, Fernando J/0000-0002-4319-5608; Liu, Jie/0000-0003-0451-6111; Lee, T. Randall/0000-0001-9584-8861; Hafner, Jason H/0000-0002-6943-4232; Bradley, Robert/0000-0003-3805-1869; Shon, Young-Seok/0000-0003-4765-6130; Iverson, Terrence/0000-0003-1519-8358				Bubke K, 1997, APPL PHYS LETT, V71, P1906, DOI 10.1063/1.119976; Chen YJ, 1996, ADV MATER, V8, P1012, DOI 10.1002/adma.19960081216; EBBESEN TW, 1994, NATURE, V367, P519, DOI 10.1038/367519a0; GUO T, 1995, CHEM PHYS LETT, V243, P49, DOI 10.1016/0009-2614(95)00825-O; Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972; KINOSHITA K, 1988, CARBON ELECTROCHEMIC, P199; Liu J, 1997, NATURE, V385, P780, DOI 10.1038/385780b0; Lu KL, 1996, CARBON, V34, P814, DOI 10.1016/0008-6223(96)89470-X; Mason T. J., 1988, SONOCHEMISTRY THEORY; MCKAY SF, 1964, J APPL PHYS, V35, P1992, DOI 10.1063/1.1713794; RINZLER AG, IN PRESS APPL PHYS A; RINZLER AG, UNPUB; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Tohji K, 1996, NATURE, V383, P679, DOI 10.1038/383679a0; Tohji K, 1997, J PHYS CHEM B, V101, P1974, DOI 10.1021/jp962888c; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Yakobson BI, 1997, AM SCI, V85, P324	18	3107	3382	19	819	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1253	1256		10.1126/science.280.5367.1253	http://dx.doi.org/10.1126/science.280.5367.1253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596576				2022-12-28	WOS:000073852500045
J	Pollitz, FF; Burgmann, R; Romanowicz, B				Pollitz, FF; Burgmann, R; Romanowicz, B			Viscosity of oceanic asthenosphere inferred from remote triggering of earthquakes	SCIENCE			English	Article							CURRENT PLATE MOTIONS; UPPER-MANTLE; SOUTHERN CALIFORNIA; ISLANDS EARTHQUAKE; RUPTURE PROCESS; RECURRENCE INTERVALS; GREAT EARTHQUAKES; STRESS DIFFUSION; HEAT-FLOW; JAPAN	A sequence of large interplate earthquakes from 1952 to 1965 along the Aleutian are and Kurile-Kamchatka trench released accumulated stresses along nearly the entire northern portion of the Pacific Plate boundary. The postseismic stress evolution across the northern Pacific and Arctic basins, calculated from a viscoelastic coupling model with an asthenospheric viscosity of 5 x 10(17) pascal seconds, is consistent with triggering of oceanic intraplate earthquakes, temporal patterns in seismicity at remote plate boundaries, and space-based geodetic measurements of anomalous velocity over an area 7000 by 7000 kilometers square during the 30-year period after the sequence.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Calif Berkeley, Seismol Lab, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Pollitz, FF (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.		Burgmann, Roland/AAE-5138-2022; Romanowicz, barbara A/H-6726-2017	Romanowicz, barbara A/0000-0002-6208-6044; Burgmann, Roland/0000-0002-3560-044X				Abe K., 1973, Physics of the Earth and Planetary Interiors, V7, P143, DOI 10.1016/0031-9201(73)90004-6; ABERS GA, 1993, J GEOPHYS RES-SOL EA, V98, P2155, DOI 10.1029/92JB01868; ANDERSON DL, 1975, SCIENCE, V187, P1077, DOI 10.1126/science.187.4181.1077; BECK SL, 1991, J GEOPHYS RES-SOLID, V96, P2205, DOI 10.1029/90JB02092; BERG E, 1977, TECTONOPHYSICS, V39, P559, DOI 10.1016/0040-1951(77)90153-6; BERGMAN EA, 1980, J GEOPHYS RES, V85, P5389, DOI 10.1029/JB085iB10p05389; BOYD TM, 1988, B SEISMOL SOC AM, V78, P1653; BOYD TM, 1995, J GEOPHYS RES-SOL EA, V100, P621, DOI 10.1029/94JB02641; BUFE CG, 1994, PURE APPL GEOPHYS, V142, P83, DOI 10.1007/BF00875969; CHRISTENSEN DH, 1994, PURE APPL GEOPHYS, V142, P29, DOI 10.1007/BF00875967; COHEN SC, 1992, J GEOPHYS RES-SOL EA, V97, P15395, DOI 10.1029/92JB01078; DAVAILLE A, 1994, J GEOPHYS RES-SOL EA, V99, P19853, DOI 10.1029/94JB01405; DeMets C, 1995, GEOPHYS RES LETT, V22, P3545, DOI 10.1029/95GL03323; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Elsasser W.V., 1967, APPL MODERN PHYS EAR, P223; FUJITA K, 1990, GEOLOGY N AM, V50, P79; FUKAO Y, 1979, GEOPHYS J ROY ASTR S, V57, P23, DOI 10.1111/j.1365-246X.1979.tb03769.x; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; GIARDINI D, 1985, PHYS EARTH PLANET IN, V40, P259, DOI 10.1016/0031-9201(85)90037-8; HANKS TC, 1979, J GEOPHYS RES, V84, P2348, DOI 10.1029/JB084iB05p02348; *HARV U, 1997, HARV CENTR MOM TENS; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HODGSON JH, 1965, ANN INTERN GEOPHYS Y, V30, P33; HOLDAHL SR, 1994, PURE APPL GEOPHYS, V142, P55, DOI 10.1007/BF00875968; HUTTON LK, 1993, B SEISMOL SOC AM, V83, P313; Jaume SC, 1996, J GEOPHYS RES-SOL EA, V101, P765, DOI 10.1029/95JB02393; JEMSEK JP, 1986, J GEOPHYS RES-SOLID, V91, P13993, DOI 10.1029/JB091iB14p13993; JOHNSON JM, 1994, PURE APPL GEOPHYS, V142, P3, DOI 10.1007/BF00875966; Jones LM, 1997, GEOPHYS RES LETT, V24, P469, DOI 10.1029/97GL00188; KANAMORI H, 1976, PHYS EARTH PLANET IN, V11, P216, DOI 10.1016/0031-9201(76)90066-2; KANAMORI H, 1971, TECTONOPHYSICS, V12, P1, DOI 10.1016/0040-1951(71)90063-1; KANAMORI H, 1970, J GEOPHYS RES, V75, P5011, DOI 10.1029/JB075i026p05011; KARATO S, 1993, J GEOPHYS RES-SOL EA, V98, P9761, DOI 10.1029/93JB00472; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; LARSON K, 1977, J GEOPHYS RES, V102, P9961; MCNUTT MK, 1982, GEOPHYS J ROY ASTR S, V71, P363, DOI 10.1111/j.1365-246X.1982.tb05994.x; MELOSH HJ, 1976, J GEOPHYS RES, V81, P5621, DOI 10.1029/JB081i032p05621; MIYASHITA K, 1987, J PHYS EARTH, V35, P449, DOI 10.4294/jpe1952.35.449; NISHENKO SP, 1990, J GEOPHYS RES-SOLID, V95, P2511, DOI 10.1029/JB095iB03p02511; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Piersanti A, 1997, J GEOPHYS RES-SOL EA, V102, P477, DOI 10.1029/96JB01909; POLLITZ FF, 1994, J PHYS EARTH, V42, P1, DOI 10.4294/jpe1952.42.1; Pollitz FF, 1997, J GEOPHYS RES-SOL EA, V102, P17921, DOI 10.1029/97JB01277; Pollitz FF, 1996, J GEOPHYS RES-SOL EA, V101, P17771, DOI 10.1029/96JB01074; PRESS F, 1995, J GEOPHYS RES-SOL EA, V100, P6421, DOI 10.1029/95JB00316; ROMANOWICZ B, 1993, SCIENCE, V260, P1923, DOI 10.1126/science.260.5116.1923; RYDELEK PA, 1988, NATURE, V336, P234, DOI 10.1038/336234a0; RYDELEK PA, 1990, GEOPHYS J INT, V100, P39, DOI 10.1111/j.1365-246X.1990.tb04566.x; SANDERS CO, 1993, SCIENCE, V260, P973, DOI 10.1126/science.260.5110.973; SAVAGE JC, 1971, J GEOPHYS RES, V76, P1954, DOI 10.1029/JB076i008p01954; SAVAGE JC, 1995, J GEOPHYS RES-SOL EA, V100, P12691, DOI 10.1029/95JB01155; SAVOSTIN LA, 1981, TECTONOPHYSICS, V74, P111, DOI 10.1016/0040-1951(81)90131-1; SCHELL MM, 1989, PHYS EARTH PLANET IN, V54, P241, DOI 10.1016/0031-9201(89)90246-X; SENO T, 1980, PHYS EARTH PLANET IN, V23, P39, DOI 10.1016/0031-9201(80)90081-3; SHIMAZAKI K, 1975, PHYS EARTH PLANET IN, V9, P314, DOI 10.1016/0031-9201(74)90059-4; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Sykes L. R., 1974, Geodynamics of Iceland and the North Atlantic area, P207; SYKES LR, 1965, B SEISMOL SOC AM, V55, P501; TABEI T, 1989, J PHYS EARTH, V37, P101, DOI 10.4294/jpe1952.37.101; THATCHER W, 1980, J GEOPHYS RES, V85, P6429, DOI 10.1029/JB085iB11p06429; *US GEOL SURV, 1998, NAT EARTHQ INF CTR C; WATTS AB, 1980, NATURE, V283, P532, DOI 10.1038/283532a0; WU FT, 1973, J GEOPHYS RES, V78, P6082, DOI 10.1029/JB078i026p06082	64	155	159	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1245	1249		10.1126/science.280.5367.1245	http://dx.doi.org/10.1126/science.280.5367.1245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596574				2022-12-28	WOS:000073852500043
J	Webb, SC; Forsyth, DW				Webb, SC; Forsyth, DW			Structure of the upper mantle under the EPR from waveform inversion of regional events	SCIENCE			English	Article							VELOCITY; PACIFIC; TOMOGRAPHY; ANISOTROPY	Waveform inversions of seismograms recorded at the Mantle Electromagnetic and Tomography (MELT) Experiment ocean bottom seismometer array from regional events with paths following the East Pacific Rise (EPR) require that low shear velocities (<3.7 km/s) extend to depths of more than 100 km below the rise axis. Velocities increase with average crustal age along ray paths. The reconciliation of Love and Rayleigh wave data requires that shear flow has aligned melt pockets or olivine crystals, creating an anisotropic uppermost mantle.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Brown University	Webb, SC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	scwebb@ucsd.edu		Webb, Spahr/0000-0002-7277-174X				ANDERSON DL, 1982, GEOPHYS J ROY ASTR S, V69, P383, DOI 10.1111/j.1365-246X.1982.tb04956.x; CARA M, 1979, GEOPHYS J ROY ASTR S, V57, P649, DOI 10.1111/j.1365-246X.1979.tb06783.x; DING XY, 1993, J GEOPHYS RES-SOL EA, V98, P1973, DOI 10.1029/92JB02175; DZIEWONSKI AM, 1983, J GEOPHYS RES, V88, P3247, DOI 10.1029/JB088iB04p03247; Ekstrom G, 1997, J GEOPHYS RES-SOL EA, V102, P8137, DOI 10.1029/96JB03729; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; FRIEDERICH W, 1994, GEOPHYS J INT, V119, P931, DOI 10.1111/j.1365-246X.1994.tb04026.x; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; LEVEQUE JJ, 1991, GEOPHYS J INT, V104, P565, DOI 10.1111/j.1365-246X.1991.tb05702.x; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; Park J, 1996, GEOPHYS J INT, V126, P173, DOI 10.1111/j.1365-246X.1996.tb05276.x; PARK J, 1993, SCIENCE, V261, P1159, DOI 10.1126/science.261.5125.1159; RANDALL GE, 1994, GEOPHYS J INT, V118, P245, DOI 10.1111/j.1365-246X.1994.tb04687.x; ROMANOWICZ B, 1991, ANNU REV EARTH PL SC, V19, P77, DOI 10.1146/annurev.ea.19.050191.000453; SU WJ, 1992, NATURE, V360, P149, DOI 10.1038/360149a0; WOODWARD RL, 1991, J GEOPHYS RES-SOLID, V96, P6351, DOI 10.1029/90JB01445; Xu YB, 1997, J GEOPHYS RES-SOL EA, V102, P27439, DOI 10.1029/97JB02564; Zhang YS, 1996, J GEOPHYS RES-SOL EA, V101, P8415, DOI 10.1029/96JB00167; Zhao DP, 1997, SCIENCE, V278, P254, DOI 10.1126/science.278.5336.254	20	55	55	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1227	1229		10.1126/science.280.5367.1227	http://dx.doi.org/10.1126/science.280.5367.1227			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596568				2022-12-28	WOS:000073852500037
J	Westphal, RS; Anderson, KA; Means, AR; Wadzinski, BE				Westphal, RS; Anderson, KA; Means, AR; Wadzinski, BE			A signaling complex of Ca2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A	SCIENCE			English	Article							TRANSCRIPTION FACTOR NFAT1; T-LYMPHOCYTES; CREB; PHOSPHORYLATION; ACTIVATION; AUTOPHOSPHORYLATION; DEPHOSPHORYLATION; PROLIFERATION; EXPRESSION; ANTIGENS	Stimulation of T lymphocytes results in a rapid increase in intracellular calcium concentration ([Ca2+](i)) that parallels the activation of Ca2+-calmodulin-dependent protein kinase IV (CaMKIV), a nuclear enzyme that can phosphorylate and activate the cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB). However, inactivation of CaMKIV occurs despite the sustained increase in [Ca2+](i) that is required for T cell activation. A stable and stoichiometric complex of CaM KIV with protein serine-threonine phosphatase 2A (PP2A) was identified in wh ich PP2A dephosphorylates CaMKIV and functions as a negative regulator of CaMKIV signaling. In Jurkat T cells, inhibition of PP2A activity by small t antigen enhanced activation of CREB-mediated transcription by CaMKIV. These findings reveal an intracellular signaling mechanism whereby a protein serine-threonine kinase (CaMKIV) is regulated by a tightly associated protein serine-threonine phosphatase (PP2A).	Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Vanderbilt University; Duke University	Wadzinski, BE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA.				NICHD NIH HHS [HD07503] Funding Source: Medline; NIGMS NIH HHS [GM51366, GM33976] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051366, R56GM051366, R01GM033976] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON K, UNPUB; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; KAMESHITA I, 1993, J BIOCHEM-TOKYO, V113, P583, DOI 10.1093/oxfordjournals.jbchem.a124087; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCDONALD OB, 1993, J BIOL CHEM, V268, P10054; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WESTPHAL R, UNPUB	32	219	226	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1258	1261		10.1126/science.280.5367.1258	http://dx.doi.org/10.1126/science.280.5367.1258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596578				2022-12-28	WOS:000073852500047
J	Wolfe, CJ; Solomon, SC				Wolfe, CJ; Solomon, SC			Shear-wave splitting and implications for mantle flow beneath the MELT region of the East Pacific Rise	SCIENCE			English	Article							ANISOTROPY; LITHOSPHERE; RIDGES	Shear-wave splitting across the fast-spreading East Pacific Rise has been measured from records of SKS and SKKS phases on the ocean-bottom seismometers of the Mantle Electromagnetic and Tomography (MELT) Experiment. The direction of fast shear-wave polarization is aligned parallel to the spreading direction. Delay times between fast and slow shear waves are asymmetric across the rise, and off-axis values on the Pacific Plate are twice those on the Nazca Plate. Splitting on the Pacific Plate may reflect anisotropy associated with spreading-induced flow above a depth of about 100 km, as well as a deeper contribution from warm asthenospheric return flow from the Pacific Superswell region.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Woods Hole Oceanographic Institution; Carnegie Institution for Science	Wolfe, CJ (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.		Wolfe, Cecily/E-7874-2011	Wolfe, Cecily/0000-0003-3144-5697				Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; Blackman DK, 1997, PHILOS T R SOC A, V355, P217, DOI 10.1098/rsta.1997.0007; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V76, P89, DOI 10.1111/j.1365-246X.1984.tb05025.x; COCHRAN JR, 1986, GEOPHYS J INT, V87, P421, DOI 10.1111/j.1365-246X.1986.tb06631.x; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; KENDALL JM, 1994, GEOPHYS RES LETT, V21, P301, DOI 10.1029/93GL02791; MAINPRICE D, 1993, PHYS EARTH PLANET IN, V78, P257, DOI 10.1016/0031-9201(93)90160-B; MCNUTT MK, 1990, SCIENCE, V248, P969, DOI 10.1126/science.248.4958.969; MEADE C, 1995, GEOPHYS RES LETT, V22, P1293, DOI 10.1029/95GL01091; MORGAN JP, 1992, NATURE, V359, P524, DOI 10.1038/359524a0; Scheirer DS, 1998, SCIENCE, V280, P1221, DOI 10.1126/science.280.5367.1221; SILVER PG, 1994, GEOPHYS J INT, V119, P949, DOI 10.1111/j.1365-246X.1994.tb04027.x; SILVER PG, 1991, J GEOPHYS RES-SOL EA, V96, P16429, DOI 10.1029/91JB00899; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; VINNIK LP, 1989, GEOPHYS J INT, V99, P549, DOI 10.1111/j.1365-246X.1989.tb02039.x; Wolfe CJ, 1998, J GEOPHYS RES-SOL EA, V103, P749, DOI 10.1029/97JB02023	19	155	156	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1230	1232		10.1126/science.280.5367.1230	http://dx.doi.org/10.1126/science.280.5367.1230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596569				2022-12-28	WOS:000073852500038
J	Zuany-Amorim, C; Ruffie, C; Haile, S; Vargaftig, BB; Pereira, P; Pretolani, M				Zuany-Amorim, C; Ruffie, C; Haile, S; Vargaftig, BB; Pereira, P; Pretolani, M			Requirement for gamma delta T cells in allergic airway inflammation	SCIENCE			English	Article							EOSINOPHILIC INFLAMMATION; IMMUNE-RESPONSES; TRANSGENIC MICE; IN-VIVO; ASTHMA; INTERLEUKIN-4; IGE; RECRUITMENT; LYMPHOCYTE; THYMOCYTES	The factors that contribute to allergic asthma are unclear but the resulting condition is considered a consequence of a type-2 T helper (T(H)2) cell response. In a model of pulmonary allergic inflammation, mice that lacked gamma delta T cells had decreases in specific immunoglobulin E (IgE) and IgG1 and pulmonary interleukin-5 (IL-5) release as well as in eosinophil and T cell infiltration compared with wild-type mice. These responses were restored by administration of IL-4 to gamma delta T cell-deficient mice during the primary immunization. Thus, gamma delta T cells are essential for inducing IL-4-dependent IgE and IgG1 responses and for T(H)2-mediated airway inflammation to peptidic antigens.	Inst Pasteur, Unite Pharmacol Cellulaire, U485, Paris, France; Inst Pasteur, Immunol Unit, CNRS, URA 1961, Paris, France; Inst Pasteur, Hepatol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pretolani, M (corresponding author), Inst Pasteur, Unite Pharmacol Cellulaire, U485, Paris, France.		Pereira, Pablo/M-7224-2014; Pretolani, Marina/G-6643-2017; Vargaftig, Bernardo Boris B.B.J./C-3323-2013	Pereira, Pablo/0000-0003-1784-2776				ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chvatchko Y, 1996, J EXP MED, V184, P2353, DOI 10.1084/jem.184.6.2353; CORRY DB, 1996, J EXP MED, V183, P1; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUNG TT, 1995, AM J RESP CELL MOL, V12, P404, DOI 10.1165/ajrcmb.12.4.7695919; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Vicari AP, 1996, EUR J IMMUNOL, V26, P1424, DOI 10.1002/eji.1830260704; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; ZuanyAmorim C, 1996, J IMMUNOL, V157, P377; ZUANYAMORIM C, 1995, J CLIN INVEST, V95, P2644, DOI 10.1172/JCI117966	28	228	237	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1265	1267		10.1126/science.280.5367.1265	http://dx.doi.org/10.1126/science.280.5367.1265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596580				2022-12-28	WOS:000073852500049
J	Ross, RT; Mathiesen, R				Ross, RT; Mathiesen, R			Volitional and emotional supranuclear facial weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Manchester, Winnipeg, MB R3A 1R9, Canada; Hlth Sci Ctr, Winnipeg, MB R3A 1R9, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Ross, RT (corresponding author), Univ Manchester, Winnipeg, MB R3A 1R9, Canada.								0	14	14	1	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1515	1515		10.1056/NEJM199805213382105	http://dx.doi.org/10.1056/NEJM199805213382105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9593790				2022-12-28	WOS:000073699100005
J	Russell, CT; Khurana, KK; Huddleston, DE; Kivelson, MG				Russell, CT; Khurana, KK; Huddleston, DE; Kivelson, MG			Localized reconnection in the near Jovian magnetotail	SCIENCE			English	Article								The oppositely directed magnetic field in the jovian magnetic tail is expected eventually to reconnect across the current sheet, allowing plasma produced deep inside the magnetosphere near lo's orbit to escape in the antisolar direction down the tail. The Galileo spacecraft found localized regions of strong northward and southward field components beyond about 50 jovian radii in the postmidnight, predawn sector of the jovian magnetosphere. These pockets of vertical magnetic fields can be stronger than the surrounding magnetotail and magnetodisk fields. They may result from episodic reconnection of patches of the near jovian magnetotail.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Russell, CT (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.		Kivelson, Margaret G/I-9019-2012; Russell, Christopher T/E-7745-2012	Kivelson, Margaret G/0000-0003-3859-8581; Russell, Christopher T/0000-0003-1639-8298; Khurana, Krishan/0000-0002-2856-1171				Acuna M. H., 1983, PHYSICS JOVIAN MAGNE, P1, DOI [10. 1017/cbo9780511564574. 003, DOI 10.1017/CBO9780511564574.003]; BALOGH A, 1992, SCIENCE, V257, P1515, DOI 10.1126/science.257.5076.1515; Hill T. W., 1983, PHYSICS JOVIAN MAGNE, P353, DOI DOI 10.1017/CBO9780511564574.012; HUDDLESTON DE, IN PRESS J GEOPHYS R; Khurana KK, 1997, J GEOPHYS RES-SPACE, V102, P11295, DOI 10.1029/97JA00563; KIVELSON MG, 1992, SPACE SCI REV, V60, P357, DOI 10.1007/BF00216862; KRUPP N, 1997, EOS S, V78, pF470; RUSSELL CT, 1973, SPACE SCI REV, V15, P205, DOI 10.1007/BF00169321; SMITH EJ, 1979, JUPITER, P788; Vasyliunas V.M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI [10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013, 10.1017/cbo9780511564574.013]	10	95	95	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1061	1064		10.1126/science.280.5366.1061	http://dx.doi.org/10.1126/science.280.5366.1061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582116				2022-12-28	WOS:000073663600042
J	Kanopka, A; Muhlemann, O; Petersen-Mahrt, S; Estmer, C; Ohrmalm, C; Akusjarvi, G				Kanopka, A; Muhlemann, O; Petersen-Mahrt, S; Estmer, C; Ohrmalm, C; Akusjarvi, G			Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins	NATURE			English	Article							PRE-MESSENGER-RNA; PHOSPHORYLATION; TRANSCRIPTION; INFECTION; SITES; LEVEL	SR proteins are a family of essential splicing factors required for early recognition of splice sites during spliceosome assembly(1,2). They also function as alternative RNA splicing factors when overexpressed in vivo or added in excess to extracts in vitro(1,2). SR proteins are highly phosphorylated in vivo, a modification that is required for their function in spliceosome assembly(3,4) and splicing catalysis(5,6). Here we show that SR proteins purified from late adenovirus-infected cells are inactivated as splicing enhancer or splicing repressor proteins by virus-induced dephosphorylation. We further show that the virus-encoded protein E4-ORF4 activates dephosphorylation by protein phosphatase 2A of HeLa SR proteins and converts their splicing properties into that of SR proteins purified from late adenovirus-infected cells. Taken together, our results suggest that E4-ORF4 is an important factor controlling the temporal shift in adenovirus alternative RNA splicing,We conclude that alternative pre-mRNA splicing, like many other biological processes, is regulated by reversible protein phosphorylation.	Univ Uppsala, BMC, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden	Uppsala University	Akusjarvi, G (corresponding author), Univ Uppsala, BMC, Dept Med Biochem & Microbiol, Box 582, S-75123 Uppsala, Sweden.			Ohrmalm, Christina/0000-0002-3287-3549				Bondesson M, 1996, J VIROL, V70, P3844, DOI 10.1128/JVI.70.6.3844-3851.1996; CAO W, 1997, RNA, V3, P1; FU XD, 1995, RNA, V1, P663; HIMMELSPACH M, 1995, RNA, V1, P794; IMPERIALE M, 1995, CURR TOP MICROBIOL, P139; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; KREIVI JP, 1994, NUCLEIC ACIDS RES, V22, P332, DOI 10.1093/nar/22.3.332; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Moore DD, 1995, GLOB MOB SURV; MUHLEMANN O, 1995, J VIROL, V69, P7324; MULLER U, 1992, J VIROL, V66, P5867; OHMAN K, 1993, VIROLOGY, V194, P50, DOI 10.1006/viro.1993.1234; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	19	165	169	1	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					185	187		10.1038/30277	http://dx.doi.org/10.1038/30277			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603524				2022-12-28	WOS:000073619900053
J	Bernabei, R; Landi, F; Gambassi, G; Sgadari, J; Zuccala, G; Mor, V; Rubenstein, LZ; Carbonin, P				Bernabei, R; Landi, F; Gambassi, G; Sgadari, J; Zuccala, G; Mor, V; Rubenstein, LZ; Carbonin, P			Randomised trial of impact of model of integrated care and case management for older people living in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM-CARE; HOME; PROGRAM	Objective: To elaluate the impact of a programme of integrated social and medical care among frail elderly people lining in the community. Design: Randomised study with 1 year follow up. Setting: Town in northern Italy (Rovereto). Subjects: 200 older people already receiving conventional community care services. Intervention: Random allocation to an intervention group receiving integrated social and medical care and case management or to a control group receiving conventional care. Main outcome measures: Admission to an institution, use and costs of health services, variations in functional status. Results: Survival analysis showed that admission to hospital or nursing home in the intervention group occurred later and was less common than in controls (hazard ratio 0.69; 95% confidence internal 0.53 to 0.91). Health services were used to the same extent, but control subjects received more frequent home visits by general practitioners. In the intervention group the estimated financial savings were in the order of pound 1125 ($1800) per year of follow up. The intervention group had improved physical function (activities of daily living score improved by 5.1% v 13.0% loss in controls; P < 0.001). Decline of cognitive status (measured bt the short portable mental status questionnaire) was also reduced (3.8% v 9.4%; P < 0.05). Conclusion: Integrated social and medical care with case management programmes may provide a cost effective approach to reduce admission to institutions and functional decline in older people living in the community.	Univ Cattolica Sacro Cuore, Ist Med Interna & Geriatr, I-00168 Rome, Italy; Brown Univ, Ctr Gerontol & Hlth Care Res, Dept Community Hlth, Sch Med, Providence, RI 02912 USA; Univ Calif Los Angeles, Sch Med, Ctr Geriatr Res Educ & Clin, Sepulveda, CA 91343 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Brown University; Geriatric Research Education & Clinical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bernabei, R (corresponding author), Univ Cattolica Sacro Cuore, Ist Med Interna & Geriatr, I-00168 Rome, Italy.	md0516@mclink.it	Bernabei, Roberto/AAB-2704-2019; Zuccalà, Giuseppe/AAC-4677-2022	Bernabei, Roberto/0000-0002-9197-004X; Zuccalà, Giuseppe/0000-0002-2567-2220; Rubenstein, Laurence/0000-0001-5910-0266				ABATE G, 1992, REALTA PROSPETTIVE S, P53; *AM GER SOC PUBL P, 1991, J AM GERIATR SOC, V39, P429; APPLEBAUM RA, 1988, GERONTOLOGIST, V28, P172, DOI 10.1093/geront/28.2.172; Black D, 1997, BRIT MED J, V315, P441, DOI 10.1136/bmj.315.7106.441; Black N, 1996, BRIT MED J, V312, P1215; BULA CJ, 1995, J AM GERIATR SOC, V43, P1016; COLEMAN BJ, 1995, INT J HEALTH SERV, V25, P455, DOI 10.2190/FYP6-DLWY-WKKT-6NNJ; HING E, 1991, AM J PUBLIC HEALTH, V81, P223, DOI 10.2105/AJPH.81.2.223; HOLLANDER MJ, 1995, AGING-CLIN EXP RES, V7, P94, DOI 10.1007/BF03324298; KANE RL, 1995, JAMA-J AM MED ASSOC, V273, P1690, DOI 10.1001/jama.273.21.1690; Khaw KT, 1997, LANCET, V350, P53; Landi F, 1996, AGING-CLIN EXP RES, V8, P211, DOI 10.1007/BF03339679; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RUBENSTEIN LZ, 1995, GERIATRIC ASSESSMENT, P1; SALVAGE AV, 1989, AGE AGEING, V18, P380, DOI 10.1093/ageing/18.6.380; STEEL K, 1991, ARCH INTERN MED, V151, P439, DOI 10.1001/archinte.151.3.439; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	18	274	280	1	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1348	1351		10.1136/bmj.316.7141.1348	http://dx.doi.org/10.1136/bmj.316.7141.1348			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZL882	9563983	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073483000015
J	Eccles, M; Freemantle, N; Mason, J				Eccles, M; Freemantle, N; Mason, J		N England ACE inhibitor Guideline Dev Grp	North of England evidence based development project: guideline for angiotensin converting-enzyme inhibitors in primary care management of adults with symptomatic heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; LEFT-VENTRICULAR DYSFUNCTION; DOUBLE-BLIND; MYOCARDIAL-INFARCTION; EXERCISE PERFORMANCE; LONG-TERM; MULTICENTER TRIAL; ACE-INHIBITORS; CAPTOPRIL; MILD		Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ York, Ctr Hlth Econ, York, N Yorkshire, England	Newcastle University - UK; University of York - UK	Eccles, M (corresponding author), Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	Martin.Eccles@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020; Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Freemantle, Nick/0000-0001-5807-5740				*AG HLTH CAR POL R, 1994, CLIN PRACT GUID, V11; [Anonymous], 1988, JAMA, V259, P539; [Anonymous], 1997, UNIT COSTS HLTH SOCI; BALL SG, 1993, LANCET, V342, P821; BARABINO A, 1991, CARDIOLOGY, V78, P243, DOI 10.1159/000174791; *BRIT MED ASS ROYA, 1996, BRIT NAT FORM, V32; BROWN EJ, 1995, AM J CARDIOL, V75, P596, DOI 10.1016/S0002-9149(99)80624-9; BUSSMANN WD, 1987, J CARDIOVASC PHARM, V9, pS50, DOI 10.1097/00005344-198700002-00012; CLARKE KW, 1994, BRIT HEART J, V71, P584; CLELAND JG, 1995, EUR HEART J, V16, P741; CLELAND JGF, 1985, BRIT HEART J, V54, P305; COHN JN, 1983, J AM COLL CARDIOL, V2, P755; COLFER HT, 1992, AM J CARDIOL, V70, P354, DOI 10.1016/0002-9149(92)90618-9; DEBOCK VD, 1994, J GERONTOL, V49, pM148, DOI 10.1093/geronj/49.3.M148; *DEP HLTH, 1995, HOSP EP STAT 1993 4; *DEP HLTH OFF POP, 1994, GOV EXP PLANS 1994 9; DICKSTEIN K, 1991, J AM COLL CARDIOL, V18, P596, DOI 10.1016/0735-1097(91)90619-K; DOSSEGGER L, 1993, EUR HEART J, V14, P18, DOI 10.1093/eurheartj/14.suppl_C.18; DREXLER H, 1989, CIRCULATION, V79, P491, DOI 10.1161/01.CIR.79.3.491; Eccles M, 1998, BRIT MED J, V316, P1232, DOI 10.1136/bmj.316.7139.1232; *EN CONG HEART FAI, 1987, HEART FAIL, V3, P102; FRANK GJ, 1989, CARDIOLOGY, V76, P56, DOI 10.1159/000174560; GALCERATOMAS J, 1993, EUR HEART J, V14, P259, DOI 10.1093/eurheartj/14.2.259; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GILBERT EM, 1993, CIRCULATION, V88, P472, DOI 10.1161/01.CIR.88.2.472; GILES TD, 1990, CIRCULATION, V82, P323; GORDON M, 1991, EVALUATION EFFICACY; *HEALTHC FIN MAN A, 1997, HLTH SERV FIN DAT 19; Karrison TG, 1997, CONTROL CLIN TRIALS, V18, P151, DOI 10.1016/S0197-2456(96)00089-X; KEREN G, 1992, CARDIOLOGY, V81, P196, DOI 10.1159/000175805; KLEBER FX, 1992, BRIT HEART J, V67, P289; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; LECHAT P, 1993, AM HEART J, V126, P798, DOI 10.1016/0002-8703(93)90933-Z; LEMARIE JC, 1992, MULTICENTRE DOUBLE B; MAASS L, 1991, EVALUATION EFFECT RA; MAASS L, 1991, EFFICACY SAFETY RAMI; MAASS L, 1991, DOUBLE BLIND COMP TR; MAGNANI B, 1986, POSTGRAD MED J, V62, P153; Mair FS, 1996, BRIT J GEN PRACT, V46, P77; MCCORMICK A, 1995, MORB STAT GEN PR MB5; MCGARRY R, 1991, GHBA194 CIB PHARM; MCMURRAY J, 1993, BR J MED EC, V6, P99; *N ENGL EV BAS GUI, 1997, EV BAS CLIN PRACT GU; Narang R, 1996, EUR HEART J, V17, P120; NICHOLLS MG, 1984, BRIT J CLIN PHARMACO, V18, pS163, DOI 10.1111/j.1365-2125.1984.tb02594.x; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; NORTHRIDGE DB, 1993, EUR HEART J, V14, P403, DOI 10.1093/eurheartj/14.3.403; ONEILL CJA, 1988, EUR J CLIN PHARMACOL, V35, P143, DOI 10.1007/BF00609243; PARAMESHWAR J, 1992, BRIT J GEN PRACT, V42, P287; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; POULEUR H, 1993, BASIC RES CARDIOL, V88, P203; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; RIEGGER GAJ, 1990, J CARDIOVASC PHARM, V15, pS41, DOI 10.1097/00005344-199000152-00008; ROGERS WJ, 1994, J AM COLL CARDIOL, V23, P393, DOI 10.1016/0735-1097(94)90426-X; RUCINSKA EJ, 1991, ENALAPRIL VS PLACEBO; RUCINSKA EJ, 1991, DOUBL BLIND PLAC CON; RUCKINSKA EJ, 1991, LISINOPRIL 1 LINE TH; SEINO Y, 1995, CARDIOLOGY, V86, P34, DOI 10.1159/000176828; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; SWEDBERG K, 1991, CIRCULATION, V57, P226; UPRICHARD A, 1994, 12 WEEK DOUBLE BLIND; UPRICHARD A, 1994, 16 WEEK DOUBLE BLIND; UPRICHARD A, 1994, 18 WEEK DOUBLE BLIND; WHEELDON NM, 1993, Q J MED, V86, P17; WIDIMSKY J, 1995, EUR J CLIN PHARMACOL, V49, P95, DOI 10.1007/BF00192366; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; ZWEHL W, 1990, FOCUS CLIN EFFECTS L, P3140	67	55	56	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	1998	316	7141					1369	1375		10.1136/bmj.316.7141.1369	http://dx.doi.org/10.1136/bmj.316.7141.1369			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563995	Green Published			2022-12-28	WOS:000073483000027
J	Hemingway, H; Shipley, M; Christie, D; Marmot, M				Hemingway, H; Shipley, M; Christie, D; Marmot, M			Is cardiothoracic ratio in healthy middle aged men an independent predictor of coronary heart disease mortality? Whitehall study 25 year follow up	BRITISH MEDICAL JOURNAL			English	Article									Univ Newcastle, Dept Environm & Occupat Hlth, Newcastle, NSW 2308, Australia; Kensington Chelsea & Westminster Hlth Author, Dept Res & Dev, London W2 6LX, England; UCL, Sch Med, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England	University of Newcastle; University of London; University College London; UCL Medical School	Hemingway, H (corresponding author), UCL, Sch Med, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, Mortimer St, London WC1E 6BT, England.	h.hemingway@public-health.ucl.ac.uk	Hemingway, Harry/C-1219-2009; Marmot, M G/Y-3920-2019	Hemingway, Harry/0000-0003-2279-0624; Marmot, M G/0000-0002-2431-6419	Medical Research Council [G8802774] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CHAMBERS J, 1995, BRIT MED J, V311, P273, DOI 10.1136/bmj.311.7000.273; CHRISTIE D, 1978, ACTA RADIOL DIAGN, V19, P732, DOI 10.1177/028418517801900503; DAVIS JL, 1986, AM J CARDIOL, V58, P658, DOI 10.1016/0002-9149(86)90300-0; RAUTAHARJU PM, 1988, AM J CARDIOL, V62, P59, DOI 10.1016/0002-9149(88)91365-3; REID DD, 1974, LANCET, V1, P469	5	13	13	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1353	1354		10.1136/bmj.316.7141.1353	http://dx.doi.org/10.1136/bmj.316.7141.1353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563985	Green Published, Green Submitted			2022-12-28	WOS:000073483000018
J	Kilpatrick, ES				Kilpatrick, ES			Has the BMJ discovered an end to ageing?	BRITISH MEDICAL JOURNAL			English	Letter									Royal Manchester Childrens Hosp, Manchester M27 4HA, Lancs, England	Royal Manchester Children's Hospital	Kilpatrick, ES (corresponding author), Royal Manchester Childrens Hosp, Manchester M27 4HA, Lancs, England.							Kilpatrick ES, 1996, QJM-MON J ASSOC PHYS, V89, P307; Thompson Della, 1995, CONCISE OXFORD DICT, V9th	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1384	1384		10.1136/bmj.316.7141.1384	http://dx.doi.org/10.1136/bmj.316.7141.1384			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9564001	Green Published			2022-12-28	WOS:000073483000036
J	Surani, MA				Surani, MA			Imprinting and the initiation of gene silencing in the germ line	CELL			English	Review							ESTABLISHMENT; EXPRESSION; MOUSE		Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England	University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England.			Surani, Azim/0000-0002-8640-4318	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; Barlow DP, 1997, EMBO J, V16, P6899, DOI 10.1093/emboj/16.23.6899; Bishop CP, 1996, GENETICA, V97, P33, DOI 10.1007/BF00132578; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Elson DA, 1997, MOL CELL BIOL, V17, P309, DOI 10.1128/MCB.17.1.309; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lyko F, 1997, NAT GENET, V16, P171, DOI 10.1038/ng0697-171; LYKO F, 1998, IN PRESS P NATL ACAD; Mertineit C, 1998, DEVELOPMENT, V125, P889; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; REIK W, 1998, IN PRESS CURR OPIN G; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	21	268	279	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 1	1998	93	3					309	312		10.1016/S0092-8674(00)81156-3	http://dx.doi.org/10.1016/S0092-8674(00)81156-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590162	Bronze			2022-12-28	WOS:000073471500003
J	Brooke, NM; Garcia-Fernandez, J; Holland, PWH				Brooke, NM; Garcia-Fernandez, J; Holland, PWH			The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster	NATURE			English	Article							HOMEOBOX GENES; MOUSE CHROMOSOME-5; DROSOPHILA; EXPRESSION; INSIGHTS; ZOOTYPE; EMBRYOS; IPF1	Genes of the Hox cluster are restricted to the animal kingdom and play a central role in axial patterning in divergent animal phyla(1). Despite its evolutionary and developmental significance, the origin of the Hox gene cluster is obscure. The consensus is that a primordial Hox cluster arose by tandem gene duplication close to animal origins(2-5). Several homeobox genes with high sequence identity to Hox genes are found outside the Hox cluster and are known as 'dispersed' Hox-like genes; these genes may have been transposed away from an expanding clusters. Here we show that three of these dispersed homeobox genes form a novel gene cluster in the cephalochordate amphioxus, We argue that this 'ParaHox' gene cluster is an ancient paralogue (evolutionary sister) of the Hox gene cluster; the two gene clusters arose by duplication of a ProtoHox gene cluster. Furthermore, we show that amphioxus ParaHox genes have co-linear developmental expression patterns in anterior, middle and posterior tissues. We propose that the origin of distinct Hox and ParaHox genes by gene-duster duplication facilitated an increase in body complexity during the Cambrian explosion.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain	University of Reading; University of Barcelona	Holland, PWH (corresponding author), Univ Reading, Sch Anim & Microbial Sci, POB 228, Reading RG6 6AJ, Berks, England.		Garcia-Fernandez, Jordi/B-3839-2013	Garcia-Fernandez, Jordi/0000-0001-5677-5970; Holland, Peter/0000-0003-1533-9376				Averof M, 1996, SEMIN CELL DEV BIOL, V7, P539, DOI 10.1006/scdb.1996.0068; Burglin Thomas R., 1994, P25; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; FELSENSTEIN J, 1993, PHYLIP VERSION 3 5C; FIEDOREK FT, 1995, GENOMICS, V28, P581, DOI 10.1006/geno.1995.1193; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GORBMAN A, 1983, AM ZOOL, V23, P639; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; Irvine SQ, 1997, MOL PHYLOGENET EVOL, V7, P331, DOI 10.1006/mpev.1997.0407; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KAPPEN C, 1989, P NATL ACAD SCI USA, V86, P5458; KOZAK CA, 1994, MAMM GENOME, V5, pS65; LEHRACH H, 1990, GENOME ANAL, V1, P38; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; MILLER DJ, 1993, NATURE, V365, P215, DOI 10.1038/365215b0; MORRIS SC, 1994, DEVELOPMENT, P1; Offield MF, 1996, DEVELOPMENT, V122, P983; Popodi E, 1996, MOL BIOL EVOL, V13, P1078, DOI 10.1093/oxfordjournals.molbev.a025670; SCHUBERT FR, 1993, P NATL ACAD SCI USA, V90, P143, DOI 10.1073/pnas.90.1.143; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; STOFFEL M, 1995, GENOMICS, V28, P125, DOI 10.1006/geno.1995.1120; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Williams NA, 1996, NATURE, V383, P490, DOI 10.1038/383490a0; WRIGHT CVE, 1988, DEVELOPMENT, V104, P787; WYSOCKADILLER J, 1995, DEV BIOL, V171, P439, DOI 10.1006/dbio.1995.1294; Zhang JZ, 1996, GENETICS, V142, P295	30	341	354	6	37	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					920	922		10.1038/31933	http://dx.doi.org/10.1038/31933			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582071				2022-12-28	WOS:000073359900048
J	Gage, FH				Gage, FH			Cell therapy	NATURE			English	Review							HIGH-DOSE CHEMOTHERAPY; HEMATOPOIETIC STEM-CELLS; HUMAN FACTOR-IX; PARKINSONS-DISEASE; GENE-THERAPY; ARTIFICIAL PANCREAS; MAMMALIAN-CELLS; BREAST-CANCER; TRANSPLANTATION; EXPRESSION	Cell therapy has emerged as a strategy for the treatment of many human diseases. Because no single cell or universal donor is likely to be useful for all diseases, it is the source and the desired function of the eel that will dictate which cell type is most useful for each disease. Concerns related to immunological compatibility, ability to multiply cells in vitro before transplantation and general issues of quality control and safety are now being addressed by the convergence of disciplines interested in the potential for cell therapy.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							AEBISCHER P, 1986, T AM SOC ART INT ORG, V32, P134; Algvere PV, 1997, GRAEF ARCH CLIN EXP, V235, P149, DOI 10.1007/BF00941722; ANASETTI C, 1994, BLOOD, V84, pA249; Baron MS, 1996, ANN NEUROL, V40, P355, DOI 10.1002/ana.410400305; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BLAU HM, 1995, NEW ENGL J MED, V333, P1554, DOI 10.1056/NEJM199512073332308; BOON T, 1983, ADV CANCER RES, V39, P121, DOI 10.1016/S0065-230X(08)61034-9; Borlongan CV, 1996, NEUROL RES, V18, P297; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; BROXMEYER HE, 1991, BLOOD CELLS, V17, P313; CEPKO CL, 1987, ANNU REV NEUROSCI, V12, P47; CHANG PL, 1995, SOMATIC GENE THERAPY; CHEN KS, 1995, J NEUROSCI, V15, P2819; CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649; *COMM PROP MED PRO, 1989, J BIOL STAND, V17, P213; CUONO C, 1986, LANCET, V1, P1123, DOI 10.1016/S0140-6736(86)91838-6; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0; Falci S, 1997, J NEUROTRAUM, V14, P875, DOI 10.1089/neu.1997.14.875; FISHER LJ, 1993, PHYSIOL REV, V73, P583, DOI 10.1152/physrev.1993.73.3.583; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GAGE FH, 1993, NATURE, V361, P405, DOI 10.1038/361405a0; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GASPARI AA, 1988, J IMMUNOL, V140, P2956; GEPPERT TD, 1985, J IMMUNOL, V135, P3750; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V23, P268; Gouras P, 1996, VISION RES, V36, P4121, DOI 10.1016/S0042-6989(96)00180-0; GRIBBEN JG, 1991, NEW ENGL J MED, V325, P1525, DOI 10.1056/NEJM199111283252201; Grill R, 1997, J NEUROSCI, V17, P5560; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HANSBROUGH JF, 1993, WOUNDS, V5, P174; HANSBROUGH JF, 1992, SURGERY, V111, P438; HARTNER WC, 1994, TRANSPL P, V19, P476; Hay R J, 1996, Hum Cell, V9, P143; Hohlfeld Reinhard, 1997, Current Opinion in Rheumatology, V9, P520, DOI 10.1097/00002281-199711000-00007; HORWICH AL, 1991, CURR TOP MICROBIOL, V168, P185; Hoshimaru M, 1996, P NATL ACAD SCI USA, V93, P1518, DOI 10.1073/pnas.93.4.1518; JOSEPH JM, 1994, CELL TRANSPLANT, V3, P355, DOI 10.1177/096368979400300502; Kaplan HJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P1168, DOI 10.1001/archopht.1997.01100160338012; KOLLER W, 1997, TREMOR ANN NEUROL, V42, P292; KORDOWER JJ, 1997, NEW ENGL J MED, V2717, P1118; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; MAGOMETSCHNIGG H, 1992, J VASC SURG, V15, P527, DOI 10.1016/0741-5214(92)90192-B; MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Naffakh N, 1996, HUM GENE THER, V7, P11, DOI 10.1089/hum.1996.7.1-11; Naughton G, 1997, ARTIF ORGANS, V21, P1203; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; OLANOW CW, 1990, ARCH NEUROL-CHICAGO, V47, P1286, DOI 10.1001/archneur.1990.00530120030006; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; OVERTURF KM, 1997, AM J PATHOL, V151, P1078; PALMER TD, 1989, BLOOD, V73, P438; PARDOLL DM, 1993, IMMUNOL TODAY, V14, P310, DOI 10.1016/0167-5699(93)90051-L; PETERS WP, 1993, J CLIN ONCOL, V11, P1132, DOI 10.1200/JCO.1993.11.6.1132; POBER JS, 1983, NATURE, V305, P726, DOI 10.1038/305726a0; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Sabatini DM, 1997, MOL NEUROBIOL, V15, P223, DOI 10.1007/BF02740635; Sah DWY, 1997, NAT BIOTECHNOL, V15, P574, DOI 10.1038/nbt0697-574; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167; SCHILLING A, 1976, SURG GYNECOL OBSTET, V142, P29; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; SHPALL EJ, 1994, J CLIN ONCOL, V12, P28, DOI 10.1200/JCO.1994.12.1.28; Shpall Elizabeth J., 1994, Current Opinion in Oncology, V6, P135, DOI 10.1097/00001622-199403000-00004; SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843; SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124; SUSSMAN NL, 1992, HEPATOLOGY, V16, P60, DOI 10.1002/hep.1840160112; TAKAYAMA H, 1995, NAT MED, V1, P53, DOI 10.1038/nm0195-53; Taylor RM, 1997, NAT MED, V3, P771, DOI 10.1038/nm0797-771; THOMAS FH, 1991, CURR SURG, P343; THOMAS FT, 1990, TRANSPLANT P, V22, P1083; THOMAS JM, 1991, TRANSPLANT REV, V5, P209; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; UCHIDA N, 1994, BLOOD, V83, P3758; US Food and Drug Administration (FDA), 1993, POINTS CONS CHAR CEL; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899; YAO SN, 1994, GENE THER, V1, P99	94	218	275	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	1998	392	6679		S			18	24						7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK760	9579857				2022-12-28	WOS:000073360100005
J	Schriger, DL; Kalafut, M; Starkman, S; Krueger, M; Saver, JL				Schriger, DL; Kalafut, M; Starkman, S; Krueger, M; Saver, JL			Cranial computed tomography interpretation in acute stroke - Physician accuracy in determining eligibility for thrombolytic therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context.-Intracranial hemorrhage must be excluded prior to administration of thrombolytic agents in acute stroke. Objective.-To evaluate physician accuracy in cranial computed tomography scan interpretation for determining eligibility for thrombolytic therapy in acute stroke. Design.-Administration of randomly selected, randomly ordered series of 15 computed tomography scans from a pool of 54 scans that demonstrated intracerebral hemorrhage, acute infarction, intracerebral calcifications (impostor for hemorrhage), old cerebral infarction (impostor for acute infarction), and normal findings. Participants.-A convenience sample of 38 emergency physicians, 29 neurologists, and 36 general radiologists. Main Outcome Measures.-Physician determination of eligibility for thrombolytic therapy based on computed tomography scan interpretation. Results.-Average correct score by all physicians on all computed tomography scans was 77% (95% confidence interval, 74%-80%), Of 569 computed tomography readings by emergency physicians, 67% were correct; of 435 readings by neurologists, 83% were correct; and of 540 readings by radiologists, 83% were correct. Overall sensitivity for detecting hemorrhage was 82% (95% confidence interval, 78%-85%); 17% of emergency physicians, 40% of neurologists, and 52% of radiologists achieved 100% sensitivity for identification of hemorrhage. Conclusion.-Physicians in this study did not uniformly achieve a level of sensitivity for identification of intracerebral hemorrhage sufficient to permit safe selection of candidates for thrombolytic therapy.	Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Schriger, DL (corresponding author), 924 Westwood Blvd,Suite 300, Los Angeles, CA 90024 USA.	schriger@ucla.edu		Schriger, David/0000-0003-0242-1127; Saver, Jeffrey/0000-0001-9141-2251				Adams HP, 1996, STROKE, V27, P1711; Adams HP, 1996, NEUROLOGY, V47, P835; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; CANDELISE L, 1995, LANCET, V346, P1509; Chavot D, 1996, CEREBROVASC DIS, V6, P182; Donnan GA, 1996, JAMA-J AM MED ASSOC, V276, P961, DOI 10.1001/jama.276.12.961; EBEL RL, 1986, ESSENTIALS ED MEASUR, P335; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hommel M, 1996, NEW ENGL J MED, V335, P145; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; *NAT STROK ASS, 1997, STROK CLIN UPD; Nightingale SL, 1996, JAMA-J AM MED ASSOC, V276, P443; SACCO RL, 1994, CLIN ATLAS CEREBROVA; *STAT CORP, 1997, STAT STAT SOFTW REL, P235; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wainer H.W., 1990, COMPUTERIZED ADAPTIV	18	160	163	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1293	1297		10.1001/jama.279.16.1293	http://dx.doi.org/10.1001/jama.279.16.1293			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9565011	Bronze			2022-12-28	WOS:000073090300036
J	Wennberg, DE; Lucas, FL; Birkmeyer, JD; Bredenberg, CE; Fisher, ES				Wennberg, DE; Lucas, FL; Birkmeyer, JD; Bredenberg, CE; Fisher, ES			Variation in carotid endarterectomy mortality in the Medicare population - Trial hospitals, volume, and patient characteristics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STENOSIS; ATHEROSCLEROSIS; COMPLICATIONS	Context.-The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomatic Carotid Atherosclerosis Study (ACAS) demonstrated the efficacy of carotid endarterectomy (CEA) in reducing the risk of stroke and death in selected patients when surgery was performed in institutions whose participation depended on demonstrated excellence. Thirty-day mortality rates in the trials were very low: 0.6% in NASCET and 0.1% in ACAS. Objective.-To assess perioperative mortality among Medicare patients undergoing CEA in all nonfederal institutional settings. Design.-Retrospective national cohort study. Setting and Patients.-All 113 300 Medicare patients undergoing CEA during 1992 and 1993 in "trial hospitals" (those participating in NASCET and ACAS, n=86) and "nontrial hospitals" tall other nonfederal institutions performing CEAs, n=2613). Nontrial hospitals were stratified into terciles based on volume of CEAs performed. Main Outcome Measures.-Crude and adjusted perioperative (30 day) mortality rates. Results.-The perioperative mortality rate was 1.4% (95% confidence interval [CI], 1.2%-1.7%) at trial hospitals; mortality in nontrial hospitals was higher: 1.7% (95% CI, 1.6%-1.8%) thigh volume); 1.9% (95% CI, 1.7%-2.1%) (average volume); 2.5% (95% CI, 2.0%-2.9%) (low volume); (P for trend, <.001). In multivariate modeling, patients undergoing their procedures at trial hospitals had a mortality risk reduction of 15% (95% CI, 0%-31%) compared with high-volume nontrial hospitals, 25% (95% CI, 7%-40%) compared with average-volume hospitals, and 43% (95% CI, 25%-56%) compared with low-volume hospitals (P for trend, <.001). Conclusion.-Medicare patients' perioperative mortality following CEA is substantially higher than that reported in the trials, even in those institutions that participated in the randomized studies. Caution is advised in translating the efficacy of carefully controlled studies of CEA to effectiveness in everyday practice.	Maine Med Ctr, Div Hlth Serv Res, Portland, ME 04102 USA; Maine Med Ctr, Dept Surg, Portland, ME 04102 USA; Maine Med Assessment Fdn, Augusta, ME USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH 03756 USA; Dept Vet Affairs Med Ctr, White River Jct, VT USA	Maine Medical Center; Maine Medical Center; Dartmouth College	Wennberg, DE (corresponding author), Maine Med Ctr, Div Hlth Serv Res, Portland, ME 04102 USA.	wennbd@mail.mmc.org						BARNETT HJM, 1995, ANN INTERN MED, V123, P723, DOI 10.7326/0003-4819-123-9-199511010-00012; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Barnett HJM, 1996, NEUROLOGY, V46, P603, DOI 10.1212/WNL.46.3.603; BROOK RH, 1990, ANN INTERN MED, V113, P747, DOI 10.7326/0003-4819-113-10-747; BROTT T, 1995, ANN INTERN MED, V123, P720, DOI 10.7326/0003-4819-123-9-199511010-00011; DAVIDOFF F, 1995, ANN INTERN MED, V123, P729, DOI 10.7326/0003-4819-123-9-199511010-00015; DIENER HC, 1991, STROKE, V22, P1229; *EUR CAR SURG TRIA, 1996, LANCET, V347, P1592; FISHER ES, 1989, AM J PUBLIC HEALTH, V79, P1617, DOI 10.2105/AJPH.79.12.1617; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GRAVES EJ, 1997, VITAL HLTH STAT 13, V130, P124; Hertzer NR, 1996, J VASC SURG, V23, P167, DOI 10.1016/S0741-5214(05)80049-7; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; HOSMER DW, 1989, APPL LOGISTIC REGRES; HSIA DC, 1992, J VASC SURG, V16, P201, DOI 10.1016/0741-5214(92)90108-K; KISTLER JP, 1991, NEW ENGL J MED, V325, P505, DOI 10.1056/NEJM199108153250709; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Mitchell JB, 1996, HEALTH SERV RES, V31, P141; MOORE WS, 1991, STROKE, V22, P1353, DOI 10.1161/01.STR.22.11.1353; *N AM SYMPT CAR EN, 1991, STROKE, V22, P816; *NAT I NEUR DIS ST, 1994, CLIN AL CLIN ADV CAR; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sarasin FP, 1995, NEUROLOGY, V45, P2147, DOI 10.1212/WNL.45.12.2147; Stukenborg GJ, 1997, ARCH NEUROL-CHICAGO, V54, P826, DOI 10.1001/archneur.1997.00550190018009; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WENNBERG J, 1997, DARTMOUTH ATLAS HLTH; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513; World Health Organisation, 1977, INT CLASS DIS 9 REV	31	364	381	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 29	1998	279	16					1278	1281		10.1001/jama.279.16.1278	http://dx.doi.org/10.1001/jama.279.16.1278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH270	9565008	Bronze			2022-12-28	WOS:000073090300033
J	McCord, TB; Hansen, GB; Fanale, FP; Carlson, RW; Matson, DL; Johnson, TV; Smythe, WD; Crowley, JK; Martin, PD; Ocampo, A; Hibbitts, CA; Granahan, JC				McCord, TB; Hansen, GB; Fanale, FP; Carlson, RW; Matson, DL; Johnson, TV; Smythe, WD; Crowley, JK; Martin, PD; Ocampo, A; Hibbitts, CA; Granahan, JC		NIMS Team	Salts an Europa's surface detected by Galileo's Near Infrared Mapping Spectrometer	SCIENCE			English	Article							MAGNETOSPHERIC ION-BOMBARDMENT; PLAYA EVAPORITE MINERALS; AMORPHOUS SOLID WATER; MU-M; DEATH-VALLEY; SATELLITES; REFLECTANCE; SPECTRA; ICE; SPECTROSCOPY	Reflectance spectra in the 1- to 2.5-micrometer wavelength region of the surface of Europa obtained by Galileo's Near Infrared Mapping Spectrometer exhibit distorted water absorption bands that indicate the presence of hydrated minerals, The laboratory spectra of hydrated salt minerals such as magnesium sulfates and sodium carbonates and mixtures of these minerals provide a close match to the Europa spectra. The distorted bands are only observed in the optically darker areas of Europa, including the lineaments, and may represent evaporite deposits formed by water, rich in dissolved salts, reaching the surface from a water-rich layer underlying an ice crust.	Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Reston, VA 22091 USA; STI Inc, Honolulu, HI 96813 USA	University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey	McCord, TB (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.		Hibbitts, Charles/B-7787-2016	Hibbitts, Charles/0000-0001-9089-4391				Anderson JD, 1997, SCIENCE, V276, P1236, DOI 10.1126/science.276.5316.1236; CALVIN WM, 1995, J GEOPHYS RES-PLANET, V100, P19041, DOI 10.1029/94JE03349; Carlson R, 1996, SCIENCE, V274, P385, DOI 10.1126/science.274.5286.385; CARLSON RW, 1992, SPACE SCI REV, V60, P457, DOI 10.1007/BF00216865; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; CARR MH, 1997, LUNAR PLANET SCI, V28, P207; CASSEN P, 1980, GEOPHYS RES LETT, V7, P987, DOI 10.1029/GL007i011p00987; CASSEN P, 1979, GEOPHYS RES LETT, V6, P731, DOI 10.1029/GL006i009p00731; CLARK RN, 1980, ICARUS, V44, P388, DOI 10.1016/0019-1035(80)90033-0; CLARK RN, 1981, J GEOPHYS RES, V86, P3087, DOI 10.1029/JB086iB04p03087; CLARK RN, 1982, ICARUS, V49, P244, DOI 10.1016/0019-1035(82)90075-6; Crowley JK, 1996, ECON GEOL BULL SOC, V91, P622, DOI 10.2113/gsecongeo.91.3.622; CROWLEY JK, 1991, J GEOPHYS RES-SOL EA, V96, P16231, DOI 10.1029/91JB01714; CROWLEY JK, 1993, REMOTE SENS ENVIRON, V44, P337, DOI 10.1016/0034-4257(93)90025-S; FANALE FP, 1998, LUNAR PLANET SCI, V29, P1248; FANALE FP, UNPUB; FANALE FP, 1977, PLANETARY SATELLITES, P379; FINK UWE, 1975, ICARUS, V24, P411, DOI 10.1016/0019-1035(75)90058-5; Gaines R.V., 1998, DANAS NEW MINERALOGY, V120, P2693; GRANAHAN JC, 1997, B AM ASTRON SOC, V29, P982; GRANAHAN JC, 1997, EOS S, V78, pF417; GRUNDY WM, IN PRESS J GEOPHYS R; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HAGEN W, 1982, SPECTROCHIM ACTA A, V38, P1089, DOI 10.1016/0584-8539(82)80040-8; HANSEN GB, 1997, LUNAR PLANET SCI, V28, P505; HARDIE LA, 1968, GEOCHIM COSMOCHIM AC, V32, P1279, DOI 10.1016/0016-7037(68)90029-X; HOBBS PV, 1974, ICE PHYSICS; Hunt G. R., 1973, Modern Geology, V4, P85; Hunten D. M., 1971, Comments on Astrophysics and Space Physics, V3, P1; IRVINE WM, 1968, ICARUS, V8, P324, DOI 10.1016/0019-1035(68)90083-3; JOHNSON RE, 1988, ICARUS, V75, P423, DOI 10.1016/0019-1035(88)90155-8; JOHNSON TV, 1983, J GEOPHYS RES, V88, P5789, DOI 10.1029/JB088iB07p05789; JOHNSON TV, 1971, ASTROPHYS J, V169, P589, DOI 10.1086/151177; KARGEL JS, 1991, ICARUS, V94, P368, DOI 10.1016/0019-1035(91)90235-L; Kempe S, 1989, ORIGIN EVOLUTION MOD, P29; KIEFFER HH, 1974, ICARUS, V21, P506, DOI 10.1016/0019-1035(74)90153-5; KUIPER GP, 1961, SOLAR SYSTEM, V3, P305; LANE AL, 1981, NATURE, V292, P38, DOI 10.1038/292038a0; Luchitta B. K., 1982, SATELLITES JUPITER, P521; MALIN MC, 1986, SATELLITES, P689; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; McCord TB, 1997, SCIENCE, V278, P271, DOI 10.1126/science.278.5336.271; MCCORD TB, 1997, EOS T AGU S, V78, pF407; MCCORD TB, 1998, LUNAR PLANET SCI, V29, P1560; MCCORD TB, 1997, EOS S, V78, pS202; MOROZ VI, 1965, T SOVIET ASTRON A J, V9, P999; NELSON RM, 1987, ICARUS, V72, P358, DOI 10.1016/0019-1035(87)90180-1; NOLL KS, 1995, J GEOPHYS RES-PLANET, V100, P19057, DOI 10.1029/94JE03294; OCKMAN N, 1958, ADV PHYS, V7, P199, DOI 10.1080/00018735800101227; PITCHER CB, 1972, SCIENCE, V178, P1087; POLLACK JB, 1978, ICARUS, V36, P271, DOI 10.1016/0019-1035(78)90110-0; POSPIESZALSKA MK, 1989, ICARUS, V78, P1, DOI 10.1016/0019-1035(89)90065-1; REYNOLDS RT, 1983, ICARUS, V56, P246, DOI 10.1016/0019-1035(83)90037-4; SACK NJ, 1992, ICARUS, V100, P534, DOI 10.1016/0019-1035(92)90116-O; SMITH BA, 1979, SCIENCE, V206, P927, DOI 10.1126/science.206.4421.927; SQUYRES SW, 1983, NATURE, V301, P225, DOI 10.1038/301225a0; STANIER RY, 1986, MICROBIAL WORLD, P22; Swayze G., 1993, B AM ASTRON SOC, V25, P1033; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; WISCOMBE WJ, 1980, J ATMOS SCI, V37, P2712, DOI 10.1175/1520-0469(1980)037<2712:AMFTSA>2.0.CO;2	60	299	306	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1242	1245		10.1126/science.280.5367.1242	http://dx.doi.org/10.1126/science.280.5367.1242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596573				2022-12-28	WOS:000073852500042
J	Herzog, KH; Chong, MJ; Kapsetaki, M; Morgan, JI; McKinnon, PJ				Herzog, KH; Chong, MJ; Kapsetaki, M; Morgan, JI; McKinnon, PJ			Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system	SCIENCE			English	Article							ATAXIA-TELANGIECTASIA; DEFICIENT MICE; P53; APOPTOSIS; CYCLE	Ataxia telangiectasia (AT) is characterized by progressive neurodegeneration that results from mutation of the ATM gene. However, neither the normal function of ATM in the nervous system nor the biological basis of the degeneration in AT is known. Resistance to apoptosis in the developing central nervous system (CNS) of Atm(-/-) mice was observed after ionizing radiation, This lack of death occurred in diverse regions of the CNS, including the cerebellum, which is markedly affected in AT. In wild-type, but not Atm(-/-) mice, up-regulation of p53 coincided with cell death, suggesting that Atm-dependent apoptosis in the CNS is mediated by p53, Further, p53 null mice showed a similar lack of radiation-induced cell death in the developing nervous system, Atm may function at a developmental survival checkpoint that serves to eliminate neurons with excessive DNA damage.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38101 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38101 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale, Memphis, TN 38101 USA.	peter.mckinnon@stjude.org	Morgan, James/N-8104-2018; Morgan, James/GRO-2905-2022	Morgan, James/0000-0002-8920-1065	NCI NIH HHS [CA-21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Cowan W M, 1980, Curr Top Dev Biol, V15 Pt 1, P103; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Heintz N, 1996, CURR OPIN NEUROL, V9, P137, DOI 10.1097/00019052-199604000-00014; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MCKINNON PJ, 1987, HUM GENET, V75, P197, DOI 10.1007/BF00281059; MIDGLEY CA, 1992, J CELL SCI, V101, P183; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SOARES HA, IN PRESS NEUROSCIENC; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; WOOD KA, 1995, J NEUROSCI, V15, P5851; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437	29	359	372	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1089	1091		10.1126/science.280.5366.1089	http://dx.doi.org/10.1126/science.280.5366.1089			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582124				2022-12-28	WOS:000073663600050
J	Weil, MD; Lamborn, K; Edwards, MSB; Wara, WM				Weil, MD; Lamborn, K; Edwards, MSB; Wara, WM			Influence of a child's sex on medulloblastoma outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIATION-THERAPY; ADJUVANT CHEMOTHERAPY; PEDIATRIC-PATIENTS; SURVIVAL; TUMORS; VINCRISTINE; IRRADIATION; PATTERNS; GROWTH; TRIAL	Context.-Aggressive treatment of medulloblastoma, the most common pediatric brain tumor, has not improved survival. Identifying better prognostic indicators may warrant less morbid therapy. Objective.-To investigate the role of sex on outcome of medulloblastoma. Design.-Retrospective study of significant factors for survival with a median follow-up of 82 months. Setting.-University medical center. Patients.-A total of 109 consecutive, pediatric patients treated for primary medulloblastoma from 1970 to 1995 with surgery and postoperative radiotherapy and, after 1979, chemotherapy. Main Outcome Measures.-Factors independently associated with survival. Results.-The final multivariate model predicting improved survival included sex (hazard ratio, 0.52; 95% confidence interval [CI], 0.29-0.92; P=.03; favoring female), metastases at presentation (hazard ratio, 2.01,95% CI, 1.14-3.52; P=.02), and extent of surgical resection (hazard ratio, 0.60; 95% CI, 0.34-1.04; P=.07; favoring greater resection). The overall, 5-year freedom from progression was 40% and survival was 49%. Radiotherapy dose (P=.72), and chemotherapy (P=.90) did not significantly affect a disease outcome. Conclusions.-The sex of the child was an important predictor for survival of medulloblastoma; girls had a much better outcome. The difference in survival between sexes should be evaluated in prospective, clinical trials.	Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weil, MD (corresponding author), Univ Colorado, Ctr Canc, Dept Radiat Oncol, Box A031, Denver, CO 80262 USA.							AGARD ET, 1985, HEALTH PHYS, V48, P447, DOI 10.1097/00004032-198504000-00007; BLOOM HJG, 1969, AMER J ROENTGENOL RA, V105, P43, DOI 10.2214/ajr.105.1.43; BOURNE JP, 1992, J NEURO-ONCOL, V14, P263; BROWN IH, 1983, ARCH DIS CHILD, V58, P722, DOI 10.1136/adc.58.9.722; COX DR, 1972, J R STAT SOC B, V34, P187; Danjoux CE, 1996, MED PEDIATR ONCOL, V26, P1, DOI 10.1002/(SICI)1096-911X(199601)26:1<1::AID-MPO1>3.0.CO;2-Q; DIDCOCK E, 1995, J CLIN ONCOL, V13, P2503, DOI 10.1200/JCO.1995.13.10.2503; DUFFNER PK, 1985, CANCER-AM CANCER SOC, V56, P1841, DOI 10.1002/1097-0142(19851001)56:7+<1841::AID-CNCR2820561325>3.0.CO;2-C; EVANS AE, 1990, J NEUROSURG, V72, P572, DOI 10.3171/jns.1990.72.4.0572; FARWELL JR, 1984, J NEUROSURG, V61, P657, DOI 10.3171/jns.1984.61.4.0657; GARTON GR, 1990, MAYO CLIN PROC, V65, P1077, DOI 10.1016/S0025-6196(12)62720-7; HUGHES EN, 1988, CANCER, V61, P1992, DOI 10.1002/1097-0142(19880515)61:10<1992::AID-CNCR2820611011>3.0.CO;2-J; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KHALID H, 1995, CANCER, V75, P2571, DOI 10.1002/1097-0142(19950515)75:10<2571::AID-CNCR2820751026>3.0.CO;2-U; MOSS SD, 1988, NEUROSURGERY, V22, P758; NOVAKOVIC B, 1994, MED PEDIATR ONCOL, V23, P480, DOI 10.1002/mpo.2950230606; PACKER RJ, 1994, J NEUROSURG, V81, P690, DOI 10.3171/jns.1994.81.5.0690; PACKER RJ, 1991, J NEUROSURG, V74, P433, DOI 10.3171/jns.1991.74.3.0433; PRADOS MD, 1994, INT J RADIAT ONCOL, V28, P431, DOI 10.1016/0360-3016(94)90067-1; PRESTONMARTIN S, 1993, NEUROEPIDEMIOLOGY, V12, P270, DOI 10.1159/000110328; SILBER JH, 1992, J CLIN ONCOL, V10, P1390, DOI 10.1200/JCO.1992.10.9.1390; TAIT DM, 1990, EUR J CANCER, V26, P464; WARA WM, 1994, INT J RADIAT ONCOL, V30, P551, DOI 10.1016/0360-3016(92)90940-J	23	60	60	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1474	1476		10.1001/jama.279.18.1474	http://dx.doi.org/10.1001/jama.279.18.1474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600483	Bronze			2022-12-28	WOS:000073463500038
J	Wetterhall, SF; Coulombier, DM; Herndon, JM; Zaza, S; Cantwell, JD				Wetterhall, SF; Coulombier, DM; Herndon, JM; Zaza, S; Cantwell, JD		Ctrs Dis Control Prevention Olympics Surveilan	Medical care delivery at the 1996 Olympic Games	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERIENCE	Context.-Mass gatherings like the 1996 Olympic Games require medical services for large populations assembled under unusual circumstances. Objective.-To examine delivery of medical services and to provide data for planning future events. Design.-ObservationaI cohort study, with review of medical records at Olympics medical facilities. Setting.-One large multipurpose clinic and 128 medical aid stations operating at Olympics-sponsored sites in the vicinity of Atlanta, Ga. Participants.-A total of 10 715 patients, including 1804 athletes, 890 officials, 480 Olympic dignitaries, 3280 volunteers, 3482 spectators, and 779 others who received medical care from a physician at an Olympic medical station. Main Outcome Measures.-Number of injuries and cases of heat-related illness among participant categories, medical use rates among participants with official Games credentials, and use rates per 10 000 persons attending athletic competitions. Results.-Injuries, accounting for 35% of all medical visits, were more common among athletes (51.9% of their visits, P < .001) than among other groups. Injuries accounted for 31.4% of all other groups combined. Spectators and volunteers accounted for most (88.9%, P < .001) of the 1059 visits for heat-related illness. The rates for number of medical encounters treated by a physician were highest for athletes (16.2 per 100 persons, P < .001) and lowest for volunteers (2.0 per 100). Overall physician treatment rate was 4.2 per 10 000 in attendance (range, 1.6-30.1 per 10 000). A total of 432 patients were transferred to hospitals. Conclusions.-Organizers used these data during the Games to monitor the health of participants and to redirect medical and other resources to areas of increased need. These data should be useful for planning medical services for future mass gatherings.	Ctr Dis Control & Prevent, Off Program Planning & Evaluat, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA; Reseau Natl Sante Publ, Unite Syst Informat & Commun, St Maurice, France	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Wetterhall, SF (corresponding author), Ctr Dis Control & Prevent, Off Program Planning & Evaluat, MS D-45,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	sfw1@cdc.gov						BAKER WM, 1986, ANN EMERG MED, V15, P185, DOI 10.1016/S0196-0644(86)80019-1; Cantwell JD, 1996, JAMA-J AM MED ASSOC, V276, P248; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P581; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P631; DANZIG JD, 1997, JAMA-J AM MED ASSOC, V278, P431; DELORENZO RA, 1993, ANN EMERG MED, V22, P1711, DOI 10.1016/S0196-0644(05)81310-1; EHRESMANN KR, 1995, J INFECT DIS, V171, P679, DOI 10.1093/infdis/171.3.679; GOODMAN RA, 1994, JAMA-J AM MED ASSOC, V271, P862, DOI 10.1001/jama.271.11.862; KASSANOFF I, 1972, J AMER MED ASSOC, V221, P397, DOI 10.1001/jama.221.4.397; Leonard Ralph B., 1996, Emergency Medicine Clinics of North America, V14, P383, DOI 10.1016/S0733-8627(05)70257-1; Meehan P, 1998, JAMA-J AM MED ASSOC, V279, P1469, DOI 10.1001/jama.279.18.1469; *NAT CTR HLTH STAT, 1997, HLTH US 1996 97 INJ, P204; OSLER DC, 1975, CLIN PEDIATR, V14, P390, DOI 10.1177/000992287501400412; OUNANIAN LL, 1986, ANN EMERG MED, V15, P520, DOI 10.1016/S0196-0644(86)80986-6; Paul H M, 1993, JEMS, V18, P64; THOMPSON JM, 1991, ANN EMERG MED, V20, P385, DOI 10.1016/S0196-0644(05)81660-9; Tucker JB, 1997, JAMA-J AM MED ASSOC, V278, P362, DOI 10.1001/jama.278.5.362; *US OL COMM, 1997, GAM ATL REC; WEISS BP, 1988, AM J PUBLIC HEALTH, V78, P686, DOI 10.2105/AJPH.78.6.686; Woodfin B A, 1997, J Med Assoc Ga, V86, P15	20	68	73	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1463	1468		10.1001/jama.279.18.1463	http://dx.doi.org/10.1001/jama.279.18.1463			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600481				2022-12-28	WOS:000073463500036
J	Beecham, L				Beecham, L			Defence society paid 67m pound to defend accused doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1465	1465						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572776				2022-12-28	WOS:000073651600075
J	Kerrigan, DC; Todd, MK; Riley, PO				Kerrigan, DC; Todd, MK; Riley, PO			Knee osteoarthritis and high-heeled shoes	LANCET			English	Article							REACTION FORCES; GAIT; WALKING; KINEMATICS; PRESSURE; HEIGHT		Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Spaulding Rehabil Hosp, Gait Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Spaulding Rehabilitation Hospital	Kerrigan, DC (corresponding author), Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02114 USA.		Riley, Patrick O/B-3053-2009	Bergman, Mary Todd/0000-0002-7033-5362				BERG R, 1995, VOGUE, V185, P99; BONNEY G, 1952, J BONE JOINT SURG BR, V34, P366, DOI 10.1302/0301-620X.34B3.366; BRESLER B, 1950, T AM SOC MECH ENG, V72, P27; CORRIGAN JP, 1993, FOOT ANKLE, V14, P148, DOI 10.1177/107110079301400307; DAVIS MA, 1991, J RHEUMATOL, V18, P591; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; EGOLF DB, 1991, SEX ROLES, V24, P365, DOI 10.1007/BF00288309; Eisenhardt J.R., 1996, GAIT POSTURE, V4, P280, DOI 10.1016/0966-6362(95)01053-X; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; GAGE JR, 1993, CLIN ORTHOP RELAT R, P126; GOLLNICK PD, 1964, RES QUART, V35, P370, DOI 10.1080/10671188.1964.10613326; Jones B., 2015, DESIGN ANAL CROSS OV, V3rd; KAISER SB, 1987, AM J SEMIOTICS, V5, P13, DOI 10.5840/ajs19875128; Katz BP, 1996, HEALTH SERV RES, V31, P125; KERRIGAN DC, 1994, AM J PHYS MED REHAB, V73, P421, DOI 10.1097/00002060-199411000-00007; Kerrigan DC, 1997, ARCH PHYS MED REHAB, V78, P1085; MCBRIDE ID, 1991, FOOT ANKLE, V11, P282, DOI 10.1177/107110079101100505; MEGLAN D, 1994, HUMAN WALKING, P73; Murray M P, 1970, Arch Phys Med Rehabil, V51, P637; Nyska M, 1996, FOOT ANKLE INT, V17, P662, DOI 10.1177/107110079601701103; OGATA K, 1977, CLIN ORTHOP RELAT R, P313; OPILACORREIA KA, 1990, ARCH PHYS MED REHAB, V71, P304; Perry J., 1992, GAIT ANAL NORMAL PAT; REILLY DT, 1972, ACTA ORTHOP SCAND, V43, P126, DOI 10.3109/17453677208991251; SIMON SR, 1978, J BONE JOINT SURG AM, V60, P465, DOI 10.2106/00004623-197860040-00006; SNOW RE, 1994, ARCH PHYS MED REHAB, V75, P568; SNOW RE, 1992, FOOT ANKLE, V13, P85, DOI 10.1177/107110079201300206; SOARNES RW, 1985, BIOMECHANICS, P446; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P354, DOI 10.2106/00004623-198062030-00005; Windsor R., 1994, ARTHRITIS SURG, P794; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8; Winter DA, 1990, BIOMECHANICS MOTOR C	32	122	132	1	23	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	MAY 9	1998	351	9113					1399	1401		10.1016/S0140-6736(97)11281-8	http://dx.doi.org/10.1016/S0140-6736(97)11281-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM665	9593411				2022-12-28	WOS:000073563400011
J	Esker, AR; Mengel, C; Wegner, G				Esker, AR; Mengel, C; Wegner, G			Ultrathin films of a polyelectrolyte with layered architecture	SCIENCE			English	Article							LANGMUIR-BLODGETT-FILMS; AIR-WATER-INTERFACE; 2ND-HARMONIC GENERATION; WAVE-GUIDE; BLUE-LIGHT; CELLULOSE	Posttransfer modification of preformed Langmuir-Blodgett films of poly(tert-butyl methacrylate) and poly(tert-butyl acrylate) by gaseous hydrochloric acid yields films with layered architecture of poly(methacrylic acid) and poly(acrylic acid), respectively. X-ray reflectivity and infrared spectroscopy confirm monolayer by monolayer transfer of the source polymers and their transformation to acid multilayer assemblies with retention of low surface roughnesses. The incorporation of cross-linking groups into the system offers the possibility for further chemical modification to produce ultrathin films of model networks desirable for bioadsorption studies and as hydrophilic spacing layers for tethered membranes.	Max Planck Inst Polymerforsch, D-55128 Mainz, Germany	Max Planck Society	Wegner, G (corresponding author), Max Planck Inst Polymerforsch, Ackermann Weg 10, D-55128 Mainz, Germany.			Esker, Alan/0000-0003-1440-5933				BARDOSOVA M, 1995, LANGMUIR, V11, P1273, DOI 10.1021/la00004a038; Bruening ML, 1997, LANGMUIR, V13, P770, DOI 10.1021/la961098r; Buchholz V, 1996, ADV MATER, V8, P399; Buchholz V, 1997, LANGMUIR, V13, P3206, DOI 10.1021/la970085q; CLAYS K, 1993, J OPT SOC AM B, V10, P886, DOI 10.1364/JOSAB.10.000886; CLAYS K, 1993, CHEM MATER, V5, P1032, DOI 10.1021/cm00031a026; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; EGERTON PL, 1981, MACROMOLECULES, V14, P95, DOI 10.1021/ma50002a019; FUKUSHIMA H, 1994, THIN SOLID FILMS, V244, P789; HARTMANN A, 1994, THIN SOLID FILMS, V245, P206, DOI 10.1016/0040-6090(94)90901-6; IIDA S, 1993, ADV MATER, V5, P564, DOI 10.1002/adma.19930050711; KAWAGUCHI M, 1989, MACROMOLECULES, V22, P1735, DOI 10.1021/ma00194a039; KAZANSKII KS, 1992, ADV POLYM SCI, V104, P97; KIM S, 1992, PROG COLL POL SCI S, V89, P202; PENNER TL, 1994, NATURE, V367, P49, DOI 10.1038/367049a0; PETTY MC, 1990, LANGMUIRBLODGETT FIL; PO R, 1994, REV MACROMOL CHEM PH, V34, P607; ROBERTS GG, 1990, LANGMUIRBLODGETT FIL; Rulkens R, 1996, BER BUNSEN PHYS CHEM, V100, P707, DOI 10.1002/bbpc.19961000605; SACCHETTI M, 1993, LANGMUIR, V9, P2168, DOI 10.1021/la00032a044; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; SCHAUB M, 1993, ADV MATER, V5, P919, DOI 10.1002/adma.19930051209; SCHAUB M, 1995, MACROMOLECULES, V28, P1221, DOI 10.1021/ma00108a059; SEEGER S, 1992, SYNTHETIC MICROSTRUC, P586; SEUFERT M, 1995, ANGEW CHEM INT EDIT, V34, P340, DOI 10.1002/anie.199503401; Sigl H, 1997, EUR BIOPHYS J BIOPHY, V25, P249, DOI 10.1007/s002490050037; SUTHERLAND JE, 1969, J POLYM SCI POL LETT, V7, P871, DOI 10.1002/pol.1969.110071210; Swalen J. D., 1986, Journal of Molecular Electronics, V2, P155; TAKAHARA A, 1989, MACROMOLECULES, V22, P617, DOI 10.1021/ma00192a018; TAMURA M, 1991, CHEM LETT, P399, DOI 10.1246/cl.1991.399; TIPPMANNKRAYER P, 1991, LANGMUIR, V7, P2298, DOI 10.1021/la00058a053; Ulman A., 1991, INTRO ULTRATHIN ORGA; van Krevelen D., 1976, PROPERTIES POLYM; Wegner G., 1993, Molecular Crystals and Liquid Crystals, V235, P1, DOI 10.1080/10587259308055176; Wijekoon WMKP, 1996, J AM CHEM SOC, V118, P4480, DOI 10.1021/ja953974d; Zhou YF, 1996, LANGMUIR, V12, P5519, DOI 10.1021/la960693q; Zhou YF, 1996, J AM CHEM SOC, V118, P3773, DOI 10.1021/ja960142m	37	94	95	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					892	895		10.1126/science.280.5365.892	http://dx.doi.org/10.1126/science.280.5365.892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572731				2022-12-28	WOS:000073532900038
J	Epping-Jordan, MP; Watkins, SS; Koob, GF; Markou, A				Epping-Jordan, MP; Watkins, SS; Koob, GF; Markou, A			Dramatic decreases in brain reward function during nicotine withdrawal	NATURE			English	Article							ABSTINENCE SYNDROME; NUCLEUS-ACCUMBENS; SMOKING CESSATION; RAT; STIMULATION; DEPENDENCE; ANTAGONIST; TOLERANCE; THRESHOLD; INFUSION	Tobacco smoking is a worldwide public health problem. In the United States alone, over 400,000 deaths and $50 billion in medical costs annually are directly attributed to smoking(1). Accumulated evidence indicates that nicotine is the component of tobacco smoke that leads to addiction(2), but the means by which nicotine produces addiction remain unclear. Nicotine is less effective as a positive reinforcer than other drugs of abuse in non-dependent animals(3). Nevertheless, nicotine-withdrawal symptoms, including depressed mood, anxiety, irritability and craving(4,5) in dependent subjects may contribute to the addictive liability of nicotine(6,7). We show here that spontaneous nicotine withdrawal in rats resulted in a significant decrease in brain reward function, as measured by elevations in brain reward thresholds, which persisted for four days. Further, systemic injections of a competitive nicotinic-receptor antagonists led to a dose-dependent increase in brain reward thresholds in chronic nicotine-treated rats. The decreased function in brain reward systems during nicotine withdrawal is comparable in magnitude and duration to that of other major drugs of abuse(9-13), and may constitute an important motivational factor that contributes to craving, relapse and continued tobacco consumption in humans(7).	Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute	Markou, A (corresponding author), Scripps Res Inst, Dept Neuropharmacol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552				BAUCO P, 1994, J PHARMACOL EXP THER, V271, P294; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; DAMAJ MI, 1995, PSYCHOPHARMACOLOGY, V117, P67, DOI 10.1007/BF02245100; DOHERTY K, 1995, PSYCHOPHARMACOLOGY, V119, P171, DOI 10.1007/BF02246158; GELLERT VF, 1978, J PHARMACOL EXP THER, V205, P536; Hildebrand BE, 1997, PSYCHOPHARMACOLOGY, V129, P348, DOI 10.1007/s002130050200; HUGHES JR, 1992, HEALTH PSYCHOL, V11, P331, DOI 10.1037/0278-6133.11.5.331; HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; KILLEN JD, 1991, PSYCHOPHARMACOLOGY, V105, P191, DOI 10.1007/BF02244308; KORNETSKY C, 1979, FED PROC, V38, P2473; LEITH NJ, 1976, PSYCHOPHARMACOLOGIA, V46, P19, DOI 10.1007/BF00421544; MALARCHER AM, 1997, MMWR-MORBID MORTAL W, V46, P444; MALIN DH, 1993, PSYCHOPHARMACOLOGY, V112, P339, DOI 10.1007/BF02244930; MALIN DH, 1994, PSYCHOPHARMACOLOGY, V115, P180, DOI 10.1007/BF02244770; MALIN DH, 1992, PHARMACOL BIOCHEM BE, V43, P779, DOI 10.1016/0091-3057(92)90408-8; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; MENDELSON JH, 1979, NEW ENGL J MED, V301, P912, DOI 10.1056/NEJM197910253011704; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; OKAMOTO M, 1976, EUR J PHARMACOL, V40, P107, DOI 10.1016/0014-2999(76)90360-5; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; SCHULTEIS G, 1994, J PHARMACOL EXP THER, V271, P1391; Shiffman S, 1996, J CONSULT CLIN PSYCH, V64, P993, DOI 10.1037//0022-006X.64.5.993; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; *US DEP HHS, 1988, HLTH CONS SMOK NIC A	30	524	536	0	33	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 7	1998	393	6680					76	79		10.1038/30001	http://dx.doi.org/10.1038/30001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590692				2022-12-28	WOS:000073497500050
J	Soumerai, SB; McLaughlin, TJ; Gurwitz, JH; Guadagnoli, E; Hauptman, PJ; Borbas, C; Morris, N; McLaughlin, B; Gao, XM; Willison, DJ; Asinger, R; Gobel, F				Soumerai, SB; McLaughlin, TJ; Gurwitz, JH; Guadagnoli, E; Hauptman, PJ; Borbas, C; Morris, N; McLaughlin, B; Gao, XM; Willison, DJ; Asinger, R; Gobel, F			Effect of local medical opinion leaders on quality of care for acute myocardial infarction - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	14th Annual Meeting of the Association-for-Health-Services-Research	JUN 15-17, 1997	CHICAGO, IL	Assoc Hlth Serv Res			CONTINUING-EDUCATION; PRACTICE GUIDELINES; HEALTH-CARE; DISEASE; PHYSICIANS; MANAGEMENT	Context.-The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. Objective.-To evaluate a guideline-implementation intervention of clinician education by local opinion leaders and performance feedback to (1) increase use of lifesaving drugs (aspirin and thrombolytics in eligible elderly patients, beta-blockers in all eligible patients) for acute myocardial infarction (AMI), and (2) decrease use of a potentially harmful therapy (prophylactic lidocaine). Design.-Randomized controlled trial with hospital as the unit of randomization, intervention, and analysis. Setting.-Thirty-seven community hospitals in Minnesota. Patients.-All patients with AMI admitted to study hospitals over 10 months before (1992-1993, N=2409) or after (1995-1996, N=2938) the intervention. Intervention.-Using a validated survey, we identified opinion leaders at 20 experimental hospitals who influenced peers through small and large group discussions, informal consultations, and revisions of protocols and clinical pathways. They focused on (1) evidence (drug efficacy), (2) comparative performance, and (3) barriers to change. Control hospitals received mailed performance feedback. Main Outcome Measures.-Hospital-specific changes before and after the intervention in the proportion of eligible patients receiving each study drug. Results.-Among experimental hospitals, the median change in the proportion of eligible elderly patients receiving aspirin was +0.13 (17% increase from 0.77 at baseline), compared with a change of -0.03 at control hospitals (P=.04), For beta-blockers, the respective changes were +0.31 (63% increase from 0.49 at baseline) vs +0.18 (30% increase from baseline) for controls (P=.02), Lidocaine use declined by about 50% in both groups. The intervention did not increase thrombolysis in the elderly (from 0.73 at baseline), but nearly two thirds of eligible nonrecipients were older than 85 years, had severe comorbidities, or presented after at least 6 hours. Conclusions.-Working with opinion leaders and providing performance feedback can accelerate adoption of some beneficial AMI therapies (eg, aspirin, beta-blockers). Secular changes in knowledge and hospital protocols may extinguish outdated practices (eg, prophylactic lidocaine), However, it is more difficult to increase use of effective but riskier treatments (eg, thrombolysis) for frail elderly patients.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Meyers Primary Care Inst, Worcester, MA USA; Fallon Healthcare Syst, Worcester, MA USA; Univ Massachusetts, Med Ctr, Worcester, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Healthcare Educ & Res Fdn, St Paul, MN USA; McMaster Univ, Fac Hlth Sci, Syst Linked Res Unit Hlth & Social Serv Utilizat, Hamilton, ON, Canada; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Minneapolis Heart Inst, Minneapolis, MN 55407 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; McMaster University; Hennepin County Medical Center; Minneapolis Heart Institute Foundation	Soumerai, SB (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.	soumerai@warren.med.harvard.edu			AHRQ HHS [HSO7357] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HEART ASS, 1996, 1997 HEART STROK STA; Angell M, 1996, NEW ENGL J MED, V335, P883, DOI 10.1056/NEJM199609193351209; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V2, P57; ARMITAGE P, 1994, STAT METHODS MED RES, P453; Berwick DM, 1996, NEW ENGL J MED, V335, P1227, DOI 10.1056/NEJM199610173351611; Blumenthal D, 1996, NEW ENGL J MED, V335, P1146, DOI 10.1056/NEJM199610103351511; Blumenthal D, 1996, NEW ENGL J MED, V335, P891, DOI 10.1056/NEJM199609193351213; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Chassin MR, 1996, NEW ENGL J MED, V335, P1060, DOI 10.1056/NEJM199610033351413; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Collins R, 1997, NEW ENGL J MED, V336, P847, DOI 10.1056/NEJM199703203361207; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; Gurwitz JH, 1997, ANN INTERN MED, V126, P593, DOI 10.7326/0003-4819-126-8-199704150-00001; Gurwitz JH, 1997, JAMA-J AM MED ASSOC, V277, P1723, DOI 10.1001/jama.277.21.1723; GURWITZ JH, 1991, JAMA-J AM MED ASSOC, V265, P1720, DOI 10.1001/jama.265.13.1720; *HEALTHC ED RES FD, 1991, PRACT GUID REC MAN P; HINE LK, 1989, ARCH INTERN MED, V149, P2694, DOI 10.1001/archinte.149.12.2694; HISS RG, 1978, P 17 ANN C RES MED E, P283; JANSEN RWMM, 1994, DRUG AGING, V4, P175, DOI 10.2165/00002512-199404030-00001; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LOMAS J, 1991, JAMA-J AM MED ASSOC, V265, P2202, DOI 10.1001/jama.265.17.2202; McLaughlin TJ, 1997, J GEN INTERN MED, V12, P1, DOI 10.1046/j.1525-1497.1997.12105.x; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; PASHOS CL, 1994, J AM COLL CARDIOL, V23, P1023, DOI 10.1016/0735-1097(94)90585-1; Rogers EM, 1962, DIFFUSION INNOVATION; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; SOUMERAI SB, 1984, MILBANK FUND Q, V62, P447, DOI 10.2307/3349860; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Soumerai SB, 1994, PHARMACOEPIDEM DR S, P395; STROSS JK, 1980, ARTHRITIS RHEUM, V23, P846, DOI 10.1002/art.1780230711; STROSS JK, 1983, AM REV RESPIR DIS, V127, P739; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WILLISON DJ, IN PRESS ARCH INTERN; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; YUSUF S, 1990, CIRCULATION, V82, P117	44	334	336	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1358	1363		10.1001/jama.279.17.1358	http://dx.doi.org/10.1001/jama.279.17.1358			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	ZK758	9582043	Green Published, Bronze			2022-12-28	WOS:000073359800027
J	Taylor, S; Lever, JH; Harvey, RP				Taylor, S; Lever, JH; Harvey, RP			Accretion rate of cosmic spherules measured at the South Pole	NATURE			English	Article							DEEP-SEA SEDIMENTS; NATURAL-CONVECTION; MASS-DISTRIBUTION; BLUE ICE; DUST; ANTARCTICA; GREENLAND; INFLUX; WATER	Micrometeorites are terrestrially collected, extraterrestrial particles smaller than about 1 mm, which account for most of the mass being accreted to the Earth(1,2). Compared with meteorites, micrometeorites more completely represent the Earth-crossing meteoroid complex(3,4) and should include fragments of asteroids, comets, Mars and our Moon, as well as pre-solar and interstellar grains(3,6). Previous measurements of the flux of micrometeoroids that survive to the Earth's surface have large uncertainties owing to the destruction of particles by weathering(7-9), inefficiencies in magnetic collection or separation techniques(7-9), low particle counts(10,11), poor age constraint(7-9,12,13) or highly variable concentrating processes(12,13), Here we describe an attempt to circumvent these problems through the collection of thousands of well preserved and dated micrometeorites from the bottom of the South Pole water well, which supplies drinking water for the Scott-Amundsen station. Using this collection, we have determined precise estimates of the flu and mass distribution for 50-700-mu m cosmic spherules (melted micrometeorites). Allowing for the expected abundance of unmelted micrometeorites(1)4 in the samples, our results indicate that about 90% of the incoming mass of submillimetre particles evaporates during atmospheric entry. Our data indicate the loss of glass-rich and small stony spherules from deep-sea deposits(7,8), and they provide constraints for models describing the survival probability of micrometeoroids(15,16).	USA, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); Case Western Reserve University	Lever, JH (corresponding author), USA, Cold Reg Res & Engn Lab, 72 Lyme Rd, Hanover, NH 03755 USA.	jlever@crrel.usace.army.mil						BLANCHARD MB, 1980, EARTH PLANET SC LETT, V46, P178, DOI 10.1016/0012-821X(80)90004-7; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Brownlee D. E., 1993, 24 LUN PLAN SCI C, P205; Brownlee DE, 1997, METEORIT PLANET SCI, V32, P157, DOI 10.1111/j.1945-5100.1997.tb01257.x; BROWNLEE DE, 1981, SEA, pCH19; FIREMAN EL, 1965, GEOCHIM COSMOCHIM AC, V29, P21, DOI 10.1016/0016-7037(65)90074-8; *FLUENT INC, 1995, FLUENT VERS 4 3; FLYNN GJ, 1989, ICARUS, V77, P287, DOI 10.1016/0019-1035(89)90091-2; GRUN E, 1985, ICARUS, V62, P244, DOI 10.1016/0019-1035(85)90121-6; HARVEY RP, 1991, P LUNAR PLANET SCI, V21, P569; KOEBERL C, 1989, GEOCHIM COSMOCHIM AC, V53, P937, DOI 10.1016/0016-7037(89)90039-2; Kuivinen K.C., 1982, ANTARCT J US, V17, P89; KYTE FT, 1983, THESIS U CALIFORNIA; LANKFORD KE, 1986, J HEAT TRANS-T ASME, V108, P755, DOI 10.1115/1.3247009; LEVER JH, 1996, LUNAR PLANET SCI, V27, P747; LIN DS, 1987, J HEAT TRANS-T ASME, V109, P899, DOI 10.1115/1.3248201; LOVE SG, 1991, ICARUS, V89, P26, DOI 10.1016/0019-1035(91)90085-8; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; MAURETTE M, 1991, NATURE, V351, P44, DOI 10.1038/351044a0; MAURETTE M, 1986, SCIENCE, V233, P869, DOI 10.1126/science.233.4766.869; MAURETTE M, 1987, NATURE, V328, P699, DOI 10.1038/328699a0; MAURETTE M, 1990, MANTLE METEORITES, P87; MCCORKELL RH, 1970, INT ASS SCI HYDROL, V86, P25; MURRELL MT, 1980, GEOCHIM COSMOCHIM AC, V44, P2067, DOI 10.1016/0016-7037(80)90204-5; PENG HC, 1989, METEORITICS, V24, P315; PeuckerEhrenbrink B, 1996, GEOCHIM COSMOCHIM AC, V60, P3187, DOI 10.1016/0016-7037(96)00161-5; TAYLOR S, 1997, 971 COLD REG RES ENG; VANONI VA, 1975, ASCE MANUALS REPORTS, V54, P91; YIOU F, 1987, METEORITICS, V22, P539; YIOU F, 1989, METEORITICS, V24, P344	30	157	159	0	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679					899	903		10.1038/31894	http://dx.doi.org/10.1038/31894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK759	9582069				2022-12-28	WOS:000073359900041
J	Fersht, AR				Fersht, AR			Research: Protein structure - Sieves in sequence	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Cambridge, Ctr Prot Engn, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Fersht, AR (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	arf10@cam.ac.uk	Fersht, Alan R/B-2189-2008					BALDWIN AN, 1966, J BIOL CHEM, V241, P839; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Fersht A. R., 1977, ENZYME STRUCTURE MEC, P283; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Stoll A., 1958, FESTSCHRIFT A STOLL, P597; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198	10	40	40	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	1998	280	5363					541	541		10.1126/science.280.5363.541	http://dx.doi.org/10.1126/science.280.5363.541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ684	9575099				2022-12-28	WOS:000073242100031
J	Peters, R; Sikorski, R				Peters, R; Sikorski, R			Beauty in simplicity	SCIENCE			English	Article									Harvard Univ, Sch Med, Boston, MA 02115 USA; NCI, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Arras M, 1998, NAT BIOTECHNOL, V16, P159, DOI 10.1038/nbt0298-159; BATTLER A, 1993, J AM COLL CARDIOL, V22, P2001, DOI 10.1016/0735-1097(93)90790-8; ITO W, COMMUNICATION	3	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	1998	280	5362					456	457						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH907	9575088				2022-12-28	WOS:000073159600055
J	Fleming, DM; Charlton, JRH				Fleming, DM; Charlton, JRH			Morbidity and healthcare utilisation of children in households with one adult: comparative observational study	BRITISH MEDICAL JOURNAL			English	Article							PRESCHOOL-CHILDREN; SINGLE MOTHERS; ACCIDENTS	Objective: To identify and consider differences in morbidity in children in households with one adult presenting to general practitioners compared with children in households with more than one adult. Design: Observational study; data analysed with logistic regression controlling for age, sex, and practice. Subjects: 93 356 children aged 0-15 years included in the fourth national study of morbidity in general practice and for whom data about household structure were available. Among them 10 983 (11.8%) were living in households with a sole adult. Methods: Morbidity data were recorded from each consultation as the assessment diagnosis made by the general practitioner. Main outcome measures: Number of consultations and consultations per person for any illness, infections, acute respiratory infections, asthma, and accidents; number presenting and mean consultations per person for immunisation; number receiving home visits and home visits per person visited; average annual frequency of consultation among those consulting. Results: Compared with children in other households, a higher proportion of children in households with one adult consulted for infections and accidents. The proportion consulting for immunisation was lower and the proportion receiving home visits greater, Mean numbers of consultations per person consulting were also generally higher for all conditions. For infections, accidents, and home visits, the differences were evident in all age groups. Conclusions: The study confirms the importance of single parent families as an indicator of deprivation. Children in such families should be targeted for immunisation and accident prevention.	Royal Coll Gen Practitioners, Birmingham Res Unit, Birmingham B17 9DB, W Midlands, England; Off Natl Stat, London SW1V 2QQ, England		Fleming, DM (corresponding author), Royal Coll Gen Practitioners, Birmingham Res Unit, Birmingham B17 9DB, W Midlands, England.							BOLDEN KJ, 1980, J MATERNAL CHILD HLT, V5, P256; BOLDEN KJ, 1980, J MATERNAL CHILD HLT, V5, P258; BRADSHAW J, 1989, LONE PARENTS POLICY; Carter Y H, 1995, Inj Prev, V1, P164, DOI 10.1136/ip.1.3.164; *DEP HLTH SOC SEC, 1974, REP COMM ON PAR FAM; Douglas J W, 1970, J R Coll Physicians Lond, V4, P203; Fleming DM, 1996, BRIT J GEN PRACT, V46, P217; FRANCIS B, 1993, GLIM SYSTEM GEN LINE; HASKEY J, 1996, POPULATION TRENDS, V85, P7; HUNT J, 1973, FAMILIES THEIR NEEDS; JARMAN B, 1984, BRIT MED J, V289, P1587, DOI 10.1136/bmj.289.6458.1587; Jennings A, 1986, Health Visit, V59, P337; JUDGE K, 1993, BRIT MED J, V306, P677, DOI 10.1136/bmj.306.6879.677; Kai J, 1996, BRIT MED J, V313, P983; KAMIEN M, 1983, MED J AUSTRALIA, V2, P499, DOI 10.5694/j.1326-5377.1983.tb122618.x; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KURT S, 1983, FAMILIES RISK, P119; MCCORMICK A, 1995, MORBIDITY STAT GEN P; MORGAN DR, 1991, THESIS U BIRMINGHAM; OAKLEY A, 1990, BRIT J OBSTET GYNAEC, V97, P155, DOI 10.1111/j.1471-0528.1990.tb01741.x; *OFF NAT STAT, 1996, FAM SPEND REP 1995 9; Read J, 1986, BRIT J HEALTHC COMP, V3, P22; ROBERTS I, 1995, BRIT MED J, V311, P925; Roberts I, 1996, BRIT MED J, V312, P29, DOI 10.1136/bmj.312.7022.29; *SECR STAT HLTH, 1992, CM1986; SMITH SM, 1974, BRIT J PSYCHIAT, V125, P568, DOI 10.1192/bjp.125.6.568; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; UNDERWOOD P, 1984, AUST PAEDIATR J, V20, P203; WADSWORTH J, 1983, J EPIDEMIOL COMMUN H, V37, P100, DOI 10.1136/jech.37.2.100	29	35	35	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1572	1576		10.1136/bmj.316.7144.1572	http://dx.doi.org/10.1136/bmj.316.7144.1572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596597	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000073867800024
J	Xie, DX; Feys, BF; James, S; Nieto-Rostro, M; Turner, JG				Xie, DX; Feys, BF; James, S; Nieto-Rostro, M; Turner, JG			COI1: An Arabidopsis gene required for jasmonate-regulated defense and fertility	SCIENCE			English	Article							LEUCINE-RICH REPEATS; METHYL JASMONATE; YAC LIBRARY; THALIANA; RESISTANCE; PROTEIN; PLANTS; TRANSFORMATION; CONSTRUCTION; ENCODES	The coi1 mutation defines an Arabidopsis gene required for response to jasmonates, which regulate defense against insects and pathogens, wound healing, and pollen fertility. The wild-type allele, COI1, was mapped to a 90-kilobase genomic fragment and located by complementation of coi1-1 mutants. The predicted amino acid sequence of the COI1 protein contains 16 leucine-rich repeats and an F-box motif. It has similarity to the F-box proteins Arabidopsis TIR1, human Skp2, and yeast Grr1, which appear to function by targeting repressor proteins for removal by ubiquitination.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Turner, JG (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.		xie, daoxin d/C-8646-2017; Nieto-Rostro, Manuela/C-1621-2008					Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; CHRISTOU P, 1990, TRENDS BIOTECHNOL, V8, P145, DOI 10.1016/0167-7799(90)90160-Y; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CREUSOT F, 1995, PLANT J, V8, P763, DOI 10.1046/j.1365-313X.1995.08050763.x; ECKER J R, 1990, Methods (Orlando), V1, P186, DOI 10.1016/S1046-2023(05)80134-3; EPPEL CE, 1995, PLANT PHYSIOL, V109, P1813; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; PENACORTES H, 1993, PLANTA, V191, P123, DOI 10.1007/BF00240903; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Rojo E, 1998, PLANT J, V13, P153, DOI 10.1046/j.1365-313X.1998.00020.x; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; RYAN CA, 1992, PLANT MOL BIOL, V19, P123, DOI 10.1007/BF00015610; SCHMIDT R, 1992, AUST J PLANT PHYSIOL, V19, P341, DOI 10.1071/PP9920341; SEMBDNER G, 1993, ANNU REV PLANT PHYS, V44, P569, DOI 10.1146/annurev.pp.44.060193.003033; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; XIE DX, UNPUB; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	34	1205	1320	15	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	1998	280	5366					1091	1094		10.1126/science.280.5366.1091	http://dx.doi.org/10.1126/science.280.5366.1091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582125				2022-12-28	WOS:000073663600051
J	Lynch, JW				Lynch, JW			Regaining compassion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1422	1422		10.1001/jama.279.18.1422-a	http://dx.doi.org/10.1001/jama.279.18.1422-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600460				2022-12-28	WOS:000073463500001
J	Ewan, PW				Ewan, PW			ABC of allergies - Anaphylaxis	BRITISH MEDICAL JOURNAL			English	Review							FEATURES		MRC, London W1N 4AL, England; Addenbrookes Hosp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ewan, PW (corresponding author), MRC, London W1N 4AL, England.							Ewan PW, 1996, BRIT MED J, V312, P1074; FISHER MM, 1993, ANN FR ANESTH, V12, P97, DOI 10.1016/S0750-7658(05)81016-0; Stewart AG, 1996, QJM-MON J ASSOC PHYS, V89, P859, DOI 10.1093/qjmed/89.11.859; Turjanmaa K, 1996, ALLERGY, V51, P593, DOI 10.1111/j.1398-9995.1996.tb04678.x; Vickers DW, 1997, CLIN EXP ALLERGY, V27, P898	5	70	73	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1442	1445		10.1136/bmj.316.7142.1442	http://dx.doi.org/10.1136/bmj.316.7142.1442			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572760	Green Published			2022-12-28	WOS:000073651600035
J	Carney, JP; Maser, RS; Olivares, H; Davis, EM; Le Beau, M; Yates, JR; Hays, L; Morgan, WF; Petrini, JHJ				Carney, JP; Maser, RS; Olivares, H; Davis, EM; Le Beau, M; Yates, JR; Hays, L; Morgan, WF; Petrini, JHJ			The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response	CELL			English	Article							ATAXIA-TELANGIECTASIA; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BLOOMS SYNDROME; MEIOTIC RECOMBINATION; GENETIC-RECOMBINATION; HUMAN MRE11; IDENTIFICATION; RAD50; FIBROBLASTS	Nijmegen breakage syndrome (NBS) is an autosomal recessive disorder characterized by increased cancer incidence, cell cycle checkpoint defects, and ionizing radiation sensitivity. We have isolated the gene encoding p95, a member of the hMre11/hRad50 double-strand break repair complex. The p95 gene mapped to 8q21.3, the region that contains the NBS locus, and p95 was absent from NBS cells established from NBS patients, p95 deficiency in these cells completely abrogates the formation of hMre11/hRad50 ionizing radiation-induced foci. Comparison of the p95 cDNA to the NBS1 cDNA indicated that the p95 gene and NBS1 are identical. The implication of hMre11/hRad50/p95 protein complex in NBS reveals a direct molecular link between DSB repair and cell cycle checkpoint functions.	Univ Wisconsin, Sch Med, Genet Lab, Madison, WI 53706 USA; Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of Chicago	Petrini, JHJ (corresponding author), Univ Wisconsin, Sch Med, Genet Lab, Madison, WI 53706 USA.		Maser, Richard/B-2970-2012		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052095, R01GM056888] Funding Source: NIH RePORTER; NCRR NIH HHS [5P41RR11823-02] Funding Source: Medline; NIGMS NIH HHS [GM 52095, GM56888] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AJIMURA M, 1993, GENETICS, V133, P51; BIGBEE WL, 1989, AM J HUM GENET, V44, P402; BLOCHER D, 1991, INT J RADIAT BIOL, V60, P791, DOI 10.1080/09553009114552601; BUBLEY GJ, 1987, SOMAT CELL MOLEC GEN, V13, P111, DOI 10.1007/BF01534691; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cleaver J E, 1989, Birth Defects Orig Artic Ser, V25, P61; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; CORNFORTH MN, 1985, SCIENCE, V227, P1589, DOI 10.1126/science.3975628; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GERMAN J, 1983, CHROMOSOME MUTATION, P11; GIBSON FP, 1992, J BACTERIOL, V174, P1222, DOI 10.1128/jb.174.4.1222-1228.1992; Harlow E., 1988, ANTIBODIES LAB MANUA; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; HOJO ETS, 1995, MUTAT RES-ENVIR MUTA, V334, P59; HSIEH CL, 1993, J BIOL CHEM, V268, P20105; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Ivanov EL, 1996, GENETICS, V142, P693; JACKSON SP, 1995, CURR BIOL, V5, P1210, DOI 10.1016/S0960-9822(95)00238-7; James P, 1996, GENETICS, V144, P1425; Jayakumar A, 1996, P NATL ACAD SCI USA, V93, P14509, DOI 10.1073/pnas.93.25.14509; JOHZUKA K, 1995, GENETICS, V139, P1521; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; Link AJ, 1997, ELECTROPHORESIS, V18, P1314, DOI 10.1002/elps.1150180808; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuura S, 1997, AM J HUM GENET, V60, P1487, DOI 10.1086/515461; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; MEYN MS, 1995, CANCER RES, V55, P5991; MURNANE JP, 1995, CANCER METAST REV, V14, P17, DOI 10.1007/BF00690208; NELMS BE, 1998, IN PRESS SCIENCE; NISHIDA C, 1988, J BIOL CHEM, V263, P501; OGAWA H, 1995, ADV BIOPHYS, V31, P67, DOI 10.1016/0065-227X(95)99383-Z; PANDITA TK, 1992, RADIAT RES, V130, P94, DOI 10.2307/3578485; PerezVera P, 1997, AM J MED GENET, V70, P24, DOI 10.1002/(SICI)1096-8628(19970502)70:1<24::AID-AJMG5>3.0.CO;2-R; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; PETRINI JHJ, 1994, J IMMUNOL, V152, P176; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; ROWLEY JD, 1994, LEUKEMIA, V8, pS1; Saar K, 1997, AM J HUM GENET, V60, P605; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Stumm M, 1997, AM J HUM GENET, V60, P1246; Sullivan KE, 1997, CLIN IMMUNOL IMMUNOP, V82, P43, DOI 10.1006/clin.1996.4275; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WEEMAES CMR, 1994, INT J RADIAT BIOL, V66, pS185; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040	67	958	983	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	1998	93	3					477	486		10.1016/S0092-8674(00)81175-7	http://dx.doi.org/10.1016/S0092-8674(00)81175-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZL787	9590181	Bronze			2022-12-28	WOS:000073471500022
J	Gravel, S; Larrivee, M; Labrecque, P; Wellinger, RJ				Gravel, S; Larrivee, M; Labrecque, P; Wellinger, RJ			Yeast Ku as a regulator of chromosomal DNA end structure	SCIENCE			English	Article							STRAND-BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; TELOMERE MAINTENANCE; BINDING PROTEIN; INVOLVEMENT; MECHANISM; ABSENCE; HDF1; GENE	During telomere replication in yeast, chromosome ends acquire an S-phase-specific overhang of the guanosine-rich strand. Here it is shown that in cells lacking Ku, a heterodimeric protein involved in nonhomologous DNA end joining, these overhangs are present throughout the cell cycle. In vivo cross-linking experiments demonstrated that Ku is bound to telomeric DNA, These results show that Ku plays a direct role in establishing a normal DNA end structure on yeast chromosomes, conceivably by functioning as a terminus-binding factor. Because Ku-mediated DNA end joining involving telomeres would result in chromosome instability, our data also suggest that Ku;has a distinct function when bound to telomeres.	Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Wellinger, RJ (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.		Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759				Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Blackburn EH, 1995, TELOMERES; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; GRAVEL S, UNPUB; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Lieber MR, 1997, CURR OPIN GENET DEV, V7, P99, DOI 10.1016/S0959-437X(97)80116-5; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910; Milne GT, 1996, MOL CELL BIOL, V16, P4189; MIMORI T, 1986, J BIOL CHEM, V261, P375; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; ROTH DB, 1995, CURR BIOL, V5, P496, DOI 10.1016/S0960-9822(95)00101-1; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Siede W, 1996, GENETICS, V142, P91; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Tsukamoto Y, 1996, NUCLEIC ACIDS RES, V24, P2067, DOI 10.1093/nar/24.11.2067; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Wellinger RJ, 1997, EUR J CANCER, V33, P735, DOI 10.1016/S0959-8049(97)00067-1; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	35	366	371	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					741	744		10.1126/science.280.5364.741	http://dx.doi.org/10.1126/science.280.5364.741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563951				2022-12-28	WOS:000073415600049
J	Jha, TK; Olliaro, P; Thakur, CPN; Kanyok, TP; Singhania, BL; Singh, IJ; Singh, NKP; Akhoury, S; Jha, S				Jha, TK; Olliaro, P; Thakur, CPN; Kanyok, TP; Singhania, BL; Singh, IJ; Singh, NKP; Akhoury, S; Jha, S			Randomised controlled trial of aminosidine (paromomycin) upsilon sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India	BRITISH MEDICAL JOURNAL			English	Article							PANCREATITIS	Objectives: To assess the efficacy and tolerability of aminosidine compared with sodium stibogluconate for treating visceral leishmaniasis. Design: Randomised, unblinded, controlled trial with 180 day follow up. Setting: Kala-Azar Research Centre, Brahmpura, Muzaffarpur, Bihar, India. Subjects: People of either sex aged 6-50 years with symptoms and signs suggestive of visceral leishmaniasis (fever, loss of appetite, enlarged spleen). with leishmania amastigotes detected in Giemsa stained aspirates of spleen or bone marrow. Interventions: Aminosidine at three daily doses (12, 16, and 20 mg/kg) for 21 days and sodium stibogluconate 20 mg/kg/day for 30 days. Main outcome measures: Laboratory measures of efficacy: parasite count, haemoglobin concentration, white cell count platelet count, serum albumin concentration. Clinical measures of efficacy: spleen size, fever, body weight, and liver size. Measures of safety: liver and renal function tests, reports of adverse events. Results: Of the 120 patients enrolled (30 per treatment arm), 119 completed treatment and follow up. Cure at end of follow up was achieved in 23 (77%), 28 (93%), and 29 (97%) patients treated with 12, 16, and 20 mg aminosidine/kg/day respectively, and in 19 (63%) patients given sodium stibogluconate. At 16 and 20 mg/kg/day, aminosidine was significantly more active than sodium stibogluconate in both clinical and laboratory measures of efficacy. No significant clinical or laboratory toxicity occurred in any treatment group. Conclusions: A 21 day course of aminosidine 16 or 20 mg/kg/day should be considered as first line treatment for visceral leishmaniasis in Bihar.	WHO, UNDP World Bank WHO, Special Programme Res & Training Trop Dis, Steering Comm Drugs Malaria, CH-1211 Geneva 27, Switzerland; WHO, UNDP World Bank WHO, Special Programme Res & Training Trop Dis, Paromomycin Dev Team, CH-1211 Geneva, Switzerland; Ctr Muzzaffarpur Brahmpura, Muzaffarpur 842003, Bihar, India	The World Bank; World Health Organization; The World Bank; World Health Organization	Olliaro, P (corresponding author), WHO, UNDP World Bank WHO, Special Programme Res & Training Trop Dis, Steering Comm Drugs Malaria, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	olliarop@who.ch						BALZAN M, 1992, T ROY SOC TROP MED H, V86, P515, DOI 10.1016/0035-9203(92)90091-P; BRACONIER JH, 1993, J ANTIMICROB CHEMOTH, V31, P187, DOI 10.1093/jac/31.1.187; CHUNGE CN, 1990, T ROY SOC TROP MED H, V84, P221, DOI 10.1016/0035-9203(90)90263-E; DELALLA F, 1993, CLIN INFECT DIS, V16, P730, DOI 10.1093/clind/16.5.730; DONOVAN KL, 1990, J INFECTION, V21, P107, DOI 10.1016/0163-4453(90)90830-2; HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296; Kellina O. I., 1961, Meditsinskaya Parazitologiya Mosk, V30, P684; NEAL RA, 1995, J ANTIMICROB CHEMOTH, V35, P577, DOI 10.1093/jac/35.5.577; NEAL RA, 1968, ANN TROP MED PARASIT, V62, P54, DOI 10.1080/00034983.1968.11686529; OLLIARO PL, 1993, PARASITOL TODAY, V9, P323, DOI 10.1016/0169-4758(93)90231-4; SCHILLINGS RT, 1961, ANTIMICROBIAL AGENTS, V4, P274; SCOTT JAG, 1992, T ROY SOC TROP MED H, V86, P617, DOI 10.1016/0035-9203(92)90151-2; SEAMAN J, 1993, J INFECT DIS, V168, P715, DOI 10.1093/infdis/168.3.715; Singh N K, 1995, J Assoc Physicians India, V43, P319; Singh N K, 1989, J Assoc Physicians India, V37, P514; THAKUR CP, 1995, T ROY SOC TROP MED H, V89, P219, DOI 10.1016/0035-9203(95)90503-0; THAKUR CP, 1992, T R SOC TROP MED HYG, V86, P617; *WHO, 1990, WHO TECHN SER, V793	18	126	126	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 18	1998	316	7139					1200	1205		10.1136/bmj.316.7139.1200	http://dx.doi.org/10.1136/bmj.316.7139.1200			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ518	9583927	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000073224100020
J	Bush, TG; Savidge, TC; Freeman, TC; Cox, HJ; Campbell, EA; Mucke, L; Johnson, MH; Sofroniew, MV				Bush, TG; Savidge, TC; Freeman, TC; Cox, HJ; Campbell, EA; Mucke, L; Johnson, MH; Sofroniew, MV			Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice	CELL			English	Article							INFLAMMATORY BOWEL-DISEASE; FIBRILLARY ACIDIC PROTEIN; RECEPTOR MUTANT MICE; NERVOUS-SYSTEM; LACKING GDNF; INTESTINAL INFLAMMATION; REACTIVE ASTROCYTES; NEURONS; CELLS; EXPRESSION	To investigate the roles of astroglial cells, we targeted their ablation genetically. Transgenic mice were generated expressing herpes simplex virus thymidine kinase from the mouse glial fibrillary acidic protein (GFAP) promoter. In adult transgenic mice, 2 weeks of subcutaneous treatment with the antiviral agent ganciclovir preferentially ablated transgene-expressing, GFAP-positive glia from the jejunum and ileum, causing a fulminating and fatal jejuno-ileitis. This pathology was independent of bacterial overgrowth and was characterized by increased myeloperoxidase activity, moderate degeneration of myenteric neurons, and intraluminal hemorrhage. These findings demonstrate that enteric glia play an essential role in maintaining the integrity of the bowel and suggest that their loss or dysfunction may contribute to the cellular mechanisms of inflammatory bowel disease.	MRC, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Birmingham, Inst Child Hlth, Birmingham B16 8ET, W Midlands, England; Sanger Ctr, Hinxton CB10 1SA, England; Univ Calif San Francisco, Gladstone Mol Neurobiol Program, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of Cambridge; University of Cambridge; University of Birmingham; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Sofroniew, MV (corresponding author), MRC, Cambridge Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 2PY, England.			Mucke, Lennart/0000-0001-6256-9559; Freeman, Thomas/0000-0001-5235-8483; johnson, martin/0000-0002-5906-5883	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; Bar KJ, 1997, GASTROENTEROLOGY, V112, P1381, DOI 10.1016/S0016-5085(97)70154-9; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; DAHL JL, 1987, GASTROENTEROLOGY, V92, P338, DOI 10.1016/0016-5085(87)90126-0; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; FRANK KB, 1984, J BIOL CHEM, V259, P1566; GERSHON MD, 1991, GLIA, V4, P195, DOI 10.1002/glia.440040211; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; HOGAN B, 1986, MANIPULATING MOUSE E; Holst MC, 1995, J NEUROSCI METH, V62, P121, DOI 10.1016/0165-0270(95)00064-X; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; JOHNSON WB, 1995, GLIA, V13, P174, DOI 10.1002/glia.440130304; Karaosmanoglu T, 1996, ANAT RECORD, V244, P470, DOI 10.1002/(SICI)1097-0185(199604)244:4<470::AID-AR5>3.0.CO;2-Z; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kirchgessner AL, 1997, J NEUROSCI, V17, P8804; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; McCafferty DM, 1997, AM J PHYSIOL-GASTR L, V272, pG272, DOI 10.1152/ajpgi.1997.272.2.G272; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MILLER MJS, 1993, J PHARMACOL EXP THER, V264, P11; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sharkey KA, 1996, CAN J GASTROENTEROL, V10, P335, DOI 10.1155/1996/502865; SHARKEY KA, 1990, NEUROSCIENCE, V38, P13, DOI 10.1016/0306-4522(90)90370-J; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; Theodosis DT, 1996, TRENDS NEUROSCI, V19, P363, DOI 10.1016/0166-2236(96)10055-2; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; WALLACE H, 1991, ENDOCRINOLOGY, V129, P3217, DOI 10.1210/endo-129-6-3217	38	438	447	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	1998	93	2					189	201		10.1016/S0092-8674(00)81571-8	http://dx.doi.org/10.1016/S0092-8674(00)81571-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568712	Bronze			2022-12-28	WOS:000073174000006
J	Berger, A				Berger, A			Science commentary: Why conjugate vaccines protect longer	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1571	1571		10.1136/bmj.316.7144.1571	http://dx.doi.org/10.1136/bmj.316.7144.1571			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596596	Green Published			2022-12-28	WOS:000073867800023
J	Goldblatt, D; Miller, E; McCloskey, N; Cartwright, K				Goldblatt, D; Miller, E; McCloskey, N; Cartwright, K			Immunological response to conjugate vaccines in infants: follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION		Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England; Gloucestershire Royal Hosp, Publ Hlth Lab, Gloucester GL1 3NN, England	University of London; University College London; Public Health England; Gloucestershire Royal Hospital	Goldblatt, D (corresponding author), Inst Child Hlth, Immunobiol Unit, 30 Guilford St, London WC1N 1EH, England.	d.goldblatt@ich.ucl.ac.uk	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Booy R, 1997, LANCET, V349, P1197, DOI 10.1016/S0140-6736(96)06392-1; DECKER MD, 1993, J PEDIATR-US, V122, P410, DOI 10.1016/S0022-3476(05)83428-6; Goldblatt D, 1996, BRIT MED J, V312, P817; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Steinhoff MC, 1997, LANCET, V349, P1186, DOI 10.1016/S0140-6736(97)22017-9	5	30	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1570	1571						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596595	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073867800022
J	Forsyth, DW; Webb, SC; Dorman, LM; Shen, Y				Forsyth, DW; Webb, SC; Dorman, LM; Shen, Y			Phase velocities of Rayleigh waves in the MELT experiment on the East Pacific Rise	SCIENCE			English	Article							UPPER MANTLE; TOMOGRAPHY; RIDGE	The phase velocities of Rayleigh waves increase more rapidly with distance from the East Pacific Rise (EPR) axis than is predicted by models of conductive cooling of the lithosphere. Low velocities near the axis are probably caused by partial melt at depths of 20 to 70 kilometers in a zone several hundred kilometers wide. The lowest velocities are offset to the west of the EPR, Wave propagation is anisotropic; the fast direction is approximately perpendicular to the ridge, parallel to the spreading direction. Anisotropy increases from a minimum near the axis to 3 percent or more on the flanks.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Brown University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution	Forsyth, DW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	donald_forsyth@brown.edu		Shen, Yang/0000-0002-4185-6089; Webb, Spahr/0000-0002-7277-174X				Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; Cormier MH, 1996, MAR GEOPHYS RES, V18, P53, DOI 10.1007/BF00286203; EBERLE MA, IN PRESS NATURE; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; FRIEDERICH W, 1994, GEOPHYS J INT, V119, P931, DOI 10.1111/j.1365-246X.1994.tb04026.x; HIRTH G, 1995, J GEOPHYS RES-SOL EA, V100, P1981, DOI 10.1029/94JB02128; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; KURZ M, UNPUB; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; MAHONEY JJ, 1994, EARTH PLANET SC LETT, V121, P173, DOI 10.1016/0012-821X(94)90039-6; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; Scheirer DS, 1998, SCIENCE, V280, P1221, DOI 10.1126/science.280.5367.1221; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; WHITE RS, 1992, J GEOPHYS RES-SOL EA, V97, P19683, DOI 10.1029/92JB01749; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230; Zhao DP, 1997, SCIENCE, V278, P254, DOI 10.1126/science.278.5336.254	20	161	162	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1235	1238		10.1126/science.280.5367.1235	http://dx.doi.org/10.1126/science.280.5367.1235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596571				2022-12-28	WOS:000073852500040
J	Gunatilake, SB				Gunatilake, SB			Rapid resolution of symptoms and signs of intracerebral haemorrhage: case reports	BRITISH MEDICAL JOURNAL			English	Article							HEMORRHAGE		Univ Kelaniya, Fac Med, Ragama, Sri Lanka	University Kelaniya	Gunatilake, SB (corresponding author), 75 Galpotta Rd, Nawala, Rajagiriya, Sri Lanka.							DENNIS MS, 1987, BRIT MED J, V295, P379, DOI 10.1136/bmj.295.6594.379; Hankey GJ, 1994, MAJOR PROBLEMS NEURO, V27; SCOTT WR, 1985, ARCH NEUROL-CHICAGO, V42, P133, DOI 10.1001/archneur.1985.04060020043013; WARLOW C, 1996, STROKE PRACTICAL GUI	4	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1495	1496		10.1136/bmj.316.7143.1495	http://dx.doi.org/10.1136/bmj.316.7143.1495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582134	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073707700023
J	Vervloet, D; Durham, S				Vervloet, D; Durham, S			ABC of allergies - Adverse reactions to drugs	BRITISH MEDICAL JOURNAL			English	Article									Hop St Marguerite, Chest Dis Dept, Div Allergy, Marseille, France; Royal Brompton Hosp, London SW3 6LY, England	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Brompton Hospital	Vervloet, D (corresponding author), Hop St Marguerite, Chest Dis Dept, Div Allergy, Marseille, France.							CERIO R, 1992, COLOUR ATLAS ALLERGI; PRADAL M, 1997, ALLERGY ALLERGIC DIS, P1671; Sullivan TJ, 1993, ALLERGY PRINCIPLES P, P1726; Vervloet D, 1992, DRUG ALLERGY	4	98	105	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1511	1514		10.1136/bmj.316.7143.1511	http://dx.doi.org/10.1136/bmj.316.7143.1511			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582146	Green Published			2022-12-28	WOS:000073707700036
J	Fox, IJ; Chowdhury, JR; Kaufman, SS; Goertzen, TC; Chowdhury, NR; Warkentin, PI; Dorko, K; Sauter, BV; Strom, SC				Fox, IJ; Chowdhury, JR; Kaufman, SS; Goertzen, TC; Chowdhury, NR; Warkentin, PI; Dorko, K; Sauter, BV; Strom, SC			Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	48th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases	NOV 07-12, 1997	CHICAGO, IL	Amer Assoc Study Liver Dis			LIVER-TRANSPLANTATION; GILBERTS-SYNDROME; BILIRUBIN; THERAPY		Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Radiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Lab Med, Omaha, NE 68198 USA; Albert Einstein Coll Med, Dept Med, New York, NY USA; Albert Einstein Coll Med, Dept Mol Genet, New York, NY USA; Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, New York, NY USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Yeshiva University; Yeshiva University; Yeshiva University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fox, IJ (corresponding author), Univ Nebraska, Med Ctr, Dept Surg, 600 S 42nd St, Omaha, NE 68198 USA.		Strom, Stephen C/A-6501-2008; Kaufman, Stuart/AAE-7183-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048794, R01DK046057, R01DK039137] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46057, DK39137, DK48794] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Benedetti E, 1997, TRANSPLANTATION, V63, P1206, DOI 10.1097/00007890-199705150-00003; Bilir B., 1996, Hepatology, V24, p308A; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; CHOWDHURY J R, 1981, Hepatology, V1, P622; CRIGLER JF, 1952, PEDIATRICS, V10, P169; FEVERY J, 1977, J CLIN INVEST, V60, P970, DOI 10.1172/JCI108877; FOX IJ, 1995, HEPATOLOGY, V21, P837, DOI 10.1002/hep.1840210334; FOX IJ, 1997, ACUTE LIVER FAILURE, P285; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; GUPTA S, 1995, P NATL ACAD SCI USA, V92, P5860, DOI 10.1073/pnas.92.13.5860; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; KAUFMAN SS, 1986, HEPATOLOGY, V6, P1259, DOI 10.1002/hep.1840060606; MITO M, 1993, CELL TRANSPLANT, V2, P65, DOI 10.1177/096368979300200109; PETT S, 1987, MOL ASPECTS MED, V9, P473, DOI 10.1016/0098-2997(87)90009-4; Reyes J., 1996, Hepatology, V24, p308A; Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; SUSSMAN NL, 1993, HEPATOLOGY, V17, P1163, DOI 10.1016/0270-9139(93)90136-B; vanderVeere CN, 1996, HEPATOLOGY, V24, P311; WHITINGTON PF, 1993, LANCET, V342, P779, DOI 10.1016/0140-6736(93)91543-U	23	787	817	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	1998	338	20					1422	1426		10.1056/NEJM199805143382004	http://dx.doi.org/10.1056/NEJM199805143382004			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	ZM667	9580649				2022-12-28	WOS:000073563700004
J	Avorn, J; Monette, J; Lacour, A; Bohn, RL; Monane, M; Mogun, H; LeLorier, J				Avorn, J; Monette, J; Lacour, A; Bohn, RL; Monane, M; Mogun, H; LeLorier, J			Persistence of use of lipid-lowering medications - A cross-national study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHOLESTEROL-REDUCTION; CLINICAL-TRIALS; MEDICAID DATA; DRUG-THERAPY; PATIENT; PRAVASTATIN; COSTS	Context.-Although clinical trials have demonstrated the benefits of lipid-lowering therapy, little is known about how these drugs are prescribed or used in the general population. Objective.-To estimate predictors of persistence with therapy for lipid-lowering drug regimens in typical populations of patients in the United States and Canada. Design.-A cohort study defining all prescriptions filled for lipid-lowering drugs during 1 year, as well as patients' demographic and clinical characteristics. Setting.-New Jersey's Medicaid and Pharmacy Assistance for the Aged and Disabled programs and Quebec's provincial medical care program. Patients.-All continuously enrolled patients older than 65 years who filled 1 or more prescriptions for lipid-lowering drugs (N = 5611 in the US programs, and N = 1676 drawn from a 10% sample in Quebec). Main Outcome Measures.-Proportion of days during the study year for which patients had filled prescriptions for lipid-lowering drugs; predictors of good vs poor persistence with therapy. Results.-In both populations, patients failed to fill prescriptions for lipid-lowering drugs for about 40% of the study year. Persistence rates with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors were significantly higher than those seen with cholestyramine (64.3% vs 36.6% of days with drug available, respectively). Patients with hypertension, diabetes, or coronary artery disease had significantly higher rates of persistence with lipid-lowering regimens. In New Jersey, multivariable analysis indicated that the poorest patients (those enrolled in Medicaid) had lower rates of drug use than less indigent patients (those enrolled in Pharmacy Assistance for the Aged and Disabled) after adjusting for possible confounders, despite virtually complete drug coverage in both programs. When rates of use were measured in the US population for the 5 years following the study year, only 52% of surviving patients who were initially prescribed lipid-lowering drugs were still filling prescriptions for this drug class. Conclusion.-In all populations studied, patients who were prescribed lipid-lowering drug regimens remained without filled prescriptions for over a third of the study year on average. Rates of persistence varied substantially with choice of agent prescribed, comorbidity, and socioeconomic status, despite universal coverage of prescription drug costs. After 5 years, about half of the surviving original cohort in the United States had stopped using lipid-lowering therapy altogether.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Univ Montreal, Hotel Dieu, Ctr Rech, Montreal, PQ, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Laval University; Universite de Montreal	Avorn, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 221 Londwood Ave, Boston, MA 02115 USA.							ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; BRIGHT RA, 1989, J CLIN EPIDEMIOL, V42, P937, DOI 10.1016/0895-4356(89)90158-3; CARON HS, 1968, J AMER MED ASSOC, V203, P922, DOI 10.1001/jama.203.11.922; COX DR, 1990, ANAL BINARY DATA; CRAMER JA, 1989, JAMA-J AM MED ASSOC, V261, P3273, DOI 10.1001/jama.261.22.3273; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; EFRON B, 1991, J AM STAT ASSOC, V86, P9, DOI 10.2307/2289707; EVANS L, 1983, DRUGS, V25, P63, DOI 10.2165/00003495-198325010-00004; Garber AM, 1996, ANN INTERN MED, V124, P515, DOI 10.7326/0003-4819-124-5-199603010-00013; GLICKMAN L, 1994, J AM GERIATR SOC, V42, P992, DOI 10.1111/j.1532-5415.1994.tb06594.x; HERSHEY JC, 1980, AM J PUBLIC HEALTH, V70, P1081, DOI 10.2105/AJPH.70.10.1081; HULLEY SB, 1994, JAMA-J AM MED ASSOC, V272, P1372, DOI 10.1001/jama.272.17.1372; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; LAROSA JC, 1994, ARCH INTERN MED, V154, P529, DOI 10.1001/archinte.154.5.529; MELLIES MJ, 1993, ATHEROSCLEROSIS, V101, P97, DOI 10.1016/0021-9150(93)90105-4; Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805, DOI 10.2105/AJPH.86.12.1805; MONANE M, 1994, ARCH INTERN MED, V154, P433, DOI 10.1001/archinte.154.4.433; National Council on Patient Information and Education, 1990, TALK INF ED; Oster G, 1996, ARCH INTERN MED, V156, P731, DOI 10.1001/archinte.156.7.731; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; ROSENSTOCK IM, 1988, AM J PREV MED, V4, P349, DOI 10.1016/S0749-3797(18)31145-0; ROSNER B, 1986, FUNDAMENTALS BIOSTAT, P302; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALZMAN C, 1995, J CLIN PSYCHIAT, V56, P18; *SAS I INC, 1988, SAS STAT US GUID REL, P405; SPAETH GL, 1970, INVEST OPHTH VISUAL, V9, P73; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H	30	510	515	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1458	1462		10.1001/jama.279.18.1458	http://dx.doi.org/10.1001/jama.279.18.1458			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600480	Bronze			2022-12-28	WOS:000073463500035
J	Danesh, J; Collins, R; Appleby, P; Peto, R				Danesh, J; Collins, R; Appleby, P; Peto, R			Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BLOOD-CELL COUNT; CARDIOVASCULAR RISK-FACTORS; ACUTE MYOCARDIAL-INFARCTION; IRON-BINDING PROTEINS; AMYLOID-A-PROTEIN; SERUM-ALBUMIN; HEMOSTATIC FACTORS; UNSTABLE ANGINA; OLDER PERSONS; FOLLOW-UP	Context.-A large number of epidemiologic studies have reported on associations between various "inflammatory" factors and coronary heart disease (CHD). Objective.-To assess the associations of blood levels of fibrinogen, C-reactive protein (CRP), and albumin and leukocyte count with the subsequent risk of CHD. Data Sources.-Meta-analyses of any long-term prospective studies of CHD published before 1998 on any of these 4 factors. Studies were identified by MEDLINE searches, scanning of relevant reference lists, hand searching of cardiology, epidemiology, and other relevant journals, and discussions with authors of relevant reports. Study Selection.-All relevant studies identified were included. Data Extraction.-The following information was abstracted from published reports (supplemented, in several cases, by the authors): size and type of cohort, mean age, mean duration of follow-up, assay methods, degree of adjustment for confounders, and relationship of CHD risk to the baseline assay results. Data Synthesis.-For fibrinogen, with 4018 CHD cases in 18 studies, comparison of individuals in the top third with those in the bottom third of the baseline measurements yielded a combined risk ratio of 1.8 (95% confidence interval [CI], 1.6-2.0) associated with a difference in long-term usual mean fibrinogen levels of 2.9 mu mol/L (0.1 g/dL) between the top and bottom thirds (10.3 vs 7.4 mu mol/L [0.35 vs 0.25 g/dL]). For CRP, with 1053 CHD cases in 7 studies, the combined risk ratio of 1.7 (95% CI, 1.4-2.1) was associated with a difference of 1.4 mg/L (2.4 vs 1.0 mg/L). For albumin, with 3770 CHD cases in 8 studies, the combined risk ratio of 1.5 (95% CI, 1.3-1.7) was associated with a difference of 4 g/L (38 vs 42 g/L, ie, an inverse association). For leukocyte count, with 5337 CHD cases in the 7 largest studies, the combined risk ratio of 1.4 (95% CI, 1.3-1.5) was associated with a difference of 2.8x10(9)/L (8.4 vs 5.6x10(9)/L). Each of these overall results was highly significant (P<.0001). Conclusions.-The published results from these prospective studies are remarkably consistent for each factor, indicating moderate but highly statistically significant associations with CHD. Hence, even though mechanisms that might ac count for these associations are not clear, further study of the relevance of these factors to the causation of CHD is warranted.	Univ Oxford, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Nuffield Dept Clin Med, Epidemiol Studies Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Imperial Canc Res Fund, Canc Epidemiol Unit, Oxford OX2 6HE, England	University of Oxford; University of Oxford; Radcliffe Infirmary; University of Oxford	Danesh, J (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Clin Trial Serv Unit, Harkness Bldg, Oxford OX2 6HE, England.	john.danesh@balliol.ox.ac.uk						AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Amaro A, 1993, Rev Port Cardiol, V12, P913; ANDERSON JL, 1997, CIRCULATION S1, V96, P100; Anzai T, 1997, CIRCULATION, V96, P778; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Benderly M, 1996, ARTERIOSCL THROM VAS, V16, P351, DOI 10.1161/01.ATV.16.3.351; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Corti MC, 1996, J CLIN EPIDEMIOL, V49, P519, DOI 10.1016/0895-4356(95)00562-5; CREMER P, 1991, DIAGN LABOR, V42, P28; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1998, BRIT MED J, V316, P1130, DOI 10.1136/bmj.316.7138.1130; DARNE B, 1990, LANCET, V335, P350; DEBEER FC, 1982, BRIT HEART J, V47, P239; DELABRY LO, 1990, J CLIN EPIDEMIOL, V43, P153, DOI 10.1016/0895-4356(90)90178-R; DELORGERIL M, 1990, LANCET, V335, P349; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ERIKSSON H, 1992, FIBRINOGEN NEW CARDI, P115; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; ERNST E, 1987, JAMA-J AM MED ASSOC, V257, P2318, DOI 10.1001/jama.257.17.2318; FESKENS EJM, 1997, CAN J CARDIOL SB, V13, pB282; FOLSOM AR, 1995, EUR HEART J, V16, P21, DOI 10.1093/eurheartj/16.suppl_A.21; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; GILLUM RF, 1992, AM HEART J, V123, P507, DOI 10.1016/0002-8703(92)90667-K; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; GOSLING P, 1990, LANCET, V335, P349; Guijarro C, 1996, AM J KIDNEY DIS, V27, P117, DOI 10.1016/S0272-6386(96)90038-4; HAINES AP, 1983, THROMB HAEMOSTASIS, V50, P800; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Junker R, 1997, ARTERIOSCL THROM VAS, V17, P1539, DOI 10.1161/01.ATV.17.8.1539; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; KANNEL WB, 1992, FIBRINOGEN NEW CARDI, P101; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7; KOENIG W, 1997, CIRCULATION S1, V96, P99; KOSTIS JB, 1982, CHEST, V81, P571, DOI 10.1378/chest.81.5.571; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; KULLER LH, 1991, AM J EPIDEMIOL, V134, P1266, DOI 10.1093/oxfordjournals.aje.a116030; Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97; LAW MR, 1994, INT J EPIDEMIOL, V23, P38, DOI 10.1093/ije/23.1.38; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; LIUZZO G, 1995, J AM COLL CARDIOL S, V25, pA250; LOWE GDO, 1985, THROMB HAEMOSTASIS, V54, P700; Lowe GDO, 1997, BRIT J HAEMATOL, V96, P168, DOI 10.1046/j.1365-2141.1997.8532481.x; Mach F, 1997, EUR HEART J, V18, P1897; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANTTARI M, 1992, AM HEART J, V123, P873, DOI 10.1016/0002-8703(92)90690-W; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; MAZZONE A, 1993, CIRCULATION, V88, P358, DOI 10.1161/01.CIR.88.2.358; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; Mendall MA, 1996, BRIT MED J, V312, P1061; MITCHINSON MJ, 1987, LANCET, V2, P146; MORROW DA, 1997, CIRCULATION S1, V96, P216; MUNRO JM, 1988, LAB INVEST, V58, P249; Murray WM, 1997, NEW ENGL J MED, V337, P422; NAGAI H, 1984, Japanese Journal of Geriatrics, V21, P588; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; Oltrona L, 1997, AM J CARDIOL, V80, P1002, DOI 10.1016/S0002-9149(97)00593-6; OLTRONA L, 1995, NEW ENGL J MED, V332, P399; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; PEPYS MB, 1985, INT REV EXP PATHOL, V27, P83; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PETITTI DB, 1986, AM J EPIDEMIOL, V123, P89, DOI 10.1093/oxfordjournals.aje.a114227; PHILLIPS A, 1989, LANCET, V2, P1434; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; PHILLIPS AN, 1992, CANCER-AM CANCER SOC, V69, P680, DOI 10.1002/1097-0142(19920201)69:3<680::AID-CNCR2820690314>3.0.CO;2-D; Pietila K, 1997, AM J CARDIOL, V80, P1075, DOI 10.1016/S0002-9149(97)00606-1; Pietila KO, 1996, EUR HEART J, V17, P1345; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; REFSUM H, 1985, CLIN CHEM, V31, P624; RICH MW, 1992, AM J MED, V92, P7, DOI 10.1016/0002-9343(92)90008-Y; RICHARD JL, 1985, REV EPIDEMIOL SANTE, V33, P347; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rozzini R, 1997, J CLIN EPIDEMIOL, V50, P865; Rus H, 1997, NEW ENGL J MED, V337, P423; Sahyoun NR, 1996, J CLIN EPIDEMIOL, V49, P981, DOI 10.1016/0895-4356(96)00135-7; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; SHIBATA H, 1991, AGE AGEING, V20, P417, DOI 10.1093/ageing/20.6.417; SINZINGER H, 1992, FIBRINOGEN NEW CARDI, P46; SOETERS PB, 1990, LANCET, V335, P348, DOI 10.1016/0140-6736(90)90633-G; STEVENS RG, 1986, J NATL CANCER I, V76, P605, DOI 10.1093/jnci/76.4.605; STEVENS RG, 1983, AM J EPIDEMIOL, V118, P550, DOI 10.1093/oxfordjournals.aje.a113660; STEVENS RG, 1988, NEW ENGL J MED, V319, P1047, DOI 10.1056/NEJM198810203191603; STEVENS RG, 1990, LANCET, V335, P351; STONE MC, 1985, J ROY COLL GEN PRACT, V35, P565; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Sweetnam PM, 1996, EUR HEART J, V17, P1814; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; THOMPSON WD, 1992, FIBRINOGEN NEW CARDI, P35; Toss H, 1997, CIRCULATION, V96, P4204; TRACY R, 1997, CIRCULATION, V93, P622; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499; Weijenberg MP, 1997, EPIDEMIOLOGY, V8, P87, DOI 10.1097/00001648-199701000-00014; WEISS ST, 1995, AM J EPIDEMIOL, V142, P493, DOI 10.1093/oxfordjournals.aje.a117665; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; Woodward M, 1997, BRIT J HAEMATOL, V97, P785, DOI 10.1046/j.1365-2141.1997.1232935.x; YUDKIN JS, 1988, LANCET, V2, P530; ZALOKAR JB, 1981, NEW ENGL J MED, V304, P465, DOI 10.1056/NEJM198102193040806; Zhao YW, 1996, BIOCHEMISTRY-US, V35, P7174, DOI 10.1021/bi952242v; Zoellner H, 1996, J CELL SCI, V109, P2571	107	1684	1740	2	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1477	1482		10.1001/jama.279.18.1477	http://dx.doi.org/10.1001/jama.279.18.1477			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600484				2022-12-28	WOS:000073463500039
J	Ansari, A; Rockswold, G				Ansari, A; Rockswold, G			Cervical-disk herniation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Abbott NW Hosp, Minneapolis, MN 55407 USA		Ansari, A (corresponding author), Abbott NW Hosp, Minneapolis, MN 55407 USA.								0	4	5	1	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1358	1358		10.1056/NEJM199805073381905	http://dx.doi.org/10.1056/NEJM199805073381905			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571256				2022-12-28	WOS:000073463700005
J	Tsaloumas, MD; Potamitis, T; Kritzinger, EE				Tsaloumas, MD; Potamitis, T; Kritzinger, EE			Lesson of the week - Two cases of retention of wooden foreign bodies in orbit of eye	BRITISH MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; WOUNDS; AIR		City Hosp NHS Trust, Birmingham & Midland Eye Ctr, Birmingham B18 7QH, W Midlands, England		Tsaloumas, MD (corresponding author), City Hosp NHS Trust, Birmingham & Midland Eye Ctr, Birmingham B18 7QH, W Midlands, England.							GREANEY MJ, 1994, EYE, V8, P713, DOI 10.1038/eye.1994.185; GREEN BF, 1990, OPHTHALMOLOGY, V97, P608; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; MACRAE JA, 1979, BRIT J OPHTHALMOL, V63, P848, DOI 10.1136/bjo.63.12.848; MUTLUKAN E, 1991, BRIT J OPHTHALMOL, V75, P374, DOI 10.1136/bjo.75.6.374; SPECHT CS, 1992, SURV OPHTHALMOL, V36, P341, DOI 10.1016/0039-6257(92)90110-F; WEISMAN RA, 1983, ARCH OTOLARYNGOL, V109, P265	7	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1363	1364		10.1136/bmj.316.7141.1363	http://dx.doi.org/10.1136/bmj.316.7141.1363			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563992	Green Published			2022-12-28	WOS:000073483000023
J	Williams, DH; Maguire, AJ; Tsuzuki, W; Westwell, MS				Williams, DH; Maguire, AJ; Tsuzuki, W; Westwell, MS			An analysis of the origins of a cooperative binding energy of dimerization	SCIENCE			English	Article								The cooperativity between binding of cell wall precursor analogs (ligands)to and antibiotic dimerization of the clinically important vancomycin group antibiotics was investigated by nuclear magnetic resonance. When dimerization was weak in the absence of a ligand, the increase in the dimerization constant in the presence of a ligand derived largely from changes associated with tightening of the dimer interface. When dimerization was strong in the absence of a ligand,, the increase in the dimerization constant in the presence of a ligand derived largely from changes associated with tightening of the ligand-antibiotic interface. These results illustrate how, when a protein has a loose structure, the binding energy of another molecule to the protein can derive in part from changes occurring within the protein.	Univ Cambridge, Dept Chem, Cambridge Ctr Mol Recognit, Cambridge CB2 1EW, England; Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge CB2 2QW, England; Minist Agr Forestry & Fisheries, Natl Food Res Inst, Tsukuba, Ibaraki 305, Japan; Univ Oxford, Dyson Perrins Lab, Oxford OX1 3QY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ministry of Agriculture Forestry & Fisheries - Japan; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; University of Oxford	Williams, DH (corresponding author), Univ Cambridge, Dept Chem, Cambridge Ctr Mol Recognit, Lensfield Rd, Cambridge CB2 1EW, England.							BEAUREGARD DA, 1995, ANTIMICROB AGENTS CH, V39, P781, DOI 10.1128/AAC.39.3.781; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4501; Loll PJ, 1997, J AM CHEM SOC, V119, P1516, DOI 10.1021/ja963566p; MACKAY JP, 1994, J AM CHEM SOC, V116, P4581, DOI 10.1021/ja00090a006; Schafer M, 1996, STRUCTURE, V4, P1509, DOI 10.1016/S0969-2126(96)00156-6; SEARLE MS, 1996, J CHEM SOC P1, V10, P2781; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P89, DOI 10.1107/S0108768194010190; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STRYER L, 1988, BIOCHEMISTRY-US, P82; Williams DH, 1997, CHEM BIOL, V4, P507, DOI 10.1016/S1074-5521(97)90322-7; WILLIAMS DH, 1991, J AM CHEM SOC, V113, P7020, DOI 10.1021/ja00018a047; WILLIAMS DH, 1996, CHEM BIOL, V3, P6953	13	152	154	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					711	714		10.1126/science.280.5364.711	http://dx.doi.org/10.1126/science.280.5364.711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563941				2022-12-28	WOS:000073415600039
J	Anderson, WF				Anderson, WF			Human gene therapy	NATURE			English	Review							RETROVIRAL VECTORS; VIRUS; TRANSDUCTION; DELIVERY; RECEPTOR; DELETIONS; TISSUE; CELLS; LINE	Although gene therapy as a treatment for disease holds great promise, progress in developing effective clinical protocols has been slow. The problem lies in the development of safe and efficient gene-delivery systems. This review will evaluate the problems and the potential solutions in this new field of medicine.	Univ So Calif, Sch Med, Gene Therapy Labs, Los Angeles, CA 90033 USA	University of Southern California	Anderson, WF (corresponding author), Univ So Calif, Sch Med, Gene Therapy Labs, 1441 Eastlake Ave, Los Angeles, CA 90033 USA.							ALI M, 1994, GENE THER, V1, P367; ANDERSON WF, 1984, SCIENCE, V226, P401, DOI 10.1126/science.6093246; ANDERSON WF, 1993, HUM GENE THER, V4, P311, DOI 10.1089/hum.1993.4.3-311; ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; ANDERSON WF, 1989, J MED PHILOS, V14, P681, DOI 10.1093/jmp/14.6.681; Bilbao G, 1997, FASEB J, V11, P624, DOI 10.1096/fasebj.11.8.9240964; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; BREAKEFIELD XO, 1991, NEW BIOL, V3, P203; Brenner M, 1996, HUM GENE THER, V7, P1927, DOI 10.1089/hum.1996.7.16-1927; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Cosset FL, 1996, GENE THER, V3, P946; Cristiano RJ, 1996, CANCER GENE THER, V3, P49; Dass CR, 1997, DRUG DELIV, V4, P151, DOI 10.3109/10717549709051887; Dedieu JF, 1997, J VIROL, V71, P4626, DOI 10.1128/JVI.71.6.4626-4637.1997; DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125; Elkon KB, 1997, P NATL ACAD SCI USA, V94, P9814, DOI 10.1073/pnas.94.18.9814; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Fass D, 1997, SCIENCE, V277, P1662, DOI 10.1126/science.277.5332.1662; Fink DJ, 1997, NAT MED, V3, P357, DOI 10.1038/nm0397-357; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Fletcher J C, 1992, Law Med Health Care, V20, P26; Fletcher JC, 1996, HUM GENE THER, V7, P1605, DOI 10.1089/hum.1996.7.13-1605; Forestell SP, 1997, GENE THER, V4, P600, DOI 10.1038/sj.gt.3300420; Gao GP, 1996, J VIROL, V70, P8934, DOI 10.1128/JVI.70.12.8934-8943.1996; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; Haecker SE, 1996, HUM GENE THER, V7, P1907, DOI 10.1089/hum.1996.7.15-1907; Hall FL, 1997, HUM GENE THER, V8, P2183, DOI 10.1089/hum.1997.8.18-2183; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Haubrich R, 1995, Hum Gene Ther, V6, P941, DOI 10.1089/hum.1995.6.7-941; Havenga M, 1997, STEM CELLS, V15, P162, DOI 10.1002/stem.150162; Jacoby DR, 1997, GENE THER, V4, P1281, DOI 10.1038/sj.gt.3300578; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kaplan JM, 1997, HUM GENE THER, V8, P45, DOI 10.1089/hum.1997.8.1-45; KASAHARA N, 1994, SCIENCE, V266, P1373, DOI 10.1126/science.7973726; Kay MA, 1997, P NATL ACAD SCI USA, V94, P12744, DOI 10.1073/pnas.94.24.12744; Kearns WG, 1996, GENE THER, V3, P748; LI LN, 1995, NAT MED, V1, P705, DOI 10.1038/nm0795-705; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Linden RM, 1997, GENE THER, V4, P4, DOI 10.1038/sj.gt.3300357; Miller AD, 1997, NAT MED, V3, P278, DOI 10.1038/nm0397-278; Miller N, 1997, HUM GENE THER, V8, P803, DOI 10.1089/hum.1997.8.7-803; Nabel GJ, 1996, P NATL ACAD SCI USA, V93, P15388, DOI 10.1073/pnas.93.26.15388; OLDFIELD EH, 1993, HUM GENE THER, V4, P39, DOI 10.1089/hum.1993.4.1-39; *ORDA, 1988, ORDA REP HUM GEN THE; Orlic D, 1996, P NATL ACAD SCI USA, V93, P11097, DOI 10.1073/pnas.93.20.11097; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; Russell DW, 1996, J VIROL, V70, P217, DOI 10.1128/JVI.70.1.217-222.1996; SALMONS B, 1993, HUM GENE THER, V4, P129, DOI 10.1089/hum.1993.4.2-129; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schnierle BS, 1996, GENE THER, V3, P1069; Stopeck AT, 1997, J CLIN ONCOL, V15, P341, DOI 10.1200/JCO.1997.15.1.341; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Zhao Y, 1997, J VIROL, V71, P6967, DOI 10.1128/JVI.71.9.6967-6972.1997; ZHAO Y, IN PRESS J VIROL; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	56	818	1600	2	112	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 30	1998	392	6679		S			25	30						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK760	9579858				2022-12-28	WOS:000073360100006
J	Hartman, JJ; Mahr, J; McNally, K; Okawa, K; Iwamatsu, A; Thomas, S; Cheesman, S; Heuser, J; Vale, RD; McNally, FJ				Hartman, JJ; Mahr, J; McNally, K; Okawa, K; Iwamatsu, A; Thomas, S; Cheesman, S; Heuser, J; Vale, RD; McNally, FJ			Katanin, a microtubule-severing protein, is a novel AAA ATPase that targets to the centrosome using a WD40-containing subunit	CELL			English	Article							SENSITIVE FUSION PROTEIN; DYNAMIC INSTABILITY; GAMMA-TUBULIN; CAENORHABDITIS-ELEGANS; STABLE MICROTUBULES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MITOTIC SPINDLE; BETA-GAMMA; COMPLEX	Microtubule disassembly at centrosomes is involved in mitotic spindle function. The microtubule-severing protein katanin, a heterodimer of 60 and 80 kDa subunits, was previously purified and shown to localize to centrosomes in vivo. Here we report the sequences and activities of the katanin subunits, p60 is a new member of the AAA family of ATPases, and we show that expressed p60 has microtubule-stimulated ATPase and microtubule-severing activities in the absence of p80. p80 is a novel protein containing WD40 repeats, which are frequently involved in protein-protein interactions. The p80 WD40 domain does not participate in p60 dimerization, but localizes to centrosomes in transfected mammalian cells. These results indicate katanin's activities are segregated into a subunit (p60) that possesses enzymatic activity and a subunit (p80) that targets the enzyme to the centrosome.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Kanagawa, Japan; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Davis; Kirin Brewery Company Limited; Washington University (WUSTL)	McNally, FJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.				NIGMS NIH HHS [GM53060, GM49752] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049752, R01GM053060] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APTE AN, 1993, BIOTECHNIQUES, V15, P890; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DESAI A, 1995, J CELL BIOL, V28, P1; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Harlow E., 1988, ANTIBODIES LAB MANUA; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; HEUSER JE, 1983, J MOL BIOL, V169, P155, DOI 10.1016/S0022-2836(83)80179-X; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYMAN A, 1990, METHOD ENZYMOL, V196, P303; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; KITANISHIYUMURA T, 1987, CELL MOTIL CYTOSKEL, V8, P106, DOI 10.1002/cm.970080203; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; KOWALSKI RJ, 1993, J BIOL CHEM, V268, P9847; LIN CC, 1995, INT J CANCER, V63, P140, DOI 10.1002/ijc.2910630125; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; LYNCH TJ, 1986, J BIOL CHEM, V261, P7156; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1996, J CELL SCI, V109, P561; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; MORGAN A, 1994, J BIOL CHEM, V269, P29347; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F; SHIINA N, 1992, EMBO J, V11, P4723, DOI 10.1002/j.1460-2075.1992.tb05577.x; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; TUMA PL, 1994, J BIOL CHEM, V269, P30842; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; WEISS SA, 1995, BACULOVIRUS EXPRESSI, P79; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	58	262	272	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					277	287		10.1016/S0092-8674(00)81578-0	http://dx.doi.org/10.1016/S0092-8674(00)81578-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568719	Bronze			2022-12-28	WOS:000073174000013
J	Stapleton, JA; Sutherland, G; Russell, NAH				Stapleton, JA; Sutherland, G; Russell, NAH			How much does relapse after one year erode effectiveness of smoking cessation treatments? Long term follow up of randomised trial of nicotine nasal spray	BRITISH MEDICAL JOURNAL			English	Article									Inst Psychiat, Tobacco Res Sect, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London	Stapleton, JA (corresponding author), Inst Psychiat, Tobacco Res Sect, Natl Addict Ctr, London SE5 8AF, England.		Stapleton, John A/I-6550-2012					ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Mikkelsen K, 1994, J SMOK REL DIS, V5, P95; SILAGY C, 1994, LANCET, V343, P139, DOI 10.1016/S0140-6736(94)90933-4; SUTHERLAND G, 1992, LANCET, V340, P324, DOI 10.1016/0140-6736(92)91403-U; *US DHHS, 1990, DHHS PUBL	5	45	47	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 14	1998	316	7134					830	831		10.1136/bmj.316.7134.830	http://dx.doi.org/10.1136/bmj.316.7134.830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZC488	9565457	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000072584300030
J	Comuzzie, AG; Allison, DB				Comuzzie, AG; Allison, DB			The search for human obesity genes	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-MASS INDEX; DISCORDANT SIB PAIRS; LINKAGE ANALYSIS; MAJOR GENE; ENVIRONMENTAL CORRELATIONS; RECESSIVE INHERITANCE; EXTREME OVERWEIGHT; PIMA-INDIANS; FAT MASS	Understanding of the genetic influences on obesity has increased at a tremendous rate in recent years. By some estimates, 40 to 70 percent of the variation in obesity-related phenotypes in humans is heritable. Although several single-gene mutations have been shown to cause obesity in animal models, the situation in humans is considerably more complex. The most common forms of human obesity arise from the interactions of multiple genes, environmental factors, and behavior, and this complex etiology makes the search for obesity genes especially challenging. This article discusses the strategies currently being used to search for human obesity genes and recent promising results from these efforts.	Retina Fdn SW, Dept Genet, San Antonio, TX 78245 USA; Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA	Retina Foundation of the Southwest; Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Comuzzie, AG (corresponding author), Retina Fdn SW, Dept Genet, POB 760549, San Antonio, TX 78245 USA.			Allison, David/0000-0003-3566-9399	NHLBI NIH HHS [HL28972, HL45522] Funding Source: Medline; NIDDK NIH HHS [DK47256] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047256] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1997, BEHAV GENET, V27, P273, DOI 10.1023/A:1025627712109; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1998, GENETICS, V148, P859; Allison DB, 1996, INT J OBESITY, V20, P501; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; ALLISON DB, IN PRESS INT J OBES; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BAILEYWILSON JE, 1993, GENET EPIDEMIOL, V10, P665, DOI 10.1002/gepi.1370100656; Borecki I B, 1994, Obes Res, V2, P213; BORECKI IB, 1995, OBES RES, V3, P1; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Bouchard C, 1996, OBES RES, V4, P81, DOI 10.1002/j.1550-8528.1996.tb00516.x; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; Bouchard C, 1997, J NUTR, V127, pS1887, DOI 10.1093/jn/127.9.1887S; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CASSARD AM, 1990, J CELL BIOCHEM, V43, P255, DOI 10.1002/jcb.240430306; Chagnon YC, 1997, OBES RES, V5, P115, DOI 10.1002/j.1550-8528.1997.tb00651.x; Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Clement K, 1996, INT J OBESITY, V20, P507; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1996, J CLIN ENDOCR METAB, V81, P597, DOI 10.1210/jc.81.2.597; COMUZZIE AG, 1993, AM J HUM BIOL, V5, P725, DOI 10.1002/ajhb.1310050616; COMUZZIE AG, 1994, INT J OBESITY, V18, P413; Davenport CB., 1923, BODY BUILD ITS INHER; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Duggirala R, 1996, AM J HUM GENET, V59, P694; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; GEFFROY S, 1995, GENOMICS, V28, P603, DOI 10.1006/geno.1995.1201; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; HALL C, 1993, GENOMICS, V15, P461, DOI 10.1006/geno.1993.1093; Hani E, 1997, DIABETES, V46, P688, DOI 10.2337/diabetes.46.4.688; HASSTEDT SJ, 1989, AM J HUM GENET, V45, P917; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HUPPI K, 1995, GENOMICS, V25, P727, DOI 10.1016/0888-7543(95)80018-H; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MAGENIS RE, 1994, MAMM GENOME, V5, P503, DOI 10.1007/BF00369320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MEYER JM, 1995, BEHAV GENETIC APPROA; Meyer JM, 1993, OBESITY THEORY THERA; Michaud EJ, 1997, J ENDOCRINOL, V155, P207, DOI 10.1677/joe.0.1550207; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; Mitchell BD, 1998, J CLIN INVEST, V101, P584, DOI 10.1172/JCI512; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mountjoy KG, 1997, MOL CELL ENDOCRINOL, V128, P171, DOI 10.1016/S0303-7207(96)04017-8; Murray J. D., 1994, American Journal of Human Genetics, V55, pA197; Nakamura M, 1997, BBA-BIOMEMBRANES, V1328, P83, DOI 10.1016/S0005-2736(97)00131-4; NESS R, 1991, HUM BIOL, V63, P39; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; Norman RA, 1997, AM J HUM GENET, V60, P166; PERUSSE L, 1997, DIABETES, V5, P49; Pomp D, 1997, BEHAV GENET, V27, P285, DOI 10.1023/A:1025631813018; Price RA, 1996, INT J OBESITY, V20, P1044; PRICE RA, 1990, HUM BIOL, V62, P747; PRICE RA, 1996, REGULATION BODY WEIG; PROCHAZKA M, 1995, DIABETOLOGIA, V38, P461, DOI 10.1007/s001250050306; PROCHAZKA M, 1991, MOUSE GENOME, V89, P280; RICE T, 1993, AM J HUM GENET, V52, P967; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Solanes G, 1997, J BIOL CHEM, V272, P25433, DOI 10.1074/jbc.272.41.25433; Steinberg KK, 1997, AM J EPIDEMIOL, V145, P917; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; WILSON AF, 1991, AM J HUM GENET, V48, P862; ZHANG W, 1992, J ANIM SCI, V70, P1307, DOI 10.2527/1992.7051307x	81	377	398	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	1998	280	5368					1374	1377		10.1126/science.280.5368.1374	http://dx.doi.org/10.1126/science.280.5368.1374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603720				2022-12-28	WOS:000073883400034
J	Beecham, L				Beecham, L			Medical students face average overdraft of 1000 pound	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1540	1540						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582163				2022-12-28	WOS:000073707700090
J	Morrell, CJ; Walters, SJ; Dixon, S; Collins, KA; Brereton, LML; Peters, J; Brooker, CGD				Morrell, CJ; Walters, SJ; Dixon, S; Collins, KA; Brereton, LML; Peters, J; Brooker, CGD			Cost effectiveness of community leg ulcer clinics: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS ULCERS; COMPRESSION; INDEX; CARE	Objectives: To establish the relative cost effectiveness of community leg ulcer clinics that use four layer compression bandaging versus usual care provided by district nurses. Design: Randomised controlled trial with 1 year of follow up. Setting: Eight community based research clinics in four trusts in Trent Subjects: 233 patients with venous leg ulcers allocated at random to intervention (120) or control (113) group. Interventions: Weekly treatment with four layer bandaging in a leg ulcer clinic (clinic group) or usual care at home by the district nursing service (control group). Main outcome measures: Time to complete ulcer healing, patient health status, and recurrence of ulcers. Satisfaction with care, use of services, and personal costs were also monitored. Results: The ulcers of patients in the clinic group tended to heal sooner than those in the control group over the whole 12 month follow up (log rank P = 0.03). At 12 weeks, 34% of patients in the clinic group were healed compared with 24% in the control. The crude initial healing rate of ulcers in intervention compared with control patients was 1.45 (95% confidence interval 1.04 to 2.03), No significant differences were found between the groups in health status. Mean total NHS costs were pound 878.06 per year for the clinic group and pound 859.34 for the control (P = 0.89). Conclusions: Community based leg ulcer clinics with trained nurses using four layer bandaging is more effective than traditional home based treatment. This benefit is achieved at a small additional cost and could be delivered at reduced cost if certain service configurations were used.	Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; No Gen Hosp, Sch Nursing & Midwifery, Sheffield S5 7NA, S Yorkshire, England; Univ Manchester, Sch Nursing, Manchester M13 9PL, Lancs, England	University of Sheffield; Northern General Hospital; University of Manchester	Morrell, CJ (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.	j.morrell1@sheffield.ac.uk		Brooker, Charlie/0000-0003-1005-526X; Dixon, Simon/0000-0001-7394-7009				ANDERSON MH, 1995, QUAL LIFE RES, V4, P388; [Anonymous], 1997, BRIT J COMMUNITY HLT, V2, P427; [Anonymous], 1995, COMP HLTH STAT; BLAIR SD, 1988, BRIT MED J, V297, P1159, DOI 10.1136/bmj.297.6657.1159; BLAIR SD, 1988, PHLEBOLOGY, V31, P129; Bosanquet N, 1993, Health Trends, V25, P146; BOSANQUET N, 1992, PHLEBOLOGY, V7, P44; Brereton, 1998, BRIT J COMMUNITY NUR, V3, P6; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; CALLAM MJ, 1985, BRIT MED J, V290, P1855, DOI 10.1136/bmj.290.6485.1855; COLGAN MP, 1990, BRIT MED J, V300, P972, DOI 10.1136/bmj.300.6730.972; Collett D, 1994, MODELLING SURVIVAL D; CULLUM N, 1994, NURSING MANAGEMENT L; Efron B., 1994, MONOGRAPHS STAT APPL; Fletcher A, 1995, J Wound Care, V4, P471; FRANKS PJ, 1995, AGE AGEING, V24, P490, DOI 10.1093/ageing/24.6.490; Hamer C, 1994, J Wound Care, V3, P99; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Hyland M E, 1994, J Wound Care, V3, P294; LAING W, 1992, CHRONIC VENOUS DIS L; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MOFFATT CJ, 1992, BRIT MED J, V305, P1389, DOI 10.1136/bmj.305.6866.1389; Morrell L., 1997, BRIT J COMMUNITY HLT, V2, P156; NETTEN A, 1996, UNIT COSTS HLTH SOCI; NORUSIS NJ, 1993, SPSS WINDOWS ADV STA; Price P, 1993, J Wound Care, V2, P304; Simon DA, 1996, BRIT MED J, V312, P1648, DOI 10.1136/bmj.312.7047.1648; SKENE AI, 1992, BRIT MED J, V305, P1119, DOI 10.1136/bmj.305.6862.1119; Thompson B, 1996, J WOUND CARE, V5, P212; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson E., 1989, HLTH THENDS, V21, P97	33	104	106	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	1998	316	7143					1487	1491		10.1136/bmj.316.7143.1487	http://dx.doi.org/10.1136/bmj.316.7143.1487			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582132	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000073707700020
J	Nolan, JP				Nolan, JP			Internal medicine in the current health care environment: A need for reaffirmation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FAMILY-PRACTICE; PHYSICIAN; SPECIALTY	Managed care has substantially changed the environment of health care delivery for general internists and internist-subspecialists. In the current system, one may wonder whether detailed and thoughtful workups still have a role when the direction of medical practice increasingly prizes a high volume of brief encounters. However, the very forces that drive managed care make the role of internist in the care of adults even more central. The internist's unique training and clinical approach should lead to both medically effective and cost-effective health care for adults. This type of health care will be increasingly important as the U.S. population ages and an increasing number of Americans have chronic, multisystem disease. Over the past century, internal medicine has evolved from a consultative model to a discipline that encompasses total adult care, from prevention to diagnosis and treatment of acute and chronic illness and from outpatient care in the off ice to inpatient care in the intensive care unit. However, the leadership role of internists in the medical care of adults is now being threatened by family medicine and by fragmentation within internal medicine itself. Managed care organizations and the general public must be shown why internists are better able than family physicians to meet the health care needs of adults. Furthermore, as the marketplace becomes more competitive, the issue of when care given by a subspecialist is superior to that given by an internist has become more prominent. The rapidly developing "hospitalist" movement also threatens the traditional role of the internist as the caregiver for adults in health and disease. Given the historic flexibility of internal medicine and the assumption that appropriate roles can be defined for family physicians, subspecialists, and hospitalists, internists will continue to play a central role in providing the best care for adults in the new world of health care delivery.	SUNY Buffalo, Dept Med, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nolan, JP (corresponding author), SUNY Buffalo, Dept Med, 462 Grider St, Buffalo, NY 14215 USA.							BEESON PB, 1986, ANN INTERN MED, V105, P436, DOI 10.7326/0003-4819-105-3-436; Bender FH, 1996, AM J KIDNEY DIS, V28, P67, DOI 10.1016/S0272-6386(96)90132-8; CHERKIN DC, 1986, MED CARE, V24, P1136, DOI 10.1097/00005650-198612000-00006; Davidson C, 1997, LANCET, V350, P1645, DOI 10.1016/S0140-6736(05)64270-5; GLICKMAN RM, 1993, ANN INTERN MED, V118, P903, DOI 10.7326/0003-4819-118-11-199306010-00014; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; KASSIRER JP, 1994, NEW ENGL J MED, V331, P1151, DOI 10.1056/NEJM199410273311709; KIMBALL HR, 1994, JAMA-J AM MED ASSOC, V271, P315, DOI 10.1001/jama.271.4.315; NOLAN JP, 1994, NEW ENGL J MED, V330, P1456, DOI 10.1056/NEJM199405193302014; Saultz JW, 1996, ANN INTERN MED, V124, P600, DOI 10.7326/0003-4819-124-6-199603150-00009; STEVENS R, 1986, ANN INTERN MED, V105, P592, DOI 10.7326/0003-4819-105-4-592; TURNER BJ, 1994, MED CARE, V32, P902, DOI 10.1097/00005650-199409000-00002; WACHTE RM, 1996, NEW ENGL J MED, V335, P512; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027	14	18	20	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					857	862		10.7326/0003-4819-128-10-199805150-00010	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599199				2022-12-28	WOS:000073586500010
J	Beecham, L				Beecham, L			Irish qualifications and the specialist register	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1465	1465						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572776				2022-12-28	WOS:000073651600074
J	Pounder, D; Carson, D; Davison, M; Orihara, Y				Pounder, D; Carson, D; Davison, M; Orihara, Y			Evaluation of indices of obesity in men: descriptive study	BRITISH MEDICAL JOURNAL			English	Article							WAIST CIRCUMFERENCE		Dundee Royal Infirm, Dept Forens Med, Dundee DD1 9ND, Scotland		Pounder, D (corresponding author), Dundee Royal Infirm, Dept Forens Med, Dundee DD1 9ND, Scotland.							BJORNTORP P, 1992, ANN MED, V24, P15, DOI 10.3109/07853899209164140; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; TunstallPedoe H, 1997, BMJ-BRIT MED J, V314, P1291, DOI 10.1136/bmj.314.7090.1291	5	14	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 9	1998	316	7142					1428	1429		10.1136/bmj.316.7142.1428	http://dx.doi.org/10.1136/bmj.316.7142.1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN495	9572754	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000073651600030
J	Koshland, DE				Koshland, DE			The era of pathway quantification	SCIENCE			English	Article							COVALENT MODIFICATION; SYSTEMS; ULTRASENSITIVITY; PHOSPHORYLATION; SENSITIVITY; CASCADE		Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Koshland, DE (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.							Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; GOLDBETER A, 1987, J BIOL CHEM, V262, P4460; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Lehninger A., 1993, PRINCIPLES BIOCH; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Stryer L., 1988, BIOCHEMISTRY-US	12	82	83	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					852	853		10.1126/science.280.5365.852	http://dx.doi.org/10.1126/science.280.5365.852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9599157				2022-12-28	WOS:000073532900028
J	Perottoni, CA; da Jornada, JAH				Perottoni, CA; da Jornada, JAH			Pressure-induced amorphization and negative thermal expansion in ZrW2O8	SCIENCE			English	Article							X-RAY-DIFFRACTION; FRAMEWORK SILICATES; MEMORY-GLASS; INSTABILITY; MODES; ICE	It has recently been shown that zirconium tungstate (ZrW2O8) exhibits isotropic negative thermal expansion over its entire temperature range of stability. This rather unusual behavior makes this compound particularly suitable for testing model predictions of a connection between negative thermal expansion and pressure-induced amorphization. High-pressure x-ray diffraction and Raman scattering experiments showed that ZrW2O8 becomes progressively amorphous from 1.5 to 3.5 gigapascals. The amorphous phase was retained after pressure release, but the original crystalline phase returned after annealing at 923 kelvin. The results indicate a general trend between negative thermal expansion and pressure-induced amorphization in highly flexible framework structures.	Univ Fed Rio Grande Sul, Inst Fis, BR-91501970 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	da Jornada, JAH (corresponding author), Univ Fed Rio Grande Sul, Inst Fis, BR-91501970 Porto Alegre, RS, Brazil.	jornada@if.ufrgs.br	Perottoni, Cláudio A./B-8409-2008	Perottoni, Cláudio A./0000-0002-8425-845X				CHANG LLY, 1967, J AM CERAM SOC, V50, P211, DOI 10.1111/j.1151-2916.1967.tb15084.x; DESGRENIERS S, 1994, J APPL CRYSTALLOGR, V27, P432, DOI 10.1107/S0021889893012610; Dove MT, 1995, MINERAL MAG, V59, P629, DOI 10.1180/minmag.1995.059.397.07; Evans JSO, 1997, SCIENCE, V275, P61, DOI 10.1126/science.275.5296.61; Evans JSO, 1996, CHEM MATER, V8, P2809, DOI 10.1021/cm9602959; EVANS JSO, 1997, CHEM MATER, V275, P61; GILLET P, 1995, PHYS REV B, V51, P11262, DOI 10.1103/PhysRevB.51.11262; GOTOTSKI YG, 1997, MATER RES INNOV, V1, P3; GRAHAM J, 1959, J AM CERAM SOC, V42, P570, DOI 10.1111/j.1151-2916.1959.tb13575.x; Khvostantsev L. G., 1984, High Temperatures - High Pressures, V16, P165; KRUGER MB, 1990, SCIENCE, V249, P647, DOI 10.1126/science.249.4969.647; Lyapin AG, 1996, PHYS REV B, V54, P12036, DOI 10.1103/PhysRevB.54.12036; MEADE C, 1992, PHYS REV LETT, V69, P1387, DOI 10.1103/PhysRevLett.69.1387; Mishima O, 1996, NATURE, V384, P546, DOI 10.1038/384546a0; Nguyen JH, 1997, PHYS REV LETT, V78, P1936, DOI 10.1103/PhysRevLett.78.1936; PIERMARINI GJ, 1975, REV SCI INSTRUM, V46, P973, DOI 10.1063/1.1134381; PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957; Pryde AKA, 1996, J PHYS-CONDENS MAT, V8, P10973, DOI 10.1088/0953-8984/8/50/023; SCLORTINO F, 1995, PHYS REV E, V52, P6484; SERGHIOU GC, 1992, PHYS REV LETT, V68, P3311, DOI 10.1103/PhysRevLett.68.3311; Sharma SM, 1996, PROG MATER SCI, V40, P1, DOI 10.1016/0079-6425(95)00006-2; SHERMAN WF, 1987, EXPT TECHNIQUES HIGH, pCH6; Speedy RJ, 1996, J PHYS-CONDENS MAT, V8, P10907, DOI 10.1088/0953-8984/8/50/017; TSE JS, 1993, PHYS REV LETT, V70, P174, DOI 10.1103/PhysRevLett.70.174; TSE JS, 1994, NATURE, V369, P724, DOI 10.1038/369724a0; TSE JS, 1992, J CHEM PHYS, V96, P5482, DOI 10.1063/1.462732	30	233	258	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	1998	280	5365					886	889		10.1126/science.280.5365.886	http://dx.doi.org/10.1126/science.280.5365.886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9572729				2022-12-28	WOS:000073532900036
J	Nightingale, SL				Nightingale, SL			New rule proposed for home drug abuse test kits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Hlth Affairs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Nightingale, SL (corresponding author), US FDA, Off Hlth Affairs, Parklawn Bldg,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1339	1339		10.1001/jama.279.17.1339	http://dx.doi.org/10.1001/jama.279.17.1339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK758	9582030				2022-12-28	WOS:000073359800005
J	Lewin, RJP; Ingleton, R; Newens, AJ; Thompson, DR				Lewin, RJP; Ingleton, R; Newens, AJ; Thompson, DR			Adherence to cardiac rehabilitation guidelines: a survey of rehabilitation programmes in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article									Univ Hull, Fac Hlth, Inst Rehabil, Hull HU3 2PG, N Humberside, England	University of Hull	Lewin, RJP (corresponding author), Univ York, Dept Hlth Studies, British Heart Fdn Rehabil Res Unit, York YO10 5DQ, N Yorkshire, England.		Thompson, David R/E-2431-2018; Thompson, David R/C-6320-2009	Thompson, David R/0000-0001-8518-6307; 				*AUD COMM, 1995, DEAR OUR HEARTS COMM; LEWIN R, 1997, CARDIAC REHABILITATI, P21; Thompson DR, 1996, HEART, V75, P89, DOI 10.1136/hrt.75.1.89; Thompson DR, 1997, INT J CARDIOL, V59, P299, DOI 10.1016/S0167-5273(97)02951-3; World Health Organization [WHO], 1993, NEEDS ACT PRIOR CARD	5	47	47	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 2	1998	316	7141					1354	1355		10.1136/bmj.316.7141.1354	http://dx.doi.org/10.1136/bmj.316.7141.1354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL882	9563986	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000073483000019
J	Kelso, JAS; Fuchs, A; Lancaster, R; Holroyd, T; Cheyne, D; Weinberg, H				Kelso, JAS; Fuchs, A; Lancaster, R; Holroyd, T; Cheyne, D; Weinberg, H			Dynamic cortical activity in the human brain reveals motor equivalence	NATURE			English	Article							CELL DISCHARGE; ARM MOVEMENTS; CORTEX; DIRECTION; FIELDS	That animals and humans can accomplish the same goal using different effecters and different goals using the same effecters attests to the remarkable flexibility of the central nervous system. This phenomenon has been termed 'motor equivalence'(1,2), an example being the writing of a name with a pencil held between the toes or teeth. The idea of motor equivalence has reappeared because single-cell studies in monkeys have shown that parameters of voluntary movement (such as direction) may be specified in the brain, relegating muscle activation to spinal interneuronal systems(3,4). Using a novel experimental paradigm(5) and a full-head SQUID (for superconducting quantum interference device) array to record magnetic fields corresponding to ongoing brain activity, we demonstrate: (1), a robust relationship between time-dependent activity in sensorimotor cortex and movement velocity, independent of explicit task requirements; and (2) neural activations that are specific to task demands alone. It appears, therefore, that signatures of motor equivalence in humans may be found in dynamic patterns of cortical activity.	Florida Atlantic Univ, Ctr Complex Syst, Program Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; Simon Fraser Univ, Brain Behav Lab, Burnaby, BC V5A 1S6, Canada	State University System of Florida; Florida Atlantic University; Simon Fraser University	Kelso, JAS (corresponding author), Florida Atlantic Univ, Ctr Complex Syst, Program Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.			Cheyne, Douglas/0000-0002-2663-498X				BARTLETT NR, 1959, PSYCHOL REV, V66, P203, DOI 10.1037/h0046490; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; CHEYNE D, 1989, EXP BRAIN RES, V78, P604; Dunlap K, 1910, PSYCHOL REV, V17, P399, DOI 10.1037/h0074736; Fuchs A, 1992, INT J BIFURCAT CHAOS, V2, P917, DOI 10.1142/S0218127492000537; Georgopoulos AP, 1997, NEUROSCIENTIST, V3, P52, DOI 10.1177/107385849700300115; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; KRISTEVA R, 1991, ELECTROEN CLIN NEURO, V81, P284, DOI 10.1016/0168-5597(91)90015-P; Lashley KS, 1930, PSYCHOL REV, V37, P1, DOI 10.1037/h0074134; MORAN DW, IN PRESS J NEUROPHYS; Romani G L, 1989, ADV BIOMAGNETISM, P33; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; UHL C, 1995, PHYS REV E, V51, P3890, DOI 10.1103/PhysRevE.51.3890; WIESENDANGER M, 1982, PHYSIOL REV, V62, P1234, DOI 10.1152/physrev.1982.62.4.1234; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; [No title captured]	18	135	137	2	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1998	392	6678					814	818		10.1038/33922	http://dx.doi.org/10.1038/33922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZJ679	9572140				2022-12-28	WOS:000073241200053
J	Wilmoth, JR				Wilmoth, JR			The future of human longevity: A demographer's perspective	SCIENCE			English	Article							MORTALITY; LIMITS		Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wilmoth, JR (corresponding author), Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA.	jrw@demog.berkeley.edu						AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bourgeois-pichat J, 1978, Popul Bull UN, P12; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; PARTRIDGE L, 1997, ZEUS SALMON BIODEMOG, P78; Preston SH, 1995, STATE HUMANITY, P30; *SOC SEC ADM, 1997, 112 SOC SEC ADM OFF; *UN, 1977, WORLD POP PROSP ASS; United Nations. Dept. for Economic and Social Information and Policy Analysis. Population Division, 1995, WORLD POP PROSP 1994; Wilmoth J., 1997, ZEUS SALMON BIODEMOG, P38; Wilmoth J. R., 1996, HLTH MORTALITY ELDER, P266	15	87	89	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	1998	280	5362					395	397		10.1126/science.280.5362.395	http://dx.doi.org/10.1126/science.280.5362.395			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH907	9575086				2022-12-28	WOS:000073159600033
J	Baron, JH				Baron, JH			Sir Francis Avery Jones - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																		JONES FJ, PUBLICATION LIST	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1678	1678		10.1136/bmj.316.7145.1678	http://dx.doi.org/10.1136/bmj.316.7145.1678			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603768	Green Published			2022-12-28	WOS:000074022700056
J	Pencheon, D				Pencheon, D			Managing demand: Matching demand and supply fairly and efficiently	BRITISH MEDICAL JOURNAL			English	Article									Univ Cambridge, Inst Publ Hlth, Cambridge CB2 2SR, England	University of Cambridge	Pencheon, D (corresponding author), Univ Cambridge, Inst Publ Hlth, Forvie Site, Cambridge CB2 2SR, England.							BARRY MJ, 1995, MED CARE, V33, P771, DOI 10.1097/00005650-199508000-00003; Coulter A, 1997, J Health Serv Res Policy, V2, P112; DelMar AR, 1996, BRIT MED J, V313, P1334; Little P, 1997, BRIT MED J, V315, P350; Ovretveit JA, 1997, EUR J PUBLIC HEALTH, V7, P128, DOI 10.1093/eurpub/7.2.128; Pencheon D, 1998, BRIT MED J, V316, P215; PEYSNER J, 1996, J MED DENTAL DEFENCE, V12, P4; Stevens A, 1991, Health Trends, V23, P20; VICKERY DM, 1995, J OCCUP ENVIRON MED, V37, P551, DOI 10.1097/00043764-199505000-00001	9	41	41	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1665	1667		10.1136/bmj.316.7145.1665	http://dx.doi.org/10.1136/bmj.316.7145.1665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603757	Green Published			2022-12-28	WOS:000074022700033
J	Altare, F; Durandy, A; Lammas, D; Emile, JF; Lamhamedi, S; Le Deist, F; Drysdale, P; Jouanguy, E; Doffinger, R; Bernaudin, F; Jeppsson, O; Gollob, JA; Meinl, E; Segal, AW; Fischer, A; Kumararatne, D; Casanova, JL				Altare, F; Durandy, A; Lammas, D; Emile, JF; Lamhamedi, S; Le Deist, F; Drysdale, P; Jouanguy, E; Doffinger, R; Bernaudin, F; Jeppsson, O; Gollob, JA; Meinl, E; Segal, AW; Fischer, A; Kumararatne, D; Casanova, JL			Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency	SCIENCE			English	Article							IFN-GAMMA PRODUCTION; HUMAN T-CELLS; INFECTION; CYTOKINE; RESISTANCE; COMPLEX; PROTEIN; MICE	In humans, interferon gamma (IFN-gamma) receptor deficiency leads to a predisposition to mycobacterial infections and impairs the formation of mature granulomas. Interleukin-12 (IL-12) receptor deficiency was found in otherwise healthy individuals with mycobacterial infections. Mature granulomas were seen, surrounded by T cells and centered with epithelioid and multinucleated giant cells, yet reduced IFN-gamma concentrations were found to be secreted by activated natural killer and T cells. Thus, IL-12-dependent IFN-gamma secretion in humans seems essential in the control of mycobacterial infections, despite the formation of mature granulomas due to IL-12-independent IFN-gamma secretion.	Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; UCL, Dept Med, London WC1 E6JJ, England; Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Hosp, Dept Pediat, S-14501 Norsborg, Sweden; Ctr Hosp Intercommunal, Serv Pediat, F-94010 Creteil, France; Hop Paul Brousse, Serv Anatomopathol, F-94804 Villejuif, France; Univ Birmingham, Sch Med, Dept Immunol, Birmingham B15 2TT, W Midlands, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of Erlangen Nuremberg; Harvard University; Dana-Farber Cancer Institute; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; University of Birmingham	Casanova, JL (corresponding author), Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France.	casanova@ceylan.necker.fr	Casanova, Jean-Laurent/I-3418-2017; Jouanguy, Emmanuelle/H-7901-2017; altare, frederic/K-8664-2015; Durandy, Anne/H-7475-2017	Jouanguy, Emmanuelle/0000-0002-7358-9157; altare, frederic/0000-0002-5077-4616; Meinl, Edgar/0000-0002-2570-6785; Segal, Anthony/0000-0001-7602-9043; Durandy, Anne/0000-0001-7706-8466; Casanova, Jean-Laurent/0000-0002-7782-4169				Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; ALTARE F, 1997, RES INFECT DIS B I P, V95, P143; ANDERSON P, 1990, J IMMUNOL, V144, P574; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; CASANOVA JL, IN PRESS PRIMARY IMM; CHUA AO, 1994, J IMMUNOL, V153, P128; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; de Jong R, 1998, SCIENCE, V280, P1435; deJong R, 1997, J IMMUNOL, V159, P786; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Frucht DM, 1996, J IMMUNOL, V157, P411; Gollob JA, 1997, EUR J IMMUNOL, V27, P647, DOI 10.1002/eji.1830270311; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1997, J INTERF CYTOK RES, V17, P583, DOI 10.1089/jir.1997.17.583; JOUANGUY E, UNPUB; Kohno K, 1997, J IMMUNOL, V158, P1541; Lamhamedi S, 1998, INT J MOL MED, V1, P415; LEDEIST F, 1987, J IMMUNOL, V138, P423; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1997, INFECT IMMUN, V65, P4378, DOI 10.1128/IAI.65.11.4378-4383.1997; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; MEINL E, 1995, IMMUNOL TODAY, V16, P55, DOI 10.1016/0167-5699(95)80087-5; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Modlin RL, 1995, RES IMMUNOL, V146, P526, DOI 10.1016/0923-2494(96)83027-6; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Wu CY, 1997, J IMMUNOL, V159, P1658	39	650	667	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	1998	280	5368					1432	1435		10.1126/science.280.5368.1432	http://dx.doi.org/10.1126/science.280.5368.1432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ591	9603732				2022-12-28	WOS:000073883400055
J	Kuttner, R				Kuttner, R			Must good HMOs go bad? First of two parts - The commercialization of prepaid group health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											Kuttner, R (corresponding author), 6 Univ Rd, Cambridge, MA 02138 USA.							*ADV BOARD, 1996, CAP STRAT, P171; *AETN US HEALTHC, 1997, QUAL CAR COMP SYST M; *AM SOC INT MED, 1995, PAT ACC INT SUBSP GA, P6; *AM SOC INT MED, 1995, ASS APPR PAT CAR CAP; Crowley W., 1996, SERVE GREATEST NUMBE; *FAM US, 1997, COMP MED HMOS DO THE; GOLD MR, 1995, NEW ENGL J MED, V333, P1678, DOI 10.1056/NEJM199512213332505; *HJ KAIS FAM FDN, 1998, MARK FACTS FEBR 1998; *HLTH CAR ADV BOAR, 1997, FUT REV SUST GROWTH, P15; *HLTH CAR FIN ADM, 1997, REQ PHYS INC PLANS; Luft HS, 1996, MILBANK Q, V74, P445, DOI 10.2307/3350389; NELSON H, 1997, NONPROFIT FOR PROFIT, P1; *OXF HLTH PLANS, 1997, REP SEC EXCH COMM; *PAC BUS GROUP HLT, 1997, CONS SAT HMOS; Simon CJ, 1997, HEALTH AFFAIR, V16, P120, DOI 10.1377/hlthaff.16.3.120; Starr P, 1982, SOCIAL TRANSFORMATIO; Thompson RS, 1996, MILBANK Q, V74, P469, DOI 10.2307/3350390; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; 1996, CONSUMER REPORTS AUG, P40; 1997, US NEWS WORLD R 1023, P62	20	54	54	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	1998	338	21					1558	1563		10.1056/NEJM199805213382123	http://dx.doi.org/10.1056/NEJM199805213382123			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZN943	9599120				2022-12-28	WOS:000073699100032
J	Szczech, LA; Berlin, JA; Feldman, HI				Szczech, LA; Berlin, JA; Feldman, HI		Anti-Lymphocyte Antibody Induction Therapy Stu	The effect of antilymphocyte induction therapy on renal allograft survival - A meta-analysis of individual patient-level data	ANNALS OF INTERNAL MEDICINE			English	Article						kidney transplantation; antilymphocyte serum; transplantation, homologous; graft survival; meta-analysis	CYCLOSPORINE-TREATED RECIPIENTS; CADAVER KIDNEY-TRANSPLANTS; RANDOMIZED CLINICAL-TRIAL; OKT3 MONOCLONAL-ANTIBODY; 3-YEAR FOLLOW-UP; MULTIVARIATE-ANALYSIS; GRAFT-SURVIVAL; IMMUNOSUPPRESSION; GLOBULIN; REJECTION	Purpose: Randomized, controlled trials have not shown that the perioperative use of antilymphocyte antibodies (induction therapy) improves survival of cadaveric kidney allografts. This study combined individual patient-level data from published trials to examine the effect of induction therapy on allograft survival. Data Sources: Randomized, controlled trials identified from MEDLINE. Study Selection: Published trials that compared adult recipients of cadaveric renal allografts who did and did not receive antilymphocyte antibodies in the perioperative period were selected if individual patient-level data were available. Data Extraction and Analysis: Individual patient-level data were collected for each of 628 study patients. Multivariable Cox proportional hazards regression was used to estimate the effect of induction therapy on allograft survival. Results: The adjusted rate ratio for allograft failure with induction therapy compared with conventional therapy was 0.62 (95% CI, 0.43 to 0.90) (P = 0.012) over 2 years and 0.82 (CI, 0.62 to 1.09) (P = 0.17) over 5 years. The effect of induction therapy on allograft survival diminished over time; no benefit overall was seen after 2 years after transplantation (rate ratio, 1.13 [CI, 0.72 to 1.78]) (P > 0.2). Greater HLA-DR mismatch, delayed allograft function, diabetes mellitus in the recipient, African-American ethnicity of the recipient, and presensitization (panel-reactive antibody levels greater than or equal to 20%) were significantly associated with allograft failure at 5 years. Among high-risk patients, only those who were presensitized benefited from induction therapy at 2 years (rate ratio, 0.12 [CI, 0.03 to 0.44]) (P = 0.001). Results were similar at 5 years. Conclusions: Using individual-level data, this study showed a benefit of induction therapy at 2 years, particularly among presensitized patients. Although the benefit of this therapy subsequently waned, presensitized patients continued to have benefit at 5 years.	Univ Penn, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; New York Med Coll, Westchester Cty Med Ctr, Div Nephrol, Valhalla, NY 10595 USA	University of Pennsylvania; New York Medical College; Westchester Medical Center	Feldman, HI (corresponding author), Univ Penn, Med Ctr, Ctr Clin Epidemiol & Biostat, 720 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK045191, T32DK007006] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-45191, DK-07006] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE O, 1992, LANCET, V339, P71; ABRAMOWICZ D, 1992, TRANSPLANTATION, V54, P433, DOI 10.1097/00007890-199209000-00009; [Anonymous], 1992, Lancet, V339, P1; BABCOCK SK, 1987, TRANSPLANT P, V19, P303; BANHEGYI C, 1991, TRANSPLANT P, V23, P2207; BELITSKY P, 1994, TRANSPLANT P, V26, P2485; BELITSKY P, 1991, TRANSPLANT P, V23, P999; BENVENISTY AI, 1990, TRANSPLANTATION, V49, P321, DOI 10.1097/00007890-199002000-00019; CACCIARELLI T, 1993, CLIN NEPHROL, V39, P335; CALNE RY, 1985, LANCET, V2, P549; Canadian Multicentre Transplant Study Group, 1986, N Engl J Med, V314, P1219; CANAFAX DM, 1993, TRANSPLANT P, V25, P1692; CECKA JM, 1992, TRANSPLANTATION, V53, P59, DOI 10.1097/00007890-199201000-00011; CHANG TW, 1981, P NATL ACAD SCI-BIOL, V78, P1805, DOI 10.1073/pnas.78.3.1805; CHO YW, 1994, CLIN TRANSPLANTS 199, P469; CHO YW, 1995, CLIN TRANSPLANTS 199, P435; Collett D, 1994, MODELLING SURVIVAL D; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Cox D. R., 1984, ANAL SURVIVAL DATA; Feldman HI, 1996, NEPHROL DIAL TRANSPL, V11, P1306; FORTIN PR, 1995, J CLIN EPIDEMIOL, V48, P1379, DOI 10.1016/0895-4356(95)00028-3; FRANCO A, 1994, TRANSPLANT P, V26, P2522; GASTON RS, 1992, TRANSPLANTATION, V53, P103, DOI 10.1097/00007890-199201000-00020; HALLORAN PF, 1988, TRANSPLANTATION, V46, P223, DOI 10.1097/00007890-198808000-00007; KAHAN BD, 1987, TRANSPLANTATION, V43, P65, DOI 10.1097/00007890-198701000-00015; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KERMAN RH, 1991, TRANSPLANTATION, V51, P338, DOI 10.1097/00007890-199102000-00013; LAFFERTY KJ, 1984, TRANSPLANT P, V16, P927; LLOVERAS J, 1992, TRANSPLANT P, V24, P43; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *MED EC, 1997, 1997 DRUG TOP RED BO; MICHAEL HJ, 1989, TRANSPLANTATION, V48, P805, DOI 10.1097/00007890-198911000-00016; MOZES MF, 1993, TRANSPLANT P, V25, P575; NORMAN DJ, 1993, TRANSPLANTATION, V55, P44, DOI 10.1097/00007890-199301000-00009; OPELZ G, 1978, NEW ENGL J MED, V299, P369, DOI 10.1056/NEJM197808242990801; OPELZ G, 1989, TRANSPLANT P, V21, P3918; OPELZ G, 1987, TRANSPLANT P, V19, P3737; OPELZ G, 1992, TRANSPLANT P, V24, P2342; Opelz G, 1995, TRANSPLANTATION, V60, P1220; OPELZ G, 1987, TRANSPLANT P, V19, P641; PONTICELLI C, 1988, TRANSPLANTATION, V45, P908, DOI 10.1097/00007890-198805000-00013; SHACKLETON CR, 1991, TRANSPLANTATION, V52, P1008, DOI 10.1097/00007890-199112000-00014; SLAKEY DP, 1993, TRANSPLANTATION, V56, P827, DOI 10.1097/00007890-199310000-00009; SNELL GD, 1957, ANNU REV MICROBIOL, V11, P439, DOI 10.1146/annurev.mi.11.100157.002255; SOMMER BG, 1987, TRANSPLANTATION, V43, P85, DOI 10.1097/00007890-198701000-00019; Steinberg KK, 1997, AM J EPIDEMIOL, V145, P917; STEINMULLER DR, 1991, TRANSPLANTATION, V52, P67, DOI 10.1097/00007890-199107000-00014; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1991, BRIT MED J, V303, P884; SWINNEN LJ, 1990, NEW ENGL J MED, V323, P1723, DOI 10.1056/NEJM199012203232502; Szczech LA, 1997, J AM SOC NEPHROL, V8, P1771; TERASAKI P, 1994, CLIN TRANSPLANTS 199, P553; Terasaki P I, 1995, Clin Transpl, P487; THISTLETHWAITE JR, 1989, AM J KIDNEY DIS, V14, P28; THISTLETHWAITE JR, 1988, AM J KIDNEY DIS, V11, P112, DOI 10.1016/S0272-6386(88)80192-6; *US DEP HHS, 1994, ANN REP US SCI REG T; WEIMAR W, 1987, TRANSPLANT P, V19, P3612	57	104	108	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	1998	128	10					817	+		10.7326/0003-4819-128-10-199805150-00004	http://dx.doi.org/10.7326/0003-4819-128-10-199805150-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZM889	9599193				2022-12-28	WOS:000073586500004
J	Saunders, RC; Kolachana, BS; Bachevalier, J; Weinberger, DR				Saunders, RC; Kolachana, BS; Bachevalier, J; Weinberger, DR			Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine	NATURE			English	Article							VENTRAL TEGMENTAL AREA; CAUDATE-NUCLEUS; SUBCORTICAL DOPAMINE; RHESUS-MONKEY; RELEASE; CORTEX; RATS; SCHIZOPHRENIA; PROJECTIONS; DAMAGE	The effects of early brain damage are often, but not always, milder than the effects of comparable damage in adults, depending on the age at which injury occurred, the region of the brain damaged, and the brain functions involved(1-7). Studies of the impact of early brain damage have generally focused on functions primarily associated with the neural structures injured, even though the development and function of distant but interconnected neural systems might also show effects. Here we examine the regulation of striatal dopamine by the dorsolateral prefrontal cortex, in adult monkeys that had had either neonatal or adult lesions of the medial-temporal lobe and in normal animals. We use microdialysis to measure the dopamine response in the caudate nucleus after the infusion of amphetamine into the dorsolateral prefrontal cortex. Normal animals and those with adult lesions showed a reduction in dopamine overflow; in contrast, monkeys with neonatal lesions showed increased dopamine release. Thus, early injury to the primate medial-temporal lobe disrupts the normal regulation of striatal dopamine activity by the dorsolateral prefrontal cortex during adulthood. Early focal lesions may have substantial and long-lasting impacts on the function of a distant neural system.	Univ Texas, Dept Neurobiol & Anat, Houston, TX 77030 USA; St Elizabeths Hosp, NIMH, Ctr Neurosci, Clin Brain Disorders Branch, Washington, DC 20032 USA	University of Texas System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Saunders, RC (corresponding author), NIMH, Clin Brain Disorders Branch, Bldg 49,Room 1B80,49 Convent Dr, Bethesda, MD 20892 USA.	rcs@ln.nimh.nih.gov						Bebbington P. E., 1995, P587; Bertolino A, 1997, CEREB CORTEX, V7, P740, DOI 10.1093/cercor/7.8.740; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Carlsson A, 1997, LIFE SCI, V61, P75, DOI 10.1016/S0024-3205(97)00228-2; Fuster J.M., 1989, PREFRONTAL CORTEX; GOLDMAN PS, 1974, PLASTICITY RECOVERY, P147; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; Karreman M, 1996, J NEUROCHEM, V66, P589; KOLACHANA BS, 1995, NEUROSCIENCE, V69, P859, DOI 10.1016/0306-4522(95)00246-F; Kolachana BS, 1997, SYNAPSE, V25, P285; KOLB B, 1987, BEHAV BRAIN RES, V25, P205, DOI 10.1016/0166-4328(87)90069-6; KOLB B, 1994, BRAIN RES, V645, P85, DOI 10.1016/0006-8993(94)91641-1; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; LIPSKA BK, 1995, P NATL ACAD SCI USA, V92, P8906, DOI 10.1073/pnas.92.19.8906; MAHUT H, 1986, HIPPOCAMPUS, V4, P241; Malkova L, 1997, ANN NY ACAD SCI, V807, P538, DOI 10.1111/j.1749-6632.1997.tb51961.x; MALKOVA L, 1995, BEHAV NEUROSCI, V109, P212, DOI 10.1037/0735-7044.109.2.212; MOGHADDAM B, 1993, SYNAPSE, V13, P215, DOI 10.1002/syn.890130304; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; SMITH Y, 1986, NEUROSCIENCE, V18, P347, DOI 10.1016/0306-4522(86)90159-4; TABER MT, 1995, J NEUROCHEM, V65, P1407; WEBSTER MJ, 1991, NEUROREPORT, V2, P769, DOI 10.1097/00001756-199112000-00010; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C; [No title captured]	29	125	125	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 14	1998	393	6681					169	171		10.1038/30245	http://dx.doi.org/10.1038/30245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	9603519				2022-12-28	WOS:000073619900048
J	Sankila, R; Olsen, JH; Anderson, H; Garwicz, S; Glattre, E; Hertz, H; Langmark, F; Lanning, M; Moller, T; Tulinius, H				Sankila, R; Olsen, JH; Anderson, H; Garwicz, S; Glattre, E; Hertz, H; Langmark, F; Lanning, M; Moller, T; Tulinius, H		Assoc Nordic Canc Registries; Nordic Soc Paediatric Haematology Oncology	Risk of cancer among offspring of childhood-cancer survivors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Increasing numbers of children with cancer survive and reach reproductive age. However, the risk of cancer (other than retinoblastoma) in the offspring of survivors of childhood and adolescent cancer is uncertain. Methods Using data from national cancer and birth registries, we assessed the risk of cancer among 5847 offspring of 14,652 survivors of cancer in childhood or adolescence diagnosed since the 1940s and 1950s in Denmark, Finland, Iceland, Norway, and Sweden. The offspring were followed up for a diagnosis of cancer for 86,780 person-years, and standardized incidence ratios were calculated. Results Among the 5847 offspring, 44 malignant neoplasms were diagnosed (standardized incidence ratio, 2.6; 95 percent confidence interval, 1.9 to 3.5). There were 17 retinoblastomas, yielding a standardized incidence ratio of 37. There were 27 neoplasms other than retinoblastoma (standardized incidence ratio, 1.6; 95 percent confidence interval, 1.1 to 2.4). The second most common primary site of cancer among the offspring was the brain and nervous system, in which eight tumors were observed (standardized incidence ratio, 2.0; 95 percent confidence interval, 0.9 to 3.9). There were between zero and four apparently sporadic cases of cancer in other primary sites among the offspring. Excluding 4 likely cases of hereditary cancer and 2 subsequent cancers among the offspring with hereditary retinoblastoma, there were 22 sporadic cancers, for a standardized incidence ratio of 1.3 (95 percent confidence interval, 0.8 to 2.0). Conclusions There is no evidence of a significantly increased risk of nonhereditary cancer among the offspring of survivors of cancer in childhood. (C)1998, Massachusetts Medical Society.	Finnish Canc Registry, FIN-00170 Helsinki, Finland; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; So Swedish Reg Canc Registry, Lund, Sweden; Univ Lund Hosp, Dept Pediat, S-22185 Lund, Sweden; Canc Registry Norway, Oslo, Norway; Copenhagen Univ Hosp, Dept Pediat, Copenhagen, Denmark; Univ Hosp Oulu, Dept Pediat, Oulu, Finland; Iceland Canc Registry, Reykjavik, Iceland	Finnish Cancer Registry; Danish Cancer Society; Lund University; Skane University Hospital; University of Oslo; University of Copenhagen	Sankila, R (corresponding author), Finnish Canc Registry, Liisankatu 21 B, FIN-00170 Helsinki, Finland.			Olsen, Jorgen Helge/0000-0001-9633-5662				BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BROWN PD, 1995, ACTA PAEDIATR, V84, P316, DOI 10.1111/j.1651-2227.1995.tb13636.x; *CAN SOC FINL, 1996, CANC SOC FINL PUBL, V57; HAWKINS MM, 1995, BRIT J CANCER, V71, P1335, DOI 10.1038/bjc.1995.259; HAWKINS MM, 1989, INT J CANCER, V43, P975, DOI 10.1002/ijc.2910430604; MULVIHILL JJ, 1987, LANCET, V2, P813; OLSEN JH, 1993, BRIT MED J, V307, P1030, DOI 10.1136/bmj.307.6911.1030; *WHO, 1957, MAN INT STAT CLASS D, V1	8	121	123	1	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1339	1344		10.1056/NEJM199805073381902	http://dx.doi.org/10.1056/NEJM199805073381902			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571253	Bronze			2022-12-28	WOS:000073463700002
J	Landon, BE; Wilson, IB; Cleary, PD				Landon, BE; Wilson, IB; Cleary, PD			A conceptual model of the effects of health care organizations on the quality of medical care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED-CARE; MAINTENANCE ORGANIZATION; FINANCIAL INCENTIVES; PHYSICIANS; ARRANGEMENTS; HMOS; INTEGRATION; CAPITATION; GUIDELINES; DELIVERY	There has been a great deal of interest in recent years in developing measures of health care quality that can be used to characterize and study the effects of health plans. However, because of the recent emergence of diverse types of health care organizations, it is often difficult to know which parts of a plan should be combined for analysis purposes. Also, simple taxonomies of health maintenance organizations (eg, staff, independent practice associations, group, and network) no longer adequately describe the diverse types of organizations that have become common. In this article we describe these trends, explain why older taxonomies of health care plans are not adequate, and present a new framework for characterizing and studying the effects of diverse types of plans.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; Tufts Univ, New England Med Ctr Hosp, Sch Med, Primary Care Outcomes Res Inst, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr Hosp, Sch Med, Dept Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University	Cleary, PD (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	Cleary@hcp.med.harvard.edu	Cleary, Paul/AAF-7048-2019; Wilson, Ira/F-9190-2016	Wilson, Ira/0000-0002-0246-738X	BHP HRSA HHS [5T 32 PE 11001-8] Funding Source: Medline	BHP HRSA HHS		BURNS LR, 1994, HEALTH SERV RES, V29, P583; CHERKIN DC, 1989, MED CARE, V27, P1036, DOI 10.1097/00005650-198911000-00005; CORRIGAN J, 1992, MED CARE, V33, pJS18; DIACON SR, 1995, INT REV LAW ECON, V15, P405, DOI 10.1016/0144-8188(95)00038-0; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1972, MILBANK MEML FUND Q, V50, P103, DOI 10.2307/3349436; EISENBERG J, 1986, DOCTORS DECISIONS CO; EISENBERG JM, 1981, JAMA-J AM MED ASSOC, V246, P2195, DOI 10.1001/jama.246.19.2195; Friedman E, 1996, JAMA-J AM MED ASSOC, V275, P957, DOI 10.1001/jama.275.12.957; Gold M, 1997, INQUIRY-J HEALTH CAR, V34, P29; GOLD MR, 1995, NEW ENGL J MED, V333, P1678, DOI 10.1056/NEJM199512213332505; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; HILLMAN AL, 1987, NEW ENGL J MED, V317, P1743, DOI 10.1056/NEJM198712313172725; HILLMAN AL, 1992, MED CARE, V30, P136, DOI 10.1097/00005650-199202000-00005; HILLMAN AL, 1991, HEALTH AFFAIR, V10, P138, DOI 10.1377/hlthaff.10.4.138; HILLMAN AL, 1990, ANN INTERN MED, V112, P891, DOI 10.7326/0003-4819-112-12-891; IGLEHART JK, 1992, NEW ENGL J MED, V327, P742, DOI 10.1056/NEJM199209033271029; KERR EA, 1995, ANN INTERN MED, V123, P500, DOI 10.7326/0003-4819-123-7-199510010-00004; Kletke PR, 1996, JAMA-J AM MED ASSOC, V276, P555, DOI 10.1001/jama.276.7.555; Kralewski J E, 1996, J Ambul Care Manage, V19, P1; LASKER RD, 1992, INQUIRY-J HEALTH CAR, V29, P287; LEWIS LM, 1995, ANN EMERG MED, V25, P9, DOI 10.1016/S0196-0644(95)70348-9; Luft HS, 1996, MILBANK Q, V74, P445, DOI 10.2307/3350389; MADISON DL, 1988, MILBANK Q, V66, P240, DOI 10.2307/3350032; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; MCNEIL BJ, 1992, INQUIRY-J HEALTH CAR, V29, P298; MOLINARI C, 1995, MED CARE, V33, P170; Morrisey MA, 1996, HEALTH AFFAIR, V15, P62, DOI 10.1377/hlthaff.15.4.62; MUNDINGER MO, 1994, NEW ENGL J MED, V330, P211, DOI 10.1056/NEJM199401203300314; NEWHOUSE JP, 1978, J HUM RESOUR, V13, P159, DOI 10.2307/145251; Office of Technology Assessment, 1986, 37 OFF TECHN ASS; OLEARY D, 1992, MED CARE, V33, pJS13; PFEFFER J, 1973, ADMIN SCI QUART, V18, P349, DOI 10.2307/2391668; Schlackman N, 1993, Am J Med Qual, V8, P103, DOI 10.1177/0885713X9300800214; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; SHORTELL SM, 1995, MILBANK Q, V73, P131, DOI 10.2307/3350254; SHORTELL SM, 1994, HEALTH AFFAIR, V13, P46, DOI 10.1377/hlthaff.13.5.46; SOX HC, 1979, ANN INTERN MED, V91, P459, DOI 10.7326/0003-4819-91-3-459; Swartz K, 1996, ANN INTERN MED, V124, P442, DOI 10.7326/0003-4819-124-4-199602150-00009; Tierney W M, 1996, Proc AMIA Annu Fall Symp, P459; TIERNEY WM, 1995, J AM MED INFORM ASSN, V2, P316, DOI 10.1136/jamia.1995.96073834; UDVARHELYI IS, 1991, ANN INTERN MED, V115, P394, DOI 10.7326/0003-4819-115-5-394; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WEINER JP, 1993, J HEALTH POLIT POLIC, V18, P75, DOI 10.1215/03616878-18-1-75; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553; WELCH WP, 1990, MILBANK Q, V68, P221, DOI 10.2307/3350097; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; 1996, FED REG, V61, P13430	49	135	141	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	1998	279	17					1377	1382		10.1001/jama.279.17.1377	http://dx.doi.org/10.1001/jama.279.17.1377			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZK758	9582046				2022-12-28	WOS:000073359800030
J	Green, J; Britten, N				Green, J; Britten, N			Qualitative research and evidence based medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England; United Med & Dent Sch Guys & St Thomas Hosp, Dept Gen Practice, London SE11 6SP, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Green, J (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	j.green@lshtm.ac.uk		Green, Judith/0000-0002-2315-5326				Adams S, 1997, SOC SCI MED, V45, P189, DOI 10.1016/S0277-9536(96)00333-4; [Anonymous], 1993, BRIT MED J, V306, P776; Atkinson P, 1995, MED TALK MED WORK LI; *AUD COMM, 1996, WHAT DOCT ORD STUD G; Blaxter M., 1996, MED SOCIOLOGY NEWS, V22, P68; Boulton M, 1996, J Eval Clin Pract, V2, P171, DOI 10.1111/j.1365-2753.1996.tb00041.x; BRITTEN N, 1994, BRIT J GEN PRACT, V44, P465; BurdettSmith P, 1997, BRIT MED J, V314, P1549; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; DOWELL J, 1995, SCOTTISH CONSENSUS S; Fitzpatrick R, 1994, Qual Health Care, V3, P107; Freidson E., 1988, PROFESSION MED STUDY; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; GREER AL, 1994, CONTROL CLIN TRIALS, V15, P431, DOI 10.1016/0197-2456(94)90001-9; HEWETT G, 1994, JUST PART ME MENS RE; HULL FM, 1987, FAM PRACT, V4, P123, DOI 10.1093/fampra/4.2.123; Katon W, 1981, RELEVANCE SOCIAL SCI, P253; Marinker M, 1997, BRIT MED J, V314, P747, DOI 10.1136/bmj.314.7082.747; Mays N, 1996, QUALITATIVE RES HLTH; Mishler EG, 1984, DISCOURSE MED DIALEC; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; OAKLEY A, 1990, WOMENS HLTH COUNTS; OSMAN LM, 1993, THORAX, V48, P827, DOI 10.1136/thx.48.8.827; Tuckett D., 1985, M EXPERTS APPROACH S; *U COLL LOND MED S, 1997, 4 UK WORKSH TEACH EV	26	276	286	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	1998	316	7139					1230	1232		10.1136/bmj.316.7139.1230	http://dx.doi.org/10.1136/bmj.316.7139.1230			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ518	9583929	Green Published			2022-12-28	WOS:000073224100031
J	Schrenzel, J; Serrander, L; Banfi, B; Nusse, O; Fouyouzi, R; Lew, DP; Demaurex, N; Krause, KH				Schrenzel, J; Serrander, L; Banfi, B; Nusse, O; Fouyouzi, R; Lew, DP; Demaurex, N; Krause, KH			Electron currents generated by the human phagocyte NADPH oxidase	NATURE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; HUMAN-NEUTROPHILS; CONDUCTANCE; METABOLISM; CHANNELS; CELLS	Electron transport across biological membranes is a well-known feature of bacteria, mitochondria and chloroplasts, where it provides motive forces for vectorial transport processes(1). In contrast, electron transport is generally not found in the plasma membrane of eukaryotic cells, possibly because it would interfere with electric processes at the plasma membrane. An exception is provided by the phagocyte NADPH oxidase, which generates superoxide (O-2(.-)) through electron transfer from cytosolic NADPH to extracellular oxygen(2-5). The enzyme is essential for host defence, and patients with chronic granulomatous disease, who lack the functional enzyme, suffer from severe infections(6,7). It has been suggested that electron transfer by the NADPH oxidase might be electrogenic(8). Here we demonstrate, using the whole-cell patch-clamp technique, the generation of electron currents by the NADPH oxidase in human eosinophil granulocytes. The currents were absent in granulocytes of sufferers of chronic granulomatous disease and under conditions of low oxygen. Generation of electron currents across the plasma membrane of eukaryotic cells has not been observed previously and might be - independently of the generation of superoxide - a physiologically relevant function of the phagocyte NADPH oxidase.	Univ Hosp Geneva, Dept Med, Div Infect Dis, CH-1211 Geneva 4, Switzerland; Univ Geneva, Med Ctr, Dept Physiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Krause, KH (corresponding author), Univ Hosp Geneva, Dept Med, Div Infect Dis, CH-1211 Geneva 4, Switzerland.		Nüsse, Oliver/J-8645-2013; Schrenzel, Jacques/P-8525-2017; Krause, Karl-Heinz/E-8030-2011; Serrander, Lena/W-4117-2017	Nüsse, Oliver/0000-0003-0068-8346; Schrenzel, Jacques/0000-0001-5464-7764; Krause, Karl-Heinz/0000-0002-9033-6768; Serrander, Lena/0000-0002-9058-3582; Demaurex, Nicolas/0000-0002-9933-6772; Banfi, Botond/0000-0001-9273-1318				BENESCH RE, 1953, SCIENCE, V118, P447, DOI 10.1126/science.118.3068.447; Boxer L A, 1996, Pediatr Rev, V17, P19, DOI 10.1542/pir.17-1-19; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CLARK RA, 1990, HOSP PRACT, V25, P51; CORRONS JLV, 1982, BLOOD, V59, P428; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DEMAUREX N, 1993, EUR J HAEMATOL, V51, P309; DEMAUREX N, 1992, J CLIN INVEST, V90, P830, DOI 10.1172/JCI115958; GALLIN EK, 1990, CURR TOP MEMBR TRANS, V35, P127; GORDIENKO DV, 1996, J PHYSL, V496, P229; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Hille B., 1992, IONIC CHANNELS EXCIT; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; MITCHELL P, 1991, BIOSCIENCE REP, V11, P297, DOI 10.1007/BF01130212; NANDA A, 1991, Cellular Physiology and Biochemistry, V1, P65, DOI 10.1159/000154595; NEWBURGER PE, 1979, NEW ENGL J MED, V300, P178, DOI 10.1056/NEJM197901253000406; Saier MH, 1997, ASM NEWS, V63, P13; Schrenzel J, 1996, AM J PHYSIOL-CELL PH, V271, pC1861, DOI 10.1152/ajpcell.1996.271.6.C1861; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; SHULT PA, 1985, J LAB CLIN MED, V106, P638; VARNAI P, 1993, J PHYSIOL-LONDON, V472, P373, DOI 10.1113/jphysiol.1993.sp019952; ZIMMERLI W, 1983, HELV PAEDIATR ACTA, V38, P51	24	165	168	2	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 16	1998	392	6677					734	737		10.1038/33725	http://dx.doi.org/10.1038/33725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565037				2022-12-28	WOS:000073129000064
J	Savulescu, J				Savulescu, J			Commentary: Safety of participants in non-therapeutic research must be ensured	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOXIA		Monash Univ, Ctr Human Bioeth, Clayton, Vic 3168, Australia	Monash University	Savulescu, J (corresponding author), Monash Univ, Ctr Human Bioeth, Gallery Bldg,Wellington Rd, Clayton, Vic 3168, Australia.							*COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; FOSTER L, 1996, MANUAL RES ETHICS CO; *ROYAL COLL PHYS, 1986, RES HLTH VOL WORK PA; SEVERINGHAUS JW, 1989, J CLIN MONITOR, V5, P72, DOI 10.1007/BF01617877; Waters KA, 1996, RESP PHYSIOL, V105, P135, DOI 10.1016/0034-5687(96)00046-1	5	13	13	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 21	1998	316	7135					891	892						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD691	9569393				2022-12-28	WOS:000072713300023
J	Reidy, A; Minassian, DC; Vafidis, G; Joseph, J; Farrow, S; Wu, J; Desai, P; Connolly, A				Reidy, A; Minassian, DC; Vafidis, G; Joseph, J; Farrow, S; Wu, J; Desai, P; Connolly, A			Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							URBAN-POPULATION	Objective: To estimate the magnitude of serious eye disorders and of visual impairment in a defined elderly population of a typical metropolitan area in England, and to assess the frequency they were in touch with, Or known to, the eye care services. Design: Cross sectional survey using two stage cluster random sampling. Setting: General practices in north London. Subjects: Random sample of people aged 65 and older, drawn from a defined population of elderly people registered with 17 general practice groups. Main outcome measures: Proportions and population prevalence estimates were determined for visual acuity, assessed with the person's own spectacles (if any), classified into four categories: prevalence of cataract, age related macular degeneration, and refractive error causing visual impairment and of definite primary open angle glaucoma; and status of contact with eye services. Results: 1547 of 1840 (84%) eligible people were examined. The population prevalence of bilateral Sampling visual impairment (visual acuity < 6/12) was 30%, of which 72% was potentially remediable. 92 of these 448 cases (21%) had visual acuity < 6/60 ("blindness") in one or both eyes. Prevalence of cataract causing visual impairment was 30%; 88% of these people were not in touch with the eye services. The prevalence of vision impairing, age related macular degeneration was 8% and of glaucoma (definite cases) was 3%. Three quarters of the people with definite glaucoma were not known to the eye services. Conclusions: Untreated visual impairment and eye disorders affect a substantial proportion of people aged 65 years and older. These findings should contribute to the setting up of future strategies for preservation of sight and eye health services in general.	UCL, Inst Ophthalmol, London EC1V 9EJ, England; Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Cent Middlesex Hosp, London NW10 7NS, England; Middlesex Univ, London N11 2NQ, England; Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of London; University College London; University of Southampton; Imperial College London; Middlesex University; University of Southampton	Minassian, DC (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EJ, England.							Attebo K, 1996, OPHTHALMOLOGY, V103, P357; CHYLACK LT, 1988, ARCH OPHTHALMOL-CHIC, V106, P330; Cochran W.G., 2007, SAMPLING TECHNIQUES; COFFEY M, 1993, BRIT J OPHTHALMOL, V77, P17, DOI 10.1136/bjo.77.1.17; GIBSON JM, 1985, T OPHTHAL SOC UK, V104, P196; JARMAN B, 1984, BRIT MED J, V289, P1587, DOI 10.1136/bmj.289.6458.1587; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Livingston P M, 1995, Ophthalmic Epidemiol, V2, P151, DOI 10.3109/09286589509057097; Rahmani B, 1996, OPHTHALMOLOGY, V103, P1721, DOI 10.1016/S0161-6420(96)30435-1; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; WORMALD RPL, 1992, BRIT MED J, V304, P1226, DOI 10.1136/bmj.304.6836.1226	12	165	168	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 30	1998	316	7145					1643	1646		10.1136/bmj.316.7145.1643	http://dx.doi.org/10.1136/bmj.316.7145.1643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZR867	9603746	Bronze, Green Published			2022-12-28	WOS:000074022700023
J	Harrington, R; Whittaker, J; Shoebridge, P; Campbell, F				Harrington, R; Whittaker, J; Shoebridge, P; Campbell, F			Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder	BRITISH MEDICAL JOURNAL			English	Review							SCHOOL-CHILDREN; SOCIAL SKILLS; FOLLOW-UP; INTERVENTION; TRIAL; SYMPTOMS; NORTRIPTYLINE; METAANALYSIS; PREVENTION; PROGRAM	Objective: To determine whether cognitive behaviour therapy is an effective treatment for childhood and adolescent depressive disorder. Design: Systematic review of six randomised trials comparing the efficacy of cognitive behaviour therapy with inactive interventions in subjects aged 8 to 19 years with depressive disorder. Main outcome measure: Remission from depressive disorder. Results: The rate of remission from depressive disorder was higher in the therapy group (129/208; 62%) than in the comparison group (61/168; 36%). The pooled odds ratio was 3.2 (95% confidence interval 1.9 to 5.2), suggesting a significant benefit of active treatment. Most studies, however, were based on relatively mild cases of depression and were of only moderate quality. Conclusions: Cognitive behaviour therapy may be of benefit for depressive disorder of moderate severity in children and adolescents. It cannot, however, yet be recommended for severe depression. Definitive large trials will be required to determine whether the results of this systematic review are reliable.	Royal Manchester Childrens Hosp, Dept Child & Adolescent Psychiat, Manchester M27 1HA, Lancs, England; Hope Hosp, Res & Dev Support Unit, Salford M6 8HD, Lancs, England	Royal Manchester Children's Hospital	Harrington, R (corresponding author), Royal Manchester Childrens Hosp, Dept Child & Adolescent Psychiat, Manchester M27 1HA, Lancs, England.	R.C.Harrington@man.ac.uk						American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Beardslee WR, 1996, J AM ACAD CHILD PSY, V35, P774, DOI 10.1097/00004583-199606000-00017; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; BUTLER L, 1980, AM EDUC RES J, V17, P111, DOI 10.3102/00028312017001111; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; CLARKE G, 1992, BEHAV THER, V23, P341, DOI 10.1016/S0005-7894(05)80162-5; CLARKE GN, 1995, J AM ACAD CHILD PSY, V34, P312, DOI 10.1097/00004583-199503000-00016; Clarke GN., 1993, J ADOL RES, V8, P183, DOI [10.1177/074355489382004, DOI 10.1177/074355489382004]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; FINE S, 1991, J AM ACAD CHILD PSY, V30, P79, DOI 10.1097/00004583-199101000-00012; GELLER B, 1992, J AM ACAD CHILD PSY, V31, P34, DOI 10.1097/00004583-199201000-00007; GELLER B, 1990, PSYCHOPHARMACOL BULL, V26, P85; GOODYER IM, 1992, HDB AFFECTIVE DISORD, P585; Harrington R, 1994, CHILD ADOL PSYCH CL, P330; HARRINGTON RC, 1998, COGNITIVE BEHAV THER, P163; Hawton KE, 1989, COGNITIVE BEHAV THER; HAZELL P, 1995, BRIT MED J, V310, P897, DOI 10.1136/bmj.310.6984.897; JAYCOX LH, 1994, BEHAV RES THER, V32, P801, DOI 10.1016/0005-7967(94)90160-0; Jayson D, 1998, J AM ACAD CHILD PSY, V37, P35, DOI 10.1097/00004583-199801000-00014; KAHN JS, 1990, SCHOOL PSYCHOL REV, V19, P196; KELLAM SG, 1991, AM J COMMUN PSYCHOL, V19, P563, DOI 10.1007/BF00937992; KING CA, 1990, J COMMUNITY PSYCHOL, V18, P167, DOI 10.1002/1520-6629(199004)18:2<167::AID-JCOP2290180208>3.0.CO;2-Z; KOLVIN I, 1991, BRIT J PSYCHIAT, V159, P9, DOI 10.1192/S0007125000292106; Kroll L, 1996, J AM ACAD CHILD PSY, V35, P1156, DOI 10.1097/00004583-199609000-00013; LEWINSOHN P, 1997, PSYCHOSOCIAL TREATME, P109; LEWINSOHN PM, 1990, BEHAV THER, V21, P385, DOI 10.1016/S0005-7894(05)80353-3; LIDDLE B, 1990, BEHAV PSYCHOTHER, V18, P85, DOI 10.1017/S0141347300018218; Marcotte D., 1993, CAN J COUNS, V27, P77; Mufson L., 1993, INTERPERSONAL PSYCHO; PUIGANTICH J, 1987, ARCH GEN PSYCHIAT, V44, P81; REED MK, 1994, ADOLESCENCE, V29, P293; REYNOLDS WM, 1986, J CONSULT CLIN PSYCH, V54, P653, DOI 10.1037/0022-006X.54.5.653; Ross James D., 1996, P157, DOI 10.1037/10196-007; Rutter M., 1986, DEPRESSION YOUNG PEO, P3; SANDLER IN, 1992, AM J COMMUN PSYCHOL, V20, P491, DOI 10.1007/BF00937756; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; Stark K. D., 1990, CHILDHOOD DEPRESSION; STARK KD, 1987, J ABNORM CHILD PSYCH, V15, P91, DOI 10.1007/BF00916468; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Vostanis P, 1996, J AFFECT DISORDERS, V40, P105, DOI 10.1016/0165-0327(96)00054-7; Vostanis P., 1996, CLIN CHILD PSYCHOL P, V1, P199, DOI DOI 10.1177/1359104596012003; Weisz JR, 1997, J CONSULT CLIN PSYCH, V65, P703, DOI 10.1037/0022-006X.65.4.703; WILLIAMS JMG, 1992, PSYCHOL TREATMENT DE; Wood A, 1996, J CHILD PSYCHOL PSYC, V37, P737, DOI 10.1111/j.1469-7610.1996.tb01466.x	46	109	112	0	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 23	1998	316	7144					1559	1563		10.1136/bmj.316.7144.1559	http://dx.doi.org/10.1136/bmj.316.7144.1559			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZQ495	9596592	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000073867800019
J	Kewley, GD				Kewley, GD			Personal paper: Attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Learning Assessment Ctr, Horsham RH12 2PD, W Sussex, England		Kewley, GD (corresponding author), Learning Assessment Ctr, Horsham RH12 2PD, W Sussex, England.	achorsham@aol.com						*AUSTR NAT HLTH ME, 1996, REP WORK PART ADHD; Barkley RA., 1991, ATTENTION DEFICIT HY; Cantwell DP, 1996, J AM ACAD CHILD PSY, V35, P978, DOI 10.1097/00004583-199608000-00008; Dulcan MK, 1997, J AM ACAD CHILD PSY, V36, P1311; KEWLEY GD, IN PRESS ADHD GUIDE; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Parliamentary Office of Science and Technology, 1997, POST TECH REP, V92, P1; Rutter M, 1970, NEUROPSYCHIATRIC STU; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; TAYLOR E, 1995, BRIT MED J, V310, P1617, DOI 10.1136/bmj.310.6995.1617; WILLIAMS R, 1995, CHILD ADOLESCENT MEN	11	30	30	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	1998	316	7144					1594	1595		10.1136/bmj.316.7144.1594	http://dx.doi.org/10.1136/bmj.316.7144.1594			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZQ495	9596603	Green Published			2022-12-28	WOS:000073867800032
J	Schoelkopf, RJ; Wahlgren, P; Kozhevnikov, AA; Delsing, P; Prober, DE				Schoelkopf, RJ; Wahlgren, P; Kozhevnikov, AA; Delsing, P; Prober, DE			The radio-frequency single-electron transistor (RF-SET): A fast and ultrasensitive electrometer	SCIENCE			English	Article							SMALL TUNNEL-JUNCTIONS; COULOMB BLOCKADE; DC SQUIDS; NOISE; OSCILLATIONS	A new type of electrometer is described that uses a single-electron transistor (SET) and that allows large operating speeds and extremely high charge sensitivity. The SET readout was accomplished by measuring the damping of a 1.7-gigahertz resonant circuit in which the device is embedded, and in some ways is the electrostatic "dual" of the well-known radio-frequency superconducting quantum interference device. The device is more than two orders of magnitude faster than previous single-electron devices, with a constant gain from de to greater than 100 megahertz. For a still-unoptimized device, a charge sensitivity of 1.2 x 10(-5) e/root hertz was obtained at a frequency of 1.1 megahertz, which is about an order of magnitude better than a typical, 1/f-noise-limited SET,and corresponds to an energy sensitivity (in joules per hertz) of about 41 (h) over bar.	Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Dept Phys, New Haven, CT 06520 USA; Chalmers, Dept Microelect & Nanosci, S-41296 Gothenburg, Sweden; Univ Goteborg, S-41296 Gothenburg, Sweden	Yale University; Yale University; Chalmers University of Technology; University of Gothenburg	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	rob.schoelkopf@yale.edu	Kozhevnikov, Alexay/A-1092-2013; Schoelkopf, Robert J/J-8178-2012; Delsing, Per/F-7288-2010	Kozhevnikov, Alexay/0000-0002-0033-9747; Delsing, Per/0000-0002-1222-3506; Wahlgren, Paula/0000-0001-9645-8021				AVERIN DV, 1990, PHYS REV LETT, V65, P2446, DOI 10.1103/PhysRevLett.65.2446; AVERIN DV, 1986, J LOW TEMP PHYS, V62, P345, DOI 10.1007/BF00683469; BOUCHIAT V, 1997, THESIS U PARIS; CLARKE J, 1989, P IEEE, V77, P1208, DOI 10.1109/5.34120; CLELAND AN, 1992, APPL PHYS LETT, V61, P2820, DOI 10.1063/1.108048; CROMAR MW, 1981, APPL PHYS LETT, V38, P723, DOI 10.1063/1.92472; DOLAN GJ, 1977, APPL PHYS LETT, V31, P337, DOI 10.1063/1.89690; DRESSELHAUS PD, 1994, PHYS REV LETT, V72, P3226, DOI 10.1103/PhysRevLett.72.3226; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; HARADA Y, 1994, APPL PHYS LETT, V65, P636, DOI 10.1063/1.112255; Keller MW, 1996, APPL PHYS LETT, V69, P1804, DOI 10.1063/1.117492; KOCH RH, 1981, APPL PHYS LETT, V38, P380, DOI 10.1063/1.92345; KOROTKOV AN, 1994, PHYS REV B, V49, P10381, DOI 10.1103/PhysRevB.49.10381; KOROTKOV AN, 1992, SPRIN S ELE, V31, P45; KRIVOY GS, 1990, PHYSICA B, V165, P83, DOI 10.1016/S0921-4526(90)80891-L; KRIVOY GS, 1993, J APPL PHYS, V74, P2925, DOI 10.1063/1.354649; LAFARGE P, 1991, Z PHYS B CON MAT, V85, P327, DOI 10.1007/BF01307627; LIKHAREV KK, 1985, J LOW TEMP PHYS, V59, P347, DOI 10.1007/BF00683782; LIKHAREV KK, 1987, IEEE T MAGN, V23, P1142, DOI 10.1109/TMAG.1987.1065001; LIKHAREV KK, 1990, NATO ASI SERIES B, V251; Niemeyer J, 1974, PTB-MITT, V84, P251; Pettersson J, 1996, PHYS REV B, V53, P13272, DOI 10.1103/PhysRevB.53.R13272; STARMARK B, COMMUNICATION; STARMARK B, 1997, 6 INT SUP EL C, V2, P391; VANHARLINGEN DJ, 1982, APPL PHYS LETT, V41, P197, DOI 10.1063/1.93460; Visscher EH, 1996, APPL PHYS LETT, V68, P2014, DOI 10.1063/1.115622; WAHLGREN P, UNPUB; Wei YY, 1997, APPL PHYS LETT, V71, P2514, DOI 10.1063/1.120104; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; ZIMMERLI G, 1992, APPL PHYS LETT, V61, P237, DOI 10.1063/1.108195	31	638	655	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	1998	280	5367					1238	1242		10.1126/science.280.5367.1238	http://dx.doi.org/10.1126/science.280.5367.1238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596572				2022-12-28	WOS:000073852500041
J	Shen, Y; Sheehan, AF; Dueker, KG; de Groot-Hedlin, C; Gilbert, H				Shen, Y; Sheehan, AF; Dueker, KG; de Groot-Hedlin, C; Gilbert, H			Mantle discontinuity structure beneath the southern East Pacific Rise from P-to-S converted phases	SCIENCE			English	Article							ZONE; TOPOGRAPHY	Receiver functions derived from teleseismic body waves recorded by ocean-bottom seismometers on the southern East Pacific Rise reveal shear waves converted from compressional waves at the mantle discontinuities near 410- and 660-kilometer depth. The thickness of the mantle transition zone between the two discontinuities is normal relative to the global average and indicates that upwelling beneath the southern East Pacific Rise is not associated with an excess temperature in the mantle transition zone.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Woods Hole Oceanographic Institution; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; Scripps Institution of Oceanography	Shen, Y (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.		de Groot-Hedlin, Catherine/A-4919-2013; Sheehan, Anne F/B-3954-2014	de Groot-Hedlin, Catherine/0000-0002-3063-2805; Sheehan, Anne F/0000-0002-9629-1687; Shen, Yang/0000-0002-4185-6089; Dueker, Ken G/0000-0002-7601-675X; Gilbert, Hersh/0000-0002-7446-3898				BINA CR, 1994, J GEOPHYS RES-SOL EA, V99, P15853, DOI 10.1029/94JB00462; Bostock MG, 1996, J GEOPHYS RES-SOL EA, V101, P8393, DOI 10.1029/95JB03741; Chaljub E, 1997, GEOPHYS RES LETT, V24, P2613, DOI 10.1029/97GL52693; Dueker KG, 1997, J GEOPHYS RES-SOL EA, V102, P8313, DOI 10.1029/96JB03857; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; KANASEWICH ER, 1973, GEOPHYSICS, V38, P327, DOI 10.1190/1.1440343; Kennett B., 1983, SEISMIC WAVE PROPAGA; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; LANGSTON CA, 1977, B SEISMOL SOC AM, V67, P713; Lee DK, 1996, GEOPHYS RES LETT, V23, P3369, DOI 10.1029/96GL03103; LI A, 1997, EOS FALL S, V78, pF11; LIU L, 1979, EARTH ITS ORIGIN STR, P177; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; OWENS TJ, 1984, J GEOPHYS RES, V89, P7783, DOI 10.1029/JB089iB09p07783; REVENAUGH J, 1991, J GEOPHYS RES-SOL EA, V96, P19781, DOI 10.1029/91JB01487; RITZWOLLER M, 1988, J GEOPHYS RES-SOLID, V93, P6369, DOI 10.1029/JB093iB06p06369; SHEN Y, IN PRESS NATURE; STAMMLER K, 1992, GEOPHYS RES LETT, V19, P1563, DOI 10.1029/92GL01504; SU W, 1992, NATURE, V360, P678; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; TURCOTTE DL, 1993, MANTLE FLOW MELT GEN, P155; VANDERLEE S, 1994, PHYS EARTH PLANET IN, V86, P147, DOI 10.1016/0031-9201(94)05066-X; Vinnik L, 1996, GEOPHYS RES LETT, V23, P2449, DOI 10.1029/96GL02263; WICKS CW, 1993, SCIENCE, V261, P1424, DOI 10.1126/science.261.5127.1424; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230; ZHANG YS, 1992, NATURE, V355, P45, DOI 10.1038/355045a0; ZHONG SJ, 1994, J GEOPHYS RES-SOL EA, V99, P15903, DOI 10.1029/94JB00545	28	51	57	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	1998	280	5367					1232	1235		10.1126/science.280.5367.1232	http://dx.doi.org/10.1126/science.280.5367.1232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZQ351	9596570				2022-12-28	WOS:000073852500039
J	Douglas, C				Douglas, C			Soundings - Join the club	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 16	1998	316	7143					1541	1541		10.1136/bmj.316.7143.1541	http://dx.doi.org/10.1136/bmj.316.7143.1541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP020	9582164	Green Published			2022-12-28	WOS:000073707700091
J	Wang, DG; Fan, JB; Siao, CJ; Berno, A; Young, P; Sapolsky, R; Ghandour, G; Perkins, N; Winchester, E; Spencer, J; Kruglyak, L; Stein, L; Hsie, L; Topaloglou, T; Hubbell, E; Robinson, E; Mittmann, M; Morris, MS; Shen, NP; Kilburn, D; Rioux, J; Nusbaum, C; Rozen, S; Hudson, TJ; Lipshutz, R; Chee, M; Lander, ES				Wang, DG; Fan, JB; Siao, CJ; Berno, A; Young, P; Sapolsky, R; Ghandour, G; Perkins, N; Winchester, E; Spencer, J; Kruglyak, L; Stein, L; Hsie, L; Topaloglou, T; Hubbell, E; Robinson, E; Mittmann, M; Morris, MS; Shen, NP; Kilburn, D; Rioux, J; Nusbaum, C; Rozen, S; Hudson, TJ; Lipshutz, R; Chee, M; Lander, ES			Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome	SCIENCE			English	Article							ARRAYS; HYBRIDIZATION; MAP	Single-nucleotide polymorphisms (SNPs) are the most frequent type of variation in the human genome, and they provide powerful tools for a variety of medical genetic studies. In a large-scale survey for SNPs, 2.3 megabases of human genomic DNA was examined by a combination of gel-based sequencing and high-density variation-detection DNA chips. A total of 3241 candidate SNPs were identified. A genetic map was constructed showing the location of 2227 of these SNPs. Prototype genotyping chips were developed that allow simultaneous genotyping of 500 SNPs. The results provide a characterization of human diversity at the nucleotide level and demonstrate the feasibility of large-scale identification of human SNPs.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Affymetrix Inc, Santa Clara, CA 95051 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Affymetrix	Lipshutz, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Rioux, John D/A-9599-2015; Rozen, Steven G./J-5939-2013	Rioux, John D/0000-0001-7560-8326; Spencer, Jessica/0000-0001-8156-514X; Rozen, Steven G./0000-0002-4288-0056; Hubbell, Earl/0000-0001-7301-3759	NHGRI NIH HHS [HG00098, HG01323] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG001323] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; COOPER DN, 1990, HUM GENET, V85, P55; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; deJong D. H., UNPUB; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KOONTZ WLG, 1972, IEEE T COMPUT, VC 21, P171, DOI 10.1109/TC.1972.5008922; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li W. H, 1997, MOL EVOLUTION; NEI M, 1984, EVOL BIOL, V17, P73; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22	19	1576	1971	3	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	1998	280	5366					1077	1082		10.1126/science.280.5366.1077	http://dx.doi.org/10.1126/science.280.5366.1077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN615	9582121				2022-12-28	WOS:000073663600047
J	Bowman, MA; Nicklin, DE				Bowman, MA; Nicklin, DE			New developments in family medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Penn, Sch Med, Dept Family Practice & Community Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bowman, MA (corresponding author), Univ Penn, Sch Med, Hosp Univ Penn, Dept Family Practice & Community Med, 3400 Spruce St, Philadelphia, PA 19104 USA.		bowman, marjorie a/F-7235-2013	bowman, marjorie a/0000-0002-1945-9212				Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; Holgate ST, 1997, NEW ENGL J MED, V337, P1690, DOI 10.1056/NEJM199712043372312; Kelleher KJ, 1997, ARCH PEDIAT ADOL MED, V151, P1109, DOI 10.1001/archpedi.1997.02170480039006; Koff RS, 1997, ANN INTERN MED, V127, P918, DOI 10.7326/0003-4819-127-10-199711150-00011; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; 1997, MED LETT, V39, P107	15	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	1998	279	18					1437	1438		10.1001/jama.279.18.1437	http://dx.doi.org/10.1001/jama.279.18.1437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL718	9600467				2022-12-28	WOS:000073463500014
J	Bloom, DE				Bloom, DE			Technology, experimentation, and the quality of survey data	SCIENCE			English	Article									Harvard Univ, Inst Int Dev, Cambridge, MA 02138 USA	Harvard University	Bloom, DE (corresponding author), Harvard Univ, Inst Int Dev, Cambridge, MA 02138 USA.							GROSH M, 1995, 120 LSMS WORLD BANK; PENDLETON A, 1984, ASSESSING QUALITY RE; SCHUMAN H, 1981, QUESTIONS ANSWERS AT; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867	4	52	52	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	1998	280	5365					847	848		10.1126/science.280.5365.847	http://dx.doi.org/10.1126/science.280.5365.847			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM380	9599156				2022-12-28	WOS:000073532900024
J	Hall, CD; Dafni, U; Simpson, D; Clifford, D; Wetherill, PE; Cohen, B; McArthur, J; Hollander, H; Yainnoutsos, C; Major, E; Millar, L; Timpone, J				Hall, CD; Dafni, U; Simpson, D; Clifford, D; Wetherill, PE; Cohen, B; McArthur, J; Hollander, H; Yainnoutsos, C; Major, E; Millar, L; Timpone, J		AIDS Clinical Trials Group 243 Team	Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; STEREOTAXIC BRAIN BIOPSY; AIDS; DIAGNOSIS; 3'-AZIDO-3'-DEOXYTHYMIDINE; INTERFERON; REMISSION	Background Progressive multifocal leukoencephalopathy affects about 4 percent of patients with the acquired immunodeficiency syndrome (AIDS), and survival after the diagnosis of leukoencephalopathy averages only about three months. There have been anecdotal reports of improvement but no controlled trials of therapy with antiretroviral treatment plus intravenous or intrathecal cytarabine. Methods In this multicenter trial, 57 patients with human immunodeficiency virus (HIV) infection and biopsy-confirmed progressive multifocal leukoencephalopathy were randomly assigned to receive one of three treatments: antiretroviral therapy alone, antiretroviral therapy plus intravenous cytarabine, or antiretroviral therapy plus intrathecal cytarabine. After a lead-in period of 1 to 2 weeks, active treatment was given for 24 weeks. For most patients, antiretroviral therapy consisted of zidovudine plus either didanosine or stavudine. Results At the time of the last analysis, 14 patients in each treatment group had died, and there were no significant differences in survival among the three groups (P=0.85 by the log-rank test). The median survival times (11, 8, and 15 weeks) were similar to those in previous studies. Only seven patients completed the 24 weeks of treatment. Anemia and thrombocytopenia were more frequent in patients who received antiretroviral therapy in combination with intravenous cytarabine than in the other groups. Conclusions Cytarabine administered either intravenously or intrathecally does not improve the prognosis of HIV-infected patients with progressive multifocal leukoencephalopathy who are treated with the antiretroviral agents we used, nor does high-dose antiretroviral therapy alone appear to improve survival over that reported in untreated patients. (C)1998, Massachusetts Medical Society.	Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; Harvard Univ, Sch Med, Boston, MA USA; Mt Sinai Sch Med, New York, NY USA; Washington Univ, Sch Med, St Louis, MO USA; Yale Univ, Sch Med, New Haven, CT USA; Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; NINDS, Bethesda, MD 20892 USA; Frontier Sci & Technol Res Fdn, Amherst, NY USA; Washington Gen Hosp, Washington, DC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Yale University; Northwestern University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Frontier Science Foundation	Hall, CD (corresponding author), Univ N Carolina, Sch Med, Dept Neurol, CB702, Chapel Hill, NC 27599 USA.		Dafni, Ourania/AAH-4453-2019	Dafni, Ourania/0000-0003-4367-4497	NCRR NIH HHS [RR00036-37] Funding Source: Medline; NINDS NIH HHS [1 PO1 NS3228] Funding Source: Medline; PHS HHS [A1-25868] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; BAUER WR, 1973, JAMA-J AM MED ASSOC, V226, P174, DOI 10.1001/jama.226.2.174; BERGER J, 1992, AM AC NEUR ANN GEN M; Berger Joseph R., 1997, P569; BERGER JR, 1987, ANN INTERN MED, V107, P78, DOI 10.7326/0003-4819-107-1-78; BERGER JR, 1988, NEUROLOGY, V38, P1060, DOI 10.1212/WNL.38.7.1060; BETTS RF, 1975, ANN INTERN MED, V82, P778, DOI 10.7326/0003-4819-82-6-778; BRITTON CB, 1992, NEUROSCIENCE HIV INF, P40; BROOKS BR, 1984, NEUROL CLIN, V2, P299, DOI 10.1016/S0733-8619(18)31105-8; CHAPPELL ET, 1992, NEUROSURGERY, V30, P825, DOI 10.1227/00006123-199206000-00001; COLOSIMO C, 1992, ACTA NEUROL BELG, V92, P24; CONWAY B, 1990, REV INFECT DIS, V12, P479; COUNCIHAN JT, 1996, J NEUROAIDS, V1, P79; DAVIS CM, 1973, JAMA-J AM MED ASSOC, V224, P122; Elliot Bethany C., 1996, P222; EMBREY JR, 1988, J UROLOGY, V139, P580, DOI 10.1016/S0022-5347(17)42533-X; FIALA M, 1988, REV INFECT DIS, V10, P250; FONG IW, 1995, CLIN INFECT DIS, V20, P1305, DOI 10.1093/clinids/20.5.1305; GARROTE FJ, 1990, REV CLIN ESP, V187, P404; HEDLEYWHYTE E, 1966, J NEUROPATH EXP NEUR, V25, P107, DOI 10.1097/00005072-196601000-00007; KARAHALIOS D, 1992, J ACQ IMMUN DEF SYND, V5, P1030; LIDMAN C, 1991, AIDS, V5, P1039, DOI 10.1097/00002030-199108000-00025; Major Eugene O., 1995, P1090; MARRIOTT PJ, 1975, J NEUROL NEUROSUR PS, V38, P205, DOI 10.1136/jnnp.38.3.205; MCGUIRE D, 1995, ANN NEUROL, V37, P395, DOI 10.1002/ana.410370316; MILENO M, 1997, 4 C RETR OPP INF WAS, P129; NICOLI F, 1992, LANCET, V339, P306, DOI 10.1016/0140-6736(92)91376-J; ORIORDAN T, 1990, J INFECTION, V20, P51, DOI 10.1016/S0163-4453(90)92324-E; PADGETT BL, 1971, LANCET, V1, P1257; PORTEGIES P, 1991, LANCET, V337, P680, DOI 10.1016/0140-6736(91)92504-U; RAND KH, 1977, ANN NEUROL, P458; SILVER SA, 1995, ACTA CYTOL, V39, P35; STEIGER MJ, 1993, ANN NEUROL, V33, P407, DOI 10.1002/ana.410330415; URTIZBEREA JA, 1993, 9 INT C AIDS AFF 4 S, P421; WEBER T, 1994, J INFECT DIS, V169, P1138, DOI 10.1093/infdis/169.5.1138; Wolinsky J S, 1976, Trans Am Neurol Assoc, V101, P81; ZAKY DA, 1975, ANTIMICROB AGENTS CH, V7, P229, DOI 10.1128/AAC.7.3.229	37	232	241	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	1998	338	19					1345	1351		10.1056/NEJM199805073381903	http://dx.doi.org/10.1056/NEJM199805073381903			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL720	9571254	Green Published			2022-12-28	WOS:000073463700003
J	Leakey, MG; Feibel, CS; McDougall, I; Ward, C; Walker, A				Leakey, MG; Feibel, CS; McDougall, I; Ward, C; Walker, A			New specimens and confirmation of an early ape for Australopithecus anamensis	NATURE			English	Article							1974-1977 COLLECTIONS; HADAR FORMATION; ETHIOPIA; HOMINID	The discovery of Australopithecus anamensis fossils(1) from strata lying between tephra dated at 4.17 and 4.12 million years ago, and from slightly higher strata not well constrained in age by overlying dated units, provoked the claim that more than one species might be represented: it was suggested that the stratigraphically higher fossils, which include the important tibia, humerus and a large, presumed male, mandible (KNM-KP 29287), might belong to a later, more derived hominid(2). We have recovered new fossils from Kanapoi and Allia Bay Kenya, during field work in 1995-1997 that confirm the primitive status of Austalopithecus anamensis, the earliest species of Australopithecus. Isotope dating confirms A. anamensis' intermediate age as being between those of Ardipithecus ramidus(3,4) and Australopithecus afarensis(5,6). New specimens of maxilla, mandible and capitate show that this species is demonstrably more primitive than A. afarensis. A lower first deciduous molar (dm1) is intermediate in morphology between that reported for Ardipithecus ramidus(4) and A. afarensis(7). Single-crystal 40Ar-39Ar age determinations on the Kanapoi Tuff show that, except for a large mandible, all of the hominid fossils from Kanapoi are from sediments deposited between 4.17 +/- 0.03 and 4.07 +/- 0.02 million years ago.	Natl Museums Kenya, Nairobi, Kenya; Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Missouri, Dept Antropol & Pathol, Columbia, MO 65211 USA; Univ Missouri, Dept Anat Sci, Columbia, MO 65211 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Rutgers State University New Brunswick; Australian National University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Leakey, MG (corresponding author), Natl Museums Kenya, POB 40658, Nairobi, Kenya.	mfgupa@iconnect.co.ke		Ward, Carol/0000-0001-6255-9668				ANDREWS P, 1995, NATURE, V376, P555, DOI 10.1038/376555a0; BUSH ME, 1982, AM J PHYS ANTHROPOL, V57, P651, DOI 10.1002/ajpa.1330570410; Cebula G.T., 1986, TERRA COGNITA, V6, P139; Gould SJ, 1997, NAT HIST, V106, P20; GOULD SJ, 1997, NAT HIST, V106, P69; HAFLEAB B, 1995, GEOCHEMISTRY GEOCHRO; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; KIMBEL WH, 1994, NATURE, V368, P449, DOI 10.1038/368449a0; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; MCDOUGALL I, 1988, GEOCHRONOLOGY THERMO; POWERS DW, 1980, GEOLOGY MIOCENE SEDI; Robinson J.T., 1972, EARLY HOMINID POSTUR; WHITE TD, 1995, NATURE, V375, P88, DOI 10.1038/375088a0; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0	15	197	203	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	1998	393	6680					62	66		10.1038/29972	http://dx.doi.org/10.1038/29972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM028	9590689				2022-12-28	WOS:000073497500046
J	Collins, SL; Knapp, AK; Briggs, JM; Blair, JM; Steinauer, EM				Collins, SL; Knapp, AK; Briggs, JM; Blair, JM; Steinauer, EM			Modulation of diversity by grazing and mowing in native tallgrass prairie	SCIENCE			English	Article							SPECIES COMPOSITION; NITROGEN; FIRE; DETERMINANTS; MANAGEMENT; VEGETATION; RESPONSES; DYNAMICS; GRASS	Species diversity has declined in ecosystems worldwide as a result of habitat fragmentation, eutrophication, and land-use change. If such decline is to be halted ecological mechanisms that restore or maintain biodiversity are needed. Two long-term field experiments were performed in native grassland to assess the effects of fire, nitrogen addition, and grazing or mowing on plant species diversity. In one experiment, richness declined on burned and fertilized treatments, whereas mowing maintained diversity under these conditions. In the second experiment, loss of species diversity due to frequent burning was reversed by bison, a keystone herbivore in North American grasslands. Thus, mowing or the reestablishment of grazing in anthropogenically stressed grasslands enhanced biodiversity.	Natl Sci Fdn, Div Environm Biol, Arlington, VA 22230 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); NSF - Division of Environmental Biology (DEB); Kansas State University; University of Oklahoma System; University of Oklahoma - Norman	Collins, SL (corresponding author), Natl Sci Fdn, Div Environm Biol, 4201 Wilson Blvd, Arlington, VA 22230 USA.	scollins@nsf.gov	Collins, Scott L/P-7742-2014; Blair, John M/I-4082-2014; Knapp, Alan K/A-2931-2008	Collins, Scott L/0000-0002-0193-2892; Blair, John M/0000-0003-0072-0721; 				ABER JD, 1993, ECOL APPL, V3, P156, DOI 10.2307/1941798; BERENDSE F, 1992, BIOL CONSERV, V62, P59, DOI 10.1016/0006-3207(92)91152-I; Blair JM, 1997, ECOLOGY, V78, P2359, DOI 10.1890/0012-9658(1997)078[2359:FNAAPR]2.0.CO;2; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Collins Scott L., 1996, P253; COLLINS SL, 1987, ECOLOGY, V68, P1243, DOI 10.2307/1939208; COLLINS SL, 1995, ECOLOGY, V76, P486, DOI 10.2307/1941207; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; COLLINS SL, 1985, VEGETATIO, V64, P87; COLLINS SL, IN PRESS GRASSLAND D; Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3; DITOMMASO A, 1989, VEGETATIO, V84, P9, DOI 10.1007/BF00054662; GIBSON DJ, 1987, VEGETATIO, V72, P175; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; HARTNETT DC, IN PRESS GRASSLAND D; HOBBS NT, 1991, ECOLOGY, V72, P1374, DOI 10.2307/1941109; Hulbert LC, 1985, PRAIRIE SCOUT, V5, P63; KNAPP AK, IN PRESS GRASSLAND D; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; MCNAUGHTON SJ, 1993, ECOL APPL, V3, P17, DOI 10.2307/1941782; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; PLUMB GE, 1993, ECOL APPL, V3, P631, DOI 10.2307/1942096; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Schulze E.D., 1993, BIODIVERSITY ECOSYST; SEASTEDT TR, 1993, AM NAT, V141, P621, DOI 10.1086/285494; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; Steinauer EM., 1996, PRAIRIE CONSERVATION, P39; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D., 1982, Monographs in Population Biology, pi; Turner CL, 1996, ECOLOGY, V77, P1738, DOI 10.2307/2265779; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vogl RJ., 1974, FIRE ECOSYSTEMS, P139, DOI DOI 10.1016/B978-0-12-424255-5.50010-9; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720	38	703	763	14	494	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	1998	280	5364					745	747		10.1126/science.280.5364.745	http://dx.doi.org/10.1126/science.280.5364.745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563952				2022-12-28	WOS:000073415600050
J	Olson, TM; Michels, VV; Thibodeau, SN; Tai, YS; Keating, MT				Olson, TM; Michels, VV; Thibodeau, SN; Tai, YS; Keating, MT			Actin mutations in dilated cardiomyopathy, a heritable form of heart failure	SCIENCE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; ALPHA-ACTININ; MUSCLE; GENE; EXPRESSION	To test the hypothesis that actin dysfunction leads to heart failure, patients with hereditary idiopathic dilated cardiomyopathy (IDC) were examined for mutations in the cardiac actin gene (ACTC). Missense mutations in ACTC that cosegregate with IDC were identified in two unrelated families. Both mutations affect universally conserved amino acids in domains of actin that attach to Z bands and intercalated discs. Coupled with previous data showing that dystrophin mutations also cause dilated cardiomyopathy, these results raise the possibility that defective transmission of force in cardiac myocytes is a mechanism underlying heart failure.	Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Eccles Inst Human Genet,Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Mayo Clinic; Mayo Clinic; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Olson, TM (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA.				NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHLBI NIH HHS [5-P50-HL-53773] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham WT, 1997, CIRCULATION, V96, P2755, DOI 10.1161/01.CIR.96.9.2755; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203; Gregorio CC, 1997, CELL STRUCT FUNCT, V22, P191, DOI 10.1247/csf.22.191; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P5901, DOI 10.1073/pnas.79.19.5901; HENNESSEY ES, 1993, BIOCHEM J, V282, P657; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KUHLMAN PA, 1992, FEBS LETT, V304, P201, DOI 10.1016/0014-5793(92)80619-R; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; LEVINE BA, 1992, FEBS LETT, V298, P44, DOI 10.1016/0014-5793(92)80019-D; LU MH, 1992, J CELL BIOL, V117, P1007, DOI 10.1083/jcb.117.5.1007; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MESTRONI L, 1994, BRIT HEART J, V72, pS35; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MICHELS VV, 1985, AM J CARDIOL, V55, P1232, DOI 10.1016/0002-9149(85)90675-7; Olson TM, 1997, TRENDS CARDIOVAS MED, V7, P60, DOI 10.1016/S1050-1738(96)00139-9; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITZLOPEZ R, 1997, CIRCULATION, V95, P2434; Reisler E, 1993, CURR OPIN CELL BIOL, V5, P41, DOI 10.1016/S0955-0674(05)80006-7; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; VANDEKERCKHOVE J, 1986, J BIOL CHEM, V261, P1838; Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063	30	530	553	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					750	752		10.1126/science.280.5364.750	http://dx.doi.org/10.1126/science.280.5364.750			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563954				2022-12-28	WOS:000073415600052
J	Quensen, JF; Mueller, SA; Jain, MK; Tiedje, JM				Quensen, JF; Mueller, SA; Jain, MK; Tiedje, JM			Reductive dechlorination of DDE to DDMU in marine sediment microcosms	SCIENCE			English	Article								DDT is reductively dechlorinated to DDD and dehydrochlorinated to DDE; it has been thought that DDE is not degraded further in the environment. Laboratory experiments with DDE-containing marine sediments showed that DDE is dechlorinated to DDMU in both methanogenic and sulfidogenic microcosms and that DDD is dehydrochlorinated to DDMU three orders of magnitude more slowly. Thus, DDD does not appear to be an important precursor of the DDMU found in these sediments. These results imply that remediation decisions and risk assessments based on the recalcitrance of DDE in marine and estuarine sediments should be reevaluated.	MBI Int, Lansing, MI 48909 USA; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University	Quensen, JF (corresponding author), MBI Int, 3900 Collins Rd,POB 27609, Lansing, MI 48909 USA.							LEE HJ, 1994, DISTRIBUTION CHARACT; LIST EJ, 1997, UNPUB EROSION PALOS; LIST EJ, 1997, BIODEGRADATION DDT D; Niedoroda AW, 1996, SCI TOTAL ENVIRON, V179, P109, DOI 10.1016/0048-9697(95)04875-8; QUENSEN JF, 1988, SCIENCE, V242, P752, DOI 10.1126/science.242.4879.752; QUENSEN JF, 1990, APPL ENV MIROBIOL, V56, P2368; ROCHKIND ML, 1986, MICROBIAL DECOMPOSIT, P138; Sayles GD, 1997, ENVIRON SCI TECHNOL, V31, P3448, DOI 10.1021/es9701669; VOGEL TM, 1987, ENVIRON SCI TECHNOL, V21, P722, DOI 10.1021/es00162a001; WEDEMEYER G, 1967, APPL MICROBIOL, V15, P569, DOI 10.1128/AEM.15.3.569-574.1967; World Health Organization (WHO), 1979, ENV HLTH CRIT, V9; [No title captured]	12	134	144	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	1998	280	5364					722	724		10.1126/science.280.5364.722	http://dx.doi.org/10.1126/science.280.5364.722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL268	9563945				2022-12-28	WOS:000073415600043
J	Platt, JL				Platt, JL			New directions for organ transplantation	NATURE			English	Review							HYPERACUTE REJECTION; XENOGRAFT REJECTION; DISCORDANT XENOGRAFTS; LIVER-TRANSPLANTATION; CARDIAC XENOGRAFTS; HEPARAN-SULFATE; COMPLEMENT; TOLERANCE; XENOTRANSPLANTATION; MODEL	Organ transplantation is In many cases the preferred treatment for the chronic failure of the major organs. There has been considerable success in preventing the rejection of transplanted organs, and further Improvements In the outcome of transplantation are in prospect. However, the main limitation on the fullest possible use of organ transplantation is the shortage of donated human organs. One solution to this problem would be xenotransplantation, the use of animals Instead of humans as the source of organs and tissues for transplant. The Immunological barriers to this procedure are now well defined and this review describes the various strategies that are being developed to try to overcome them.	Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Platt, JL (corresponding author), Duke Univ, Med Ctr, Box 2605, Durham, NC 27710 USA.		Platt, Jeffrey/AHB-0480-2022	Platt, Jeffrey/0000-0002-4915-0419				Akhter SA, 1997, P NATL ACAD SCI USA, V94, P12100, DOI 10.1073/pnas.94.22.12100; Allan JS, 1996, NAT MED, V2, P18, DOI 10.1038/nm0196-18; ALTER BJ, 1990, J EXP MED, V171, P333, DOI 10.1084/jem.171.1.333; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Bach FH, 1996, IMMUNOL TODAY, V17, P379, DOI 10.1016/0167-5699(96)10024-4; CALNE RY, 1970, TRANSPL P, V2, P550; CHARI RS, 1994, NEW ENGL J MED, V331, P234, DOI 10.1056/NEJM199407283310404; CHARLTON B, 1994, ANNU REV IMMUNOL, V12, P707, DOI 10.1146/annurev.immunol.12.1.707; CHOPEK MW, 1987, TRANSPLANT P, V19, P4553; COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; Cozzi E., 1997, XENOTRANSPLANTATION, P665; DAGGETT CW, IN PRESS J THOR CARD; Deacon T, 1997, NAT MED, V3, P350, DOI 10.1038/nm0397-350; EVANS RW, 1992, JAMA-J AM MED ASSOC, V267, P239, DOI 10.1001/jama.267.2.239; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; GOOD AH, 1992, TRANSPL P, V24, P559; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Guthrie C., 1912, BLOOD VESSEL SURG IT; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; IHRCKE NS, 1993, IMMUNOL TODAY, V14, P500, DOI 10.1016/0167-5699(93)90265-M; INVERARDI L, 1992, J IMMUNOL, V149, P1416; ISACSON O, 1995, NAT MED, V1, P1189, DOI 10.1038/nm1195-1189; KYPSON AP, IN PRESS J THOR CARD; Lawson JH, 1996, TRANSPLANTATION, V62, P303, DOI 10.1097/00007890-199608150-00001; LEVENTHAL JR, 1993, TRANSPLANTATION, V56, P1, DOI 10.1097/00007890-199307000-00001; LEVENTHAL JR, 1993, TRANSPLANTATION, V55, P857, DOI 10.1097/00007890-199304000-00033; LI H, 1994, TRANSPLANTATION, V57, P592; Lin SS, 1997, TRANSPL IMMUNOL, V5, P212, DOI 10.1016/S0966-3274(97)80040-8; LIN SS, IN PRESS J CLIN INVE; MAGEE JC, 1995, J CLIN INVEST, V96, P2404, DOI 10.1172/JCI118297; Malyguine AM, 1997, J IMMUNOL, V159, P4659; McCurry KR, 1997, HUM IMMUNOL, V58, P91, DOI 10.1016/S0198-8859(97)00229-2; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; MOSES RD, 1992, TRANSPLANTATION, V53, P203, DOI 10.1097/00007890-199201000-00039; NAGAYASU T, 1998, GRAFT, V1, P19; Parker W, 1997, J CLIN IMMUNOL, V17, P311, DOI 10.1023/A:1027378716015; Parker W, 1996, IMMUNOL TODAY, V17, P373, DOI 10.1016/0167-5699(96)10028-1; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; PLATT JL, 1991, TRANSPLANTATION, V52, P214, DOI 10.1097/00007890-199108000-00006; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; PRUITT SK, 1994, TRANSPLANTATION, V57, P363, DOI 10.1097/00007890-199402150-00009; Robson SC, 1996, TRANSPLANTATION, V61, P862, DOI 10.1097/00007890-199603270-00003; SAADI S, 1995, J EXP MED, V182, P1807, DOI 10.1084/jem.182.6.1807; Saadi Soheyla, 1996, P31; Sablinski Tomasz, 1995, Xenotransplantation, V2, P264, DOI 10.1111/j.1399-3089.1995.tb00107.x; Sachs David H., 1995, Xenotransplantation, V2, P234, DOI 10.1111/j.1399-3089.1995.tb00101.x; SANDRIN MS, 1995, NAT MED, V1, P1261, DOI 10.1038/nm1295-1261; Sharma A, 1996, P NATL ACAD SCI USA, V93, P7190, DOI 10.1073/pnas.93.14.7190; STARZL TE, 1993, LANCET, V341, P65, DOI 10.1016/0140-6736(93)92553-6; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Wagner E, 1998, J IMMUNOL, V160, P1936; WALDMANN H, 1993, IMMUNOL TODAY, V14, P247, DOI 10.1016/0167-5699(93)90040-R; WRENSHALL LE, 1995, J IMMUNOL, V154, P871; ZEHR KJ, 1994, TRANSPLANTATION, V57, P900, DOI 10.1097/00007890-199403270-00023; Zhao Y, 1996, NAT MED, V2, P1211, DOI 10.1038/nm1196-1211	56	180	202	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	1998	392	6679		S			11	17						7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZK760	9579856				2022-12-28	WOS:000073360100004
J	Molkentin, JD; Lu, JR; Antos, CL; Markham, B; Richardson, J; Robbins, J; Grant, SR; Olson, EN				Molkentin, JD; Lu, JR; Antos, CL; Markham, B; Richardson, J; Robbins, J; Grant, SR; Olson, EN			A calcineurin-dependent transcriptional pathway for cardiac hypertrophy	CELL			English	Article							NATRIURETIC-PEPTIDE GENE; T-CELL ACTIVATION; MYOCYTES IN-VITRO; HEAVY-CHAIN GENE; PROTEIN-KINASE-C; CYCLOSPORINE-A; FACTOR NFAT1; MECHANICAL-STRESS; NUCLEAR FACTOR; FAMILY MEMBER	In response to numerous pathologic stimuli, the myocardium undergoes a hypertrophic response characterized by increased myocardial cell size and activation of fetal cardiac genes. We show that cardiac hypertrophy is induced by the calcium-dependent phosphatase calcineurin, which dephosphorylates the transcription factor NF-AT3, enabling it to translocate to the nucleus. NF-AT3 interacts with the cardiac zinc finger transcription factor GATA4, resulting in synergistic activation of cardiac transcription. Transgenic mice that express activated forms of calcineurin or NF-AT3 in the heart develop cardiac hypertrophy and heart failure that mimic human heart disease. Pharmacologic inhibition of calcineurin activity blocks hypertrophy in vivo and in vitro. These results define a novel hypertrophic signaling pathway and suggest pharmacologic approaches to prevent cardiac hypertrophy and heart failure.	Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75225 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75225 USA; Childrens Hosp, Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; Univ N Texas, Hlth Sci Ctr, Lab Cardiac & Vasc Mol Genet, Inst Cardiovasc Res, Ft Worth, TX 76107 USA; Warner Lambert Parke Davis, Ann Arbor, MI 48105 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University of North Texas System; University of North Texas Health Science Center; Pfizer	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, 6000 Harry Hines Blvd, Dallas, TX 75225 USA.		Antos, Christopher L/E-8171-2010; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040; Molkentin, Jeffery/0000-0002-3558-6529	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053351] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL053351] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOTINELLI R, 1997, CIRC RES, V82, P106; BUSTAMANTE JO, 1991, J CARDIOVASC PHARM, V17, pS110, DOI 10.1097/00005344-199117002-00024; CHIEN KR, 1993, ANNU REV PHYSIOL, V55, P77, DOI 10.1146/annurev.ph.55.030193.000453; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Evans T, 1997, TRENDS CARDIOVAS MED, V7, P75, DOI 10.1016/S1050-1738(97)00010-8; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; Hasegawa K, 1997, CIRCULATION, V96, P3943; HAVERICH A, 1994, TRANSPLANT P, V26, P2713; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HONGO K, 1995, AM J PHYSIOL-CELL PH, V269, pC690, DOI 10.1152/ajpcell.1995.269.3.C690; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; JONES WK, 1994, DEV DYNAM, V200, P117, DOI 10.1002/aja.1002000204; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARLINER JS, 1990, EXPERIENTIA, V46, P81, DOI 10.1007/BF01955423; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; KovacicMilivojevic B, 1996, ENDOCRINOLOGY, V137, P1108, DOI 10.1210/en.137.3.1108; Kudoh S, 1997, CIRC RES, V80, P139, DOI 10.1161/01.RES.80.1.139; LEGUENNEC JY, 1991, EXP PHYSIOL, V76, P975, DOI 10.1113/expphysiol.1991.sp003560; LEITE MF, 1994, AM J PHYSIOL-HEART C, V267, pH2193, DOI 10.1152/ajpheart.1994.267.6.H2193; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MARBAN E, 1987, P NATL ACAD SCI USA, V84, P6005, DOI 10.1073/pnas.84.16.6005; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Molkentin JD, 1997, CIRCULATION, V96, P3833; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; OGAWA Y, 1995, J MOL MED-JMM, V73, P457; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Palmiter KA, 1997, BASIC RES CARDIOL, V92, P63, DOI 10.1007/BF00794070; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; PERREAULT CL, 1994, AM J PHYSIOL, V266, pH2436, DOI 10.1152/ajpheart.1994.266.6.H2436; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; REID CJ, 1988, BRIT HEART J, V59, P397; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SAEKI Y, 1993, ADV EXP MED BIOL, V332, P639; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; SU QX, 1995, EUR J BIOCHEM, V230, P469, DOI 10.1111/j.1432-1033.1995.0469h.x; THORBURN A, 1993, J BIOL CHEM, V268, P2244; Vikstrom KL, 1996, CURR OPIN CELL BIOL, V8, P97, DOI 10.1016/S0955-0674(96)80053-6; WATKINS H, 1995, HUM MOL GENET, V4, P1721, DOI 10.1093/hmg/4.suppl_1.1721; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0; Woods A, 1994, LAB HISTOPATHOLOGY C; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; Yamazaki T, 1997, CIRCULATION, V95, P1260; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	61	2090	2241	4	111	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 17	1998	93	2					215	228		10.1016/S0092-8674(00)81573-1	http://dx.doi.org/10.1016/S0092-8674(00)81573-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZJ045	9568714	Green Accepted, Bronze			2022-12-28	WOS:000073174000008
J	Casares, F; Mann, RS				Casares, F; Mann, RS			Control of antennal versus leg development in Drosophila	NATURE			English	Article							ECTOPIC EXPRESSION; GENE-EXPRESSION; IMAGINAL DISKS; MELANOGASTER; PROTEIN; SPECIFICATION; EXTRADENTICLE; SEGMENTATION; ORGANIZATION; LOCALIZATION	During the evolution of insects from a millipede-like ancestor, the Hox genes are thought to have promoted the diversification of originally identical body structures(1,2). In Drosophila melanogaster ter, antennae and legs are homologous structures that differ from each other as a result of the Hox gene Antennapedia (Antp), which promotes leg identities by repressing unknown antennal-determining genes(3-7). Here we present four lines of evidence that identify extradenticle (exd) and homothorax (hth) as antennal-determining genes. First, removing the function of exd(8,9) or hth, which is required for the nuclear localization of Exd protein(10), transforms the antenna into leg; such transformations occur without activation of Antp. Second, hth is expressed and Exd is nuclear in most antennal cells, whereas both are restricted to proximal cells of the leg. Third, Antp is a repressor of hth. Fourth, ectopic expression of Meisl, a murine hth homologue(10), can trigger antennal development elsewhere in the fly. Taken together, these data indicate that hth is an antennal selector gene, and that Antp promotes leg development by repressing hth and consequently nuclear Exd.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St,HHSC 1108, New York, NY 10032 USA.		Casares, Fernando/M-5451-2019	Casares, Fernando/0000-0002-2181-3858	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM058575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058575, R01 GM054510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBOTT MK, 1986, GENETICS, V114, P919; AKAM M, 1988, DEVELOPMENT S, P123; Azpiazu N, 1998, GENE DEV, V12, P261, DOI 10.1101/gad.12.2.261; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brower, 1991, DROSOPHILA INFORMATI, V70, P52; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; Casares F, 1997, DEV GENES EVOL, V207, P216, DOI 10.1007/s004270050110; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; Freeland DE, 1996, MECH DEVELOP, V56, P61, DOI 10.1016/0925-4773(96)00511-4; Gehring W., 1966, ARCH JULIUS KALAUSST, V41, P44; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZCRESPO S, 1995, DEVELOPMENT, V121, P2117; GonzalezCrespo S, 1996, DEVELOPMENT, V122, P3921; KAUFMAN TC, 1980, GENETICS, V94, P115; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Pignoni F, 1997, DEVELOPMENT, V124, P271; RAUSKOLB C, 1995, DEVELOPMENT, V121, P3663; RAUSKOLB C, 1993, CELL, V74, P1; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; STEINER E, 1976, ROUX ARCH DEV BIOL, V180, P9, DOI 10.1007/BF00848882; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x	31	244	247	1	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 16	1998	392	6677					723	726		10.1038/33706	http://dx.doi.org/10.1038/33706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZH612	9565034				2022-12-28	WOS:000073129000061
J	Vallance, P				Vallance, P			Separate R & D budget is needed for monitoring effects of new drugs	BRITISH MEDICAL JOURNAL			English	Letter									UCL, Dept Med, Ctr Clin Pharmacol, Cruciform Project, London W1P 9LN, England	University of London; University College London	Vallance, P (corresponding author), UCL, Dept Med, Ctr Clin Pharmacol, Cruciform Project, London W1P 9LN, England.	patrick.vallance@ucl.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 21	1998	316	7135					939	939		10.1136/bmj.316.7135.939b	http://dx.doi.org/10.1136/bmj.316.7135.939b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD691	9552860				2022-12-28	WOS:000072713300065
